data_2j5o_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2j5o _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.588 -0.205 . . . . 0.0 112.588 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.56 -49.75 2.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.141 0.496 . . . . 0.0 110.262 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.69 -50.52 0.08 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.95 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -124.1 95.23 4.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.266 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.3 t70 -122.44 142.46 37.25 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.531 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -37.24 -28.88 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.057 2.505 . . . . 0.0 113.582 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 749' ' ' LEU . . . . . 0.424 HD13 ' NE ' ' A' ' 778' ' ' ARG . 31.6 mt -119.96 -16.87 8.58 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 750' ' ' TYR . . . . . 0.525 ' CE2' ' CG2' ' A' ' 754' ' ' VAL . 72.4 t80 -53.4 -48.54 68.6 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 120.344 -0.543 . . . . 0.0 110.457 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -53.37 -36.15 61.08 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 752' ' ' GLU . . . . . 0.413 ' HB2' ' CD2' ' A' ' 772' ' ' LEU . 1.8 mt-10 -70.95 -40.95 71.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.024 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -63.85 -52.93 57.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.043 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 754' ' ' VAL . . . . . 0.525 ' CG2' ' CE2' ' A' ' 750' ' ' TYR . 8.8 t -56.14 -39.99 62.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.281 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.65 -35.71 75.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.312 0.577 . . . . 0.0 109.461 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 756' ' ' PHE . . . . . 0.499 ' HD2' ' HD3' ' A' ' 771' ' ' LYS . 1.0 OUTLIER -66.58 -46.05 77.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.861 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 757' ' ' VAL . . . . . 0.411 HG12 ' CB ' ' A' ' 763' ' ' ALA . 45.6 t -68.6 -47.1 78.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.973 0.416 . . . . 0.0 110.452 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 8.4 p -53.93 -43.18 69.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.972 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -78.88 -36.81 41.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.361 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 17.9 p -76.63 -15.07 59.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.454 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 63.07 19.9 11.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.696 0.284 . . . . 0.0 111.415 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -154.87 140.03 17.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.844 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 763' ' ' ALA . . . . . 0.411 ' CB ' HG12 ' A' ' 757' ' ' VAL . . . -106.84 89.76 3.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 111.528 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 764' ' ' SER . . . . . 0.496 ' O ' HG21 ' A' ' 768' ' ' VAL . 1.4 m -122.62 118.64 28.66 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 765' ' ' ILE . . . . . 0.434 HG21 ' N ' ' A' ' 780' ' ' ALA . 22.6 mt -53.46 -49.71 52.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.75 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 766' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 12.9 t -53.77 -43.81 69.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.2 0.524 . . . . 0.0 110.578 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -67.86 -45.12 75.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.533 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 768' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 764' ' ' SER . 26.5 t -56.5 -49.15 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.364 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . 0.572 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -63.52 -33.42 75.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.594 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 770' ' ' ARG . . . . . 0.474 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 21.2 mtt180 -70.73 -42.65 70.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.231 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . 0.499 ' HD3' ' HD2' ' A' ' 756' ' ' PHE . 0.0 OUTLIER -78.53 -36.15 45.22 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.522 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 772' ' ' LEU . . . . . 0.413 ' CD2' ' HB2' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -90.87 -10.13 43.77 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp 60.67 41.29 15.34 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 774' ' ' ILE . . . . . 0.572 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 22.6 pt -111.75 -173.88 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.486 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.57 153.75 23.53 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.02 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -56.94 -46.42 82.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 0.0 110.797 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -63.57 -44.52 93.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.799 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . 0.424 ' NE ' HD13 ' A' ' 749' ' ' LEU . 0.4 OUTLIER -62.06 -50.22 72.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.753 179.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -58.34 -48.54 80.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.092 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 780' ' ' ALA . . . . . 0.434 ' N ' HG21 ' A' ' 765' ' ' ILE . . . -56.07 -43.43 77.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.899 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -59.12 -48.53 81.26 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.855 0.359 . . . . 0.0 110.125 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 782' ' ' MET . . . . . . . . . . . . . 2.7 mtp -63.7 -38.31 90.62 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 783' ' ' ILE . . . . . 0.479 ' CG2' ' NH2' ' A' ' 801' ' ' ARG . 7.8 mm -61.31 -40.53 86.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.259 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -44.19 91.21 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.431 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -58.97 -33.65 70.91 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.92 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 786' ' ' MET . . . . . 0.479 ' HG2' HG21 ' A' ' 754' ' ' VAL . 14.0 mtm -66.46 -37.73 85.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.106 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 787' ' ' GLU . . . . . 0.455 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 2.5 mt-10 -62.46 -54.17 44.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.519 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 73.4 mtp -68.07 -38.22 82.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.473 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -70.14 -21.57 63.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.955 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 89.79 16.85 55.78 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.85 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.478 ' C ' HG13 ' A' ' 804' ' ' ILE . 44.8 t -81.93 -31.68 10.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.796 0.331 . . . . 0.0 110.887 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 792' ' ' VAL . . . . . 0.447 HG23 ' CB ' ' A' ' 786' ' ' MET . 7.1 m -135.59 140.76 43.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.074 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 793' ' ' THR . . . . . 0.466 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 9.4 p -78.59 159.69 73.87 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.737 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 794' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 19.3 Cg_endo -59.49 167.25 6.65 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.049 1.832 . . . . 0.0 111.824 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -59.5 163.57 4.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.036 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -105.56 176.55 5.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.859 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 5.4 t -57.27 -30.33 64.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.796 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -88.13 -17.63 30.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.048 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.92 36.71 3.61 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.664 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 17.1 m -127.88 129.13 46.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.906 0.384 . . . . 0.0 111.267 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 801' ' ' ARG . . . . . 0.479 ' NH2' ' CG2' ' A' ' 783' ' ' ILE . 6.7 mtp85 -83.64 170.36 14.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.287 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 802' ' ' GLU . . . . . 0.447 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 3.2 mt-10 -134.87 174.2 10.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.698 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 803' ' ' VAL . . . . . . . . . . . . . 20.7 t -109.74 136.25 46.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.06 0.457 . . . . 0.0 112.13 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 804' ' ' ILE . . . . . 0.478 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -109.78 -26.94 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.264 178.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 805' ' ' ALA . . . . . . . . . . . . . . . -76.32 122.59 87.04 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.041 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -50.26 163.96 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.604 2.203 . . . . 0.0 112.897 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.137 179.99 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.606 -0.198 . . . . 0.0 112.606 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 4.5 m -121.55 -62.68 1.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.122 0.487 . . . . 0.0 110.392 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -145.41 -49.16 0.23 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.234 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.62 95.23 4.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.556 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.9 t70 -122.48 142.31 36.96 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.373 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -38.51 -27.45 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.848 2.366 . . . . 0.0 113.513 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 749' ' ' LEU . . . . . . . . . . . . . 48.4 mt -120.01 -17.02 8.52 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 750' ' ' TYR . . . . . 0.505 ' CE2' ' CG2' ' A' ' 754' ' ' VAL . 65.3 t80 -55.62 -46.82 77.33 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.349 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -53.38 -35.67 60.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -71.02 -43.7 67.38 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.161 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -61.92 -51.7 67.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.206 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 754' ' ' VAL . . . . . 0.571 HG21 ' HG2' ' A' ' 786' ' ' MET . 2.3 t -56.33 -42.25 73.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.261 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -69.16 -35.4 76.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.192 0.52 . . . . 0.0 109.909 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 756' ' ' PHE . . . . . 0.406 ' CE2' ' CG2' ' A' ' 768' ' ' VAL . 2.3 t80 -66.58 -45.93 77.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.922 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 757' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.2 -44.56 80.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.926 0.393 . . . . 0.0 110.951 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 3.9 p -58.21 -43.73 87.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.295 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.76 -43.23 26.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.433 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 760' ' ' SER . . . . . 0.417 ' HB2' ' NE ' ' A' ' 762' ' ' ARG . 83.1 p -71.93 -19.96 61.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.039 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 63.52 50.63 2.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.599 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 762' ' ' ARG . . . . . 0.417 ' NE ' ' HB2' ' A' ' 760' ' ' SER . 0.0 OUTLIER 179.81 139.61 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.49 179.399 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 763' ' ' ALA . . . . . . . . . . . . . . . -108.75 89.73 3.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.989 0.423 . . . . 0.0 111.597 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 764' ' ' SER . . . . . 0.492 ' O ' HG21 ' A' ' 768' ' ' VAL . 0.7 OUTLIER -125.54 118.44 25.75 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.705 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 765' ' ' ILE . . . . . 0.416 HG21 ' N ' ' A' ' 780' ' ' ALA . 2.3 mp -53.16 -51.3 40.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.897 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 766' ' ' SER . . . . . 0.45 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 12.4 t -53.42 -41.84 66.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.116 0.484 . . . . 0.0 110.622 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -70.02 -42.96 72.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.536 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 768' ' ' VAL . . . . . 0.492 HG21 ' O ' ' A' ' 764' ' ' SER . 45.6 t -59.03 -47.14 90.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.268 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . 0.572 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.7 OUTLIER -65.56 -33.55 76.19 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.694 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 770' ' ' ARG . . . . . 0.464 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 0.4 OUTLIER -68.26 -42.78 79.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.093 179.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.62 -42.06 29.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.806 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 772' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 768' ' ' VAL . 0.2 OUTLIER -85.02 -8.54 58.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.742 -179.522 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt 58.29 41.94 22.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.185 0.517 . . . . 0.0 109.75 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 774' ' ' ILE . . . . . 0.572 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 29.9 pt -112.01 -173.91 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.789 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -91.87 152.52 21.43 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.872 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -57.91 -46.57 84.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.886 0.374 . . . . 0.0 110.838 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -57.49 -47.51 81.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.13 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -50.31 63.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.909 0.385 . . . . 0.0 110.773 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 779' ' ' ALA . . . . . 0.401 ' HB2' ' CD1' ' A' ' 774' ' ' ILE . . . -54.6 -50.05 68.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.658 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 780' ' ' ALA . . . . . 0.416 ' N ' HG21 ' A' ' 765' ' ' ILE . . . -58.85 -42.95 90.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.826 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -58.97 -48.38 81.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.108 0.48 . . . . 0.0 109.814 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 782' ' ' MET . . . . . 0.407 ' SD ' ' N ' ' A' ' 750' ' ' TYR . 34.8 mtm -65.27 -34.88 79.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.497 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 783' ' ' ILE . . . . . 0.424 ' CD1' HG22 ' A' ' 768' ' ' VAL . 6.5 mm -64.21 -37.27 79.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -64.47 -39.45 93.83 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.452 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -60.68 -34.32 74.15 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.418 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 786' ' ' MET . . . . . 0.571 ' HG2' HG21 ' A' ' 754' ' ' VAL . 14.4 mtm -66.81 -39.96 87.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.992 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -59.59 -54.18 49.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.708 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 68.4 mtm -68.92 -38.29 79.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.147 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -66.54 -21.51 66.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.728 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 91.39 14.14 57.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.903 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.437 ' C ' HG13 ' A' ' 804' ' ' ILE . 24.0 t -84.27 -30.4 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.817 0.341 . . . . 0.0 110.85 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 792' ' ' VAL . . . . . 0.463 HG22 ' NH1' ' A' ' 801' ' ' ARG . 17.7 m -136.83 141.1 41.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.538 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 793' ' ' THR . . . . . 0.47 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 6.2 p -82.61 160.28 61.95 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.818 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 794' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 20.7 Cg_endo -60.05 166.64 8.51 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.137 1.891 . . . . 0.0 112.15 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 2.6 mtt -65.5 163.26 16.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.116 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -105.48 176.55 5.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 7.3 t -58.34 -34.6 70.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -82.01 -17.5 46.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.124 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 100.82 34.6 4.59 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.608 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 15.8 m -124.68 129.06 49.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.971 0.415 . . . . 0.0 111.061 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 801' ' ' ARG . . . . . 0.463 ' NH1' HG22 ' A' ' 792' ' ' VAL . 10.4 mtt-85 -89.9 170.71 10.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.441 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 802' ' ' GLU . . . . . 0.412 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 0.1 OUTLIER -134.14 169.82 16.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.071 179.15 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 803' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 792' ' ' VAL . 21.5 t -109.94 136.19 46.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.993 0.425 . . . . 0.0 111.718 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 804' ' ' ILE . . . . . 0.437 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -104.92 -30.53 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.261 179.083 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 805' ' ' ALA . . . . . . . . . . . . . . . -75.46 127.59 85.79 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.887 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.62 163.85 25.93 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.744 2.296 . . . . 0.0 112.159 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.243 -179.836 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.635 -0.186 . . . . 0.0 112.635 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 1.1 m -126.37 -51.11 1.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.108 0.48 . . . . 0.0 110.542 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -154.94 -51.06 0.09 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.435 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -124.9 95.39 4.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.502 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.49 142.32 37.01 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.41 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 748' ' ' PRO . . . . . 0.4 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 44.2 Cg_exo -36.01 -29.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.094 2.53 . . . . 0.0 113.692 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 749' ' ' LEU . . . . . 0.451 HD21 HD22 ' A' ' 772' ' ' LEU . 39.9 mt -120.09 -17.12 8.45 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 750' ' ' TYR . . . . . 0.521 ' CZ ' ' CG2' ' A' ' 754' ' ' VAL . 69.2 t80 -54.94 -47.67 74.16 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.29 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -53.2 -36.71 61.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 752' ' ' GLU . . . . . 0.503 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 4.1 tp10 -70.97 -43.39 68.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.352 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -61.51 -52.39 64.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.086 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 754' ' ' VAL . . . . . 0.521 ' CG2' ' CZ ' ' A' ' 750' ' ' TYR . 4.0 t -56.15 -39.93 61.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.939 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -67.93 -36.1 79.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.387 0.613 . . . . 0.0 109.545 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 756' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 771' ' ' LYS . 4.4 t80 -66.59 -46.21 76.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.076 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 757' ' ' VAL . . . . . 0.414 HG12 ' CB ' ' A' ' 763' ' ' ALA . 57.6 t -69.52 -44.64 79.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.866 0.365 . . . . 0.0 110.798 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 4.8 p -55.26 -44.18 75.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.773 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -78.78 -31.63 46.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.27 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 24.3 p -81.02 -14.69 57.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.57 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.95 16.1 8.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.633 0.254 . . . . 0.0 111.504 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.83 142.31 22.59 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.701 0.286 . . . . 0.0 110.741 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 763' ' ' ALA . . . . . 0.414 ' CB ' HG12 ' A' ' 757' ' ' VAL . . . -109.24 89.93 3.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.852 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 764' ' ' SER . . . . . 0.554 ' O ' HG21 ' A' ' 768' ' ' VAL . 63.7 m -121.02 118.57 30.15 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 765' ' ' ILE . . . . . 0.43 HG12 ' HA ' ' A' ' 780' ' ' ALA . 14.8 mt -54.15 -48.9 65.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.622 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 766' ' ' SER . . . . . 0.406 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 23.2 t -54.85 -42.25 71.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.229 0.537 . . . . 0.0 110.368 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -69.88 -40.25 75.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.584 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 768' ' ' VAL . . . . . 0.554 HG21 ' O ' ' A' ' 764' ' ' SER . 39.0 t -61.59 -46.66 96.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.212 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . 0.572 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.15 -34.07 77.51 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.618 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 770' ' ' ARG . . . . . 0.49 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 12.6 mtt180 -71.0 -42.19 69.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.131 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . 0.408 ' HB2' ' CE1' ' A' ' 756' ' ' PHE . 0.1 OUTLIER -78.56 -36.06 45.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.961 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 772' ' ' LEU . . . . . 0.503 ' CD2' ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -91.23 -9.92 43.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.755 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt 59.76 41.55 18.13 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 774' ' ' ILE . . . . . 0.572 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 20.7 pt -111.82 -174.01 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.345 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.79 150.97 21.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.013 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -54.94 -45.87 74.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.948 0.404 . . . . 0.0 110.748 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -62.96 -45.39 92.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.764 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.18 -50.31 72.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.762 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.53 -50.63 71.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.395 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 780' ' ' ALA . . . . . 0.43 ' HA ' HG12 ' A' ' 765' ' ' ILE . . . -55.99 -39.3 71.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.759 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -59.0 -48.38 81.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.897 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 782' ' ' MET . . . . . 0.449 ' CE ' ' CB ' ' A' ' 749' ' ' LEU . 0.0 OUTLIER -63.45 -44.68 93.81 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.78 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 783' ' ' ILE . . . . . 0.475 ' CG2' ' NH2' ' A' ' 801' ' ' ARG . 16.9 mm -54.69 -44.59 70.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.492 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.02 -46.63 82.2 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.424 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -58.17 -33.54 69.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.888 178.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 786' ' ' MET . . . . . 0.506 ' HG2' HG21 ' A' ' 754' ' ' VAL . 13.2 mtm -66.11 -37.59 86.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.131 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 787' ' ' GLU . . . . . 0.457 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 2.8 mt-10 -63.32 -53.86 46.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.13 0.491 . . . . 0.0 110.526 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 63.2 mtp -67.16 -38.01 84.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.352 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 789' ' ' ALA . . . . . 0.404 ' HB3' HG22 ' A' ' 791' ' ' VAL . . . -71.09 -21.51 62.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.973 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 89.35 18.33 53.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.863 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.485 ' C ' HG13 ' A' ' 804' ' ' ILE . 41.0 t -83.45 -32.05 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.797 0.332 . . . . 0.0 110.85 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 792' ' ' VAL . . . . . 0.448 HG23 ' CB ' ' A' ' 786' ' ' MET . 8.4 m -135.34 142.08 40.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.1 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 793' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.2 p -80.99 160.61 65.65 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.773 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 794' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 18.6 Cg_endo -58.26 167.38 4.75 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.04 1.826 . . . . 0.0 111.93 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 1.2 mtt -60.12 163.37 4.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.045 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 37.8 m-20 -103.83 176.5 5.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.876 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 5.4 t -57.73 -31.02 66.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -87.08 -17.5 32.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.128 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 102.86 35.98 3.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.748 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 15.3 m -127.77 129.53 47.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.947 0.403 . . . . 0.0 111.137 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 801' ' ' ARG . . . . . 0.475 ' NH2' ' CG2' ' A' ' 783' ' ' ILE . 6.7 mtp85 -82.23 170.57 15.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.181 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -132.85 178.2 7.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.637 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 803' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 792' ' ' VAL . 19.9 t -116.21 134.07 60.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.102 0.477 . . . . 0.0 112.218 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 804' ' ' ILE . . . . . 0.485 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -104.73 -29.38 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.767 178.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 805' ' ' ALA . . . . . . . . . . . . . . . -79.86 123.42 83.78 Favored Pre-proline 0 N--CA 1.451 -0.401 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.463 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.2 163.74 22.09 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.483 2.122 . . . . 0.0 112.163 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.094 -179.77 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.74 -74.38 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.98 0.419 . . . . 0.0 110.636 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -134.0 -48.29 0.8 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.558 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -125.29 95.43 4.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.751 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . 0.477 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.4 t70 -122.27 141.89 35.62 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.373 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -36.5 -29.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.125 2.55 . . . . 0.0 113.706 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 749' ' ' LEU . . . . . 0.448 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 53.5 mt -120.02 -17.26 8.46 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 750' ' ' TYR . . . . . 0.496 ' CZ ' ' CG2' ' A' ' 754' ' ' VAL . 65.9 t80 -55.88 -46.95 78.18 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.678 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -53.26 -36.06 60.72 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 752' ' ' GLU . . . . . 0.536 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 0.0 OUTLIER -71.15 -45.41 63.6 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.138 178.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -59.22 -52.86 63.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.3 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 754' ' ' VAL . . . . . 0.561 HG21 ' HG2' ' A' ' 786' ' ' MET . 2.4 t -56.17 -42.29 72.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.958 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 37.5 mtt180 -66.88 -35.41 79.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.322 0.582 . . . . 0.0 109.692 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 756' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -66.66 -46.05 76.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.911 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 757' ' ' VAL . . . . . 0.412 ' CG1' HG13 ' A' ' 792' ' ' VAL . 40.8 t -70.28 -44.11 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.992 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 5.1 p -57.54 -42.82 83.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.953 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.86 -40.85 31.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.26 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 21.1 p -73.86 -18.68 60.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.246 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 63.16 28.58 15.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.183 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -157.49 131.18 7.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 763' ' ' ALA . . . . . . . . . . . . . . . -102.35 89.84 3.7 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.973 0.416 . . . . 0.0 111.253 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 764' ' ' SER . . . . . 0.496 ' O ' HG21 ' A' ' 768' ' ' VAL . 1.0 OUTLIER -126.08 118.64 25.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.434 179.082 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 765' ' ' ILE . . . . . 0.441 HG21 ' N ' ' A' ' 780' ' ' ALA . 23.2 mt -53.05 -50.64 44.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.822 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 766' ' ' SER . . . . . 0.417 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 47.5 t -53.3 -43.56 67.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.207 0.527 . . . . 0.0 110.659 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.78 76.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.634 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 768' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 764' ' ' SER . 40.1 t -58.67 -47.25 89.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.291 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . 0.568 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.8 OUTLIER -65.64 -33.34 75.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.679 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 770' ' ' ARG . . . . . 0.46 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 14.9 mtt180 -69.05 -42.22 76.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.109 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 7.4 tptt -78.6 -42.18 29.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.911 0.386 . . . . 0.0 111.688 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 772' ' ' LEU . . . . . 0.536 ' CD2' ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -84.81 -9.09 58.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.854 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt 57.7 42.75 23.25 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 774' ' ' ILE . . . . . 0.568 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 24.7 pt -111.8 -173.92 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.73 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -91.08 151.31 21.01 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.074 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -56.53 -46.59 80.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.935 0.397 . . . . 0.0 110.778 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -59.51 -44.63 93.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.069 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.18 -50.34 61.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.888 0.375 . . . . 0.0 110.869 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.1 -48.59 75.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.269 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 780' ' ' ALA . . . . . 0.441 ' N ' HG21 ' A' ' 765' ' ' ILE . . . -56.2 -45.98 79.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.901 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 -58.92 -48.5 81.24 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.059 0.457 . . . . 0.0 110.333 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 782' ' ' MET . . . . . . . . . . . . . 32.7 mtm -64.84 -34.96 79.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.884 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 783' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 786' ' ' MET . 7.7 mm -65.38 -38.56 82.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.199 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -63.65 -38.82 92.56 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.472 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -61.75 -34.28 75.56 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.37 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 786' ' ' MET . . . . . 0.561 ' HG2' HG21 ' A' ' 754' ' ' VAL . 13.9 mtm -66.68 -39.13 88.01 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.087 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -61.18 -54.04 49.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.663 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 49.6 mtm -68.46 -37.95 80.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.158 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -67.11 -21.5 65.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.716 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 90.93 18.29 47.88 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.835 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.458 ' C ' HG13 ' A' ' 804' ' ' ILE . 21.7 t -88.57 -30.33 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.76 0.314 . . . . 0.0 111.122 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 792' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 803' ' ' VAL . 19.4 m -137.38 137.69 45.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.419 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 793' ' ' THR . . . . . . . . . . . . . 1.1 p -85.07 159.98 55.92 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.845 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 794' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -52.12 172.09 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.267 1.978 . . . . 0.0 112.368 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.02 164.99 24.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.98 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -105.52 176.48 5.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.852 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 3.2 t -60.67 -34.73 74.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -79.27 -17.57 54.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 102.74 29.14 5.98 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.514 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 9.8 m -123.68 129.93 51.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 111.053 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 801' ' ' ARG . . . . . 0.42 ' NH1' HG22 ' A' ' 792' ' ' VAL . 7.1 mtt-85 -85.34 170.66 12.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.186 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -128.64 167.19 17.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.104 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 803' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 792' ' ' VAL . 22.0 t -110.47 135.06 50.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.921 0.391 . . . . 0.0 111.558 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 804' ' ' ILE . . . . . 0.458 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -103.58 -27.76 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.251 179.178 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 805' ' ' ALA . . . . . 0.423 ' CB ' ' HA ' ' A' ' 791' ' ' VAL . . . -82.85 123.54 77.89 Favored Pre-proline 0 N--CA 1.453 -0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.887 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.4 163.7 28.65 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.608 2.205 . . . . 0.0 112.167 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.162 -179.86 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 N-CA-C 112.587 -0.205 . . . . 0.0 112.587 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 64.8 m -117.29 -46.68 2.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.153 0.501 . . . . 0.0 110.15 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -159.97 -49.48 0.05 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.132 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -126.0 95.16 4.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.386 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . 0.493 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 13.2 t70 -122.47 143.33 39.39 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.335 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 748' ' ' PRO . . . . . 0.404 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 46.8 Cg_exo -37.7 -28.04 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.044 2.496 . . . . 0.0 113.563 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 749' ' ' LEU . . . . . 0.42 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 28.5 mt -119.97 -17.08 8.53 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 750' ' ' TYR . . . . . 0.514 ' CE2' ' CG2' ' A' ' 754' ' ' VAL . 80.1 t80 -52.61 -50.17 63.62 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.503 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -53.07 -36.54 60.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -70.95 -40.76 71.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.966 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -63.84 -53.38 51.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.075 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 754' ' ' VAL . . . . . 0.514 ' CG2' ' CE2' ' A' ' 750' ' ' TYR . 8.0 t -56.15 -39.39 58.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.301 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 755' ' ' ARG . . . . . 0.401 ' HA ' ' OG1' ' A' ' 758' ' ' THR . 70.2 mtt180 -70.14 -36.83 75.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.231 0.539 . . . . 0.0 109.711 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 756' ' ' PHE . . . . . 0.456 ' CE1' ' CG2' ' A' ' 768' ' ' VAL . 1.0 OUTLIER -66.77 -46.19 76.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.676 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 757' ' ' VAL . . . . . 0.449 HG12 ' CB ' ' A' ' 763' ' ' ALA . 61.5 t -69.29 -42.94 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 110.775 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 758' ' ' THR . . . . . 0.401 ' OG1' ' HA ' ' A' ' 755' ' ' ARG . 8.0 p -56.78 -44.57 81.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.85 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -78.82 -33.5 46.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.241 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 760' ' ' SER . . . . . 0.427 ' HB3' ' O ' ' A' ' 756' ' ' PHE . 18.5 p -74.69 -16.39 60.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.244 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 64.72 15.03 9.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.436 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.71 143.01 21.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.445 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 763' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 801' ' ' ARG . . . -107.74 89.62 3.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.883 0.373 . . . . 0.0 111.941 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 764' ' ' SER . . . . . 0.55 ' O ' HG21 ' A' ' 768' ' ' VAL . 1.3 m -118.97 118.47 31.58 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 765' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 780' ' ' ALA . 14.7 mt -54.1 -48.6 65.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.506 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 766' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 16.7 p -55.08 -42.15 72.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.303 0.573 . . . . 0.0 110.538 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -70.51 -40.91 73.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.571 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 768' ' ' VAL . . . . . 0.55 HG21 ' O ' ' A' ' 764' ' ' SER . 48.2 t -59.64 -47.86 89.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . 0.563 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.21 -33.9 77.1 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.804 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 770' ' ' ARG . . . . . 0.479 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 15.9 mtt180 -69.35 -42.42 75.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.184 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . 0.4 ' HD3' ' HE2' ' A' ' 756' ' ' PHE . 2.3 tptt -78.63 -40.03 35.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.829 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 772' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 768' ' ' VAL . 0.1 OUTLIER -86.69 -9.66 55.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.847 -179.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp 60.92 40.6 15.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.019 0.438 . . . . 0.0 109.874 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 774' ' ' ILE . . . . . 0.563 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 21.1 pt -111.85 -173.86 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.542 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.91 150.27 20.93 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.028 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -54.72 -45.12 74.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.966 0.412 . . . . 0.0 110.722 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -63.85 -47.82 79.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.873 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.06 -50.31 74.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.935 0.398 . . . . 0.0 110.716 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -55.99 -48.67 75.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.272 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 780' ' ' ALA . . . . . 0.435 ' HA ' HG12 ' A' ' 765' ' ' ILE . . . -56.2 -41.67 75.95 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.003 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 17.4 mtm-85 -58.87 -47.31 85.38 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 782' ' ' MET . . . . . . . . . . . . . 2.3 mtp -63.61 -42.91 98.18 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 783' ' ' ILE . . . . . 0.451 ' CG2' ' NH1' ' A' ' 801' ' ' ARG . 9.9 mm -57.5 -37.68 59.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.71 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -62.31 -45.88 91.25 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.43 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -58.12 -33.59 69.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.805 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 786' ' ' MET . . . . . 0.51 ' HG2' HG21 ' A' ' 754' ' ' VAL . 13.2 mtm -66.49 -39.65 88.86 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.476 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.58 -49.68 74.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.12 0.486 . . . . 0.0 110.518 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 32.2 mtm -70.57 -36.92 73.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.371 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -71.25 -21.53 62.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.123 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 92.05 19.75 38.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.693 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.516 ' HA ' ' CB ' ' A' ' 805' ' ' ALA . 63.2 t -88.94 -30.47 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 122.517 0.327 . . . . 0.0 111.092 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 792' ' ' VAL . . . . . 0.44 ' CG2' ' HB3' ' A' ' 786' ' ' MET . 20.4 m -139.33 142.79 32.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.53 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 793' ' ' THR . . . . . 0.511 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.2 p -85.24 164.69 40.01 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 794' ' ' PRO . . . . . 0.511 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 29.5 Cg_endo -61.94 164.65 16.05 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 121.989 1.793 . . . . 0.0 112.003 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.67 162.48 3.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.329 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -105.18 176.5 5.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.743 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 15.3 t -63.18 -32.64 74.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -80.66 -17.64 50.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.231 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 102.48 28.56 6.31 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.364 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 57.5 m -125.75 130.75 52.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.988 0.423 . . . . 0.0 110.919 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 801' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 763' ' ' ALA . 15.4 mtt-85 -84.25 170.7 13.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.44 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -129.68 167.73 17.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.992 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 803' ' ' VAL . . . . . 0.444 HG23 ' CG1' ' A' ' 757' ' ' VAL . 11.9 t -108.8 139.19 32.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.004 0.431 . . . . 0.0 112.076 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 804' ' ' ILE . . . . . 0.471 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -110.84 -27.96 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.454 178.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 805' ' ' ALA . . . . . 0.516 ' CB ' ' HA ' ' A' ' 791' ' ' VAL . . . -77.97 121.05 83.51 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.078 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -50.29 163.94 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.731 2.287 . . . . 0.0 112.916 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.552 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.997 179.824 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 743' ' ' GLY . . . . . 0.434 ' CA ' ' HG3' ' A' ' 782' ' ' MET . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.72 -158.92 0.65 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.579 0.228 . . . . 0.0 110.626 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -51.91 -42.97 63.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.842 0.353 . . . . 0.0 111.329 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.01 95.42 4.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.059 0.456 . . . . 0.0 110.911 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . 0.477 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 12.1 t70 -122.61 142.52 37.68 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.647 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 748' ' ' PRO . . . . . 0.401 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 43.0 Cg_exo -37.49 -28.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.034 2.49 . . . . 0.0 113.672 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 749' ' ' LEU . . . . . 0.506 HD21 HD22 ' A' ' 772' ' ' LEU . 40.6 mt -119.93 -17.27 8.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 750' ' ' TYR . . . . . 0.516 ' CE2' HG22 ' A' ' 754' ' ' VAL . 64.5 t80 -53.81 -47.42 70.86 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.67 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -53.34 -37.41 62.31 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 752' ' ' GLU . . . . . 0.592 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 0.7 OUTLIER -70.9 -39.95 72.48 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.264 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 753' ' ' ALA . . . . . 0.46 ' HB2' ' CE ' ' A' ' 782' ' ' MET . . . -63.89 -54.35 36.11 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.217 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 754' ' ' VAL . . . . . 0.54 HG21 ' HG2' ' A' ' 786' ' ' MET . 4.3 t -56.19 -38.3 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.01 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 53.8 ttt85 -69.53 -36.58 76.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.646 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 756' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -67.07 -46.11 75.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.189 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 757' ' ' VAL . . . . . 0.557 HG12 ' CA ' ' A' ' 763' ' ' ALA . 39.0 t -70.28 -45.42 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 120.928 0.394 . . . . 0.0 110.715 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 17.8 p -53.78 -44.18 69.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.815 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.96 -35.55 50.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.347 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 16.7 p -78.51 -14.98 59.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.45 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 63.46 19.86 11.93 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.727 0.299 . . . . 0.0 111.348 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -152.72 143.78 23.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.569 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 763' ' ' ALA . . . . . 0.557 ' CA ' HG12 ' A' ' 757' ' ' VAL . . . -115.47 89.93 3.22 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 764' ' ' SER . . . . . 0.537 ' O ' HG21 ' A' ' 768' ' ' VAL . 7.3 m -120.96 118.31 29.53 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 765' ' ' ILE . . . . . 0.44 HG21 ' N ' ' A' ' 780' ' ' ALA . 21.2 mt -51.12 -46.06 31.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.525 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 766' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 11.7 p -58.53 -39.19 79.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.347 0.594 . . . . 0.0 110.393 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -72.39 -35.94 68.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.481 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 768' ' ' VAL . . . . . 0.537 HG21 ' O ' ' A' ' 764' ' ' SER . 40.3 t -66.88 -47.28 83.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.384 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . 0.598 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.57 -33.97 77.15 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.845 0.355 . . . . 0.0 110.599 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 19.0 mtt-85 -70.62 -42.16 71.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.985 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.61 -36.95 43.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.297 -0.41 . . . . 0.0 112.095 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 772' ' ' LEU . . . . . 0.592 ' CD2' ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -89.8 -10.65 44.69 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp 61.61 40.43 13.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.237 0.541 . . . . 0.0 109.55 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 774' ' ' ILE . . . . . 0.598 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 23.6 pt -111.75 -174.53 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.381 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.15 150.08 21.17 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.163 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -54.11 -45.85 71.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 110.776 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -63.03 -47.54 82.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.854 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . 0.407 ' NE ' HD13 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -59.94 -49.6 77.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.755 179.821 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 779' ' ' ALA . . . . . 0.402 ' HB2' ' CD1' ' A' ' 774' ' ' ILE . . . -57.02 -50.0 74.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.57 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 780' ' ' ALA . . . . . 0.44 ' N ' HG21 ' A' ' 765' ' ' ILE . . . -56.02 -40.76 73.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.584 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.74 -48.02 82.64 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.994 0.426 . . . . 0.0 109.913 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 782' ' ' MET . . . . . 0.46 ' CE ' ' HB2' ' A' ' 753' ' ' ALA . 2.0 mtp -62.78 -43.72 98.07 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 783' ' ' ILE . . . . . 0.484 ' CG2' ' NH2' ' A' ' 801' ' ' ARG . 12.4 mm -57.16 -40.59 74.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.456 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.7 -45.43 92.15 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.439 ' HB3' ' CE1' ' A' ' 750' ' ' TYR . . . -59.63 -33.37 71.43 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.79 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 786' ' ' MET . . . . . 0.54 ' HG2' HG21 ' A' ' 754' ' ' VAL . 13.3 mtm -64.96 -37.63 88.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.063 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 787' ' ' GLU . . . . . 0.456 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 1.6 mt-10 -64.54 -52.88 55.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.458 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 51.5 mtm -66.5 -38.4 87.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.764 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 789' ' ' ALA . . . . . 0.435 ' HB3' HG22 ' A' ' 791' ' ' VAL . . . -73.0 -21.61 60.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.067 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 790' ' ' GLY . . . . . 0.455 ' HA3' HD13 ' A' ' 804' ' ' ILE . . . 90.91 18.95 45.22 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.754 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.496 ' C ' HG13 ' A' ' 804' ' ' ILE . 44.0 t -83.26 -30.05 8.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.726 0.298 . . . . 0.0 110.825 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 792' ' ' VAL . . . . . 0.517 HG23 ' HB3' ' A' ' 786' ' ' MET . 5.7 m -137.15 143.66 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.901 0.381 . . . . 0.0 111.434 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 793' ' ' THR . . . . . 0.451 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.6 p -81.9 160.63 63.12 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.961 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 794' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 22.5 Cg_endo -60.55 167.0 8.82 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.122 1.882 . . . . 0.0 111.988 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 1.5 mtt -58.31 158.83 6.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.243 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -99.55 176.51 5.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.881 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 10.0 t -58.44 -29.13 65.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.981 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -89.08 -17.53 29.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.188 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 103.9 35.16 3.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.728 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 18.0 m -127.79 129.73 47.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.779 0.323 . . . . 0.0 111.14 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 801' ' ' ARG . . . . . 0.484 ' NH2' ' CG2' ' A' ' 783' ' ' ILE . 6.8 mtp85 -81.7 170.54 15.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.015 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -134.97 173.53 11.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.8 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 803' ' ' VAL . . . . . 0.515 HG23 ' CG1' ' A' ' 757' ' ' VAL . 31.2 t -109.94 135.89 47.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 804' ' ' ILE . . . . . 0.496 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -106.07 -27.87 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.693 178.246 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 805' ' ' ALA . . . . . . . . . . . . . . . -81.67 123.88 80.22 Favored Pre-proline 0 N--CA 1.453 -0.289 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.71 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -63.16 163.81 21.78 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.66 2.24 . . . . 0.0 112.604 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.102 -179.879 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.617 -0.193 . . . . 0.0 112.617 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.98 -60.95 1.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.056 0.455 . . . . 0.0 110.537 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -144.71 -49.75 0.26 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.331 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -124.03 95.34 4.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.585 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . 0.452 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.31 141.82 35.54 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.476 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -36.87 -29.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.172 2.581 . . . . 0.0 113.614 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 749' ' ' LEU . . . . . 0.445 ' CB ' ' CE ' ' A' ' 782' ' ' MET . 42.9 mt -119.94 -16.98 8.57 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 750' ' ' TYR . . . . . 0.546 ' CZ ' ' CG2' ' A' ' 754' ' ' VAL . 68.0 t80 -54.62 -46.75 73.91 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.123 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -53.49 -36.1 61.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -71.04 -42.62 69.24 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.297 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -62.43 -53.77 50.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.021 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 754' ' ' VAL . . . . . 0.546 ' CG2' ' CZ ' ' A' ' 750' ' ' TYR . 5.0 t -56.22 -42.26 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.324 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -67.26 -35.24 79.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.272 0.558 . . . . 0.0 109.622 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 756' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -67.82 -46.12 72.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.141 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 757' ' ' VAL . . . . . 0.402 HG12 ' CB ' ' A' ' 763' ' ' ALA . 43.9 t -71.18 -42.24 75.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.796 0.331 . . . . 0.0 110.873 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 14.3 p -60.58 -40.3 91.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.016 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -78.03 -49.09 14.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.329 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 760' ' ' SER . . . . . 0.457 ' O ' ' HD3' ' A' ' 762' ' ' ARG . 7.8 p -69.55 -28.13 65.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.902 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 761' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 760' ' ' SER . 20.7 mmt180 73.96 32.11 1.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.55 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 762' ' ' ARG . . . . . 0.457 ' HD3' ' O ' ' A' ' 760' ' ' SER . 0.3 OUTLIER -150.14 131.18 14.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.699 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 763' ' ' ALA . . . . . 0.41 ' HB2' ' CB ' ' A' ' 801' ' ' ARG . . . -107.4 89.67 3.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.047 0.451 . . . . 0.0 110.638 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 764' ' ' SER . . . . . 0.481 ' O ' HG21 ' A' ' 768' ' ' VAL . 6.2 m -131.74 118.58 20.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.569 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 765' ' ' ILE . . . . . 0.439 HG21 ' N ' ' A' ' 780' ' ' ALA . 23.3 mt -51.44 -49.79 31.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.802 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 766' ' ' SER . . . . . 0.415 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 11.7 t -54.19 -43.03 70.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.097 0.475 . . . . 0.0 110.649 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -69.82 -39.68 76.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.772 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 768' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 764' ' ' SER . 45.4 t -62.54 -45.83 97.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.29 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . 0.569 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.4 OUTLIER -66.36 -33.47 75.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.542 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 770' ' ' ARG . . . . . 0.47 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 17.8 mtt180 -71.32 -42.3 68.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.084 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -37.11 42.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.954 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 772' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 768' ' ' VAL . 0.1 OUTLIER -90.52 -10.29 44.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.664 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt 60.77 41.53 14.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.185 0.517 . . . . 0.0 109.688 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 774' ' ' ILE . . . . . 0.569 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 26.0 pt -111.9 -174.0 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.595 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.58 154.19 24.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.081 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -58.75 -46.11 88.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 0.0 110.71 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -63.53 -43.59 96.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.877 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.44 -50.25 68.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.716 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.0 -50.12 71.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.301 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 780' ' ' ALA . . . . . 0.439 ' N ' HG21 ' A' ' 765' ' ' ILE . . . -55.96 -39.62 72.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.786 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.0 -48.49 81.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.977 0.418 . . . . 0.0 110.019 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 782' ' ' MET . . . . . 0.445 ' CE ' ' CB ' ' A' ' 749' ' ' LEU . 0.0 OUTLIER -63.9 -44.58 92.54 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.771 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 783' ' ' ILE . . . . . 0.469 ' CG2' ' NH2' ' A' ' 801' ' ' ARG . 7.4 mm -56.33 -41.46 71.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.708 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.96 -45.04 91.49 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.421 ' HB3' ' CE1' ' A' ' 750' ' ' TYR . . . -59.61 -33.57 71.66 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.519 -1.218 . . . . 0.0 109.816 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 786' ' ' MET . . . . . 0.495 ' HB3' HG23 ' A' ' 792' ' ' VAL . 13.8 mtm -65.4 -37.64 87.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.047 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 787' ' ' GLU . . . . . 0.441 ' HG3' ' CZ ' ' A' ' 801' ' ' ARG . 2.6 mt-10 -64.19 -54.04 39.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.704 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 40.0 mtp -67.28 -38.19 84.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.551 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -70.41 -21.71 62.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.951 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 89.54 19.79 47.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.978 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.464 ' C ' HG13 ' A' ' 804' ' ' ILE . 14.1 t -83.61 -32.58 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 120.892 0.377 . . . . 0.0 110.866 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 792' ' ' VAL . . . . . 0.495 HG23 ' HB3' ' A' ' 786' ' ' MET . 11.3 m -134.49 139.13 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.184 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 793' ' ' THR . . . . . 0.451 ' OG1' ' HB2' ' A' ' 802' ' ' GLU . 8.0 p -75.95 158.56 82.26 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.918 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 794' ' ' PRO . . . . . 0.444 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 19.7 Cg_endo -59.52 166.66 7.55 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.14 1.893 . . . . 0.0 112.01 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -56.98 161.02 3.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.149 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -104.73 176.55 5.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.788 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 5.2 t -54.68 -32.78 59.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.032 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -87.21 -17.64 32.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.15 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.46 37.29 3.56 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.5 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 16.2 m -127.82 129.14 46.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.003 0.43 . . . . 0.0 111.042 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 801' ' ' ARG . . . . . 0.469 ' NH2' ' CG2' ' A' ' 783' ' ' ILE . 6.8 mtp85 -83.64 170.62 14.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.327 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 802' ' ' GLU . . . . . 0.451 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 3.0 mt-10 -132.43 -170.77 2.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.606 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 803' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 792' ' ' VAL . 20.6 t -125.03 135.16 64.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.067 0.46 . . . . 0.0 112.018 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 804' ' ' ILE . . . . . 0.464 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -108.43 -33.66 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.352 179.241 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 805' ' ' ALA . . . . . 0.461 ' CB ' ' HD2' ' A' ' 806' ' ' PRO . . . -59.16 171.04 0.77 Allowed Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.242 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 806' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 805' ' ' ALA . 56.6 Cg_endo -71.2 163.62 38.53 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.771 2.314 . . . . 0.0 112.233 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.101 -179.947 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.253 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 5.9 m -116.16 -62.27 1.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.14 0.495 . . . . 0.0 110.73 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -140.01 -49.85 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.199 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -123.67 95.3 4.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.364 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 14.1 t70 -122.28 142.35 36.72 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.426 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -33.82 -31.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.387 2.724 . . . . 0.0 114.016 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 749' ' ' LEU . . . . . 0.437 HD21 HD22 ' A' ' 772' ' ' LEU . 33.8 mt -120.06 -17.15 8.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 750' ' ' TYR . . . . . 0.502 ' CZ ' ' CG2' ' A' ' 754' ' ' VAL . 67.9 t80 -53.26 -47.43 69.08 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.968 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -53.23 -37.18 61.81 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 752' ' ' GLU . . . . . 0.52 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 51.7 tt0 -71.01 -41.56 70.74 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.305 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -62.53 -51.52 67.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.034 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 754' ' ' VAL . . . . . 0.502 ' CG2' ' CZ ' ' A' ' 750' ' ' TYR . 2.2 t -56.15 -41.2 68.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.735 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -67.91 -35.4 78.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.746 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 756' ' ' PHE . . . . . 0.405 ' CE2' ' CG2' ' A' ' 768' ' ' VAL . 3.5 t80 -67.01 -46.09 75.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.991 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 757' ' ' VAL . . . . . 0.433 HG13 HG13 ' A' ' 792' ' ' VAL . 43.6 t -70.16 -47.34 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 120.811 0.338 . . . . 0.0 110.794 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 6.6 p -54.78 -43.74 73.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.002 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -78.88 -37.95 38.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.182 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 54.6 p -75.79 -16.25 60.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.46 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 60.11 31.38 20.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.931 0.396 . . . . 0.0 110.552 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.55 137.3 8.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.338 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 763' ' ' ALA . . . . . 0.403 ' CB ' HG12 ' A' ' 757' ' ' VAL . . . -110.58 89.84 3.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.91 0.386 . . . . 0.0 111.409 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 764' ' ' SER . . . . . 0.496 ' O ' HG21 ' A' ' 768' ' ' VAL . 15.2 m -127.14 118.61 24.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.617 178.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 765' ' ' ILE . . . . . 0.436 HG21 ' N ' ' A' ' 780' ' ' ALA . 25.0 mt -51.83 -50.19 33.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.755 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 766' ' ' SER . . . . . 0.408 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 22.0 t -53.45 -43.82 68.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.238 0.542 . . . . 0.0 110.537 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -69.12 -41.59 77.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.661 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 768' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 764' ' ' SER . 40.9 t -59.4 -47.53 90.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.212 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . 0.558 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.7 OUTLIER -65.46 -33.39 75.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.744 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 770' ' ' ARG . . . . . 0.465 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 5.8 mtt180 -68.75 -42.49 77.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.133 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.63 -42.13 29.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.877 0.37 . . . . 0.0 111.684 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 772' ' ' LEU . . . . . 0.52 ' CD2' ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -84.81 -8.58 58.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.791 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 22.6 mtpt 57.41 42.35 24.86 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 774' ' ' ILE . . . . . 0.558 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 30.1 pt -111.87 -174.14 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.626 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.25 155.45 25.19 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.238 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -59.2 -46.56 88.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.916 0.389 . . . . 0.0 110.653 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -62.22 -47.47 84.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.771 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -61.17 -50.37 73.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.775 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.41 -50.55 71.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.427 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 780' ' ' ALA . . . . . 0.436 ' N ' HG21 ' A' ' 765' ' ' ILE . . . -56.03 -41.03 74.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.81 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -58.95 -48.42 81.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.978 0.418 . . . . 0.0 110.009 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 782' ' ' MET . . . . . 0.41 ' CE ' ' CB ' ' A' ' 749' ' ' LEU . 0.5 OUTLIER -63.67 -43.12 97.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.386 178.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 783' ' ' ILE . . . . . 0.476 ' CG2' ' NH2' ' A' ' 801' ' ' ARG . 7.6 mm -56.96 -41.72 77.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.318 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.21 -44.9 92.27 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.446 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -58.39 -33.63 69.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.048 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 786' ' ' MET . . . . . 0.464 ' HG2' HG21 ' A' ' 754' ' ' VAL . 16.3 mtm -66.85 -38.59 86.65 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.991 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 787' ' ' GLU . . . . . 0.431 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 2.0 mt-10 -61.55 -54.05 48.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.664 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 24.1 mtm -68.85 -38.39 79.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.418 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -68.52 -21.67 64.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.775 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 90.74 15.07 57.25 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.897 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.525 ' C ' HG13 ' A' ' 804' ' ' ILE . 40.6 t -80.67 -31.91 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.924 0.392 . . . . 0.0 110.896 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 792' ' ' VAL . . . . . 0.434 HG23 ' HB3' ' A' ' 786' ' ' MET . 11.2 m -136.58 135.45 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.143 0.497 . . . . 0.0 111.161 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 793' ' ' THR . . . . . 0.465 HG21 HG12 ' A' ' 804' ' ' ILE . 10.3 p -72.92 159.81 84.42 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.686 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 794' ' ' PRO . . . . . 0.464 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 25.4 Cg_endo -60.58 165.13 11.97 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 121.996 1.797 . . . . 0.0 111.771 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -58.78 162.74 3.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.185 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -105.58 176.57 5.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.954 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 55.8 p -56.4 -31.11 63.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -86.32 -17.57 34.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.115 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 100.71 34.44 4.67 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.542 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 28.8 m -127.75 130.31 48.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 111.113 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 801' ' ' ARG . . . . . 0.476 ' NH2' ' CG2' ' A' ' 783' ' ' ILE . 4.5 mtp85 -81.57 170.13 16.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.397 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -138.52 124.18 19.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.909 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 803' ' ' VAL . . . . . 0.417 ' CG2' HG13 ' A' ' 757' ' ' VAL . 18.8 t -64.92 134.22 29.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.96 0.409 . . . . 0.0 112.065 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 804' ' ' ILE . . . . . 0.525 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -103.77 -33.29 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.891 178.546 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 805' ' ' ALA . . . . . . . . . . . . . . . -74.63 126.03 89.03 Favored Pre-proline 0 N--CA 1.451 -0.4 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.836 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.07 163.81 24.46 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.71 2.273 . . . . 0.0 112.168 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.272 -179.856 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.424 0 N-CA-C 112.09 -0.404 . . . . 0.0 112.09 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 3.5 m -115.57 -39.3 3.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.065 0.459 . . . . 0.0 110.462 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 745' ' ' GLU . . . . . 0.429 ' O ' ' CD2' ' A' ' 750' ' ' TYR . 0.9 OUTLIER -168.57 -45.97 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.941 179.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -129.13 95.06 3.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.439 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.47 143.35 39.43 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.376 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 748' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 28.7 Cg_exo -35.34 -30.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.258 2.639 . . . . 0.0 113.795 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 749' ' ' LEU . . . . . 0.433 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 21.8 mt -120.09 -17.08 8.46 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 750' ' ' TYR . . . . . 0.718 ' CE2' HG22 ' A' ' 754' ' ' VAL . 83.7 t80 -51.73 -50.65 60.14 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.837 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -53.17 -35.89 60.29 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.71 -0.396 . . . . 0.0 109.984 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 752' ' ' GLU . . . . . 0.535 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 6.0 tp10 -70.93 -38.5 72.9 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.803 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 753' ' ' ALA . . . . . 0.441 ' HA ' HD12 ' A' ' 772' ' ' LEU . . . -66.28 -52.93 42.57 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.804 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 754' ' ' VAL . . . . . 0.718 HG22 ' CE2' ' A' ' 750' ' ' TYR . 7.0 t -56.36 -38.42 55.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.751 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -69.87 -39.16 76.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.601 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 756' ' ' PHE . . . . . 0.487 ' HE1' ' HD3' ' A' ' 771' ' ' LYS . 1.4 t80 -65.77 -45.09 83.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.611 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 757' ' ' VAL . . . . . 0.501 HG12 ' HB1' ' A' ' 763' ' ' ALA . 84.5 t -69.84 -41.33 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.781 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 9.9 p -59.12 -46.08 89.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.335 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -77.97 -30.36 50.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.795 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 39.5 p -78.02 -16.0 58.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.5 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 63.39 20.09 12.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.718 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -157.61 137.58 12.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.745 0.307 . . . . 0.0 110.931 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 763' ' ' ALA . . . . . 0.501 ' HB1' HG12 ' A' ' 757' ' ' VAL . . . -100.7 89.87 4.04 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.949 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 764' ' ' SER . . . . . 0.489 ' O ' HG21 ' A' ' 768' ' ' VAL . 5.9 m -120.65 118.44 30.12 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 765' ' ' ILE . . . . . 0.516 HG22 ' N ' ' A' ' 780' ' ' ALA . 10.3 mt -57.1 -51.32 70.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.368 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 766' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 11.3 t -53.93 -38.41 64.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.291 0.567 . . . . 0.0 110.103 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -71.36 -40.22 70.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.234 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 768' ' ' VAL . . . . . 0.489 HG21 ' O ' ' A' ' 764' ' ' SER . 45.5 t -61.43 -49.94 82.44 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.179 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . 0.587 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -63.64 -33.57 75.92 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.974 -179.499 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -69.45 -42.52 74.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.37 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . 0.487 ' HD3' ' HE1' ' A' ' 756' ' ' PHE . 3.1 tptt -78.59 -38.24 40.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.766 0.317 . . . . 0.0 111.677 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 772' ' ' LEU . . . . . 0.535 ' CD2' ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -86.87 -10.91 52.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt 61.21 39.58 15.64 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 774' ' ' ILE . . . . . 0.587 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 25.6 pt -111.86 -173.98 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.424 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -90.34 153.55 22.85 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.236 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -56.6 -45.79 81.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.816 0.341 . . . . 0.0 110.87 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -63.25 -47.79 80.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.82 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.1 -49.98 75.8 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.641 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 779' ' ' ALA . . . . . 0.407 ' HB2' ' CD1' ' A' ' 774' ' ' ILE . . . -57.23 -50.69 72.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.637 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 780' ' ' ALA . . . . . 0.516 ' N ' HG22 ' A' ' 765' ' ' ILE . . . -55.99 -40.42 73.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.947 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -60.66 -43.77 97.23 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 782' ' ' MET . . . . . 0.43 ' HE2' ' CB ' ' A' ' 749' ' ' LEU . 0.1 OUTLIER -64.94 -43.62 92.14 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.293 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 783' ' ' ILE . . . . . 0.508 ' CG2' ' NH1' ' A' ' 801' ' ' ARG . 15.0 mm -57.62 -39.73 71.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.696 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -61.85 -46.78 87.95 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.423 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -58.01 -33.64 69.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.808 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 786' ' ' MET . . . . . 0.508 ' HB3' HG21 ' A' ' 792' ' ' VAL . 15.4 mtm -67.79 -38.29 83.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.565 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 787' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 792' ' ' VAL . 1.6 mt-10 -62.41 -45.93 90.89 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.124 0.488 . . . . 0.0 110.072 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 37.0 mtm -73.08 -37.98 66.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.245 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -70.81 -21.53 62.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.982 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 94.62 15.94 44.55 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.67 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.561 ' C ' HG13 ' A' ' 804' ' ' ILE . 77.5 t -84.96 -34.2 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 122.637 0.375 . . . . 0.0 111.476 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 792' ' ' VAL . . . . . 0.508 HG21 ' HB3' ' A' ' 786' ' ' MET . 15.4 m -136.61 148.41 27.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.887 0.375 . . . . 0.0 111.655 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 793' ' ' THR . . . . . 0.588 HG21 HG12 ' A' ' 804' ' ' ILE . 10.3 p -96.75 171.8 5.73 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 794' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.47 178.86 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 121.982 1.788 . . . . 0.0 111.812 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 795' ' ' MET . . . . . 0.498 ' HA ' ' HG3' ' A' ' 801' ' ' ARG . 0.0 OUTLIER -77.04 170.12 17.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.499 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -105.61 176.59 5.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.754 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 4.6 t -60.78 -26.99 67.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.052 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -92.19 -17.62 24.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.398 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 108.73 29.84 3.97 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.649 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 18.0 m -124.42 131.13 53.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.923 0.392 . . . . 0.0 110.647 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 801' ' ' ARG . . . . . 0.508 ' NH1' ' CG2' ' A' ' 783' ' ' ILE . 8.8 mtt-85 -85.34 170.65 12.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.078 0.466 . . . . 0.0 111.524 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 802' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 793' ' ' THR . 6.9 mt-10 -127.13 126.76 43.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.576 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 803' ' ' VAL . . . . . 0.494 HG23 ' CG1' ' A' ' 757' ' ' VAL . 19.4 t -69.25 137.94 23.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.836 0.35 . . . . 0.0 111.8 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 804' ' ' ILE . . . . . 0.588 HG12 HG21 ' A' ' 793' ' ' THR . 0.0 OUTLIER -108.19 -28.08 2.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.292 178.415 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 805' ' ' ALA . . . . . 0.503 ' CB ' ' HA ' ' A' ' 791' ' ' VAL . . . -78.24 119.56 77.81 Favored Pre-proline 0 N--CA 1.455 -0.209 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.641 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.24 163.82 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.413 2.075 . . . . 0.0 112.733 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.961 -179.99 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 743' ' ' GLY . . . . . 0.406 ' CA ' ' HG2' ' A' ' 782' ' ' MET . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.0 -157.83 0.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.584 0.23 . . . . 0.0 110.43 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -51.29 -38.44 52.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.666 0.27 . . . . 0.0 111.445 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -129.06 95.51 4.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.062 0.458 . . . . 0.0 111.415 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.4 t70 -122.49 141.52 35.1 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.372 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -38.32 -28.02 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.956 2.437 . . . . 0.0 113.64 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 749' ' ' LEU . . . . . 0.431 HD21 HD22 ' A' ' 772' ' ' LEU . 40.4 mt -119.94 -16.85 8.59 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 750' ' ' TYR . . . . . 0.521 ' CE1' ' CG2' ' A' ' 754' ' ' VAL . 62.2 t80 -55.12 -46.5 75.59 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.469 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -53.51 -36.37 61.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -70.95 -43.09 68.85 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.217 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -61.93 -51.67 67.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.238 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 754' ' ' VAL . . . . . 0.574 HG21 ' HG2' ' A' ' 786' ' ' MET . 2.3 t -56.21 -42.69 74.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.39 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -69.16 -38.13 78.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.294 0.569 . . . . 0.0 110.231 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 756' ' ' PHE . . . . . 0.433 ' CE1' ' HB2' ' A' ' 771' ' ' LYS . 4.0 t80 -65.15 -46.15 82.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.114 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 757' ' ' VAL . . . . . . . . . . . . . 59.7 t -69.49 -45.13 79.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.902 0.382 . . . . 0.0 110.775 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 6.8 p -55.22 -42.65 73.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.96 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -78.8 -35.63 43.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.414 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 6.8 p -76.84 -19.61 57.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.575 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 67.2 24.93 9.08 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.662 0.268 . . . . 0.0 111.477 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.26 132.39 7.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.883 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 763' ' ' ALA . . . . . . . . . . . . . . . -100.05 89.71 4.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.933 0.397 . . . . 0.0 111.281 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 764' ' ' SER . . . . . 0.521 ' O ' HG21 ' A' ' 768' ' ' VAL . 7.6 m -121.78 118.59 29.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.593 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 765' ' ' ILE . . . . . 0.423 HG21 ' N ' ' A' ' 780' ' ' ALA . 26.3 mt -54.54 -47.34 71.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.487 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 766' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 60.5 p -57.69 -40.5 79.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.172 0.51 . . . . 0.0 110.493 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -71.58 -36.23 70.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.612 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 768' ' ' VAL . . . . . 0.521 HG21 ' O ' ' A' ' 764' ' ' SER . 58.8 t -66.4 -46.44 86.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.223 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . 0.579 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -66.05 -33.37 75.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.486 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 770' ' ' ARG . . . . . 0.459 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 20.8 mtt-85 -69.98 -42.41 73.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.087 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . 0.433 ' HB2' ' CE1' ' A' ' 756' ' ' PHE . 1.8 tmtt? -78.62 -39.62 36.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.042 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 772' ' ' LEU . . . . . 0.431 HD22 HD21 ' A' ' 749' ' ' LEU . 0.2 OUTLIER -88.33 -9.23 53.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.664 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt 60.03 42.31 16.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.061 0.458 . . . . 0.0 109.775 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 774' ' ' ILE . . . . . 0.579 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 26.8 pt -111.94 -173.94 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.609 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.42 147.18 19.36 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.027 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -54.11 -42.54 69.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.834 0.35 . . . . 0.0 110.703 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 -64.12 -47.53 79.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.923 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -50.3 71.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.894 0.378 . . . . 0.0 110.835 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -54.48 -49.13 70.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.411 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 780' ' ' ALA . . . . . 0.423 ' N ' HG21 ' A' ' 765' ' ' ILE . . . -56.07 -43.63 78.14 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.911 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -58.98 -48.41 81.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.034 0.445 . . . . 0.0 109.973 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 782' ' ' MET . . . . . 0.438 ' SD ' ' N ' ' A' ' 750' ' ' TYR . 34.4 mtm -65.3 -34.3 78.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.711 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 783' ' ' ILE . . . . . 0.421 HG22 ' NH1' ' A' ' 801' ' ' ARG . 7.1 mm -65.45 -35.71 75.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.11 -44.69 94.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.458 ' HB1' ' CE2' ' A' ' 750' ' ' TYR . . . -59.12 -33.76 71.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.766 178.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 786' ' ' MET . . . . . 0.574 ' HG2' HG21 ' A' ' 754' ' ' VAL . 12.7 mtm -65.62 -39.14 91.17 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.912 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -62.43 -51.15 68.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.45 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 25.4 mtm -67.9 -38.49 83.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.574 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -71.4 -21.62 61.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.882 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 93.12 16.76 46.04 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.914 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.436 ' HA ' ' CB ' ' A' ' 805' ' ' ALA . 10.1 t -83.57 -33.28 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.887 0.375 . . . . 0.0 110.726 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 792' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 803' ' ' VAL . 19.8 m -135.94 139.54 45.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.404 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 793' ' ' THR . . . . . 0.495 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 2.8 p -83.77 161.87 54.54 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.709 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 794' ' ' PRO . . . . . 0.495 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 18.1 Cg_endo -58.62 167.23 5.35 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.153 1.902 . . . . 0.0 112.083 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.88 160.06 15.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.201 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -104.31 176.59 5.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.803 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 39.1 p -61.76 -34.74 76.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.926 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.14 -17.61 58.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.195 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 100.58 28.38 7.11 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.515 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 58.0 m -126.64 130.39 50.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.942 0.401 . . . . 0.0 110.964 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 801' ' ' ARG . . . . . 0.421 ' NH1' HG22 ' A' ' 783' ' ' ILE . 9.4 mtt-85 -82.72 170.72 14.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.222 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -130.2 166.28 20.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.814 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 803' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 792' ' ' VAL . 39.0 t -109.63 135.19 49.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.064 0.459 . . . . 0.0 111.597 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 804' ' ' ILE . . . . . 0.42 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -103.35 -28.56 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.266 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 805' ' ' ALA . . . . . 0.436 ' CB ' ' HA ' ' A' ' 791' ' ' VAL . . . -82.22 124.51 78.4 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.934 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.9 163.71 27.26 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.632 2.221 . . . . 0.0 112.082 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.241 -179.812 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.41 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.68 -53.57 2.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.159 0.504 . . . . 0.0 110.396 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -153.13 -50.13 0.1 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.968 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -124.01 95.11 4.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.416 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . 0.472 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.7 t70 -122.37 142.09 36.25 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.439 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -37.73 -28.35 0.1 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.989 2.459 . . . . 0.0 113.51 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 749' ' ' LEU . . . . . 0.408 HD13 ' NE ' ' A' ' 778' ' ' ARG . 31.8 mt -120.05 -16.87 8.52 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 750' ' ' TYR . . . . . 0.514 ' CZ ' ' CG2' ' A' ' 754' ' ' VAL . 71.3 t80 -53.99 -47.76 71.1 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.376 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -53.4 -36.3 61.31 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -71.0 -42.27 69.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.117 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -61.85 -53.82 50.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.068 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 754' ' ' VAL . . . . . 0.514 ' CG2' ' CZ ' ' A' ' 750' ' ' TYR . 4.0 t -56.19 -42.97 74.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.407 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -66.43 -36.94 84.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.37 0.605 . . . . 0.0 109.797 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 756' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -66.82 -46.18 75.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.169 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 757' ' ' VAL . . . . . 0.425 HG12 ' CB ' ' A' ' 763' ' ' ALA . 61.8 t -69.56 -45.41 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 120.8 0.333 . . . . 0.0 110.664 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 4.8 p -55.37 -43.45 75.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.783 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -78.71 -32.15 46.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.214 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 27.3 p -81.63 -14.83 56.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.531 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 61.92 18.92 10.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.614 0.245 . . . . 0.0 111.223 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -151.88 136.35 16.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.763 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 763' ' ' ALA . . . . . 0.425 ' CB ' HG12 ' A' ' 757' ' ' VAL . . . -106.06 89.88 3.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.602 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 764' ' ' SER . . . . . 0.528 ' O ' HG21 ' A' ' 768' ' ' VAL . 3.9 m -122.32 118.59 28.86 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 765' ' ' ILE . . . . . 0.428 HG21 ' N ' ' A' ' 780' ' ' ALA . 19.5 mt -53.6 -48.28 59.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.499 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 766' ' ' SER . . . . . . . . . . . . . 11.4 t -55.74 -41.23 73.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.114 0.483 . . . . 0.0 110.284 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -70.58 -39.48 73.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.688 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 768' ' ' VAL . . . . . 0.528 HG21 ' O ' ' A' ' 764' ' ' SER . 41.9 t -62.94 -46.72 95.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.291 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . 0.564 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.93 -33.41 75.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.452 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 770' ' ' ARG . . . . . 0.473 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 24.8 mtt180 -71.54 -41.84 68.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.059 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.7 -37.26 42.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.967 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 772' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 768' ' ' VAL . 0.2 OUTLIER -91.17 -9.64 44.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.634 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt 60.8 41.55 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.038 0.447 . . . . 0.0 109.8 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 774' ' ' ILE . . . . . 0.564 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 22.0 pt -111.84 -173.92 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.476 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.51 151.13 22.3 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.201 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -55.38 -46.05 76.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.965 0.412 . . . . 0.0 110.707 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -63.37 -47.79 80.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.823 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . 0.408 ' NE ' HD13 ' A' ' 749' ' ' LEU . 0.6 OUTLIER -59.61 -50.13 75.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.845 0.355 . . . . 0.0 110.793 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.33 -49.9 74.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.271 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 780' ' ' ALA . . . . . 0.428 ' N ' HG21 ' A' ' 765' ' ' ILE . . . -56.11 -40.35 73.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -60.69 -48.41 81.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.92 0.39 . . . . 0.0 109.999 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 782' ' ' MET . . . . . 0.402 ' HE2' ' CB ' ' A' ' 749' ' ' LEU . 3.1 mtp -63.79 -38.41 91.01 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 783' ' ' ILE . . . . . 0.493 ' CG2' ' NH2' ' A' ' 801' ' ' ARG . 7.3 mm -61.32 -40.85 87.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.132 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.23 -43.52 87.8 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 177.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.42 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -60.32 -33.48 72.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.526 -1.216 . . . . 0.0 109.828 178.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 786' ' ' MET . . . . . 0.497 ' HG2' HG21 ' A' ' 754' ' ' VAL . 12.9 mtm -65.67 -37.56 86.84 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.974 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 787' ' ' GLU . . . . . 0.451 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 2.4 mt-10 -63.38 -54.13 41.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.111 0.481 . . . . 0.0 110.548 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 33.5 mtm -67.85 -37.12 81.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.49 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -70.94 -21.59 62.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.985 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 89.62 18.37 52.1 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.875 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.491 ' C ' HG13 ' A' ' 804' ' ' ILE . 52.4 t -83.23 -32.72 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.854 0.359 . . . . 0.0 110.809 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 792' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' A' ' 786' ' ' MET . 11.4 m -135.61 140.64 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.188 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 793' ' ' THR . . . . . 0.415 HG21 HG12 ' A' ' 804' ' ' ILE . 1.3 p -78.34 159.06 75.81 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 794' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 18.6 Cg_endo -58.8 166.11 7.18 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.115 1.876 . . . . 0.0 111.743 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -66.08 155.38 36.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.972 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -105.43 176.56 5.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.918 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 5.5 t -55.37 -29.98 59.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.06 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -78.65 -17.52 55.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.151 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 91.9 29.62 11.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.48 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 24.6 m -127.82 130.19 48.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.905 0.383 . . . . 0.0 111.031 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 801' ' ' ARG . . . . . 0.493 ' NH2' ' CG2' ' A' ' 783' ' ' ILE . 6.8 mtp85 -81.63 170.59 15.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.307 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -129.9 -176.93 4.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.667 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 803' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 792' ' ' VAL . 16.9 t -119.81 134.64 62.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 804' ' ' ILE . . . . . 0.491 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -106.99 -28.09 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.961 178.56 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 805' ' ' ALA . . . . . . . . . . . . . . . -82.74 121.49 77.8 Favored Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.586 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.49 163.8 22.79 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.475 2.116 . . . . 0.0 112.304 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.225 -179.8 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 1.3 m -119.3 -47.24 2.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.121 0.486 . . . . 0.0 110.396 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -159.33 -48.63 0.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.182 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -126.9 95.1 4.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.337 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.6 t70 -122.51 143.09 38.85 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.425 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 748' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 35.7 Cg_exo -35.97 -29.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.157 2.571 . . . . 0.0 113.763 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 749' ' ' LEU . . . . . 0.458 HD21 HD22 ' A' ' 772' ' ' LEU . 34.6 mt -120.03 -17.27 8.45 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 750' ' ' TYR . . . . . 0.525 ' CE2' ' CG2' ' A' ' 754' ' ' VAL . 74.5 t80 -53.3 -48.54 68.29 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.797 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.27 -36.34 61.03 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 752' ' ' GLU . . . . . 0.552 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 12.6 tt0 -71.0 -42.05 70.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.242 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 753' ' ' ALA . . . . . 0.491 ' HB3' ' HE3' ' A' ' 782' ' ' MET . . . -62.92 -52.5 62.8 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.182 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 754' ' ' VAL . . . . . 0.553 HG21 ' HG2' ' A' ' 786' ' ' MET . 5.1 t -56.2 -40.32 64.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.675 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -67.01 -35.52 80.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.41 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 756' ' ' PHE . . . . . 0.516 ' HD2' ' HD3' ' A' ' 771' ' ' LYS . 1.4 t80 -67.65 -45.94 73.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.018 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 757' ' ' VAL . . . . . 0.416 HG12 ' CB ' ' A' ' 763' ' ' ALA . 47.4 t -69.64 -42.08 80.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.937 0.399 . . . . 0.0 110.837 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 8.2 p -58.71 -45.38 89.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.69 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -77.75 -35.26 51.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.101 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 48.7 p -76.38 -14.74 60.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.291 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 56.5 28.0 13.12 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.008 0.433 . . . . 0.0 110.577 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -160.87 136.0 7.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.92 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 763' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 801' ' ' ARG . . . -106.32 89.6 3.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.09 0.472 . . . . 0.0 111.698 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 764' ' ' SER . . . . . 0.526 ' O ' HG21 ' A' ' 768' ' ' VAL . 68.1 m -121.24 118.64 30.11 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 765' ' ' ILE . . . . . 0.479 HG21 ' N ' ' A' ' 780' ' ' ALA . 17.5 mt -54.06 -47.58 65.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.637 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 766' ' ' SER . . . . . 0.584 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 10.9 t -58.89 -36.73 75.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.27 0.557 . . . . 0.0 110.363 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -72.78 -41.34 65.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.217 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 768' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 764' ' ' SER . 23.2 t -61.13 -49.8 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.096 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . 0.593 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -63.05 -33.85 76.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.374 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 21.2 mtt180 -70.08 -42.54 72.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.279 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . 0.516 ' HD3' ' HD2' ' A' ' 756' ' ' PHE . 0.0 OUTLIER -78.53 -35.72 45.8 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.527 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 772' ' ' LEU . . . . . 0.552 ' CD2' ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -90.6 -10.35 43.66 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm 60.61 40.61 16.42 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 774' ' ' ILE . . . . . 0.593 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 27.7 pt -111.69 -175.33 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.39 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.63 150.54 21.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.097 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -54.28 -45.97 72.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.653 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -61.91 -47.48 84.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.759 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . 0.401 ' HG2' ' SD ' ' A' ' 782' ' ' MET . 0.1 OUTLIER -60.37 -50.19 74.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.687 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.22 -49.76 74.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.354 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 780' ' ' ALA . . . . . 0.479 ' N ' HG21 ' A' ' 765' ' ' ILE . . . -56.2 -41.52 75.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.771 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 -59.54 -48.26 82.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.045 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 782' ' ' MET . . . . . 0.491 ' HE3' ' HB3' ' A' ' 753' ' ' ALA . 0.0 OUTLIER -61.71 -44.55 96.71 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.407 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 783' ' ' ILE . . . . . 0.456 ' CG2' ' NH1' ' A' ' 801' ' ' ARG . 12.0 mm -55.32 -37.07 42.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.786 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -64.03 -46.03 86.26 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . . . . . . . . . . . -59.26 -33.56 71.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.633 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 786' ' ' MET . . . . . 0.553 ' HG2' HG21 ' A' ' 754' ' ' VAL . 13.4 mtm -65.46 -40.68 93.47 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.316 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.16 -49.14 77.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.092 0.472 . . . . 0.0 110.587 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 32.9 mtm -70.66 -36.85 73.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.385 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -71.86 -21.56 61.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.082 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 93.72 17.23 42.33 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.718 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.504 ' HA ' ' CB ' ' A' ' 805' ' ' ALA . 60.2 t -87.72 -29.46 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 122.505 0.322 . . . . 0.0 111.27 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 792' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 786' ' ' MET . 20.5 m -139.58 141.93 33.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.869 0.366 . . . . 0.0 111.824 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 793' ' ' THR . . . . . 0.512 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.1 p -86.17 165.65 32.83 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 794' ' ' PRO . . . . . 0.512 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 32.6 Cg_endo -63.45 166.38 15.39 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 121.951 1.767 . . . . 0.0 111.815 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -69.6 158.1 35.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.373 . . . . 0.0 111.213 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 36.8 p30 -105.72 176.56 5.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.83 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 2.8 t -57.84 -31.21 66.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.999 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -74.22 -17.58 60.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.246 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 93.62 26.44 15.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.566 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 17.9 m -127.24 134.6 50.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 0.0 110.809 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 801' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' A' ' 763' ' ' ALA . 13.5 mtt-85 -85.03 170.79 12.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.251 0.548 . . . . 0.0 111.545 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -129.1 166.5 19.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.842 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 803' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 792' ' ' VAL . 19.3 t -107.6 138.55 33.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.885 0.374 . . . . 0.0 111.978 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 804' ' ' ILE . . . . . 0.464 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -109.98 -25.35 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.555 179.03 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 805' ' ' ALA . . . . . 0.504 ' CB ' ' HA ' ' A' ' 791' ' ' VAL . . . -80.87 121.56 81.07 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.239 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -50.34 163.94 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.639 2.226 . . . . 0.0 112.885 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.053 179.934 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.405 0 N-CA-C 112.439 -0.264 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 50.4 m -118.97 -46.87 2.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.126 0.489 . . . . 0.0 110.487 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -159.17 -47.48 0.06 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.19 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -128.89 95.27 4.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.394 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . 0.495 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.2 t70 -122.5 143.48 39.81 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.312 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 748' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 40.0 Cg_exo -36.75 -28.77 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.081 2.521 . . . . 0.0 113.793 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 749' ' ' LEU . . . . . 0.44 HD21 HD22 ' A' ' 772' ' ' LEU . 28.7 mt -119.99 -17.09 8.51 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 750' ' ' TYR . . . . . 0.718 ' CE2' HG22 ' A' ' 754' ' ' VAL . 78.5 t80 -53.15 -50.91 63.58 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.935 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -53.07 -35.11 59.18 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 752' ' ' GLU . . . . . 0.503 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 9.1 tp10 -71.1 -42.02 69.84 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.174 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 753' ' ' ALA . . . . . 0.433 ' HB3' ' CE ' ' A' ' 782' ' ' MET . . . -63.58 -53.73 47.11 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.188 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 754' ' ' VAL . . . . . 0.718 HG22 ' CE2' ' A' ' 750' ' ' TYR . 6.2 t -56.1 -39.27 57.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.865 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -68.22 -35.47 78.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.652 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 756' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -68.79 -46.33 68.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.038 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 757' ' ' VAL . . . . . 0.554 HG13 HG13 ' A' ' 792' ' ' VAL . 21.1 t -71.29 -38.88 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 120.903 0.383 . . . . 0.0 111.114 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 20.6 p -63.12 -41.43 99.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.702 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -76.96 -46.63 23.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.148 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 760' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 761' ' ' ARG . 22.8 p -70.6 -33.86 71.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.975 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 761' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 760' ' ' SER . 0.0 OUTLIER 78.27 23.73 0.69 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.401 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 762' ' ' ARG . . . . . 0.453 ' HD3' ' O ' ' A' ' 760' ' ' SER . 0.5 OUTLIER -145.03 114.29 7.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.507 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 763' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 801' ' ' ARG . . . -88.19 89.49 8.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.039 0.447 . . . . 0.0 111.442 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 764' ' ' SER . . . . . 0.576 ' O ' HG21 ' A' ' 768' ' ' VAL . 17.0 m -126.84 118.35 24.45 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 765' ' ' ILE . . . . . 0.467 HG21 ' N ' ' A' ' 780' ' ' ALA . 11.0 mt -52.99 -45.56 52.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.491 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 766' ' ' SER . . . . . 0.477 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 6.6 t -60.57 -37.7 82.15 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.152 0.501 . . . . 0.0 110.308 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -73.64 -35.26 65.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.52 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 768' ' ' VAL . . . . . 0.576 HG21 ' O ' ' A' ' 764' ' ' SER . 40.4 t -67.71 -46.98 81.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . 0.578 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.12 -34.12 77.66 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.491 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 14.9 mtt-85 -71.32 -42.57 68.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.2 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.74 -34.92 45.41 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 772' ' ' LEU . . . . . 0.503 ' CD2' ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -92.41 -10.41 38.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp 61.71 40.79 12.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.106 0.479 . . . . 0.0 109.721 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 774' ' ' ILE . . . . . 0.578 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 23.0 pt -111.74 -173.78 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.661 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.59 151.69 22.67 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.186 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -56.9 -45.78 82.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 0.0 110.729 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 -63.29 -46.56 86.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.69 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -50.07 74.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.776 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.41 -49.46 76.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.21 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 780' ' ' ALA . . . . . 0.467 ' N ' HG21 ' A' ' 765' ' ' ILE . . . -55.93 -42.47 76.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.966 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -59.38 -43.37 92.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.125 0.488 . . . . 0.0 110.016 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 782' ' ' MET . . . . . 0.433 ' CE ' ' HB3' ' A' ' 753' ' ' ALA . 2.5 mtp -67.66 -42.02 82.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.592 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 783' ' ' ILE . . . . . 0.447 ' CG2' ' NH1' ' A' ' 801' ' ' ARG . 9.5 mm -58.59 -37.32 64.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.443 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -63.56 -48.27 78.15 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.413 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -56.16 -33.41 65.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.693 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 786' ' ' MET . . . . . 0.541 ' HB3' HG21 ' A' ' 792' ' ' VAL . 13.1 mtm -66.8 -40.77 88.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.178 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.93 -49.41 77.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.61 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 28.5 mtm -72.81 -37.79 67.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.546 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -68.16 -21.5 64.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.136 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 94.91 16.93 39.76 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.459 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.51 ' HA ' ' CB ' ' A' ' 805' ' ' ALA . 55.1 t -86.34 -35.45 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 122.422 0.289 . . . . 0.0 111.306 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 792' ' ' VAL . . . . . 0.554 HG13 HG13 ' A' ' 757' ' ' VAL . 22.0 m -136.4 151.44 28.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.128 0.49 . . . . 0.0 111.69 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 793' ' ' THR . . . . . 0.521 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.3 p -94.83 165.67 16.65 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.282 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 794' ' ' PRO . . . . . 0.521 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 29.6 Cg_endo -62.3 166.01 13.87 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 121.869 1.713 . . . . 0.0 111.94 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -72.07 158.5 35.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.985 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -105.51 176.51 5.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 53.1 p -57.86 -30.17 65.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.202 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -75.34 -17.6 60.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.296 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 94.15 23.23 22.94 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.576 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 58.9 m -123.26 132.54 54.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.824 0.345 . . . . 0.0 110.649 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 801' ' ' ARG . . . . . 0.551 ' HB2' ' O ' ' A' ' 763' ' ' ALA . 11.7 mtt-85 -85.14 170.79 12.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.189 0.519 . . . . 0.0 111.716 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 802' ' ' GLU . . . . . 0.402 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 3.8 mt-10 -127.54 171.05 11.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.868 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 803' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 792' ' ' VAL . 22.3 t -114.22 138.38 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 804' ' ' ILE . . . . . 0.46 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -106.89 -28.31 2.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.454 178.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 805' ' ' ALA . . . . . 0.51 ' CB ' ' HA ' ' A' ' 791' ' ' VAL . . . -82.7 121.44 77.84 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.001 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -65.48 163.73 28.71 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.541 2.161 . . . . 0.0 112.088 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.144 -179.753 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.15 -160.78 0.7 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.635 0.255 . . . . 0.0 110.611 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -51.11 -44.35 61.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.808 0.337 . . . . 0.0 111.121 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -127.39 95.56 4.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.122 0.487 . . . . 0.0 110.956 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.57 143.21 39.26 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.445 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 748' ' ' PRO . . . . . 0.407 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 40.5 Cg_exo -36.22 -29.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.108 2.538 . . . . 0.0 113.962 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 749' ' ' LEU . . . . . 0.452 HD21 HD22 ' A' ' 772' ' ' LEU . 26.3 mt -120.02 -17.15 8.48 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 750' ' ' TYR . . . . . 0.527 ' CE1' ' CG2' ' A' ' 754' ' ' VAL . 65.6 t80 -53.81 -47.81 70.5 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.783 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -53.23 -37.49 62.09 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 752' ' ' GLU . . . . . 0.535 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 11.8 tt0 -71.0 -43.38 68.1 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.083 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 753' ' ' ALA . . . . . 0.402 ' HB3' ' CE ' ' A' ' 782' ' ' MET . . . -59.74 -54.4 46.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.159 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 754' ' ' VAL . . . . . 0.606 HG21 ' HG2' ' A' ' 786' ' ' MET . 4.8 t -56.19 -40.82 67.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.142 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 44.5 ttt85 -65.89 -36.02 82.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.543 178.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 756' ' ' PHE . . . . . 0.453 ' CE1' ' CG2' ' A' ' 768' ' ' VAL . 1.2 t80 -69.78 -44.95 69.06 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.83 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 757' ' ' VAL . . . . . 0.472 ' HA ' ' OG ' ' A' ' 760' ' ' SER . 61.2 t -69.74 -39.59 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 121.002 0.43 . . . . 0.0 110.763 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 10.1 p -62.8 -44.81 95.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.8 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -78.58 -33.08 47.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.177 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 760' ' ' SER . . . . . 0.472 ' OG ' ' HA ' ' A' ' 757' ' ' VAL . 93.7 p -75.54 -15.68 60.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.278 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 62.84 17.34 9.85 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.426 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 -155.77 140.37 16.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.572 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 763' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 801' ' ' ARG . . . -105.57 89.62 3.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.922 0.391 . . . . 0.0 111.658 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 764' ' ' SER . . . . . 0.599 ' O ' HG21 ' A' ' 768' ' ' VAL . 1.7 m -118.96 118.67 32.12 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 765' ' ' ILE . . . . . 0.461 HG12 ' HA ' ' A' ' 780' ' ' ALA . 7.4 mt -55.69 -47.74 78.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.563 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 766' ' ' SER . . . . . 0.44 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 39.3 t -57.4 -39.09 75.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.14 0.495 . . . . 0.0 110.275 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -71.88 -39.56 69.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.448 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 768' ' ' VAL . . . . . 0.599 HG21 ' O ' ' A' ' 764' ' ' SER . 46.2 t -61.81 -48.15 89.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.996 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . 0.57 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.46 -33.33 75.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 770' ' ' ARG . . . . . 0.459 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 20.1 mtt180 -70.1 -41.85 73.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.139 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . 0.422 ' HD3' ' HE2' ' A' ' 756' ' ' PHE . 4.5 tptt -78.49 -39.84 37.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.644 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 772' ' ' LEU . . . . . 0.535 ' CD2' ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -87.68 -9.49 54.01 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.522 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt 60.32 41.27 16.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.025 0.44 . . . . 0.0 109.825 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 774' ' ' ILE . . . . . 0.57 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 20.1 pt -111.89 -173.95 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.342 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.51 150.03 20.97 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.05 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -54.24 -45.34 72.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.879 0.371 . . . . 0.0 110.751 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -64.19 -47.92 77.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.712 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.76 -49.97 75.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.766 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.54 -49.9 74.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.28 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 780' ' ' ALA . . . . . 0.461 ' HA ' HG12 ' A' ' 765' ' ' ILE . . . -55.94 -40.04 72.59 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.797 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -59.63 -47.04 87.14 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 782' ' ' MET . . . . . 0.402 ' CE ' ' HB3' ' A' ' 753' ' ' ALA . 1.6 mtp -63.07 -43.13 99.42 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 783' ' ' ILE . . . . . 0.518 ' CG2' ' NH1' ' A' ' 801' ' ' ARG . 12.3 mm -57.45 -38.77 64.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.682 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -62.15 -43.3 99.14 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.416 ' HB1' ' CE2' ' A' ' 750' ' ' TYR . . . -61.15 -33.41 73.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.581 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 786' ' ' MET . . . . . 0.606 ' HG2' HG21 ' A' ' 754' ' ' VAL . 13.2 mtm -65.63 -39.44 91.48 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.275 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -63.57 -45.3 91.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.19 0.519 . . . . 0.0 110.312 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 53.0 mtm -72.01 -36.86 69.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.664 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -75.53 -21.66 57.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.137 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 790' ' ' GLY . . . . . 0.416 ' O ' ' HB ' ' A' ' 804' ' ' ILE . . . 94.14 18.52 36.44 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.621 -178.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.522 ' HA ' ' CB ' ' A' ' 805' ' ' ALA . 57.5 t -86.82 -30.2 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.723 0.296 . . . . 0.0 110.961 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 792' ' ' VAL . . . . . 0.466 HG13 ' CG1' ' A' ' 757' ' ' VAL . 22.2 m -139.31 144.06 29.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.629 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 793' ' ' THR . . . . . 0.54 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.1 p -87.37 166.81 23.68 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 794' ' ' PRO . . . . . 0.54 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 28.5 Cg_endo -62.07 166.13 13.17 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.074 1.849 . . . . 0.0 112.262 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.31 161.92 13.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.173 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -105.31 176.34 5.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.826 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 44.8 p -61.79 -32.5 72.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.818 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -79.69 -17.55 53.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.178 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.27 25.1 8.47 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.46 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 20.8 m -122.14 129.96 52.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 110.935 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 801' ' ' ARG . . . . . 0.518 ' NH1' ' CG2' ' A' ' 783' ' ' ILE . 12.1 mtt-85 -83.82 170.67 13.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.287 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -127.81 167.75 16.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.926 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 803' ' ' VAL . . . . . 0.458 HG23 ' CG1' ' A' ' 757' ' ' VAL . 16.4 t -109.05 137.92 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.956 0.407 . . . . 0.0 112.017 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 804' ' ' ILE . . . . . 0.461 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -108.26 -27.36 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.267 178.751 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 805' ' ' ALA . . . . . 0.522 ' CB ' ' HA ' ' A' ' 791' ' ' VAL . . . -83.11 123.96 76.9 Favored Pre-proline 0 N--CA 1.454 -0.237 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.996 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.57 163.79 31.36 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.679 2.253 . . . . 0.0 112.252 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.216 -179.923 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.61 -0.196 . . . . 0.0 112.61 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 1.4 m -123.04 -55.96 1.76 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.148 0.499 . . . . 0.0 110.282 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -151.05 -47.92 0.12 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.23 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.03 95.33 4.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.527 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.9 t70 -122.5 142.34 37.04 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.353 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -38.04 -27.82 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.921 2.414 . . . . 0.0 113.556 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 749' ' ' LEU . . . . . 0.466 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 43.5 mt -119.91 -17.36 8.49 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 750' ' ' TYR . . . . . 0.5 ' CE2' ' CG2' ' A' ' 754' ' ' VAL . 66.3 t80 -55.14 -46.94 75.69 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.816 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -53.27 -36.73 61.46 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 752' ' ' GLU . . . . . 0.541 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 0.6 OUTLIER -71.04 -45.04 64.58 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.018 178.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -59.35 -52.3 66.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.352 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 754' ' ' VAL . . . . . 0.559 HG21 ' HG2' ' A' ' 786' ' ' MET . 2.3 t -56.12 -43.02 74.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.958 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -66.72 -35.56 80.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.353 0.597 . . . . 0.0 109.708 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 756' ' ' PHE . . . . . 0.405 ' CE2' ' CG2' ' A' ' 768' ' ' VAL . 3.5 t80 -66.24 -46.1 78.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.921 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 757' ' ' VAL . . . . . 0.416 ' CG1' HG13 ' A' ' 792' ' ' VAL . 43.7 t -69.31 -45.05 79.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.932 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 2.0 p -56.64 -42.92 79.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.794 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -78.9 -39.82 33.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.285 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 760' ' ' SER . . . . . 0.406 ' OG ' ' HA ' ' A' ' 757' ' ' VAL . 92.4 p -74.46 -16.88 60.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.35 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 9.0 mmm-85 62.35 24.96 14.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.591 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -157.87 133.14 8.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.678 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 763' ' ' ALA . . . . . . . . . . . . . . . -102.61 89.77 3.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.965 0.412 . . . . 0.0 111.564 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 764' ' ' SER . . . . . 0.484 ' O ' HG21 ' A' ' 768' ' ' VAL . 1.8 m -125.02 118.53 26.4 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 765' ' ' ILE . . . . . 0.422 HG12 ' HA ' ' A' ' 780' ' ' ALA . 2.2 mp -51.16 -51.49 22.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.952 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 766' ' ' SER . . . . . 0.444 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 14.3 t -53.32 -42.21 66.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.155 0.502 . . . . 0.0 110.629 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -70.1 -42.12 73.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.549 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 768' ' ' VAL . . . . . 0.484 HG21 ' O ' ' A' ' 764' ' ' SER . 42.5 t -59.47 -47.48 90.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.215 179.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . 0.567 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.8 OUTLIER -65.49 -33.46 75.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.719 -179.729 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 770' ' ' ARG . . . . . 0.464 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 0.0 OUTLIER -68.89 -42.25 77.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.046 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -78.55 -42.16 30.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.693 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 772' ' ' LEU . . . . . 0.541 ' CD2' ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -84.98 -8.79 58.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.889 -179.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp 58.21 41.83 22.94 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 774' ' ' ILE . . . . . 0.567 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 26.9 pt -111.84 -173.9 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.72 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -91.53 153.08 21.88 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.972 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -58.5 -46.69 86.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.832 0.349 . . . . 0.0 110.73 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -57.57 -47.74 81.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.064 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.0 -50.28 64.83 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.693 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -54.85 -50.09 69.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.674 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 780' ' ' ALA . . . . . 0.422 ' HA ' HG12 ' A' ' 765' ' ' ILE . . . -59.31 -42.92 92.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.76 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -58.93 -48.49 81.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.105 0.478 . . . . 0.0 109.88 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 782' ' ' MET . . . . . . . . . . . . . 33.5 mtm -65.21 -34.52 78.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.45 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 783' ' ' ILE . . . . . 0.42 HG22 ' NH1' ' A' ' 801' ' ' ARG . 5.9 mm -64.6 -36.2 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.094 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.99 -39.94 94.22 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.458 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -60.11 -34.6 73.72 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.42 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 786' ' ' MET . . . . . 0.559 ' HG2' HG21 ' A' ' 754' ' ' VAL . 13.9 mtm -67.07 -39.07 86.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.975 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.51 -54.12 50.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.726 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 20.1 mtm -70.36 -38.34 74.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.129 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -65.54 -21.59 66.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.558 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 91.14 14.97 56.84 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.84 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.438 ' C ' HG13 ' A' ' 804' ' ' ILE . 23.7 t -84.51 -30.69 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-O 120.892 0.377 . . . . 0.0 111.028 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 792' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' A' ' 786' ' ' MET . 18.9 m -137.07 140.06 43.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.278 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 793' ' ' THR . . . . . 0.461 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 2.3 p -85.18 160.56 54.43 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.831 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 794' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 17.7 Cg_endo -58.94 167.55 5.41 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.137 1.891 . . . . 0.0 111.873 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.54 157.01 38.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.202 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 35.9 p30 -105.55 176.61 5.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.826 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 7.9 t -57.31 -33.95 68.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.023 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -71.95 -17.51 62.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.14 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 92.99 27.76 13.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.474 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 3.5 m -127.72 133.95 49.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 0.0 110.898 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 801' ' ' ARG . . . . . 0.42 ' NH1' HG22 ' A' ' 783' ' ' ILE . 8.4 mtt-85 -85.6 170.66 12.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.243 0.544 . . . . 0.0 111.354 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -130.86 167.34 19.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.042 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 803' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 792' ' ' VAL . 21.9 t -109.5 135.87 47.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.951 0.405 . . . . 0.0 111.63 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 804' ' ' ILE . . . . . 0.438 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -104.51 -28.43 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.259 179.058 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 805' ' ' ALA . . . . . 0.406 ' CB ' ' HA ' ' A' ' 791' ' ' VAL . . . -81.33 124.15 80.77 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.87 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.32 163.85 25.05 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.671 2.247 . . . . 0.0 112.188 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.2 -179.799 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.743 -0.143 . . . . 0.0 112.743 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.5 -51.69 2.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.141 0.496 . . . . 0.0 110.267 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -157.03 -49.14 0.07 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.024 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -124.93 95.07 4.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.227 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 13.1 t70 -122.57 143.31 39.52 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.344 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 748' ' ' PRO . . . . . 0.4 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 45.3 Cg_exo -36.14 -29.32 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.011 2.474 . . . . 0.0 113.789 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 749' ' ' LEU . . . . . 0.439 HD21 HD22 ' A' ' 772' ' ' LEU . 23.8 mt -120.05 -17.24 8.44 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 750' ' ' TYR . . . . . 0.528 ' CE2' ' CG2' ' A' ' 754' ' ' VAL . 70.1 t80 -53.39 -48.37 68.72 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.949 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -53.24 -37.29 61.94 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 752' ' ' GLU . . . . . 0.579 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 0.5 OUTLIER -70.94 -42.12 70.25 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.085 178.679 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 753' ' ' ALA . . . . . 0.421 ' HB2' ' CE ' ' A' ' 782' ' ' MET . . . -60.96 -53.7 54.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.202 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 754' ' ' VAL . . . . . 0.539 HG21 ' HG2' ' A' ' 786' ' ' MET . 8.0 t -56.27 -39.98 63.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.063 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 37.9 mtt180 -67.62 -37.37 82.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.39 0.614 . . . . 0.0 109.766 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 756' ' ' PHE . . . . . 0.412 ' CE1' ' HB2' ' A' ' 771' ' ' LYS . 4.6 t80 -67.68 -46.06 73.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.288 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 757' ' ' VAL . . . . . 0.445 HG12 ' CB ' ' A' ' 763' ' ' ALA . 54.3 t -69.46 -43.94 80.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.958 0.409 . . . . 0.0 110.61 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 12.5 p -56.67 -45.6 81.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.052 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -78.8 -34.39 45.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.634 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 760' ' ' SER . . . . . 0.504 ' HB2' ' NE ' ' A' ' 762' ' ' ARG . 91.7 p -75.25 -17.76 60.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.527 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 5.9 mmm-85 63.68 33.55 12.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.349 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 762' ' ' ARG . . . . . 0.504 ' NE ' ' HB2' ' A' ' 760' ' ' SER . 0.0 OUTLIER -170.61 136.64 1.27 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.403 179.535 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 763' ' ' ALA . . . . . 0.481 ' HB2' ' HD3' ' A' ' 801' ' ' ARG . . . -104.46 89.76 3.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 0.0 111.82 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 764' ' ' SER . . . . . 0.531 ' O ' HG21 ' A' ' 768' ' ' VAL . 1.0 OUTLIER -121.36 118.52 29.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.571 178.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 765' ' ' ILE . . . . . 0.442 HG12 ' HA ' ' A' ' 780' ' ' ALA . 1.6 mt -53.33 -50.49 47.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.618 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 766' ' ' SER . . . . . 0.437 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 16.3 t -55.27 -39.04 69.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.167 0.508 . . . . 0.0 110.492 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -71.8 -37.54 70.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.503 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 768' ' ' VAL . . . . . 0.531 HG21 ' O ' ' A' ' 764' ' ' SER . 44.5 t -65.57 -47.85 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.241 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . 0.572 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -64.85 -33.39 75.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.478 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 770' ' ' ARG . . . . . 0.448 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 2.6 mtt180 -70.91 -42.5 69.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.117 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . 0.412 ' HB2' ' CE1' ' A' ' 756' ' ' PHE . 0.2 OUTLIER -78.52 -36.43 44.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.086 -179.425 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 772' ' ' LEU . . . . . 0.579 ' CD2' ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -91.59 -9.35 44.48 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.885 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt 60.76 40.94 15.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.073 0.463 . . . . 0.0 109.815 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 774' ' ' ILE . . . . . 0.572 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 20.5 pt -111.84 -173.92 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.292 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.91 150.96 21.87 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.12 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -55.63 -45.37 77.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.855 0.359 . . . . 0.0 110.582 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -63.77 -47.94 78.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.771 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -50.12 75.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.893 0.378 . . . . 0.0 110.783 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.64 72.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.458 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 780' ' ' ALA . . . . . 0.442 ' HA ' HG12 ' A' ' 765' ' ' ILE . . . -56.27 -40.69 74.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.941 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 12.5 mtt180 -58.86 -46.35 87.97 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 782' ' ' MET . . . . . 0.421 ' CE ' ' HB2' ' A' ' 753' ' ' ALA . 2.3 mtp -64.74 -42.59 95.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 783' ' ' ILE . . . . . 0.431 ' CG2' ' NH1' ' A' ' 801' ' ' ARG . 9.9 mm -57.22 -35.64 49.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.291 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.12 -45.47 88.45 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.434 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -58.26 -33.62 69.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.603 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 786' ' ' MET . . . . . 0.539 ' HG2' HG21 ' A' ' 754' ' ' VAL . 14.4 mtm -67.2 -38.21 84.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.083 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -62.27 -47.9 82.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.582 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 36.3 mtm -73.56 -37.53 65.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.272 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -70.46 -21.58 62.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.599 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 92.22 15.51 53.44 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.819 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.49 ' C ' HG13 ' A' ' 804' ' ' ILE . 59.7 t -83.93 -29.12 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.744 0.307 . . . . 0.0 111.101 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 792' ' ' VAL . . . . . 0.429 HG22 ' NH1' ' A' ' 801' ' ' ARG . 18.8 m -139.39 135.42 40.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.953 0.406 . . . . 0.0 111.375 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 793' ' ' THR . . . . . 0.639 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 4.7 p -80.49 168.31 26.45 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.597 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 794' ' ' PRO . . . . . 0.639 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 38.7 Cg_endo -65.44 163.38 29.93 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 121.877 1.718 . . . . 0.0 111.965 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 795' ' ' MET . . . . . 0.405 ' HA ' ' HG3' ' A' ' 801' ' ' ARG . 0.1 OUTLIER -60.8 162.27 6.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.453 -179.69 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -105.53 176.5 5.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.892 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 60.2 p -60.58 -30.41 69.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.022 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -83.79 -17.53 40.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.252 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.41 26.41 7.74 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.513 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 50.7 m -123.27 130.44 52.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.911 0.386 . . . . 0.0 110.825 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 801' ' ' ARG . . . . . 0.481 ' HD3' ' HB2' ' A' ' 763' ' ' ALA . 9.3 mtt-85 -83.68 170.57 14.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.213 0.53 . . . . 0.0 111.465 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -132.14 134.51 45.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.934 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 803' ' ' VAL . . . . . 0.409 HG23 ' CG1' ' A' ' 757' ' ' VAL . 18.9 t -76.91 136.86 23.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.985 0.422 . . . . 0.0 111.904 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 804' ' ' ILE . . . . . 0.49 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -107.04 -29.78 2.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.516 178.875 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 805' ' ' ALA . . . . . 0.464 ' CB ' ' HA ' ' A' ' 791' ' ' VAL . . . -75.08 120.15 80.29 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -50.2 163.9 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.678 2.252 . . . . 0.0 112.92 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.148 179.989 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 14.6 m -119.35 -47.5 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.134 0.492 . . . . 0.0 110.363 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -159.26 -49.67 0.06 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.223 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.38 95.21 4.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.355 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.42 142.96 38.39 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.316 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 748' ' ' PRO . . . . . 0.41 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 43.8 Cg_exo -36.69 -28.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.015 2.477 . . . . 0.0 113.774 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 749' ' ' LEU . . . . . 0.466 HD21 HD22 ' A' ' 772' ' ' LEU . 28.6 mt -119.99 -17.1 8.51 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 750' ' ' TYR . . . . . 0.543 ' CE2' HG22 ' A' ' 754' ' ' VAL . 82.3 t80 -52.81 -50.47 63.59 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.791 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -52.93 -35.99 59.17 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 752' ' ' GLU . . . . . 0.583 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 5.9 tt0 -71.05 -41.89 70.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.23 178.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -62.89 -53.77 48.98 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.987 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 754' ' ' VAL . . . . . 0.543 HG22 ' CE2' ' A' ' 750' ' ' TYR . 9.1 t -56.02 -41.43 68.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.738 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -65.6 -35.11 79.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.281 178.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 756' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -69.73 -46.3 66.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.367 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 757' ' ' VAL . . . . . 0.477 HG12 ' CB ' ' A' ' 763' ' ' ALA . 51.6 t -70.44 -38.37 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 120.921 0.391 . . . . 0.0 110.843 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 22.4 p -65.21 -42.48 93.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.177 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -77.14 -46.48 23.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.373 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 92.5 p -74.68 -10.47 59.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.154 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.65 30.25 17.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.06 0.457 . . . . 0.0 110.607 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -145.5 138.46 26.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.543 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 763' ' ' ALA . . . . . 0.477 ' CB ' HG12 ' A' ' 757' ' ' VAL . . . -117.76 89.57 3.15 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.97 0.414 . . . . 0.0 111.025 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 764' ' ' SER . . . . . 0.504 ' O ' HG21 ' A' ' 768' ' ' VAL . 2.7 m -133.91 118.45 17.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.637 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 765' ' ' ILE . . . . . 0.447 HG21 ' N ' ' A' ' 780' ' ' ALA . 19.1 mt -50.01 -46.65 23.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.704 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 766' ' ' SER . . . . . 0.461 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 12.1 t -58.9 -39.0 80.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.136 0.493 . . . . 0.0 110.534 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -72.93 -36.61 67.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.349 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 768' ' ' VAL . . . . . 0.504 HG21 ' O ' ' A' ' 764' ' ' SER . 40.7 t -65.22 -48.01 85.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.067 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . 0.581 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.41 -33.47 76.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.569 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 770' ' ' ARG . . . . . 0.415 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 12.1 mtt180 -71.54 -41.53 69.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.065 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.63 -36.52 43.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.829 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 772' ' ' LEU . . . . . 0.583 ' CD2' ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -91.28 -10.03 42.93 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt 61.61 39.94 13.97 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 774' ' ' ILE . . . . . 0.581 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 24.1 pt -111.77 -174.49 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.481 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.69 152.98 23.57 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.228 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -57.16 -46.34 82.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.926 0.393 . . . . 0.0 110.625 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -62.87 -47.83 81.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.724 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . 0.422 ' NE ' HD13 ' A' ' 749' ' ' LEU . 0.4 OUTLIER -60.27 -50.24 74.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.82 -179.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.84 -50.04 73.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.349 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 780' ' ' ALA . . . . . 0.447 ' N ' HG21 ' A' ' 765' ' ' ILE . . . -55.64 -42.89 75.63 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.781 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -58.66 -43.09 89.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.097 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 782' ' ' MET . . . . . . . . . . . . . 2.6 mtp -68.38 -40.04 81.55 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 783' ' ' ILE . . . . . 0.479 HG21 ' NH2' ' A' ' 801' ' ' ARG . 5.3 mm -58.14 -40.08 75.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.798 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 784' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 787' ' ' GLU . 2.3 mt-10 -63.99 -46.18 85.7 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.444 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -54.76 -33.42 61.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.508 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 786' ' ' MET . . . . . 0.526 ' HG2' HG21 ' A' ' 754' ' ' VAL . 14.9 mtm -67.7 -39.36 84.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.848 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 787' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 784' ' ' GLU . 0.4 OUTLIER -57.62 -51.5 69.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.669 179.415 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 46.9 mtm -75.46 -38.37 59.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.915 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -64.31 -21.2 66.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.921 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 91.87 19.77 39.04 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.419 -178.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.474 ' C ' HG13 ' A' ' 804' ' ' ILE . 79.2 t -89.2 -32.78 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.793 0.33 . . . . 0.0 111.059 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 792' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 803' ' ' VAL . 28.3 m -137.49 143.44 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.0 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 793' ' ' THR . . . . . 0.513 HG21 HG12 ' A' ' 804' ' ' ILE . 6.8 p -82.03 155.2 70.16 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.421 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 794' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.75 169.03 3.62 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.424 2.083 . . . . 0.0 112.345 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 795' ' ' MET . . . . . 0.486 ' HA ' ' HG3' ' A' ' 801' ' ' ARG . 1.4 mtp -60.92 159.52 11.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.303 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -102.48 176.56 5.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.805 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 38.2 p -60.59 -28.01 68.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.07 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -90.9 -17.59 26.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.327 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 104.8 28.55 5.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.765 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 19.3 m -121.91 129.88 52.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.871 0.367 . . . . 0.0 110.929 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 801' ' ' ARG . . . . . 0.486 ' HG3' ' HA ' ' A' ' 795' ' ' MET . 0.4 OUTLIER -94.46 170.49 9.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.125 0.488 . . . . 0.0 111.387 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.95 -172.42 2.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.488 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 803' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 792' ' ' VAL . 30.2 t -121.14 138.66 50.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.843 0.354 . . . . 0.0 111.741 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 804' ' ' ILE . . . . . 0.513 HG12 HG21 ' A' ' 793' ' ' THR . 0.0 OUTLIER -110.16 -27.13 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.777 179.282 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 805' ' ' ALA . . . . . 0.472 ' CB ' ' HA ' ' A' ' 791' ' ' VAL . . . -84.74 120.87 74.43 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.889 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.42 163.71 28.63 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.59 2.193 . . . . 0.0 112.163 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.168 -179.903 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.375 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 9.8 p -101.76 -158.04 0.65 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.592 0.234 . . . . 0.0 110.656 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -50.78 -45.31 59.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.722 0.296 . . . . 0.0 111.505 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -128.13 95.61 4.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.069 0.461 . . . . 0.0 111.34 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 14.6 t70 -122.36 142.34 36.82 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.413 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -35.12 -30.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.311 2.674 . . . . 0.0 113.993 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 749' ' ' LEU . . . . . 0.423 HD21 HD22 ' A' ' 772' ' ' LEU . 44.7 mt -120.02 -16.91 8.54 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 750' ' ' TYR . . . . . 0.524 ' HB2' ' HB3' ' A' ' 747' ' ' ASP . 67.7 t80 -54.08 -47.81 71.31 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.483 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -53.45 -35.73 60.81 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 752' ' ' GLU . . . . . 0.424 ' HB2' ' CD2' ' A' ' 772' ' ' LEU . 8.4 mt-10 -70.95 -40.91 71.74 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.182 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 753' ' ' ALA . . . . . 0.41 ' HA ' HD12 ' A' ' 772' ' ' LEU . . . -64.24 -52.35 59.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.118 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 754' ' ' VAL . . . . . 0.544 HG21 ' HG2' ' A' ' 786' ' ' MET . 3.1 t -56.35 -40.09 64.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.005 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.59 -35.32 77.2 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 756' ' ' PHE . . . . . 0.553 ' HD2' ' HD2' ' A' ' 771' ' ' LYS . 1.1 t80 -67.42 -46.12 74.11 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.93 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 757' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 761' ' ' ARG . 43.3 t -70.82 -41.07 77.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.86 0.362 . . . . 0.0 110.757 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 20.3 p -62.18 -42.08 98.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.568 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -77.26 -47.03 21.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.882 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 6.3 p -70.98 -18.54 62.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.765 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 761' ' ' ARG . . . . . 0.404 ' N ' ' O ' ' A' ' 757' ' ' VAL . 0.0 OUTLIER 65.17 18.69 11.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.771 -179.626 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -139.74 145.39 38.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.749 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 763' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 801' ' ' ARG . . . -117.43 89.46 3.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.237 0.541 . . . . 0.0 110.83 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 764' ' ' SER . . . . . 0.498 ' O ' HG21 ' A' ' 768' ' ' VAL . 23.7 m -129.99 118.59 21.84 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 765' ' ' ILE . . . . . 0.443 HG12 ' HA ' ' A' ' 780' ' ' ALA . 11.2 mt -51.77 -47.17 39.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.697 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 766' ' ' SER . . . . . 0.55 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 22.2 t -59.3 -37.73 78.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.149 0.499 . . . . 0.0 110.571 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -73.1 -42.17 63.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.229 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 768' ' ' VAL . . . . . 0.498 HG21 ' O ' ' A' ' 764' ' ' SER . 30.4 t -59.76 -50.91 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.971 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . 0.615 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -63.58 -33.45 75.63 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.713 -179.649 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -67.03 -43.87 81.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.122 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . 0.553 ' HD2' ' HD2' ' A' ' 756' ' ' PHE . 0.9 OUTLIER -78.64 -42.16 29.5 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.838 0.351 . . . . 0.0 111.794 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 772' ' ' LEU . . . . . 0.424 ' CD2' ' HB2' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -81.37 -10.57 59.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.815 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm 60.03 40.76 18.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.193 0.521 . . . . 0.0 109.701 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 774' ' ' ILE . . . . . 0.615 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 24.2 pt -111.82 -173.99 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.563 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.55 149.91 21.45 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.111 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -53.98 -44.72 71.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 110.662 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 777' ' ' ASN . . . . . 0.42 ' O ' ' HG3' ' A' ' 781' ' ' ARG . 79.3 m-20 -65.01 -47.89 75.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.692 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.83 -50.07 74.51 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.865 0.364 . . . . 0.0 110.752 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 779' ' ' ALA . . . . . 0.412 ' HB2' ' CD1' ' A' ' 774' ' ' ILE . . . -58.14 -45.88 86.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.105 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 780' ' ' ALA . . . . . 0.443 ' HA ' HG12 ' A' ' 765' ' ' ILE . . . -56.93 -44.3 82.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.103 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 781' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 777' ' ' ASN . 7.4 mtt180 -58.76 -46.86 86.51 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 782' ' ' MET . . . . . 0.419 ' HE2' ' HB3' ' A' ' 749' ' ' LEU . 2.5 mtp -64.06 -41.81 97.22 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 783' ' ' ILE . . . . . 0.439 ' CG2' ' NH1' ' A' ' 801' ' ' ARG . 7.2 mm -58.73 -37.16 64.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.448 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.26 -45.2 92.61 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.433 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -58.99 -33.53 70.8 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.63 178.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 786' ' ' MET . . . . . 0.544 ' HG2' HG21 ' A' ' 754' ' ' VAL . 12.4 mtm -65.79 -39.79 91.3 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.118 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.32 -47.84 82.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.147 0.499 . . . . 0.0 110.492 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 25.8 mtp -70.95 -38.29 72.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.552 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -71.19 -21.64 62.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.962 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 790' ' ' GLY . . . . . 0.405 ' O ' ' HB ' ' A' ' 804' ' ' ILE . . . 93.3 19.03 36.96 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.605 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.51 ' HA ' ' CB ' ' A' ' 805' ' ' ALA . 38.1 t -88.27 -30.19 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.716 0.293 . . . . 0.0 111.168 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 792' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 803' ' ' VAL . 20.9 m -138.76 143.73 31.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.408 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 793' ' ' THR . . . . . 0.491 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.3 p -88.06 163.59 36.83 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 794' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 18.6 Cg_endo -59.93 166.41 8.67 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 121.957 1.772 . . . . 0.0 112.129 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 1.5 mtt -61.12 162.03 7.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.227 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -105.55 176.54 5.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.766 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 44.1 p -61.62 -33.92 74.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.779 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -79.56 -17.57 53.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.56 28.07 6.87 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.417 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 19.2 m -124.68 130.45 52.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 110.909 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 801' ' ' ARG . . . . . 0.543 ' HB2' ' O ' ' A' ' 763' ' ' ALA . 11.3 mtt-85 -83.95 170.69 13.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.449 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -129.02 168.98 15.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.254 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 803' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 792' ' ' VAL . 21.4 t -110.62 137.27 43.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.011 0.434 . . . . 0.0 111.844 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 804' ' ' ILE . . . . . 0.445 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -107.5 -27.96 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.314 178.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 805' ' ' ALA . . . . . 0.51 ' CB ' ' HA ' ' A' ' 791' ' ' VAL . . . -79.34 122.73 84.39 Favored Pre-proline 0 N--CA 1.455 -0.207 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.742 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.38 163.66 31.38 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.513 2.142 . . . . 0.0 112.198 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.857 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.678 -0.169 . . . . 0.0 112.678 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.43 -47.97 2.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.149 0.5 . . . . 0.0 110.252 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -159.1 -49.59 0.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.177 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -126.35 95.17 4.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.318 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.6 t70 -122.49 143.2 39.1 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.535 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 748' ' ' PRO . . . . . 0.416 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 37.9 Cg_exo -36.72 -28.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.069 2.513 . . . . 0.0 113.895 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 749' ' ' LEU . . . . . 0.444 HD21 HD22 ' A' ' 772' ' ' LEU . 28.9 mt -120.03 -17.2 8.46 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 750' ' ' TYR . . . . . 0.508 ' CE2' ' CG2' ' A' ' 754' ' ' VAL . 80.5 t80 -52.88 -50.34 64.04 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.948 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -53.17 -35.72 60.1 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 752' ' ' GLU . . . . . 0.572 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 8.0 tt0 -71.12 -41.5 70.44 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.293 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 753' ' ' ALA . . . . . 0.433 ' HA ' HD12 ' A' ' 772' ' ' LEU . . . -64.57 -51.95 60.15 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.125 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 754' ' ' VAL . . . . . 0.55 HG21 ' HG2' ' A' ' 786' ' ' MET . 5.0 t -56.12 -38.7 54.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.504 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -69.38 -35.16 75.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.435 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 756' ' ' PHE . . . . . 0.431 ' CE2' ' CG2' ' A' ' 768' ' ' VAL . 1.5 t80 -68.57 -46.2 70.05 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.329 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 757' ' ' VAL . . . . . 0.475 HG13 ' CG2' ' A' ' 803' ' ' VAL . 35.4 t -71.23 -41.38 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-O 120.991 0.424 . . . . 0.0 110.751 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 30.1 p -62.72 -42.89 99.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.993 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -77.48 -46.31 22.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.275 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 760' ' ' SER . . . . . 0.502 ' O ' ' HD3' ' A' ' 762' ' ' ARG . 50.0 p -70.06 -29.17 66.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 761' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 760' ' ' SER . 0.0 OUTLIER 70.86 28.53 3.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.302 -179.248 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 762' ' ' ARG . . . . . 0.502 ' HD3' ' O ' ' A' ' 760' ' ' SER . 0.4 OUTLIER -147.8 110.55 4.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.368 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 763' ' ' ALA . . . . . . . . . . . . . . . -91.06 89.69 7.51 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.052 0.453 . . . . 0.0 111.257 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 764' ' ' SER . . . . . 0.493 ' O ' HG21 ' A' ' 768' ' ' VAL . 1.3 m -133.94 118.85 18.35 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.472 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 765' ' ' ILE . . . . . . . . . . . . . 1.5 mp -48.85 -52.7 9.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.952 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 766' ' ' SER . . . . . 0.508 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 7.9 t -53.34 -40.12 64.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.203 0.525 . . . . 0.0 110.635 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -71.64 -39.75 70.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.445 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 768' ' ' VAL . . . . . 0.493 HG21 ' O ' ' A' ' 764' ' ' SER . 44.4 t -61.89 -49.88 82.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.114 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . 0.575 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -63.47 -33.91 76.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.869 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 770' ' ' ARG . . . . . 0.419 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 7.2 mtt85 -68.95 -42.53 76.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.218 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.7 -39.3 36.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.701 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 772' ' ' LEU . . . . . 0.572 ' CD2' ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -87.07 -9.78 54.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.248 -179.314 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp 60.95 39.7 16.3 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 774' ' ' ILE . . . . . 0.575 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 17.8 pt -111.86 -173.83 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.165 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -90.17 153.18 22.69 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.023 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -57.09 -45.57 83.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.817 0.341 . . . . 0.0 110.64 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 777' ' ' ASN . . . . . 0.421 ' O ' ' HG3' ' A' ' 781' ' ' ARG . 66.4 m-20 -63.13 -48.08 80.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.735 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -50.17 74.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.979 0.418 . . . . 0.0 110.751 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.12 76.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.441 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 780' ' ' ALA . . . . . . . . . . . . . . . -56.97 -40.87 77.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.027 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 781' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 777' ' ' ASN . 17.3 mtt180 -58.88 -46.77 87.02 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 782' ' ' MET . . . . . . . . . . . . . 2.3 mtp -64.83 -42.24 95.09 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 783' ' ' ILE . . . . . 0.498 ' CG2' ' NH2' ' A' ' 801' ' ' ARG . 5.9 mm -55.8 -39.54 56.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.502 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.97 -46.69 86.51 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.427 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -55.19 -33.54 63.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.827 178.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 786' ' ' MET . . . . . 0.55 ' HG2' HG21 ' A' ' 754' ' ' VAL . 14.5 mtm -67.38 -40.53 85.7 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.197 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 787' ' ' GLU . . . . . 0.486 ' HG3' ' NH1' ' A' ' 801' ' ' ARG . 4.2 mt-10 -58.61 -53.66 55.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.647 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 30.9 mtm -71.06 -38.32 72.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.429 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -65.71 -21.42 66.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.7 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 790' ' ' GLY . . . . . 0.42 ' HA3' ' CD1' ' A' ' 804' ' ' ILE . . . 91.15 15.18 56.4 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.608 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.478 ' C ' HG13 ' A' ' 804' ' ' ILE . 86.1 t -84.02 -29.78 7.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.023 0.44 . . . . 0.0 110.672 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 792' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 803' ' ' VAL . 17.6 m -139.54 144.47 28.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.977 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 793' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 6.6 p -83.69 156.84 64.72 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.608 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 794' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 19.0 Cg_endo -58.77 169.51 3.3 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.498 2.132 . . . . 0.0 112.177 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 795' ' ' MET . . . . . 0.424 ' HA ' ' HG3' ' A' ' 801' ' ' ARG . 2.1 mtt -65.13 159.82 22.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.021 0.439 . . . . 0.0 111.254 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 56.6 m-20 -102.15 176.58 5.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.841 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 9.8 t -59.63 -29.52 68.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.069 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 39.1 p30 -87.3 -17.58 32.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.378 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 102.48 31.79 5.1 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.722 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 15.9 m -125.0 129.65 50.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.347 . . . . 0.0 110.75 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 801' ' ' ARG . . . . . 0.498 ' NH2' ' CG2' ' A' ' 783' ' ' ILE . 0.5 OUTLIER -93.51 169.63 10.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.348 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -130.48 -170.81 2.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.713 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 803' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 792' ' ' VAL . 30.0 t -124.58 138.52 53.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.928 0.394 . . . . 0.0 111.887 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 804' ' ' ILE . . . . . 0.478 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -108.97 -30.22 2.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.519 179.232 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 805' ' ' ALA . . . . . 0.442 ' CB ' ' HA ' ' A' ' 791' ' ' VAL . . . -79.55 119.79 78.06 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.892 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.89 163.75 32.38 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.536 2.157 . . . . 0.0 112.219 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.134 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.675 -0.17 . . . . 0.0 112.675 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 56.2 m -122.36 -56.89 1.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.068 0.461 . . . . 0.0 110.322 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -151.37 -48.81 0.12 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.208 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -124.86 95.27 4.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.532 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 747' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.0 t70 -122.45 142.42 37.18 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.501 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -38.73 -27.3 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.873 2.382 . . . . 0.0 113.547 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 749' ' ' LEU . . . . . 0.401 HD11 ' HD3' ' A' ' 778' ' ' ARG . 46.2 mt -119.99 -17.06 8.53 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 750' ' ' TYR . . . . . 0.502 ' CE2' ' CG2' ' A' ' 754' ' ' VAL . 71.1 t80 -55.62 -47.14 77.05 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.386 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -53.27 -35.72 60.36 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -71.03 -43.58 67.6 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.255 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -61.87 -53.39 56.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.205 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 754' ' ' VAL . . . . . 0.562 HG21 ' HG2' ' A' ' 786' ' ' MET . 3.2 t -56.18 -41.14 68.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.552 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -69.68 -35.43 75.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.333 0.587 . . . . 0.0 109.844 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 756' ' ' PHE . . . . . 0.405 ' CE1' ' HB2' ' A' ' 771' ' ' LYS . 4.0 t80 -66.95 -46.07 75.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.044 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 757' ' ' VAL . . . . . 0.405 HG12 ' CB ' ' A' ' 763' ' ' ALA . 59.5 t -70.47 -44.86 76.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.883 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 9.1 p -56.83 -44.87 82.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.277 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -78.84 -39.73 34.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.463 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 760' ' ' SER . . . . . 0.467 ' HB2' ' NE ' ' A' ' 762' ' ' ARG . 94.6 p -72.56 -25.04 61.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.254 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 67.98 42.71 1.8 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.377 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 762' ' ' ARG . . . . . 0.467 ' NE ' ' HB2' ' A' ' 760' ' ' SER . 0.0 OUTLIER -174.61 121.19 0.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.564 179.495 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 763' ' ' ALA . . . . . 0.405 ' CB ' HG12 ' A' ' 757' ' ' VAL . . . -93.87 89.77 6.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.972 0.415 . . . . 0.0 111.646 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 764' ' ' SER . . . . . 0.528 ' O ' HG21 ' A' ' 768' ' ' VAL . 9.9 m -123.54 118.55 27.61 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 765' ' ' ILE . . . . . 0.419 HG21 ' N ' ' A' ' 780' ' ' ALA . 24.1 mt -53.51 -50.15 50.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.738 -179.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 766' ' ' SER . . . . . 0.413 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 11.4 t -53.35 -43.24 67.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.221 0.534 . . . . 0.0 110.499 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -69.75 -39.87 76.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.768 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 768' ' ' VAL . . . . . 0.528 HG21 ' O ' ' A' ' 764' ' ' SER . 47.0 t -61.85 -45.71 98.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.253 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 769' ' ' GLN . . . . . 0.561 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.8 OUTLIER -66.5 -33.48 75.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.416 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 770' ' ' ARG . . . . . 0.461 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 20.5 mtt180 -70.95 -42.06 70.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.037 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . 0.405 ' HB2' ' CE1' ' A' ' 756' ' ' PHE . 0.7 OUTLIER -78.53 -38.27 40.94 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.007 -179.488 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 772' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 768' ' ' VAL . 0.2 OUTLIER -90.35 -9.32 48.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.573 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt 60.16 42.24 15.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 774' ' ' ILE . . . . . 0.561 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 29.4 pt -112.0 -174.05 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.816 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -90.95 150.49 20.58 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.088 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -55.03 -46.52 75.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.902 0.382 . . . . 0.0 110.885 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -59.6 -45.91 90.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.206 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 778' ' ' ARG . . . . . 0.401 ' HD3' HD11 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -66.11 -50.44 64.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.833 0.349 . . . . 0.0 110.858 -179.788 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -55.12 -50.21 69.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.202 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 780' ' ' ALA . . . . . 0.419 ' N ' HG21 ' A' ' 765' ' ' ILE . . . -56.06 -46.45 78.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.985 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -58.9 -48.42 81.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.253 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 782' ' ' MET . . . . . . . . . . . . . 33.8 mtm -63.41 -36.36 83.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.307 0.575 . . . . 0.0 109.461 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 783' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 786' ' ' MET . 7.4 mm -63.37 -40.28 88.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.18 -42.71 91.48 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 785' ' ' ALA . . . . . 0.436 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -60.02 -33.58 72.21 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.719 178.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 786' ' ' MET . . . . . 0.562 ' HG2' HG21 ' A' ' 754' ' ' VAL . 12.7 mtm -66.05 -37.62 86.29 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.062 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 787' ' ' GLU . . . . . 0.435 ' HG3' ' CZ ' ' A' ' 801' ' ' ARG . 3.3 mt-10 -63.36 -53.97 44.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.742 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 24.5 mtm -68.55 -37.64 80.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.494 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -68.73 -21.59 64.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.796 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 89.75 19.55 47.47 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.926 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 791' ' ' VAL . . . . . 0.447 ' C ' HG13 ' A' ' 804' ' ' ILE . 11.3 t -84.45 -34.67 9.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.804 0.335 . . . . 0.0 110.756 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 792' ' ' VAL . . . . . 0.508 HG23 ' HB3' ' A' ' 786' ' ' MET . 11.7 m -133.88 140.21 46.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.28 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 793' ' ' THR . . . . . 0.441 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.2 p -77.85 160.89 73.21 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 794' ' ' PRO . . . . . 0.441 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 22.7 Cg_endo -60.29 166.08 9.87 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.088 1.859 . . . . 0.0 111.967 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 2.1 mtt -56.56 158.46 4.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.196 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -101.25 176.47 5.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.921 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 9.7 t -55.63 -33.26 63.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -85.18 -17.58 36.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.121 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.6 35.96 3.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.548 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 6.0 m -127.82 130.01 47.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.956 0.408 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 801' ' ' ARG . . . . . 0.472 ' NH2' ' CG2' ' A' ' 783' ' ' ILE . 6.5 mtp85 -81.67 170.58 15.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.331 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -131.27 -170.7 2.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.659 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 803' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 792' ' ' VAL . 23.0 t -127.26 133.7 67.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.17 0.51 . . . . 0.0 112.098 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 804' ' ' ILE . . . . . 0.447 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -105.15 -28.76 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.858 178.69 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 805' ' ' ALA . . . . . . . . . . . . . . . -80.85 126.49 77.59 Favored Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.778 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.61 163.77 23.22 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.713 2.275 . . . . 0.0 112.228 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.234 -179.783 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.486 -0.245 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 2.4 p -127.29 -56.42 1.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.81 0.338 . . . . 0.0 110.863 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -107.02 112.2 25.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.974 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . 102.47 57.8 0.79 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.588 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -116.56 -49.75 2.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.141 0.496 . . . . 0.0 110.262 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.69 -50.52 0.08 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.95 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -124.1 95.23 4.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.266 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.3 t70 -122.44 142.46 37.25 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.531 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -37.24 -28.88 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.057 2.505 . . . . 0.0 113.582 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 749' ' ' LEU . . . . . 0.424 HD13 ' NE ' ' A' ' 778' ' ' ARG . 31.6 mt -119.96 -16.87 8.58 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.525 ' CE2' ' CG2' ' A' ' 754' ' ' VAL . 72.4 t80 -53.4 -48.54 68.6 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 120.344 -0.543 . . . . 0.0 110.457 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -53.37 -36.15 61.08 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . 0.413 ' HB2' ' CD2' ' A' ' 772' ' ' LEU . 1.8 mt-10 -70.95 -40.95 71.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.024 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -63.85 -52.93 57.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.043 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 754' ' ' VAL . . . . . 0.525 ' CG2' ' CE2' ' A' ' 750' ' ' TYR . 8.8 t -56.14 -39.99 62.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.281 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.65 -35.71 75.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.312 0.577 . . . . 0.0 109.461 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 756' ' ' PHE . . . . . 0.499 ' HD2' ' HD3' ' A' ' 771' ' ' LYS . 1.0 OUTLIER -66.58 -46.05 77.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.861 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 757' ' ' VAL . . . . . 0.411 HG12 ' CB ' ' A' ' 763' ' ' ALA . 45.6 t -68.6 -47.1 78.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.973 0.416 . . . . 0.0 110.452 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 8.4 p -53.93 -43.18 69.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.972 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -78.88 -36.81 41.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.361 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 17.9 p -76.63 -15.07 59.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.454 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 63.07 19.9 11.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.696 0.284 . . . . 0.0 111.415 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 5.4 ptt180 -154.87 140.03 17.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.844 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 763' ' ' ALA . . . . . 0.411 ' CB ' HG12 ' A' ' 757' ' ' VAL . . . -106.84 89.76 3.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 111.528 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 764' ' ' SER . . . . . 0.496 ' O ' HG21 ' A' ' 768' ' ' VAL . 1.4 m -122.62 118.64 28.66 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 765' ' ' ILE . . . . . 0.434 HG21 ' N ' ' A' ' 780' ' ' ALA . 22.6 mt -53.46 -49.71 52.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.75 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 766' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 12.9 t -53.77 -43.81 69.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.2 0.524 . . . . 0.0 110.578 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -67.86 -45.12 75.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.533 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 768' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 764' ' ' SER . 26.5 t -56.5 -49.15 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.364 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . 0.572 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -63.52 -33.42 75.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.594 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 770' ' ' ARG . . . . . 0.474 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 21.2 mtt180 -70.73 -42.65 70.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.231 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . 0.499 ' HD3' ' HD2' ' A' ' 756' ' ' PHE . 0.0 OUTLIER -78.53 -36.15 45.22 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.522 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 772' ' ' LEU . . . . . 0.413 ' CD2' ' HB2' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -90.87 -10.13 43.77 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp 60.67 41.29 15.34 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 774' ' ' ILE . . . . . 0.572 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 22.6 pt -111.75 -173.88 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.486 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.57 153.75 23.53 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.02 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -56.94 -46.42 82.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 0.0 110.797 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -63.57 -44.52 93.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.799 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . 0.424 ' NE ' HD13 ' A' ' 749' ' ' LEU . 0.4 OUTLIER -62.06 -50.22 72.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.753 179.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -58.34 -48.54 80.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.092 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 780' ' ' ALA . . . . . 0.434 ' N ' HG21 ' A' ' 765' ' ' ILE . . . -56.07 -43.43 77.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.899 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -59.12 -48.53 81.26 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.855 0.359 . . . . 0.0 110.125 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 782' ' ' MET . . . . . . . . . . . . . 2.7 mtp -63.7 -38.31 90.62 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 783' ' ' ILE . . . . . 0.479 ' CG2' ' NH2' ' A' ' 801' ' ' ARG . 7.8 mm -61.31 -40.53 86.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.259 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -44.19 91.21 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.431 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -58.97 -33.65 70.91 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.92 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 786' ' ' MET . . . . . 0.479 ' HG2' HG21 ' A' ' 754' ' ' VAL . 14.0 mtm -66.46 -37.73 85.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.106 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 787' ' ' GLU . . . . . 0.455 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 2.5 mt-10 -62.46 -54.17 44.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.519 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 73.4 mtp -68.07 -38.22 82.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.473 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -70.14 -21.57 63.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.955 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 89.79 16.85 55.78 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.85 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.478 ' C ' HG13 ' A' ' 804' ' ' ILE . 44.8 t -81.93 -31.68 10.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.796 0.331 . . . . 0.0 110.887 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 792' ' ' VAL . . . . . 0.447 HG23 ' CB ' ' A' ' 786' ' ' MET . 7.1 m -135.59 140.76 43.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.074 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 793' ' ' THR . . . . . 0.466 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 9.4 p -78.59 159.69 73.87 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.737 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 794' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 19.3 Cg_endo -59.49 167.25 6.65 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.049 1.832 . . . . 0.0 111.824 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -59.5 163.57 4.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.036 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -105.56 176.55 5.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.859 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 5.4 t -57.27 -30.33 64.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.796 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -88.13 -17.63 30.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.048 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.92 36.71 3.61 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.664 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 17.1 m -127.88 129.13 46.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.906 0.384 . . . . 0.0 111.267 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . 0.479 ' NH2' ' CG2' ' A' ' 783' ' ' ILE . 6.7 mtp85 -83.64 170.36 14.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.287 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 802' ' ' GLU . . . . . 0.447 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 3.2 mt-10 -134.87 174.2 10.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.698 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 803' ' ' VAL . . . . . . . . . . . . . 20.7 t -109.74 136.25 46.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.06 0.457 . . . . 0.0 112.13 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 804' ' ' ILE . . . . . 0.478 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -109.78 -26.94 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.264 178.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 805' ' ' ALA . . . . . . . . . . . . . . . -76.32 122.59 87.04 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.041 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -50.26 163.96 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.604 2.203 . . . . 0.0 112.897 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -106.87 160.71 25.35 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.137 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.06 92.75 0.81 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.551 2.168 . . . . 0.0 112.302 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 21.9 t -83.07 -37.14 13.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.118 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 4.1 mtm105 -160.75 -44.12 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.848 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.91 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 1.2 m -114.12 -49.11 2.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 0.0 110.838 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.22 -167.92 2.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.896 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . -70.49 84.11 0.35 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.606 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 4.5 m -121.55 -62.68 1.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.122 0.487 . . . . 0.0 110.392 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -145.41 -49.16 0.23 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.234 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.62 95.23 4.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.556 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . 0.466 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.9 t70 -122.48 142.31 36.96 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.373 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -38.51 -27.45 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.848 2.366 . . . . 0.0 113.513 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 749' ' ' LEU . . . . . . . . . . . . . 48.4 mt -120.01 -17.02 8.52 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.505 ' CE2' ' CG2' ' A' ' 754' ' ' VAL . 65.3 t80 -55.62 -46.82 77.33 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.349 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -53.38 -35.67 60.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -71.02 -43.7 67.38 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.161 178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -61.92 -51.7 67.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.206 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 754' ' ' VAL . . . . . 0.571 HG21 ' HG2' ' A' ' 786' ' ' MET . 2.3 t -56.33 -42.25 73.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.261 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -69.16 -35.4 76.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.192 0.52 . . . . 0.0 109.909 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 756' ' ' PHE . . . . . 0.406 ' CE2' ' CG2' ' A' ' 768' ' ' VAL . 2.3 t80 -66.58 -45.93 77.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.922 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 757' ' ' VAL . . . . . . . . . . . . . 47.4 t -69.2 -44.56 80.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.926 0.393 . . . . 0.0 110.951 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 3.9 p -58.21 -43.73 87.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.295 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.76 -43.23 26.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.433 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 760' ' ' SER . . . . . 0.417 ' HB2' ' NE ' ' A' ' 762' ' ' ARG . 83.1 p -71.93 -19.96 61.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.039 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 63.52 50.63 2.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.599 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 762' ' ' ARG . . . . . 0.417 ' NE ' ' HB2' ' A' ' 760' ' ' SER . 0.0 OUTLIER 179.81 139.61 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.49 179.399 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 763' ' ' ALA . . . . . . . . . . . . . . . -108.75 89.73 3.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.989 0.423 . . . . 0.0 111.597 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 764' ' ' SER . . . . . 0.492 ' O ' HG21 ' A' ' 768' ' ' VAL . 0.7 OUTLIER -125.54 118.44 25.75 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.705 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 765' ' ' ILE . . . . . 0.416 HG21 ' N ' ' A' ' 780' ' ' ALA . 2.3 mp -53.16 -51.3 40.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.897 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 766' ' ' SER . . . . . 0.45 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 12.4 t -53.42 -41.84 66.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.116 0.484 . . . . 0.0 110.622 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -70.02 -42.96 72.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.536 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 768' ' ' VAL . . . . . 0.492 HG21 ' O ' ' A' ' 764' ' ' SER . 45.6 t -59.03 -47.14 90.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.268 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . 0.572 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.7 OUTLIER -65.56 -33.55 76.19 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.694 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 770' ' ' ARG . . . . . 0.464 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 0.4 OUTLIER -68.26 -42.78 79.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.093 179.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.62 -42.06 29.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.806 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 772' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 768' ' ' VAL . 0.2 OUTLIER -85.02 -8.54 58.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.742 -179.522 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt 58.29 41.94 22.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.185 0.517 . . . . 0.0 109.75 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 774' ' ' ILE . . . . . 0.572 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 29.9 pt -112.01 -173.91 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.789 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -91.87 152.52 21.43 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.872 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -57.91 -46.57 84.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.886 0.374 . . . . 0.0 110.838 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -57.49 -47.51 81.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.13 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -50.31 63.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.909 0.385 . . . . 0.0 110.773 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 779' ' ' ALA . . . . . 0.401 ' HB2' ' CD1' ' A' ' 774' ' ' ILE . . . -54.6 -50.05 68.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.658 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 780' ' ' ALA . . . . . 0.416 ' N ' HG21 ' A' ' 765' ' ' ILE . . . -58.85 -42.95 90.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.826 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -58.97 -48.38 81.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.108 0.48 . . . . 0.0 109.814 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 782' ' ' MET . . . . . 0.407 ' SD ' ' N ' ' A' ' 750' ' ' TYR . 34.8 mtm -65.27 -34.88 79.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.497 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 783' ' ' ILE . . . . . 0.424 ' CD1' HG22 ' A' ' 768' ' ' VAL . 6.5 mm -64.21 -37.27 79.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -64.47 -39.45 93.83 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.452 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -60.68 -34.32 74.15 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.418 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 786' ' ' MET . . . . . 0.571 ' HG2' HG21 ' A' ' 754' ' ' VAL . 14.4 mtm -66.81 -39.96 87.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.992 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -59.59 -54.18 49.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.708 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 68.4 mtm -68.92 -38.29 79.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.147 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -66.54 -21.51 66.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.728 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 91.39 14.14 57.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.903 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.437 ' C ' HG13 ' A' ' 804' ' ' ILE . 24.0 t -84.27 -30.4 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.817 0.341 . . . . 0.0 110.85 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 792' ' ' VAL . . . . . 0.463 HG22 ' NH1' ' A' ' 801' ' ' ARG . 17.7 m -136.83 141.1 41.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.538 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 793' ' ' THR . . . . . 0.47 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 6.2 p -82.61 160.28 61.95 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.818 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 794' ' ' PRO . . . . . 0.47 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 20.7 Cg_endo -60.05 166.64 8.51 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.137 1.891 . . . . 0.0 112.15 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 2.6 mtt -65.5 163.26 16.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.116 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -105.48 176.55 5.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 7.3 t -58.34 -34.6 70.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -82.01 -17.5 46.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.124 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 100.82 34.6 4.59 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.608 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 15.8 m -124.68 129.06 49.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.971 0.415 . . . . 0.0 111.061 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . 0.463 ' NH1' HG22 ' A' ' 792' ' ' VAL . 10.4 mtt-85 -89.9 170.71 10.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.441 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 802' ' ' GLU . . . . . 0.412 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 0.1 OUTLIER -134.14 169.82 16.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.071 179.15 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 803' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 792' ' ' VAL . 21.5 t -109.94 136.19 46.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.993 0.425 . . . . 0.0 111.718 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 804' ' ' ILE . . . . . 0.437 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -104.92 -30.53 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.261 179.083 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 805' ' ' ALA . . . . . . . . . . . . . . . -75.46 127.59 85.79 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.887 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.62 163.85 25.93 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.744 2.296 . . . . 0.0 112.159 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -86.14 154.77 57.74 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.243 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.95 105.82 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.642 2.228 . . . . 0.0 112.273 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 12.1 t 68.6 -67.98 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.23 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -143.12 -47.0 0.3 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.963 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.944 179.997 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.45 31.23 3.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.857 0.36 . . . . 0.0 110.887 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 61.08 92.44 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . 92.97 68.91 1.11 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.635 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 1.1 m -126.37 -51.11 1.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.108 0.48 . . . . 0.0 110.542 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -154.94 -51.06 0.09 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.435 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -124.9 95.39 4.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.502 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . 0.446 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.49 142.32 37.01 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.41 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 748' ' ' PRO . . . . . 0.4 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 44.2 Cg_exo -36.01 -29.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.094 2.53 . . . . 0.0 113.692 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 749' ' ' LEU . . . . . 0.451 HD21 HD22 ' A' ' 772' ' ' LEU . 39.9 mt -120.09 -17.12 8.45 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.521 ' CZ ' ' CG2' ' A' ' 754' ' ' VAL . 69.2 t80 -54.94 -47.67 74.16 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.29 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -53.2 -36.71 61.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . 0.503 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 4.1 tp10 -70.97 -43.39 68.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.352 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -61.51 -52.39 64.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.086 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 754' ' ' VAL . . . . . 0.521 ' CG2' ' CZ ' ' A' ' 750' ' ' TYR . 4.0 t -56.15 -39.93 61.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.939 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -67.93 -36.1 79.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.387 0.613 . . . . 0.0 109.545 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 756' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 771' ' ' LYS . 4.4 t80 -66.59 -46.21 76.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.076 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 757' ' ' VAL . . . . . 0.414 HG12 ' CB ' ' A' ' 763' ' ' ALA . 57.6 t -69.52 -44.64 79.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.866 0.365 . . . . 0.0 110.798 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 4.8 p -55.26 -44.18 75.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.773 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -78.78 -31.63 46.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.27 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 24.3 p -81.02 -14.69 57.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.57 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.95 16.1 8.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.633 0.254 . . . . 0.0 111.504 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.83 142.31 22.59 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.701 0.286 . . . . 0.0 110.741 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 763' ' ' ALA . . . . . 0.414 ' CB ' HG12 ' A' ' 757' ' ' VAL . . . -109.24 89.93 3.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.852 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 764' ' ' SER . . . . . 0.554 ' O ' HG21 ' A' ' 768' ' ' VAL . 63.7 m -121.02 118.57 30.15 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 765' ' ' ILE . . . . . 0.43 HG12 ' HA ' ' A' ' 780' ' ' ALA . 14.8 mt -54.15 -48.9 65.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.622 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 766' ' ' SER . . . . . 0.406 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 23.2 t -54.85 -42.25 71.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.229 0.537 . . . . 0.0 110.368 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -69.88 -40.25 75.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.584 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 768' ' ' VAL . . . . . 0.554 HG21 ' O ' ' A' ' 764' ' ' SER . 39.0 t -61.59 -46.66 96.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.212 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . 0.572 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.15 -34.07 77.51 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.618 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 770' ' ' ARG . . . . . 0.49 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 12.6 mtt180 -71.0 -42.19 69.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.131 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . 0.408 ' HB2' ' CE1' ' A' ' 756' ' ' PHE . 0.1 OUTLIER -78.56 -36.06 45.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.961 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 772' ' ' LEU . . . . . 0.503 ' CD2' ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -91.23 -9.92 43.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.755 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt 59.76 41.55 18.13 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 774' ' ' ILE . . . . . 0.572 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 20.7 pt -111.82 -174.01 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.345 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.79 150.97 21.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.013 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -54.94 -45.87 74.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.948 0.404 . . . . 0.0 110.748 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -62.96 -45.39 92.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.764 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.18 -50.31 72.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.762 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.53 -50.63 71.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.395 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 780' ' ' ALA . . . . . 0.43 ' HA ' HG12 ' A' ' 765' ' ' ILE . . . -55.99 -39.3 71.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.759 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -59.0 -48.38 81.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.897 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 782' ' ' MET . . . . . 0.449 ' CE ' ' CB ' ' A' ' 749' ' ' LEU . 0.0 OUTLIER -63.45 -44.68 93.81 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.78 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 783' ' ' ILE . . . . . 0.475 ' CG2' ' NH2' ' A' ' 801' ' ' ARG . 16.9 mm -54.69 -44.59 70.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.492 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.02 -46.63 82.2 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.424 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -58.17 -33.54 69.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.888 178.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 786' ' ' MET . . . . . 0.506 ' HG2' HG21 ' A' ' 754' ' ' VAL . 13.2 mtm -66.11 -37.59 86.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.131 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 787' ' ' GLU . . . . . 0.457 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 2.8 mt-10 -63.32 -53.86 46.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.13 0.491 . . . . 0.0 110.526 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 63.2 mtp -67.16 -38.01 84.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.352 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 789' ' ' ALA . . . . . 0.404 ' HB3' HG22 ' A' ' 791' ' ' VAL . . . -71.09 -21.51 62.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.973 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 89.35 18.33 53.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.863 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.485 ' C ' HG13 ' A' ' 804' ' ' ILE . 41.0 t -83.45 -32.05 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.797 0.332 . . . . 0.0 110.85 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 792' ' ' VAL . . . . . 0.448 HG23 ' CB ' ' A' ' 786' ' ' MET . 8.4 m -135.34 142.08 40.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.1 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 793' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.2 p -80.99 160.61 65.65 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.773 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 794' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 18.6 Cg_endo -58.26 167.38 4.75 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.04 1.826 . . . . 0.0 111.93 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 1.2 mtt -60.12 163.37 4.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.045 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 37.8 m-20 -103.83 176.5 5.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.876 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 5.4 t -57.73 -31.02 66.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -87.08 -17.5 32.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.128 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 102.86 35.98 3.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.748 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 15.3 m -127.77 129.53 47.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.947 0.403 . . . . 0.0 111.137 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . 0.475 ' NH2' ' CG2' ' A' ' 783' ' ' ILE . 6.7 mtp85 -82.23 170.57 15.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.181 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -132.85 178.2 7.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.637 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 803' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 792' ' ' VAL . 19.9 t -116.21 134.07 60.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.102 0.477 . . . . 0.0 112.218 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 804' ' ' ILE . . . . . 0.485 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -104.73 -29.38 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.767 178.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 805' ' ' ALA . . . . . . . . . . . . . . . -79.86 123.42 83.78 Favored Pre-proline 0 N--CA 1.451 -0.401 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.463 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.2 163.74 22.09 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.483 2.122 . . . . 0.0 112.163 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -93.54 165.18 18.7 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.094 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.0 111.63 3.32 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.568 2.179 . . . . 0.0 112.432 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 31.2 t -86.58 -35.99 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.991 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.54 96.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.003 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.819 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 39.0 m -149.01 -69.52 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.329 . . . . 0.0 110.895 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -122.84 -78.14 0.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.799 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . -73.93 85.05 0.67 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.442 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.74 -74.38 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.98 0.419 . . . . 0.0 110.636 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -134.0 -48.29 0.8 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.558 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -125.29 95.43 4.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.751 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . 0.477 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.4 t70 -122.27 141.89 35.62 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.373 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -36.5 -29.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.125 2.55 . . . . 0.0 113.706 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 749' ' ' LEU . . . . . 0.448 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 53.5 mt -120.02 -17.26 8.46 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.496 ' CZ ' ' CG2' ' A' ' 754' ' ' VAL . 65.9 t80 -55.88 -46.95 78.18 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.678 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -53.26 -36.06 60.72 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . 0.536 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 0.0 OUTLIER -71.15 -45.41 63.6 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.138 178.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -59.22 -52.86 63.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.3 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 754' ' ' VAL . . . . . 0.561 HG21 ' HG2' ' A' ' 786' ' ' MET . 2.4 t -56.17 -42.29 72.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.958 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 37.5 mtt180 -66.88 -35.41 79.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.322 0.582 . . . . 0.0 109.692 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 756' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -66.66 -46.05 76.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.911 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 757' ' ' VAL . . . . . 0.412 ' CG1' HG13 ' A' ' 792' ' ' VAL . 40.8 t -70.28 -44.11 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.992 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 5.1 p -57.54 -42.82 83.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.953 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.86 -40.85 31.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.26 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 21.1 p -73.86 -18.68 60.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.246 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 63.16 28.58 15.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.183 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -157.49 131.18 7.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 763' ' ' ALA . . . . . . . . . . . . . . . -102.35 89.84 3.7 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.973 0.416 . . . . 0.0 111.253 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 764' ' ' SER . . . . . 0.496 ' O ' HG21 ' A' ' 768' ' ' VAL . 1.0 OUTLIER -126.08 118.64 25.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.434 179.082 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 765' ' ' ILE . . . . . 0.441 HG21 ' N ' ' A' ' 780' ' ' ALA . 23.2 mt -53.05 -50.64 44.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.822 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 766' ' ' SER . . . . . 0.417 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 47.5 t -53.3 -43.56 67.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.207 0.527 . . . . 0.0 110.659 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.78 76.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.634 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 768' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 764' ' ' SER . 40.1 t -58.67 -47.25 89.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.291 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . 0.568 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.8 OUTLIER -65.64 -33.34 75.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.679 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 770' ' ' ARG . . . . . 0.46 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 14.9 mtt180 -69.05 -42.22 76.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.109 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 7.4 tptt -78.6 -42.18 29.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.911 0.386 . . . . 0.0 111.688 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 772' ' ' LEU . . . . . 0.536 ' CD2' ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -84.81 -9.09 58.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.854 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt 57.7 42.75 23.25 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 774' ' ' ILE . . . . . 0.568 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 24.7 pt -111.8 -173.92 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.73 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -91.08 151.31 21.01 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.074 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -56.53 -46.59 80.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.935 0.397 . . . . 0.0 110.778 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -59.51 -44.63 93.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.069 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.18 -50.34 61.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.888 0.375 . . . . 0.0 110.869 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.1 -48.59 75.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.269 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 780' ' ' ALA . . . . . 0.441 ' N ' HG21 ' A' ' 765' ' ' ILE . . . -56.2 -45.98 79.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.901 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 -58.92 -48.5 81.24 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.059 0.457 . . . . 0.0 110.333 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 782' ' ' MET . . . . . . . . . . . . . 32.7 mtm -64.84 -34.96 79.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.884 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 783' ' ' ILE . . . . . 0.415 ' O ' ' HB2' ' A' ' 786' ' ' MET . 7.7 mm -65.38 -38.56 82.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.199 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -63.65 -38.82 92.56 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.472 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -61.75 -34.28 75.56 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.37 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 786' ' ' MET . . . . . 0.561 ' HG2' HG21 ' A' ' 754' ' ' VAL . 13.9 mtm -66.68 -39.13 88.01 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.087 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -61.18 -54.04 49.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.663 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 49.6 mtm -68.46 -37.95 80.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.158 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -67.11 -21.5 65.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.716 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 90.93 18.29 47.88 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.835 -179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.458 ' C ' HG13 ' A' ' 804' ' ' ILE . 21.7 t -88.57 -30.33 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.76 0.314 . . . . 0.0 111.122 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 792' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 803' ' ' VAL . 19.4 m -137.38 137.69 45.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.419 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 793' ' ' THR . . . . . . . . . . . . . 1.1 p -85.07 159.98 55.92 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.845 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 794' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -52.12 172.09 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.267 1.978 . . . . 0.0 112.368 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.02 164.99 24.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.98 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -105.52 176.48 5.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.852 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 3.2 t -60.67 -34.73 74.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -79.27 -17.57 54.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 102.74 29.14 5.98 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.514 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 9.8 m -123.68 129.93 51.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 111.053 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . 0.42 ' NH1' HG22 ' A' ' 792' ' ' VAL . 7.1 mtt-85 -85.34 170.66 12.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.186 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -128.64 167.19 17.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.104 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 803' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 792' ' ' VAL . 22.0 t -110.47 135.06 50.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.921 0.391 . . . . 0.0 111.558 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 804' ' ' ILE . . . . . 0.458 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -103.58 -27.76 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.251 179.178 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 805' ' ' ALA . . . . . 0.423 ' CB ' ' HA ' ' A' ' 791' ' ' VAL . . . -82.85 123.54 77.89 Favored Pre-proline 0 N--CA 1.453 -0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.887 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.4 163.7 28.65 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.608 2.205 . . . . 0.0 112.167 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -95.67 167.33 12.83 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.162 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.6 104.81 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.481 2.12 . . . . 0.0 112.279 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.33 -32.96 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.158 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -174.44 -40.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.925 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.961 179.939 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.38 28.46 16.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.803 0.335 . . . . 0.0 110.88 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -94.25 108.93 20.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.716 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . 90.48 57.94 1.59 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.587 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 64.8 m -117.29 -46.68 2.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.153 0.501 . . . . 0.0 110.15 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -159.97 -49.48 0.05 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.132 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -126.0 95.16 4.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.386 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . 0.493 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 13.2 t70 -122.47 143.33 39.39 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.335 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 748' ' ' PRO . . . . . 0.404 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 46.8 Cg_exo -37.7 -28.04 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.044 2.496 . . . . 0.0 113.563 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 749' ' ' LEU . . . . . 0.42 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 28.5 mt -119.97 -17.08 8.53 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.514 ' CE2' ' CG2' ' A' ' 754' ' ' VAL . 80.1 t80 -52.61 -50.17 63.62 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.503 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -53.07 -36.54 60.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -70.95 -40.76 71.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.966 178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -63.84 -53.38 51.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.075 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 754' ' ' VAL . . . . . 0.514 ' CG2' ' CE2' ' A' ' 750' ' ' TYR . 8.0 t -56.15 -39.39 58.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.301 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 755' ' ' ARG . . . . . 0.401 ' HA ' ' OG1' ' A' ' 758' ' ' THR . 70.2 mtt180 -70.14 -36.83 75.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.231 0.539 . . . . 0.0 109.711 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 756' ' ' PHE . . . . . 0.456 ' CE1' ' CG2' ' A' ' 768' ' ' VAL . 1.0 OUTLIER -66.77 -46.19 76.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.676 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 757' ' ' VAL . . . . . 0.449 HG12 ' CB ' ' A' ' 763' ' ' ALA . 61.5 t -69.29 -42.94 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 110.775 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 758' ' ' THR . . . . . 0.401 ' OG1' ' HA ' ' A' ' 755' ' ' ARG . 8.0 p -56.78 -44.57 81.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.85 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -78.82 -33.5 46.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.241 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 760' ' ' SER . . . . . 0.427 ' HB3' ' O ' ' A' ' 756' ' ' PHE . 18.5 p -74.69 -16.39 60.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.244 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 64.72 15.03 9.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.436 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -153.71 143.01 21.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.445 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 763' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 801' ' ' ARG . . . -107.74 89.62 3.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.883 0.373 . . . . 0.0 111.941 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 764' ' ' SER . . . . . 0.55 ' O ' HG21 ' A' ' 768' ' ' VAL . 1.3 m -118.97 118.47 31.58 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 765' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 780' ' ' ALA . 14.7 mt -54.1 -48.6 65.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.506 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 766' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 16.7 p -55.08 -42.15 72.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.303 0.573 . . . . 0.0 110.538 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -70.51 -40.91 73.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.571 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 768' ' ' VAL . . . . . 0.55 HG21 ' O ' ' A' ' 764' ' ' SER . 48.2 t -59.64 -47.86 89.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . 0.563 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.21 -33.9 77.1 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.804 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 770' ' ' ARG . . . . . 0.479 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 15.9 mtt180 -69.35 -42.42 75.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.184 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . 0.4 ' HD3' ' HE2' ' A' ' 756' ' ' PHE . 2.3 tptt -78.63 -40.03 35.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.829 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 772' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 768' ' ' VAL . 0.1 OUTLIER -86.69 -9.66 55.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.847 -179.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp 60.92 40.6 15.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.019 0.438 . . . . 0.0 109.874 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 774' ' ' ILE . . . . . 0.563 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 21.1 pt -111.85 -173.86 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.542 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.91 150.27 20.93 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.028 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -54.72 -45.12 74.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.966 0.412 . . . . 0.0 110.722 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -63.85 -47.82 79.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.873 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -60.06 -50.31 74.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.935 0.398 . . . . 0.0 110.716 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -55.99 -48.67 75.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.272 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 780' ' ' ALA . . . . . 0.435 ' HA ' HG12 ' A' ' 765' ' ' ILE . . . -56.2 -41.67 75.95 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.003 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 17.4 mtm-85 -58.87 -47.31 85.38 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 782' ' ' MET . . . . . . . . . . . . . 2.3 mtp -63.61 -42.91 98.18 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 783' ' ' ILE . . . . . 0.451 ' CG2' ' NH1' ' A' ' 801' ' ' ARG . 9.9 mm -57.5 -37.68 59.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.71 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -62.31 -45.88 91.25 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.43 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -58.12 -33.59 69.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.805 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 786' ' ' MET . . . . . 0.51 ' HG2' HG21 ' A' ' 754' ' ' VAL . 13.2 mtm -66.49 -39.65 88.86 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.476 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.58 -49.68 74.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.12 0.486 . . . . 0.0 110.518 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 32.2 mtm -70.57 -36.92 73.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.371 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -71.25 -21.53 62.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.123 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 92.05 19.75 38.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.693 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.516 ' HA ' ' CB ' ' A' ' 805' ' ' ALA . 63.2 t -88.94 -30.47 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 122.517 0.327 . . . . 0.0 111.092 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 792' ' ' VAL . . . . . 0.44 ' CG2' ' HB3' ' A' ' 786' ' ' MET . 20.4 m -139.33 142.79 32.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.53 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 793' ' ' THR . . . . . 0.511 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.2 p -85.24 164.69 40.01 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 794' ' ' PRO . . . . . 0.511 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 29.5 Cg_endo -61.94 164.65 16.05 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 121.989 1.793 . . . . 0.0 112.003 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.67 162.48 3.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.329 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -105.18 176.5 5.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.743 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 15.3 t -63.18 -32.64 74.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -80.66 -17.64 50.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.231 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 102.48 28.56 6.31 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.364 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 57.5 m -125.75 130.75 52.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.988 0.423 . . . . 0.0 110.919 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 763' ' ' ALA . 15.4 mtt-85 -84.25 170.7 13.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.44 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -129.68 167.73 17.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.992 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 803' ' ' VAL . . . . . 0.444 HG23 ' CG1' ' A' ' 757' ' ' VAL . 11.9 t -108.8 139.19 32.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.004 0.431 . . . . 0.0 112.076 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 804' ' ' ILE . . . . . 0.471 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -110.84 -27.96 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.454 178.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 805' ' ' ALA . . . . . 0.516 ' CB ' ' HA ' ' A' ' 791' ' ' VAL . . . -77.97 121.05 83.51 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.078 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -50.29 163.94 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.731 2.287 . . . . 0.0 112.916 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -104.37 143.92 27.65 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.997 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.65 107.12 2.24 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.477 2.118 . . . . 0.0 112.343 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 21.4 t -91.69 -32.68 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.135 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -173.68 -40.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.868 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.822 -179.952 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 48.6 p -171.42 80.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.351 . . . . 0.0 110.912 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -114.48 -34.38 5.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.994 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 743' ' ' GLY . . . . . 0.434 ' CA ' ' HG3' ' A' ' 782' ' ' MET . . . 74.11 44.3 29.98 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.457 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.72 -158.92 0.65 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.579 0.228 . . . . 0.0 110.626 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -51.91 -42.97 63.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.842 0.353 . . . . 0.0 111.329 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.01 95.42 4.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.059 0.456 . . . . 0.0 110.911 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . 0.477 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 12.1 t70 -122.61 142.52 37.68 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.647 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 748' ' ' PRO . . . . . 0.401 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 43.0 Cg_exo -37.49 -28.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.034 2.49 . . . . 0.0 113.672 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 749' ' ' LEU . . . . . 0.506 HD21 HD22 ' A' ' 772' ' ' LEU . 40.6 mt -119.93 -17.27 8.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.516 ' CE2' HG22 ' A' ' 754' ' ' VAL . 64.5 t80 -53.81 -47.42 70.86 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.67 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -53.34 -37.41 62.31 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . 0.592 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 0.7 OUTLIER -70.9 -39.95 72.48 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.264 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 753' ' ' ALA . . . . . 0.46 ' HB2' ' CE ' ' A' ' 782' ' ' MET . . . -63.89 -54.35 36.11 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.217 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 754' ' ' VAL . . . . . 0.54 HG21 ' HG2' ' A' ' 786' ' ' MET . 4.3 t -56.19 -38.3 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.01 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 53.8 ttt85 -69.53 -36.58 76.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.646 178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 756' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -67.07 -46.11 75.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.189 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 757' ' ' VAL . . . . . 0.557 HG12 ' CA ' ' A' ' 763' ' ' ALA . 39.0 t -70.28 -45.42 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 120.928 0.394 . . . . 0.0 110.715 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 17.8 p -53.78 -44.18 69.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.815 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.96 -35.55 50.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.347 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 16.7 p -78.51 -14.98 59.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.45 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 63.46 19.86 11.93 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.727 0.299 . . . . 0.0 111.348 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -152.72 143.78 23.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.569 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 763' ' ' ALA . . . . . 0.557 ' CA ' HG12 ' A' ' 757' ' ' VAL . . . -115.47 89.93 3.22 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 764' ' ' SER . . . . . 0.537 ' O ' HG21 ' A' ' 768' ' ' VAL . 7.3 m -120.96 118.31 29.53 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 765' ' ' ILE . . . . . 0.44 HG21 ' N ' ' A' ' 780' ' ' ALA . 21.2 mt -51.12 -46.06 31.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.525 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 766' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 11.7 p -58.53 -39.19 79.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.347 0.594 . . . . 0.0 110.393 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -72.39 -35.94 68.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.481 179.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 768' ' ' VAL . . . . . 0.537 HG21 ' O ' ' A' ' 764' ' ' SER . 40.3 t -66.88 -47.28 83.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.384 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . 0.598 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.57 -33.97 77.15 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.845 0.355 . . . . 0.0 110.599 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 19.0 mtt-85 -70.62 -42.16 71.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.985 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.61 -36.95 43.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.297 -0.41 . . . . 0.0 112.095 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 772' ' ' LEU . . . . . 0.592 ' CD2' ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -89.8 -10.65 44.69 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp 61.61 40.43 13.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.237 0.541 . . . . 0.0 109.55 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 774' ' ' ILE . . . . . 0.598 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 23.6 pt -111.75 -174.53 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.381 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.15 150.08 21.17 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.163 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -54.11 -45.85 71.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 110.776 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -63.03 -47.54 82.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.854 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . 0.407 ' NE ' HD13 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -59.94 -49.6 77.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.755 179.821 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 779' ' ' ALA . . . . . 0.402 ' HB2' ' CD1' ' A' ' 774' ' ' ILE . . . -57.02 -50.0 74.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.57 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 780' ' ' ALA . . . . . 0.44 ' N ' HG21 ' A' ' 765' ' ' ILE . . . -56.02 -40.76 73.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.584 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.74 -48.02 82.64 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.994 0.426 . . . . 0.0 109.913 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 782' ' ' MET . . . . . 0.46 ' CE ' ' HB2' ' A' ' 753' ' ' ALA . 2.0 mtp -62.78 -43.72 98.07 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 783' ' ' ILE . . . . . 0.484 ' CG2' ' NH2' ' A' ' 801' ' ' ARG . 12.4 mm -57.16 -40.59 74.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.456 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.7 -45.43 92.15 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.439 ' HB3' ' CE1' ' A' ' 750' ' ' TYR . . . -59.63 -33.37 71.43 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.79 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 786' ' ' MET . . . . . 0.54 ' HG2' HG21 ' A' ' 754' ' ' VAL . 13.3 mtm -64.96 -37.63 88.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.063 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 787' ' ' GLU . . . . . 0.456 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 1.6 mt-10 -64.54 -52.88 55.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.458 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 51.5 mtm -66.5 -38.4 87.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.764 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 789' ' ' ALA . . . . . 0.435 ' HB3' HG22 ' A' ' 791' ' ' VAL . . . -73.0 -21.61 60.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.067 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 790' ' ' GLY . . . . . 0.455 ' HA3' HD13 ' A' ' 804' ' ' ILE . . . 90.91 18.95 45.22 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.754 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.496 ' C ' HG13 ' A' ' 804' ' ' ILE . 44.0 t -83.26 -30.05 8.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.726 0.298 . . . . 0.0 110.825 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 792' ' ' VAL . . . . . 0.517 HG23 ' HB3' ' A' ' 786' ' ' MET . 5.7 m -137.15 143.66 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.901 0.381 . . . . 0.0 111.434 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 793' ' ' THR . . . . . 0.451 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.6 p -81.9 160.63 63.12 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.961 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 794' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 22.5 Cg_endo -60.55 167.0 8.82 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.122 1.882 . . . . 0.0 111.988 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 1.5 mtt -58.31 158.83 6.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.243 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -99.55 176.51 5.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.881 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 10.0 t -58.44 -29.13 65.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.981 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -89.08 -17.53 29.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.188 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 103.9 35.16 3.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.728 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 18.0 m -127.79 129.73 47.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.779 0.323 . . . . 0.0 111.14 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . 0.484 ' NH2' ' CG2' ' A' ' 783' ' ' ILE . 6.8 mtp85 -81.7 170.54 15.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.015 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -134.97 173.53 11.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.8 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 803' ' ' VAL . . . . . 0.515 HG23 ' CG1' ' A' ' 757' ' ' VAL . 31.2 t -109.94 135.89 47.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 804' ' ' ILE . . . . . 0.496 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -106.07 -27.87 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.693 178.246 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 805' ' ' ALA . . . . . . . . . . . . . . . -81.67 123.88 80.22 Favored Pre-proline 0 N--CA 1.453 -0.289 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.71 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -63.16 163.81 21.78 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.66 2.24 . . . . 0.0 112.604 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -93.98 162.92 25.4 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.102 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -77.54 114.36 3.69 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.668 2.245 . . . . 0.0 112.461 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 22.0 t -99.5 -32.55 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -176.14 -39.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.782 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.865 179.957 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -145.22 -50.22 0.25 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.839 0.352 . . . . 0.0 110.923 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -142.36 108.58 5.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.965 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . 85.97 65.23 1.44 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.617 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -121.98 -60.95 1.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.056 0.455 . . . . 0.0 110.537 179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -144.71 -49.75 0.26 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.331 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -124.03 95.34 4.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.585 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . 0.452 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.31 141.82 35.54 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.476 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -36.87 -29.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.172 2.581 . . . . 0.0 113.614 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 749' ' ' LEU . . . . . 0.445 ' CB ' ' CE ' ' A' ' 782' ' ' MET . 42.9 mt -119.94 -16.98 8.57 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.546 ' CZ ' ' CG2' ' A' ' 754' ' ' VAL . 68.0 t80 -54.62 -46.75 73.91 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.123 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -53.49 -36.1 61.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -71.04 -42.62 69.24 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.297 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -62.43 -53.77 50.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.021 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 754' ' ' VAL . . . . . 0.546 ' CG2' ' CZ ' ' A' ' 750' ' ' TYR . 5.0 t -56.22 -42.26 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.324 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -67.26 -35.24 79.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.272 0.558 . . . . 0.0 109.622 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 756' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -67.82 -46.12 72.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.141 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 757' ' ' VAL . . . . . 0.402 HG12 ' CB ' ' A' ' 763' ' ' ALA . 43.9 t -71.18 -42.24 75.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.796 0.331 . . . . 0.0 110.873 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 14.3 p -60.58 -40.3 91.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.016 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -78.03 -49.09 14.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.329 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 760' ' ' SER . . . . . 0.457 ' O ' ' HD3' ' A' ' 762' ' ' ARG . 7.8 p -69.55 -28.13 65.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.902 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 761' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 760' ' ' SER . 20.7 mmt180 73.96 32.11 1.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.55 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 762' ' ' ARG . . . . . 0.457 ' HD3' ' O ' ' A' ' 760' ' ' SER . 0.3 OUTLIER -150.14 131.18 14.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.699 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 763' ' ' ALA . . . . . 0.41 ' HB2' ' CB ' ' A' ' 801' ' ' ARG . . . -107.4 89.67 3.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.047 0.451 . . . . 0.0 110.638 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 764' ' ' SER . . . . . 0.481 ' O ' HG21 ' A' ' 768' ' ' VAL . 6.2 m -131.74 118.58 20.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.569 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 765' ' ' ILE . . . . . 0.439 HG21 ' N ' ' A' ' 780' ' ' ALA . 23.3 mt -51.44 -49.79 31.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.802 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 766' ' ' SER . . . . . 0.415 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 11.7 t -54.19 -43.03 70.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.097 0.475 . . . . 0.0 110.649 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -69.82 -39.68 76.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.772 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 768' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 764' ' ' SER . 45.4 t -62.54 -45.83 97.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.29 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . 0.569 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.4 OUTLIER -66.36 -33.47 75.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.542 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 770' ' ' ARG . . . . . 0.47 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 17.8 mtt180 -71.32 -42.3 68.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.084 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -37.11 42.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.954 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 772' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 768' ' ' VAL . 0.1 OUTLIER -90.52 -10.29 44.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.664 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt 60.77 41.53 14.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.185 0.517 . . . . 0.0 109.688 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 774' ' ' ILE . . . . . 0.569 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 26.0 pt -111.9 -174.0 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.595 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.58 154.19 24.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.081 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -58.75 -46.11 88.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 0.0 110.71 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -63.53 -43.59 96.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.877 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.44 -50.25 68.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.716 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.0 -50.12 71.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.301 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 780' ' ' ALA . . . . . 0.439 ' N ' HG21 ' A' ' 765' ' ' ILE . . . -55.96 -39.62 72.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.786 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.0 -48.49 81.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.977 0.418 . . . . 0.0 110.019 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 782' ' ' MET . . . . . 0.445 ' CE ' ' CB ' ' A' ' 749' ' ' LEU . 0.0 OUTLIER -63.9 -44.58 92.54 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.771 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 783' ' ' ILE . . . . . 0.469 ' CG2' ' NH2' ' A' ' 801' ' ' ARG . 7.4 mm -56.33 -41.46 71.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.708 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.96 -45.04 91.49 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.421 ' HB3' ' CE1' ' A' ' 750' ' ' TYR . . . -59.61 -33.57 71.66 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.519 -1.218 . . . . 0.0 109.816 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 786' ' ' MET . . . . . 0.495 ' HB3' HG23 ' A' ' 792' ' ' VAL . 13.8 mtm -65.4 -37.64 87.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.047 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 787' ' ' GLU . . . . . 0.441 ' HG3' ' CZ ' ' A' ' 801' ' ' ARG . 2.6 mt-10 -64.19 -54.04 39.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.704 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 40.0 mtp -67.28 -38.19 84.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.551 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -70.41 -21.71 62.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.951 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 89.54 19.79 47.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.978 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.464 ' C ' HG13 ' A' ' 804' ' ' ILE . 14.1 t -83.61 -32.58 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 120.892 0.377 . . . . 0.0 110.866 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 792' ' ' VAL . . . . . 0.495 HG23 ' HB3' ' A' ' 786' ' ' MET . 11.3 m -134.49 139.13 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.184 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 793' ' ' THR . . . . . 0.451 ' OG1' ' HB2' ' A' ' 802' ' ' GLU . 8.0 p -75.95 158.56 82.26 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.918 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 794' ' ' PRO . . . . . 0.444 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 19.7 Cg_endo -59.52 166.66 7.55 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.14 1.893 . . . . 0.0 112.01 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -56.98 161.02 3.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.149 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -104.73 176.55 5.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.788 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 5.2 t -54.68 -32.78 59.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.032 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -87.21 -17.64 32.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.15 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.46 37.29 3.56 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.5 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 16.2 m -127.82 129.14 46.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.003 0.43 . . . . 0.0 111.042 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . 0.469 ' NH2' ' CG2' ' A' ' 783' ' ' ILE . 6.8 mtp85 -83.64 170.62 14.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.327 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 802' ' ' GLU . . . . . 0.451 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 3.0 mt-10 -132.43 -170.77 2.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.606 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 803' ' ' VAL . . . . . 0.438 ' HA ' ' HA ' ' A' ' 792' ' ' VAL . 20.6 t -125.03 135.16 64.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.067 0.46 . . . . 0.0 112.018 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 804' ' ' ILE . . . . . 0.464 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -108.43 -33.66 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.352 179.241 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 805' ' ' ALA . . . . . 0.461 ' CB ' ' HD2' ' A' ' 806' ' ' PRO . . . -59.16 171.04 0.77 Allowed Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.242 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 806' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 805' ' ' ALA . 56.6 Cg_endo -71.2 163.62 38.53 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.771 2.314 . . . . 0.0 112.233 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -119.53 111.66 36.18 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.101 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.89 117.61 4.06 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.401 2.067 . . . . 0.0 112.306 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -124.26 175.83 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -87.02 -33.18 19.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.83 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 3.3 p30 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.153 -0.927 . . . . 0.0 110.876 -179.954 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.471 -0.251 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 99.9 p -163.81 38.07 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.748 0.308 . . . . 0.0 110.884 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -153.01 -177.85 6.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.945 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . 122.51 76.66 0.38 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.484 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 5.9 m -116.16 -62.27 1.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.14 0.495 . . . . 0.0 110.73 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -140.01 -49.85 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.199 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -123.67 95.3 4.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.364 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 14.1 t70 -122.28 142.35 36.72 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.426 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -33.82 -31.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.387 2.724 . . . . 0.0 114.016 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 749' ' ' LEU . . . . . 0.437 HD21 HD22 ' A' ' 772' ' ' LEU . 33.8 mt -120.06 -17.15 8.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.502 ' CZ ' ' CG2' ' A' ' 754' ' ' VAL . 67.9 t80 -53.26 -47.43 69.08 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.968 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -53.23 -37.18 61.81 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . 0.52 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 51.7 tt0 -71.01 -41.56 70.74 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.305 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -62.53 -51.52 67.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.034 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 754' ' ' VAL . . . . . 0.502 ' CG2' ' CZ ' ' A' ' 750' ' ' TYR . 2.2 t -56.15 -41.2 68.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.735 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -67.91 -35.4 78.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.746 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 756' ' ' PHE . . . . . 0.405 ' CE2' ' CG2' ' A' ' 768' ' ' VAL . 3.5 t80 -67.01 -46.09 75.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.991 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 757' ' ' VAL . . . . . 0.433 HG13 HG13 ' A' ' 792' ' ' VAL . 43.6 t -70.16 -47.34 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 120.811 0.338 . . . . 0.0 110.794 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 6.6 p -54.78 -43.74 73.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.002 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -78.88 -37.95 38.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.182 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 54.6 p -75.79 -16.25 60.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.46 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 60.11 31.38 20.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.931 0.396 . . . . 0.0 110.552 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -160.55 137.3 8.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.338 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 763' ' ' ALA . . . . . 0.403 ' CB ' HG12 ' A' ' 757' ' ' VAL . . . -110.58 89.84 3.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.91 0.386 . . . . 0.0 111.409 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 764' ' ' SER . . . . . 0.496 ' O ' HG21 ' A' ' 768' ' ' VAL . 15.2 m -127.14 118.61 24.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.617 178.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 765' ' ' ILE . . . . . 0.436 HG21 ' N ' ' A' ' 780' ' ' ALA . 25.0 mt -51.83 -50.19 33.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.755 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 766' ' ' SER . . . . . 0.408 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 22.0 t -53.45 -43.82 68.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.238 0.542 . . . . 0.0 110.537 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -69.12 -41.59 77.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.661 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 768' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 764' ' ' SER . 40.9 t -59.4 -47.53 90.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.212 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . 0.558 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.7 OUTLIER -65.46 -33.39 75.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.744 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 770' ' ' ARG . . . . . 0.465 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 5.8 mtt180 -68.75 -42.49 77.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.133 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.63 -42.13 29.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.877 0.37 . . . . 0.0 111.684 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 772' ' ' LEU . . . . . 0.52 ' CD2' ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -84.81 -8.58 58.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.791 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 22.6 mtpt 57.41 42.35 24.86 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 774' ' ' ILE . . . . . 0.558 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 30.1 pt -111.87 -174.14 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.626 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.25 155.45 25.19 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.238 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -59.2 -46.56 88.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.916 0.389 . . . . 0.0 110.653 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -62.22 -47.47 84.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.771 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -61.17 -50.37 73.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.775 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.41 -50.55 71.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.427 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 780' ' ' ALA . . . . . 0.436 ' N ' HG21 ' A' ' 765' ' ' ILE . . . -56.03 -41.03 74.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.81 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -58.95 -48.42 81.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.978 0.418 . . . . 0.0 110.009 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 782' ' ' MET . . . . . 0.41 ' CE ' ' CB ' ' A' ' 749' ' ' LEU . 0.5 OUTLIER -63.67 -43.12 97.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.386 178.781 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 783' ' ' ILE . . . . . 0.476 ' CG2' ' NH2' ' A' ' 801' ' ' ARG . 7.6 mm -56.96 -41.72 77.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.318 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.21 -44.9 92.27 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.446 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -58.39 -33.63 69.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.048 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 786' ' ' MET . . . . . 0.464 ' HG2' HG21 ' A' ' 754' ' ' VAL . 16.3 mtm -66.85 -38.59 86.65 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.991 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 787' ' ' GLU . . . . . 0.431 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 2.0 mt-10 -61.55 -54.05 48.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.664 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 24.1 mtm -68.85 -38.39 79.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.418 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -68.52 -21.67 64.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.775 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 90.74 15.07 57.25 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.897 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.525 ' C ' HG13 ' A' ' 804' ' ' ILE . 40.6 t -80.67 -31.91 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.924 0.392 . . . . 0.0 110.896 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 792' ' ' VAL . . . . . 0.434 HG23 ' HB3' ' A' ' 786' ' ' MET . 11.2 m -136.58 135.45 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.143 0.497 . . . . 0.0 111.161 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 793' ' ' THR . . . . . 0.465 HG21 HG12 ' A' ' 804' ' ' ILE . 10.3 p -72.92 159.81 84.42 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.686 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 794' ' ' PRO . . . . . 0.464 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 25.4 Cg_endo -60.58 165.13 11.97 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 121.996 1.797 . . . . 0.0 111.771 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -58.78 162.74 3.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.185 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -105.58 176.57 5.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.954 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 55.8 p -56.4 -31.11 63.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -86.32 -17.57 34.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.115 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 100.71 34.44 4.67 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.542 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 28.8 m -127.75 130.31 48.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 111.113 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . 0.476 ' NH2' ' CG2' ' A' ' 783' ' ' ILE . 4.5 mtp85 -81.57 170.13 16.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.397 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -138.52 124.18 19.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.909 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 803' ' ' VAL . . . . . 0.417 ' CG2' HG13 ' A' ' 757' ' ' VAL . 18.8 t -64.92 134.22 29.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.96 0.409 . . . . 0.0 112.065 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 804' ' ' ILE . . . . . 0.525 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -103.77 -33.29 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.891 178.546 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 805' ' ' ALA . . . . . . . . . . . . . . . -74.63 126.03 89.03 Favored Pre-proline 0 N--CA 1.451 -0.4 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.836 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.07 163.81 24.46 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.71 2.273 . . . . 0.0 112.168 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -101.41 163.96 16.89 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.272 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -74.22 106.2 2.18 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.644 2.229 . . . . 0.0 112.354 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 21.4 t -123.79 -43.13 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.23 94.84 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 12.3 t70 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.877 179.933 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 24.3 t -97.19 33.62 1.92 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 0.0 111.031 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -98.32 102.89 14.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.685 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . 103.06 58.85 0.74 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.09 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 3.5 m -115.57 -39.3 3.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.065 0.459 . . . . 0.0 110.462 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 745' ' ' GLU . . . . . 0.429 ' O ' ' CD2' ' A' ' 750' ' ' TYR . 0.9 OUTLIER -168.57 -45.97 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.941 179.519 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -129.13 95.06 3.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.439 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.47 143.35 39.43 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.376 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 748' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 28.7 Cg_exo -35.34 -30.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.258 2.639 . . . . 0.0 113.795 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 749' ' ' LEU . . . . . 0.433 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 21.8 mt -120.09 -17.08 8.46 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.718 ' CE2' HG22 ' A' ' 754' ' ' VAL . 83.7 t80 -51.73 -50.65 60.14 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.837 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -53.17 -35.89 60.29 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.71 -0.396 . . . . 0.0 109.984 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . 0.535 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 6.0 tp10 -70.93 -38.5 72.9 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.803 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 753' ' ' ALA . . . . . 0.441 ' HA ' HD12 ' A' ' 772' ' ' LEU . . . -66.28 -52.93 42.57 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.804 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 754' ' ' VAL . . . . . 0.718 HG22 ' CE2' ' A' ' 750' ' ' TYR . 7.0 t -56.36 -38.42 55.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.751 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -69.87 -39.16 76.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.601 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 756' ' ' PHE . . . . . 0.487 ' HE1' ' HD3' ' A' ' 771' ' ' LYS . 1.4 t80 -65.77 -45.09 83.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.611 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 757' ' ' VAL . . . . . 0.501 HG12 ' HB1' ' A' ' 763' ' ' ALA . 84.5 t -69.84 -41.33 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.781 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 9.9 p -59.12 -46.08 89.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.335 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -77.97 -30.36 50.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.795 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 39.5 p -78.02 -16.0 58.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.5 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 63.39 20.09 12.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.718 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -157.61 137.58 12.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.745 0.307 . . . . 0.0 110.931 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 763' ' ' ALA . . . . . 0.501 ' HB1' HG12 ' A' ' 757' ' ' VAL . . . -100.7 89.87 4.04 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.949 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 764' ' ' SER . . . . . 0.489 ' O ' HG21 ' A' ' 768' ' ' VAL . 5.9 m -120.65 118.44 30.12 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 765' ' ' ILE . . . . . 0.516 HG22 ' N ' ' A' ' 780' ' ' ALA . 10.3 mt -57.1 -51.32 70.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.368 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 766' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 11.3 t -53.93 -38.41 64.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.291 0.567 . . . . 0.0 110.103 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -71.36 -40.22 70.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.234 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 768' ' ' VAL . . . . . 0.489 HG21 ' O ' ' A' ' 764' ' ' SER . 45.5 t -61.43 -49.94 82.44 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.179 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . 0.587 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -63.64 -33.57 75.92 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.974 -179.499 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -69.45 -42.52 74.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.37 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . 0.487 ' HD3' ' HE1' ' A' ' 756' ' ' PHE . 3.1 tptt -78.59 -38.24 40.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.766 0.317 . . . . 0.0 111.677 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 772' ' ' LEU . . . . . 0.535 ' CD2' ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -86.87 -10.91 52.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt 61.21 39.58 15.64 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 774' ' ' ILE . . . . . 0.587 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 25.6 pt -111.86 -173.98 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.424 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -90.34 153.55 22.85 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.236 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -56.6 -45.79 81.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.816 0.341 . . . . 0.0 110.87 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -63.25 -47.79 80.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.82 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.1 -49.98 75.8 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.641 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 779' ' ' ALA . . . . . 0.407 ' HB2' ' CD1' ' A' ' 774' ' ' ILE . . . -57.23 -50.69 72.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.637 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 780' ' ' ALA . . . . . 0.516 ' N ' HG22 ' A' ' 765' ' ' ILE . . . -55.99 -40.42 73.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.947 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -60.66 -43.77 97.23 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 782' ' ' MET . . . . . 0.43 ' HE2' ' CB ' ' A' ' 749' ' ' LEU . 0.1 OUTLIER -64.94 -43.62 92.14 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.293 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 783' ' ' ILE . . . . . 0.508 ' CG2' ' NH1' ' A' ' 801' ' ' ARG . 15.0 mm -57.62 -39.73 71.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.696 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -61.85 -46.78 87.95 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.423 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -58.01 -33.64 69.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.808 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 786' ' ' MET . . . . . 0.508 ' HB3' HG21 ' A' ' 792' ' ' VAL . 15.4 mtm -67.79 -38.29 83.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.565 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 787' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 792' ' ' VAL . 1.6 mt-10 -62.41 -45.93 90.89 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.124 0.488 . . . . 0.0 110.072 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 37.0 mtm -73.08 -37.98 66.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.245 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -70.81 -21.53 62.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.982 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 94.62 15.94 44.55 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.67 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.561 ' C ' HG13 ' A' ' 804' ' ' ILE . 77.5 t -84.96 -34.2 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 122.637 0.375 . . . . 0.0 111.476 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 792' ' ' VAL . . . . . 0.508 HG21 ' HB3' ' A' ' 786' ' ' MET . 15.4 m -136.61 148.41 27.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.887 0.375 . . . . 0.0 111.655 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 793' ' ' THR . . . . . 0.588 HG21 HG12 ' A' ' 804' ' ' ILE . 10.3 p -96.75 171.8 5.73 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 794' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -59.47 178.86 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 121.982 1.788 . . . . 0.0 111.812 179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 795' ' ' MET . . . . . 0.498 ' HA ' ' HG3' ' A' ' 801' ' ' ARG . 0.0 OUTLIER -77.04 170.12 17.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.499 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -105.61 176.59 5.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.754 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 4.6 t -60.78 -26.99 67.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.052 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -92.19 -17.62 24.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.398 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 108.73 29.84 3.97 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.649 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 18.0 m -124.42 131.13 53.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.923 0.392 . . . . 0.0 110.647 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . 0.508 ' NH1' ' CG2' ' A' ' 783' ' ' ILE . 8.8 mtt-85 -85.34 170.65 12.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.078 0.466 . . . . 0.0 111.524 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 802' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 793' ' ' THR . 6.9 mt-10 -127.13 126.76 43.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.576 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 803' ' ' VAL . . . . . 0.494 HG23 ' CG1' ' A' ' 757' ' ' VAL . 19.4 t -69.25 137.94 23.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.836 0.35 . . . . 0.0 111.8 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 804' ' ' ILE . . . . . 0.588 HG12 HG21 ' A' ' 793' ' ' THR . 0.0 OUTLIER -108.19 -28.08 2.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.292 178.415 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 805' ' ' ALA . . . . . 0.503 ' CB ' ' HA ' ' A' ' 791' ' ' VAL . . . -78.24 119.56 77.81 Favored Pre-proline 0 N--CA 1.455 -0.209 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.641 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.24 163.82 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.413 2.075 . . . . 0.0 112.733 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -109.48 137.56 20.34 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.961 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.82 117.65 5.12 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.558 2.172 . . . . 0.0 112.559 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.37 -38.49 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.306 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 63.06 97.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.819 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.92 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.19 0 N-CA-C 112.469 -0.253 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 1.6 m 60.1 82.07 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.849 0.357 . . . . 0.0 110.905 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -95.57 99.39 11.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.949 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 743' ' ' GLY . . . . . 0.406 ' CA ' ' HG2' ' A' ' 782' ' ' MET . . . 116.37 46.35 0.54 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.528 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.0 -157.83 0.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.584 0.23 . . . . 0.0 110.43 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -51.29 -38.44 52.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.666 0.27 . . . . 0.0 111.445 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -129.06 95.51 4.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.062 0.458 . . . . 0.0 111.415 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.4 t70 -122.49 141.52 35.1 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.372 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -38.32 -28.02 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.956 2.437 . . . . 0.0 113.64 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 749' ' ' LEU . . . . . 0.431 HD21 HD22 ' A' ' 772' ' ' LEU . 40.4 mt -119.94 -16.85 8.59 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.521 ' CE1' ' CG2' ' A' ' 754' ' ' VAL . 62.2 t80 -55.12 -46.5 75.59 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.469 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -53.51 -36.37 61.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -70.95 -43.09 68.85 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.217 178.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -61.93 -51.67 67.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.238 179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 754' ' ' VAL . . . . . 0.574 HG21 ' HG2' ' A' ' 786' ' ' MET . 2.3 t -56.21 -42.69 74.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.39 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -69.16 -38.13 78.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.294 0.569 . . . . 0.0 110.231 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 756' ' ' PHE . . . . . 0.433 ' CE1' ' HB2' ' A' ' 771' ' ' LYS . 4.0 t80 -65.15 -46.15 82.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.114 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 757' ' ' VAL . . . . . . . . . . . . . 59.7 t -69.49 -45.13 79.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.902 0.382 . . . . 0.0 110.775 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 6.8 p -55.22 -42.65 73.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.96 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -78.8 -35.63 43.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.414 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 6.8 p -76.84 -19.61 57.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.575 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 67.2 24.93 9.08 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.662 0.268 . . . . 0.0 111.477 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -159.26 132.39 7.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.883 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 763' ' ' ALA . . . . . . . . . . . . . . . -100.05 89.71 4.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.933 0.397 . . . . 0.0 111.281 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 764' ' ' SER . . . . . 0.521 ' O ' HG21 ' A' ' 768' ' ' VAL . 7.6 m -121.78 118.59 29.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.593 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 765' ' ' ILE . . . . . 0.423 HG21 ' N ' ' A' ' 780' ' ' ALA . 26.3 mt -54.54 -47.34 71.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.487 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 766' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 60.5 p -57.69 -40.5 79.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.172 0.51 . . . . 0.0 110.493 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -71.58 -36.23 70.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.612 179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 768' ' ' VAL . . . . . 0.521 HG21 ' O ' ' A' ' 764' ' ' SER . 58.8 t -66.4 -46.44 86.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.223 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . 0.579 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -66.05 -33.37 75.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.486 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 770' ' ' ARG . . . . . 0.459 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 20.8 mtt-85 -69.98 -42.41 73.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.087 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . 0.433 ' HB2' ' CE1' ' A' ' 756' ' ' PHE . 1.8 tmtt? -78.62 -39.62 36.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.042 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 772' ' ' LEU . . . . . 0.431 HD22 HD21 ' A' ' 749' ' ' LEU . 0.2 OUTLIER -88.33 -9.23 53.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.664 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt 60.03 42.31 16.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.061 0.458 . . . . 0.0 109.775 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 774' ' ' ILE . . . . . 0.579 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 26.8 pt -111.94 -173.94 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.609 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.42 147.18 19.36 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.027 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -54.11 -42.54 69.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.834 0.35 . . . . 0.0 110.703 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 -64.12 -47.53 79.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.923 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -50.3 71.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.894 0.378 . . . . 0.0 110.835 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -54.48 -49.13 70.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.411 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 780' ' ' ALA . . . . . 0.423 ' N ' HG21 ' A' ' 765' ' ' ILE . . . -56.07 -43.63 78.14 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.911 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -58.98 -48.41 81.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.034 0.445 . . . . 0.0 109.973 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 782' ' ' MET . . . . . 0.438 ' SD ' ' N ' ' A' ' 750' ' ' TYR . 34.4 mtm -65.3 -34.3 78.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.711 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 783' ' ' ILE . . . . . 0.421 HG22 ' NH1' ' A' ' 801' ' ' ARG . 7.1 mm -65.45 -35.71 75.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.11 -44.69 94.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.458 ' HB1' ' CE2' ' A' ' 750' ' ' TYR . . . -59.12 -33.76 71.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.766 178.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 786' ' ' MET . . . . . 0.574 ' HG2' HG21 ' A' ' 754' ' ' VAL . 12.7 mtm -65.62 -39.14 91.17 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.912 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -62.43 -51.15 68.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.45 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 25.4 mtm -67.9 -38.49 83.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.574 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -71.4 -21.62 61.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.882 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 93.12 16.76 46.04 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.914 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.436 ' HA ' ' CB ' ' A' ' 805' ' ' ALA . 10.1 t -83.57 -33.28 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.887 0.375 . . . . 0.0 110.726 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 792' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 803' ' ' VAL . 19.8 m -135.94 139.54 45.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.404 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 793' ' ' THR . . . . . 0.495 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 2.8 p -83.77 161.87 54.54 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.709 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 794' ' ' PRO . . . . . 0.495 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 18.1 Cg_endo -58.62 167.23 5.35 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.153 1.902 . . . . 0.0 112.083 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.88 160.06 15.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.201 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -104.31 176.59 5.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.803 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 39.1 p -61.76 -34.74 76.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.926 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.14 -17.61 58.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.195 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 100.58 28.38 7.11 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.515 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 58.0 m -126.64 130.39 50.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.942 0.401 . . . . 0.0 110.964 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . 0.421 ' NH1' HG22 ' A' ' 783' ' ' ILE . 9.4 mtt-85 -82.72 170.72 14.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.222 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -130.2 166.28 20.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.814 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 803' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 792' ' ' VAL . 39.0 t -109.63 135.19 49.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.064 0.459 . . . . 0.0 111.597 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 804' ' ' ILE . . . . . 0.42 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -103.35 -28.56 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.266 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 805' ' ' ALA . . . . . 0.436 ' CB ' ' HA ' ' A' ' 791' ' ' VAL . . . -82.22 124.51 78.4 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.934 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.9 163.71 27.26 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.632 2.221 . . . . 0.0 112.082 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -85.83 153.86 58.02 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.241 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.11 120.9 6.22 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.649 2.233 . . . . 0.0 112.216 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -82.28 176.12 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.785 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -150.34 -46.05 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.936 0.398 . . . . 0.0 111.057 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.847 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 12.3 m -162.51 -46.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.742 0.306 . . . . 0.0 110.844 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -111.59 109.62 19.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.774 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . 104.28 59.09 0.69 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.455 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.68 -53.57 2.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.159 0.504 . . . . 0.0 110.396 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -153.13 -50.13 0.1 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.968 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -124.01 95.11 4.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.416 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . 0.472 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.7 t70 -122.37 142.09 36.25 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.439 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -37.73 -28.35 0.1 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.989 2.459 . . . . 0.0 113.51 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 749' ' ' LEU . . . . . 0.408 HD13 ' NE ' ' A' ' 778' ' ' ARG . 31.8 mt -120.05 -16.87 8.52 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.514 ' CZ ' ' CG2' ' A' ' 754' ' ' VAL . 71.3 t80 -53.99 -47.76 71.1 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.376 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -53.4 -36.3 61.31 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -71.0 -42.27 69.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.117 178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -61.85 -53.82 50.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.068 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 754' ' ' VAL . . . . . 0.514 ' CG2' ' CZ ' ' A' ' 750' ' ' TYR . 4.0 t -56.19 -42.97 74.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.407 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -66.43 -36.94 84.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.37 0.605 . . . . 0.0 109.797 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 756' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -66.82 -46.18 75.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.169 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 757' ' ' VAL . . . . . 0.425 HG12 ' CB ' ' A' ' 763' ' ' ALA . 61.8 t -69.56 -45.41 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 120.8 0.333 . . . . 0.0 110.664 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 4.8 p -55.37 -43.45 75.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.783 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -78.71 -32.15 46.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.214 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 27.3 p -81.63 -14.83 56.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.531 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 61.92 18.92 10.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.614 0.245 . . . . 0.0 111.223 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 10.2 ptt180 -151.88 136.35 16.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.763 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 763' ' ' ALA . . . . . 0.425 ' CB ' HG12 ' A' ' 757' ' ' VAL . . . -106.06 89.88 3.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.602 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 764' ' ' SER . . . . . 0.528 ' O ' HG21 ' A' ' 768' ' ' VAL . 3.9 m -122.32 118.59 28.86 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 765' ' ' ILE . . . . . 0.428 HG21 ' N ' ' A' ' 780' ' ' ALA . 19.5 mt -53.6 -48.28 59.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.499 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 766' ' ' SER . . . . . . . . . . . . . 11.4 t -55.74 -41.23 73.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.114 0.483 . . . . 0.0 110.284 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -70.58 -39.48 73.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.688 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 768' ' ' VAL . . . . . 0.528 HG21 ' O ' ' A' ' 764' ' ' SER . 41.9 t -62.94 -46.72 95.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.291 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . 0.564 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.93 -33.41 75.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.452 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 770' ' ' ARG . . . . . 0.473 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 24.8 mtt180 -71.54 -41.84 68.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.059 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.7 -37.26 42.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.967 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 772' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 768' ' ' VAL . 0.2 OUTLIER -91.17 -9.64 44.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.634 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt 60.8 41.55 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.038 0.447 . . . . 0.0 109.8 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 774' ' ' ILE . . . . . 0.564 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 22.0 pt -111.84 -173.92 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.476 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.51 151.13 22.3 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.201 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -55.38 -46.05 76.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.965 0.412 . . . . 0.0 110.707 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -63.37 -47.79 80.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.823 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . 0.408 ' NE ' HD13 ' A' ' 749' ' ' LEU . 0.6 OUTLIER -59.61 -50.13 75.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.845 0.355 . . . . 0.0 110.793 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.33 -49.9 74.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.271 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 780' ' ' ALA . . . . . 0.428 ' N ' HG21 ' A' ' 765' ' ' ILE . . . -56.11 -40.35 73.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -60.69 -48.41 81.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.92 0.39 . . . . 0.0 109.999 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 782' ' ' MET . . . . . 0.402 ' HE2' ' CB ' ' A' ' 749' ' ' LEU . 3.1 mtp -63.79 -38.41 91.01 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 783' ' ' ILE . . . . . 0.493 ' CG2' ' NH2' ' A' ' 801' ' ' ARG . 7.3 mm -61.32 -40.85 87.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.132 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.23 -43.52 87.8 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 177.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.42 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -60.32 -33.48 72.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.526 -1.216 . . . . 0.0 109.828 178.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 786' ' ' MET . . . . . 0.497 ' HG2' HG21 ' A' ' 754' ' ' VAL . 12.9 mtm -65.67 -37.56 86.84 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.974 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 787' ' ' GLU . . . . . 0.451 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 2.4 mt-10 -63.38 -54.13 41.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.111 0.481 . . . . 0.0 110.548 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 33.5 mtm -67.85 -37.12 81.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.49 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -70.94 -21.59 62.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.985 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 89.62 18.37 52.1 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.875 -178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.491 ' C ' HG13 ' A' ' 804' ' ' ILE . 52.4 t -83.23 -32.72 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.854 0.359 . . . . 0.0 110.809 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 792' ' ' VAL . . . . . 0.488 HG23 ' HB3' ' A' ' 786' ' ' MET . 11.4 m -135.61 140.64 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.188 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 793' ' ' THR . . . . . 0.415 HG21 HG12 ' A' ' 804' ' ' ILE . 1.3 p -78.34 159.06 75.81 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 794' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 18.6 Cg_endo -58.8 166.11 7.18 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.115 1.876 . . . . 0.0 111.743 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -66.08 155.38 36.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.972 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -105.43 176.56 5.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.918 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 5.5 t -55.37 -29.98 59.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.06 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -78.65 -17.52 55.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.151 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 91.9 29.62 11.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.48 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 24.6 m -127.82 130.19 48.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.905 0.383 . . . . 0.0 111.031 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . 0.493 ' NH2' ' CG2' ' A' ' 783' ' ' ILE . 6.8 mtp85 -81.63 170.59 15.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.307 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -129.9 -176.93 4.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.667 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 803' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 792' ' ' VAL . 16.9 t -119.81 134.64 62.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 804' ' ' ILE . . . . . 0.491 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -106.99 -28.09 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.961 178.56 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 805' ' ' ALA . . . . . . . . . . . . . . . -82.74 121.49 77.8 Favored Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.586 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.49 163.8 22.79 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.475 2.116 . . . . 0.0 112.304 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -111.2 170.87 4.82 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.225 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.15 119.77 5.14 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.634 2.223 . . . . 0.0 112.426 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.64 -42.77 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.182 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.93 96.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.853 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.891 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.557 -0.217 . . . . 0.0 112.557 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 14.9 m 61.09 92.98 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.759 0.314 . . . . 0.0 110.906 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -149.35 100.84 3.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.836 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . 92.23 62.79 1.15 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.496 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 1.3 m -119.3 -47.24 2.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.121 0.486 . . . . 0.0 110.396 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -159.33 -48.63 0.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.182 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -126.9 95.1 4.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.337 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.6 t70 -122.51 143.09 38.85 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.425 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 748' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 35.7 Cg_exo -35.97 -29.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.157 2.571 . . . . 0.0 113.763 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 749' ' ' LEU . . . . . 0.458 HD21 HD22 ' A' ' 772' ' ' LEU . 34.6 mt -120.03 -17.27 8.45 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.525 ' CE2' ' CG2' ' A' ' 754' ' ' VAL . 74.5 t80 -53.3 -48.54 68.29 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.797 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.27 -36.34 61.03 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . 0.552 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 12.6 tt0 -71.0 -42.05 70.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.242 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 753' ' ' ALA . . . . . 0.491 ' HB3' ' HE3' ' A' ' 782' ' ' MET . . . -62.92 -52.5 62.8 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.182 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 754' ' ' VAL . . . . . 0.553 HG21 ' HG2' ' A' ' 786' ' ' MET . 5.1 t -56.2 -40.32 64.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.675 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -67.01 -35.52 80.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.41 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 756' ' ' PHE . . . . . 0.516 ' HD2' ' HD3' ' A' ' 771' ' ' LYS . 1.4 t80 -67.65 -45.94 73.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.018 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 757' ' ' VAL . . . . . 0.416 HG12 ' CB ' ' A' ' 763' ' ' ALA . 47.4 t -69.64 -42.08 80.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.937 0.399 . . . . 0.0 110.837 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 8.2 p -58.71 -45.38 89.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.69 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -77.75 -35.26 51.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.101 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 48.7 p -76.38 -14.74 60.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.291 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 56.5 28.0 13.12 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.008 0.433 . . . . 0.0 110.577 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -160.87 136.0 7.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.92 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 763' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 801' ' ' ARG . . . -106.32 89.6 3.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.09 0.472 . . . . 0.0 111.698 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 764' ' ' SER . . . . . 0.526 ' O ' HG21 ' A' ' 768' ' ' VAL . 68.1 m -121.24 118.64 30.11 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 765' ' ' ILE . . . . . 0.479 HG21 ' N ' ' A' ' 780' ' ' ALA . 17.5 mt -54.06 -47.58 65.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.637 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 766' ' ' SER . . . . . 0.584 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 10.9 t -58.89 -36.73 75.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.27 0.557 . . . . 0.0 110.363 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -72.78 -41.34 65.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.217 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 768' ' ' VAL . . . . . 0.526 HG21 ' O ' ' A' ' 764' ' ' SER . 23.2 t -61.13 -49.8 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.096 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . 0.593 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -63.05 -33.85 76.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.374 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 21.2 mtt180 -70.08 -42.54 72.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.279 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . 0.516 ' HD3' ' HD2' ' A' ' 756' ' ' PHE . 0.0 OUTLIER -78.53 -35.72 45.8 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.527 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 772' ' ' LEU . . . . . 0.552 ' CD2' ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -90.6 -10.35 43.66 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm 60.61 40.61 16.42 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 774' ' ' ILE . . . . . 0.593 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 27.7 pt -111.69 -175.33 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.39 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.63 150.54 21.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.097 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -54.28 -45.97 72.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.653 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -61.91 -47.48 84.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.759 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . 0.401 ' HG2' ' SD ' ' A' ' 782' ' ' MET . 0.1 OUTLIER -60.37 -50.19 74.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.687 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.22 -49.76 74.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.354 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 780' ' ' ALA . . . . . 0.479 ' N ' HG21 ' A' ' 765' ' ' ILE . . . -56.2 -41.52 75.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.771 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 -59.54 -48.26 82.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.045 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 782' ' ' MET . . . . . 0.491 ' HE3' ' HB3' ' A' ' 753' ' ' ALA . 0.0 OUTLIER -61.71 -44.55 96.71 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.407 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 783' ' ' ILE . . . . . 0.456 ' CG2' ' NH1' ' A' ' 801' ' ' ARG . 12.0 mm -55.32 -37.07 42.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.786 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -64.03 -46.03 86.26 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . . . . . . . . . . . -59.26 -33.56 71.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.633 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 786' ' ' MET . . . . . 0.553 ' HG2' HG21 ' A' ' 754' ' ' VAL . 13.4 mtm -65.46 -40.68 93.47 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.316 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.16 -49.14 77.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.092 0.472 . . . . 0.0 110.587 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 32.9 mtm -70.66 -36.85 73.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.385 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -71.86 -21.56 61.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.082 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 93.72 17.23 42.33 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.718 -178.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.504 ' HA ' ' CB ' ' A' ' 805' ' ' ALA . 60.2 t -87.72 -29.46 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 122.505 0.322 . . . . 0.0 111.27 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 792' ' ' VAL . . . . . 0.434 ' CG2' ' HB3' ' A' ' 786' ' ' MET . 20.5 m -139.58 141.93 33.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.869 0.366 . . . . 0.0 111.824 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 793' ' ' THR . . . . . 0.512 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.1 p -86.17 165.65 32.83 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 794' ' ' PRO . . . . . 0.512 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 32.6 Cg_endo -63.45 166.38 15.39 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 121.951 1.767 . . . . 0.0 111.815 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -69.6 158.1 35.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.373 . . . . 0.0 111.213 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 36.8 p30 -105.72 176.56 5.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.83 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 2.8 t -57.84 -31.21 66.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.999 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -74.22 -17.58 60.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.246 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 93.62 26.44 15.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.566 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 17.9 m -127.24 134.6 50.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 0.0 110.809 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' A' ' 763' ' ' ALA . 13.5 mtt-85 -85.03 170.79 12.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.251 0.548 . . . . 0.0 111.545 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -129.1 166.5 19.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.842 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 803' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 792' ' ' VAL . 19.3 t -107.6 138.55 33.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.885 0.374 . . . . 0.0 111.978 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 804' ' ' ILE . . . . . 0.464 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -109.98 -25.35 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.555 179.03 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 805' ' ' ALA . . . . . 0.504 ' CB ' ' HA ' ' A' ' 791' ' ' VAL . . . -80.87 121.56 81.07 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.239 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -50.34 163.94 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.639 2.226 . . . . 0.0 112.885 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -109.26 145.17 31.26 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.053 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.54 107.46 2.17 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.498 2.132 . . . . 0.0 112.243 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 22.8 t -85.3 -68.53 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.185 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 16.2 ttt-85 -92.9 -32.2 14.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.844 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.911 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 53.4 p -164.94 31.91 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.881 0.372 . . . . 0.0 110.948 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -140.09 86.39 2.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.793 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . 72.92 59.46 4.32 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.439 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 50.4 m -118.97 -46.87 2.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.126 0.489 . . . . 0.0 110.487 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -159.17 -47.48 0.06 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.19 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -128.89 95.27 4.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.394 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . 0.495 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.2 t70 -122.5 143.48 39.81 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.312 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 748' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 40.0 Cg_exo -36.75 -28.77 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.081 2.521 . . . . 0.0 113.793 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 749' ' ' LEU . . . . . 0.44 HD21 HD22 ' A' ' 772' ' ' LEU . 28.7 mt -119.99 -17.09 8.51 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.718 ' CE2' HG22 ' A' ' 754' ' ' VAL . 78.5 t80 -53.15 -50.91 63.58 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.935 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -53.07 -35.11 59.18 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . 0.503 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 9.1 tp10 -71.1 -42.02 69.84 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.174 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 753' ' ' ALA . . . . . 0.433 ' HB3' ' CE ' ' A' ' 782' ' ' MET . . . -63.58 -53.73 47.11 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.188 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 754' ' ' VAL . . . . . 0.718 HG22 ' CE2' ' A' ' 750' ' ' TYR . 6.2 t -56.1 -39.27 57.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.865 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -68.22 -35.47 78.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.652 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 756' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -68.79 -46.33 68.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.038 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 757' ' ' VAL . . . . . 0.554 HG13 HG13 ' A' ' 792' ' ' VAL . 21.1 t -71.29 -38.88 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 120.903 0.383 . . . . 0.0 111.114 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 20.6 p -63.12 -41.43 99.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.702 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -76.96 -46.63 23.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.148 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 760' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 761' ' ' ARG . 22.8 p -70.6 -33.86 71.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.975 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 761' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 760' ' ' SER . 0.0 OUTLIER 78.27 23.73 0.69 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.401 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 762' ' ' ARG . . . . . 0.453 ' HD3' ' O ' ' A' ' 760' ' ' SER . 0.5 OUTLIER -145.03 114.29 7.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.507 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 763' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 801' ' ' ARG . . . -88.19 89.49 8.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.039 0.447 . . . . 0.0 111.442 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 764' ' ' SER . . . . . 0.576 ' O ' HG21 ' A' ' 768' ' ' VAL . 17.0 m -126.84 118.35 24.45 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 765' ' ' ILE . . . . . 0.467 HG21 ' N ' ' A' ' 780' ' ' ALA . 11.0 mt -52.99 -45.56 52.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.491 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 766' ' ' SER . . . . . 0.477 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 6.6 t -60.57 -37.7 82.15 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.152 0.501 . . . . 0.0 110.308 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -73.64 -35.26 65.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.52 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 768' ' ' VAL . . . . . 0.576 HG21 ' O ' ' A' ' 764' ' ' SER . 40.4 t -67.71 -46.98 81.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . 0.578 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.12 -34.12 77.66 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.491 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 14.9 mtt-85 -71.32 -42.57 68.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.2 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.74 -34.92 45.41 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 772' ' ' LEU . . . . . 0.503 ' CD2' ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -92.41 -10.41 38.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp 61.71 40.79 12.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.106 0.479 . . . . 0.0 109.721 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 774' ' ' ILE . . . . . 0.578 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 23.0 pt -111.74 -173.78 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.661 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.59 151.69 22.67 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.186 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -56.9 -45.78 82.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 0.0 110.729 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 -63.29 -46.56 86.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.69 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.23 -50.07 74.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.776 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.41 -49.46 76.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.21 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 780' ' ' ALA . . . . . 0.467 ' N ' HG21 ' A' ' 765' ' ' ILE . . . -55.93 -42.47 76.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.966 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -59.38 -43.37 92.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.125 0.488 . . . . 0.0 110.016 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 782' ' ' MET . . . . . 0.433 ' CE ' ' HB3' ' A' ' 753' ' ' ALA . 2.5 mtp -67.66 -42.02 82.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.592 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 783' ' ' ILE . . . . . 0.447 ' CG2' ' NH1' ' A' ' 801' ' ' ARG . 9.5 mm -58.59 -37.32 64.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.443 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -63.56 -48.27 78.15 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.413 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -56.16 -33.41 65.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.693 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 786' ' ' MET . . . . . 0.541 ' HB3' HG21 ' A' ' 792' ' ' VAL . 13.1 mtm -66.8 -40.77 88.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.178 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -59.93 -49.41 77.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.61 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 28.5 mtm -72.81 -37.79 67.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.546 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -68.16 -21.5 64.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.136 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 94.91 16.93 39.76 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.459 -178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.51 ' HA ' ' CB ' ' A' ' 805' ' ' ALA . 55.1 t -86.34 -35.45 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 122.422 0.289 . . . . 0.0 111.306 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 792' ' ' VAL . . . . . 0.554 HG13 HG13 ' A' ' 757' ' ' VAL . 22.0 m -136.4 151.44 28.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.128 0.49 . . . . 0.0 111.69 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 793' ' ' THR . . . . . 0.521 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.3 p -94.83 165.67 16.65 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.282 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 794' ' ' PRO . . . . . 0.521 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 29.6 Cg_endo -62.3 166.01 13.87 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 121.869 1.713 . . . . 0.0 111.94 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -72.07 158.5 35.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.985 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -105.51 176.51 5.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 53.1 p -57.86 -30.17 65.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.202 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -75.34 -17.6 60.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.296 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 94.15 23.23 22.94 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.576 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 58.9 m -123.26 132.54 54.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.824 0.345 . . . . 0.0 110.649 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . 0.551 ' HB2' ' O ' ' A' ' 763' ' ' ALA . 11.7 mtt-85 -85.14 170.79 12.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.189 0.519 . . . . 0.0 111.716 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 802' ' ' GLU . . . . . 0.402 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 3.8 mt-10 -127.54 171.05 11.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.868 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 803' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 792' ' ' VAL . 22.3 t -114.22 138.38 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 804' ' ' ILE . . . . . 0.46 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -106.89 -28.31 2.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.454 178.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 805' ' ' ALA . . . . . 0.51 ' CB ' ' HA ' ' A' ' 791' ' ' VAL . . . -82.7 121.44 77.84 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.001 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -65.48 163.73 28.71 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.541 2.161 . . . . 0.0 112.088 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -91.5 147.2 34.78 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.144 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -56.74 117.02 3.62 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.518 2.146 . . . . 0.0 112.265 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.37 176.72 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.735 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.02 -35.43 5.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.353 . . . . 0.0 110.975 -179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 2.0 p30 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.894 -179.868 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 78.9 p -171.78 89.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.877 0.37 . . . . 0.0 110.969 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -111.2 173.4 6.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.881 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . 75.78 36.57 42.02 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.532 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.15 -160.78 0.7 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.635 0.255 . . . . 0.0 110.611 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -51.11 -44.35 61.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.808 0.337 . . . . 0.0 111.121 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -127.39 95.56 4.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.122 0.487 . . . . 0.0 110.956 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.57 143.21 39.26 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.445 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 748' ' ' PRO . . . . . 0.407 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 40.5 Cg_exo -36.22 -29.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.108 2.538 . . . . 0.0 113.962 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 749' ' ' LEU . . . . . 0.452 HD21 HD22 ' A' ' 772' ' ' LEU . 26.3 mt -120.02 -17.15 8.48 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.527 ' CE1' ' CG2' ' A' ' 754' ' ' VAL . 65.6 t80 -53.81 -47.81 70.5 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.783 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -53.23 -37.49 62.09 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . 0.535 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 11.8 tt0 -71.0 -43.38 68.1 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.083 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 753' ' ' ALA . . . . . 0.402 ' HB3' ' CE ' ' A' ' 782' ' ' MET . . . -59.74 -54.4 46.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.159 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 754' ' ' VAL . . . . . 0.606 HG21 ' HG2' ' A' ' 786' ' ' MET . 4.8 t -56.19 -40.82 67.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.142 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 44.5 ttt85 -65.89 -36.02 82.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.543 178.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 756' ' ' PHE . . . . . 0.453 ' CE1' ' CG2' ' A' ' 768' ' ' VAL . 1.2 t80 -69.78 -44.95 69.06 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.83 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 757' ' ' VAL . . . . . 0.472 ' HA ' ' OG ' ' A' ' 760' ' ' SER . 61.2 t -69.74 -39.59 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 121.002 0.43 . . . . 0.0 110.763 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 10.1 p -62.8 -44.81 95.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.8 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -78.58 -33.08 47.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.177 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 760' ' ' SER . . . . . 0.472 ' OG ' ' HA ' ' A' ' 757' ' ' VAL . 93.7 p -75.54 -15.68 60.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.278 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 62.84 17.34 9.85 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.426 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 -155.77 140.37 16.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.572 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 763' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 801' ' ' ARG . . . -105.57 89.62 3.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.922 0.391 . . . . 0.0 111.658 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 764' ' ' SER . . . . . 0.599 ' O ' HG21 ' A' ' 768' ' ' VAL . 1.7 m -118.96 118.67 32.12 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 765' ' ' ILE . . . . . 0.461 HG12 ' HA ' ' A' ' 780' ' ' ALA . 7.4 mt -55.69 -47.74 78.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.563 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 766' ' ' SER . . . . . 0.44 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 39.3 t -57.4 -39.09 75.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.14 0.495 . . . . 0.0 110.275 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -71.88 -39.56 69.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.448 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 768' ' ' VAL . . . . . 0.599 HG21 ' O ' ' A' ' 764' ' ' SER . 46.2 t -61.81 -48.15 89.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.996 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . 0.57 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.46 -33.33 75.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 770' ' ' ARG . . . . . 0.459 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 20.1 mtt180 -70.1 -41.85 73.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.139 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . 0.422 ' HD3' ' HE2' ' A' ' 756' ' ' PHE . 4.5 tptt -78.49 -39.84 37.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.644 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 772' ' ' LEU . . . . . 0.535 ' CD2' ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -87.68 -9.49 54.01 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.522 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt 60.32 41.27 16.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.025 0.44 . . . . 0.0 109.825 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 774' ' ' ILE . . . . . 0.57 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 20.1 pt -111.89 -173.95 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.342 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.51 150.03 20.97 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.05 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -54.24 -45.34 72.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.879 0.371 . . . . 0.0 110.751 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -64.19 -47.92 77.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.712 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.76 -49.97 75.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.766 179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.54 -49.9 74.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.28 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 780' ' ' ALA . . . . . 0.461 ' HA ' HG12 ' A' ' 765' ' ' ILE . . . -55.94 -40.04 72.59 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.797 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -59.63 -47.04 87.14 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 782' ' ' MET . . . . . 0.402 ' CE ' ' HB3' ' A' ' 753' ' ' ALA . 1.6 mtp -63.07 -43.13 99.42 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 783' ' ' ILE . . . . . 0.518 ' CG2' ' NH1' ' A' ' 801' ' ' ARG . 12.3 mm -57.45 -38.77 64.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.682 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -62.15 -43.3 99.14 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.416 ' HB1' ' CE2' ' A' ' 750' ' ' TYR . . . -61.15 -33.41 73.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.581 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 786' ' ' MET . . . . . 0.606 ' HG2' HG21 ' A' ' 754' ' ' VAL . 13.2 mtm -65.63 -39.44 91.48 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.275 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -63.57 -45.3 91.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.19 0.519 . . . . 0.0 110.312 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 53.0 mtm -72.01 -36.86 69.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.664 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -75.53 -21.66 57.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.137 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 790' ' ' GLY . . . . . 0.416 ' O ' ' HB ' ' A' ' 804' ' ' ILE . . . 94.14 18.52 36.44 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.621 -178.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.522 ' HA ' ' CB ' ' A' ' 805' ' ' ALA . 57.5 t -86.82 -30.2 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.723 0.296 . . . . 0.0 110.961 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 792' ' ' VAL . . . . . 0.466 HG13 ' CG1' ' A' ' 757' ' ' VAL . 22.2 m -139.31 144.06 29.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.629 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 793' ' ' THR . . . . . 0.54 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.1 p -87.37 166.81 23.68 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 794' ' ' PRO . . . . . 0.54 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 28.5 Cg_endo -62.07 166.13 13.17 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.074 1.849 . . . . 0.0 112.262 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.31 161.92 13.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.173 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -105.31 176.34 5.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.826 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 44.8 p -61.79 -32.5 72.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.818 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -79.69 -17.55 53.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.178 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.27 25.1 8.47 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.46 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 20.8 m -122.14 129.96 52.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 110.935 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . 0.518 ' NH1' ' CG2' ' A' ' 783' ' ' ILE . 12.1 mtt-85 -83.82 170.67 13.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.287 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -127.81 167.75 16.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.926 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 803' ' ' VAL . . . . . 0.458 HG23 ' CG1' ' A' ' 757' ' ' VAL . 16.4 t -109.05 137.92 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.956 0.407 . . . . 0.0 112.017 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 804' ' ' ILE . . . . . 0.461 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -108.26 -27.36 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.267 178.751 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 805' ' ' ALA . . . . . 0.522 ' CB ' ' HA ' ' A' ' 791' ' ' VAL . . . -83.11 123.96 76.9 Favored Pre-proline 0 N--CA 1.454 -0.237 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.996 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.57 163.79 31.36 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.679 2.253 . . . . 0.0 112.252 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -104.09 165.3 13.66 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.216 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.09 112.18 3.49 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.625 2.217 . . . . 0.0 112.351 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 21.7 t -125.49 -37.24 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.375 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -172.44 -39.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.007 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.889 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 2.7 m -155.7 -46.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.827 0.346 . . . . 0.0 110.924 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -131.63 109.01 9.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.981 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . 101.91 67.02 0.78 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.61 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 1.4 m -123.04 -55.96 1.76 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.148 0.499 . . . . 0.0 110.282 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -151.05 -47.92 0.12 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.23 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.03 95.33 4.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.527 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . 0.486 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.9 t70 -122.5 142.34 37.04 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.353 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -38.04 -27.82 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.921 2.414 . . . . 0.0 113.556 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 749' ' ' LEU . . . . . 0.466 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 43.5 mt -119.91 -17.36 8.49 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.5 ' CE2' ' CG2' ' A' ' 754' ' ' VAL . 66.3 t80 -55.14 -46.94 75.69 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.816 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -53.27 -36.73 61.46 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . 0.541 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 0.6 OUTLIER -71.04 -45.04 64.58 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.018 178.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -59.35 -52.3 66.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.352 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 754' ' ' VAL . . . . . 0.559 HG21 ' HG2' ' A' ' 786' ' ' MET . 2.3 t -56.12 -43.02 74.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.958 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -66.72 -35.56 80.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.353 0.597 . . . . 0.0 109.708 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 756' ' ' PHE . . . . . 0.405 ' CE2' ' CG2' ' A' ' 768' ' ' VAL . 3.5 t80 -66.24 -46.1 78.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.921 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 757' ' ' VAL . . . . . 0.416 ' CG1' HG13 ' A' ' 792' ' ' VAL . 43.7 t -69.31 -45.05 79.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.932 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 2.0 p -56.64 -42.92 79.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.794 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -78.9 -39.82 33.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.285 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 760' ' ' SER . . . . . 0.406 ' OG ' ' HA ' ' A' ' 757' ' ' VAL . 92.4 p -74.46 -16.88 60.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.35 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 9.0 mmm-85 62.35 24.96 14.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.591 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 6.3 ptt180 -157.87 133.14 8.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.678 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 763' ' ' ALA . . . . . . . . . . . . . . . -102.61 89.77 3.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.965 0.412 . . . . 0.0 111.564 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 764' ' ' SER . . . . . 0.484 ' O ' HG21 ' A' ' 768' ' ' VAL . 1.8 m -125.02 118.53 26.4 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 765' ' ' ILE . . . . . 0.422 HG12 ' HA ' ' A' ' 780' ' ' ALA . 2.2 mp -51.16 -51.49 22.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.952 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 766' ' ' SER . . . . . 0.444 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 14.3 t -53.32 -42.21 66.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.155 0.502 . . . . 0.0 110.629 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -70.1 -42.12 73.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.549 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 768' ' ' VAL . . . . . 0.484 HG21 ' O ' ' A' ' 764' ' ' SER . 42.5 t -59.47 -47.48 90.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.215 179.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . 0.567 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.8 OUTLIER -65.49 -33.46 75.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.719 -179.729 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 770' ' ' ARG . . . . . 0.464 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 0.0 OUTLIER -68.89 -42.25 77.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.046 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -78.55 -42.16 30.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.693 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 772' ' ' LEU . . . . . 0.541 ' CD2' ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -84.98 -8.79 58.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.889 -179.594 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp 58.21 41.83 22.94 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 774' ' ' ILE . . . . . 0.567 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 26.9 pt -111.84 -173.9 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.72 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -91.53 153.08 21.88 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.972 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -58.5 -46.69 86.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.832 0.349 . . . . 0.0 110.73 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -57.57 -47.74 81.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.064 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.0 -50.28 64.83 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.693 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -54.85 -50.09 69.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.674 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 780' ' ' ALA . . . . . 0.422 ' HA ' HG12 ' A' ' 765' ' ' ILE . . . -59.31 -42.92 92.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.76 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -58.93 -48.49 81.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.105 0.478 . . . . 0.0 109.88 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 782' ' ' MET . . . . . . . . . . . . . 33.5 mtm -65.21 -34.52 78.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.45 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 783' ' ' ILE . . . . . 0.42 HG22 ' NH1' ' A' ' 801' ' ' ARG . 5.9 mm -64.6 -36.2 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.094 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.99 -39.94 94.22 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.458 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -60.11 -34.6 73.72 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.42 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 786' ' ' MET . . . . . 0.559 ' HG2' HG21 ' A' ' 754' ' ' VAL . 13.9 mtm -67.07 -39.07 86.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.975 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.51 -54.12 50.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.726 179.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 20.1 mtm -70.36 -38.34 74.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.129 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -65.54 -21.59 66.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.558 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 91.14 14.97 56.84 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.84 -179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.438 ' C ' HG13 ' A' ' 804' ' ' ILE . 23.7 t -84.51 -30.69 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-O 120.892 0.377 . . . . 0.0 111.028 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 792' ' ' VAL . . . . . 0.439 ' CG2' ' HB3' ' A' ' 786' ' ' MET . 18.9 m -137.07 140.06 43.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.278 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 793' ' ' THR . . . . . 0.461 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 2.3 p -85.18 160.56 54.43 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.831 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 794' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 17.7 Cg_endo -58.94 167.55 5.41 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.137 1.891 . . . . 0.0 111.873 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.54 157.01 38.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.202 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 35.9 p30 -105.55 176.61 5.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.826 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 7.9 t -57.31 -33.95 68.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.023 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -71.95 -17.51 62.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.14 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 92.99 27.76 13.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.474 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 3.5 m -127.72 133.95 49.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 0.0 110.898 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . 0.42 ' NH1' HG22 ' A' ' 783' ' ' ILE . 8.4 mtt-85 -85.6 170.66 12.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.243 0.544 . . . . 0.0 111.354 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -130.86 167.34 19.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.042 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 803' ' ' VAL . . . . . 0.437 ' HA ' ' HA ' ' A' ' 792' ' ' VAL . 21.9 t -109.5 135.87 47.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.951 0.405 . . . . 0.0 111.63 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 804' ' ' ILE . . . . . 0.438 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -104.51 -28.43 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.259 179.058 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 805' ' ' ALA . . . . . 0.406 ' CB ' ' HA ' ' A' ' 791' ' ' VAL . . . -81.33 124.15 80.77 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.87 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.32 163.85 25.05 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.671 2.247 . . . . 0.0 112.188 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -92.22 166.78 16.45 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.2 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.99 95.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.625 2.217 . . . . 0.0 112.277 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 11.9 t 69.12 -67.31 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.184 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -136.87 -46.22 0.59 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.005 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 2.0 p30 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.908 179.974 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.6 -47.9 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.807 0.337 . . . . 0.0 110.855 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 63.1 88.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.086 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . 101.79 60.11 0.77 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.743 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -117.5 -51.69 2.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.141 0.496 . . . . 0.0 110.267 179.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -157.03 -49.14 0.07 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.024 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -124.93 95.07 4.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.227 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 13.1 t70 -122.57 143.31 39.52 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.344 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 748' ' ' PRO . . . . . 0.4 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 45.3 Cg_exo -36.14 -29.32 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.011 2.474 . . . . 0.0 113.789 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 749' ' ' LEU . . . . . 0.439 HD21 HD22 ' A' ' 772' ' ' LEU . 23.8 mt -120.05 -17.24 8.44 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.528 ' CE2' ' CG2' ' A' ' 754' ' ' VAL . 70.1 t80 -53.39 -48.37 68.72 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.949 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -53.24 -37.29 61.94 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . 0.579 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 0.5 OUTLIER -70.94 -42.12 70.25 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.085 178.679 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 753' ' ' ALA . . . . . 0.421 ' HB2' ' CE ' ' A' ' 782' ' ' MET . . . -60.96 -53.7 54.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.202 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 754' ' ' VAL . . . . . 0.539 HG21 ' HG2' ' A' ' 786' ' ' MET . 8.0 t -56.27 -39.98 63.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.063 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 37.9 mtt180 -67.62 -37.37 82.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.39 0.614 . . . . 0.0 109.766 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 756' ' ' PHE . . . . . 0.412 ' CE1' ' HB2' ' A' ' 771' ' ' LYS . 4.6 t80 -67.68 -46.06 73.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.288 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 757' ' ' VAL . . . . . 0.445 HG12 ' CB ' ' A' ' 763' ' ' ALA . 54.3 t -69.46 -43.94 80.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.958 0.409 . . . . 0.0 110.61 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 12.5 p -56.67 -45.6 81.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.052 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -78.8 -34.39 45.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.634 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 760' ' ' SER . . . . . 0.504 ' HB2' ' NE ' ' A' ' 762' ' ' ARG . 91.7 p -75.25 -17.76 60.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.527 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 5.9 mmm-85 63.68 33.55 12.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.349 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 762' ' ' ARG . . . . . 0.504 ' NE ' ' HB2' ' A' ' 760' ' ' SER . 0.0 OUTLIER -170.61 136.64 1.27 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.403 179.535 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 763' ' ' ALA . . . . . 0.481 ' HB2' ' HD3' ' A' ' 801' ' ' ARG . . . -104.46 89.76 3.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 0.0 111.82 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 764' ' ' SER . . . . . 0.531 ' O ' HG21 ' A' ' 768' ' ' VAL . 1.0 OUTLIER -121.36 118.52 29.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.571 178.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 765' ' ' ILE . . . . . 0.442 HG12 ' HA ' ' A' ' 780' ' ' ALA . 1.6 mt -53.33 -50.49 47.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.618 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 766' ' ' SER . . . . . 0.437 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 16.3 t -55.27 -39.04 69.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.167 0.508 . . . . 0.0 110.492 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -71.8 -37.54 70.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.503 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 768' ' ' VAL . . . . . 0.531 HG21 ' O ' ' A' ' 764' ' ' SER . 44.5 t -65.57 -47.85 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.241 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . 0.572 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -64.85 -33.39 75.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.478 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 770' ' ' ARG . . . . . 0.448 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 2.6 mtt180 -70.91 -42.5 69.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.117 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . 0.412 ' HB2' ' CE1' ' A' ' 756' ' ' PHE . 0.2 OUTLIER -78.52 -36.43 44.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.086 -179.425 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 772' ' ' LEU . . . . . 0.579 ' CD2' ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -91.59 -9.35 44.48 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.885 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt 60.76 40.94 15.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.073 0.463 . . . . 0.0 109.815 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 774' ' ' ILE . . . . . 0.572 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 20.5 pt -111.84 -173.92 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.292 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.91 150.96 21.87 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.12 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -55.63 -45.37 77.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.855 0.359 . . . . 0.0 110.582 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -63.77 -47.94 78.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.771 179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.44 -50.12 75.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.893 0.378 . . . . 0.0 110.783 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.64 72.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.458 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 780' ' ' ALA . . . . . 0.442 ' HA ' HG12 ' A' ' 765' ' ' ILE . . . -56.27 -40.69 74.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.941 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 12.5 mtt180 -58.86 -46.35 87.97 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 782' ' ' MET . . . . . 0.421 ' CE ' ' HB2' ' A' ' 753' ' ' ALA . 2.3 mtp -64.74 -42.59 95.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 783' ' ' ILE . . . . . 0.431 ' CG2' ' NH1' ' A' ' 801' ' ' ARG . 9.9 mm -57.22 -35.64 49.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.291 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.12 -45.47 88.45 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.434 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -58.26 -33.62 69.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.603 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 786' ' ' MET . . . . . 0.539 ' HG2' HG21 ' A' ' 754' ' ' VAL . 14.4 mtm -67.2 -38.21 84.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.083 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -62.27 -47.9 82.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.582 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 36.3 mtm -73.56 -37.53 65.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.272 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -70.46 -21.58 62.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.599 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 92.22 15.51 53.44 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.819 -179.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.49 ' C ' HG13 ' A' ' 804' ' ' ILE . 59.7 t -83.93 -29.12 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.744 0.307 . . . . 0.0 111.101 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 792' ' ' VAL . . . . . 0.429 HG22 ' NH1' ' A' ' 801' ' ' ARG . 18.8 m -139.39 135.42 40.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.953 0.406 . . . . 0.0 111.375 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 793' ' ' THR . . . . . 0.639 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 4.7 p -80.49 168.31 26.45 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.597 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 794' ' ' PRO . . . . . 0.639 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 38.7 Cg_endo -65.44 163.38 29.93 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 121.877 1.718 . . . . 0.0 111.965 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 795' ' ' MET . . . . . 0.405 ' HA ' ' HG3' ' A' ' 801' ' ' ARG . 0.1 OUTLIER -60.8 162.27 6.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.453 -179.69 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -105.53 176.5 5.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.892 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 60.2 p -60.58 -30.41 69.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.022 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -83.79 -17.53 40.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.252 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.41 26.41 7.74 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.513 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 50.7 m -123.27 130.44 52.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.911 0.386 . . . . 0.0 110.825 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . 0.481 ' HD3' ' HB2' ' A' ' 763' ' ' ALA . 9.3 mtt-85 -83.68 170.57 14.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.213 0.53 . . . . 0.0 111.465 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -132.14 134.51 45.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.934 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 803' ' ' VAL . . . . . 0.409 HG23 ' CG1' ' A' ' 757' ' ' VAL . 18.9 t -76.91 136.86 23.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.985 0.422 . . . . 0.0 111.904 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 804' ' ' ILE . . . . . 0.49 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -107.04 -29.78 2.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.516 178.875 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 805' ' ' ALA . . . . . 0.464 ' CB ' ' HA ' ' A' ' 791' ' ' VAL . . . -75.08 120.15 80.29 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -50.2 163.9 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.678 2.252 . . . . 0.0 112.92 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -95.34 146.1 30.71 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.148 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.77 111.51 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.549 2.166 . . . . 0.0 112.335 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 16.7 t 67.56 -69.88 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.285 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -142.97 -46.3 0.31 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.927 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.909 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 6.0 t -157.06 -47.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.772 0.32 . . . . 0.0 110.769 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -139.23 129.65 25.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.893 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . 78.96 61.5 2.38 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.518 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 14.6 m -119.35 -47.5 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.134 0.492 . . . . 0.0 110.363 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -159.26 -49.67 0.06 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.223 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.38 95.21 4.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.355 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . 0.48 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.42 142.96 38.39 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.316 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 748' ' ' PRO . . . . . 0.41 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 43.8 Cg_exo -36.69 -28.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.015 2.477 . . . . 0.0 113.774 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 749' ' ' LEU . . . . . 0.466 HD21 HD22 ' A' ' 772' ' ' LEU . 28.6 mt -119.99 -17.1 8.51 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.543 ' CE2' HG22 ' A' ' 754' ' ' VAL . 82.3 t80 -52.81 -50.47 63.59 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.791 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -52.93 -35.99 59.17 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . 0.583 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 5.9 tt0 -71.05 -41.89 70.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.23 178.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -62.89 -53.77 48.98 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.987 179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 754' ' ' VAL . . . . . 0.543 HG22 ' CE2' ' A' ' 750' ' ' TYR . 9.1 t -56.02 -41.43 68.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.738 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -65.6 -35.11 79.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.281 178.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 756' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -69.73 -46.3 66.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.367 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 757' ' ' VAL . . . . . 0.477 HG12 ' CB ' ' A' ' 763' ' ' ALA . 51.6 t -70.44 -38.37 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 120.921 0.391 . . . . 0.0 110.843 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 22.4 p -65.21 -42.48 93.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.177 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -77.14 -46.48 23.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.373 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 92.5 p -74.68 -10.47 59.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.154 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.65 30.25 17.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.06 0.457 . . . . 0.0 110.607 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 10.6 mtm180 -145.5 138.46 26.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.543 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 763' ' ' ALA . . . . . 0.477 ' CB ' HG12 ' A' ' 757' ' ' VAL . . . -117.76 89.57 3.15 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.97 0.414 . . . . 0.0 111.025 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 764' ' ' SER . . . . . 0.504 ' O ' HG21 ' A' ' 768' ' ' VAL . 2.7 m -133.91 118.45 17.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.637 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 765' ' ' ILE . . . . . 0.447 HG21 ' N ' ' A' ' 780' ' ' ALA . 19.1 mt -50.01 -46.65 23.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.704 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 766' ' ' SER . . . . . 0.461 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 12.1 t -58.9 -39.0 80.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.136 0.493 . . . . 0.0 110.534 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -72.93 -36.61 67.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.349 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 768' ' ' VAL . . . . . 0.504 HG21 ' O ' ' A' ' 764' ' ' SER . 40.7 t -65.22 -48.01 85.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.067 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . 0.581 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.41 -33.47 76.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.569 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 770' ' ' ARG . . . . . 0.415 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 12.1 mtt180 -71.54 -41.53 69.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.065 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.63 -36.52 43.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.829 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 772' ' ' LEU . . . . . 0.583 ' CD2' ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -91.28 -10.03 42.93 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt 61.61 39.94 13.97 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 774' ' ' ILE . . . . . 0.581 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 24.1 pt -111.77 -174.49 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.481 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.69 152.98 23.57 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.228 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -57.16 -46.34 82.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.926 0.393 . . . . 0.0 110.625 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -62.87 -47.83 81.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.724 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . 0.422 ' NE ' HD13 ' A' ' 749' ' ' LEU . 0.4 OUTLIER -60.27 -50.24 74.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.82 -179.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.84 -50.04 73.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.349 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 780' ' ' ALA . . . . . 0.447 ' N ' HG21 ' A' ' 765' ' ' ILE . . . -55.64 -42.89 75.63 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.781 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -58.66 -43.09 89.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.097 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 782' ' ' MET . . . . . . . . . . . . . 2.6 mtp -68.38 -40.04 81.55 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 783' ' ' ILE . . . . . 0.479 HG21 ' NH2' ' A' ' 801' ' ' ARG . 5.3 mm -58.14 -40.08 75.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.798 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 784' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 787' ' ' GLU . 2.3 mt-10 -63.99 -46.18 85.7 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.444 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -54.76 -33.42 61.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.508 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 786' ' ' MET . . . . . 0.526 ' HG2' HG21 ' A' ' 754' ' ' VAL . 14.9 mtm -67.7 -39.36 84.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.848 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 787' ' ' GLU . . . . . 0.416 ' HB2' ' O ' ' A' ' 784' ' ' GLU . 0.4 OUTLIER -57.62 -51.5 69.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.669 179.415 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 46.9 mtm -75.46 -38.37 59.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.915 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -64.31 -21.2 66.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.921 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 91.87 19.77 39.04 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.419 -178.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.474 ' C ' HG13 ' A' ' 804' ' ' ILE . 79.2 t -89.2 -32.78 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.793 0.33 . . . . 0.0 111.059 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 792' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 803' ' ' VAL . 28.3 m -137.49 143.44 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.0 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 793' ' ' THR . . . . . 0.513 HG21 HG12 ' A' ' 804' ' ' ILE . 6.8 p -82.03 155.2 70.16 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.421 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 794' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -58.75 169.03 3.62 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.424 2.083 . . . . 0.0 112.345 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 795' ' ' MET . . . . . 0.486 ' HA ' ' HG3' ' A' ' 801' ' ' ARG . 1.4 mtp -60.92 159.52 11.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.303 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -102.48 176.56 5.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.805 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 38.2 p -60.59 -28.01 68.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.07 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -90.9 -17.59 26.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.327 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 104.8 28.55 5.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.765 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 19.3 m -121.91 129.88 52.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.871 0.367 . . . . 0.0 110.929 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . 0.486 ' HG3' ' HA ' ' A' ' 795' ' ' MET . 0.4 OUTLIER -94.46 170.49 9.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.125 0.488 . . . . 0.0 111.387 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.95 -172.42 2.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.488 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 803' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 792' ' ' VAL . 30.2 t -121.14 138.66 50.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.843 0.354 . . . . 0.0 111.741 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 804' ' ' ILE . . . . . 0.513 HG12 HG21 ' A' ' 793' ' ' THR . 0.0 OUTLIER -110.16 -27.13 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.777 179.282 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 805' ' ' ALA . . . . . 0.472 ' CB ' ' HA ' ' A' ' 791' ' ' VAL . . . -84.74 120.87 74.43 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.889 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.42 163.71 28.63 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.59 2.193 . . . . 0.0 112.163 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -92.28 148.23 36.16 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.168 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -55.57 110.37 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.577 2.184 . . . . 0.0 112.278 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 21.8 t -91.15 -33.38 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.083 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -125.33 30.6 5.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.914 -179.979 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 112.55 -0.22 . . . . 0.0 112.55 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 5.4 m -108.62 30.2 6.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.775 0.321 . . . . 0.0 110.892 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.21 148.93 52.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.872 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . -69.08 67.25 0.49 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.515 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 9.8 p -101.76 -158.04 0.65 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.592 0.234 . . . . 0.0 110.656 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -50.78 -45.31 59.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.722 0.296 . . . . 0.0 111.505 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -128.13 95.61 4.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.069 0.461 . . . . 0.0 111.34 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 14.6 t70 -122.36 142.34 36.82 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.413 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_exo -35.12 -30.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.311 2.674 . . . . 0.0 113.993 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 749' ' ' LEU . . . . . 0.423 HD21 HD22 ' A' ' 772' ' ' LEU . 44.7 mt -120.02 -16.91 8.54 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.524 ' HB2' ' HB3' ' A' ' 747' ' ' ASP . 67.7 t80 -54.08 -47.81 71.31 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.483 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -53.45 -35.73 60.81 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . 0.424 ' HB2' ' CD2' ' A' ' 772' ' ' LEU . 8.4 mt-10 -70.95 -40.91 71.74 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.182 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 753' ' ' ALA . . . . . 0.41 ' HA ' HD12 ' A' ' 772' ' ' LEU . . . -64.24 -52.35 59.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.118 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 754' ' ' VAL . . . . . 0.544 HG21 ' HG2' ' A' ' 786' ' ' MET . 3.1 t -56.35 -40.09 64.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.005 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.59 -35.32 77.2 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.488 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 756' ' ' PHE . . . . . 0.553 ' HD2' ' HD2' ' A' ' 771' ' ' LYS . 1.1 t80 -67.42 -46.12 74.11 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.93 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 757' ' ' VAL . . . . . 0.404 ' O ' ' N ' ' A' ' 761' ' ' ARG . 43.3 t -70.82 -41.07 77.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.86 0.362 . . . . 0.0 110.757 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 20.3 p -62.18 -42.08 98.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.568 179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -77.26 -47.03 21.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.882 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 6.3 p -70.98 -18.54 62.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.765 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 761' ' ' ARG . . . . . 0.404 ' N ' ' O ' ' A' ' 757' ' ' VAL . 0.0 OUTLIER 65.17 18.69 11.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.771 -179.626 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -139.74 145.39 38.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.749 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 763' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 801' ' ' ARG . . . -117.43 89.46 3.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.237 0.541 . . . . 0.0 110.83 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 764' ' ' SER . . . . . 0.498 ' O ' HG21 ' A' ' 768' ' ' VAL . 23.7 m -129.99 118.59 21.84 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 765' ' ' ILE . . . . . 0.443 HG12 ' HA ' ' A' ' 780' ' ' ALA . 11.2 mt -51.77 -47.17 39.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.697 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 766' ' ' SER . . . . . 0.55 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 22.2 t -59.3 -37.73 78.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.149 0.499 . . . . 0.0 110.571 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -73.1 -42.17 63.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.229 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 768' ' ' VAL . . . . . 0.498 HG21 ' O ' ' A' ' 764' ' ' SER . 30.4 t -59.76 -50.91 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.971 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . 0.615 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -63.58 -33.45 75.63 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.713 -179.649 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -67.03 -43.87 81.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.122 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . 0.553 ' HD2' ' HD2' ' A' ' 756' ' ' PHE . 0.9 OUTLIER -78.64 -42.16 29.5 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.838 0.351 . . . . 0.0 111.794 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 772' ' ' LEU . . . . . 0.424 ' CD2' ' HB2' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -81.37 -10.57 59.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.815 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm 60.03 40.76 18.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.193 0.521 . . . . 0.0 109.701 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 774' ' ' ILE . . . . . 0.615 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 24.2 pt -111.82 -173.99 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.563 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.55 149.91 21.45 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.111 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -53.98 -44.72 71.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 110.662 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 777' ' ' ASN . . . . . 0.42 ' O ' ' HG3' ' A' ' 781' ' ' ARG . 79.3 m-20 -65.01 -47.89 75.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.692 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.83 -50.07 74.51 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.865 0.364 . . . . 0.0 110.752 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 779' ' ' ALA . . . . . 0.412 ' HB2' ' CD1' ' A' ' 774' ' ' ILE . . . -58.14 -45.88 86.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.105 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 780' ' ' ALA . . . . . 0.443 ' HA ' HG12 ' A' ' 765' ' ' ILE . . . -56.93 -44.3 82.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.103 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 781' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 777' ' ' ASN . 7.4 mtt180 -58.76 -46.86 86.51 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 782' ' ' MET . . . . . 0.419 ' HE2' ' HB3' ' A' ' 749' ' ' LEU . 2.5 mtp -64.06 -41.81 97.22 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 783' ' ' ILE . . . . . 0.439 ' CG2' ' NH1' ' A' ' 801' ' ' ARG . 7.2 mm -58.73 -37.16 64.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.448 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.26 -45.2 92.61 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.433 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -58.99 -33.53 70.8 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.63 178.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 786' ' ' MET . . . . . 0.544 ' HG2' HG21 ' A' ' 754' ' ' VAL . 12.4 mtm -65.79 -39.79 91.3 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.118 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.32 -47.84 82.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.147 0.499 . . . . 0.0 110.492 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 25.8 mtp -70.95 -38.29 72.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.552 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -71.19 -21.64 62.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.962 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 790' ' ' GLY . . . . . 0.405 ' O ' ' HB ' ' A' ' 804' ' ' ILE . . . 93.3 19.03 36.96 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.605 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.51 ' HA ' ' CB ' ' A' ' 805' ' ' ALA . 38.1 t -88.27 -30.19 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.716 0.293 . . . . 0.0 111.168 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 792' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 803' ' ' VAL . 20.9 m -138.76 143.73 31.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.408 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 793' ' ' THR . . . . . 0.491 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.3 p -88.06 163.59 36.83 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 794' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 18.6 Cg_endo -59.93 166.41 8.67 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 121.957 1.772 . . . . 0.0 112.129 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 1.5 mtt -61.12 162.03 7.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.227 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -105.55 176.54 5.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.766 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 44.1 p -61.62 -33.92 74.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.779 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -79.56 -17.57 53.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.56 28.07 6.87 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.417 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 19.2 m -124.68 130.45 52.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 110.909 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . 0.543 ' HB2' ' O ' ' A' ' 763' ' ' ALA . 11.3 mtt-85 -83.95 170.69 13.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.449 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -129.02 168.98 15.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.254 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 803' ' ' VAL . . . . . 0.46 ' HA ' ' HA ' ' A' ' 792' ' ' VAL . 21.4 t -110.62 137.27 43.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.011 0.434 . . . . 0.0 111.844 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 804' ' ' ILE . . . . . 0.445 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -107.5 -27.96 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.314 178.991 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 805' ' ' ALA . . . . . 0.51 ' CB ' ' HA ' ' A' ' 791' ' ' VAL . . . -79.34 122.73 84.39 Favored Pre-proline 0 N--CA 1.455 -0.207 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.742 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.38 163.66 31.38 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.513 2.142 . . . . 0.0 112.198 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -79.34 148.23 70.16 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.24 110.85 3.17 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.535 2.157 . . . . 0.0 112.335 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 21.5 t -72.74 -32.73 41.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.086 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -171.75 -41.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.958 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 9.0 t0 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.891 179.995 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 112.392 -0.283 . . . . 0.0 112.392 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 2.0 m -146.1 28.46 1.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 110.949 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -94.25 104.83 16.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.991 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . 75.44 60.68 3.18 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.678 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.43 -47.97 2.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.149 0.5 . . . . 0.0 110.252 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -159.1 -49.59 0.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.177 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -126.35 95.17 4.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.318 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . 0.498 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.6 t70 -122.49 143.2 39.1 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.535 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 748' ' ' PRO . . . . . 0.416 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 37.9 Cg_exo -36.72 -28.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.069 2.513 . . . . 0.0 113.895 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 749' ' ' LEU . . . . . 0.444 HD21 HD22 ' A' ' 772' ' ' LEU . 28.9 mt -120.03 -17.2 8.46 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.508 ' CE2' ' CG2' ' A' ' 754' ' ' VAL . 80.5 t80 -52.88 -50.34 64.04 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.948 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -53.17 -35.72 60.1 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . 0.572 ' HB3' ' CD2' ' A' ' 772' ' ' LEU . 8.0 tt0 -71.12 -41.5 70.44 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.293 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 753' ' ' ALA . . . . . 0.433 ' HA ' HD12 ' A' ' 772' ' ' LEU . . . -64.57 -51.95 60.15 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.125 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 754' ' ' VAL . . . . . 0.55 HG21 ' HG2' ' A' ' 786' ' ' MET . 5.0 t -56.12 -38.7 54.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.504 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -69.38 -35.16 75.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.435 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 756' ' ' PHE . . . . . 0.431 ' CE2' ' CG2' ' A' ' 768' ' ' VAL . 1.5 t80 -68.57 -46.2 70.05 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.329 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 757' ' ' VAL . . . . . 0.475 HG13 ' CG2' ' A' ' 803' ' ' VAL . 35.4 t -71.23 -41.38 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-O 120.991 0.424 . . . . 0.0 110.751 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 30.1 p -62.72 -42.89 99.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.993 179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -77.48 -46.31 22.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.275 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 760' ' ' SER . . . . . 0.502 ' O ' ' HD3' ' A' ' 762' ' ' ARG . 50.0 p -70.06 -29.17 66.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 761' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 760' ' ' SER . 0.0 OUTLIER 70.86 28.53 3.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.302 -179.248 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 762' ' ' ARG . . . . . 0.502 ' HD3' ' O ' ' A' ' 760' ' ' SER . 0.4 OUTLIER -147.8 110.55 4.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.368 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 763' ' ' ALA . . . . . . . . . . . . . . . -91.06 89.69 7.51 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.052 0.453 . . . . 0.0 111.257 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 764' ' ' SER . . . . . 0.493 ' O ' HG21 ' A' ' 768' ' ' VAL . 1.3 m -133.94 118.85 18.35 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.472 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 765' ' ' ILE . . . . . . . . . . . . . 1.5 mp -48.85 -52.7 9.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.952 -178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 766' ' ' SER . . . . . 0.508 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 7.9 t -53.34 -40.12 64.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.203 0.525 . . . . 0.0 110.635 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -71.64 -39.75 70.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.445 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 768' ' ' VAL . . . . . 0.493 HG21 ' O ' ' A' ' 764' ' ' SER . 44.4 t -61.89 -49.88 82.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.114 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . 0.575 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -63.47 -33.91 76.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.869 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 770' ' ' ARG . . . . . 0.419 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 7.2 mtt85 -68.95 -42.53 76.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.218 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.7 -39.3 36.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.701 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 772' ' ' LEU . . . . . 0.572 ' CD2' ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -87.07 -9.78 54.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.248 -179.314 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp 60.95 39.7 16.3 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 774' ' ' ILE . . . . . 0.575 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 17.8 pt -111.86 -173.83 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.165 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -90.17 153.18 22.69 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.023 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -57.09 -45.57 83.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.817 0.341 . . . . 0.0 110.64 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 777' ' ' ASN . . . . . 0.421 ' O ' ' HG3' ' A' ' 781' ' ' ARG . 66.4 m-20 -63.13 -48.08 80.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.735 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.88 -50.17 74.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.979 0.418 . . . . 0.0 110.751 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.12 76.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.441 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 780' ' ' ALA . . . . . . . . . . . . . . . -56.97 -40.87 77.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.027 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 781' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 777' ' ' ASN . 17.3 mtt180 -58.88 -46.77 87.02 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 782' ' ' MET . . . . . . . . . . . . . 2.3 mtp -64.83 -42.24 95.09 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 783' ' ' ILE . . . . . 0.498 ' CG2' ' NH2' ' A' ' 801' ' ' ARG . 5.9 mm -55.8 -39.54 56.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.502 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.97 -46.69 86.51 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.427 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -55.19 -33.54 63.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.827 178.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 786' ' ' MET . . . . . 0.55 ' HG2' HG21 ' A' ' 754' ' ' VAL . 14.5 mtm -67.38 -40.53 85.7 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.197 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 787' ' ' GLU . . . . . 0.486 ' HG3' ' NH1' ' A' ' 801' ' ' ARG . 4.2 mt-10 -58.61 -53.66 55.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.647 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 30.9 mtm -71.06 -38.32 72.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.429 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -65.71 -21.42 66.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.7 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 790' ' ' GLY . . . . . 0.42 ' HA3' ' CD1' ' A' ' 804' ' ' ILE . . . 91.15 15.18 56.4 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.608 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.478 ' C ' HG13 ' A' ' 804' ' ' ILE . 86.1 t -84.02 -29.78 7.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.023 0.44 . . . . 0.0 110.672 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 792' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 803' ' ' VAL . 17.6 m -139.54 144.47 28.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.977 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 793' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 6.6 p -83.69 156.84 64.72 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.608 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 794' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 19.0 Cg_endo -58.77 169.51 3.3 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.498 2.132 . . . . 0.0 112.177 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 795' ' ' MET . . . . . 0.424 ' HA ' ' HG3' ' A' ' 801' ' ' ARG . 2.1 mtt -65.13 159.82 22.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.021 0.439 . . . . 0.0 111.254 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 56.6 m-20 -102.15 176.58 5.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.841 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 9.8 t -59.63 -29.52 68.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.069 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 39.1 p30 -87.3 -17.58 32.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.378 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 102.48 31.79 5.1 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.722 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 15.9 m -125.0 129.65 50.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.347 . . . . 0.0 110.75 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . 0.498 ' NH2' ' CG2' ' A' ' 783' ' ' ILE . 0.5 OUTLIER -93.51 169.63 10.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.348 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -130.48 -170.81 2.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.713 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 803' ' ' VAL . . . . . 0.543 ' HA ' ' HA ' ' A' ' 792' ' ' VAL . 30.0 t -124.58 138.52 53.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.928 0.394 . . . . 0.0 111.887 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 804' ' ' ILE . . . . . 0.478 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -108.97 -30.22 2.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.519 179.232 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 805' ' ' ALA . . . . . 0.442 ' CB ' ' HA ' ' A' ' 791' ' ' VAL . . . -79.55 119.79 78.06 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.892 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.89 163.75 32.38 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.536 2.157 . . . . 0.0 112.219 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -79.25 145.55 64.78 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.134 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.66 115.83 4.15 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.592 2.194 . . . . 0.0 112.435 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -98.75 176.41 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.633 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.91 -35.6 6.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.019 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.962 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.114 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 4.7 m -147.05 -54.28 0.23 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.871 0.367 . . . . 0.0 110.914 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 59.68 27.67 16.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.99 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . 114.36 68.93 0.48 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.675 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 56.2 m -122.36 -56.89 1.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.068 0.461 . . . . 0.0 110.322 179.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -151.37 -48.81 0.12 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.208 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -124.86 95.27 4.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.532 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 747' ' ' ASP . . . . . 0.479 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.0 t70 -122.45 142.42 37.18 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.501 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -38.73 -27.3 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.873 2.382 . . . . 0.0 113.547 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 749' ' ' LEU . . . . . 0.401 HD11 ' HD3' ' A' ' 778' ' ' ARG . 46.2 mt -119.99 -17.06 8.53 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 750' ' ' TYR . . . . . 0.502 ' CE2' ' CG2' ' A' ' 754' ' ' VAL . 71.1 t80 -55.62 -47.14 77.05 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.386 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -53.27 -35.72 60.36 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 752' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -71.03 -43.58 67.6 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.255 178.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -61.87 -53.39 56.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.205 179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 754' ' ' VAL . . . . . 0.562 HG21 ' HG2' ' A' ' 786' ' ' MET . 3.2 t -56.18 -41.14 68.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.552 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -69.68 -35.43 75.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.333 0.587 . . . . 0.0 109.844 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 756' ' ' PHE . . . . . 0.405 ' CE1' ' HB2' ' A' ' 771' ' ' LYS . 4.0 t80 -66.95 -46.07 75.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.044 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 757' ' ' VAL . . . . . 0.405 HG12 ' CB ' ' A' ' 763' ' ' ALA . 59.5 t -70.47 -44.86 76.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.883 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 758' ' ' THR . . . . . . . . . . . . . 9.1 p -56.83 -44.87 82.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.277 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -78.84 -39.73 34.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.463 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 760' ' ' SER . . . . . 0.467 ' HB2' ' NE ' ' A' ' 762' ' ' ARG . 94.6 p -72.56 -25.04 61.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.254 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 67.98 42.71 1.8 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.377 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 762' ' ' ARG . . . . . 0.467 ' NE ' ' HB2' ' A' ' 760' ' ' SER . 0.0 OUTLIER -174.61 121.19 0.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.564 179.495 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 763' ' ' ALA . . . . . 0.405 ' CB ' HG12 ' A' ' 757' ' ' VAL . . . -93.87 89.77 6.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.972 0.415 . . . . 0.0 111.646 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 764' ' ' SER . . . . . 0.528 ' O ' HG21 ' A' ' 768' ' ' VAL . 9.9 m -123.54 118.55 27.61 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 765' ' ' ILE . . . . . 0.419 HG21 ' N ' ' A' ' 780' ' ' ALA . 24.1 mt -53.51 -50.15 50.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.738 -179.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 766' ' ' SER . . . . . 0.413 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 11.4 t -53.35 -43.24 67.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.221 0.534 . . . . 0.0 110.499 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -69.75 -39.87 76.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.768 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 768' ' ' VAL . . . . . 0.528 HG21 ' O ' ' A' ' 764' ' ' SER . 47.0 t -61.85 -45.71 98.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.253 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 769' ' ' GLN . . . . . 0.561 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.8 OUTLIER -66.5 -33.48 75.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.416 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 770' ' ' ARG . . . . . 0.461 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 20.5 mtt180 -70.95 -42.06 70.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.037 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . 0.405 ' HB2' ' CE1' ' A' ' 756' ' ' PHE . 0.7 OUTLIER -78.53 -38.27 40.94 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.007 -179.488 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 772' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' A' ' 768' ' ' VAL . 0.2 OUTLIER -90.35 -9.32 48.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.573 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt 60.16 42.24 15.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 774' ' ' ILE . . . . . 0.561 ' CG1' ' HA ' ' A' ' 769' ' ' GLN . 29.4 pt -112.0 -174.05 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.816 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -90.95 150.49 20.58 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.088 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -55.03 -46.52 75.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.902 0.382 . . . . 0.0 110.885 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -59.6 -45.91 90.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.206 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 778' ' ' ARG . . . . . 0.401 ' HD3' HD11 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -66.11 -50.44 64.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.833 0.349 . . . . 0.0 110.858 -179.788 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -55.12 -50.21 69.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.202 179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 780' ' ' ALA . . . . . 0.419 ' N ' HG21 ' A' ' 765' ' ' ILE . . . -56.06 -46.45 78.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.985 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -58.9 -48.42 81.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.253 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 782' ' ' MET . . . . . . . . . . . . . 33.8 mtm -63.41 -36.36 83.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.307 0.575 . . . . 0.0 109.461 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 783' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 786' ' ' MET . 7.4 mm -63.37 -40.28 88.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.18 -42.71 91.48 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 785' ' ' ALA . . . . . 0.436 ' HB1' ' CE1' ' A' ' 750' ' ' TYR . . . -60.02 -33.58 72.21 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.719 178.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 786' ' ' MET . . . . . 0.562 ' HG2' HG21 ' A' ' 754' ' ' VAL . 12.7 mtm -66.05 -37.62 86.29 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.062 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 787' ' ' GLU . . . . . 0.435 ' HG3' ' CZ ' ' A' ' 801' ' ' ARG . 3.3 mt-10 -63.36 -53.97 44.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.742 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 24.5 mtm -68.55 -37.64 80.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.494 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -68.73 -21.59 64.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.796 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 790' ' ' GLY . . . . . . . . . . . . . . . 89.75 19.55 47.47 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.926 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 791' ' ' VAL . . . . . 0.447 ' C ' HG13 ' A' ' 804' ' ' ILE . 11.3 t -84.45 -34.67 9.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.804 0.335 . . . . 0.0 110.756 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 792' ' ' VAL . . . . . 0.508 HG23 ' HB3' ' A' ' 786' ' ' MET . 11.7 m -133.88 140.21 46.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.28 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 793' ' ' THR . . . . . 0.441 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.2 p -77.85 160.89 73.21 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 794' ' ' PRO . . . . . 0.441 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 22.7 Cg_endo -60.29 166.08 9.87 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.088 1.859 . . . . 0.0 111.967 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 2.1 mtt -56.56 158.46 4.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.196 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -101.25 176.47 5.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.921 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 9.7 t -55.63 -33.26 63.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -85.18 -17.58 36.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.121 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.6 35.96 3.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.548 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 6.0 m -127.82 130.01 47.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.956 0.408 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 801' ' ' ARG . . . . . 0.472 ' NH2' ' CG2' ' A' ' 783' ' ' ILE . 6.5 mtp85 -81.67 170.58 15.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.331 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -131.27 -170.7 2.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.659 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 803' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 792' ' ' VAL . 23.0 t -127.26 133.7 67.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.17 0.51 . . . . 0.0 112.098 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 804' ' ' ILE . . . . . 0.447 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -105.15 -28.76 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.858 178.69 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 805' ' ' ALA . . . . . . . . . . . . . . . -80.85 126.49 77.59 Favored Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.778 179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.61 163.77 23.22 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.713 2.275 . . . . 0.0 112.228 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -106.95 159.64 29.2 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.234 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -77.13 115.19 3.93 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.621 2.214 . . . . 0.0 112.481 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 58.44 175.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.966 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 3.9 mtt180 -95.24 -33.33 12.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 3.9 p30 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.906 179.973 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 743' ' ' GLY . . . . . 0.622 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.588 -0.205 . . . . 0.0 112.588 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 744' ' ' SER . . . . . 0.503 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 0.8 OUTLIER -116.56 -49.75 2.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.141 0.496 . . . . 0.0 110.262 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.69 -50.52 0.08 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.95 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -124.1 95.23 4.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.266 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 747' ' ' ASP . . . . . 0.537 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.3 t70 -122.44 142.46 37.25 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.531 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 748' ' ' PRO . . . . . 0.408 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 45.7 Cg_exo -37.24 -28.88 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.057 2.505 . . . . 0.0 113.582 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 749' ' ' LEU . . . . . 0.802 HD13 ' CG2' ' A' ' 774' ' ' ILE . 31.6 mt -119.96 -16.87 8.58 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 750' ' ' TYR . . . . . 0.751 ' CE2' HG21 ' A' ' 754' ' ' VAL . 72.4 t80 -53.4 -48.54 68.6 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 120.344 -0.543 . . . . 0.0 110.457 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -53.37 -36.15 61.08 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 752' ' ' GLU . . . . . 0.948 ' HB2' HD21 ' A' ' 772' ' ' LEU . 1.8 mt-10 -70.95 -40.95 71.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.024 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 753' ' ' ALA . . . . . 0.447 ' O ' HG23 ' A' ' 757' ' ' VAL . . . -63.85 -52.93 57.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.043 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 754' ' ' VAL . . . . . 0.751 HG21 ' CE2' ' A' ' 750' ' ' TYR . 8.8 t -56.14 -39.99 62.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.281 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.65 -35.71 75.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.312 0.577 . . . . 0.0 109.461 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 756' ' ' PHE . . . . . 0.847 ' CE1' HG22 ' A' ' 768' ' ' VAL . 1.0 OUTLIER -66.58 -46.05 77.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.861 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 757' ' ' VAL . . . . . 1.026 HG12 HG22 ' A' ' 803' ' ' VAL . 45.6 t -68.6 -47.1 78.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.973 0.416 . . . . 0.0 110.452 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 758' ' ' THR . . . . . 0.7 ' HA ' HG11 ' A' ' 803' ' ' VAL . 8.4 p -53.93 -43.18 69.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.972 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -78.88 -36.81 41.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.361 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 17.9 p -76.63 -15.07 59.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.454 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 63.07 19.9 11.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.696 0.284 . . . . 0.0 111.415 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 762' ' ' ARG . . . . . 0.561 ' O ' HG13 ' A' ' 757' ' ' VAL . 5.4 ptt180 -154.87 140.03 17.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.844 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 763' ' ' ALA . . . . . 0.585 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -106.84 89.76 3.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 111.528 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 764' ' ' SER . . . . . 0.81 ' O ' HG23 ' A' ' 768' ' ' VAL . 1.4 m -122.62 118.64 28.66 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 765' ' ' ILE . . . . . 0.699 HD13 ' HB2' ' A' ' 780' ' ' ALA . 22.6 mt -53.46 -49.71 52.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.75 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 766' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 12.9 t -53.77 -43.81 69.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.2 0.524 . . . . 0.0 110.578 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -67.86 -45.12 75.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.533 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 768' ' ' VAL . . . . . 0.886 HG21 HD11 ' A' ' 783' ' ' ILE . 26.5 t -56.5 -49.15 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.364 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 769' ' ' GLN . . . . . 0.593 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 1.1 pt20 -63.52 -33.42 75.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.594 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 770' ' ' ARG . . . . . 0.476 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 21.2 mtt180 -70.73 -42.65 70.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.231 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.493 ' HD3' ' HD2' ' A' ' 756' ' ' PHE . 0.0 OUTLIER -78.53 -36.15 45.22 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.522 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 772' ' ' LEU . . . . . 0.948 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -90.87 -10.13 43.77 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp 60.67 41.29 15.34 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 774' ' ' ILE . . . . . 0.802 ' CG2' HD13 ' A' ' 749' ' ' LEU . 22.6 pt -111.75 -173.88 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.486 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.57 153.75 23.53 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.02 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -56.94 -46.42 82.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 0.0 110.797 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -63.57 -44.52 93.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.799 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.797 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.4 OUTLIER -62.06 -50.22 72.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.753 179.858 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -58.34 -48.54 80.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.092 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 780' ' ' ALA . . . . . 0.699 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.07 -43.43 77.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.899 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -59.12 -48.53 81.26 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.855 0.359 . . . . 0.0 110.125 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 782' ' ' MET . . . . . 0.423 ' HE2' ' HB2' ' A' ' 753' ' ' ALA . 2.7 mtp -63.7 -38.31 90.62 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 783' ' ' ILE . . . . . 0.886 HD11 HG21 ' A' ' 768' ' ' VAL . 7.8 mm -61.31 -40.53 86.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.259 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -44.19 91.21 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 743' ' ' GLY . . . -58.97 -33.65 70.91 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.92 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 786' ' ' MET . . . . . 0.658 ' SD ' HG21 ' A' ' 757' ' ' VAL . 14.0 mtm -66.46 -37.73 85.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.106 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 787' ' ' GLU . . . . . 0.462 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 2.5 mt-10 -62.46 -54.17 44.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.519 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 73.4 mtp -68.07 -38.22 82.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.473 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -70.14 -21.57 63.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.955 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 790' ' ' GLY . . . . . 0.444 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 89.79 16.85 55.78 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.85 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.677 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 44.8 t -81.93 -31.68 10.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.796 0.331 . . . . 0.0 110.887 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 792' ' ' VAL . . . . . 0.673 HG21 HH21 ' A' ' 801' ' ' ARG . 7.1 m -135.59 140.76 43.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.074 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 793' ' ' THR . . . . . 0.525 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 9.4 p -78.59 159.69 73.87 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.737 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 794' ' ' PRO . . . . . 0.525 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 19.3 Cg_endo -59.49 167.25 6.65 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.049 1.832 . . . . 0.0 111.824 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -59.5 163.57 4.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.036 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -105.56 176.55 5.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.859 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 5.4 t -57.27 -30.33 64.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.796 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -88.13 -17.63 30.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.048 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.92 36.71 3.61 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.664 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 17.1 m -127.88 129.13 46.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.906 0.384 . . . . 0.0 111.267 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 801' ' ' ARG . . . . . 0.673 HH21 HG21 ' A' ' 792' ' ' VAL . 6.7 mtp85 -83.64 170.36 14.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.287 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 802' ' ' GLU . . . . . 0.47 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 3.2 mt-10 -134.87 174.2 10.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.698 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 803' ' ' VAL . . . . . 1.026 HG22 HG12 ' A' ' 757' ' ' VAL . 20.7 t -109.74 136.25 46.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.06 0.457 . . . . 0.0 112.13 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 804' ' ' ILE . . . . . 0.494 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -109.78 -26.94 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.264 178.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 805' ' ' ALA . . . . . 0.677 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -76.32 122.59 87.04 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.041 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -50.26 163.96 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.604 2.203 . . . . 0.0 112.897 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.137 179.99 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.606 -0.198 . . . . 0.0 112.606 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 744' ' ' SER . . . . . 0.773 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 4.5 m -121.55 -62.68 1.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.122 0.487 . . . . 0.0 110.392 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -145.41 -49.16 0.23 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.234 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.62 95.23 4.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.556 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 747' ' ' ASP . . . . . 0.522 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.9 t70 -122.48 142.31 36.96 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.373 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -38.51 -27.45 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.848 2.366 . . . . 0.0 113.513 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 749' ' ' LEU . . . . . 0.849 HD13 ' CG2' ' A' ' 774' ' ' ILE . 48.4 mt -120.01 -17.02 8.52 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 750' ' ' TYR . . . . . 0.663 ' CE2' HG21 ' A' ' 754' ' ' VAL . 65.3 t80 -55.62 -46.82 77.33 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.349 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -53.38 -35.67 60.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 752' ' ' GLU . . . . . 0.896 ' HB2' HD21 ' A' ' 772' ' ' LEU . 2.5 mt-10 -71.02 -43.7 67.38 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.161 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 753' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 757' ' ' VAL . . . -61.92 -51.7 67.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.206 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 754' ' ' VAL . . . . . 0.749 HG22 HG11 ' A' ' 791' ' ' VAL . 2.3 t -56.33 -42.25 73.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.261 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -69.16 -35.4 76.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.192 0.52 . . . . 0.0 109.909 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 756' ' ' PHE . . . . . 0.746 ' CE2' HG22 ' A' ' 768' ' ' VAL . 2.3 t80 -66.58 -45.93 77.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.922 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 757' ' ' VAL . . . . . 0.943 HG12 HG22 ' A' ' 803' ' ' VAL . 47.4 t -69.2 -44.56 80.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.926 0.393 . . . . 0.0 110.951 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 758' ' ' THR . . . . . 0.58 ' HA ' HG11 ' A' ' 803' ' ' VAL . 3.9 p -58.21 -43.73 87.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.295 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.76 -43.23 26.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.433 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 760' ' ' SER . . . . . 0.424 ' OG ' ' HD2' ' A' ' 762' ' ' ARG . 83.1 p -71.93 -19.96 61.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.039 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 63.52 50.63 2.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.599 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 762' ' ' ARG . . . . . 0.712 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.0 OUTLIER 179.81 139.61 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.49 179.399 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 763' ' ' ALA . . . . . 0.585 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -108.75 89.73 3.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.989 0.423 . . . . 0.0 111.597 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 764' ' ' SER . . . . . 0.739 ' O ' HG23 ' A' ' 768' ' ' VAL . 0.7 OUTLIER -125.54 118.44 25.75 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.705 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 765' ' ' ILE . . . . . 0.552 HG21 ' HB2' ' A' ' 780' ' ' ALA . 2.3 mp -53.16 -51.3 40.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.897 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 766' ' ' SER . . . . . 0.477 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 12.4 t -53.42 -41.84 66.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.116 0.484 . . . . 0.0 110.622 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -70.02 -42.96 72.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.536 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 768' ' ' VAL . . . . . 0.977 HG21 HD11 ' A' ' 783' ' ' ILE . 45.6 t -59.03 -47.14 90.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.268 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 769' ' ' GLN . . . . . 0.593 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 3.2 pt20 -65.56 -33.55 76.19 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.694 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 770' ' ' ARG . . . . . 0.468 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 0.4 OUTLIER -68.26 -42.78 79.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.093 179.796 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.62 -42.06 29.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.806 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 772' ' ' LEU . . . . . 0.896 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -85.02 -8.54 58.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.742 -179.522 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt 58.29 41.94 22.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.185 0.517 . . . . 0.0 109.75 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 774' ' ' ILE . . . . . 0.849 ' CG2' HD13 ' A' ' 749' ' ' LEU . 29.9 pt -112.01 -173.91 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.789 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -91.87 152.52 21.43 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.872 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -57.91 -46.57 84.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.886 0.374 . . . . 0.0 110.838 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -57.49 -47.51 81.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.13 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.821 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.0 OUTLIER -66.45 -50.31 63.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.909 0.385 . . . . 0.0 110.773 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 779' ' ' ALA . . . . . 0.422 ' HB2' ' CD1' ' A' ' 774' ' ' ILE . . . -54.6 -50.05 68.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.658 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 780' ' ' ALA . . . . . 0.552 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -58.85 -42.95 90.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.826 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -58.97 -48.38 81.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.108 0.48 . . . . 0.0 109.814 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 782' ' ' MET . . . . . 0.448 ' HE3' ' HB2' ' A' ' 753' ' ' ALA . 34.8 mtm -65.27 -34.88 79.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.497 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 783' ' ' ILE . . . . . 0.977 HD11 HG21 ' A' ' 768' ' ' VAL . 6.5 mm -64.21 -37.27 79.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -64.47 -39.45 93.83 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.773 ' HB1' ' O ' ' A' ' 744' ' ' SER . . . -60.68 -34.32 74.15 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.418 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 786' ' ' MET . . . . . 0.698 ' HB3' HG22 ' A' ' 792' ' ' VAL . 14.4 mtm -66.81 -39.96 87.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.992 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -59.59 -54.18 49.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.708 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 68.4 mtm -68.92 -38.29 79.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.147 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -66.54 -21.51 66.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.728 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 790' ' ' GLY . . . . . 0.617 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 91.39 14.14 57.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.903 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.749 HG11 HG22 ' A' ' 754' ' ' VAL . 24.0 t -84.27 -30.4 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.817 0.341 . . . . 0.0 110.85 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 792' ' ' VAL . . . . . 0.698 HG22 ' HB3' ' A' ' 786' ' ' MET . 17.7 m -136.83 141.1 41.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.538 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 793' ' ' THR . . . . . 0.528 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 6.2 p -82.61 160.28 61.95 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.818 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 794' ' ' PRO . . . . . 0.528 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 20.7 Cg_endo -60.05 166.64 8.51 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.137 1.891 . . . . 0.0 112.15 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 2.6 mtt -65.5 163.26 16.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.116 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -105.48 176.55 5.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 7.3 t -58.34 -34.6 70.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -82.01 -17.5 46.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.124 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 100.82 34.6 4.59 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.608 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 15.8 m -124.68 129.06 49.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.971 0.415 . . . . 0.0 111.061 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 801' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' A' ' 763' ' ' ALA . 10.4 mtt-85 -89.9 170.71 10.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.441 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 802' ' ' GLU . . . . . 0.432 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 0.1 OUTLIER -134.14 169.82 16.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.071 179.15 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 803' ' ' VAL . . . . . 0.943 HG22 HG12 ' A' ' 757' ' ' VAL . 21.5 t -109.94 136.19 46.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.993 0.425 . . . . 0.0 111.718 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 804' ' ' ILE . . . . . 0.617 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -104.92 -30.53 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.261 179.083 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 805' ' ' ALA . . . . . 0.678 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -75.46 127.59 85.79 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.887 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.62 163.85 25.93 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.744 2.296 . . . . 0.0 112.159 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.243 -179.836 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 743' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.635 -0.186 . . . . 0.0 112.635 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 744' ' ' SER . . . . . 0.44 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 1.1 m -126.37 -51.11 1.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.108 0.48 . . . . 0.0 110.542 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -154.94 -51.06 0.09 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.435 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -124.9 95.39 4.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.502 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 747' ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.49 142.32 37.01 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.41 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 748' ' ' PRO . . . . . 0.408 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 44.2 Cg_exo -36.01 -29.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.094 2.53 . . . . 0.0 113.692 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 749' ' ' LEU . . . . . 0.768 HD13 ' CG2' ' A' ' 774' ' ' ILE . 39.9 mt -120.09 -17.12 8.45 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 750' ' ' TYR . . . . . 0.729 ' CE2' HG21 ' A' ' 754' ' ' VAL . 69.2 t80 -54.94 -47.67 74.16 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.29 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -53.2 -36.71 61.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 752' ' ' GLU . . . . . 1.041 ' HB3' HD21 ' A' ' 772' ' ' LEU . 4.1 tp10 -70.97 -43.39 68.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.352 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -61.51 -52.39 64.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.086 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 754' ' ' VAL . . . . . 0.73 HG22 HG11 ' A' ' 791' ' ' VAL . 4.0 t -56.15 -39.93 61.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.939 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -67.93 -36.1 79.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.387 0.613 . . . . 0.0 109.545 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 756' ' ' PHE . . . . . 0.706 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.4 t80 -66.59 -46.21 76.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.076 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 757' ' ' VAL . . . . . 0.92 HG12 HG22 ' A' ' 803' ' ' VAL . 57.6 t -69.52 -44.64 79.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.866 0.365 . . . . 0.0 110.798 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 758' ' ' THR . . . . . 0.676 ' HA ' HG11 ' A' ' 803' ' ' VAL . 4.8 p -55.26 -44.18 75.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.773 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -78.78 -31.63 46.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.27 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 24.3 p -81.02 -14.69 57.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.57 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.95 16.1 8.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.633 0.254 . . . . 0.0 111.504 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 762' ' ' ARG . . . . . 0.629 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.0 OUTLIER -151.83 142.31 22.59 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.701 0.286 . . . . 0.0 110.741 179.81 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 763' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -109.24 89.93 3.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.852 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 764' ' ' SER . . . . . 0.775 ' O ' HG23 ' A' ' 768' ' ' VAL . 63.7 m -121.02 118.57 30.15 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 765' ' ' ILE . . . . . 0.575 HG21 ' HB2' ' A' ' 780' ' ' ALA . 14.8 mt -54.15 -48.9 65.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.622 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 766' ' ' SER . . . . . 0.433 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 23.2 t -54.85 -42.25 71.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.229 0.537 . . . . 0.0 110.368 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -69.88 -40.25 75.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.584 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 768' ' ' VAL . . . . . 0.88 HG21 HD11 ' A' ' 783' ' ' ILE . 39.0 t -61.59 -46.66 96.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.212 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 769' ' ' GLN . . . . . 0.591 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 1.0 OUTLIER -65.15 -34.07 77.51 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.618 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 770' ' ' ARG . . . . . 0.492 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 12.6 mtt180 -71.0 -42.19 69.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.131 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.419 ' HB2' ' CE1' ' A' ' 756' ' ' PHE . 0.1 OUTLIER -78.56 -36.06 45.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.961 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 772' ' ' LEU . . . . . 1.041 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -91.23 -9.92 43.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.755 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt 59.76 41.55 18.13 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 774' ' ' ILE . . . . . 0.768 ' CG2' HD13 ' A' ' 749' ' ' LEU . 20.7 pt -111.82 -174.01 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.345 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.79 150.97 21.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.013 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -54.94 -45.87 74.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.948 0.404 . . . . 0.0 110.748 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -62.96 -45.39 92.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.764 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.767 ' HE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -62.18 -50.31 72.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.762 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.53 -50.63 71.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.395 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 780' ' ' ALA . . . . . 0.575 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -55.99 -39.3 71.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.759 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -59.0 -48.38 81.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.897 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 782' ' ' MET . . . . . 0.488 ' HE3' ' HB2' ' A' ' 749' ' ' LEU . 0.0 OUTLIER -63.45 -44.68 93.81 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.78 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 783' ' ' ILE . . . . . 0.88 HD11 HG21 ' A' ' 768' ' ' VAL . 16.9 mm -54.69 -44.59 70.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.492 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.02 -46.63 82.2 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.519 ' HB3' ' CE1' ' A' ' 750' ' ' TYR . . . -58.17 -33.54 69.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.888 178.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 786' ' ' MET . . . . . 0.578 ' HB3' HG13 ' A' ' 792' ' ' VAL . 13.2 mtm -66.11 -37.59 86.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.131 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 787' ' ' GLU . . . . . 0.463 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 2.8 mt-10 -63.32 -53.86 46.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.13 0.491 . . . . 0.0 110.526 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 63.2 mtp -67.16 -38.01 84.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.352 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -71.09 -21.51 62.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.973 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 790' ' ' GLY . . . . . 0.539 ' CA ' HD12 ' A' ' 804' ' ' ILE . . . 89.35 18.33 53.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.863 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.73 HG11 HG22 ' A' ' 754' ' ' VAL . 41.0 t -83.45 -32.05 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.797 0.332 . . . . 0.0 110.85 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 792' ' ' VAL . . . . . 0.663 HG21 HH21 ' A' ' 801' ' ' ARG . 8.4 m -135.34 142.08 40.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.1 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 793' ' ' THR . . . . . 0.49 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.2 p -80.99 160.61 65.65 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.773 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 794' ' ' PRO . . . . . 0.49 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 18.6 Cg_endo -58.26 167.38 4.75 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.04 1.826 . . . . 0.0 111.93 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 1.2 mtt -60.12 163.37 4.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.045 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 37.8 m-20 -103.83 176.5 5.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.876 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 5.4 t -57.73 -31.02 66.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -87.08 -17.5 32.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.128 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 102.86 35.98 3.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.748 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 15.3 m -127.77 129.53 47.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.947 0.403 . . . . 0.0 111.137 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 801' ' ' ARG . . . . . 0.663 HH21 HG21 ' A' ' 792' ' ' VAL . 6.7 mtp85 -82.23 170.57 15.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.181 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -132.85 178.2 7.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.637 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 803' ' ' VAL . . . . . 0.92 HG22 HG12 ' A' ' 757' ' ' VAL . 19.9 t -116.21 134.07 60.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.102 0.477 . . . . 0.0 112.218 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 804' ' ' ILE . . . . . 0.539 HD12 ' CA ' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -104.73 -29.38 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.767 178.548 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 805' ' ' ALA . . . . . 0.603 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -79.86 123.42 83.78 Favored Pre-proline 0 N--CA 1.451 -0.401 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.463 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.2 163.74 22.09 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.483 2.122 . . . . 0.0 112.163 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.094 -179.77 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 743' ' ' GLY . . . . . 0.673 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 744' ' ' SER . . . . . 0.86 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 0.1 OUTLIER -118.74 -74.38 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.98 0.419 . . . . 0.0 110.636 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -134.0 -48.29 0.8 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.558 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -125.29 95.43 4.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.751 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 747' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.4 t70 -122.27 141.89 35.62 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.373 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -36.5 -29.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.125 2.55 . . . . 0.0 113.706 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 749' ' ' LEU . . . . . 0.825 HD13 ' CG2' ' A' ' 774' ' ' ILE . 53.5 mt -120.02 -17.26 8.46 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 750' ' ' TYR . . . . . 0.682 ' CE2' HG21 ' A' ' 754' ' ' VAL . 65.9 t80 -55.88 -46.95 78.18 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.678 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -53.26 -36.06 60.72 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 752' ' ' GLU . . . . . 0.89 ' HB3' HD21 ' A' ' 772' ' ' LEU . 0.0 OUTLIER -71.15 -45.41 63.6 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.138 178.678 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 753' ' ' ALA . . . . . 0.457 ' HB2' ' HE3' ' A' ' 782' ' ' MET . . . -59.22 -52.86 63.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.3 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 754' ' ' VAL . . . . . 0.682 HG21 ' CE2' ' A' ' 750' ' ' TYR . 2.4 t -56.17 -42.29 72.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.958 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 37.5 mtt180 -66.88 -35.41 79.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.322 0.582 . . . . 0.0 109.692 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 756' ' ' PHE . . . . . 0.754 ' CE2' HG22 ' A' ' 768' ' ' VAL . 3.4 t80 -66.66 -46.05 76.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.911 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 757' ' ' VAL . . . . . 0.882 HG12 HG22 ' A' ' 803' ' ' VAL . 40.8 t -70.28 -44.11 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.992 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 758' ' ' THR . . . . . 0.595 ' HA ' HG11 ' A' ' 803' ' ' VAL . 5.1 p -57.54 -42.82 83.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.953 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.86 -40.85 31.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.26 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 21.1 p -73.86 -18.68 60.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.246 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 63.16 28.58 15.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.183 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 762' ' ' ARG . . . . . 0.514 ' C ' HG13 ' A' ' 757' ' ' VAL . 13.0 ptt180 -157.49 131.18 7.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.901 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 763' ' ' ALA . . . . . 0.474 ' HB2' ' CG1' ' A' ' 792' ' ' VAL . . . -102.35 89.84 3.7 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.973 0.416 . . . . 0.0 111.253 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 764' ' ' SER . . . . . 0.805 ' O ' HG23 ' A' ' 768' ' ' VAL . 1.0 OUTLIER -126.08 118.64 25.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.434 179.082 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 765' ' ' ILE . . . . . 0.875 HD13 ' CB ' ' A' ' 780' ' ' ALA . 23.2 mt -53.05 -50.64 44.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.822 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 766' ' ' SER . . . . . 0.444 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 47.5 t -53.3 -43.56 67.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.207 0.527 . . . . 0.0 110.659 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.78 76.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.634 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 768' ' ' VAL . . . . . 1.002 HG21 HD11 ' A' ' 783' ' ' ILE . 40.1 t -58.67 -47.25 89.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.291 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 769' ' ' GLN . . . . . 0.59 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 3.2 pt20 -65.64 -33.34 75.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.679 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 770' ' ' ARG . . . . . 0.465 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 14.9 mtt180 -69.05 -42.22 76.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.109 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 7.4 tptt -78.6 -42.18 29.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.911 0.386 . . . . 0.0 111.688 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 772' ' ' LEU . . . . . 0.89 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -84.81 -9.09 58.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.854 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt 57.7 42.75 23.25 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 774' ' ' ILE . . . . . 0.825 ' CG2' HD13 ' A' ' 749' ' ' LEU . 24.7 pt -111.8 -173.92 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.73 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -91.08 151.31 21.01 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.074 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -56.53 -46.59 80.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.935 0.397 . . . . 0.0 110.778 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -59.51 -44.63 93.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.069 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.807 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -67.18 -50.34 61.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.888 0.375 . . . . 0.0 110.869 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.1 -48.59 75.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.269 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 780' ' ' ALA . . . . . 0.875 ' CB ' HD13 ' A' ' 765' ' ' ILE . . . -56.2 -45.98 79.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.901 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 -58.92 -48.5 81.24 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.059 0.457 . . . . 0.0 110.333 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 782' ' ' MET . . . . . 0.457 ' HE3' ' HB2' ' A' ' 753' ' ' ALA . 32.7 mtm -64.84 -34.96 79.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.884 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 783' ' ' ILE . . . . . 1.002 HD11 HG21 ' A' ' 768' ' ' VAL . 7.7 mm -65.38 -38.56 82.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.199 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -63.65 -38.82 92.56 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.86 ' HB1' ' O ' ' A' ' 744' ' ' SER . . . -61.75 -34.28 75.56 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.37 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 786' ' ' MET . . . . . 0.744 ' HB3' HG22 ' A' ' 792' ' ' VAL . 13.9 mtm -66.68 -39.13 88.01 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.087 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -61.18 -54.04 49.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.663 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 49.6 mtm -68.46 -37.95 80.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.158 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -67.11 -21.5 65.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.716 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 790' ' ' GLY . . . . . 0.678 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 90.93 18.29 47.88 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.835 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.657 HG11 HG22 ' A' ' 754' ' ' VAL . 21.7 t -88.57 -30.33 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.76 0.314 . . . . 0.0 111.122 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 792' ' ' VAL . . . . . 0.744 HG22 ' HB3' ' A' ' 786' ' ' MET . 19.4 m -137.38 137.69 45.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.419 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 793' ' ' THR . . . . . . . . . . . . . 1.1 p -85.07 159.98 55.92 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.845 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 794' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -52.12 172.09 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.267 1.978 . . . . 0.0 112.368 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.02 164.99 24.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.98 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -105.52 176.48 5.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.852 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 3.2 t -60.67 -34.73 74.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -79.27 -17.57 54.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 102.74 29.14 5.98 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.514 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 9.8 m -123.68 129.93 51.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 111.053 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 801' ' ' ARG . . . . . 0.492 ' NH1' HG21 ' A' ' 792' ' ' VAL . 7.1 mtt-85 -85.34 170.66 12.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.186 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -128.64 167.19 17.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.104 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 803' ' ' VAL . . . . . 0.882 HG22 HG12 ' A' ' 757' ' ' VAL . 22.0 t -110.47 135.06 50.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.921 0.391 . . . . 0.0 111.558 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 804' ' ' ILE . . . . . 0.678 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -103.58 -27.76 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.251 179.178 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 805' ' ' ALA . . . . . 0.635 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -82.85 123.54 77.89 Favored Pre-proline 0 N--CA 1.453 -0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.887 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.4 163.7 28.65 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.608 2.205 . . . . 0.0 112.167 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.162 -179.86 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 743' ' ' GLY . . . . . 0.596 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.45 -0.375 0 N-CA-C 112.587 -0.205 . . . . 0.0 112.587 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 744' ' ' SER . . . . . 0.436 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 64.8 m -117.29 -46.68 2.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.153 0.501 . . . . 0.0 110.15 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -159.97 -49.48 0.05 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.132 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -126.0 95.16 4.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.386 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 747' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 13.2 t70 -122.47 143.33 39.39 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.335 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 748' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 46.8 Cg_exo -37.7 -28.04 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.044 2.496 . . . . 0.0 113.563 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 749' ' ' LEU . . . . . 0.882 HD13 ' CG2' ' A' ' 774' ' ' ILE . 28.5 mt -119.97 -17.08 8.53 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 750' ' ' TYR . . . . . 0.734 ' CE2' HG21 ' A' ' 754' ' ' VAL . 80.1 t80 -52.61 -50.17 63.62 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.503 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -53.07 -36.54 60.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 752' ' ' GLU . . . . . 0.891 ' HB2' HD21 ' A' ' 772' ' ' LEU . 40.5 mt-10 -70.95 -40.76 71.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.966 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 753' ' ' ALA . . . . . 0.519 ' HB2' ' HE1' ' A' ' 782' ' ' MET . . . -63.84 -53.38 51.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.075 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 754' ' ' VAL . . . . . 0.734 HG21 ' CE2' ' A' ' 750' ' ' TYR . 8.0 t -56.15 -39.39 58.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.301 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -70.14 -36.83 75.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.231 0.539 . . . . 0.0 109.711 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 756' ' ' PHE . . . . . 0.786 ' CE1' HG22 ' A' ' 768' ' ' VAL . 1.0 OUTLIER -66.77 -46.19 76.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.676 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 757' ' ' VAL . . . . . 0.676 HG11 ' CG1' ' A' ' 792' ' ' VAL . 61.5 t -69.29 -42.94 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 110.775 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 758' ' ' THR . . . . . 0.552 ' HA ' HG11 ' A' ' 803' ' ' VAL . 8.0 p -56.78 -44.57 81.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.85 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -78.82 -33.5 46.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.241 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 760' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' A' ' 756' ' ' PHE . 18.5 p -74.69 -16.39 60.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.244 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 64.72 15.03 9.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.436 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 762' ' ' ARG . . . . . 0.538 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.1 OUTLIER -153.71 143.01 21.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.445 179.808 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 763' ' ' ALA . . . . . 0.561 ' HB2' ' CG1' ' A' ' 792' ' ' VAL . . . -107.74 89.62 3.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.883 0.373 . . . . 0.0 111.941 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 764' ' ' SER . . . . . 0.733 ' O ' HG23 ' A' ' 768' ' ' VAL . 1.3 m -118.97 118.47 31.58 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 765' ' ' ILE . . . . . 0.537 HD13 ' HB2' ' A' ' 780' ' ' ALA . 14.7 mt -54.1 -48.6 65.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.506 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 766' ' ' SER . . . . . 0.474 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 16.7 p -55.08 -42.15 72.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.303 0.573 . . . . 0.0 110.538 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -70.51 -40.91 73.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.571 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 768' ' ' VAL . . . . . 0.871 HG21 HD11 ' A' ' 783' ' ' ILE . 48.2 t -59.64 -47.86 89.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 769' ' ' GLN . . . . . 0.584 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.4 OUTLIER -65.21 -33.9 77.1 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.804 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 770' ' ' ARG . . . . . 0.48 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 15.9 mtt180 -69.35 -42.42 75.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.184 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.404 ' HD3' ' HE2' ' A' ' 756' ' ' PHE . 2.3 tptt -78.63 -40.03 35.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.829 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 772' ' ' LEU . . . . . 0.891 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -86.69 -9.66 55.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.847 -179.503 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp 60.92 40.6 15.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.019 0.438 . . . . 0.0 109.874 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 774' ' ' ILE . . . . . 0.882 ' CG2' HD13 ' A' ' 749' ' ' LEU . 21.1 pt -111.85 -173.86 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.542 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.91 150.27 20.93 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.028 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -54.72 -45.12 74.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.966 0.412 . . . . 0.0 110.722 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -63.85 -47.82 79.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.873 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.768 ' HE ' HD12 ' A' ' 749' ' ' LEU . 0.7 OUTLIER -60.06 -50.31 74.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.935 0.398 . . . . 0.0 110.716 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -55.99 -48.67 75.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.272 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 780' ' ' ALA . . . . . 0.537 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.2 -41.67 75.95 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.003 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 17.4 mtm-85 -58.87 -47.31 85.38 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 782' ' ' MET . . . . . 0.519 ' HE1' ' HB2' ' A' ' 753' ' ' ALA . 2.3 mtp -63.61 -42.91 98.18 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 783' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 768' ' ' VAL . 9.9 mm -57.5 -37.68 59.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.71 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -62.31 -45.88 91.25 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 743' ' ' GLY . . . -58.12 -33.59 69.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.805 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 786' ' ' MET . . . . . 0.745 ' HB3' HG22 ' A' ' 792' ' ' VAL . 13.2 mtm -66.49 -39.65 88.86 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.476 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.58 -49.68 74.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.12 0.486 . . . . 0.0 110.518 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 32.2 mtm -70.57 -36.92 73.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.371 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -71.25 -21.53 62.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.123 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 790' ' ' GLY . . . . . 0.75 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 92.05 19.75 38.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.693 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.766 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 63.2 t -88.94 -30.47 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 122.517 0.327 . . . . 0.0 111.092 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 792' ' ' VAL . . . . . 0.745 HG22 ' HB3' ' A' ' 786' ' ' MET . 20.4 m -139.33 142.79 32.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.53 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 793' ' ' THR . . . . . 0.552 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.2 p -85.24 164.69 40.01 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 794' ' ' PRO . . . . . 0.552 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 29.5 Cg_endo -61.94 164.65 16.05 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 121.989 1.793 . . . . 0.0 112.003 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.67 162.48 3.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.329 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -105.18 176.5 5.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.743 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 15.3 t -63.18 -32.64 74.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -80.66 -17.64 50.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.231 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 102.48 28.56 6.31 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.364 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 57.5 m -125.75 130.75 52.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.988 0.423 . . . . 0.0 110.919 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 801' ' ' ARG . . . . . 0.508 ' HB3' ' HB3' ' A' ' 763' ' ' ALA . 15.4 mtt-85 -84.25 170.7 13.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.44 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -129.68 167.73 17.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.992 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 803' ' ' VAL . . . . . 0.611 HG22 HG12 ' A' ' 757' ' ' VAL . 11.9 t -108.8 139.19 32.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.004 0.431 . . . . 0.0 112.076 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 804' ' ' ILE . . . . . 0.75 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -110.84 -27.96 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.454 178.866 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 805' ' ' ALA . . . . . 0.766 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -77.97 121.05 83.51 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.078 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -50.29 163.94 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.731 2.287 . . . . 0.0 112.916 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.552 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.997 179.824 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 743' ' ' GLY . . . . . 0.454 ' CA ' ' HG3' ' A' ' 782' ' ' MET . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.72 -158.92 0.65 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.579 0.228 . . . . 0.0 110.626 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -51.91 -42.97 63.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.842 0.353 . . . . 0.0 111.329 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.01 95.42 4.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.059 0.456 . . . . 0.0 110.911 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 747' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 12.1 t70 -122.61 142.52 37.68 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.647 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 748' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 43.0 Cg_exo -37.49 -28.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.034 2.49 . . . . 0.0 113.672 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 749' ' ' LEU . . . . . 0.819 HD13 ' CG2' ' A' ' 774' ' ' ILE . 40.6 mt -119.93 -17.27 8.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 750' ' ' TYR . . . . . 0.727 ' CE2' HG21 ' A' ' 754' ' ' VAL . 64.5 t80 -53.81 -47.42 70.86 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.67 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -53.34 -37.41 62.31 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 752' ' ' GLU . . . . . 1.072 ' HB3' HD21 ' A' ' 772' ' ' LEU . 0.7 OUTLIER -70.9 -39.95 72.48 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.264 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 753' ' ' ALA . . . . . 0.489 ' HB2' ' HE1' ' A' ' 782' ' ' MET . . . -63.89 -54.35 36.11 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.217 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 754' ' ' VAL . . . . . 0.764 HG22 HG11 ' A' ' 791' ' ' VAL . 4.3 t -56.19 -38.3 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.01 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 755' ' ' ARG . . . . . 0.41 ' HA ' ' HG1' ' A' ' 758' ' ' THR . 53.8 ttt85 -69.53 -36.58 76.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.646 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 756' ' ' PHE . . . . . 0.67 ' CE2' HG22 ' A' ' 768' ' ' VAL . 3.3 t80 -67.07 -46.11 75.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.189 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 757' ' ' VAL . . . . . 0.897 HG13 ' O ' ' A' ' 762' ' ' ARG . 39.0 t -70.28 -45.42 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 120.928 0.394 . . . . 0.0 110.715 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 758' ' ' THR . . . . . 0.602 ' HA ' HG11 ' A' ' 803' ' ' VAL . 17.8 p -53.78 -44.18 69.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.815 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.96 -35.55 50.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.347 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 16.7 p -78.51 -14.98 59.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.45 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 63.46 19.86 11.93 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.727 0.299 . . . . 0.0 111.348 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 762' ' ' ARG . . . . . 0.897 ' O ' HG13 ' A' ' 757' ' ' VAL . 10.3 ptt180 -152.72 143.78 23.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.569 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 763' ' ' ALA . . . . . 0.692 ' HB2' HG11 ' A' ' 757' ' ' VAL . . . -115.47 89.93 3.22 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 764' ' ' SER . . . . . 0.622 ' O ' HG23 ' A' ' 768' ' ' VAL . 7.3 m -120.96 118.31 29.53 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 765' ' ' ILE . . . . . 0.697 HD13 ' HB2' ' A' ' 780' ' ' ALA . 21.2 mt -51.12 -46.06 31.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.525 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 766' ' ' SER . . . . . 0.503 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 11.7 p -58.53 -39.19 79.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.347 0.594 . . . . 0.0 110.393 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 767' ' ' ALA . . . . . 0.414 ' HB1' ' HZ ' ' A' ' 756' ' ' PHE . . . -72.39 -35.94 68.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.481 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 768' ' ' VAL . . . . . 0.851 HG21 HD11 ' A' ' 783' ' ' ILE . 40.3 t -66.88 -47.28 83.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.384 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 769' ' ' GLN . . . . . 0.619 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.57 -33.97 77.15 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.845 0.355 . . . . 0.0 110.599 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 19.0 mtt-85 -70.62 -42.16 71.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.985 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.61 -36.95 43.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.297 -0.41 . . . . 0.0 112.095 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 772' ' ' LEU . . . . . 1.072 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -89.8 -10.65 44.69 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp 61.61 40.43 13.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.237 0.541 . . . . 0.0 109.55 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 774' ' ' ILE . . . . . 0.819 ' CG2' HD13 ' A' ' 749' ' ' LEU . 23.6 pt -111.75 -174.53 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.381 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.15 150.08 21.17 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.163 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -54.11 -45.85 71.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 110.776 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -63.03 -47.54 82.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.854 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.781 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -59.94 -49.6 77.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.755 179.821 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.02 -50.0 74.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.57 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 780' ' ' ALA . . . . . 0.697 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.02 -40.76 73.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.584 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.74 -48.02 82.64 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.994 0.426 . . . . 0.0 109.913 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 782' ' ' MET . . . . . 0.489 ' HE1' ' HB2' ' A' ' 753' ' ' ALA . 2.0 mtp -62.78 -43.72 98.07 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 783' ' ' ILE . . . . . 0.851 HD11 HG21 ' A' ' 768' ' ' VAL . 12.4 mm -57.16 -40.59 74.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.456 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.7 -45.43 92.15 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.568 ' HB3' ' CE1' ' A' ' 750' ' ' TYR . . . -59.63 -33.37 71.43 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.79 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 786' ' ' MET . . . . . 0.605 ' CE ' HD13 ' A' ' 783' ' ' ILE . 13.3 mtm -64.96 -37.63 88.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.063 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 787' ' ' GLU . . . . . 0.474 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 1.6 mt-10 -64.54 -52.88 55.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.458 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 51.5 mtm -66.5 -38.4 87.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.764 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -73.0 -21.61 60.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.067 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 790' ' ' GLY . . . . . 0.51 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 90.91 18.95 45.22 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.754 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.764 HG11 HG22 ' A' ' 754' ' ' VAL . 44.0 t -83.26 -30.05 8.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.726 0.298 . . . . 0.0 110.825 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 792' ' ' VAL . . . . . 0.689 HG21 HH21 ' A' ' 801' ' ' ARG . 5.7 m -137.15 143.66 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.901 0.381 . . . . 0.0 111.434 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 793' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.6 p -81.9 160.63 63.12 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.961 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 794' ' ' PRO . . . . . 0.499 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 22.5 Cg_endo -60.55 167.0 8.82 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.122 1.882 . . . . 0.0 111.988 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 1.5 mtt -58.31 158.83 6.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.243 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -99.55 176.51 5.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.881 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 10.0 t -58.44 -29.13 65.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.981 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -89.08 -17.53 29.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.188 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 103.9 35.16 3.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.728 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 18.0 m -127.79 129.73 47.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.779 0.323 . . . . 0.0 111.14 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 801' ' ' ARG . . . . . 0.689 HH21 HG21 ' A' ' 792' ' ' VAL . 6.8 mtp85 -81.7 170.54 15.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.015 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 802' ' ' GLU . . . . . 0.415 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 2.6 mt-10 -134.97 173.53 11.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.8 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 803' ' ' VAL . . . . . 0.879 HG22 HG12 ' A' ' 757' ' ' VAL . 31.2 t -109.94 135.89 47.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 804' ' ' ILE . . . . . 0.514 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -106.07 -27.87 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.693 178.246 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 805' ' ' ALA . . . . . 0.615 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -81.67 123.88 80.22 Favored Pre-proline 0 N--CA 1.453 -0.289 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.71 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -63.16 163.81 21.78 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.66 2.24 . . . . 0.0 112.604 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.102 -179.879 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.617 -0.193 . . . . 0.0 112.617 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 744' ' ' SER . . . . . 0.775 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 0.8 OUTLIER -121.98 -60.95 1.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.056 0.455 . . . . 0.0 110.537 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -144.71 -49.75 0.26 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.331 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -124.03 95.34 4.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.585 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 747' ' ' ASP . . . . . 0.509 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.31 141.82 35.54 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.476 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -36.87 -29.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.172 2.581 . . . . 0.0 113.614 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 749' ' ' LEU . . . . . 0.806 HD13 ' CG2' ' A' ' 774' ' ' ILE . 42.9 mt -119.94 -16.98 8.57 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 750' ' ' TYR . . . . . 0.754 ' CE2' HG21 ' A' ' 754' ' ' VAL . 68.0 t80 -54.62 -46.75 73.91 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.123 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -53.49 -36.1 61.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 752' ' ' GLU . . . . . 0.928 ' HB2' HD21 ' A' ' 772' ' ' LEU . 1.3 mm-40 -71.04 -42.62 69.24 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.297 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -62.43 -53.77 50.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.021 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 754' ' ' VAL . . . . . 0.754 HG21 ' CE2' ' A' ' 750' ' ' TYR . 5.0 t -56.22 -42.26 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.324 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -67.26 -35.24 79.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.272 0.558 . . . . 0.0 109.622 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 756' ' ' PHE . . . . . 0.661 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.5 t80 -67.82 -46.12 72.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.141 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 757' ' ' VAL . . . . . 0.878 HG12 HG22 ' A' ' 803' ' ' VAL . 43.9 t -71.18 -42.24 75.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.796 0.331 . . . . 0.0 110.873 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 758' ' ' THR . . . . . 0.702 ' HA ' HG11 ' A' ' 803' ' ' VAL . 14.3 p -60.58 -40.3 91.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.016 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -78.03 -49.09 14.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.329 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 760' ' ' SER . . . . . 0.467 ' O ' ' HD3' ' A' ' 762' ' ' ARG . 7.8 p -69.55 -28.13 65.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.902 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 761' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 760' ' ' SER . 20.7 mmt180 73.96 32.11 1.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.55 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 762' ' ' ARG . . . . . 0.667 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.3 OUTLIER -150.14 131.18 14.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.699 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 763' ' ' ALA . . . . . 0.673 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -107.4 89.67 3.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.047 0.451 . . . . 0.0 110.638 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 764' ' ' SER . . . . . 0.711 ' O ' HG23 ' A' ' 768' ' ' VAL . 6.2 m -131.74 118.58 20.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.569 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 765' ' ' ILE . . . . . 0.888 HD13 ' HB2' ' A' ' 780' ' ' ALA . 23.3 mt -51.44 -49.79 31.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.802 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 766' ' ' SER . . . . . 0.443 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 11.7 t -54.19 -43.03 70.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.097 0.475 . . . . 0.0 110.649 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -69.82 -39.68 76.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.772 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 768' ' ' VAL . . . . . 0.899 HG21 HD11 ' A' ' 783' ' ' ILE . 45.4 t -62.54 -45.83 97.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.29 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 769' ' ' GLN . . . . . 0.59 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 2.1 pt20 -66.36 -33.47 75.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.542 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 770' ' ' ARG . . . . . 0.473 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 17.8 mtt180 -71.32 -42.3 68.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.084 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -37.11 42.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.954 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 772' ' ' LEU . . . . . 0.928 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -90.52 -10.29 44.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.664 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt 60.77 41.53 14.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.185 0.517 . . . . 0.0 109.688 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 774' ' ' ILE . . . . . 0.806 ' CG2' HD13 ' A' ' 749' ' ' LEU . 26.0 pt -111.9 -174.0 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.595 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.58 154.19 24.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.081 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -58.75 -46.11 88.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 0.0 110.71 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -63.53 -43.59 96.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.877 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.772 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -64.44 -50.25 68.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.716 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.0 -50.12 71.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.301 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 780' ' ' ALA . . . . . 0.888 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -55.96 -39.62 72.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.786 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.0 -48.49 81.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.977 0.418 . . . . 0.0 110.019 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 782' ' ' MET . . . . . 0.445 ' CE ' ' CB ' ' A' ' 749' ' ' LEU . 0.0 OUTLIER -63.9 -44.58 92.54 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.771 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 783' ' ' ILE . . . . . 0.899 HD11 HG21 ' A' ' 768' ' ' VAL . 7.4 mm -56.33 -41.46 71.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.708 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.96 -45.04 91.49 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.775 ' HB1' ' O ' ' A' ' 744' ' ' SER . . . -59.61 -33.57 71.66 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.519 -1.218 . . . . 0.0 109.816 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 786' ' ' MET . . . . . 0.57 ' HB3' HG22 ' A' ' 792' ' ' VAL . 13.8 mtm -65.4 -37.64 87.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.047 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 787' ' ' GLU . . . . . 0.455 ' HG3' ' CZ ' ' A' ' 801' ' ' ARG . 2.6 mt-10 -64.19 -54.04 39.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.704 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 40.0 mtp -67.28 -38.19 84.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.551 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 789' ' ' ALA . . . . . 0.469 ' HB3' HG23 ' A' ' 791' ' ' VAL . . . -70.41 -21.71 62.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.951 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 790' ' ' GLY . . . . . 0.451 ' CA ' HD12 ' A' ' 804' ' ' ILE . . . 89.54 19.79 47.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.978 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.671 HG11 HG22 ' A' ' 754' ' ' VAL . 14.1 t -83.61 -32.58 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 120.892 0.377 . . . . 0.0 110.866 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 792' ' ' VAL . . . . . 0.679 HG21 HH21 ' A' ' 801' ' ' ARG . 11.3 m -134.49 139.13 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.184 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 793' ' ' THR . . . . . 0.502 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 8.0 p -75.95 158.56 82.26 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.918 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 794' ' ' PRO . . . . . 0.502 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 19.7 Cg_endo -59.52 166.66 7.55 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.14 1.893 . . . . 0.0 112.01 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -56.98 161.02 3.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.149 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -104.73 176.55 5.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.788 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 5.2 t -54.68 -32.78 59.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.032 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -87.21 -17.64 32.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.15 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.46 37.29 3.56 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.5 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 16.2 m -127.82 129.14 46.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.003 0.43 . . . . 0.0 111.042 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 801' ' ' ARG . . . . . 0.679 HH21 HG21 ' A' ' 792' ' ' VAL . 6.8 mtp85 -83.64 170.62 14.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.327 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 802' ' ' GLU . . . . . 0.473 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 3.0 mt-10 -132.43 -170.77 2.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.606 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 803' ' ' VAL . . . . . 0.878 HG22 HG12 ' A' ' 757' ' ' VAL . 20.6 t -125.03 135.16 64.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.067 0.46 . . . . 0.0 112.018 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 804' ' ' ILE . . . . . 0.483 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -108.43 -33.66 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.352 179.241 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 805' ' ' ALA . . . . . 0.868 ' HB1' ' HD2' ' A' ' 806' ' ' PRO . . . -59.16 171.04 0.77 Allowed Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.242 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 806' ' ' PRO . . . . . 0.868 ' HD2' ' HB1' ' A' ' 805' ' ' ALA . 56.6 Cg_endo -71.2 163.62 38.53 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.771 2.314 . . . . 0.0 112.233 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.101 -179.947 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 743' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.452 -0.253 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 744' ' ' SER . . . . . 0.807 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 5.9 m -116.16 -62.27 1.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.14 0.495 . . . . 0.0 110.73 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -140.01 -49.85 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.199 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -123.67 95.3 4.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.364 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 747' ' ' ASP . . . . . 0.552 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 14.1 t70 -122.28 142.35 36.72 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.426 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -33.82 -31.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.387 2.724 . . . . 0.0 114.016 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 749' ' ' LEU . . . . . 0.799 HD13 ' CG2' ' A' ' 774' ' ' ILE . 33.8 mt -120.06 -17.15 8.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 750' ' ' TYR . . . . . 0.65 ' CE2' HG21 ' A' ' 754' ' ' VAL . 67.9 t80 -53.26 -47.43 69.08 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.968 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -53.23 -37.18 61.81 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 752' ' ' GLU . . . . . 1.054 ' HB3' HD21 ' A' ' 772' ' ' LEU . 51.7 tt0 -71.01 -41.56 70.74 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.305 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 753' ' ' ALA . . . . . 0.497 ' HB2' ' HE2' ' A' ' 782' ' ' MET . . . -62.53 -51.52 67.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.034 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 754' ' ' VAL . . . . . 0.85 HG22 HG11 ' A' ' 791' ' ' VAL . 2.2 t -56.15 -41.2 68.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.735 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -67.91 -35.4 78.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.746 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 756' ' ' PHE . . . . . 0.744 ' CE2' HG22 ' A' ' 768' ' ' VAL . 3.5 t80 -67.01 -46.09 75.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.991 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 757' ' ' VAL . . . . . 1.055 HG12 HG22 ' A' ' 803' ' ' VAL . 43.6 t -70.16 -47.34 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 120.811 0.338 . . . . 0.0 110.794 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 758' ' ' THR . . . . . 0.796 ' HA ' HG11 ' A' ' 803' ' ' VAL . 6.6 p -54.78 -43.74 73.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.002 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -78.88 -37.95 38.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.182 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 54.6 p -75.79 -16.25 60.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.46 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 60.11 31.38 20.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.931 0.396 . . . . 0.0 110.552 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 762' ' ' ARG . . . . . 0.632 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.3 OUTLIER -160.55 137.3 8.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.338 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 763' ' ' ALA . . . . . 0.493 ' HB3' ' CB ' ' A' ' 801' ' ' ARG . . . -110.58 89.84 3.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.91 0.386 . . . . 0.0 111.409 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 764' ' ' SER . . . . . 0.758 ' O ' HG23 ' A' ' 768' ' ' VAL . 15.2 m -127.14 118.61 24.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.617 178.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 765' ' ' ILE . . . . . 0.882 HD13 ' HB2' ' A' ' 780' ' ' ALA . 25.0 mt -51.83 -50.19 33.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.755 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 766' ' ' SER . . . . . 0.433 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 22.0 t -53.45 -43.82 68.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.238 0.542 . . . . 0.0 110.537 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -69.12 -41.59 77.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.661 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 768' ' ' VAL . . . . . 0.925 HG21 HD11 ' A' ' 783' ' ' ILE . 40.9 t -59.4 -47.53 90.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.212 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 769' ' ' GLN . . . . . 0.578 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 2.8 pt20 -65.46 -33.39 75.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.744 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 770' ' ' ARG . . . . . 0.47 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 5.8 mtt180 -68.75 -42.49 77.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.133 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.63 -42.13 29.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.877 0.37 . . . . 0.0 111.684 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 772' ' ' LEU . . . . . 1.054 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -84.81 -8.58 58.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.791 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 22.6 mtpt 57.41 42.35 24.86 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 774' ' ' ILE . . . . . 0.799 ' CG2' HD13 ' A' ' 749' ' ' LEU . 30.1 pt -111.87 -174.14 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.626 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.25 155.45 25.19 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.238 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -59.2 -46.56 88.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.916 0.389 . . . . 0.0 110.653 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -62.22 -47.47 84.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.771 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.623 ' NE ' HD12 ' A' ' 749' ' ' LEU . 2.8 ttt180 -61.17 -50.37 73.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.775 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.41 -50.55 71.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.427 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 780' ' ' ALA . . . . . 0.882 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.03 -41.03 74.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.81 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -58.95 -48.42 81.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.978 0.418 . . . . 0.0 110.009 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 782' ' ' MET . . . . . 0.497 ' HE2' ' HB2' ' A' ' 753' ' ' ALA . 0.5 OUTLIER -63.67 -43.12 97.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.386 178.781 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 783' ' ' ILE . . . . . 0.925 HD11 HG21 ' A' ' 768' ' ' VAL . 7.6 mm -56.96 -41.72 77.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.318 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.21 -44.9 92.27 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.807 ' HB1' ' O ' ' A' ' 744' ' ' SER . . . -58.39 -33.63 69.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.048 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 786' ' ' MET . . . . . 0.594 ' HB3' HG22 ' A' ' 792' ' ' VAL . 16.3 mtm -66.85 -38.59 86.65 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.991 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 787' ' ' GLU . . . . . 0.444 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 2.0 mt-10 -61.55 -54.05 48.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.664 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 24.1 mtm -68.85 -38.39 79.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.418 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -68.52 -21.67 64.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.775 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 790' ' ' GLY . . . . . 0.501 ' O ' HD12 ' A' ' 804' ' ' ILE . . . 90.74 15.07 57.25 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.897 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.85 HG11 HG22 ' A' ' 754' ' ' VAL . 40.6 t -80.67 -31.91 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.924 0.392 . . . . 0.0 110.896 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 792' ' ' VAL . . . . . 0.667 HG21 HH21 ' A' ' 801' ' ' ARG . 11.2 m -136.58 135.45 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.143 0.497 . . . . 0.0 111.161 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 793' ' ' THR . . . . . 0.767 HG23 ' O ' ' A' ' 802' ' ' GLU . 10.3 p -72.92 159.81 84.42 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.686 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 794' ' ' PRO . . . . . 0.527 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 25.4 Cg_endo -60.58 165.13 11.97 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 121.996 1.797 . . . . 0.0 111.771 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -58.78 162.74 3.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.185 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -105.58 176.57 5.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.954 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 55.8 p -56.4 -31.11 63.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -86.32 -17.57 34.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.115 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 100.71 34.44 4.67 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.542 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 28.8 m -127.75 130.31 48.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 111.113 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 801' ' ' ARG . . . . . 0.667 HH21 HG21 ' A' ' 792' ' ' VAL . 4.5 mtp85 -81.57 170.13 16.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.397 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 802' ' ' GLU . . . . . 0.767 ' O ' HG23 ' A' ' 793' ' ' THR . 3.5 mt-10 -138.52 124.18 19.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.909 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 803' ' ' VAL . . . . . 1.055 HG22 HG12 ' A' ' 757' ' ' VAL . 18.8 t -64.92 134.22 29.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.96 0.409 . . . . 0.0 112.065 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 804' ' ' ILE . . . . . 0.629 HG23 HG22 ' A' ' 793' ' ' THR . 0.0 OUTLIER -103.77 -33.29 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.891 178.546 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 805' ' ' ALA . . . . . 0.559 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -74.63 126.03 89.03 Favored Pre-proline 0 N--CA 1.451 -0.4 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.836 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.07 163.81 24.46 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.71 2.273 . . . . 0.0 112.168 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.272 -179.856 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 743' ' ' GLY . . . . . 0.709 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.45 -0.424 0 N-CA-C 112.09 -0.404 . . . . 0.0 112.09 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 3.5 m -115.57 -39.3 3.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.065 0.459 . . . . 0.0 110.462 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 745' ' ' GLU . . . . . 0.429 ' O ' ' CD2' ' A' ' 750' ' ' TYR . 0.9 OUTLIER -168.57 -45.97 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.941 179.519 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -129.13 95.06 3.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.439 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 747' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.47 143.35 39.43 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.376 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 748' ' ' PRO . . . . . 0.423 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 28.7 Cg_exo -35.34 -30.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.258 2.639 . . . . 0.0 113.795 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 749' ' ' LEU . . . . . 0.729 HD12 ' NE ' ' A' ' 778' ' ' ARG . 21.8 mt -120.09 -17.08 8.46 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -178.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 750' ' ' TYR . . . . . 0.669 ' CE2' HG21 ' A' ' 754' ' ' VAL . 83.7 t80 -51.73 -50.65 60.14 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.837 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -53.17 -35.89 60.29 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.71 -0.396 . . . . 0.0 109.984 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 752' ' ' GLU . . . . . 0.988 ' HB3' HD21 ' A' ' 772' ' ' LEU . 6.0 tp10 -70.93 -38.5 72.9 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.803 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 753' ' ' ALA . . . . . 0.409 ' HB2' ' HE2' ' A' ' 782' ' ' MET . . . -66.28 -52.93 42.57 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.804 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 754' ' ' VAL . . . . . 0.688 HG22 HG11 ' A' ' 791' ' ' VAL . 7.0 t -56.36 -38.42 55.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.751 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -69.87 -39.16 76.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.601 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 756' ' ' PHE . . . . . 0.751 ' CE2' HG22 ' A' ' 768' ' ' VAL . 1.4 t80 -65.77 -45.09 83.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.611 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 757' ' ' VAL . . . . . 0.684 HG11 HG12 ' A' ' 792' ' ' VAL . 84.5 t -69.84 -41.33 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.781 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 758' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 754' ' ' VAL . 9.9 p -59.12 -46.08 89.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.335 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -77.97 -30.36 50.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.795 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 39.5 p -78.02 -16.0 58.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.5 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 63.39 20.09 12.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.718 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -157.61 137.58 12.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.745 0.307 . . . . 0.0 110.931 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 763' ' ' ALA . . . . . 0.528 ' HB3' ' CB ' ' A' ' 801' ' ' ARG . . . -100.7 89.87 4.04 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.949 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 764' ' ' SER . . . . . 0.764 ' O ' HG23 ' A' ' 768' ' ' VAL . 5.9 m -120.65 118.44 30.12 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 765' ' ' ILE . . . . . 0.474 HG21 ' HB2' ' A' ' 780' ' ' ALA . 10.3 mt -57.1 -51.32 70.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.368 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 766' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 11.3 t -53.93 -38.41 64.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.291 0.567 . . . . 0.0 110.103 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 767' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' A' ' 764' ' ' SER . . . -71.36 -40.22 70.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.234 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 768' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 764' ' ' SER . 45.5 t -61.43 -49.94 82.44 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.179 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 769' ' ' GLN . . . . . 0.608 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.4 OUTLIER -63.64 -33.57 75.92 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.974 -179.499 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -69.45 -42.52 74.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.37 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.489 ' HD3' ' HE1' ' A' ' 756' ' ' PHE . 3.1 tptt -78.59 -38.24 40.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.766 0.317 . . . . 0.0 111.677 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 772' ' ' LEU . . . . . 0.988 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -86.87 -10.91 52.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt 61.21 39.58 15.64 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 774' ' ' ILE . . . . . 0.69 ' CG2' HD13 ' A' ' 749' ' ' LEU . 25.6 pt -111.86 -173.98 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.424 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -90.34 153.55 22.85 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.236 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -56.6 -45.79 81.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.816 0.341 . . . . 0.0 110.87 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -63.25 -47.79 80.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.82 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.729 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.5 OUTLIER -59.1 -49.98 75.8 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.641 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.23 -50.69 72.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.637 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 780' ' ' ALA . . . . . 0.474 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -55.99 -40.42 73.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.947 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -60.66 -43.77 97.23 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 782' ' ' MET . . . . . 0.448 ' HE3' ' HB2' ' A' ' 749' ' ' LEU . 0.1 OUTLIER -64.94 -43.62 92.14 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.293 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 783' ' ' ILE . . . . . 0.73 HD11 HG21 ' A' ' 768' ' ' VAL . 15.0 mm -57.62 -39.73 71.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.696 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -61.85 -46.78 87.95 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 743' ' ' GLY . . . -58.01 -33.64 69.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.808 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 786' ' ' MET . . . . . 0.646 ' HG2' HG22 ' A' ' 754' ' ' VAL . 15.4 mtm -67.79 -38.29 83.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.565 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 787' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 792' ' ' VAL . 1.6 mt-10 -62.41 -45.93 90.89 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.124 0.488 . . . . 0.0 110.072 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 37.0 mtm -73.08 -37.98 66.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.245 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -70.81 -21.53 62.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.982 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 790' ' ' GLY . . . . . 0.746 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 94.62 15.94 44.55 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.67 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.823 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 77.5 t -84.96 -34.2 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 122.637 0.375 . . . . 0.0 111.476 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 792' ' ' VAL . . . . . 0.684 HG12 HG11 ' A' ' 757' ' ' VAL . 15.4 m -136.61 148.41 27.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.887 0.375 . . . . 0.0 111.655 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 793' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 802' ' ' GLU . 10.3 p -96.75 171.8 5.73 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 794' ' ' PRO . . . . . 0.434 ' CD ' ' HB ' ' A' ' 793' ' ' THR . 31.1 Cg_exo -59.47 178.86 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 121.982 1.788 . . . . 0.0 111.812 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 795' ' ' MET . . . . . 0.518 ' HA ' ' HG3' ' A' ' 801' ' ' ARG . 0.0 OUTLIER -77.04 170.12 17.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.499 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -105.61 176.59 5.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.754 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 4.6 t -60.78 -26.99 67.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.052 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -92.19 -17.62 24.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.398 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 108.73 29.84 3.97 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.649 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 18.0 m -124.42 131.13 53.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.923 0.392 . . . . 0.0 110.647 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 801' ' ' ARG . . . . . 0.528 ' CB ' ' HB3' ' A' ' 763' ' ' ALA . 8.8 mtt-85 -85.34 170.65 12.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.078 0.466 . . . . 0.0 111.524 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 802' ' ' GLU . . . . . 0.74 ' O ' HG23 ' A' ' 793' ' ' THR . 6.9 mt-10 -127.13 126.76 43.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.576 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 803' ' ' VAL . . . . . 0.57 HG22 HG12 ' A' ' 757' ' ' VAL . 19.4 t -69.25 137.94 23.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.836 0.35 . . . . 0.0 111.8 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 804' ' ' ILE . . . . . 0.746 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -108.19 -28.08 2.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.292 178.415 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 805' ' ' ALA . . . . . 0.823 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -78.24 119.56 77.81 Favored Pre-proline 0 N--CA 1.455 -0.209 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.641 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.24 163.82 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.413 2.075 . . . . 0.0 112.733 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.961 -179.99 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 743' ' ' GLY . . . . . 0.426 ' CA ' ' HG2' ' A' ' 782' ' ' MET . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.0 -157.83 0.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.584 0.23 . . . . 0.0 110.43 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -51.29 -38.44 52.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.666 0.27 . . . . 0.0 111.445 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -129.06 95.51 4.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.062 0.458 . . . . 0.0 111.415 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 747' ' ' ASP . . . . . 0.574 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.4 t70 -122.49 141.52 35.1 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.372 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -38.32 -28.02 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.956 2.437 . . . . 0.0 113.64 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 749' ' ' LEU . . . . . 0.854 HD13 ' CG2' ' A' ' 774' ' ' ILE . 40.4 mt -119.94 -16.85 8.59 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 750' ' ' TYR . . . . . 0.691 ' CE2' ' HB3' ' A' ' 785' ' ' ALA . 62.2 t80 -55.12 -46.5 75.59 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.469 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -53.51 -36.37 61.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 752' ' ' GLU . . . . . 0.909 ' HB2' HD21 ' A' ' 772' ' ' LEU . 28.7 mt-10 -70.95 -43.09 68.85 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.217 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 753' ' ' ALA . . . . . 0.517 ' HB2' ' HE3' ' A' ' 782' ' ' MET . . . -61.93 -51.67 67.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.238 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 754' ' ' VAL . . . . . 0.747 HG22 HG11 ' A' ' 791' ' ' VAL . 2.3 t -56.21 -42.69 74.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.39 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -69.16 -38.13 78.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.294 0.569 . . . . 0.0 110.231 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 756' ' ' PHE . . . . . 0.644 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.0 t80 -65.15 -46.15 82.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.114 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 757' ' ' VAL . . . . . 0.83 HG12 HG22 ' A' ' 803' ' ' VAL . 59.7 t -69.49 -45.13 79.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.902 0.382 . . . . 0.0 110.775 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 758' ' ' THR . . . . . 0.648 ' HA ' HG11 ' A' ' 803' ' ' VAL . 6.8 p -55.22 -42.65 73.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.96 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -78.8 -35.63 43.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.414 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 6.8 p -76.84 -19.61 57.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.575 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 67.2 24.93 9.08 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.662 0.268 . . . . 0.0 111.477 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 762' ' ' ARG . . . . . 0.554 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.2 OUTLIER -159.26 132.39 7.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.883 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 763' ' ' ALA . . . . . 0.548 ' HB2' ' CG1' ' A' ' 792' ' ' VAL . . . -100.05 89.71 4.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.933 0.397 . . . . 0.0 111.281 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 764' ' ' SER . . . . . 0.726 ' O ' HG23 ' A' ' 768' ' ' VAL . 7.6 m -121.78 118.59 29.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.593 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 765' ' ' ILE . . . . . 0.811 HD13 ' HB2' ' A' ' 780' ' ' ALA . 26.3 mt -54.54 -47.34 71.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.487 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 766' ' ' SER . . . . . 0.423 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 60.5 p -57.69 -40.5 79.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.172 0.51 . . . . 0.0 110.493 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 767' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 764' ' ' SER . . . -71.58 -36.23 70.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.612 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 768' ' ' VAL . . . . . 0.866 HG21 HD11 ' A' ' 783' ' ' ILE . 58.8 t -66.4 -46.44 86.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.223 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 769' ' ' GLN . . . . . 0.602 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.6 OUTLIER -66.05 -33.37 75.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.486 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 770' ' ' ARG . . . . . 0.461 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 20.8 mtt-85 -69.98 -42.41 73.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.087 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.442 ' HB2' ' CE1' ' A' ' 756' ' ' PHE . 1.8 tmtt? -78.62 -39.62 36.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.042 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 772' ' ' LEU . . . . . 0.909 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -88.33 -9.23 53.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.664 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt 60.03 42.31 16.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.061 0.458 . . . . 0.0 109.775 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 774' ' ' ILE . . . . . 0.854 ' CG2' HD13 ' A' ' 749' ' ' LEU . 26.8 pt -111.94 -173.94 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.609 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.42 147.18 19.36 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.027 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -54.11 -42.54 69.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.834 0.35 . . . . 0.0 110.703 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 -64.12 -47.53 79.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.923 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.811 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.2 OUTLIER -62.52 -50.3 71.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.894 0.378 . . . . 0.0 110.835 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 779' ' ' ALA . . . . . 0.413 ' HB2' ' CD1' ' A' ' 774' ' ' ILE . . . -54.48 -49.13 70.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.411 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 780' ' ' ALA . . . . . 0.811 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.07 -43.63 78.14 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.911 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -58.98 -48.41 81.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.034 0.445 . . . . 0.0 109.973 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 782' ' ' MET . . . . . 0.517 ' HE3' ' HB2' ' A' ' 753' ' ' ALA . 34.4 mtm -65.3 -34.3 78.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.711 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 783' ' ' ILE . . . . . 0.866 HD11 HG21 ' A' ' 768' ' ' VAL . 7.1 mm -65.45 -35.71 75.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.11 -44.69 94.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.691 ' HB3' ' CE2' ' A' ' 750' ' ' TYR . . . -59.12 -33.76 71.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.766 178.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 786' ' ' MET . . . . . 0.747 ' HB3' HG22 ' A' ' 792' ' ' VAL . 12.7 mtm -65.62 -39.14 91.17 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.912 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -62.43 -51.15 68.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.45 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 25.4 mtm -67.9 -38.49 83.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.574 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 789' ' ' ALA . . . . . 0.482 ' HB3' HG23 ' A' ' 791' ' ' VAL . . . -71.4 -21.62 61.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.882 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 790' ' ' GLY . . . . . 0.672 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 93.12 16.76 46.04 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.914 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.747 HG11 HG22 ' A' ' 754' ' ' VAL . 10.1 t -83.57 -33.28 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.887 0.375 . . . . 0.0 110.726 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 792' ' ' VAL . . . . . 0.747 HG22 ' HB3' ' A' ' 786' ' ' MET . 19.8 m -135.94 139.54 45.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.404 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 793' ' ' THR . . . . . 0.547 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 2.8 p -83.77 161.87 54.54 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.709 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 794' ' ' PRO . . . . . 0.547 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 18.1 Cg_endo -58.62 167.23 5.35 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.153 1.902 . . . . 0.0 112.083 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.88 160.06 15.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.201 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -104.31 176.59 5.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.803 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 39.1 p -61.76 -34.74 76.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.926 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.14 -17.61 58.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.195 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 100.58 28.38 7.11 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.515 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 58.0 m -126.64 130.39 50.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.942 0.401 . . . . 0.0 110.964 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 801' ' ' ARG . . . . . 0.503 ' NH1' HG21 ' A' ' 792' ' ' VAL . 9.4 mtt-85 -82.72 170.72 14.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.222 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 802' ' ' GLU . . . . . 0.405 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 5.8 mt-10 -130.2 166.28 20.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.814 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 803' ' ' VAL . . . . . 0.83 HG22 HG12 ' A' ' 757' ' ' VAL . 39.0 t -109.63 135.19 49.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.064 0.459 . . . . 0.0 111.597 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 804' ' ' ILE . . . . . 0.672 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -103.35 -28.56 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.266 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 805' ' ' ALA . . . . . 0.635 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -82.22 124.51 78.4 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.934 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.9 163.71 27.26 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.632 2.221 . . . . 0.0 112.082 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.241 -179.812 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 743' ' ' GLY . . . . . 0.569 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.45 -0.41 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 744' ' ' SER . . . . . 0.6 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 0.9 OUTLIER -117.68 -53.57 2.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.159 0.504 . . . . 0.0 110.396 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -153.13 -50.13 0.1 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.968 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -124.01 95.11 4.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.416 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 747' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.7 t70 -122.37 142.09 36.25 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.439 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -37.73 -28.35 0.1 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.989 2.459 . . . . 0.0 113.51 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 749' ' ' LEU . . . . . 0.842 HD13 ' CG2' ' A' ' 774' ' ' ILE . 31.8 mt -120.05 -16.87 8.52 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 750' ' ' TYR . . . . . 0.708 ' CE2' HG21 ' A' ' 754' ' ' VAL . 71.3 t80 -53.99 -47.76 71.1 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.376 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -53.4 -36.3 61.31 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 752' ' ' GLU . . . . . 0.937 ' HB2' HD21 ' A' ' 772' ' ' LEU . 5.5 mm-40 -71.0 -42.27 69.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.117 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 753' ' ' ALA . . . . . 0.43 ' HB2' ' CE ' ' A' ' 782' ' ' MET . . . -61.85 -53.82 50.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.068 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 754' ' ' VAL . . . . . 0.71 HG22 HG11 ' A' ' 791' ' ' VAL . 4.0 t -56.19 -42.97 74.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.407 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -66.43 -36.94 84.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.37 0.605 . . . . 0.0 109.797 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 756' ' ' PHE . . . . . 0.68 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.0 t80 -66.82 -46.18 75.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.169 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 757' ' ' VAL . . . . . 0.791 HG12 HG22 ' A' ' 803' ' ' VAL . 61.8 t -69.56 -45.41 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 120.8 0.333 . . . . 0.0 110.664 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 758' ' ' THR . . . . . 0.661 ' HA ' HG11 ' A' ' 803' ' ' VAL . 4.8 p -55.37 -43.45 75.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.783 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -78.71 -32.15 46.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.214 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 27.3 p -81.63 -14.83 56.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.531 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 61.92 18.92 10.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.614 0.245 . . . . 0.0 111.223 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 762' ' ' ARG . . . . . 0.555 ' O ' HG13 ' A' ' 757' ' ' VAL . 10.2 ptt180 -151.88 136.35 16.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.763 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 763' ' ' ALA . . . . . 0.547 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -106.06 89.88 3.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.602 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 764' ' ' SER . . . . . 0.714 ' O ' HG23 ' A' ' 768' ' ' VAL . 3.9 m -122.32 118.59 28.86 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 765' ' ' ILE . . . . . 0.698 HD13 ' HB2' ' A' ' 780' ' ' ALA . 19.5 mt -53.6 -48.28 59.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.499 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 766' ' ' SER . . . . . 0.423 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 11.4 t -55.74 -41.23 73.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.114 0.483 . . . . 0.0 110.284 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -70.58 -39.48 73.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.688 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 768' ' ' VAL . . . . . 0.84 HG21 HD11 ' A' ' 783' ' ' ILE . 41.9 t -62.94 -46.72 95.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.291 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 769' ' ' GLN . . . . . 0.587 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.7 OUTLIER -65.93 -33.41 75.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.452 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 770' ' ' ARG . . . . . 0.474 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 24.8 mtt180 -71.54 -41.84 68.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.059 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.7 -37.26 42.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.967 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 772' ' ' LEU . . . . . 0.937 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -91.17 -9.64 44.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.634 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt 60.8 41.55 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.038 0.447 . . . . 0.0 109.8 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 774' ' ' ILE . . . . . 0.842 ' CG2' HD13 ' A' ' 749' ' ' LEU . 22.0 pt -111.84 -173.92 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.476 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.51 151.13 22.3 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.201 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -55.38 -46.05 76.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.965 0.412 . . . . 0.0 110.707 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -63.37 -47.79 80.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.823 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.824 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.6 OUTLIER -59.61 -50.13 75.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.845 0.355 . . . . 0.0 110.793 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.33 -49.9 74.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.271 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 780' ' ' ALA . . . . . 0.698 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.11 -40.35 73.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -60.69 -48.41 81.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.92 0.39 . . . . 0.0 109.999 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 782' ' ' MET . . . . . 0.472 ' HE3' ' HA ' ' A' ' 750' ' ' TYR . 3.1 mtp -63.79 -38.41 91.01 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 783' ' ' ILE . . . . . 0.84 HD11 HG21 ' A' ' 768' ' ' VAL . 7.3 mm -61.32 -40.85 87.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.132 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.23 -43.52 87.8 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 177.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 744' ' ' SER . . . -60.32 -33.48 72.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.526 -1.216 . . . . 0.0 109.828 178.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 786' ' ' MET . . . . . 0.571 ' HB3' HG22 ' A' ' 792' ' ' VAL . 12.9 mtm -65.67 -37.56 86.84 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.974 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 787' ' ' GLU . . . . . 0.456 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 2.4 mt-10 -63.38 -54.13 41.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.111 0.481 . . . . 0.0 110.548 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 33.5 mtm -67.85 -37.12 81.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.49 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -70.94 -21.59 62.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.985 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 790' ' ' GLY . . . . . 0.537 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 89.62 18.37 52.1 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.875 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.71 HG11 HG22 ' A' ' 754' ' ' VAL . 52.4 t -83.23 -32.72 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.854 0.359 . . . . 0.0 110.809 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 792' ' ' VAL . . . . . 0.681 HG21 HH21 ' A' ' 801' ' ' ARG . 11.4 m -135.61 140.64 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.188 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 793' ' ' THR . . . . . 0.452 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.3 p -78.34 159.06 75.81 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 794' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 18.6 Cg_endo -58.8 166.11 7.18 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.115 1.876 . . . . 0.0 111.743 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -66.08 155.38 36.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.972 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -105.43 176.56 5.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.918 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 5.5 t -55.37 -29.98 59.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.06 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -78.65 -17.52 55.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.151 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 91.9 29.62 11.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.48 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 24.6 m -127.82 130.19 48.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.905 0.383 . . . . 0.0 111.031 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 801' ' ' ARG . . . . . 0.681 HH21 HG21 ' A' ' 792' ' ' VAL . 6.8 mtp85 -81.63 170.59 15.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.307 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -129.9 -176.93 4.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.667 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 803' ' ' VAL . . . . . 0.791 HG22 HG12 ' A' ' 757' ' ' VAL . 16.9 t -119.81 134.64 62.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 804' ' ' ILE . . . . . 0.537 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -106.99 -28.09 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.961 178.56 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 805' ' ' ALA . . . . . 0.633 ' O ' HG22 ' A' ' 758' ' ' THR . . . -82.74 121.49 77.8 Favored Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.586 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.49 163.8 22.79 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.475 2.116 . . . . 0.0 112.304 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.225 -179.8 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 743' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 744' ' ' SER . . . . . 0.458 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 1.3 m -119.3 -47.24 2.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.121 0.486 . . . . 0.0 110.396 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -159.33 -48.63 0.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.182 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -126.9 95.1 4.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.337 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 747' ' ' ASP . . . . . 0.517 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.6 t70 -122.51 143.09 38.85 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.425 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 748' ' ' PRO . . . . . 0.422 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 35.7 Cg_exo -35.97 -29.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.157 2.571 . . . . 0.0 113.763 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 749' ' ' LEU . . . . . 0.821 HD12 ' NE ' ' A' ' 778' ' ' ARG . 34.6 mt -120.03 -17.27 8.45 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 750' ' ' TYR . . . . . 0.739 ' CE2' HG21 ' A' ' 754' ' ' VAL . 74.5 t80 -53.3 -48.54 68.29 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.797 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.27 -36.34 61.03 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 752' ' ' GLU . . . . . 1.02 ' HB3' HD21 ' A' ' 772' ' ' LEU . 12.6 tt0 -71.0 -42.05 70.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.242 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 753' ' ' ALA . . . . . 0.404 ' HB2' ' HE2' ' A' ' 782' ' ' MET . . . -62.92 -52.5 62.8 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.182 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 754' ' ' VAL . . . . . 0.739 HG21 ' CE2' ' A' ' 750' ' ' TYR . 5.1 t -56.2 -40.32 64.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.675 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -67.01 -35.52 80.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.41 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 756' ' ' PHE . . . . . 0.835 ' CE1' HG22 ' A' ' 768' ' ' VAL . 1.4 t80 -67.65 -45.94 73.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.018 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 757' ' ' VAL . . . . . 0.851 HG12 HG22 ' A' ' 803' ' ' VAL . 47.4 t -69.64 -42.08 80.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.937 0.399 . . . . 0.0 110.837 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 758' ' ' THR . . . . . 0.456 ' HA ' HG11 ' A' ' 803' ' ' VAL . 8.2 p -58.71 -45.38 89.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.69 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -77.75 -35.26 51.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.101 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 48.7 p -76.38 -14.74 60.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.291 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 56.5 28.0 13.12 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.008 0.433 . . . . 0.0 110.577 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 762' ' ' ARG . . . . . 0.406 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.2 OUTLIER -160.87 136.0 7.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.92 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 763' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -106.32 89.6 3.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.09 0.472 . . . . 0.0 111.698 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 764' ' ' SER . . . . . 0.769 ' O ' HG23 ' A' ' 768' ' ' VAL . 68.1 m -121.24 118.64 30.11 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 765' ' ' ILE . . . . . 0.643 HD13 ' HB2' ' A' ' 780' ' ' ALA . 17.5 mt -54.06 -47.58 65.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.637 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 766' ' ' SER . . . . . 0.608 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 10.9 t -58.89 -36.73 75.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.27 0.557 . . . . 0.0 110.363 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 767' ' ' ALA . . . . . 0.404 ' CB ' ' HZ ' ' A' ' 756' ' ' PHE . . . -72.78 -41.34 65.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.217 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 768' ' ' VAL . . . . . 0.835 HG22 ' CE1' ' A' ' 756' ' ' PHE . 23.2 t -61.13 -49.8 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.096 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 769' ' ' GLN . . . . . 0.616 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.2 OUTLIER -63.05 -33.85 76.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.374 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 21.2 mtt180 -70.08 -42.54 72.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.279 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.507 ' HD3' ' HD2' ' A' ' 756' ' ' PHE . 0.0 OUTLIER -78.53 -35.72 45.8 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.527 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 772' ' ' LEU . . . . . 1.02 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -90.6 -10.35 43.66 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm 60.61 40.61 16.42 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 774' ' ' ILE . . . . . 0.759 ' CG2' HD13 ' A' ' 749' ' ' LEU . 27.7 pt -111.69 -175.33 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.39 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.63 150.54 21.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.097 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -54.28 -45.97 72.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.653 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -61.91 -47.48 84.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.759 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.821 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -60.37 -50.19 74.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.687 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.22 -49.76 74.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.354 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 780' ' ' ALA . . . . . 0.643 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.2 -41.52 75.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.771 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 -59.54 -48.26 82.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.045 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 782' ' ' MET . . . . . 0.437 ' HE3' ' HB2' ' A' ' 749' ' ' LEU . 0.0 OUTLIER -61.71 -44.55 96.71 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.407 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 783' ' ' ILE . . . . . 0.805 HD11 HG21 ' A' ' 768' ' ' VAL . 12.0 mm -55.32 -37.07 42.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.786 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -64.03 -46.03 86.26 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.576 ' HB3' ' CE1' ' A' ' 750' ' ' TYR . . . -59.26 -33.56 71.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.633 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 786' ' ' MET . . . . . 0.726 ' HB3' HG22 ' A' ' 792' ' ' VAL . 13.4 mtm -65.46 -40.68 93.47 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.316 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.16 -49.14 77.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.092 0.472 . . . . 0.0 110.587 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 32.9 mtm -70.66 -36.85 73.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.385 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -71.86 -21.56 61.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.082 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 790' ' ' GLY . . . . . 0.7 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 93.72 17.23 42.33 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.718 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.757 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 60.2 t -87.72 -29.46 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 122.505 0.322 . . . . 0.0 111.27 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 792' ' ' VAL . . . . . 0.726 HG22 ' HB3' ' A' ' 786' ' ' MET . 20.5 m -139.58 141.93 33.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.869 0.366 . . . . 0.0 111.824 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 793' ' ' THR . . . . . 0.559 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.1 p -86.17 165.65 32.83 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 794' ' ' PRO . . . . . 0.559 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 32.6 Cg_endo -63.45 166.38 15.39 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 121.951 1.767 . . . . 0.0 111.815 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -69.6 158.1 35.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.373 . . . . 0.0 111.213 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 36.8 p30 -105.72 176.56 5.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.83 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 2.8 t -57.84 -31.21 66.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.999 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -74.22 -17.58 60.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.246 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 93.62 26.44 15.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.566 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 17.9 m -127.24 134.6 50.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 0.0 110.809 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 801' ' ' ARG . . . . . 0.571 ' HB3' ' HB3' ' A' ' 763' ' ' ALA . 13.5 mtt-85 -85.03 170.79 12.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.251 0.548 . . . . 0.0 111.545 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -129.1 166.5 19.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.842 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 803' ' ' VAL . . . . . 0.851 HG22 HG12 ' A' ' 757' ' ' VAL . 19.3 t -107.6 138.55 33.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.885 0.374 . . . . 0.0 111.978 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 804' ' ' ILE . . . . . 0.7 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -109.98 -25.35 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.555 179.03 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 805' ' ' ALA . . . . . 0.757 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -80.87 121.56 81.07 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.239 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -50.34 163.94 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.639 2.226 . . . . 0.0 112.885 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.053 179.934 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 743' ' ' GLY . . . . . 0.567 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.45 -0.405 0 N-CA-C 112.439 -0.264 . . . . 0.0 112.439 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 744' ' ' SER . . . . . 0.464 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 50.4 m -118.97 -46.87 2.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.126 0.489 . . . . 0.0 110.487 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -159.17 -47.48 0.06 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.19 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -128.89 95.27 4.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.394 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 747' ' ' ASP . . . . . 0.548 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.2 t70 -122.5 143.48 39.81 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.312 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 748' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 40.0 Cg_exo -36.75 -28.77 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.081 2.521 . . . . 0.0 113.793 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 749' ' ' LEU . . . . . 0.817 HD13 ' CG2' ' A' ' 774' ' ' ILE . 28.7 mt -119.99 -17.09 8.51 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 750' ' ' TYR . . . . . 0.656 ' CE2' HG21 ' A' ' 754' ' ' VAL . 78.5 t80 -53.15 -50.91 63.58 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.935 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -53.07 -35.11 59.18 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 752' ' ' GLU . . . . . 1.022 ' HB3' HD21 ' A' ' 772' ' ' LEU . 9.1 tp10 -71.1 -42.02 69.84 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.174 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 753' ' ' ALA . . . . . 0.472 ' O ' HG23 ' A' ' 757' ' ' VAL . . . -63.58 -53.73 47.11 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.188 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 754' ' ' VAL . . . . . 0.758 HG22 HG11 ' A' ' 791' ' ' VAL . 6.2 t -56.1 -39.27 57.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.865 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -68.22 -35.47 78.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.652 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 756' ' ' PHE . . . . . 0.624 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.7 t80 -68.79 -46.33 68.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.038 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 757' ' ' VAL . . . . . 0.617 HG12 HG22 ' A' ' 803' ' ' VAL . 21.1 t -71.29 -38.88 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 120.903 0.383 . . . . 0.0 111.114 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 758' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 754' ' ' VAL . 20.6 p -63.12 -41.43 99.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.702 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -76.96 -46.63 23.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.148 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 760' ' ' SER . . . . . 0.468 ' O ' ' HD3' ' A' ' 762' ' ' ARG . 22.8 p -70.6 -33.86 71.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.975 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 761' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 760' ' ' SER . 0.0 OUTLIER 78.27 23.73 0.69 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.401 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 762' ' ' ARG . . . . . 0.468 ' HD3' ' O ' ' A' ' 760' ' ' SER . 0.5 OUTLIER -145.03 114.29 7.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.507 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 763' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' A' ' 801' ' ' ARG . . . -88.19 89.49 8.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.039 0.447 . . . . 0.0 111.442 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 764' ' ' SER . . . . . 0.719 ' O ' HG23 ' A' ' 768' ' ' VAL . 17.0 m -126.84 118.35 24.45 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 765' ' ' ILE . . . . . 0.603 HG21 ' HB2' ' A' ' 780' ' ' ALA . 11.0 mt -52.99 -45.56 52.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.491 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 766' ' ' SER . . . . . 0.5 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 6.6 t -60.57 -37.7 82.15 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.152 0.501 . . . . 0.0 110.308 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 767' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 764' ' ' SER . . . -73.64 -35.26 65.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.52 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 768' ' ' VAL . . . . . 0.799 HG21 HD11 ' A' ' 783' ' ' ILE . 40.4 t -67.71 -46.98 81.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 769' ' ' GLN . . . . . 0.599 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.3 OUTLIER -65.12 -34.12 77.66 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.491 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 14.9 mtt-85 -71.32 -42.57 68.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.2 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.74 -34.92 45.41 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 772' ' ' LEU . . . . . 1.022 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -92.41 -10.41 38.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp 61.71 40.79 12.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.106 0.479 . . . . 0.0 109.721 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 774' ' ' ILE . . . . . 0.817 ' CG2' HD13 ' A' ' 749' ' ' LEU . 23.0 pt -111.74 -173.78 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.661 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.59 151.69 22.67 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.186 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -56.9 -45.78 82.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 0.0 110.729 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 -63.29 -46.56 86.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.69 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.782 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.2 OUTLIER -61.23 -50.07 74.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.776 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.41 -49.46 76.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.21 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 780' ' ' ALA . . . . . 0.603 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -55.93 -42.47 76.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.966 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -59.38 -43.37 92.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.125 0.488 . . . . 0.0 110.016 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 782' ' ' MET . . . . . 0.445 ' HE2' ' HB2' ' A' ' 753' ' ' ALA . 2.5 mtp -67.66 -42.02 82.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.592 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 783' ' ' ILE . . . . . 0.799 HD11 HG21 ' A' ' 768' ' ' VAL . 9.5 mm -58.59 -37.32 64.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.443 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -63.56 -48.27 78.15 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.6 ' HB3' ' CE1' ' A' ' 750' ' ' TYR . . . -56.16 -33.41 65.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.693 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 786' ' ' MET . . . . . 0.698 ' HG2' HG22 ' A' ' 754' ' ' VAL . 13.1 mtm -66.8 -40.77 88.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.178 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 787' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 792' ' ' VAL . 0.5 OUTLIER -59.93 -49.41 77.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.61 179.711 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 28.5 mtm -72.81 -37.79 67.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.546 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -68.16 -21.5 64.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.136 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 790' ' ' GLY . . . . . 0.763 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 94.91 16.93 39.76 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.459 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.758 HG11 HG22 ' A' ' 754' ' ' VAL . 55.1 t -86.34 -35.45 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 122.422 0.289 . . . . 0.0 111.306 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 792' ' ' VAL . . . . . 0.687 HG22 ' HB3' ' A' ' 786' ' ' MET . 22.0 m -136.4 151.44 28.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.128 0.49 . . . . 0.0 111.69 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 793' ' ' THR . . . . . 0.575 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.3 p -94.83 165.67 16.65 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.282 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 794' ' ' PRO . . . . . 0.575 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 29.6 Cg_endo -62.3 166.01 13.87 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 121.869 1.713 . . . . 0.0 111.94 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -72.07 158.5 35.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.985 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -105.51 176.51 5.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 53.1 p -57.86 -30.17 65.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.202 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -75.34 -17.6 60.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.296 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 94.15 23.23 22.94 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.576 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 58.9 m -123.26 132.54 54.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.824 0.345 . . . . 0.0 110.649 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 801' ' ' ARG . . . . . 0.569 ' HB2' ' O ' ' A' ' 763' ' ' ALA . 11.7 mtt-85 -85.14 170.79 12.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.189 0.519 . . . . 0.0 111.716 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 802' ' ' GLU . . . . . 0.425 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 3.8 mt-10 -127.54 171.05 11.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.868 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 803' ' ' VAL . . . . . 0.617 HG22 HG12 ' A' ' 757' ' ' VAL . 22.3 t -114.22 138.38 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 804' ' ' ILE . . . . . 0.763 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -106.89 -28.31 2.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.454 178.811 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 805' ' ' ALA . . . . . 0.725 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -82.7 121.44 77.84 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.001 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -65.48 163.73 28.71 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.541 2.161 . . . . 0.0 112.088 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.144 -179.753 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 743' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.15 -160.78 0.7 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.635 0.255 . . . . 0.0 110.611 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -51.11 -44.35 61.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.808 0.337 . . . . 0.0 111.121 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -127.39 95.56 4.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.122 0.487 . . . . 0.0 110.956 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 747' ' ' ASP . . . . . 0.56 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.57 143.21 39.26 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.445 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 748' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 40.5 Cg_exo -36.22 -29.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.108 2.538 . . . . 0.0 113.962 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 749' ' ' LEU . . . . . 0.84 HD13 ' CG2' ' A' ' 774' ' ' ILE . 26.3 mt -120.02 -17.15 8.48 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 750' ' ' TYR . . . . . 0.732 ' CE1' HG21 ' A' ' 754' ' ' VAL . 65.6 t80 -53.81 -47.81 70.5 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.783 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -53.23 -37.49 62.09 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 752' ' ' GLU . . . . . 1.092 ' HB3' HD21 ' A' ' 772' ' ' LEU . 11.8 tt0 -71.0 -43.38 68.1 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.083 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 753' ' ' ALA . . . . . 0.67 ' HB2' ' HE1' ' A' ' 782' ' ' MET . . . -59.74 -54.4 46.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.159 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 754' ' ' VAL . . . . . 0.774 HG22 HG11 ' A' ' 791' ' ' VAL . 4.8 t -56.19 -40.82 67.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.142 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 44.5 ttt85 -65.89 -36.02 82.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.543 178.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 756' ' ' PHE . . . . . 0.787 ' CE1' HG22 ' A' ' 768' ' ' VAL . 1.2 t80 -69.78 -44.95 69.06 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.83 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 757' ' ' VAL . . . . . 0.746 HG11 ' CG1' ' A' ' 792' ' ' VAL . 61.2 t -69.74 -39.59 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 121.002 0.43 . . . . 0.0 110.763 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 758' ' ' THR . . . . . 0.445 ' HA ' HG11 ' A' ' 803' ' ' VAL . 10.1 p -62.8 -44.81 95.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.8 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -78.58 -33.08 47.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.177 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 760' ' ' SER . . . . . 0.485 ' OG ' ' HA ' ' A' ' 757' ' ' VAL . 93.7 p -75.54 -15.68 60.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.278 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 62.84 17.34 9.85 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.426 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 -155.77 140.37 16.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.572 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 763' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 801' ' ' ARG . . . -105.57 89.62 3.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.922 0.391 . . . . 0.0 111.658 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 764' ' ' SER . . . . . 0.767 ' O ' HG23 ' A' ' 768' ' ' VAL . 1.7 m -118.96 118.67 32.12 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 765' ' ' ILE . . . . . 0.522 HG21 ' HB2' ' A' ' 780' ' ' ALA . 7.4 mt -55.69 -47.74 78.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.563 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 766' ' ' SER . . . . . 0.468 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 39.3 t -57.4 -39.09 75.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.14 0.495 . . . . 0.0 110.275 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 767' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 764' ' ' SER . . . -71.88 -39.56 69.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.448 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 768' ' ' VAL . . . . . 0.797 HG21 HD11 ' A' ' 783' ' ' ILE . 46.2 t -61.81 -48.15 89.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.996 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 769' ' ' GLN . . . . . 0.59 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.1 OUTLIER -65.46 -33.33 75.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 770' ' ' ARG . . . . . 0.466 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 20.1 mtt180 -70.1 -41.85 73.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.139 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.429 ' HD3' ' HE2' ' A' ' 756' ' ' PHE . 4.5 tptt -78.49 -39.84 37.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.644 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 772' ' ' LEU . . . . . 1.092 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -87.68 -9.49 54.01 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.522 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt 60.32 41.27 16.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.025 0.44 . . . . 0.0 109.825 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 774' ' ' ILE . . . . . 0.84 ' CG2' HD13 ' A' ' 749' ' ' LEU . 20.1 pt -111.89 -173.95 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.342 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.51 150.03 20.97 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.05 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -54.24 -45.34 72.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.879 0.371 . . . . 0.0 110.751 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -64.19 -47.92 77.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.712 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.769 ' HE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -58.76 -49.97 75.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.766 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.54 -49.9 74.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.28 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 780' ' ' ALA . . . . . 0.522 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -55.94 -40.04 72.59 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.797 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -59.63 -47.04 87.14 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 782' ' ' MET . . . . . 0.67 ' HE1' ' HB2' ' A' ' 753' ' ' ALA . 1.6 mtp -63.07 -43.13 99.42 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 783' ' ' ILE . . . . . 0.797 HD11 HG21 ' A' ' 768' ' ' VAL . 12.3 mm -57.45 -38.77 64.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.682 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -62.15 -43.3 99.14 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.645 ' HB3' ' CE2' ' A' ' 750' ' ' TYR . . . -61.15 -33.41 73.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.581 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 786' ' ' MET . . . . . 0.754 ' HB3' HG22 ' A' ' 792' ' ' VAL . 13.2 mtm -65.63 -39.44 91.48 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.275 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -63.57 -45.3 91.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.19 0.519 . . . . 0.0 110.312 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 53.0 mtm -72.01 -36.86 69.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.664 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -75.53 -21.66 57.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.137 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 790' ' ' GLY . . . . . 0.808 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 94.14 18.52 36.44 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.621 -178.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.774 HG11 HG22 ' A' ' 754' ' ' VAL . 57.5 t -86.82 -30.2 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.723 0.296 . . . . 0.0 110.961 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 792' ' ' VAL . . . . . 0.754 HG22 ' HB3' ' A' ' 786' ' ' MET . 22.2 m -139.31 144.06 29.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.629 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 793' ' ' THR . . . . . 0.585 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.1 p -87.37 166.81 23.68 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 794' ' ' PRO . . . . . 0.585 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 28.5 Cg_endo -62.07 166.13 13.17 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.074 1.849 . . . . 0.0 112.262 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.31 161.92 13.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.173 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -105.31 176.34 5.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.826 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 44.8 p -61.79 -32.5 72.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.818 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -79.69 -17.55 53.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.178 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.27 25.1 8.47 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.46 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 20.8 m -122.14 129.96 52.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 110.935 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 801' ' ' ARG . . . . . 0.518 ' NH1' ' CG2' ' A' ' 783' ' ' ILE . 12.1 mtt-85 -83.82 170.67 13.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.287 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -127.81 167.75 16.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.926 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 803' ' ' VAL . . . . . 0.613 HG22 HG12 ' A' ' 757' ' ' VAL . 16.4 t -109.05 137.92 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.956 0.407 . . . . 0.0 112.017 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 804' ' ' ILE . . . . . 0.808 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -108.26 -27.36 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.267 178.751 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 805' ' ' ALA . . . . . 0.725 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -83.11 123.96 76.9 Favored Pre-proline 0 N--CA 1.454 -0.237 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.996 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.57 163.79 31.36 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.679 2.253 . . . . 0.0 112.252 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.216 -179.923 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 743' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.61 -0.196 . . . . 0.0 112.61 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 744' ' ' SER . . . . . 0.589 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 1.4 m -123.04 -55.96 1.76 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.148 0.499 . . . . 0.0 110.282 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -151.05 -47.92 0.12 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.23 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.03 95.33 4.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.527 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 747' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.9 t70 -122.5 142.34 37.04 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.353 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -38.04 -27.82 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.921 2.414 . . . . 0.0 113.556 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 749' ' ' LEU . . . . . 0.839 HD13 ' CG2' ' A' ' 774' ' ' ILE . 43.5 mt -119.91 -17.36 8.49 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 750' ' ' TYR . . . . . 0.666 ' CE2' HG21 ' A' ' 754' ' ' VAL . 66.3 t80 -55.14 -46.94 75.69 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.816 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -53.27 -36.73 61.46 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 752' ' ' GLU . . . . . 0.879 ' HB3' HD21 ' A' ' 772' ' ' LEU . 0.6 OUTLIER -71.04 -45.04 64.58 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.018 178.756 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 753' ' ' ALA . . . . . 0.445 ' O ' HG23 ' A' ' 757' ' ' VAL . . . -59.35 -52.3 66.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.352 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 754' ' ' VAL . . . . . 0.735 HG22 HG11 ' A' ' 791' ' ' VAL . 2.3 t -56.12 -43.02 74.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.958 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -66.72 -35.56 80.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.353 0.597 . . . . 0.0 109.708 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 756' ' ' PHE . . . . . 0.744 ' CE2' HG22 ' A' ' 768' ' ' VAL . 3.5 t80 -66.24 -46.1 78.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.921 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 757' ' ' VAL . . . . . 0.909 HG12 HG22 ' A' ' 803' ' ' VAL . 43.7 t -69.31 -45.05 79.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.932 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 758' ' ' THR . . . . . 0.609 HG22 ' O ' ' A' ' 805' ' ' ALA . 2.0 p -56.64 -42.92 79.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.794 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -78.9 -39.82 33.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.285 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 760' ' ' SER . . . . . 0.415 ' OG ' ' HA ' ' A' ' 757' ' ' VAL . 92.4 p -74.46 -16.88 60.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.35 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 9.0 mmm-85 62.35 24.96 14.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.591 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 762' ' ' ARG . . . . . 0.425 ' C ' HG13 ' A' ' 757' ' ' VAL . 6.3 ptt180 -157.87 133.14 8.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.678 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 763' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -102.61 89.77 3.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.965 0.412 . . . . 0.0 111.564 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 764' ' ' SER . . . . . 0.716 ' O ' HG23 ' A' ' 768' ' ' VAL . 1.8 m -125.02 118.53 26.4 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 765' ' ' ILE . . . . . 0.547 HG21 ' HB2' ' A' ' 780' ' ' ALA . 2.2 mp -51.16 -51.49 22.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.952 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 766' ' ' SER . . . . . 0.472 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 14.3 t -53.32 -42.21 66.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.155 0.502 . . . . 0.0 110.629 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -70.1 -42.12 73.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.549 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 768' ' ' VAL . . . . . 0.969 HG21 HD11 ' A' ' 783' ' ' ILE . 42.5 t -59.47 -47.48 90.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.215 179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 769' ' ' GLN . . . . . 0.589 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 3.3 pt20 -65.49 -33.46 75.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.719 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 770' ' ' ARG . . . . . 0.468 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 0.0 OUTLIER -68.89 -42.25 77.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.046 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -78.55 -42.16 30.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.693 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 772' ' ' LEU . . . . . 0.879 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -84.98 -8.79 58.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.889 -179.594 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp 58.21 41.83 22.94 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 774' ' ' ILE . . . . . 0.839 ' CG2' HD13 ' A' ' 749' ' ' LEU . 26.9 pt -111.84 -173.9 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.72 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -91.53 153.08 21.88 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.972 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -58.5 -46.69 86.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.832 0.349 . . . . 0.0 110.73 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -57.57 -47.74 81.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.064 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.798 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.0 OUTLIER -66.0 -50.28 64.83 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.693 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -54.85 -50.09 69.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.674 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 780' ' ' ALA . . . . . 0.547 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -59.31 -42.92 92.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.76 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -58.93 -48.49 81.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.105 0.478 . . . . 0.0 109.88 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 782' ' ' MET . . . . . . . . . . . . . 33.5 mtm -65.21 -34.52 78.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.45 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 783' ' ' ILE . . . . . 0.969 HD11 HG21 ' A' ' 768' ' ' VAL . 5.9 mm -64.6 -36.2 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.094 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.99 -39.94 94.22 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.589 ' HB1' ' O ' ' A' ' 744' ' ' SER . . . -60.11 -34.6 73.72 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.42 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 786' ' ' MET . . . . . 0.741 ' HB3' HG22 ' A' ' 792' ' ' VAL . 13.9 mtm -67.07 -39.07 86.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.975 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 787' ' ' GLU . . . . . 0.416 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 0.1 OUTLIER -59.51 -54.12 50.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.726 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 20.1 mtm -70.36 -38.34 74.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.129 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -65.54 -21.59 66.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.558 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 790' ' ' GLY . . . . . 0.647 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 91.14 14.97 56.84 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.84 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.735 HG11 HG22 ' A' ' 754' ' ' VAL . 23.7 t -84.51 -30.69 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-O 120.892 0.377 . . . . 0.0 111.028 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 792' ' ' VAL . . . . . 0.741 HG22 ' HB3' ' A' ' 786' ' ' MET . 18.9 m -137.07 140.06 43.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.278 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 793' ' ' THR . . . . . 0.515 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 2.3 p -85.18 160.56 54.43 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.831 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 794' ' ' PRO . . . . . 0.515 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 17.7 Cg_endo -58.94 167.55 5.41 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.137 1.891 . . . . 0.0 111.873 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.54 157.01 38.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.202 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 35.9 p30 -105.55 176.61 5.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.826 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 7.9 t -57.31 -33.95 68.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.023 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -71.95 -17.51 62.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.14 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 92.99 27.76 13.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.474 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 3.5 m -127.72 133.95 49.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 0.0 110.898 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 801' ' ' ARG . . . . . 0.509 ' NH1' HG21 ' A' ' 792' ' ' VAL . 8.4 mtt-85 -85.6 170.66 12.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.243 0.544 . . . . 0.0 111.354 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -130.86 167.34 19.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.042 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 803' ' ' VAL . . . . . 0.909 HG22 HG12 ' A' ' 757' ' ' VAL . 21.9 t -109.5 135.87 47.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.951 0.405 . . . . 0.0 111.63 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 804' ' ' ILE . . . . . 0.647 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -104.51 -28.43 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.259 179.058 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 805' ' ' ALA . . . . . 0.645 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -81.33 124.15 80.77 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.87 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.32 163.85 25.05 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.671 2.247 . . . . 0.0 112.188 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.2 -179.799 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 743' ' ' GLY . . . . . 0.558 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.743 -0.143 . . . . 0.0 112.743 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 744' ' ' SER . . . . . 0.55 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 0.7 OUTLIER -117.5 -51.69 2.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.141 0.496 . . . . 0.0 110.267 179.608 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -157.03 -49.14 0.07 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.024 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -124.93 95.07 4.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.227 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 747' ' ' ASP . . . . . 0.565 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 13.1 t70 -122.57 143.31 39.52 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.344 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 748' ' ' PRO . . . . . 0.405 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 45.3 Cg_exo -36.14 -29.32 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.011 2.474 . . . . 0.0 113.789 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 749' ' ' LEU . . . . . 0.837 HD13 ' CG2' ' A' ' 774' ' ' ILE . 23.8 mt -120.05 -17.24 8.44 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 750' ' ' TYR . . . . . 0.744 ' CE2' HG21 ' A' ' 754' ' ' VAL . 70.1 t80 -53.39 -48.37 68.72 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.949 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -53.24 -37.29 61.94 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 752' ' ' GLU . . . . . 1.014 ' HB3' HD21 ' A' ' 772' ' ' LEU . 0.5 OUTLIER -70.94 -42.12 70.25 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.085 178.679 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 753' ' ' ALA . . . . . 0.44 ' HB2' ' HE2' ' A' ' 782' ' ' MET . . . -60.96 -53.7 54.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.202 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 754' ' ' VAL . . . . . 0.744 HG21 ' CE2' ' A' ' 750' ' ' TYR . 8.0 t -56.27 -39.98 63.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.063 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 37.9 mtt180 -67.62 -37.37 82.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.39 0.614 . . . . 0.0 109.766 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 756' ' ' PHE . . . . . 0.678 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.6 t80 -67.68 -46.06 73.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.288 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 757' ' ' VAL . . . . . 0.93 HG12 HG22 ' A' ' 803' ' ' VAL . 54.3 t -69.46 -43.94 80.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.958 0.409 . . . . 0.0 110.61 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 758' ' ' THR . . . . . 0.715 ' HA ' HG11 ' A' ' 803' ' ' VAL . 12.5 p -56.67 -45.6 81.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.052 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -78.8 -34.39 45.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.634 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 760' ' ' SER . . . . . 0.505 ' HB2' ' NE ' ' A' ' 762' ' ' ARG . 91.7 p -75.25 -17.76 60.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.527 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 5.9 mmm-85 63.68 33.55 12.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.349 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 762' ' ' ARG . . . . . 0.53 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.0 OUTLIER -170.61 136.64 1.27 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.403 179.535 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 763' ' ' ALA . . . . . 0.455 ' HB2' HG11 ' A' ' 757' ' ' VAL . . . -104.46 89.76 3.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 0.0 111.82 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 764' ' ' SER . . . . . 0.704 ' O ' HG23 ' A' ' 768' ' ' VAL . 1.0 OUTLIER -121.36 118.52 29.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.571 178.775 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 765' ' ' ILE . . . . . 0.606 HG21 ' HB2' ' A' ' 780' ' ' ALA . 1.6 mt -53.33 -50.49 47.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.618 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 766' ' ' SER . . . . . 0.464 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 16.3 t -55.27 -39.04 69.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.167 0.508 . . . . 0.0 110.492 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 767' ' ' ALA . . . . . 0.408 ' HB1' ' HZ ' ' A' ' 756' ' ' PHE . . . -71.8 -37.54 70.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.503 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 768' ' ' VAL . . . . . 0.782 HG21 HD11 ' A' ' 783' ' ' ILE . 44.5 t -65.57 -47.85 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.241 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 769' ' ' GLN . . . . . 0.593 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.1 OUTLIER -64.85 -33.39 75.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.478 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 770' ' ' ARG . . . . . 0.447 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 2.6 mtt180 -70.91 -42.5 69.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.117 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.426 ' HB2' ' CE1' ' A' ' 756' ' ' PHE . 0.2 OUTLIER -78.52 -36.43 44.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.086 -179.425 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 772' ' ' LEU . . . . . 1.014 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -91.59 -9.35 44.48 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.885 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt 60.76 40.94 15.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.073 0.463 . . . . 0.0 109.815 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 774' ' ' ILE . . . . . 0.837 ' CG2' HD13 ' A' ' 749' ' ' LEU . 20.5 pt -111.84 -173.92 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.292 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.91 150.96 21.87 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.12 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -55.63 -45.37 77.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.855 0.359 . . . . 0.0 110.582 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 777' ' ' ASN . . . . . 0.404 ' O ' ' HG3' ' A' ' 781' ' ' ARG . 21.5 m-80 -63.77 -47.94 78.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.771 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.754 ' HE ' HD12 ' A' ' 749' ' ' LEU . 0.2 OUTLIER -59.44 -50.12 75.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.893 0.378 . . . . 0.0 110.783 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.64 72.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.458 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 780' ' ' ALA . . . . . 0.606 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -56.27 -40.69 74.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.941 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 781' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 777' ' ' ASN . 12.5 mtt180 -58.86 -46.35 87.97 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 782' ' ' MET . . . . . 0.44 ' HE2' ' HB2' ' A' ' 753' ' ' ALA . 2.3 mtp -64.74 -42.59 95.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 783' ' ' ILE . . . . . 0.782 HD11 HG21 ' A' ' 768' ' ' VAL . 9.9 mm -57.22 -35.64 49.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.291 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.12 -45.47 88.45 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.604 ' HB3' ' CE1' ' A' ' 750' ' ' TYR . . . -58.26 -33.62 69.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.603 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 786' ' ' MET . . . . . 0.716 ' HB3' HG22 ' A' ' 792' ' ' VAL . 14.4 mtm -67.2 -38.21 84.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.083 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -62.27 -47.9 82.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.582 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 36.3 mtm -73.56 -37.53 65.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.272 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -70.46 -21.58 62.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.599 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 790' ' ' GLY . . . . . 0.616 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 92.22 15.51 53.44 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.819 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.763 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 59.7 t -83.93 -29.12 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.744 0.307 . . . . 0.0 111.101 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 792' ' ' VAL . . . . . 0.716 HG22 ' HB3' ' A' ' 786' ' ' MET . 18.8 m -139.39 135.42 40.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.953 0.406 . . . . 0.0 111.375 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 793' ' ' THR . . . . . 0.696 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 4.7 p -80.49 168.31 26.45 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.597 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 794' ' ' PRO . . . . . 0.696 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 38.7 Cg_endo -65.44 163.38 29.93 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 121.877 1.718 . . . . 0.0 111.965 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 795' ' ' MET . . . . . 0.423 ' HA ' ' HG3' ' A' ' 801' ' ' ARG . 0.1 OUTLIER -60.8 162.27 6.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.453 -179.69 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -105.53 176.5 5.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.892 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 60.2 p -60.58 -30.41 69.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.022 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -83.79 -17.53 40.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.252 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.41 26.41 7.74 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.513 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 50.7 m -123.27 130.44 52.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.911 0.386 . . . . 0.0 110.825 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 801' ' ' ARG . . . . . 0.431 ' NH1' ' CG2' ' A' ' 783' ' ' ILE . 9.3 mtt-85 -83.68 170.57 14.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.213 0.53 . . . . 0.0 111.465 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 802' ' ' GLU . . . . . 0.627 ' O ' HG23 ' A' ' 793' ' ' THR . 5.0 mt-10 -132.14 134.51 45.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.934 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 803' ' ' VAL . . . . . 0.93 HG22 HG12 ' A' ' 757' ' ' VAL . 18.9 t -76.91 136.86 23.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.985 0.422 . . . . 0.0 111.904 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 804' ' ' ILE . . . . . 0.616 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -107.04 -29.78 2.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.516 178.875 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 805' ' ' ALA . . . . . 0.763 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -75.08 120.15 80.29 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -50.2 163.9 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.678 2.252 . . . . 0.0 112.92 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.148 179.989 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 743' ' ' GLY . . . . . 0.628 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 14.6 m -119.35 -47.5 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.134 0.492 . . . . 0.0 110.363 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -159.26 -49.67 0.06 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.223 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.38 95.21 4.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.355 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 747' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.42 142.96 38.39 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.316 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 748' ' ' PRO . . . . . 0.418 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 43.8 Cg_exo -36.69 -28.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.015 2.477 . . . . 0.0 113.774 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 749' ' ' LEU . . . . . 0.829 HD13 ' CG2' ' A' ' 774' ' ' ILE . 28.6 mt -119.99 -17.1 8.51 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 750' ' ' TYR . . . . . 0.725 ' CE2' HG21 ' A' ' 754' ' ' VAL . 82.3 t80 -52.81 -50.47 63.59 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.791 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -52.93 -35.99 59.17 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 752' ' ' GLU . . . . . 1.073 ' HB3' HD21 ' A' ' 772' ' ' LEU . 5.9 tt0 -71.05 -41.89 70.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.23 178.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 753' ' ' ALA . . . . . 0.553 ' HB2' ' HE1' ' A' ' 782' ' ' MET . . . -62.89 -53.77 48.98 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.987 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 754' ' ' VAL . . . . . 0.725 HG21 ' CE2' ' A' ' 750' ' ' TYR . 9.1 t -56.02 -41.43 68.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.738 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 755' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' A' ' 759' ' ' GLU . 1.5 ttm-85 -65.6 -35.11 79.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.281 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 756' ' ' PHE . . . . . 0.665 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.7 t80 -69.73 -46.3 66.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.367 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 757' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 762' ' ' ARG . 51.6 t -70.44 -38.37 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 120.921 0.391 . . . . 0.0 110.843 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 758' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 754' ' ' VAL . 22.4 p -65.21 -42.48 93.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.177 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 759' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 755' ' ' ARG . 1.8 tt0 -77.14 -46.48 23.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.373 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 92.5 p -74.68 -10.47 59.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.154 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.65 30.25 17.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.06 0.457 . . . . 0.0 110.607 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 762' ' ' ARG . . . . . 0.716 ' O ' HG13 ' A' ' 757' ' ' VAL . 10.6 mtm180 -145.5 138.46 26.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.543 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 763' ' ' ALA . . . . . 0.925 ' HB1' HH21 ' A' ' 801' ' ' ARG . . . -117.76 89.57 3.15 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.97 0.414 . . . . 0.0 111.025 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 764' ' ' SER . . . . . 0.63 ' O ' HG23 ' A' ' 768' ' ' VAL . 2.7 m -133.91 118.45 17.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.637 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 765' ' ' ILE . . . . . 0.731 HD13 ' HB2' ' A' ' 780' ' ' ALA . 19.1 mt -50.01 -46.65 23.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.704 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 766' ' ' SER . . . . . 0.485 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 12.1 t -58.9 -39.0 80.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.136 0.493 . . . . 0.0 110.534 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -72.93 -36.61 67.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.349 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 768' ' ' VAL . . . . . 0.679 HG21 HD11 ' A' ' 783' ' ' ILE . 40.7 t -65.22 -48.01 85.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.067 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 769' ' ' GLN . . . . . 0.602 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.4 OUTLIER -65.41 -33.47 76.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.569 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 770' ' ' ARG . . . . . 0.414 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 12.1 mtt180 -71.54 -41.53 69.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.065 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.63 -36.52 43.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.829 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 772' ' ' LEU . . . . . 1.073 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -91.28 -10.03 42.93 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt 61.61 39.94 13.97 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 774' ' ' ILE . . . . . 0.829 ' CG2' HD13 ' A' ' 749' ' ' LEU . 24.1 pt -111.77 -174.49 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.481 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.69 152.98 23.57 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.228 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -57.16 -46.34 82.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.926 0.393 . . . . 0.0 110.625 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -62.87 -47.83 81.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.724 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.79 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.4 OUTLIER -60.27 -50.24 74.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.82 -179.94 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.84 -50.04 73.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.349 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 780' ' ' ALA . . . . . 0.731 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -55.64 -42.89 75.63 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.781 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -58.66 -43.09 89.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.097 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 782' ' ' MET . . . . . 0.553 ' HE1' ' HB2' ' A' ' 753' ' ' ALA . 2.6 mtp -68.38 -40.04 81.55 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 783' ' ' ILE . . . . . 0.93 HG23 ' NH2' ' A' ' 801' ' ' ARG . 5.3 mm -58.14 -40.08 75.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.798 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 784' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 787' ' ' GLU . 2.3 mt-10 -63.99 -46.18 85.7 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.628 ' HB2' ' O ' ' A' ' 743' ' ' GLY . . . -54.76 -33.42 61.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.508 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 786' ' ' MET . . . . . 0.743 ' HB3' HG22 ' A' ' 792' ' ' VAL . 14.9 mtm -67.7 -39.36 84.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.848 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 787' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 784' ' ' GLU . 0.4 OUTLIER -57.62 -51.5 69.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.669 179.415 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 46.9 mtm -75.46 -38.37 59.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.915 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -64.31 -21.2 66.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.921 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 790' ' ' GLY . . . . . 0.551 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 91.87 19.77 39.04 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.419 -178.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.701 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 79.2 t -89.2 -32.78 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.793 0.33 . . . . 0.0 111.059 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 792' ' ' VAL . . . . . 0.864 HG21 ' NH2' ' A' ' 801' ' ' ARG . 28.3 m -137.49 143.44 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.0 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 793' ' ' THR . . . . . 0.426 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 6.8 p -82.03 155.2 70.16 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.421 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 794' ' ' PRO . . . . . 0.426 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 19.1 Cg_endo -58.75 169.03 3.62 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.424 2.083 . . . . 0.0 112.345 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 795' ' ' MET . . . . . 0.507 ' HA ' ' HG3' ' A' ' 801' ' ' ARG . 1.4 mtp -60.92 159.52 11.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.303 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -102.48 176.56 5.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.805 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 38.2 p -60.59 -28.01 68.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.07 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -90.9 -17.59 26.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.327 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 104.8 28.55 5.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.765 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 19.3 m -121.91 129.88 52.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.871 0.367 . . . . 0.0 110.929 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 801' ' ' ARG . . . . . 0.93 ' NH2' HG23 ' A' ' 783' ' ' ILE . 0.4 OUTLIER -94.46 170.49 9.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.125 0.488 . . . . 0.0 111.387 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.95 -172.42 2.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.488 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 803' ' ' VAL . . . . . 0.594 HG22 HG12 ' A' ' 757' ' ' VAL . 30.2 t -121.14 138.66 50.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.843 0.354 . . . . 0.0 111.741 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 804' ' ' ILE . . . . . 0.551 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -110.16 -27.13 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.777 179.282 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 805' ' ' ALA . . . . . 0.701 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -84.74 120.87 74.43 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.889 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.42 163.71 28.63 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.59 2.193 . . . . 0.0 112.163 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.168 -179.903 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 743' ' ' GLY . . . . . 0.595 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.45 -0.375 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 9.8 p -101.76 -158.04 0.65 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.592 0.234 . . . . 0.0 110.656 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -50.78 -45.31 59.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.722 0.296 . . . . 0.0 111.505 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -128.13 95.61 4.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.069 0.461 . . . . 0.0 111.34 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 747' ' ' ASP . . . . . 0.58 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 14.6 t70 -122.36 142.34 36.82 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.413 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 748' ' ' PRO . . . . . 0.402 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 41.0 Cg_exo -35.12 -30.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.311 2.674 . . . . 0.0 113.993 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 749' ' ' LEU . . . . . 0.83 HD12 ' NE ' ' A' ' 778' ' ' ARG . 44.7 mt -120.02 -16.91 8.54 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 750' ' ' TYR . . . . . 0.712 ' CE2' HG21 ' A' ' 754' ' ' VAL . 67.7 t80 -54.08 -47.81 71.31 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.483 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -53.45 -35.73 60.81 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 752' ' ' GLU . . . . . 0.97 ' HB2' HD21 ' A' ' 772' ' ' LEU . 8.4 mt-10 -70.95 -40.91 71.74 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.182 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 753' ' ' ALA . . . . . 0.473 ' HB2' ' HE1' ' A' ' 782' ' ' MET . . . -64.24 -52.35 59.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.118 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 754' ' ' VAL . . . . . 0.712 HG21 ' CE2' ' A' ' 750' ' ' TYR . 3.1 t -56.35 -40.09 64.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.005 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.59 -35.32 77.2 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.488 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 756' ' ' PHE . . . . . 0.829 ' CE1' HG22 ' A' ' 768' ' ' VAL . 1.1 t80 -67.42 -46.12 74.11 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.93 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 757' ' ' VAL . . . . . 0.78 HG13 ' O ' ' A' ' 762' ' ' ARG . 43.3 t -70.82 -41.07 77.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.86 0.362 . . . . 0.0 110.757 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 758' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 754' ' ' VAL . 20.3 p -62.18 -42.08 98.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.568 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -77.26 -47.03 21.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.882 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 6.3 p -70.98 -18.54 62.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.765 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 761' ' ' ARG . . . . . 0.404 ' N ' ' O ' ' A' ' 757' ' ' VAL . 0.0 OUTLIER 65.17 18.69 11.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.771 -179.626 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 762' ' ' ARG . . . . . 0.78 ' O ' HG13 ' A' ' 757' ' ' VAL . 1.0 OUTLIER -139.74 145.39 38.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.749 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 763' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' A' ' 801' ' ' ARG . . . -117.43 89.46 3.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.237 0.541 . . . . 0.0 110.83 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 764' ' ' SER . . . . . 0.726 ' O ' HG23 ' A' ' 768' ' ' VAL . 23.7 m -129.99 118.59 21.84 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 765' ' ' ILE . . . . . 0.525 HG21 ' HB2' ' A' ' 780' ' ' ALA . 11.2 mt -51.77 -47.17 39.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.697 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 766' ' ' SER . . . . . 0.571 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 22.2 t -59.3 -37.73 78.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.149 0.499 . . . . 0.0 110.571 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -73.1 -42.17 63.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.229 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 768' ' ' VAL . . . . . 0.871 HG21 HD11 ' A' ' 783' ' ' ILE . 30.4 t -59.76 -50.91 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.971 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 769' ' ' GLN . . . . . 0.641 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -63.58 -33.45 75.63 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.713 -179.649 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -67.03 -43.87 81.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.122 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.552 ' HD2' ' HD2' ' A' ' 756' ' ' PHE . 0.9 OUTLIER -78.64 -42.16 29.5 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.838 0.351 . . . . 0.0 111.794 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 772' ' ' LEU . . . . . 0.97 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -81.37 -10.57 59.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.815 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm 60.03 40.76 18.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.193 0.521 . . . . 0.0 109.701 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 774' ' ' ILE . . . . . 0.766 ' CG2' HD13 ' A' ' 749' ' ' LEU . 24.2 pt -111.82 -173.99 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.563 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.55 149.91 21.45 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.111 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -53.98 -44.72 71.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 110.662 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 777' ' ' ASN . . . . . 0.435 ' O ' ' HG3' ' A' ' 781' ' ' ARG . 79.3 m-20 -65.01 -47.89 75.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.692 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.83 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.2 OUTLIER -57.83 -50.07 74.51 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.865 0.364 . . . . 0.0 110.752 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 779' ' ' ALA . . . . . 0.4 ' HB2' ' CD1' ' A' ' 774' ' ' ILE . . . -58.14 -45.88 86.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.105 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 780' ' ' ALA . . . . . 0.525 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -56.93 -44.3 82.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.103 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 781' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 777' ' ' ASN . 7.4 mtt180 -58.76 -46.86 86.51 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 782' ' ' MET . . . . . 0.473 ' HE1' ' HB2' ' A' ' 753' ' ' ALA . 2.5 mtp -64.06 -41.81 97.22 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 783' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 768' ' ' VAL . 7.2 mm -58.73 -37.16 64.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.448 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.26 -45.2 92.61 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.637 ' HB3' ' CE1' ' A' ' 750' ' ' TYR . . . -58.99 -33.53 70.8 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.63 178.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 786' ' ' MET . . . . . 0.736 ' HB3' HG22 ' A' ' 792' ' ' VAL . 12.4 mtm -65.79 -39.79 91.3 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.118 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.32 -47.84 82.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.147 0.499 . . . . 0.0 110.492 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 25.8 mtp -70.95 -38.29 72.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.552 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -71.19 -21.64 62.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.962 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 790' ' ' GLY . . . . . 0.768 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 93.3 19.03 36.96 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.605 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.733 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 38.1 t -88.27 -30.19 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.716 0.293 . . . . 0.0 111.168 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 792' ' ' VAL . . . . . 0.736 HG22 ' HB3' ' A' ' 786' ' ' MET . 20.9 m -138.76 143.73 31.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.408 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 793' ' ' THR . . . . . 0.533 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.3 p -88.06 163.59 36.83 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 794' ' ' PRO . . . . . 0.533 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 18.6 Cg_endo -59.93 166.41 8.67 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 121.957 1.772 . . . . 0.0 112.129 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 1.5 mtt -61.12 162.03 7.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.227 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -105.55 176.54 5.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.766 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 44.1 p -61.62 -33.92 74.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.779 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -79.56 -17.57 53.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.56 28.07 6.87 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.417 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 19.2 m -124.68 130.45 52.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 110.909 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 801' ' ' ARG . . . . . 0.56 ' HB2' ' O ' ' A' ' 763' ' ' ALA . 11.3 mtt-85 -83.95 170.69 13.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.449 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -129.02 168.98 15.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.254 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 803' ' ' VAL . . . . . 0.766 HG22 HG12 ' A' ' 757' ' ' VAL . 21.4 t -110.62 137.27 43.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.011 0.434 . . . . 0.0 111.844 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 804' ' ' ILE . . . . . 0.768 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -107.5 -27.96 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.314 178.991 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 805' ' ' ALA . . . . . 0.733 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -79.34 122.73 84.39 Favored Pre-proline 0 N--CA 1.455 -0.207 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.742 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.38 163.66 31.38 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.513 2.142 . . . . 0.0 112.198 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.857 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 743' ' ' GLY . . . . . 0.645 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.678 -0.169 . . . . 0.0 112.678 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.43 -47.97 2.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.149 0.5 . . . . 0.0 110.252 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -159.1 -49.59 0.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.177 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -126.35 95.17 4.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.318 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 747' ' ' ASP . . . . . 0.55 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.6 t70 -122.49 143.2 39.1 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.535 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 748' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 37.9 Cg_exo -36.72 -28.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.069 2.513 . . . . 0.0 113.895 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 749' ' ' LEU . . . . . 0.855 HD13 ' CG2' ' A' ' 774' ' ' ILE . 28.9 mt -120.03 -17.2 8.46 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 750' ' ' TYR . . . . . 0.728 ' CE2' HG21 ' A' ' 754' ' ' VAL . 80.5 t80 -52.88 -50.34 64.04 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.948 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -53.17 -35.72 60.1 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 752' ' ' GLU . . . . . 1.036 ' HB3' HD21 ' A' ' 772' ' ' LEU . 8.0 tt0 -71.12 -41.5 70.44 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.293 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 753' ' ' ALA . . . . . 0.558 ' HB2' ' HE1' ' A' ' 782' ' ' MET . . . -64.57 -51.95 60.15 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.125 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 754' ' ' VAL . . . . . 0.728 HG21 ' CE2' ' A' ' 750' ' ' TYR . 5.0 t -56.12 -38.7 54.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.504 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -69.38 -35.16 75.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.435 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 756' ' ' PHE . . . . . 0.76 ' CE2' HG22 ' A' ' 768' ' ' VAL . 1.5 t80 -68.57 -46.2 70.05 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.329 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 757' ' ' VAL . . . . . 0.643 HG11 ' HB2' ' A' ' 763' ' ' ALA . 35.4 t -71.23 -41.38 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-O 120.991 0.424 . . . . 0.0 110.751 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 758' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 754' ' ' VAL . 30.1 p -62.72 -42.89 99.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.993 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -77.48 -46.31 22.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.275 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 760' ' ' SER . . . . . 0.513 ' O ' ' HD3' ' A' ' 762' ' ' ARG . 50.0 p -70.06 -29.17 66.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 761' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 760' ' ' SER . 0.0 OUTLIER 70.86 28.53 3.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.302 -179.248 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 762' ' ' ARG . . . . . 0.513 ' HD3' ' O ' ' A' ' 760' ' ' SER . 0.4 OUTLIER -147.8 110.55 4.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.368 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 763' ' ' ALA . . . . . 0.873 ' HB1' HH21 ' A' ' 801' ' ' ARG . . . -91.06 89.69 7.51 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.052 0.453 . . . . 0.0 111.257 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 764' ' ' SER . . . . . 0.616 ' O ' HG23 ' A' ' 768' ' ' VAL . 1.3 m -133.94 118.85 18.35 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.472 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 765' ' ' ILE . . . . . 0.557 HG21 ' HB2' ' A' ' 780' ' ' ALA . 1.5 mp -48.85 -52.7 9.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.952 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 766' ' ' SER . . . . . 0.534 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 7.9 t -53.34 -40.12 64.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.203 0.525 . . . . 0.0 110.635 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -71.64 -39.75 70.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.445 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 768' ' ' VAL . . . . . 0.76 HG22 ' CE2' ' A' ' 756' ' ' PHE . 44.4 t -61.89 -49.88 82.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.114 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 769' ' ' GLN . . . . . 0.596 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.4 OUTLIER -63.47 -33.91 76.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.869 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 770' ' ' ARG . . . . . 0.418 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 7.2 mtt85 -68.95 -42.53 76.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.218 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.7 -39.3 36.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.701 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 772' ' ' LEU . . . . . 1.036 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -87.07 -9.78 54.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.248 -179.314 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp 60.95 39.7 16.3 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 774' ' ' ILE . . . . . 0.855 ' CG2' HD13 ' A' ' 749' ' ' LEU . 17.8 pt -111.86 -173.83 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.165 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -90.17 153.18 22.69 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.023 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -57.09 -45.57 83.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.817 0.341 . . . . 0.0 110.64 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 777' ' ' ASN . . . . . 0.442 ' O ' ' HG3' ' A' ' 781' ' ' ARG . 66.4 m-20 -63.13 -48.08 80.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.735 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.778 ' HE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -59.88 -50.17 74.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.979 0.418 . . . . 0.0 110.751 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.12 76.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.441 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 780' ' ' ALA . . . . . 0.557 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -56.97 -40.87 77.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.027 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 781' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 777' ' ' ASN . 17.3 mtt180 -58.88 -46.77 87.02 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 782' ' ' MET . . . . . 0.558 ' HE1' ' HB2' ' A' ' 753' ' ' ALA . 2.3 mtp -64.83 -42.24 95.09 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 783' ' ' ILE . . . . . 1.014 HG23 ' NH2' ' A' ' 801' ' ' ARG . 5.9 mm -55.8 -39.54 56.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.502 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.97 -46.69 86.51 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.645 ' HB2' ' O ' ' A' ' 743' ' ' GLY . . . -55.19 -33.54 63.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.827 178.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 786' ' ' MET . . . . . 0.749 ' HB3' HG22 ' A' ' 792' ' ' VAL . 14.5 mtm -67.38 -40.53 85.7 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.197 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 787' ' ' GLU . . . . . 0.484 ' HG3' ' NH1' ' A' ' 801' ' ' ARG . 4.2 mt-10 -58.61 -53.66 55.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.647 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 30.9 mtm -71.06 -38.32 72.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.429 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -65.71 -21.42 66.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.7 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 790' ' ' GLY . . . . . 0.701 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 91.15 15.18 56.4 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.608 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.723 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 86.1 t -84.02 -29.78 7.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.023 0.44 . . . . 0.0 110.672 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 792' ' ' VAL . . . . . 0.918 HG21 ' NH2' ' A' ' 801' ' ' ARG . 17.6 m -139.54 144.47 28.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.977 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 793' ' ' THR . . . . . 0.478 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 6.6 p -83.69 156.84 64.72 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.608 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 794' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 19.0 Cg_endo -58.77 169.51 3.3 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.498 2.132 . . . . 0.0 112.177 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 795' ' ' MET . . . . . 0.447 ' HA ' ' HG3' ' A' ' 801' ' ' ARG . 2.1 mtt -65.13 159.82 22.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.021 0.439 . . . . 0.0 111.254 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 56.6 m-20 -102.15 176.58 5.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.841 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 9.8 t -59.63 -29.52 68.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.069 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 39.1 p30 -87.3 -17.58 32.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.378 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 102.48 31.79 5.1 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.722 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 15.9 m -125.0 129.65 50.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.347 . . . . 0.0 110.75 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 801' ' ' ARG . . . . . 1.014 ' NH2' HG23 ' A' ' 783' ' ' ILE . 0.5 OUTLIER -93.51 169.63 10.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.348 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -130.48 -170.81 2.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.713 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 803' ' ' VAL . . . . . 0.608 HG22 HG12 ' A' ' 757' ' ' VAL . 30.0 t -124.58 138.52 53.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.928 0.394 . . . . 0.0 111.887 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 804' ' ' ILE . . . . . 0.701 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -108.97 -30.22 2.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.519 179.232 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 805' ' ' ALA . . . . . 0.723 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -79.55 119.79 78.06 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.892 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.89 163.75 32.38 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.536 2.157 . . . . 0.0 112.219 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.134 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.675 -0.17 . . . . 0.0 112.675 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 744' ' ' SER . . . . . 0.544 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 56.2 m -122.36 -56.89 1.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.068 0.461 . . . . 0.0 110.322 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -151.37 -48.81 0.12 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.208 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -124.86 95.27 4.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.532 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 747' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.0 t70 -122.45 142.42 37.18 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.501 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -38.73 -27.3 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.873 2.382 . . . . 0.0 113.547 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 749' ' ' LEU . . . . . 0.855 HD13 ' CG2' ' A' ' 774' ' ' ILE . 46.2 mt -119.99 -17.06 8.53 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 750' ' ' TYR . . . . . 0.714 ' CE2' HG21 ' A' ' 754' ' ' VAL . 71.1 t80 -55.62 -47.14 77.05 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.386 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -53.27 -35.72 60.36 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 752' ' ' GLU . . . . . 0.891 ' HB2' HD21 ' A' ' 772' ' ' LEU . 1.2 mm-40 -71.03 -43.58 67.6 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.255 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 753' ' ' ALA . . . . . 0.469 ' HB2' ' HE3' ' A' ' 782' ' ' MET . . . -61.87 -53.39 56.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.205 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 754' ' ' VAL . . . . . 0.714 HG21 ' CE2' ' A' ' 750' ' ' TYR . 3.2 t -56.18 -41.14 68.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.552 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -69.68 -35.43 75.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.333 0.587 . . . . 0.0 109.844 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 756' ' ' PHE . . . . . 0.679 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.0 t80 -66.95 -46.07 75.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.044 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 757' ' ' VAL . . . . . 0.801 HG12 HG22 ' A' ' 803' ' ' VAL . 59.5 t -70.47 -44.86 76.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.883 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 758' ' ' THR . . . . . 0.771 ' HA ' HG11 ' A' ' 803' ' ' VAL . 9.1 p -56.83 -44.87 82.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.277 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -78.84 -39.73 34.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.463 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 760' ' ' SER . . . . . 0.466 ' HB2' ' NE ' ' A' ' 762' ' ' ARG . 94.6 p -72.56 -25.04 61.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.254 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 67.98 42.71 1.8 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.377 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 762' ' ' ARG . . . . . 0.466 ' NE ' ' HB2' ' A' ' 760' ' ' SER . 0.0 OUTLIER -174.61 121.19 0.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.564 179.495 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 763' ' ' ALA . . . . . 0.546 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -93.87 89.77 6.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.972 0.415 . . . . 0.0 111.646 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 764' ' ' SER . . . . . 0.744 ' O ' HG23 ' A' ' 768' ' ' VAL . 9.9 m -123.54 118.55 27.61 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 765' ' ' ILE . . . . . 0.84 HD13 ' HB2' ' A' ' 780' ' ' ALA . 24.1 mt -53.51 -50.15 50.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.738 -179.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 766' ' ' SER . . . . . 0.438 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 11.4 t -53.35 -43.24 67.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.221 0.534 . . . . 0.0 110.499 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -69.75 -39.87 76.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.768 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 768' ' ' VAL . . . . . 0.91 HG21 HD11 ' A' ' 783' ' ' ILE . 47.0 t -61.85 -45.71 98.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.253 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 769' ' ' GLN . . . . . 0.583 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 3.3 pt20 -66.5 -33.48 75.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.416 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 770' ' ' ARG . . . . . 0.466 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 20.5 mtt180 -70.95 -42.06 70.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.037 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.414 ' HB2' ' CE1' ' A' ' 756' ' ' PHE . 0.7 OUTLIER -78.53 -38.27 40.94 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.007 -179.488 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 772' ' ' LEU . . . . . 0.891 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -90.35 -9.32 48.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.573 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt 60.16 42.24 15.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 774' ' ' ILE . . . . . 0.855 ' CG2' HD13 ' A' ' 749' ' ' LEU . 29.4 pt -112.0 -174.05 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.816 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -90.95 150.49 20.58 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.088 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -55.03 -46.52 75.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.902 0.382 . . . . 0.0 110.885 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -59.6 -45.91 90.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.206 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 778' ' ' ARG . . . . . 0.818 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -66.11 -50.44 64.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.833 0.349 . . . . 0.0 110.858 -179.788 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 779' ' ' ALA . . . . . 0.421 ' HB2' ' CD1' ' A' ' 774' ' ' ILE . . . -55.12 -50.21 69.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.202 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 780' ' ' ALA . . . . . 0.84 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.06 -46.45 78.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.985 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -58.9 -48.42 81.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.253 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 782' ' ' MET . . . . . 0.469 ' HE3' ' HB2' ' A' ' 753' ' ' ALA . 33.8 mtm -63.41 -36.36 83.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.307 0.575 . . . . 0.0 109.461 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 783' ' ' ILE . . . . . 0.91 HD11 HG21 ' A' ' 768' ' ' VAL . 7.4 mm -63.37 -40.28 88.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.18 -42.71 91.48 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 785' ' ' ALA . . . . . 0.544 ' HB1' ' O ' ' A' ' 744' ' ' SER . . . -60.02 -33.58 72.21 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.719 178.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 786' ' ' MET . . . . . 0.61 ' CE ' HD13 ' A' ' 783' ' ' ILE . 12.7 mtm -66.05 -37.62 86.29 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.062 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 787' ' ' GLU . . . . . 0.447 ' HG3' ' CZ ' ' A' ' 801' ' ' ARG . 3.3 mt-10 -63.36 -53.97 44.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.742 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 24.5 mtm -68.55 -37.64 80.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.494 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 789' ' ' ALA . . . . . 0.468 ' HB3' HG23 ' A' ' 791' ' ' VAL . . . -68.73 -21.59 64.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.796 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 790' ' ' GLY . . . . . 0.55 ' CA ' HD12 ' A' ' 804' ' ' ILE . . . 89.75 19.55 47.47 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.926 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 791' ' ' VAL . . . . . 0.689 HG11 HG22 ' A' ' 754' ' ' VAL . 11.3 t -84.45 -34.67 9.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.804 0.335 . . . . 0.0 110.756 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 792' ' ' VAL . . . . . 0.661 HG21 HH21 ' A' ' 801' ' ' ARG . 11.7 m -133.88 140.21 46.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.28 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 793' ' ' THR . . . . . 0.49 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.2 p -77.85 160.89 73.21 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 794' ' ' PRO . . . . . 0.49 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 22.7 Cg_endo -60.29 166.08 9.87 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.088 1.859 . . . . 0.0 111.967 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 2.1 mtt -56.56 158.46 4.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.196 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -101.25 176.47 5.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.921 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 9.7 t -55.63 -33.26 63.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -85.18 -17.58 36.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.121 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.6 35.96 3.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.548 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 6.0 m -127.82 130.01 47.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.956 0.408 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 801' ' ' ARG . . . . . 0.661 HH21 HG21 ' A' ' 792' ' ' VAL . 6.5 mtp85 -81.67 170.58 15.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.331 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -131.27 -170.7 2.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.659 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 803' ' ' VAL . . . . . 0.801 HG22 HG12 ' A' ' 757' ' ' VAL . 23.0 t -127.26 133.7 67.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.17 0.51 . . . . 0.0 112.098 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 804' ' ' ILE . . . . . 0.55 HD12 ' CA ' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -105.15 -28.76 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.858 178.69 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 805' ' ' ALA . . . . . 0.583 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -80.85 126.49 77.59 Favored Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.778 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.61 163.77 23.22 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.713 2.275 . . . . 0.0 112.228 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.234 -179.783 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.486 -0.245 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 2.4 p -127.29 -56.42 1.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.81 0.338 . . . . 0.0 110.863 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -107.02 112.2 25.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.974 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 743' ' ' GLY . . . . . 0.622 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . 102.47 57.8 0.79 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.588 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 744' ' ' SER . . . . . 0.503 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 0.8 OUTLIER -116.56 -49.75 2.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.141 0.496 . . . . 0.0 110.262 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.69 -50.52 0.08 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.95 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -124.1 95.23 4.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.266 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 747' ' ' ASP . . . . . 0.537 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.3 t70 -122.44 142.46 37.25 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.531 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 748' ' ' PRO . . . . . 0.408 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 45.7 Cg_exo -37.24 -28.88 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.057 2.505 . . . . 0.0 113.582 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 749' ' ' LEU . . . . . 0.802 HD13 ' CG2' ' A' ' 774' ' ' ILE . 31.6 mt -119.96 -16.87 8.58 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.751 ' CE2' HG21 ' A' ' 754' ' ' VAL . 72.4 t80 -53.4 -48.54 68.6 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 120.344 -0.543 . . . . 0.0 110.457 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -53.37 -36.15 61.08 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 0.948 ' HB2' HD21 ' A' ' 772' ' ' LEU . 1.8 mt-10 -70.95 -40.95 71.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.024 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 753' ' ' ALA . . . . . 0.447 ' O ' HG23 ' A' ' 757' ' ' VAL . . . -63.85 -52.93 57.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.043 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 754' ' ' VAL . . . . . 0.751 HG21 ' CE2' ' A' ' 750' ' ' TYR . 8.8 t -56.14 -39.99 62.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.281 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.65 -35.71 75.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.312 0.577 . . . . 0.0 109.461 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 756' ' ' PHE . . . . . 0.847 ' CE1' HG22 ' A' ' 768' ' ' VAL . 1.0 OUTLIER -66.58 -46.05 77.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.861 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 757' ' ' VAL . . . . . 1.026 HG12 HG22 ' A' ' 803' ' ' VAL . 45.6 t -68.6 -47.1 78.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.973 0.416 . . . . 0.0 110.452 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 758' ' ' THR . . . . . 0.7 ' HA ' HG11 ' A' ' 803' ' ' VAL . 8.4 p -53.93 -43.18 69.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.972 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -78.88 -36.81 41.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.361 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 17.9 p -76.63 -15.07 59.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.454 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 63.07 19.9 11.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.696 0.284 . . . . 0.0 111.415 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 762' ' ' ARG . . . . . 0.561 ' O ' HG13 ' A' ' 757' ' ' VAL . 5.4 ptt180 -154.87 140.03 17.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.844 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 763' ' ' ALA . . . . . 0.585 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -106.84 89.76 3.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 111.528 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 764' ' ' SER . . . . . 0.81 ' O ' HG23 ' A' ' 768' ' ' VAL . 1.4 m -122.62 118.64 28.66 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 765' ' ' ILE . . . . . 0.699 HD13 ' HB2' ' A' ' 780' ' ' ALA . 22.6 mt -53.46 -49.71 52.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.75 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 766' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 12.9 t -53.77 -43.81 69.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.2 0.524 . . . . 0.0 110.578 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -67.86 -45.12 75.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.533 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 768' ' ' VAL . . . . . 0.886 HG21 HD11 ' A' ' 783' ' ' ILE . 26.5 t -56.5 -49.15 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.364 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 769' ' ' GLN . . . . . 0.593 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 1.1 pt20 -63.52 -33.42 75.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.594 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 770' ' ' ARG . . . . . 0.476 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 21.2 mtt180 -70.73 -42.65 70.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.231 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.493 ' HD3' ' HD2' ' A' ' 756' ' ' PHE . 0.0 OUTLIER -78.53 -36.15 45.22 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.522 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 772' ' ' LEU . . . . . 0.948 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -90.87 -10.13 43.77 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp 60.67 41.29 15.34 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 774' ' ' ILE . . . . . 0.802 ' CG2' HD13 ' A' ' 749' ' ' LEU . 22.6 pt -111.75 -173.88 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.486 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.57 153.75 23.53 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.02 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -56.94 -46.42 82.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 0.0 110.797 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -63.57 -44.52 93.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.799 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.797 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.4 OUTLIER -62.06 -50.22 72.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.753 179.858 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -58.34 -48.54 80.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.092 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 780' ' ' ALA . . . . . 0.699 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.07 -43.43 77.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.899 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -59.12 -48.53 81.26 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.855 0.359 . . . . 0.0 110.125 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 782' ' ' MET . . . . . 0.423 ' HE2' ' HB2' ' A' ' 753' ' ' ALA . 2.7 mtp -63.7 -38.31 90.62 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 783' ' ' ILE . . . . . 0.886 HD11 HG21 ' A' ' 768' ' ' VAL . 7.8 mm -61.31 -40.53 86.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.259 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -44.19 91.21 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 743' ' ' GLY . . . -58.97 -33.65 70.91 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.92 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 786' ' ' MET . . . . . 0.658 ' SD ' HG21 ' A' ' 757' ' ' VAL . 14.0 mtm -66.46 -37.73 85.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.106 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 787' ' ' GLU . . . . . 0.462 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 2.5 mt-10 -62.46 -54.17 44.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.519 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 73.4 mtp -68.07 -38.22 82.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.473 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -70.14 -21.57 63.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.955 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 790' ' ' GLY . . . . . 0.444 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 89.79 16.85 55.78 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.85 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.677 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 44.8 t -81.93 -31.68 10.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.796 0.331 . . . . 0.0 110.887 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 792' ' ' VAL . . . . . 0.673 HG21 HH21 ' A' ' 801' ' ' ARG . 7.1 m -135.59 140.76 43.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.074 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 793' ' ' THR . . . . . 0.525 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 9.4 p -78.59 159.69 73.87 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.737 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 794' ' ' PRO . . . . . 0.525 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 19.3 Cg_endo -59.49 167.25 6.65 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.049 1.832 . . . . 0.0 111.824 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -59.5 163.57 4.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.036 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -105.56 176.55 5.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.859 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 5.4 t -57.27 -30.33 64.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.796 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -88.13 -17.63 30.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.048 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.92 36.71 3.61 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.664 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 17.1 m -127.88 129.13 46.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.906 0.384 . . . . 0.0 111.267 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 801' ' ' ARG . . . . . 0.673 HH21 HG21 ' A' ' 792' ' ' VAL . 6.7 mtp85 -83.64 170.36 14.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.287 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 802' ' ' GLU . . . . . 0.47 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 3.2 mt-10 -134.87 174.2 10.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.698 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 803' ' ' VAL . . . . . 1.026 HG22 HG12 ' A' ' 757' ' ' VAL . 20.7 t -109.74 136.25 46.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.06 0.457 . . . . 0.0 112.13 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 804' ' ' ILE . . . . . 0.494 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -109.78 -26.94 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.264 178.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 805' ' ' ALA . . . . . 0.677 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -76.32 122.59 87.04 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.041 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -50.26 163.96 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.604 2.203 . . . . 0.0 112.897 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 807' ' ' ALA . . . . . 0.54 ' HB1' ' HD2' ' A' ' 808' ' ' PRO . . . -106.87 160.71 25.35 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.137 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 808' ' ' PRO . . . . . 0.54 ' HD2' ' HB1' ' A' ' 807' ' ' ALA . 61.2 Cg_endo -73.06 92.75 0.81 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.551 2.168 . . . . 0.0 112.302 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 21.9 t -83.07 -37.14 13.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.118 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 4.1 mtm105 -160.75 -44.12 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.848 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.91 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 1.2 m -114.12 -49.11 2.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 0.0 110.838 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.22 -167.92 2.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.896 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . -70.49 84.11 0.35 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.606 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 744' ' ' SER . . . . . 0.773 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 4.5 m -121.55 -62.68 1.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.122 0.487 . . . . 0.0 110.392 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -145.41 -49.16 0.23 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.234 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.62 95.23 4.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.556 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 747' ' ' ASP . . . . . 0.522 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.9 t70 -122.48 142.31 36.96 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.373 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -38.51 -27.45 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.848 2.366 . . . . 0.0 113.513 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 749' ' ' LEU . . . . . 0.849 HD13 ' CG2' ' A' ' 774' ' ' ILE . 48.4 mt -120.01 -17.02 8.52 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.663 ' CE2' HG21 ' A' ' 754' ' ' VAL . 65.3 t80 -55.62 -46.82 77.33 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.349 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -53.38 -35.67 60.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 0.896 ' HB2' HD21 ' A' ' 772' ' ' LEU . 2.5 mt-10 -71.02 -43.7 67.38 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.161 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 753' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 757' ' ' VAL . . . -61.92 -51.7 67.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.206 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 754' ' ' VAL . . . . . 0.749 HG22 HG11 ' A' ' 791' ' ' VAL . 2.3 t -56.33 -42.25 73.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.261 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -69.16 -35.4 76.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.192 0.52 . . . . 0.0 109.909 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 756' ' ' PHE . . . . . 0.746 ' CE2' HG22 ' A' ' 768' ' ' VAL . 2.3 t80 -66.58 -45.93 77.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.922 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 757' ' ' VAL . . . . . 0.943 HG12 HG22 ' A' ' 803' ' ' VAL . 47.4 t -69.2 -44.56 80.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.926 0.393 . . . . 0.0 110.951 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 758' ' ' THR . . . . . 0.58 ' HA ' HG11 ' A' ' 803' ' ' VAL . 3.9 p -58.21 -43.73 87.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.295 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.76 -43.23 26.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.433 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 760' ' ' SER . . . . . 0.424 ' OG ' ' HD2' ' A' ' 762' ' ' ARG . 83.1 p -71.93 -19.96 61.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.039 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 63.52 50.63 2.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.599 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 762' ' ' ARG . . . . . 0.712 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.0 OUTLIER 179.81 139.61 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.49 179.399 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 763' ' ' ALA . . . . . 0.585 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -108.75 89.73 3.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.989 0.423 . . . . 0.0 111.597 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 764' ' ' SER . . . . . 0.739 ' O ' HG23 ' A' ' 768' ' ' VAL . 0.7 OUTLIER -125.54 118.44 25.75 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.705 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 765' ' ' ILE . . . . . 0.552 HG21 ' HB2' ' A' ' 780' ' ' ALA . 2.3 mp -53.16 -51.3 40.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.897 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 766' ' ' SER . . . . . 0.477 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 12.4 t -53.42 -41.84 66.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.116 0.484 . . . . 0.0 110.622 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -70.02 -42.96 72.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.536 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 768' ' ' VAL . . . . . 0.977 HG21 HD11 ' A' ' 783' ' ' ILE . 45.6 t -59.03 -47.14 90.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.268 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 769' ' ' GLN . . . . . 0.593 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 3.2 pt20 -65.56 -33.55 76.19 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.694 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 770' ' ' ARG . . . . . 0.468 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 0.4 OUTLIER -68.26 -42.78 79.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.093 179.796 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.62 -42.06 29.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.806 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 772' ' ' LEU . . . . . 0.896 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -85.02 -8.54 58.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.742 -179.522 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt 58.29 41.94 22.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.185 0.517 . . . . 0.0 109.75 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 774' ' ' ILE . . . . . 0.849 ' CG2' HD13 ' A' ' 749' ' ' LEU . 29.9 pt -112.01 -173.91 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.789 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -91.87 152.52 21.43 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.872 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -57.91 -46.57 84.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.886 0.374 . . . . 0.0 110.838 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -57.49 -47.51 81.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.13 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.821 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.0 OUTLIER -66.45 -50.31 63.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.909 0.385 . . . . 0.0 110.773 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 779' ' ' ALA . . . . . 0.422 ' HB2' ' CD1' ' A' ' 774' ' ' ILE . . . -54.6 -50.05 68.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.658 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 780' ' ' ALA . . . . . 0.552 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -58.85 -42.95 90.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.826 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -58.97 -48.38 81.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.108 0.48 . . . . 0.0 109.814 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 782' ' ' MET . . . . . 0.448 ' HE3' ' HB2' ' A' ' 753' ' ' ALA . 34.8 mtm -65.27 -34.88 79.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.497 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 783' ' ' ILE . . . . . 0.977 HD11 HG21 ' A' ' 768' ' ' VAL . 6.5 mm -64.21 -37.27 79.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -64.47 -39.45 93.83 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.773 ' HB1' ' O ' ' A' ' 744' ' ' SER . . . -60.68 -34.32 74.15 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.418 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 786' ' ' MET . . . . . 0.698 ' HB3' HG22 ' A' ' 792' ' ' VAL . 14.4 mtm -66.81 -39.96 87.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.992 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -59.59 -54.18 49.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.708 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 68.4 mtm -68.92 -38.29 79.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.147 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -66.54 -21.51 66.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.728 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 790' ' ' GLY . . . . . 0.617 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 91.39 14.14 57.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.903 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.749 HG11 HG22 ' A' ' 754' ' ' VAL . 24.0 t -84.27 -30.4 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.817 0.341 . . . . 0.0 110.85 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 792' ' ' VAL . . . . . 0.698 HG22 ' HB3' ' A' ' 786' ' ' MET . 17.7 m -136.83 141.1 41.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.538 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 793' ' ' THR . . . . . 0.528 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 6.2 p -82.61 160.28 61.95 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.818 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 794' ' ' PRO . . . . . 0.528 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 20.7 Cg_endo -60.05 166.64 8.51 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.137 1.891 . . . . 0.0 112.15 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 2.6 mtt -65.5 163.26 16.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.116 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -105.48 176.55 5.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 7.3 t -58.34 -34.6 70.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -82.01 -17.5 46.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.124 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 100.82 34.6 4.59 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.608 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 15.8 m -124.68 129.06 49.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.971 0.415 . . . . 0.0 111.061 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 801' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' A' ' 763' ' ' ALA . 10.4 mtt-85 -89.9 170.71 10.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.441 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 802' ' ' GLU . . . . . 0.432 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 0.1 OUTLIER -134.14 169.82 16.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.071 179.15 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 803' ' ' VAL . . . . . 0.943 HG22 HG12 ' A' ' 757' ' ' VAL . 21.5 t -109.94 136.19 46.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.993 0.425 . . . . 0.0 111.718 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 804' ' ' ILE . . . . . 0.617 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -104.92 -30.53 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.261 179.083 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 805' ' ' ALA . . . . . 0.678 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -75.46 127.59 85.79 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.887 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.62 163.85 25.93 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.744 2.296 . . . . 0.0 112.159 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -86.14 154.77 57.74 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.243 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.95 105.82 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.642 2.228 . . . . 0.0 112.273 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 12.1 t 68.6 -67.98 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.23 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -143.12 -47.0 0.3 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.963 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.944 179.997 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.45 31.23 3.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.857 0.36 . . . . 0.0 110.887 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 61.08 92.44 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 743' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . 92.97 68.91 1.11 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.635 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 744' ' ' SER . . . . . 0.44 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 1.1 m -126.37 -51.11 1.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.108 0.48 . . . . 0.0 110.542 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -154.94 -51.06 0.09 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.435 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -124.9 95.39 4.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.502 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 747' ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.49 142.32 37.01 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.41 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 748' ' ' PRO . . . . . 0.408 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 44.2 Cg_exo -36.01 -29.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.094 2.53 . . . . 0.0 113.692 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 749' ' ' LEU . . . . . 0.768 HD13 ' CG2' ' A' ' 774' ' ' ILE . 39.9 mt -120.09 -17.12 8.45 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.729 ' CE2' HG21 ' A' ' 754' ' ' VAL . 69.2 t80 -54.94 -47.67 74.16 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.29 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -53.2 -36.71 61.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 1.041 ' HB3' HD21 ' A' ' 772' ' ' LEU . 4.1 tp10 -70.97 -43.39 68.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.352 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -61.51 -52.39 64.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.086 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 754' ' ' VAL . . . . . 0.73 HG22 HG11 ' A' ' 791' ' ' VAL . 4.0 t -56.15 -39.93 61.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.939 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -67.93 -36.1 79.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.387 0.613 . . . . 0.0 109.545 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 756' ' ' PHE . . . . . 0.706 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.4 t80 -66.59 -46.21 76.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.076 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 757' ' ' VAL . . . . . 0.92 HG12 HG22 ' A' ' 803' ' ' VAL . 57.6 t -69.52 -44.64 79.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.866 0.365 . . . . 0.0 110.798 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 758' ' ' THR . . . . . 0.676 ' HA ' HG11 ' A' ' 803' ' ' VAL . 4.8 p -55.26 -44.18 75.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.773 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -78.78 -31.63 46.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.27 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 24.3 p -81.02 -14.69 57.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.57 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.95 16.1 8.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.633 0.254 . . . . 0.0 111.504 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 762' ' ' ARG . . . . . 0.629 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.0 OUTLIER -151.83 142.31 22.59 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.701 0.286 . . . . 0.0 110.741 179.81 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 763' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -109.24 89.93 3.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.852 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 764' ' ' SER . . . . . 0.775 ' O ' HG23 ' A' ' 768' ' ' VAL . 63.7 m -121.02 118.57 30.15 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 765' ' ' ILE . . . . . 0.575 HG21 ' HB2' ' A' ' 780' ' ' ALA . 14.8 mt -54.15 -48.9 65.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.622 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 766' ' ' SER . . . . . 0.433 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 23.2 t -54.85 -42.25 71.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.229 0.537 . . . . 0.0 110.368 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -69.88 -40.25 75.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.584 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 768' ' ' VAL . . . . . 0.88 HG21 HD11 ' A' ' 783' ' ' ILE . 39.0 t -61.59 -46.66 96.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.212 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 769' ' ' GLN . . . . . 0.591 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 1.0 OUTLIER -65.15 -34.07 77.51 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.618 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 770' ' ' ARG . . . . . 0.492 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 12.6 mtt180 -71.0 -42.19 69.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.131 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.419 ' HB2' ' CE1' ' A' ' 756' ' ' PHE . 0.1 OUTLIER -78.56 -36.06 45.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.961 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 772' ' ' LEU . . . . . 1.041 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -91.23 -9.92 43.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.755 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt 59.76 41.55 18.13 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 774' ' ' ILE . . . . . 0.768 ' CG2' HD13 ' A' ' 749' ' ' LEU . 20.7 pt -111.82 -174.01 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.345 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.79 150.97 21.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.013 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -54.94 -45.87 74.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.948 0.404 . . . . 0.0 110.748 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -62.96 -45.39 92.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.764 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.767 ' HE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -62.18 -50.31 72.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.762 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.53 -50.63 71.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.395 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 780' ' ' ALA . . . . . 0.575 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -55.99 -39.3 71.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.759 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -59.0 -48.38 81.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.897 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 782' ' ' MET . . . . . 0.488 ' HE3' ' HB2' ' A' ' 749' ' ' LEU . 0.0 OUTLIER -63.45 -44.68 93.81 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.78 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 783' ' ' ILE . . . . . 0.88 HD11 HG21 ' A' ' 768' ' ' VAL . 16.9 mm -54.69 -44.59 70.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.492 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.02 -46.63 82.2 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.519 ' HB3' ' CE1' ' A' ' 750' ' ' TYR . . . -58.17 -33.54 69.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.888 178.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 786' ' ' MET . . . . . 0.578 ' HB3' HG13 ' A' ' 792' ' ' VAL . 13.2 mtm -66.11 -37.59 86.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.131 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 787' ' ' GLU . . . . . 0.463 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 2.8 mt-10 -63.32 -53.86 46.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.13 0.491 . . . . 0.0 110.526 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 63.2 mtp -67.16 -38.01 84.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.352 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -71.09 -21.51 62.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.973 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 790' ' ' GLY . . . . . 0.539 ' CA ' HD12 ' A' ' 804' ' ' ILE . . . 89.35 18.33 53.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.863 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.73 HG11 HG22 ' A' ' 754' ' ' VAL . 41.0 t -83.45 -32.05 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.797 0.332 . . . . 0.0 110.85 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 792' ' ' VAL . . . . . 0.663 HG21 HH21 ' A' ' 801' ' ' ARG . 8.4 m -135.34 142.08 40.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.1 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 793' ' ' THR . . . . . 0.49 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.2 p -80.99 160.61 65.65 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.773 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 794' ' ' PRO . . . . . 0.49 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 18.6 Cg_endo -58.26 167.38 4.75 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.04 1.826 . . . . 0.0 111.93 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 1.2 mtt -60.12 163.37 4.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.045 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 37.8 m-20 -103.83 176.5 5.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.876 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 5.4 t -57.73 -31.02 66.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -87.08 -17.5 32.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.128 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 102.86 35.98 3.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.748 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 15.3 m -127.77 129.53 47.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.947 0.403 . . . . 0.0 111.137 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 801' ' ' ARG . . . . . 0.663 HH21 HG21 ' A' ' 792' ' ' VAL . 6.7 mtp85 -82.23 170.57 15.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.181 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -132.85 178.2 7.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.637 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 803' ' ' VAL . . . . . 0.92 HG22 HG12 ' A' ' 757' ' ' VAL . 19.9 t -116.21 134.07 60.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.102 0.477 . . . . 0.0 112.218 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 804' ' ' ILE . . . . . 0.539 HD12 ' CA ' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -104.73 -29.38 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.767 178.548 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 805' ' ' ALA . . . . . 0.603 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -79.86 123.42 83.78 Favored Pre-proline 0 N--CA 1.451 -0.401 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.463 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.2 163.74 22.09 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.483 2.122 . . . . 0.0 112.163 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 807' ' ' ALA . . . . . 0.665 ' HB1' ' HD2' ' A' ' 808' ' ' PRO . . . -93.54 165.18 18.7 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.094 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 808' ' ' PRO . . . . . 0.665 ' HD2' ' HB1' ' A' ' 807' ' ' ALA . 72.9 Cg_endo -76.0 111.63 3.32 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.568 2.179 . . . . 0.0 112.432 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 31.2 t -86.58 -35.99 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.991 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.54 96.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.003 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.819 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 39.0 m -149.01 -69.52 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.329 . . . . 0.0 110.895 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -122.84 -78.14 0.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.799 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 743' ' ' GLY . . . . . 0.673 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . -73.93 85.05 0.67 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.442 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 744' ' ' SER . . . . . 0.86 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 0.1 OUTLIER -118.74 -74.38 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.98 0.419 . . . . 0.0 110.636 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -134.0 -48.29 0.8 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.558 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -125.29 95.43 4.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.751 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 747' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.4 t70 -122.27 141.89 35.62 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.373 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -36.5 -29.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.125 2.55 . . . . 0.0 113.706 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 749' ' ' LEU . . . . . 0.825 HD13 ' CG2' ' A' ' 774' ' ' ILE . 53.5 mt -120.02 -17.26 8.46 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.682 ' CE2' HG21 ' A' ' 754' ' ' VAL . 65.9 t80 -55.88 -46.95 78.18 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.678 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -53.26 -36.06 60.72 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 0.89 ' HB3' HD21 ' A' ' 772' ' ' LEU . 0.0 OUTLIER -71.15 -45.41 63.6 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.138 178.678 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 753' ' ' ALA . . . . . 0.457 ' HB2' ' HE3' ' A' ' 782' ' ' MET . . . -59.22 -52.86 63.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.3 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 754' ' ' VAL . . . . . 0.682 HG21 ' CE2' ' A' ' 750' ' ' TYR . 2.4 t -56.17 -42.29 72.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.958 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 37.5 mtt180 -66.88 -35.41 79.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.322 0.582 . . . . 0.0 109.692 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 756' ' ' PHE . . . . . 0.754 ' CE2' HG22 ' A' ' 768' ' ' VAL . 3.4 t80 -66.66 -46.05 76.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.911 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 757' ' ' VAL . . . . . 0.882 HG12 HG22 ' A' ' 803' ' ' VAL . 40.8 t -70.28 -44.11 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.992 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 758' ' ' THR . . . . . 0.595 ' HA ' HG11 ' A' ' 803' ' ' VAL . 5.1 p -57.54 -42.82 83.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.953 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.86 -40.85 31.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.26 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 21.1 p -73.86 -18.68 60.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.246 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 63.16 28.58 15.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.183 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 762' ' ' ARG . . . . . 0.514 ' C ' HG13 ' A' ' 757' ' ' VAL . 13.0 ptt180 -157.49 131.18 7.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.901 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 763' ' ' ALA . . . . . 0.474 ' HB2' ' CG1' ' A' ' 792' ' ' VAL . . . -102.35 89.84 3.7 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.973 0.416 . . . . 0.0 111.253 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 764' ' ' SER . . . . . 0.805 ' O ' HG23 ' A' ' 768' ' ' VAL . 1.0 OUTLIER -126.08 118.64 25.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.434 179.082 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 765' ' ' ILE . . . . . 0.875 HD13 ' CB ' ' A' ' 780' ' ' ALA . 23.2 mt -53.05 -50.64 44.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.822 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 766' ' ' SER . . . . . 0.444 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 47.5 t -53.3 -43.56 67.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.207 0.527 . . . . 0.0 110.659 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.78 76.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.634 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 768' ' ' VAL . . . . . 1.002 HG21 HD11 ' A' ' 783' ' ' ILE . 40.1 t -58.67 -47.25 89.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.291 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 769' ' ' GLN . . . . . 0.59 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 3.2 pt20 -65.64 -33.34 75.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.679 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 770' ' ' ARG . . . . . 0.465 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 14.9 mtt180 -69.05 -42.22 76.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.109 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 7.4 tptt -78.6 -42.18 29.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.911 0.386 . . . . 0.0 111.688 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 772' ' ' LEU . . . . . 0.89 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -84.81 -9.09 58.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.854 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt 57.7 42.75 23.25 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 774' ' ' ILE . . . . . 0.825 ' CG2' HD13 ' A' ' 749' ' ' LEU . 24.7 pt -111.8 -173.92 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.73 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -91.08 151.31 21.01 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.074 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -56.53 -46.59 80.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.935 0.397 . . . . 0.0 110.778 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -59.51 -44.63 93.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.069 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.807 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -67.18 -50.34 61.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.888 0.375 . . . . 0.0 110.869 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.1 -48.59 75.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.269 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 780' ' ' ALA . . . . . 0.875 ' CB ' HD13 ' A' ' 765' ' ' ILE . . . -56.2 -45.98 79.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.901 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 -58.92 -48.5 81.24 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.059 0.457 . . . . 0.0 110.333 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 782' ' ' MET . . . . . 0.457 ' HE3' ' HB2' ' A' ' 753' ' ' ALA . 32.7 mtm -64.84 -34.96 79.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.884 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 783' ' ' ILE . . . . . 1.002 HD11 HG21 ' A' ' 768' ' ' VAL . 7.7 mm -65.38 -38.56 82.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.199 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -63.65 -38.82 92.56 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.86 ' HB1' ' O ' ' A' ' 744' ' ' SER . . . -61.75 -34.28 75.56 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.37 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 786' ' ' MET . . . . . 0.744 ' HB3' HG22 ' A' ' 792' ' ' VAL . 13.9 mtm -66.68 -39.13 88.01 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.087 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -61.18 -54.04 49.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.663 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 49.6 mtm -68.46 -37.95 80.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.158 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -67.11 -21.5 65.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.716 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 790' ' ' GLY . . . . . 0.678 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 90.93 18.29 47.88 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.835 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.657 HG11 HG22 ' A' ' 754' ' ' VAL . 21.7 t -88.57 -30.33 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.76 0.314 . . . . 0.0 111.122 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 792' ' ' VAL . . . . . 0.744 HG22 ' HB3' ' A' ' 786' ' ' MET . 19.4 m -137.38 137.69 45.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.419 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 793' ' ' THR . . . . . . . . . . . . . 1.1 p -85.07 159.98 55.92 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.845 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 794' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -52.12 172.09 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.267 1.978 . . . . 0.0 112.368 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.02 164.99 24.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.98 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -105.52 176.48 5.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.852 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 3.2 t -60.67 -34.73 74.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -79.27 -17.57 54.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 102.74 29.14 5.98 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.514 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 9.8 m -123.68 129.93 51.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 111.053 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 801' ' ' ARG . . . . . 0.492 ' NH1' HG21 ' A' ' 792' ' ' VAL . 7.1 mtt-85 -85.34 170.66 12.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.186 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -128.64 167.19 17.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.104 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 803' ' ' VAL . . . . . 0.882 HG22 HG12 ' A' ' 757' ' ' VAL . 22.0 t -110.47 135.06 50.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.921 0.391 . . . . 0.0 111.558 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 804' ' ' ILE . . . . . 0.678 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -103.58 -27.76 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.251 179.178 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 805' ' ' ALA . . . . . 0.635 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -82.85 123.54 77.89 Favored Pre-proline 0 N--CA 1.453 -0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.887 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.4 163.7 28.65 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.608 2.205 . . . . 0.0 112.167 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 807' ' ' ALA . . . . . 0.746 ' HB1' ' HD2' ' A' ' 808' ' ' PRO . . . -95.67 167.33 12.83 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.162 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 808' ' ' PRO . . . . . 0.746 ' HD2' ' HB1' ' A' ' 807' ' ' ALA . 53.8 Cg_endo -69.6 104.81 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.481 2.12 . . . . 0.0 112.279 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.33 -32.96 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.158 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -174.44 -40.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.925 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.961 179.939 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.38 28.46 16.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.803 0.335 . . . . 0.0 110.88 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -94.25 108.93 20.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.716 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 743' ' ' GLY . . . . . 0.596 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . 90.48 57.94 1.59 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.587 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 744' ' ' SER . . . . . 0.436 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 64.8 m -117.29 -46.68 2.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.153 0.501 . . . . 0.0 110.15 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -159.97 -49.48 0.05 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.132 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -126.0 95.16 4.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.386 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 747' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 13.2 t70 -122.47 143.33 39.39 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.335 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 748' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 46.8 Cg_exo -37.7 -28.04 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.044 2.496 . . . . 0.0 113.563 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 749' ' ' LEU . . . . . 0.882 HD13 ' CG2' ' A' ' 774' ' ' ILE . 28.5 mt -119.97 -17.08 8.53 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.734 ' CE2' HG21 ' A' ' 754' ' ' VAL . 80.1 t80 -52.61 -50.17 63.62 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.503 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -53.07 -36.54 60.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 0.891 ' HB2' HD21 ' A' ' 772' ' ' LEU . 40.5 mt-10 -70.95 -40.76 71.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.966 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 753' ' ' ALA . . . . . 0.519 ' HB2' ' HE1' ' A' ' 782' ' ' MET . . . -63.84 -53.38 51.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.075 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 754' ' ' VAL . . . . . 0.734 HG21 ' CE2' ' A' ' 750' ' ' TYR . 8.0 t -56.15 -39.39 58.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.301 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -70.14 -36.83 75.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.231 0.539 . . . . 0.0 109.711 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 756' ' ' PHE . . . . . 0.786 ' CE1' HG22 ' A' ' 768' ' ' VAL . 1.0 OUTLIER -66.77 -46.19 76.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.676 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 757' ' ' VAL . . . . . 0.676 HG11 ' CG1' ' A' ' 792' ' ' VAL . 61.5 t -69.29 -42.94 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 110.775 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 758' ' ' THR . . . . . 0.552 ' HA ' HG11 ' A' ' 803' ' ' VAL . 8.0 p -56.78 -44.57 81.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.85 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -78.82 -33.5 46.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.241 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 760' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' A' ' 756' ' ' PHE . 18.5 p -74.69 -16.39 60.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.244 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 64.72 15.03 9.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.436 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 762' ' ' ARG . . . . . 0.538 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.1 OUTLIER -153.71 143.01 21.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.445 179.808 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 763' ' ' ALA . . . . . 0.561 ' HB2' ' CG1' ' A' ' 792' ' ' VAL . . . -107.74 89.62 3.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.883 0.373 . . . . 0.0 111.941 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 764' ' ' SER . . . . . 0.733 ' O ' HG23 ' A' ' 768' ' ' VAL . 1.3 m -118.97 118.47 31.58 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 765' ' ' ILE . . . . . 0.537 HD13 ' HB2' ' A' ' 780' ' ' ALA . 14.7 mt -54.1 -48.6 65.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.506 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 766' ' ' SER . . . . . 0.474 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 16.7 p -55.08 -42.15 72.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.303 0.573 . . . . 0.0 110.538 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -70.51 -40.91 73.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.571 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 768' ' ' VAL . . . . . 0.871 HG21 HD11 ' A' ' 783' ' ' ILE . 48.2 t -59.64 -47.86 89.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 769' ' ' GLN . . . . . 0.584 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.4 OUTLIER -65.21 -33.9 77.1 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.804 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 770' ' ' ARG . . . . . 0.48 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 15.9 mtt180 -69.35 -42.42 75.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.184 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.404 ' HD3' ' HE2' ' A' ' 756' ' ' PHE . 2.3 tptt -78.63 -40.03 35.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.829 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 772' ' ' LEU . . . . . 0.891 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -86.69 -9.66 55.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.847 -179.503 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp 60.92 40.6 15.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.019 0.438 . . . . 0.0 109.874 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 774' ' ' ILE . . . . . 0.882 ' CG2' HD13 ' A' ' 749' ' ' LEU . 21.1 pt -111.85 -173.86 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.542 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.91 150.27 20.93 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.028 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -54.72 -45.12 74.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.966 0.412 . . . . 0.0 110.722 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -63.85 -47.82 79.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.873 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.768 ' HE ' HD12 ' A' ' 749' ' ' LEU . 0.7 OUTLIER -60.06 -50.31 74.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.935 0.398 . . . . 0.0 110.716 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -55.99 -48.67 75.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.272 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 780' ' ' ALA . . . . . 0.537 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.2 -41.67 75.95 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.003 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 17.4 mtm-85 -58.87 -47.31 85.38 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 782' ' ' MET . . . . . 0.519 ' HE1' ' HB2' ' A' ' 753' ' ' ALA . 2.3 mtp -63.61 -42.91 98.18 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 783' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 768' ' ' VAL . 9.9 mm -57.5 -37.68 59.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.71 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -62.31 -45.88 91.25 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 743' ' ' GLY . . . -58.12 -33.59 69.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.805 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 786' ' ' MET . . . . . 0.745 ' HB3' HG22 ' A' ' 792' ' ' VAL . 13.2 mtm -66.49 -39.65 88.86 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.476 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.58 -49.68 74.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.12 0.486 . . . . 0.0 110.518 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 32.2 mtm -70.57 -36.92 73.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.371 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -71.25 -21.53 62.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.123 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 790' ' ' GLY . . . . . 0.75 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 92.05 19.75 38.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.693 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.766 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 63.2 t -88.94 -30.47 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 122.517 0.327 . . . . 0.0 111.092 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 792' ' ' VAL . . . . . 0.745 HG22 ' HB3' ' A' ' 786' ' ' MET . 20.4 m -139.33 142.79 32.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.53 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 793' ' ' THR . . . . . 0.552 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.2 p -85.24 164.69 40.01 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 794' ' ' PRO . . . . . 0.552 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 29.5 Cg_endo -61.94 164.65 16.05 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 121.989 1.793 . . . . 0.0 112.003 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.67 162.48 3.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.329 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -105.18 176.5 5.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.743 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 15.3 t -63.18 -32.64 74.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -80.66 -17.64 50.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.231 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 102.48 28.56 6.31 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.364 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 57.5 m -125.75 130.75 52.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.988 0.423 . . . . 0.0 110.919 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 801' ' ' ARG . . . . . 0.508 ' HB3' ' HB3' ' A' ' 763' ' ' ALA . 15.4 mtt-85 -84.25 170.7 13.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.44 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -129.68 167.73 17.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.992 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 803' ' ' VAL . . . . . 0.611 HG22 HG12 ' A' ' 757' ' ' VAL . 11.9 t -108.8 139.19 32.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.004 0.431 . . . . 0.0 112.076 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 804' ' ' ILE . . . . . 0.75 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -110.84 -27.96 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.454 178.866 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 805' ' ' ALA . . . . . 0.766 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -77.97 121.05 83.51 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.078 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -50.29 163.94 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.731 2.287 . . . . 0.0 112.916 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -104.37 143.92 27.65 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.997 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.65 107.12 2.24 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.477 2.118 . . . . 0.0 112.343 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 21.4 t -91.69 -32.68 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.135 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -173.68 -40.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.868 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.822 -179.952 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 48.6 p -171.42 80.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.351 . . . . 0.0 110.912 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -114.48 -34.38 5.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.994 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 743' ' ' GLY . . . . . 0.454 ' CA ' ' HG3' ' A' ' 782' ' ' MET . . . 74.11 44.3 29.98 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.457 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.72 -158.92 0.65 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.579 0.228 . . . . 0.0 110.626 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -51.91 -42.97 63.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.842 0.353 . . . . 0.0 111.329 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.01 95.42 4.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.059 0.456 . . . . 0.0 110.911 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 747' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 12.1 t70 -122.61 142.52 37.68 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.647 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 748' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 43.0 Cg_exo -37.49 -28.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.034 2.49 . . . . 0.0 113.672 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 749' ' ' LEU . . . . . 0.819 HD13 ' CG2' ' A' ' 774' ' ' ILE . 40.6 mt -119.93 -17.27 8.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.727 ' CE2' HG21 ' A' ' 754' ' ' VAL . 64.5 t80 -53.81 -47.42 70.86 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.67 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -53.34 -37.41 62.31 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 1.072 ' HB3' HD21 ' A' ' 772' ' ' LEU . 0.7 OUTLIER -70.9 -39.95 72.48 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.264 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 753' ' ' ALA . . . . . 0.489 ' HB2' ' HE1' ' A' ' 782' ' ' MET . . . -63.89 -54.35 36.11 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.217 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 754' ' ' VAL . . . . . 0.764 HG22 HG11 ' A' ' 791' ' ' VAL . 4.3 t -56.19 -38.3 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.01 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 755' ' ' ARG . . . . . 0.41 ' HA ' ' HG1' ' A' ' 758' ' ' THR . 53.8 ttt85 -69.53 -36.58 76.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.646 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 756' ' ' PHE . . . . . 0.67 ' CE2' HG22 ' A' ' 768' ' ' VAL . 3.3 t80 -67.07 -46.11 75.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.189 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 757' ' ' VAL . . . . . 0.897 HG13 ' O ' ' A' ' 762' ' ' ARG . 39.0 t -70.28 -45.42 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 120.928 0.394 . . . . 0.0 110.715 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 758' ' ' THR . . . . . 0.602 ' HA ' HG11 ' A' ' 803' ' ' VAL . 17.8 p -53.78 -44.18 69.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.815 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.96 -35.55 50.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.347 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 16.7 p -78.51 -14.98 59.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.45 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 63.46 19.86 11.93 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.727 0.299 . . . . 0.0 111.348 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 762' ' ' ARG . . . . . 0.897 ' O ' HG13 ' A' ' 757' ' ' VAL . 10.3 ptt180 -152.72 143.78 23.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.569 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 763' ' ' ALA . . . . . 0.692 ' HB2' HG11 ' A' ' 757' ' ' VAL . . . -115.47 89.93 3.22 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 764' ' ' SER . . . . . 0.622 ' O ' HG23 ' A' ' 768' ' ' VAL . 7.3 m -120.96 118.31 29.53 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 765' ' ' ILE . . . . . 0.697 HD13 ' HB2' ' A' ' 780' ' ' ALA . 21.2 mt -51.12 -46.06 31.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.525 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 766' ' ' SER . . . . . 0.503 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 11.7 p -58.53 -39.19 79.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.347 0.594 . . . . 0.0 110.393 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 767' ' ' ALA . . . . . 0.414 ' HB1' ' HZ ' ' A' ' 756' ' ' PHE . . . -72.39 -35.94 68.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.481 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 768' ' ' VAL . . . . . 0.851 HG21 HD11 ' A' ' 783' ' ' ILE . 40.3 t -66.88 -47.28 83.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.384 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 769' ' ' GLN . . . . . 0.619 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.57 -33.97 77.15 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.845 0.355 . . . . 0.0 110.599 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 19.0 mtt-85 -70.62 -42.16 71.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.985 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.61 -36.95 43.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.297 -0.41 . . . . 0.0 112.095 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 772' ' ' LEU . . . . . 1.072 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -89.8 -10.65 44.69 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp 61.61 40.43 13.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.237 0.541 . . . . 0.0 109.55 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 774' ' ' ILE . . . . . 0.819 ' CG2' HD13 ' A' ' 749' ' ' LEU . 23.6 pt -111.75 -174.53 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.381 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.15 150.08 21.17 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.163 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -54.11 -45.85 71.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 110.776 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -63.03 -47.54 82.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.854 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.781 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -59.94 -49.6 77.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.755 179.821 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.02 -50.0 74.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.57 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 780' ' ' ALA . . . . . 0.697 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.02 -40.76 73.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.584 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.74 -48.02 82.64 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.994 0.426 . . . . 0.0 109.913 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 782' ' ' MET . . . . . 0.489 ' HE1' ' HB2' ' A' ' 753' ' ' ALA . 2.0 mtp -62.78 -43.72 98.07 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 783' ' ' ILE . . . . . 0.851 HD11 HG21 ' A' ' 768' ' ' VAL . 12.4 mm -57.16 -40.59 74.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.456 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.7 -45.43 92.15 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.568 ' HB3' ' CE1' ' A' ' 750' ' ' TYR . . . -59.63 -33.37 71.43 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.79 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 786' ' ' MET . . . . . 0.605 ' CE ' HD13 ' A' ' 783' ' ' ILE . 13.3 mtm -64.96 -37.63 88.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.063 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 787' ' ' GLU . . . . . 0.474 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 1.6 mt-10 -64.54 -52.88 55.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.458 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 51.5 mtm -66.5 -38.4 87.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.764 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -73.0 -21.61 60.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.067 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 790' ' ' GLY . . . . . 0.51 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 90.91 18.95 45.22 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.754 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.764 HG11 HG22 ' A' ' 754' ' ' VAL . 44.0 t -83.26 -30.05 8.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.726 0.298 . . . . 0.0 110.825 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 792' ' ' VAL . . . . . 0.689 HG21 HH21 ' A' ' 801' ' ' ARG . 5.7 m -137.15 143.66 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.901 0.381 . . . . 0.0 111.434 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 793' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.6 p -81.9 160.63 63.12 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.961 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 794' ' ' PRO . . . . . 0.499 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 22.5 Cg_endo -60.55 167.0 8.82 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.122 1.882 . . . . 0.0 111.988 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 1.5 mtt -58.31 158.83 6.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.243 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -99.55 176.51 5.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.881 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 10.0 t -58.44 -29.13 65.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.981 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -89.08 -17.53 29.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.188 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 103.9 35.16 3.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.728 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 18.0 m -127.79 129.73 47.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.779 0.323 . . . . 0.0 111.14 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 801' ' ' ARG . . . . . 0.689 HH21 HG21 ' A' ' 792' ' ' VAL . 6.8 mtp85 -81.7 170.54 15.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.015 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 802' ' ' GLU . . . . . 0.415 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 2.6 mt-10 -134.97 173.53 11.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.8 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 803' ' ' VAL . . . . . 0.879 HG22 HG12 ' A' ' 757' ' ' VAL . 31.2 t -109.94 135.89 47.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 804' ' ' ILE . . . . . 0.514 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -106.07 -27.87 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.693 178.246 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 805' ' ' ALA . . . . . 0.615 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -81.67 123.88 80.22 Favored Pre-proline 0 N--CA 1.453 -0.289 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.71 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -63.16 163.81 21.78 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.66 2.24 . . . . 0.0 112.604 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 807' ' ' ALA . . . . . 0.571 ' HB1' ' HD2' ' A' ' 808' ' ' PRO . . . -93.98 162.92 25.4 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.102 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 808' ' ' PRO . . . . . 0.571 ' HD2' ' HB1' ' A' ' 807' ' ' ALA . 73.1 Cg_endo -77.54 114.36 3.69 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.668 2.245 . . . . 0.0 112.461 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 22.0 t -99.5 -32.55 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -176.14 -39.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.782 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.865 179.957 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -145.22 -50.22 0.25 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.839 0.352 . . . . 0.0 110.923 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -142.36 108.58 5.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.965 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . 85.97 65.23 1.44 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.617 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 744' ' ' SER . . . . . 0.775 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 0.8 OUTLIER -121.98 -60.95 1.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.056 0.455 . . . . 0.0 110.537 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -144.71 -49.75 0.26 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.331 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -124.03 95.34 4.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.585 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 747' ' ' ASP . . . . . 0.509 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.31 141.82 35.54 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.476 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -36.87 -29.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.172 2.581 . . . . 0.0 113.614 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 749' ' ' LEU . . . . . 0.806 HD13 ' CG2' ' A' ' 774' ' ' ILE . 42.9 mt -119.94 -16.98 8.57 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.754 ' CE2' HG21 ' A' ' 754' ' ' VAL . 68.0 t80 -54.62 -46.75 73.91 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.123 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -53.49 -36.1 61.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 0.928 ' HB2' HD21 ' A' ' 772' ' ' LEU . 1.3 mm-40 -71.04 -42.62 69.24 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.297 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -62.43 -53.77 50.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.021 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 754' ' ' VAL . . . . . 0.754 HG21 ' CE2' ' A' ' 750' ' ' TYR . 5.0 t -56.22 -42.26 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.324 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -67.26 -35.24 79.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.272 0.558 . . . . 0.0 109.622 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 756' ' ' PHE . . . . . 0.661 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.5 t80 -67.82 -46.12 72.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.141 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 757' ' ' VAL . . . . . 0.878 HG12 HG22 ' A' ' 803' ' ' VAL . 43.9 t -71.18 -42.24 75.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.796 0.331 . . . . 0.0 110.873 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 758' ' ' THR . . . . . 0.702 ' HA ' HG11 ' A' ' 803' ' ' VAL . 14.3 p -60.58 -40.3 91.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.016 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -78.03 -49.09 14.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.329 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 760' ' ' SER . . . . . 0.467 ' O ' ' HD3' ' A' ' 762' ' ' ARG . 7.8 p -69.55 -28.13 65.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.902 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 761' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 760' ' ' SER . 20.7 mmt180 73.96 32.11 1.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.55 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 762' ' ' ARG . . . . . 0.667 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.3 OUTLIER -150.14 131.18 14.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.699 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 763' ' ' ALA . . . . . 0.673 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -107.4 89.67 3.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.047 0.451 . . . . 0.0 110.638 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 764' ' ' SER . . . . . 0.711 ' O ' HG23 ' A' ' 768' ' ' VAL . 6.2 m -131.74 118.58 20.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.569 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 765' ' ' ILE . . . . . 0.888 HD13 ' HB2' ' A' ' 780' ' ' ALA . 23.3 mt -51.44 -49.79 31.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.802 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 766' ' ' SER . . . . . 0.443 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 11.7 t -54.19 -43.03 70.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.097 0.475 . . . . 0.0 110.649 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -69.82 -39.68 76.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.772 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 768' ' ' VAL . . . . . 0.899 HG21 HD11 ' A' ' 783' ' ' ILE . 45.4 t -62.54 -45.83 97.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.29 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 769' ' ' GLN . . . . . 0.59 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 2.1 pt20 -66.36 -33.47 75.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.542 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 770' ' ' ARG . . . . . 0.473 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 17.8 mtt180 -71.32 -42.3 68.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.084 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -37.11 42.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.954 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 772' ' ' LEU . . . . . 0.928 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -90.52 -10.29 44.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.664 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt 60.77 41.53 14.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.185 0.517 . . . . 0.0 109.688 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 774' ' ' ILE . . . . . 0.806 ' CG2' HD13 ' A' ' 749' ' ' LEU . 26.0 pt -111.9 -174.0 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.595 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.58 154.19 24.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.081 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -58.75 -46.11 88.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 0.0 110.71 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -63.53 -43.59 96.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.877 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.772 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -64.44 -50.25 68.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.716 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.0 -50.12 71.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.301 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 780' ' ' ALA . . . . . 0.888 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -55.96 -39.62 72.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.786 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.0 -48.49 81.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.977 0.418 . . . . 0.0 110.019 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 782' ' ' MET . . . . . 0.445 ' CE ' ' CB ' ' A' ' 749' ' ' LEU . 0.0 OUTLIER -63.9 -44.58 92.54 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.771 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 783' ' ' ILE . . . . . 0.899 HD11 HG21 ' A' ' 768' ' ' VAL . 7.4 mm -56.33 -41.46 71.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.708 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.96 -45.04 91.49 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.775 ' HB1' ' O ' ' A' ' 744' ' ' SER . . . -59.61 -33.57 71.66 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.519 -1.218 . . . . 0.0 109.816 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 786' ' ' MET . . . . . 0.57 ' HB3' HG22 ' A' ' 792' ' ' VAL . 13.8 mtm -65.4 -37.64 87.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.047 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 787' ' ' GLU . . . . . 0.455 ' HG3' ' CZ ' ' A' ' 801' ' ' ARG . 2.6 mt-10 -64.19 -54.04 39.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.704 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 40.0 mtp -67.28 -38.19 84.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.551 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 789' ' ' ALA . . . . . 0.469 ' HB3' HG23 ' A' ' 791' ' ' VAL . . . -70.41 -21.71 62.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.951 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 790' ' ' GLY . . . . . 0.451 ' CA ' HD12 ' A' ' 804' ' ' ILE . . . 89.54 19.79 47.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.978 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.671 HG11 HG22 ' A' ' 754' ' ' VAL . 14.1 t -83.61 -32.58 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 120.892 0.377 . . . . 0.0 110.866 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 792' ' ' VAL . . . . . 0.679 HG21 HH21 ' A' ' 801' ' ' ARG . 11.3 m -134.49 139.13 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.184 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 793' ' ' THR . . . . . 0.502 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 8.0 p -75.95 158.56 82.26 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.918 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 794' ' ' PRO . . . . . 0.502 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 19.7 Cg_endo -59.52 166.66 7.55 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.14 1.893 . . . . 0.0 112.01 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -56.98 161.02 3.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.149 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -104.73 176.55 5.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.788 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 5.2 t -54.68 -32.78 59.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.032 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -87.21 -17.64 32.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.15 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.46 37.29 3.56 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.5 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 16.2 m -127.82 129.14 46.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.003 0.43 . . . . 0.0 111.042 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 801' ' ' ARG . . . . . 0.679 HH21 HG21 ' A' ' 792' ' ' VAL . 6.8 mtp85 -83.64 170.62 14.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.327 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 802' ' ' GLU . . . . . 0.473 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 3.0 mt-10 -132.43 -170.77 2.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.606 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 803' ' ' VAL . . . . . 0.878 HG22 HG12 ' A' ' 757' ' ' VAL . 20.6 t -125.03 135.16 64.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.067 0.46 . . . . 0.0 112.018 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 804' ' ' ILE . . . . . 0.483 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -108.43 -33.66 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.352 179.241 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 805' ' ' ALA . . . . . 0.868 ' HB1' ' HD2' ' A' ' 806' ' ' PRO . . . -59.16 171.04 0.77 Allowed Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.242 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 806' ' ' PRO . . . . . 0.868 ' HD2' ' HB1' ' A' ' 805' ' ' ALA . 56.6 Cg_endo -71.2 163.62 38.53 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.771 2.314 . . . . 0.0 112.233 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -119.53 111.66 36.18 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.101 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.89 117.61 4.06 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.401 2.067 . . . . 0.0 112.306 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 809' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 810' ' ' ARG . 0.5 OUTLIER -124.26 175.83 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.877 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 810' ' ' ARG . . . . . 0.552 ' H ' HG12 ' A' ' 809' ' ' VAL . 63.1 mtt180 -87.02 -33.18 19.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.83 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 3.3 p30 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.153 -0.927 . . . . 0.0 110.876 -179.954 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.471 -0.251 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 99.9 p -163.81 38.07 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.748 0.308 . . . . 0.0 110.884 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -153.01 -177.85 6.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.945 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 743' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . 122.51 76.66 0.38 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.484 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 744' ' ' SER . . . . . 0.807 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 5.9 m -116.16 -62.27 1.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.14 0.495 . . . . 0.0 110.73 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -140.01 -49.85 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.199 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -123.67 95.3 4.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.364 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 747' ' ' ASP . . . . . 0.552 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 14.1 t70 -122.28 142.35 36.72 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.426 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -33.82 -31.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.387 2.724 . . . . 0.0 114.016 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 749' ' ' LEU . . . . . 0.799 HD13 ' CG2' ' A' ' 774' ' ' ILE . 33.8 mt -120.06 -17.15 8.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.65 ' CE2' HG21 ' A' ' 754' ' ' VAL . 67.9 t80 -53.26 -47.43 69.08 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.968 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -53.23 -37.18 61.81 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 1.054 ' HB3' HD21 ' A' ' 772' ' ' LEU . 51.7 tt0 -71.01 -41.56 70.74 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.305 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 753' ' ' ALA . . . . . 0.497 ' HB2' ' HE2' ' A' ' 782' ' ' MET . . . -62.53 -51.52 67.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.034 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 754' ' ' VAL . . . . . 0.85 HG22 HG11 ' A' ' 791' ' ' VAL . 2.2 t -56.15 -41.2 68.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.735 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -67.91 -35.4 78.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.746 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 756' ' ' PHE . . . . . 0.744 ' CE2' HG22 ' A' ' 768' ' ' VAL . 3.5 t80 -67.01 -46.09 75.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.991 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 757' ' ' VAL . . . . . 1.055 HG12 HG22 ' A' ' 803' ' ' VAL . 43.6 t -70.16 -47.34 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 120.811 0.338 . . . . 0.0 110.794 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 758' ' ' THR . . . . . 0.796 ' HA ' HG11 ' A' ' 803' ' ' VAL . 6.6 p -54.78 -43.74 73.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.002 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -78.88 -37.95 38.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.182 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 54.6 p -75.79 -16.25 60.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.46 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 60.11 31.38 20.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.931 0.396 . . . . 0.0 110.552 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 762' ' ' ARG . . . . . 0.632 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.3 OUTLIER -160.55 137.3 8.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.338 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 763' ' ' ALA . . . . . 0.493 ' HB3' ' CB ' ' A' ' 801' ' ' ARG . . . -110.58 89.84 3.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.91 0.386 . . . . 0.0 111.409 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 764' ' ' SER . . . . . 0.758 ' O ' HG23 ' A' ' 768' ' ' VAL . 15.2 m -127.14 118.61 24.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.617 178.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 765' ' ' ILE . . . . . 0.882 HD13 ' HB2' ' A' ' 780' ' ' ALA . 25.0 mt -51.83 -50.19 33.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.755 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 766' ' ' SER . . . . . 0.433 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 22.0 t -53.45 -43.82 68.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.238 0.542 . . . . 0.0 110.537 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -69.12 -41.59 77.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.661 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 768' ' ' VAL . . . . . 0.925 HG21 HD11 ' A' ' 783' ' ' ILE . 40.9 t -59.4 -47.53 90.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.212 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 769' ' ' GLN . . . . . 0.578 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 2.8 pt20 -65.46 -33.39 75.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.744 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 770' ' ' ARG . . . . . 0.47 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 5.8 mtt180 -68.75 -42.49 77.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.133 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.63 -42.13 29.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.877 0.37 . . . . 0.0 111.684 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 772' ' ' LEU . . . . . 1.054 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -84.81 -8.58 58.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.791 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 22.6 mtpt 57.41 42.35 24.86 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 774' ' ' ILE . . . . . 0.799 ' CG2' HD13 ' A' ' 749' ' ' LEU . 30.1 pt -111.87 -174.14 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.626 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.25 155.45 25.19 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.238 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -59.2 -46.56 88.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.916 0.389 . . . . 0.0 110.653 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -62.22 -47.47 84.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.771 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.623 ' NE ' HD12 ' A' ' 749' ' ' LEU . 2.8 ttt180 -61.17 -50.37 73.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.775 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.41 -50.55 71.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.427 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 780' ' ' ALA . . . . . 0.882 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.03 -41.03 74.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.81 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -58.95 -48.42 81.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.978 0.418 . . . . 0.0 110.009 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 782' ' ' MET . . . . . 0.497 ' HE2' ' HB2' ' A' ' 753' ' ' ALA . 0.5 OUTLIER -63.67 -43.12 97.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.386 178.781 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 783' ' ' ILE . . . . . 0.925 HD11 HG21 ' A' ' 768' ' ' VAL . 7.6 mm -56.96 -41.72 77.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.318 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.21 -44.9 92.27 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.807 ' HB1' ' O ' ' A' ' 744' ' ' SER . . . -58.39 -33.63 69.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.048 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 786' ' ' MET . . . . . 0.594 ' HB3' HG22 ' A' ' 792' ' ' VAL . 16.3 mtm -66.85 -38.59 86.65 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.991 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 787' ' ' GLU . . . . . 0.444 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 2.0 mt-10 -61.55 -54.05 48.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.664 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 24.1 mtm -68.85 -38.39 79.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.418 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -68.52 -21.67 64.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.775 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 790' ' ' GLY . . . . . 0.501 ' O ' HD12 ' A' ' 804' ' ' ILE . . . 90.74 15.07 57.25 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.897 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.85 HG11 HG22 ' A' ' 754' ' ' VAL . 40.6 t -80.67 -31.91 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.924 0.392 . . . . 0.0 110.896 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 792' ' ' VAL . . . . . 0.667 HG21 HH21 ' A' ' 801' ' ' ARG . 11.2 m -136.58 135.45 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.143 0.497 . . . . 0.0 111.161 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 793' ' ' THR . . . . . 0.767 HG23 ' O ' ' A' ' 802' ' ' GLU . 10.3 p -72.92 159.81 84.42 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.686 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 794' ' ' PRO . . . . . 0.527 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 25.4 Cg_endo -60.58 165.13 11.97 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 121.996 1.797 . . . . 0.0 111.771 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -58.78 162.74 3.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.185 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -105.58 176.57 5.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.954 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 55.8 p -56.4 -31.11 63.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -86.32 -17.57 34.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.115 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 100.71 34.44 4.67 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.542 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 28.8 m -127.75 130.31 48.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 111.113 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 801' ' ' ARG . . . . . 0.667 HH21 HG21 ' A' ' 792' ' ' VAL . 4.5 mtp85 -81.57 170.13 16.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.397 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 802' ' ' GLU . . . . . 0.767 ' O ' HG23 ' A' ' 793' ' ' THR . 3.5 mt-10 -138.52 124.18 19.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.909 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 803' ' ' VAL . . . . . 1.055 HG22 HG12 ' A' ' 757' ' ' VAL . 18.8 t -64.92 134.22 29.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.96 0.409 . . . . 0.0 112.065 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 804' ' ' ILE . . . . . 0.629 HG23 HG22 ' A' ' 793' ' ' THR . 0.0 OUTLIER -103.77 -33.29 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.891 178.546 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 805' ' ' ALA . . . . . 0.559 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -74.63 126.03 89.03 Favored Pre-proline 0 N--CA 1.451 -0.4 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.836 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.07 163.81 24.46 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.71 2.273 . . . . 0.0 112.168 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 807' ' ' ALA . . . . . 0.627 ' HB1' ' HD2' ' A' ' 808' ' ' PRO . . . -101.41 163.96 16.89 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.272 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 808' ' ' PRO . . . . . 0.627 ' HD2' ' HB1' ' A' ' 807' ' ' ALA . 68.6 Cg_endo -74.22 106.2 2.18 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.644 2.229 . . . . 0.0 112.354 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 21.4 t -123.79 -43.13 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.23 94.84 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 12.3 t70 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.877 179.933 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 24.3 t -97.19 33.62 1.92 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 0.0 111.031 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -98.32 102.89 14.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.685 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 743' ' ' GLY . . . . . 0.709 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . 103.06 58.85 0.74 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.09 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 3.5 m -115.57 -39.3 3.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.065 0.459 . . . . 0.0 110.462 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 745' ' ' GLU . . . . . 0.429 ' O ' ' CD2' ' A' ' 750' ' ' TYR . 0.9 OUTLIER -168.57 -45.97 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.941 179.519 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -129.13 95.06 3.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.439 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 747' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.47 143.35 39.43 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.376 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 748' ' ' PRO . . . . . 0.423 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 28.7 Cg_exo -35.34 -30.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.258 2.639 . . . . 0.0 113.795 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 749' ' ' LEU . . . . . 0.729 HD12 ' NE ' ' A' ' 778' ' ' ARG . 21.8 mt -120.09 -17.08 8.46 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -178.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.669 ' CE2' HG21 ' A' ' 754' ' ' VAL . 83.7 t80 -51.73 -50.65 60.14 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.837 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -53.17 -35.89 60.29 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.71 -0.396 . . . . 0.0 109.984 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 0.988 ' HB3' HD21 ' A' ' 772' ' ' LEU . 6.0 tp10 -70.93 -38.5 72.9 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.803 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 753' ' ' ALA . . . . . 0.409 ' HB2' ' HE2' ' A' ' 782' ' ' MET . . . -66.28 -52.93 42.57 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.804 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 754' ' ' VAL . . . . . 0.688 HG22 HG11 ' A' ' 791' ' ' VAL . 7.0 t -56.36 -38.42 55.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.751 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -69.87 -39.16 76.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.601 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 756' ' ' PHE . . . . . 0.751 ' CE2' HG22 ' A' ' 768' ' ' VAL . 1.4 t80 -65.77 -45.09 83.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.611 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 757' ' ' VAL . . . . . 0.684 HG11 HG12 ' A' ' 792' ' ' VAL . 84.5 t -69.84 -41.33 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.781 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 758' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 754' ' ' VAL . 9.9 p -59.12 -46.08 89.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.335 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -77.97 -30.36 50.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.795 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 39.5 p -78.02 -16.0 58.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.5 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 63.39 20.09 12.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.718 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -157.61 137.58 12.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.745 0.307 . . . . 0.0 110.931 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 763' ' ' ALA . . . . . 0.528 ' HB3' ' CB ' ' A' ' 801' ' ' ARG . . . -100.7 89.87 4.04 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.949 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 764' ' ' SER . . . . . 0.764 ' O ' HG23 ' A' ' 768' ' ' VAL . 5.9 m -120.65 118.44 30.12 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 765' ' ' ILE . . . . . 0.474 HG21 ' HB2' ' A' ' 780' ' ' ALA . 10.3 mt -57.1 -51.32 70.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.368 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 766' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 11.3 t -53.93 -38.41 64.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.291 0.567 . . . . 0.0 110.103 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 767' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' A' ' 764' ' ' SER . . . -71.36 -40.22 70.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.234 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 768' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 764' ' ' SER . 45.5 t -61.43 -49.94 82.44 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.179 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 769' ' ' GLN . . . . . 0.608 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.4 OUTLIER -63.64 -33.57 75.92 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.974 -179.499 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -69.45 -42.52 74.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.37 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.489 ' HD3' ' HE1' ' A' ' 756' ' ' PHE . 3.1 tptt -78.59 -38.24 40.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.766 0.317 . . . . 0.0 111.677 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 772' ' ' LEU . . . . . 0.988 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -86.87 -10.91 52.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt 61.21 39.58 15.64 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 774' ' ' ILE . . . . . 0.69 ' CG2' HD13 ' A' ' 749' ' ' LEU . 25.6 pt -111.86 -173.98 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.424 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -90.34 153.55 22.85 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.236 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -56.6 -45.79 81.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.816 0.341 . . . . 0.0 110.87 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -63.25 -47.79 80.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.82 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.729 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.5 OUTLIER -59.1 -49.98 75.8 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.641 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.23 -50.69 72.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.637 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 780' ' ' ALA . . . . . 0.474 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -55.99 -40.42 73.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.947 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -60.66 -43.77 97.23 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 782' ' ' MET . . . . . 0.448 ' HE3' ' HB2' ' A' ' 749' ' ' LEU . 0.1 OUTLIER -64.94 -43.62 92.14 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.293 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 783' ' ' ILE . . . . . 0.73 HD11 HG21 ' A' ' 768' ' ' VAL . 15.0 mm -57.62 -39.73 71.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.696 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -61.85 -46.78 87.95 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 743' ' ' GLY . . . -58.01 -33.64 69.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.808 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 786' ' ' MET . . . . . 0.646 ' HG2' HG22 ' A' ' 754' ' ' VAL . 15.4 mtm -67.79 -38.29 83.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.565 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 787' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 792' ' ' VAL . 1.6 mt-10 -62.41 -45.93 90.89 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.124 0.488 . . . . 0.0 110.072 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 37.0 mtm -73.08 -37.98 66.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.245 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -70.81 -21.53 62.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.982 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 790' ' ' GLY . . . . . 0.746 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 94.62 15.94 44.55 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.67 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.823 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 77.5 t -84.96 -34.2 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 122.637 0.375 . . . . 0.0 111.476 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 792' ' ' VAL . . . . . 0.684 HG12 HG11 ' A' ' 757' ' ' VAL . 15.4 m -136.61 148.41 27.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.887 0.375 . . . . 0.0 111.655 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 793' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 802' ' ' GLU . 10.3 p -96.75 171.8 5.73 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 794' ' ' PRO . . . . . 0.434 ' CD ' ' HB ' ' A' ' 793' ' ' THR . 31.1 Cg_exo -59.47 178.86 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 121.982 1.788 . . . . 0.0 111.812 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 795' ' ' MET . . . . . 0.518 ' HA ' ' HG3' ' A' ' 801' ' ' ARG . 0.0 OUTLIER -77.04 170.12 17.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.499 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -105.61 176.59 5.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.754 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 4.6 t -60.78 -26.99 67.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.052 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -92.19 -17.62 24.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.398 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 108.73 29.84 3.97 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.649 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 18.0 m -124.42 131.13 53.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.923 0.392 . . . . 0.0 110.647 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 801' ' ' ARG . . . . . 0.528 ' CB ' ' HB3' ' A' ' 763' ' ' ALA . 8.8 mtt-85 -85.34 170.65 12.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.078 0.466 . . . . 0.0 111.524 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 802' ' ' GLU . . . . . 0.74 ' O ' HG23 ' A' ' 793' ' ' THR . 6.9 mt-10 -127.13 126.76 43.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.576 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 803' ' ' VAL . . . . . 0.57 HG22 HG12 ' A' ' 757' ' ' VAL . 19.4 t -69.25 137.94 23.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.836 0.35 . . . . 0.0 111.8 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 804' ' ' ILE . . . . . 0.746 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -108.19 -28.08 2.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.292 178.415 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 805' ' ' ALA . . . . . 0.823 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -78.24 119.56 77.81 Favored Pre-proline 0 N--CA 1.455 -0.209 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.641 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.24 163.82 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.413 2.075 . . . . 0.0 112.733 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -109.48 137.56 20.34 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.961 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.82 117.65 5.12 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.558 2.172 . . . . 0.0 112.559 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.37 -38.49 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.306 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 63.06 97.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.819 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.92 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.19 0 N-CA-C 112.469 -0.253 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 1.6 m 60.1 82.07 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.849 0.357 . . . . 0.0 110.905 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -95.57 99.39 11.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.949 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 743' ' ' GLY . . . . . 0.426 ' CA ' ' HG2' ' A' ' 782' ' ' MET . . . 116.37 46.35 0.54 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.528 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.0 -157.83 0.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.584 0.23 . . . . 0.0 110.43 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -51.29 -38.44 52.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.666 0.27 . . . . 0.0 111.445 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -129.06 95.51 4.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.062 0.458 . . . . 0.0 111.415 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 747' ' ' ASP . . . . . 0.574 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.4 t70 -122.49 141.52 35.1 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.372 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -38.32 -28.02 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.956 2.437 . . . . 0.0 113.64 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 749' ' ' LEU . . . . . 0.854 HD13 ' CG2' ' A' ' 774' ' ' ILE . 40.4 mt -119.94 -16.85 8.59 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.691 ' CE2' ' HB3' ' A' ' 785' ' ' ALA . 62.2 t80 -55.12 -46.5 75.59 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.469 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -53.51 -36.37 61.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 0.909 ' HB2' HD21 ' A' ' 772' ' ' LEU . 28.7 mt-10 -70.95 -43.09 68.85 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.217 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 753' ' ' ALA . . . . . 0.517 ' HB2' ' HE3' ' A' ' 782' ' ' MET . . . -61.93 -51.67 67.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.238 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 754' ' ' VAL . . . . . 0.747 HG22 HG11 ' A' ' 791' ' ' VAL . 2.3 t -56.21 -42.69 74.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.39 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -69.16 -38.13 78.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.294 0.569 . . . . 0.0 110.231 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 756' ' ' PHE . . . . . 0.644 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.0 t80 -65.15 -46.15 82.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.114 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 757' ' ' VAL . . . . . 0.83 HG12 HG22 ' A' ' 803' ' ' VAL . 59.7 t -69.49 -45.13 79.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.902 0.382 . . . . 0.0 110.775 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 758' ' ' THR . . . . . 0.648 ' HA ' HG11 ' A' ' 803' ' ' VAL . 6.8 p -55.22 -42.65 73.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.96 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -78.8 -35.63 43.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.414 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 6.8 p -76.84 -19.61 57.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.575 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 67.2 24.93 9.08 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.662 0.268 . . . . 0.0 111.477 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 762' ' ' ARG . . . . . 0.554 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.2 OUTLIER -159.26 132.39 7.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.883 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 763' ' ' ALA . . . . . 0.548 ' HB2' ' CG1' ' A' ' 792' ' ' VAL . . . -100.05 89.71 4.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.933 0.397 . . . . 0.0 111.281 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 764' ' ' SER . . . . . 0.726 ' O ' HG23 ' A' ' 768' ' ' VAL . 7.6 m -121.78 118.59 29.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.593 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 765' ' ' ILE . . . . . 0.811 HD13 ' HB2' ' A' ' 780' ' ' ALA . 26.3 mt -54.54 -47.34 71.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.487 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 766' ' ' SER . . . . . 0.423 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 60.5 p -57.69 -40.5 79.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.172 0.51 . . . . 0.0 110.493 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 767' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 764' ' ' SER . . . -71.58 -36.23 70.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.612 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 768' ' ' VAL . . . . . 0.866 HG21 HD11 ' A' ' 783' ' ' ILE . 58.8 t -66.4 -46.44 86.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.223 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 769' ' ' GLN . . . . . 0.602 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.6 OUTLIER -66.05 -33.37 75.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.486 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 770' ' ' ARG . . . . . 0.461 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 20.8 mtt-85 -69.98 -42.41 73.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.087 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.442 ' HB2' ' CE1' ' A' ' 756' ' ' PHE . 1.8 tmtt? -78.62 -39.62 36.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.042 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 772' ' ' LEU . . . . . 0.909 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -88.33 -9.23 53.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.664 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt 60.03 42.31 16.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.061 0.458 . . . . 0.0 109.775 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 774' ' ' ILE . . . . . 0.854 ' CG2' HD13 ' A' ' 749' ' ' LEU . 26.8 pt -111.94 -173.94 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.609 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.42 147.18 19.36 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.027 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -54.11 -42.54 69.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.834 0.35 . . . . 0.0 110.703 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 -64.12 -47.53 79.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.923 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.811 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.2 OUTLIER -62.52 -50.3 71.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.894 0.378 . . . . 0.0 110.835 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 779' ' ' ALA . . . . . 0.413 ' HB2' ' CD1' ' A' ' 774' ' ' ILE . . . -54.48 -49.13 70.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.411 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 780' ' ' ALA . . . . . 0.811 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.07 -43.63 78.14 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.911 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -58.98 -48.41 81.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.034 0.445 . . . . 0.0 109.973 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 782' ' ' MET . . . . . 0.517 ' HE3' ' HB2' ' A' ' 753' ' ' ALA . 34.4 mtm -65.3 -34.3 78.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.711 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 783' ' ' ILE . . . . . 0.866 HD11 HG21 ' A' ' 768' ' ' VAL . 7.1 mm -65.45 -35.71 75.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.11 -44.69 94.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.691 ' HB3' ' CE2' ' A' ' 750' ' ' TYR . . . -59.12 -33.76 71.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.766 178.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 786' ' ' MET . . . . . 0.747 ' HB3' HG22 ' A' ' 792' ' ' VAL . 12.7 mtm -65.62 -39.14 91.17 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.912 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -62.43 -51.15 68.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.45 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 25.4 mtm -67.9 -38.49 83.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.574 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 789' ' ' ALA . . . . . 0.482 ' HB3' HG23 ' A' ' 791' ' ' VAL . . . -71.4 -21.62 61.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.882 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 790' ' ' GLY . . . . . 0.672 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 93.12 16.76 46.04 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.914 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.747 HG11 HG22 ' A' ' 754' ' ' VAL . 10.1 t -83.57 -33.28 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.887 0.375 . . . . 0.0 110.726 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 792' ' ' VAL . . . . . 0.747 HG22 ' HB3' ' A' ' 786' ' ' MET . 19.8 m -135.94 139.54 45.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.404 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 793' ' ' THR . . . . . 0.547 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 2.8 p -83.77 161.87 54.54 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.709 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 794' ' ' PRO . . . . . 0.547 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 18.1 Cg_endo -58.62 167.23 5.35 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.153 1.902 . . . . 0.0 112.083 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.88 160.06 15.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.201 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -104.31 176.59 5.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.803 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 39.1 p -61.76 -34.74 76.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.926 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.14 -17.61 58.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.195 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 100.58 28.38 7.11 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.515 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 58.0 m -126.64 130.39 50.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.942 0.401 . . . . 0.0 110.964 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 801' ' ' ARG . . . . . 0.503 ' NH1' HG21 ' A' ' 792' ' ' VAL . 9.4 mtt-85 -82.72 170.72 14.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.222 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 802' ' ' GLU . . . . . 0.405 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 5.8 mt-10 -130.2 166.28 20.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.814 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 803' ' ' VAL . . . . . 0.83 HG22 HG12 ' A' ' 757' ' ' VAL . 39.0 t -109.63 135.19 49.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.064 0.459 . . . . 0.0 111.597 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 804' ' ' ILE . . . . . 0.672 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -103.35 -28.56 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.266 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 805' ' ' ALA . . . . . 0.635 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -82.22 124.51 78.4 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.934 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.9 163.71 27.26 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.632 2.221 . . . . 0.0 112.082 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -85.83 153.86 58.02 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.241 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.11 120.9 6.22 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.649 2.233 . . . . 0.0 112.216 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 809' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 810' ' ' ARG . 0.7 OUTLIER -82.28 176.12 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.785 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 810' ' ' ARG . . . . . 0.568 ' H ' HG12 ' A' ' 809' ' ' VAL . 14.0 mtt180 -150.34 -46.05 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.936 0.398 . . . . 0.0 111.057 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.847 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 12.3 m -162.51 -46.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.742 0.306 . . . . 0.0 110.844 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -111.59 109.62 19.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.774 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 743' ' ' GLY . . . . . 0.569 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . 104.28 59.09 0.69 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.455 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 744' ' ' SER . . . . . 0.6 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 0.9 OUTLIER -117.68 -53.57 2.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.159 0.504 . . . . 0.0 110.396 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -153.13 -50.13 0.1 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.968 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -124.01 95.11 4.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.416 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 747' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.7 t70 -122.37 142.09 36.25 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.439 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -37.73 -28.35 0.1 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.989 2.459 . . . . 0.0 113.51 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 749' ' ' LEU . . . . . 0.842 HD13 ' CG2' ' A' ' 774' ' ' ILE . 31.8 mt -120.05 -16.87 8.52 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.708 ' CE2' HG21 ' A' ' 754' ' ' VAL . 71.3 t80 -53.99 -47.76 71.1 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.376 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -53.4 -36.3 61.31 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 0.937 ' HB2' HD21 ' A' ' 772' ' ' LEU . 5.5 mm-40 -71.0 -42.27 69.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.117 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 753' ' ' ALA . . . . . 0.43 ' HB2' ' CE ' ' A' ' 782' ' ' MET . . . -61.85 -53.82 50.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.068 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 754' ' ' VAL . . . . . 0.71 HG22 HG11 ' A' ' 791' ' ' VAL . 4.0 t -56.19 -42.97 74.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.407 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -66.43 -36.94 84.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.37 0.605 . . . . 0.0 109.797 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 756' ' ' PHE . . . . . 0.68 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.0 t80 -66.82 -46.18 75.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.169 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 757' ' ' VAL . . . . . 0.791 HG12 HG22 ' A' ' 803' ' ' VAL . 61.8 t -69.56 -45.41 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 120.8 0.333 . . . . 0.0 110.664 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 758' ' ' THR . . . . . 0.661 ' HA ' HG11 ' A' ' 803' ' ' VAL . 4.8 p -55.37 -43.45 75.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.783 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -78.71 -32.15 46.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.214 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 27.3 p -81.63 -14.83 56.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.531 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 61.92 18.92 10.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.614 0.245 . . . . 0.0 111.223 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 762' ' ' ARG . . . . . 0.555 ' O ' HG13 ' A' ' 757' ' ' VAL . 10.2 ptt180 -151.88 136.35 16.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.763 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 763' ' ' ALA . . . . . 0.547 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -106.06 89.88 3.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.602 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 764' ' ' SER . . . . . 0.714 ' O ' HG23 ' A' ' 768' ' ' VAL . 3.9 m -122.32 118.59 28.86 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 765' ' ' ILE . . . . . 0.698 HD13 ' HB2' ' A' ' 780' ' ' ALA . 19.5 mt -53.6 -48.28 59.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.499 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 766' ' ' SER . . . . . 0.423 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 11.4 t -55.74 -41.23 73.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.114 0.483 . . . . 0.0 110.284 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -70.58 -39.48 73.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.688 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 768' ' ' VAL . . . . . 0.84 HG21 HD11 ' A' ' 783' ' ' ILE . 41.9 t -62.94 -46.72 95.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.291 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 769' ' ' GLN . . . . . 0.587 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.7 OUTLIER -65.93 -33.41 75.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.452 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 770' ' ' ARG . . . . . 0.474 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 24.8 mtt180 -71.54 -41.84 68.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.059 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.7 -37.26 42.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.967 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 772' ' ' LEU . . . . . 0.937 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -91.17 -9.64 44.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.634 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt 60.8 41.55 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.038 0.447 . . . . 0.0 109.8 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 774' ' ' ILE . . . . . 0.842 ' CG2' HD13 ' A' ' 749' ' ' LEU . 22.0 pt -111.84 -173.92 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.476 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.51 151.13 22.3 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.201 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -55.38 -46.05 76.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.965 0.412 . . . . 0.0 110.707 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -63.37 -47.79 80.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.823 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.824 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.6 OUTLIER -59.61 -50.13 75.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.845 0.355 . . . . 0.0 110.793 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.33 -49.9 74.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.271 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 780' ' ' ALA . . . . . 0.698 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.11 -40.35 73.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -60.69 -48.41 81.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.92 0.39 . . . . 0.0 109.999 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 782' ' ' MET . . . . . 0.472 ' HE3' ' HA ' ' A' ' 750' ' ' TYR . 3.1 mtp -63.79 -38.41 91.01 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 783' ' ' ILE . . . . . 0.84 HD11 HG21 ' A' ' 768' ' ' VAL . 7.3 mm -61.32 -40.85 87.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.132 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.23 -43.52 87.8 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 177.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 744' ' ' SER . . . -60.32 -33.48 72.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.526 -1.216 . . . . 0.0 109.828 178.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 786' ' ' MET . . . . . 0.571 ' HB3' HG22 ' A' ' 792' ' ' VAL . 12.9 mtm -65.67 -37.56 86.84 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.974 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 787' ' ' GLU . . . . . 0.456 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 2.4 mt-10 -63.38 -54.13 41.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.111 0.481 . . . . 0.0 110.548 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 33.5 mtm -67.85 -37.12 81.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.49 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -70.94 -21.59 62.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.985 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 790' ' ' GLY . . . . . 0.537 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 89.62 18.37 52.1 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.875 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.71 HG11 HG22 ' A' ' 754' ' ' VAL . 52.4 t -83.23 -32.72 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.854 0.359 . . . . 0.0 110.809 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 792' ' ' VAL . . . . . 0.681 HG21 HH21 ' A' ' 801' ' ' ARG . 11.4 m -135.61 140.64 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.188 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 793' ' ' THR . . . . . 0.452 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.3 p -78.34 159.06 75.81 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 794' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 18.6 Cg_endo -58.8 166.11 7.18 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.115 1.876 . . . . 0.0 111.743 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -66.08 155.38 36.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.972 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -105.43 176.56 5.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.918 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 5.5 t -55.37 -29.98 59.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.06 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -78.65 -17.52 55.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.151 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 91.9 29.62 11.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.48 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 24.6 m -127.82 130.19 48.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.905 0.383 . . . . 0.0 111.031 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 801' ' ' ARG . . . . . 0.681 HH21 HG21 ' A' ' 792' ' ' VAL . 6.8 mtp85 -81.63 170.59 15.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.307 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -129.9 -176.93 4.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.667 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 803' ' ' VAL . . . . . 0.791 HG22 HG12 ' A' ' 757' ' ' VAL . 16.9 t -119.81 134.64 62.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 804' ' ' ILE . . . . . 0.537 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -106.99 -28.09 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.961 178.56 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 805' ' ' ALA . . . . . 0.633 ' O ' HG22 ' A' ' 758' ' ' THR . . . -82.74 121.49 77.8 Favored Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.586 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.49 163.8 22.79 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.475 2.116 . . . . 0.0 112.304 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 807' ' ' ALA . . . . . 0.806 ' HB1' ' HD2' ' A' ' 808' ' ' PRO . . . -111.2 170.87 4.82 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.225 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 808' ' ' PRO . . . . . 0.806 ' HD2' ' HB1' ' A' ' 807' ' ' ALA . 71.7 Cg_endo -77.15 119.77 5.14 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.634 2.223 . . . . 0.0 112.426 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.64 -42.77 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.182 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.93 96.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.853 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.891 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.557 -0.217 . . . . 0.0 112.557 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 14.9 m 61.09 92.98 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.759 0.314 . . . . 0.0 110.906 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -149.35 100.84 3.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.836 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 743' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . 92.23 62.79 1.15 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.496 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 744' ' ' SER . . . . . 0.458 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 1.3 m -119.3 -47.24 2.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.121 0.486 . . . . 0.0 110.396 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -159.33 -48.63 0.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.182 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -126.9 95.1 4.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.337 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 747' ' ' ASP . . . . . 0.517 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.6 t70 -122.51 143.09 38.85 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.425 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 748' ' ' PRO . . . . . 0.422 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 35.7 Cg_exo -35.97 -29.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.157 2.571 . . . . 0.0 113.763 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 749' ' ' LEU . . . . . 0.821 HD12 ' NE ' ' A' ' 778' ' ' ARG . 34.6 mt -120.03 -17.27 8.45 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.739 ' CE2' HG21 ' A' ' 754' ' ' VAL . 74.5 t80 -53.3 -48.54 68.29 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.797 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.27 -36.34 61.03 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 1.02 ' HB3' HD21 ' A' ' 772' ' ' LEU . 12.6 tt0 -71.0 -42.05 70.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.242 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 753' ' ' ALA . . . . . 0.404 ' HB2' ' HE2' ' A' ' 782' ' ' MET . . . -62.92 -52.5 62.8 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.182 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 754' ' ' VAL . . . . . 0.739 HG21 ' CE2' ' A' ' 750' ' ' TYR . 5.1 t -56.2 -40.32 64.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.675 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -67.01 -35.52 80.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.41 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 756' ' ' PHE . . . . . 0.835 ' CE1' HG22 ' A' ' 768' ' ' VAL . 1.4 t80 -67.65 -45.94 73.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.018 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 757' ' ' VAL . . . . . 0.851 HG12 HG22 ' A' ' 803' ' ' VAL . 47.4 t -69.64 -42.08 80.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.937 0.399 . . . . 0.0 110.837 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 758' ' ' THR . . . . . 0.456 ' HA ' HG11 ' A' ' 803' ' ' VAL . 8.2 p -58.71 -45.38 89.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.69 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -77.75 -35.26 51.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.101 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 48.7 p -76.38 -14.74 60.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.291 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 56.5 28.0 13.12 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.008 0.433 . . . . 0.0 110.577 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 762' ' ' ARG . . . . . 0.406 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.2 OUTLIER -160.87 136.0 7.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.92 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 763' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -106.32 89.6 3.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.09 0.472 . . . . 0.0 111.698 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 764' ' ' SER . . . . . 0.769 ' O ' HG23 ' A' ' 768' ' ' VAL . 68.1 m -121.24 118.64 30.11 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 765' ' ' ILE . . . . . 0.643 HD13 ' HB2' ' A' ' 780' ' ' ALA . 17.5 mt -54.06 -47.58 65.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.637 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 766' ' ' SER . . . . . 0.608 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 10.9 t -58.89 -36.73 75.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.27 0.557 . . . . 0.0 110.363 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 767' ' ' ALA . . . . . 0.404 ' CB ' ' HZ ' ' A' ' 756' ' ' PHE . . . -72.78 -41.34 65.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.217 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 768' ' ' VAL . . . . . 0.835 HG22 ' CE1' ' A' ' 756' ' ' PHE . 23.2 t -61.13 -49.8 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.096 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 769' ' ' GLN . . . . . 0.616 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.2 OUTLIER -63.05 -33.85 76.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.374 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 21.2 mtt180 -70.08 -42.54 72.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.279 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.507 ' HD3' ' HD2' ' A' ' 756' ' ' PHE . 0.0 OUTLIER -78.53 -35.72 45.8 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.527 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 772' ' ' LEU . . . . . 1.02 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -90.6 -10.35 43.66 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm 60.61 40.61 16.42 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 774' ' ' ILE . . . . . 0.759 ' CG2' HD13 ' A' ' 749' ' ' LEU . 27.7 pt -111.69 -175.33 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.39 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.63 150.54 21.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.097 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -54.28 -45.97 72.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.653 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -61.91 -47.48 84.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.759 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.821 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -60.37 -50.19 74.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.687 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.22 -49.76 74.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.354 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 780' ' ' ALA . . . . . 0.643 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.2 -41.52 75.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.771 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 -59.54 -48.26 82.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.045 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 782' ' ' MET . . . . . 0.437 ' HE3' ' HB2' ' A' ' 749' ' ' LEU . 0.0 OUTLIER -61.71 -44.55 96.71 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.407 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 783' ' ' ILE . . . . . 0.805 HD11 HG21 ' A' ' 768' ' ' VAL . 12.0 mm -55.32 -37.07 42.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.786 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -64.03 -46.03 86.26 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.576 ' HB3' ' CE1' ' A' ' 750' ' ' TYR . . . -59.26 -33.56 71.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.633 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 786' ' ' MET . . . . . 0.726 ' HB3' HG22 ' A' ' 792' ' ' VAL . 13.4 mtm -65.46 -40.68 93.47 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.316 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.16 -49.14 77.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.092 0.472 . . . . 0.0 110.587 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 32.9 mtm -70.66 -36.85 73.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.385 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -71.86 -21.56 61.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.082 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 790' ' ' GLY . . . . . 0.7 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 93.72 17.23 42.33 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.718 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.757 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 60.2 t -87.72 -29.46 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 122.505 0.322 . . . . 0.0 111.27 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 792' ' ' VAL . . . . . 0.726 HG22 ' HB3' ' A' ' 786' ' ' MET . 20.5 m -139.58 141.93 33.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.869 0.366 . . . . 0.0 111.824 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 793' ' ' THR . . . . . 0.559 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.1 p -86.17 165.65 32.83 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 794' ' ' PRO . . . . . 0.559 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 32.6 Cg_endo -63.45 166.38 15.39 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 121.951 1.767 . . . . 0.0 111.815 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -69.6 158.1 35.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.373 . . . . 0.0 111.213 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 36.8 p30 -105.72 176.56 5.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.83 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 2.8 t -57.84 -31.21 66.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.999 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -74.22 -17.58 60.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.246 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 93.62 26.44 15.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.566 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 17.9 m -127.24 134.6 50.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 0.0 110.809 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 801' ' ' ARG . . . . . 0.571 ' HB3' ' HB3' ' A' ' 763' ' ' ALA . 13.5 mtt-85 -85.03 170.79 12.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.251 0.548 . . . . 0.0 111.545 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -129.1 166.5 19.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.842 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 803' ' ' VAL . . . . . 0.851 HG22 HG12 ' A' ' 757' ' ' VAL . 19.3 t -107.6 138.55 33.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.885 0.374 . . . . 0.0 111.978 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 804' ' ' ILE . . . . . 0.7 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -109.98 -25.35 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.555 179.03 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 805' ' ' ALA . . . . . 0.757 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -80.87 121.56 81.07 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.239 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -50.34 163.94 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.639 2.226 . . . . 0.0 112.885 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -109.26 145.17 31.26 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.053 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.54 107.46 2.17 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.498 2.132 . . . . 0.0 112.243 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 22.8 t -85.3 -68.53 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.185 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 16.2 ttt-85 -92.9 -32.2 14.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.844 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.911 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 53.4 p -164.94 31.91 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.881 0.372 . . . . 0.0 110.948 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -140.09 86.39 2.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.793 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 743' ' ' GLY . . . . . 0.567 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . 72.92 59.46 4.32 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.439 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 744' ' ' SER . . . . . 0.464 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 50.4 m -118.97 -46.87 2.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.126 0.489 . . . . 0.0 110.487 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -159.17 -47.48 0.06 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.19 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -128.89 95.27 4.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.394 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 747' ' ' ASP . . . . . 0.548 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.2 t70 -122.5 143.48 39.81 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.312 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 748' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 40.0 Cg_exo -36.75 -28.77 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.081 2.521 . . . . 0.0 113.793 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 749' ' ' LEU . . . . . 0.817 HD13 ' CG2' ' A' ' 774' ' ' ILE . 28.7 mt -119.99 -17.09 8.51 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.656 ' CE2' HG21 ' A' ' 754' ' ' VAL . 78.5 t80 -53.15 -50.91 63.58 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.935 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -53.07 -35.11 59.18 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 1.022 ' HB3' HD21 ' A' ' 772' ' ' LEU . 9.1 tp10 -71.1 -42.02 69.84 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.174 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 753' ' ' ALA . . . . . 0.472 ' O ' HG23 ' A' ' 757' ' ' VAL . . . -63.58 -53.73 47.11 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.188 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 754' ' ' VAL . . . . . 0.758 HG22 HG11 ' A' ' 791' ' ' VAL . 6.2 t -56.1 -39.27 57.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.865 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -68.22 -35.47 78.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.652 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 756' ' ' PHE . . . . . 0.624 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.7 t80 -68.79 -46.33 68.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.038 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 757' ' ' VAL . . . . . 0.617 HG12 HG22 ' A' ' 803' ' ' VAL . 21.1 t -71.29 -38.88 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 120.903 0.383 . . . . 0.0 111.114 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 758' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 754' ' ' VAL . 20.6 p -63.12 -41.43 99.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.702 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -76.96 -46.63 23.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.148 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 760' ' ' SER . . . . . 0.468 ' O ' ' HD3' ' A' ' 762' ' ' ARG . 22.8 p -70.6 -33.86 71.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.975 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 761' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 760' ' ' SER . 0.0 OUTLIER 78.27 23.73 0.69 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.401 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 762' ' ' ARG . . . . . 0.468 ' HD3' ' O ' ' A' ' 760' ' ' SER . 0.5 OUTLIER -145.03 114.29 7.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.507 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 763' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' A' ' 801' ' ' ARG . . . -88.19 89.49 8.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.039 0.447 . . . . 0.0 111.442 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 764' ' ' SER . . . . . 0.719 ' O ' HG23 ' A' ' 768' ' ' VAL . 17.0 m -126.84 118.35 24.45 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 765' ' ' ILE . . . . . 0.603 HG21 ' HB2' ' A' ' 780' ' ' ALA . 11.0 mt -52.99 -45.56 52.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.491 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 766' ' ' SER . . . . . 0.5 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 6.6 t -60.57 -37.7 82.15 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.152 0.501 . . . . 0.0 110.308 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 767' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 764' ' ' SER . . . -73.64 -35.26 65.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.52 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 768' ' ' VAL . . . . . 0.799 HG21 HD11 ' A' ' 783' ' ' ILE . 40.4 t -67.71 -46.98 81.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 769' ' ' GLN . . . . . 0.599 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.3 OUTLIER -65.12 -34.12 77.66 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.491 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 14.9 mtt-85 -71.32 -42.57 68.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.2 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.74 -34.92 45.41 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 772' ' ' LEU . . . . . 1.022 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -92.41 -10.41 38.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp 61.71 40.79 12.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.106 0.479 . . . . 0.0 109.721 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 774' ' ' ILE . . . . . 0.817 ' CG2' HD13 ' A' ' 749' ' ' LEU . 23.0 pt -111.74 -173.78 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.661 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.59 151.69 22.67 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.186 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -56.9 -45.78 82.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 0.0 110.729 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 -63.29 -46.56 86.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.69 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.782 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.2 OUTLIER -61.23 -50.07 74.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.776 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.41 -49.46 76.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.21 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 780' ' ' ALA . . . . . 0.603 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -55.93 -42.47 76.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.966 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -59.38 -43.37 92.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.125 0.488 . . . . 0.0 110.016 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 782' ' ' MET . . . . . 0.445 ' HE2' ' HB2' ' A' ' 753' ' ' ALA . 2.5 mtp -67.66 -42.02 82.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.592 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 783' ' ' ILE . . . . . 0.799 HD11 HG21 ' A' ' 768' ' ' VAL . 9.5 mm -58.59 -37.32 64.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.443 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -63.56 -48.27 78.15 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.6 ' HB3' ' CE1' ' A' ' 750' ' ' TYR . . . -56.16 -33.41 65.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.693 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 786' ' ' MET . . . . . 0.698 ' HG2' HG22 ' A' ' 754' ' ' VAL . 13.1 mtm -66.8 -40.77 88.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.178 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 787' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 792' ' ' VAL . 0.5 OUTLIER -59.93 -49.41 77.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.61 179.711 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 28.5 mtm -72.81 -37.79 67.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.546 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -68.16 -21.5 64.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.136 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 790' ' ' GLY . . . . . 0.763 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 94.91 16.93 39.76 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.459 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.758 HG11 HG22 ' A' ' 754' ' ' VAL . 55.1 t -86.34 -35.45 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 122.422 0.289 . . . . 0.0 111.306 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 792' ' ' VAL . . . . . 0.687 HG22 ' HB3' ' A' ' 786' ' ' MET . 22.0 m -136.4 151.44 28.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.128 0.49 . . . . 0.0 111.69 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 793' ' ' THR . . . . . 0.575 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.3 p -94.83 165.67 16.65 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.282 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 794' ' ' PRO . . . . . 0.575 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 29.6 Cg_endo -62.3 166.01 13.87 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 121.869 1.713 . . . . 0.0 111.94 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -72.07 158.5 35.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.985 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -105.51 176.51 5.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 53.1 p -57.86 -30.17 65.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.202 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -75.34 -17.6 60.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.296 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 94.15 23.23 22.94 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.576 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 58.9 m -123.26 132.54 54.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.824 0.345 . . . . 0.0 110.649 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 801' ' ' ARG . . . . . 0.569 ' HB2' ' O ' ' A' ' 763' ' ' ALA . 11.7 mtt-85 -85.14 170.79 12.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.189 0.519 . . . . 0.0 111.716 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 802' ' ' GLU . . . . . 0.425 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 3.8 mt-10 -127.54 171.05 11.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.868 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 803' ' ' VAL . . . . . 0.617 HG22 HG12 ' A' ' 757' ' ' VAL . 22.3 t -114.22 138.38 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 804' ' ' ILE . . . . . 0.763 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -106.89 -28.31 2.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.454 178.811 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 805' ' ' ALA . . . . . 0.725 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -82.7 121.44 77.84 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.001 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -65.48 163.73 28.71 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.541 2.161 . . . . 0.0 112.088 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -91.5 147.2 34.78 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.144 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -56.74 117.02 3.62 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.518 2.146 . . . . 0.0 112.265 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 809' ' ' VAL . . . . . 0.605 HG12 ' H ' ' A' ' 810' ' ' ARG . 0.9 OUTLIER -79.37 176.72 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.735 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 810' ' ' ARG . . . . . 0.605 ' H ' HG12 ' A' ' 809' ' ' VAL . 0.0 OUTLIER -112.02 -35.43 5.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.353 . . . . 0.0 110.975 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 2.0 p30 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.894 -179.868 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 78.9 p -171.78 89.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.877 0.37 . . . . 0.0 110.969 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -111.2 173.4 6.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.881 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 743' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . 75.78 36.57 42.02 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.532 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.15 -160.78 0.7 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.635 0.255 . . . . 0.0 110.611 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -51.11 -44.35 61.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.808 0.337 . . . . 0.0 111.121 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -127.39 95.56 4.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.122 0.487 . . . . 0.0 110.956 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 747' ' ' ASP . . . . . 0.56 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.57 143.21 39.26 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.445 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 748' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 40.5 Cg_exo -36.22 -29.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.108 2.538 . . . . 0.0 113.962 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 749' ' ' LEU . . . . . 0.84 HD13 ' CG2' ' A' ' 774' ' ' ILE . 26.3 mt -120.02 -17.15 8.48 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.732 ' CE1' HG21 ' A' ' 754' ' ' VAL . 65.6 t80 -53.81 -47.81 70.5 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.783 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -53.23 -37.49 62.09 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 1.092 ' HB3' HD21 ' A' ' 772' ' ' LEU . 11.8 tt0 -71.0 -43.38 68.1 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.083 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 753' ' ' ALA . . . . . 0.67 ' HB2' ' HE1' ' A' ' 782' ' ' MET . . . -59.74 -54.4 46.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.159 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 754' ' ' VAL . . . . . 0.774 HG22 HG11 ' A' ' 791' ' ' VAL . 4.8 t -56.19 -40.82 67.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.142 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 44.5 ttt85 -65.89 -36.02 82.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.543 178.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 756' ' ' PHE . . . . . 0.787 ' CE1' HG22 ' A' ' 768' ' ' VAL . 1.2 t80 -69.78 -44.95 69.06 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.83 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 757' ' ' VAL . . . . . 0.746 HG11 ' CG1' ' A' ' 792' ' ' VAL . 61.2 t -69.74 -39.59 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 121.002 0.43 . . . . 0.0 110.763 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 758' ' ' THR . . . . . 0.445 ' HA ' HG11 ' A' ' 803' ' ' VAL . 10.1 p -62.8 -44.81 95.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.8 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -78.58 -33.08 47.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.177 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 760' ' ' SER . . . . . 0.485 ' OG ' ' HA ' ' A' ' 757' ' ' VAL . 93.7 p -75.54 -15.68 60.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.278 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 62.84 17.34 9.85 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.426 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 -155.77 140.37 16.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.572 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 763' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 801' ' ' ARG . . . -105.57 89.62 3.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.922 0.391 . . . . 0.0 111.658 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 764' ' ' SER . . . . . 0.767 ' O ' HG23 ' A' ' 768' ' ' VAL . 1.7 m -118.96 118.67 32.12 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 765' ' ' ILE . . . . . 0.522 HG21 ' HB2' ' A' ' 780' ' ' ALA . 7.4 mt -55.69 -47.74 78.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.563 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 766' ' ' SER . . . . . 0.468 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 39.3 t -57.4 -39.09 75.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.14 0.495 . . . . 0.0 110.275 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 767' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 764' ' ' SER . . . -71.88 -39.56 69.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.448 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 768' ' ' VAL . . . . . 0.797 HG21 HD11 ' A' ' 783' ' ' ILE . 46.2 t -61.81 -48.15 89.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.996 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 769' ' ' GLN . . . . . 0.59 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.1 OUTLIER -65.46 -33.33 75.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 770' ' ' ARG . . . . . 0.466 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 20.1 mtt180 -70.1 -41.85 73.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.139 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.429 ' HD3' ' HE2' ' A' ' 756' ' ' PHE . 4.5 tptt -78.49 -39.84 37.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.644 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 772' ' ' LEU . . . . . 1.092 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -87.68 -9.49 54.01 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.522 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt 60.32 41.27 16.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.025 0.44 . . . . 0.0 109.825 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 774' ' ' ILE . . . . . 0.84 ' CG2' HD13 ' A' ' 749' ' ' LEU . 20.1 pt -111.89 -173.95 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.342 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.51 150.03 20.97 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.05 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -54.24 -45.34 72.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.879 0.371 . . . . 0.0 110.751 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -64.19 -47.92 77.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.712 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.769 ' HE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -58.76 -49.97 75.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.766 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.54 -49.9 74.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.28 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 780' ' ' ALA . . . . . 0.522 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -55.94 -40.04 72.59 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.797 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -59.63 -47.04 87.14 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 782' ' ' MET . . . . . 0.67 ' HE1' ' HB2' ' A' ' 753' ' ' ALA . 1.6 mtp -63.07 -43.13 99.42 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 783' ' ' ILE . . . . . 0.797 HD11 HG21 ' A' ' 768' ' ' VAL . 12.3 mm -57.45 -38.77 64.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.682 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -62.15 -43.3 99.14 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.645 ' HB3' ' CE2' ' A' ' 750' ' ' TYR . . . -61.15 -33.41 73.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.581 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 786' ' ' MET . . . . . 0.754 ' HB3' HG22 ' A' ' 792' ' ' VAL . 13.2 mtm -65.63 -39.44 91.48 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.275 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -63.57 -45.3 91.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.19 0.519 . . . . 0.0 110.312 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 53.0 mtm -72.01 -36.86 69.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.664 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -75.53 -21.66 57.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.137 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 790' ' ' GLY . . . . . 0.808 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 94.14 18.52 36.44 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.621 -178.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.774 HG11 HG22 ' A' ' 754' ' ' VAL . 57.5 t -86.82 -30.2 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.723 0.296 . . . . 0.0 110.961 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 792' ' ' VAL . . . . . 0.754 HG22 ' HB3' ' A' ' 786' ' ' MET . 22.2 m -139.31 144.06 29.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.629 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 793' ' ' THR . . . . . 0.585 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.1 p -87.37 166.81 23.68 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 794' ' ' PRO . . . . . 0.585 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 28.5 Cg_endo -62.07 166.13 13.17 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.074 1.849 . . . . 0.0 112.262 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.31 161.92 13.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.173 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -105.31 176.34 5.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.826 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 44.8 p -61.79 -32.5 72.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.818 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -79.69 -17.55 53.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.178 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.27 25.1 8.47 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.46 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 20.8 m -122.14 129.96 52.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 110.935 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 801' ' ' ARG . . . . . 0.518 ' NH1' ' CG2' ' A' ' 783' ' ' ILE . 12.1 mtt-85 -83.82 170.67 13.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.287 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -127.81 167.75 16.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.926 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 803' ' ' VAL . . . . . 0.613 HG22 HG12 ' A' ' 757' ' ' VAL . 16.4 t -109.05 137.92 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.956 0.407 . . . . 0.0 112.017 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 804' ' ' ILE . . . . . 0.808 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -108.26 -27.36 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.267 178.751 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 805' ' ' ALA . . . . . 0.725 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -83.11 123.96 76.9 Favored Pre-proline 0 N--CA 1.454 -0.237 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.996 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.57 163.79 31.36 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.679 2.253 . . . . 0.0 112.252 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 807' ' ' ALA . . . . . 0.672 ' HB1' ' HD2' ' A' ' 808' ' ' PRO . . . -104.09 165.3 13.66 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.216 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 808' ' ' PRO . . . . . 0.672 ' HD2' ' HB1' ' A' ' 807' ' ' ALA . 73.2 Cg_endo -75.09 112.18 3.49 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.625 2.217 . . . . 0.0 112.351 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 21.7 t -125.49 -37.24 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.375 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -172.44 -39.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.007 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.889 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 2.7 m -155.7 -46.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.827 0.346 . . . . 0.0 110.924 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -131.63 109.01 9.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.981 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 743' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . 101.91 67.02 0.78 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.61 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 744' ' ' SER . . . . . 0.589 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 1.4 m -123.04 -55.96 1.76 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.148 0.499 . . . . 0.0 110.282 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -151.05 -47.92 0.12 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.23 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.03 95.33 4.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.527 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 747' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.9 t70 -122.5 142.34 37.04 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.353 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -38.04 -27.82 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.921 2.414 . . . . 0.0 113.556 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 749' ' ' LEU . . . . . 0.839 HD13 ' CG2' ' A' ' 774' ' ' ILE . 43.5 mt -119.91 -17.36 8.49 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.666 ' CE2' HG21 ' A' ' 754' ' ' VAL . 66.3 t80 -55.14 -46.94 75.69 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.816 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -53.27 -36.73 61.46 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 0.879 ' HB3' HD21 ' A' ' 772' ' ' LEU . 0.6 OUTLIER -71.04 -45.04 64.58 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.018 178.756 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 753' ' ' ALA . . . . . 0.445 ' O ' HG23 ' A' ' 757' ' ' VAL . . . -59.35 -52.3 66.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.352 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 754' ' ' VAL . . . . . 0.735 HG22 HG11 ' A' ' 791' ' ' VAL . 2.3 t -56.12 -43.02 74.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.958 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -66.72 -35.56 80.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.353 0.597 . . . . 0.0 109.708 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 756' ' ' PHE . . . . . 0.744 ' CE2' HG22 ' A' ' 768' ' ' VAL . 3.5 t80 -66.24 -46.1 78.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.921 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 757' ' ' VAL . . . . . 0.909 HG12 HG22 ' A' ' 803' ' ' VAL . 43.7 t -69.31 -45.05 79.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.932 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 758' ' ' THR . . . . . 0.609 HG22 ' O ' ' A' ' 805' ' ' ALA . 2.0 p -56.64 -42.92 79.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.794 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -78.9 -39.82 33.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.285 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 760' ' ' SER . . . . . 0.415 ' OG ' ' HA ' ' A' ' 757' ' ' VAL . 92.4 p -74.46 -16.88 60.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.35 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 9.0 mmm-85 62.35 24.96 14.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.591 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 762' ' ' ARG . . . . . 0.425 ' C ' HG13 ' A' ' 757' ' ' VAL . 6.3 ptt180 -157.87 133.14 8.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.678 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 763' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -102.61 89.77 3.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.965 0.412 . . . . 0.0 111.564 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 764' ' ' SER . . . . . 0.716 ' O ' HG23 ' A' ' 768' ' ' VAL . 1.8 m -125.02 118.53 26.4 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 765' ' ' ILE . . . . . 0.547 HG21 ' HB2' ' A' ' 780' ' ' ALA . 2.2 mp -51.16 -51.49 22.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.952 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 766' ' ' SER . . . . . 0.472 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 14.3 t -53.32 -42.21 66.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.155 0.502 . . . . 0.0 110.629 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -70.1 -42.12 73.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.549 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 768' ' ' VAL . . . . . 0.969 HG21 HD11 ' A' ' 783' ' ' ILE . 42.5 t -59.47 -47.48 90.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.215 179.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 769' ' ' GLN . . . . . 0.589 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 3.3 pt20 -65.49 -33.46 75.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.719 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 770' ' ' ARG . . . . . 0.468 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 0.0 OUTLIER -68.89 -42.25 77.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.046 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -78.55 -42.16 30.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.693 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 772' ' ' LEU . . . . . 0.879 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -84.98 -8.79 58.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.889 -179.594 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp 58.21 41.83 22.94 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 774' ' ' ILE . . . . . 0.839 ' CG2' HD13 ' A' ' 749' ' ' LEU . 26.9 pt -111.84 -173.9 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.72 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -91.53 153.08 21.88 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.972 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -58.5 -46.69 86.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.832 0.349 . . . . 0.0 110.73 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -57.57 -47.74 81.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.064 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.798 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.0 OUTLIER -66.0 -50.28 64.83 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.693 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -54.85 -50.09 69.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.674 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 780' ' ' ALA . . . . . 0.547 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -59.31 -42.92 92.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.76 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -58.93 -48.49 81.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.105 0.478 . . . . 0.0 109.88 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 782' ' ' MET . . . . . . . . . . . . . 33.5 mtm -65.21 -34.52 78.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.45 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 783' ' ' ILE . . . . . 0.969 HD11 HG21 ' A' ' 768' ' ' VAL . 5.9 mm -64.6 -36.2 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.094 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.99 -39.94 94.22 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.589 ' HB1' ' O ' ' A' ' 744' ' ' SER . . . -60.11 -34.6 73.72 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.42 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 786' ' ' MET . . . . . 0.741 ' HB3' HG22 ' A' ' 792' ' ' VAL . 13.9 mtm -67.07 -39.07 86.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.975 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 787' ' ' GLU . . . . . 0.416 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 0.1 OUTLIER -59.51 -54.12 50.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.726 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 20.1 mtm -70.36 -38.34 74.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.129 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -65.54 -21.59 66.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.558 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 790' ' ' GLY . . . . . 0.647 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 91.14 14.97 56.84 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.84 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.735 HG11 HG22 ' A' ' 754' ' ' VAL . 23.7 t -84.51 -30.69 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-O 120.892 0.377 . . . . 0.0 111.028 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 792' ' ' VAL . . . . . 0.741 HG22 ' HB3' ' A' ' 786' ' ' MET . 18.9 m -137.07 140.06 43.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.278 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 793' ' ' THR . . . . . 0.515 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 2.3 p -85.18 160.56 54.43 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.831 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 794' ' ' PRO . . . . . 0.515 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 17.7 Cg_endo -58.94 167.55 5.41 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.137 1.891 . . . . 0.0 111.873 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.54 157.01 38.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.202 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 35.9 p30 -105.55 176.61 5.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.826 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 7.9 t -57.31 -33.95 68.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.023 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -71.95 -17.51 62.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.14 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 92.99 27.76 13.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.474 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 3.5 m -127.72 133.95 49.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 0.0 110.898 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 801' ' ' ARG . . . . . 0.509 ' NH1' HG21 ' A' ' 792' ' ' VAL . 8.4 mtt-85 -85.6 170.66 12.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.243 0.544 . . . . 0.0 111.354 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -130.86 167.34 19.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.042 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 803' ' ' VAL . . . . . 0.909 HG22 HG12 ' A' ' 757' ' ' VAL . 21.9 t -109.5 135.87 47.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.951 0.405 . . . . 0.0 111.63 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 804' ' ' ILE . . . . . 0.647 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -104.51 -28.43 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.259 179.058 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 805' ' ' ALA . . . . . 0.645 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -81.33 124.15 80.77 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.87 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.32 163.85 25.05 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.671 2.247 . . . . 0.0 112.188 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 807' ' ' ALA . . . . . 0.51 ' HB1' ' HD2' ' A' ' 808' ' ' PRO . . . -92.22 166.78 16.45 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.2 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 808' ' ' PRO . . . . . 0.51 ' HD2' ' HB1' ' A' ' 807' ' ' ALA . 52.6 Cg_exo -54.99 95.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.625 2.217 . . . . 0.0 112.277 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 11.9 t 69.12 -67.31 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.184 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -136.87 -46.22 0.59 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.005 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 2.0 p30 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.908 179.974 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.6 -47.9 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.807 0.337 . . . . 0.0 110.855 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 63.1 88.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.086 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 743' ' ' GLY . . . . . 0.558 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . 101.79 60.11 0.77 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.743 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 744' ' ' SER . . . . . 0.55 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 0.7 OUTLIER -117.5 -51.69 2.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.141 0.496 . . . . 0.0 110.267 179.608 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -157.03 -49.14 0.07 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.024 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -124.93 95.07 4.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.227 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 747' ' ' ASP . . . . . 0.565 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 13.1 t70 -122.57 143.31 39.52 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.344 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 748' ' ' PRO . . . . . 0.405 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 45.3 Cg_exo -36.14 -29.32 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.011 2.474 . . . . 0.0 113.789 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 749' ' ' LEU . . . . . 0.837 HD13 ' CG2' ' A' ' 774' ' ' ILE . 23.8 mt -120.05 -17.24 8.44 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.744 ' CE2' HG21 ' A' ' 754' ' ' VAL . 70.1 t80 -53.39 -48.37 68.72 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.949 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -53.24 -37.29 61.94 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 1.014 ' HB3' HD21 ' A' ' 772' ' ' LEU . 0.5 OUTLIER -70.94 -42.12 70.25 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.085 178.679 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 753' ' ' ALA . . . . . 0.44 ' HB2' ' HE2' ' A' ' 782' ' ' MET . . . -60.96 -53.7 54.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.202 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 754' ' ' VAL . . . . . 0.744 HG21 ' CE2' ' A' ' 750' ' ' TYR . 8.0 t -56.27 -39.98 63.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.063 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 37.9 mtt180 -67.62 -37.37 82.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.39 0.614 . . . . 0.0 109.766 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 756' ' ' PHE . . . . . 0.678 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.6 t80 -67.68 -46.06 73.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.288 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 757' ' ' VAL . . . . . 0.93 HG12 HG22 ' A' ' 803' ' ' VAL . 54.3 t -69.46 -43.94 80.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.958 0.409 . . . . 0.0 110.61 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 758' ' ' THR . . . . . 0.715 ' HA ' HG11 ' A' ' 803' ' ' VAL . 12.5 p -56.67 -45.6 81.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.052 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -78.8 -34.39 45.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.634 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 760' ' ' SER . . . . . 0.505 ' HB2' ' NE ' ' A' ' 762' ' ' ARG . 91.7 p -75.25 -17.76 60.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.527 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 5.9 mmm-85 63.68 33.55 12.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.349 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 762' ' ' ARG . . . . . 0.53 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.0 OUTLIER -170.61 136.64 1.27 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.403 179.535 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 763' ' ' ALA . . . . . 0.455 ' HB2' HG11 ' A' ' 757' ' ' VAL . . . -104.46 89.76 3.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 0.0 111.82 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 764' ' ' SER . . . . . 0.704 ' O ' HG23 ' A' ' 768' ' ' VAL . 1.0 OUTLIER -121.36 118.52 29.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.571 178.775 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 765' ' ' ILE . . . . . 0.606 HG21 ' HB2' ' A' ' 780' ' ' ALA . 1.6 mt -53.33 -50.49 47.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.618 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 766' ' ' SER . . . . . 0.464 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 16.3 t -55.27 -39.04 69.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.167 0.508 . . . . 0.0 110.492 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 767' ' ' ALA . . . . . 0.408 ' HB1' ' HZ ' ' A' ' 756' ' ' PHE . . . -71.8 -37.54 70.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.503 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 768' ' ' VAL . . . . . 0.782 HG21 HD11 ' A' ' 783' ' ' ILE . 44.5 t -65.57 -47.85 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.241 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 769' ' ' GLN . . . . . 0.593 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.1 OUTLIER -64.85 -33.39 75.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.478 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 770' ' ' ARG . . . . . 0.447 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 2.6 mtt180 -70.91 -42.5 69.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.117 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.426 ' HB2' ' CE1' ' A' ' 756' ' ' PHE . 0.2 OUTLIER -78.52 -36.43 44.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.086 -179.425 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 772' ' ' LEU . . . . . 1.014 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -91.59 -9.35 44.48 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.885 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt 60.76 40.94 15.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.073 0.463 . . . . 0.0 109.815 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 774' ' ' ILE . . . . . 0.837 ' CG2' HD13 ' A' ' 749' ' ' LEU . 20.5 pt -111.84 -173.92 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.292 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.91 150.96 21.87 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.12 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -55.63 -45.37 77.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.855 0.359 . . . . 0.0 110.582 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 777' ' ' ASN . . . . . 0.404 ' O ' ' HG3' ' A' ' 781' ' ' ARG . 21.5 m-80 -63.77 -47.94 78.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.771 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.754 ' HE ' HD12 ' A' ' 749' ' ' LEU . 0.2 OUTLIER -59.44 -50.12 75.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.893 0.378 . . . . 0.0 110.783 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.64 72.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.458 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 780' ' ' ALA . . . . . 0.606 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -56.27 -40.69 74.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.941 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 781' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 777' ' ' ASN . 12.5 mtt180 -58.86 -46.35 87.97 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 782' ' ' MET . . . . . 0.44 ' HE2' ' HB2' ' A' ' 753' ' ' ALA . 2.3 mtp -64.74 -42.59 95.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 783' ' ' ILE . . . . . 0.782 HD11 HG21 ' A' ' 768' ' ' VAL . 9.9 mm -57.22 -35.64 49.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.291 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.12 -45.47 88.45 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.604 ' HB3' ' CE1' ' A' ' 750' ' ' TYR . . . -58.26 -33.62 69.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.603 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 786' ' ' MET . . . . . 0.716 ' HB3' HG22 ' A' ' 792' ' ' VAL . 14.4 mtm -67.2 -38.21 84.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.083 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -62.27 -47.9 82.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.582 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 36.3 mtm -73.56 -37.53 65.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.272 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -70.46 -21.58 62.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.599 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 790' ' ' GLY . . . . . 0.616 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 92.22 15.51 53.44 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.819 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.763 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 59.7 t -83.93 -29.12 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.744 0.307 . . . . 0.0 111.101 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 792' ' ' VAL . . . . . 0.716 HG22 ' HB3' ' A' ' 786' ' ' MET . 18.8 m -139.39 135.42 40.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.953 0.406 . . . . 0.0 111.375 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 793' ' ' THR . . . . . 0.696 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 4.7 p -80.49 168.31 26.45 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.597 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 794' ' ' PRO . . . . . 0.696 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 38.7 Cg_endo -65.44 163.38 29.93 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 121.877 1.718 . . . . 0.0 111.965 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 795' ' ' MET . . . . . 0.423 ' HA ' ' HG3' ' A' ' 801' ' ' ARG . 0.1 OUTLIER -60.8 162.27 6.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.453 -179.69 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -105.53 176.5 5.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.892 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 60.2 p -60.58 -30.41 69.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.022 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -83.79 -17.53 40.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.252 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.41 26.41 7.74 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.513 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 50.7 m -123.27 130.44 52.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.911 0.386 . . . . 0.0 110.825 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 801' ' ' ARG . . . . . 0.431 ' NH1' ' CG2' ' A' ' 783' ' ' ILE . 9.3 mtt-85 -83.68 170.57 14.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.213 0.53 . . . . 0.0 111.465 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 802' ' ' GLU . . . . . 0.627 ' O ' HG23 ' A' ' 793' ' ' THR . 5.0 mt-10 -132.14 134.51 45.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.934 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 803' ' ' VAL . . . . . 0.93 HG22 HG12 ' A' ' 757' ' ' VAL . 18.9 t -76.91 136.86 23.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.985 0.422 . . . . 0.0 111.904 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 804' ' ' ILE . . . . . 0.616 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -107.04 -29.78 2.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.516 178.875 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 805' ' ' ALA . . . . . 0.763 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -75.08 120.15 80.29 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -50.2 163.9 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.678 2.252 . . . . 0.0 112.92 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 807' ' ' ALA . . . . . 0.63 ' HB1' ' OXT' ' A' ' 811' ' ' ASP . . . -95.34 146.1 30.71 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.148 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.77 111.51 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.549 2.166 . . . . 0.0 112.335 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 16.7 t 67.56 -69.88 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.285 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -142.97 -46.3 0.31 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.927 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 811' ' ' ASP . . . . . 0.63 ' OXT' ' HB1' ' A' ' 807' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.909 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 6.0 t -157.06 -47.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.772 0.32 . . . . 0.0 110.769 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -139.23 129.65 25.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.893 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 743' ' ' GLY . . . . . 0.628 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . 78.96 61.5 2.38 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.518 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 14.6 m -119.35 -47.5 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.134 0.492 . . . . 0.0 110.363 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -159.26 -49.67 0.06 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.223 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.38 95.21 4.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.355 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 747' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.42 142.96 38.39 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.316 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 748' ' ' PRO . . . . . 0.418 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 43.8 Cg_exo -36.69 -28.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.015 2.477 . . . . 0.0 113.774 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 749' ' ' LEU . . . . . 0.829 HD13 ' CG2' ' A' ' 774' ' ' ILE . 28.6 mt -119.99 -17.1 8.51 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.725 ' CE2' HG21 ' A' ' 754' ' ' VAL . 82.3 t80 -52.81 -50.47 63.59 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.791 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -52.93 -35.99 59.17 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 1.073 ' HB3' HD21 ' A' ' 772' ' ' LEU . 5.9 tt0 -71.05 -41.89 70.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.23 178.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 753' ' ' ALA . . . . . 0.553 ' HB2' ' HE1' ' A' ' 782' ' ' MET . . . -62.89 -53.77 48.98 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.987 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 754' ' ' VAL . . . . . 0.725 HG21 ' CE2' ' A' ' 750' ' ' TYR . 9.1 t -56.02 -41.43 68.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.738 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 755' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' A' ' 759' ' ' GLU . 1.5 ttm-85 -65.6 -35.11 79.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.281 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 756' ' ' PHE . . . . . 0.665 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.7 t80 -69.73 -46.3 66.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.367 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 757' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 762' ' ' ARG . 51.6 t -70.44 -38.37 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 120.921 0.391 . . . . 0.0 110.843 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 758' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 754' ' ' VAL . 22.4 p -65.21 -42.48 93.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.177 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 759' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 755' ' ' ARG . 1.8 tt0 -77.14 -46.48 23.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.373 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 92.5 p -74.68 -10.47 59.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.154 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.65 30.25 17.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.06 0.457 . . . . 0.0 110.607 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 762' ' ' ARG . . . . . 0.716 ' O ' HG13 ' A' ' 757' ' ' VAL . 10.6 mtm180 -145.5 138.46 26.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.543 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 763' ' ' ALA . . . . . 0.925 ' HB1' HH21 ' A' ' 801' ' ' ARG . . . -117.76 89.57 3.15 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.97 0.414 . . . . 0.0 111.025 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 764' ' ' SER . . . . . 0.63 ' O ' HG23 ' A' ' 768' ' ' VAL . 2.7 m -133.91 118.45 17.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.637 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 765' ' ' ILE . . . . . 0.731 HD13 ' HB2' ' A' ' 780' ' ' ALA . 19.1 mt -50.01 -46.65 23.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.704 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 766' ' ' SER . . . . . 0.485 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 12.1 t -58.9 -39.0 80.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.136 0.493 . . . . 0.0 110.534 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -72.93 -36.61 67.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.349 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 768' ' ' VAL . . . . . 0.679 HG21 HD11 ' A' ' 783' ' ' ILE . 40.7 t -65.22 -48.01 85.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.067 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 769' ' ' GLN . . . . . 0.602 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.4 OUTLIER -65.41 -33.47 76.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.569 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 770' ' ' ARG . . . . . 0.414 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 12.1 mtt180 -71.54 -41.53 69.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.065 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.63 -36.52 43.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.829 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 772' ' ' LEU . . . . . 1.073 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -91.28 -10.03 42.93 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt 61.61 39.94 13.97 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 774' ' ' ILE . . . . . 0.829 ' CG2' HD13 ' A' ' 749' ' ' LEU . 24.1 pt -111.77 -174.49 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.481 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.69 152.98 23.57 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.228 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -57.16 -46.34 82.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.926 0.393 . . . . 0.0 110.625 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -62.87 -47.83 81.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.724 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.79 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.4 OUTLIER -60.27 -50.24 74.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.82 -179.94 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.84 -50.04 73.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.349 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 780' ' ' ALA . . . . . 0.731 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -55.64 -42.89 75.63 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.781 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -58.66 -43.09 89.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.097 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 782' ' ' MET . . . . . 0.553 ' HE1' ' HB2' ' A' ' 753' ' ' ALA . 2.6 mtp -68.38 -40.04 81.55 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 783' ' ' ILE . . . . . 0.93 HG23 ' NH2' ' A' ' 801' ' ' ARG . 5.3 mm -58.14 -40.08 75.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.798 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 784' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 787' ' ' GLU . 2.3 mt-10 -63.99 -46.18 85.7 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.628 ' HB2' ' O ' ' A' ' 743' ' ' GLY . . . -54.76 -33.42 61.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.508 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 786' ' ' MET . . . . . 0.743 ' HB3' HG22 ' A' ' 792' ' ' VAL . 14.9 mtm -67.7 -39.36 84.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.848 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 787' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 784' ' ' GLU . 0.4 OUTLIER -57.62 -51.5 69.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.669 179.415 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 46.9 mtm -75.46 -38.37 59.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.915 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -64.31 -21.2 66.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.921 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 790' ' ' GLY . . . . . 0.551 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 91.87 19.77 39.04 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.419 -178.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.701 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 79.2 t -89.2 -32.78 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.793 0.33 . . . . 0.0 111.059 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 792' ' ' VAL . . . . . 0.864 HG21 ' NH2' ' A' ' 801' ' ' ARG . 28.3 m -137.49 143.44 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.0 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 793' ' ' THR . . . . . 0.426 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 6.8 p -82.03 155.2 70.16 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.421 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 794' ' ' PRO . . . . . 0.426 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 19.1 Cg_endo -58.75 169.03 3.62 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.424 2.083 . . . . 0.0 112.345 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 795' ' ' MET . . . . . 0.507 ' HA ' ' HG3' ' A' ' 801' ' ' ARG . 1.4 mtp -60.92 159.52 11.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.303 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -102.48 176.56 5.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.805 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 38.2 p -60.59 -28.01 68.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.07 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -90.9 -17.59 26.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.327 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 104.8 28.55 5.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.765 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 19.3 m -121.91 129.88 52.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.871 0.367 . . . . 0.0 110.929 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 801' ' ' ARG . . . . . 0.93 ' NH2' HG23 ' A' ' 783' ' ' ILE . 0.4 OUTLIER -94.46 170.49 9.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.125 0.488 . . . . 0.0 111.387 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.95 -172.42 2.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.488 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 803' ' ' VAL . . . . . 0.594 HG22 HG12 ' A' ' 757' ' ' VAL . 30.2 t -121.14 138.66 50.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.843 0.354 . . . . 0.0 111.741 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 804' ' ' ILE . . . . . 0.551 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -110.16 -27.13 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.777 179.282 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 805' ' ' ALA . . . . . 0.701 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -84.74 120.87 74.43 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.889 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.42 163.71 28.63 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.59 2.193 . . . . 0.0 112.163 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -92.28 148.23 36.16 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.168 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -55.57 110.37 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.577 2.184 . . . . 0.0 112.278 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 21.8 t -91.15 -33.38 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.083 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -125.33 30.6 5.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.914 -179.979 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 112.55 -0.22 . . . . 0.0 112.55 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 5.4 m -108.62 30.2 6.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.775 0.321 . . . . 0.0 110.892 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.21 148.93 52.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.872 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 743' ' ' GLY . . . . . 0.595 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . -69.08 67.25 0.49 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.515 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 9.8 p -101.76 -158.04 0.65 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.592 0.234 . . . . 0.0 110.656 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -50.78 -45.31 59.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.722 0.296 . . . . 0.0 111.505 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -128.13 95.61 4.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.069 0.461 . . . . 0.0 111.34 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 747' ' ' ASP . . . . . 0.58 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 14.6 t70 -122.36 142.34 36.82 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.413 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 748' ' ' PRO . . . . . 0.402 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 41.0 Cg_exo -35.12 -30.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.311 2.674 . . . . 0.0 113.993 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 749' ' ' LEU . . . . . 0.83 HD12 ' NE ' ' A' ' 778' ' ' ARG . 44.7 mt -120.02 -16.91 8.54 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.712 ' CE2' HG21 ' A' ' 754' ' ' VAL . 67.7 t80 -54.08 -47.81 71.31 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.483 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -53.45 -35.73 60.81 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 0.97 ' HB2' HD21 ' A' ' 772' ' ' LEU . 8.4 mt-10 -70.95 -40.91 71.74 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.182 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 753' ' ' ALA . . . . . 0.473 ' HB2' ' HE1' ' A' ' 782' ' ' MET . . . -64.24 -52.35 59.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.118 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 754' ' ' VAL . . . . . 0.712 HG21 ' CE2' ' A' ' 750' ' ' TYR . 3.1 t -56.35 -40.09 64.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.005 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.59 -35.32 77.2 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.488 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 756' ' ' PHE . . . . . 0.829 ' CE1' HG22 ' A' ' 768' ' ' VAL . 1.1 t80 -67.42 -46.12 74.11 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.93 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 757' ' ' VAL . . . . . 0.78 HG13 ' O ' ' A' ' 762' ' ' ARG . 43.3 t -70.82 -41.07 77.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.86 0.362 . . . . 0.0 110.757 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 758' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 754' ' ' VAL . 20.3 p -62.18 -42.08 98.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.568 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -77.26 -47.03 21.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.882 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 6.3 p -70.98 -18.54 62.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.765 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 761' ' ' ARG . . . . . 0.404 ' N ' ' O ' ' A' ' 757' ' ' VAL . 0.0 OUTLIER 65.17 18.69 11.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.771 -179.626 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 762' ' ' ARG . . . . . 0.78 ' O ' HG13 ' A' ' 757' ' ' VAL . 1.0 OUTLIER -139.74 145.39 38.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.749 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 763' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' A' ' 801' ' ' ARG . . . -117.43 89.46 3.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.237 0.541 . . . . 0.0 110.83 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 764' ' ' SER . . . . . 0.726 ' O ' HG23 ' A' ' 768' ' ' VAL . 23.7 m -129.99 118.59 21.84 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 765' ' ' ILE . . . . . 0.525 HG21 ' HB2' ' A' ' 780' ' ' ALA . 11.2 mt -51.77 -47.17 39.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.697 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 766' ' ' SER . . . . . 0.571 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 22.2 t -59.3 -37.73 78.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.149 0.499 . . . . 0.0 110.571 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -73.1 -42.17 63.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.229 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 768' ' ' VAL . . . . . 0.871 HG21 HD11 ' A' ' 783' ' ' ILE . 30.4 t -59.76 -50.91 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.971 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 769' ' ' GLN . . . . . 0.641 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -63.58 -33.45 75.63 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.713 -179.649 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -67.03 -43.87 81.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.122 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.552 ' HD2' ' HD2' ' A' ' 756' ' ' PHE . 0.9 OUTLIER -78.64 -42.16 29.5 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.838 0.351 . . . . 0.0 111.794 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 772' ' ' LEU . . . . . 0.97 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -81.37 -10.57 59.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.815 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm 60.03 40.76 18.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.193 0.521 . . . . 0.0 109.701 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 774' ' ' ILE . . . . . 0.766 ' CG2' HD13 ' A' ' 749' ' ' LEU . 24.2 pt -111.82 -173.99 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.563 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.55 149.91 21.45 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.111 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -53.98 -44.72 71.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 110.662 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 777' ' ' ASN . . . . . 0.435 ' O ' ' HG3' ' A' ' 781' ' ' ARG . 79.3 m-20 -65.01 -47.89 75.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.692 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.83 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.2 OUTLIER -57.83 -50.07 74.51 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.865 0.364 . . . . 0.0 110.752 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 779' ' ' ALA . . . . . 0.4 ' HB2' ' CD1' ' A' ' 774' ' ' ILE . . . -58.14 -45.88 86.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.105 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 780' ' ' ALA . . . . . 0.525 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -56.93 -44.3 82.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.103 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 781' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 777' ' ' ASN . 7.4 mtt180 -58.76 -46.86 86.51 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 782' ' ' MET . . . . . 0.473 ' HE1' ' HB2' ' A' ' 753' ' ' ALA . 2.5 mtp -64.06 -41.81 97.22 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 783' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 768' ' ' VAL . 7.2 mm -58.73 -37.16 64.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.448 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.26 -45.2 92.61 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.637 ' HB3' ' CE1' ' A' ' 750' ' ' TYR . . . -58.99 -33.53 70.8 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.63 178.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 786' ' ' MET . . . . . 0.736 ' HB3' HG22 ' A' ' 792' ' ' VAL . 12.4 mtm -65.79 -39.79 91.3 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.118 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.32 -47.84 82.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.147 0.499 . . . . 0.0 110.492 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 25.8 mtp -70.95 -38.29 72.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.552 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -71.19 -21.64 62.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.962 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 790' ' ' GLY . . . . . 0.768 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 93.3 19.03 36.96 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.605 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.733 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 38.1 t -88.27 -30.19 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.716 0.293 . . . . 0.0 111.168 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 792' ' ' VAL . . . . . 0.736 HG22 ' HB3' ' A' ' 786' ' ' MET . 20.9 m -138.76 143.73 31.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.408 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 793' ' ' THR . . . . . 0.533 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.3 p -88.06 163.59 36.83 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 794' ' ' PRO . . . . . 0.533 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 18.6 Cg_endo -59.93 166.41 8.67 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 121.957 1.772 . . . . 0.0 112.129 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 1.5 mtt -61.12 162.03 7.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.227 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -105.55 176.54 5.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.766 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 44.1 p -61.62 -33.92 74.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.779 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -79.56 -17.57 53.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.56 28.07 6.87 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.417 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 19.2 m -124.68 130.45 52.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 110.909 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 801' ' ' ARG . . . . . 0.56 ' HB2' ' O ' ' A' ' 763' ' ' ALA . 11.3 mtt-85 -83.95 170.69 13.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.449 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -129.02 168.98 15.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.254 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 803' ' ' VAL . . . . . 0.766 HG22 HG12 ' A' ' 757' ' ' VAL . 21.4 t -110.62 137.27 43.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.011 0.434 . . . . 0.0 111.844 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 804' ' ' ILE . . . . . 0.768 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -107.5 -27.96 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.314 178.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 805' ' ' ALA . . . . . 0.733 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -79.34 122.73 84.39 Favored Pre-proline 0 N--CA 1.455 -0.207 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.742 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.38 163.66 31.38 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.513 2.142 . . . . 0.0 112.198 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -79.34 148.23 70.16 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.24 110.85 3.17 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.535 2.157 . . . . 0.0 112.335 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 21.5 t -72.74 -32.73 41.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.086 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -171.75 -41.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.958 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 9.0 t0 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.891 179.995 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 112.392 -0.283 . . . . 0.0 112.392 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 2.0 m -146.1 28.46 1.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 110.949 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -94.25 104.83 16.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.991 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 743' ' ' GLY . . . . . 0.645 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . 75.44 60.68 3.18 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.678 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.43 -47.97 2.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.149 0.5 . . . . 0.0 110.252 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -159.1 -49.59 0.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.177 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -126.35 95.17 4.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.318 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 747' ' ' ASP . . . . . 0.55 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.6 t70 -122.49 143.2 39.1 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.535 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 748' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 37.9 Cg_exo -36.72 -28.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.069 2.513 . . . . 0.0 113.895 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 749' ' ' LEU . . . . . 0.855 HD13 ' CG2' ' A' ' 774' ' ' ILE . 28.9 mt -120.03 -17.2 8.46 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.728 ' CE2' HG21 ' A' ' 754' ' ' VAL . 80.5 t80 -52.88 -50.34 64.04 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.948 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -53.17 -35.72 60.1 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 1.036 ' HB3' HD21 ' A' ' 772' ' ' LEU . 8.0 tt0 -71.12 -41.5 70.44 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.293 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 753' ' ' ALA . . . . . 0.558 ' HB2' ' HE1' ' A' ' 782' ' ' MET . . . -64.57 -51.95 60.15 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.125 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 754' ' ' VAL . . . . . 0.728 HG21 ' CE2' ' A' ' 750' ' ' TYR . 5.0 t -56.12 -38.7 54.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.504 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -69.38 -35.16 75.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.435 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 756' ' ' PHE . . . . . 0.76 ' CE2' HG22 ' A' ' 768' ' ' VAL . 1.5 t80 -68.57 -46.2 70.05 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.329 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 757' ' ' VAL . . . . . 0.643 HG11 ' HB2' ' A' ' 763' ' ' ALA . 35.4 t -71.23 -41.38 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-O 120.991 0.424 . . . . 0.0 110.751 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 758' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 754' ' ' VAL . 30.1 p -62.72 -42.89 99.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.993 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -77.48 -46.31 22.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.275 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 760' ' ' SER . . . . . 0.513 ' O ' ' HD3' ' A' ' 762' ' ' ARG . 50.0 p -70.06 -29.17 66.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 761' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 760' ' ' SER . 0.0 OUTLIER 70.86 28.53 3.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.302 -179.248 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 762' ' ' ARG . . . . . 0.513 ' HD3' ' O ' ' A' ' 760' ' ' SER . 0.4 OUTLIER -147.8 110.55 4.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.368 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 763' ' ' ALA . . . . . 0.873 ' HB1' HH21 ' A' ' 801' ' ' ARG . . . -91.06 89.69 7.51 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.052 0.453 . . . . 0.0 111.257 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 764' ' ' SER . . . . . 0.616 ' O ' HG23 ' A' ' 768' ' ' VAL . 1.3 m -133.94 118.85 18.35 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.472 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 765' ' ' ILE . . . . . 0.557 HG21 ' HB2' ' A' ' 780' ' ' ALA . 1.5 mp -48.85 -52.7 9.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.952 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 766' ' ' SER . . . . . 0.534 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 7.9 t -53.34 -40.12 64.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.203 0.525 . . . . 0.0 110.635 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -71.64 -39.75 70.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.445 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 768' ' ' VAL . . . . . 0.76 HG22 ' CE2' ' A' ' 756' ' ' PHE . 44.4 t -61.89 -49.88 82.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.114 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 769' ' ' GLN . . . . . 0.596 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.4 OUTLIER -63.47 -33.91 76.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.869 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 770' ' ' ARG . . . . . 0.418 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 7.2 mtt85 -68.95 -42.53 76.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.218 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.7 -39.3 36.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.701 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 772' ' ' LEU . . . . . 1.036 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -87.07 -9.78 54.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.248 -179.314 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp 60.95 39.7 16.3 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 774' ' ' ILE . . . . . 0.855 ' CG2' HD13 ' A' ' 749' ' ' LEU . 17.8 pt -111.86 -173.83 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.165 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -90.17 153.18 22.69 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.023 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -57.09 -45.57 83.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.817 0.341 . . . . 0.0 110.64 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 777' ' ' ASN . . . . . 0.442 ' O ' ' HG3' ' A' ' 781' ' ' ARG . 66.4 m-20 -63.13 -48.08 80.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.735 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.778 ' HE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -59.88 -50.17 74.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.979 0.418 . . . . 0.0 110.751 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.12 76.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.441 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 780' ' ' ALA . . . . . 0.557 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -56.97 -40.87 77.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.027 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 781' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 777' ' ' ASN . 17.3 mtt180 -58.88 -46.77 87.02 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 782' ' ' MET . . . . . 0.558 ' HE1' ' HB2' ' A' ' 753' ' ' ALA . 2.3 mtp -64.83 -42.24 95.09 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 783' ' ' ILE . . . . . 1.014 HG23 ' NH2' ' A' ' 801' ' ' ARG . 5.9 mm -55.8 -39.54 56.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.502 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.97 -46.69 86.51 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.645 ' HB2' ' O ' ' A' ' 743' ' ' GLY . . . -55.19 -33.54 63.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.827 178.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 786' ' ' MET . . . . . 0.749 ' HB3' HG22 ' A' ' 792' ' ' VAL . 14.5 mtm -67.38 -40.53 85.7 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.197 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 787' ' ' GLU . . . . . 0.484 ' HG3' ' NH1' ' A' ' 801' ' ' ARG . 4.2 mt-10 -58.61 -53.66 55.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.647 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 30.9 mtm -71.06 -38.32 72.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.429 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -65.71 -21.42 66.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.7 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 790' ' ' GLY . . . . . 0.701 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 91.15 15.18 56.4 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.608 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.723 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 86.1 t -84.02 -29.78 7.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.023 0.44 . . . . 0.0 110.672 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 792' ' ' VAL . . . . . 0.918 HG21 ' NH2' ' A' ' 801' ' ' ARG . 17.6 m -139.54 144.47 28.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.977 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 793' ' ' THR . . . . . 0.478 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 6.6 p -83.69 156.84 64.72 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.608 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 794' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 19.0 Cg_endo -58.77 169.51 3.3 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.498 2.132 . . . . 0.0 112.177 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 795' ' ' MET . . . . . 0.447 ' HA ' ' HG3' ' A' ' 801' ' ' ARG . 2.1 mtt -65.13 159.82 22.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.021 0.439 . . . . 0.0 111.254 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 56.6 m-20 -102.15 176.58 5.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.841 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 9.8 t -59.63 -29.52 68.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.069 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 39.1 p30 -87.3 -17.58 32.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.378 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 102.48 31.79 5.1 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.722 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 15.9 m -125.0 129.65 50.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.347 . . . . 0.0 110.75 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 801' ' ' ARG . . . . . 1.014 ' NH2' HG23 ' A' ' 783' ' ' ILE . 0.5 OUTLIER -93.51 169.63 10.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.348 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -130.48 -170.81 2.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.713 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 803' ' ' VAL . . . . . 0.608 HG22 HG12 ' A' ' 757' ' ' VAL . 30.0 t -124.58 138.52 53.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.928 0.394 . . . . 0.0 111.887 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 804' ' ' ILE . . . . . 0.701 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -108.97 -30.22 2.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.519 179.232 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 805' ' ' ALA . . . . . 0.723 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -79.55 119.79 78.06 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.892 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.89 163.75 32.38 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.536 2.157 . . . . 0.0 112.219 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -79.25 145.55 64.78 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.134 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.66 115.83 4.15 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.592 2.194 . . . . 0.0 112.435 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 809' ' ' VAL . . . . . 0.582 HG12 ' H ' ' A' ' 810' ' ' ARG . 0.8 OUTLIER -98.75 176.41 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.633 179.797 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 810' ' ' ARG . . . . . 0.582 ' H ' HG12 ' A' ' 809' ' ' VAL . 0.0 OUTLIER -109.91 -35.6 6.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.019 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.962 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.114 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 4.7 m -147.05 -54.28 0.23 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.871 0.367 . . . . 0.0 110.914 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 59.68 27.67 16.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.99 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . 114.36 68.93 0.48 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.675 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 744' ' ' SER . . . . . 0.544 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 56.2 m -122.36 -56.89 1.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.068 0.461 . . . . 0.0 110.322 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -151.37 -48.81 0.12 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.208 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -124.86 95.27 4.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.532 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 747' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.0 t70 -122.45 142.42 37.18 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.501 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -38.73 -27.3 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.873 2.382 . . . . 0.0 113.547 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 749' ' ' LEU . . . . . 0.855 HD13 ' CG2' ' A' ' 774' ' ' ILE . 46.2 mt -119.99 -17.06 8.53 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 750' ' ' TYR . . . . . 0.714 ' CE2' HG21 ' A' ' 754' ' ' VAL . 71.1 t80 -55.62 -47.14 77.05 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.386 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -53.27 -35.72 60.36 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 752' ' ' GLU . . . . . 0.891 ' HB2' HD21 ' A' ' 772' ' ' LEU . 1.2 mm-40 -71.03 -43.58 67.6 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.255 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 753' ' ' ALA . . . . . 0.469 ' HB2' ' HE3' ' A' ' 782' ' ' MET . . . -61.87 -53.39 56.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.205 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 754' ' ' VAL . . . . . 0.714 HG21 ' CE2' ' A' ' 750' ' ' TYR . 3.2 t -56.18 -41.14 68.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.552 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -69.68 -35.43 75.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.333 0.587 . . . . 0.0 109.844 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 756' ' ' PHE . . . . . 0.679 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.0 t80 -66.95 -46.07 75.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.044 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 757' ' ' VAL . . . . . 0.801 HG12 HG22 ' A' ' 803' ' ' VAL . 59.5 t -70.47 -44.86 76.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.883 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 758' ' ' THR . . . . . 0.771 ' HA ' HG11 ' A' ' 803' ' ' VAL . 9.1 p -56.83 -44.87 82.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.277 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -78.84 -39.73 34.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.463 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 760' ' ' SER . . . . . 0.466 ' HB2' ' NE ' ' A' ' 762' ' ' ARG . 94.6 p -72.56 -25.04 61.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.254 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 67.98 42.71 1.8 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.377 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 762' ' ' ARG . . . . . 0.466 ' NE ' ' HB2' ' A' ' 760' ' ' SER . 0.0 OUTLIER -174.61 121.19 0.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.564 179.495 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 763' ' ' ALA . . . . . 0.546 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -93.87 89.77 6.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.972 0.415 . . . . 0.0 111.646 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 764' ' ' SER . . . . . 0.744 ' O ' HG23 ' A' ' 768' ' ' VAL . 9.9 m -123.54 118.55 27.61 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 765' ' ' ILE . . . . . 0.84 HD13 ' HB2' ' A' ' 780' ' ' ALA . 24.1 mt -53.51 -50.15 50.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.738 -179.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 766' ' ' SER . . . . . 0.438 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 11.4 t -53.35 -43.24 67.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.221 0.534 . . . . 0.0 110.499 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -69.75 -39.87 76.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.768 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 768' ' ' VAL . . . . . 0.91 HG21 HD11 ' A' ' 783' ' ' ILE . 47.0 t -61.85 -45.71 98.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.253 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 769' ' ' GLN . . . . . 0.583 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 3.3 pt20 -66.5 -33.48 75.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.416 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 770' ' ' ARG . . . . . 0.466 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 20.5 mtt180 -70.95 -42.06 70.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.037 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.414 ' HB2' ' CE1' ' A' ' 756' ' ' PHE . 0.7 OUTLIER -78.53 -38.27 40.94 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.007 -179.488 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 772' ' ' LEU . . . . . 0.891 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -90.35 -9.32 48.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.573 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt 60.16 42.24 15.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 774' ' ' ILE . . . . . 0.855 ' CG2' HD13 ' A' ' 749' ' ' LEU . 29.4 pt -112.0 -174.05 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.816 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -90.95 150.49 20.58 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.088 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -55.03 -46.52 75.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.902 0.382 . . . . 0.0 110.885 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -59.6 -45.91 90.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.206 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 778' ' ' ARG . . . . . 0.818 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -66.11 -50.44 64.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.833 0.349 . . . . 0.0 110.858 -179.788 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 779' ' ' ALA . . . . . 0.421 ' HB2' ' CD1' ' A' ' 774' ' ' ILE . . . -55.12 -50.21 69.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.202 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 780' ' ' ALA . . . . . 0.84 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.06 -46.45 78.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.985 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -58.9 -48.42 81.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.253 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 782' ' ' MET . . . . . 0.469 ' HE3' ' HB2' ' A' ' 753' ' ' ALA . 33.8 mtm -63.41 -36.36 83.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.307 0.575 . . . . 0.0 109.461 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 783' ' ' ILE . . . . . 0.91 HD11 HG21 ' A' ' 768' ' ' VAL . 7.4 mm -63.37 -40.28 88.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.18 -42.71 91.48 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 785' ' ' ALA . . . . . 0.544 ' HB1' ' O ' ' A' ' 744' ' ' SER . . . -60.02 -33.58 72.21 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.719 178.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 786' ' ' MET . . . . . 0.61 ' CE ' HD13 ' A' ' 783' ' ' ILE . 12.7 mtm -66.05 -37.62 86.29 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.062 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 787' ' ' GLU . . . . . 0.447 ' HG3' ' CZ ' ' A' ' 801' ' ' ARG . 3.3 mt-10 -63.36 -53.97 44.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.742 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 24.5 mtm -68.55 -37.64 80.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.494 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 789' ' ' ALA . . . . . 0.468 ' HB3' HG23 ' A' ' 791' ' ' VAL . . . -68.73 -21.59 64.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.796 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 790' ' ' GLY . . . . . 0.55 ' CA ' HD12 ' A' ' 804' ' ' ILE . . . 89.75 19.55 47.47 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.926 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 791' ' ' VAL . . . . . 0.689 HG11 HG22 ' A' ' 754' ' ' VAL . 11.3 t -84.45 -34.67 9.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.804 0.335 . . . . 0.0 110.756 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 792' ' ' VAL . . . . . 0.661 HG21 HH21 ' A' ' 801' ' ' ARG . 11.7 m -133.88 140.21 46.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.28 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 793' ' ' THR . . . . . 0.49 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.2 p -77.85 160.89 73.21 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 794' ' ' PRO . . . . . 0.49 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 22.7 Cg_endo -60.29 166.08 9.87 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.088 1.859 . . . . 0.0 111.967 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 2.1 mtt -56.56 158.46 4.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.196 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -101.25 176.47 5.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.921 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 9.7 t -55.63 -33.26 63.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -85.18 -17.58 36.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.121 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.6 35.96 3.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.548 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 6.0 m -127.82 130.01 47.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.956 0.408 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 801' ' ' ARG . . . . . 0.661 HH21 HG21 ' A' ' 792' ' ' VAL . 6.5 mtp85 -81.67 170.58 15.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.331 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -131.27 -170.7 2.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.659 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 803' ' ' VAL . . . . . 0.801 HG22 HG12 ' A' ' 757' ' ' VAL . 23.0 t -127.26 133.7 67.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.17 0.51 . . . . 0.0 112.098 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 804' ' ' ILE . . . . . 0.55 HD12 ' CA ' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -105.15 -28.76 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.858 178.69 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 805' ' ' ALA . . . . . 0.583 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -80.85 126.49 77.59 Favored Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.778 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.61 163.77 23.22 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.713 2.275 . . . . 0.0 112.228 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 807' ' ' ALA . . . . . 0.471 ' HB1' ' HD2' ' A' ' 808' ' ' PRO . . . -106.95 159.64 29.2 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.234 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 808' ' ' PRO . . . . . 0.471 ' HD2' ' HB1' ' A' ' 807' ' ' ALA . 71.6 Cg_endo -77.13 115.19 3.93 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.621 2.214 . . . . 0.0 112.481 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 809' ' ' VAL . . . . . 0.555 HG12 ' H ' ' A' ' 810' ' ' ARG . 0.5 OUTLIER 58.44 175.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.966 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 810' ' ' ARG . . . . . 0.555 ' H ' HG12 ' A' ' 809' ' ' VAL . 3.9 mtt180 -95.24 -33.33 12.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 3.9 p30 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.906 179.973 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 743' ' ' GLY . . . . . 0.622 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.331 0 N-CA-C 112.588 -0.205 . . . . 0.0 112.588 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . 0.503 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 0.8 OUTLIER -116.56 -49.75 2.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.141 0.496 . . . . 0.0 110.262 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.69 -50.52 0.08 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.95 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -124.1 95.23 4.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.266 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . 0.537 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.3 t70 -122.44 142.46 37.25 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.531 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 748' ' ' PRO . . . . . 0.408 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 45.7 Cg_exo -37.24 -28.88 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.057 2.505 . . . . 0.0 113.582 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 749' ' ' LEU . . . . . 0.802 HD13 ' CG2' ' A' ' 774' ' ' ILE . 31.6 mt -119.96 -16.87 8.58 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 750' ' ' TYR . . . . . 0.751 ' CE2' HG21 ' A' ' 754' ' ' VAL . 72.4 t80 -53.4 -48.54 68.6 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 120.344 -0.543 . . . . 0.0 110.457 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -53.37 -36.15 61.08 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 752' ' ' GLU . . . . . 0.948 ' HB2' HD21 ' A' ' 772' ' ' LEU . 1.8 mt-10 -70.95 -40.95 71.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.024 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 753' ' ' ALA . . . . . 0.447 ' O ' HG23 ' A' ' 757' ' ' VAL . . . -63.85 -52.93 57.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.043 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 754' ' ' VAL . . . . . 0.751 HG21 ' CE2' ' A' ' 750' ' ' TYR . 8.8 t -56.14 -39.99 62.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.281 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.65 -35.71 75.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.312 0.577 . . . . 0.0 109.461 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 756' ' ' PHE . . . . . 0.847 ' CE1' HG22 ' A' ' 768' ' ' VAL . 1.0 OUTLIER -66.58 -46.05 77.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.861 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 757' ' ' VAL . . . . . 1.026 HG12 HG22 ' A' ' 803' ' ' VAL . 45.6 t -68.6 -47.1 78.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.973 0.416 . . . . 0.0 110.452 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 758' ' ' THR . . . . . 0.7 ' HA ' HG11 ' A' ' 803' ' ' VAL . 8.4 p -53.93 -43.18 69.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.972 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -78.88 -36.81 41.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.361 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 17.9 p -76.63 -15.07 59.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.454 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 63.07 19.9 11.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.696 0.284 . . . . 0.0 111.415 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 762' ' ' ARG . . . . . 0.561 ' O ' HG13 ' A' ' 757' ' ' VAL . 5.4 ptt180 -154.87 140.03 17.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.844 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 763' ' ' ALA . . . . . 0.585 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -106.84 89.76 3.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 111.528 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 764' ' ' SER . . . . . 0.81 ' O ' HG23 ' A' ' 768' ' ' VAL . 1.4 m -122.62 118.64 28.66 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 765' ' ' ILE . . . . . 0.699 HD13 ' HB2' ' A' ' 780' ' ' ALA . 22.6 mt -53.46 -49.71 52.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.75 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 766' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 12.9 t -53.77 -43.81 69.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.2 0.524 . . . . 0.0 110.578 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -67.86 -45.12 75.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.533 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 768' ' ' VAL . . . . . 0.886 HG21 HD11 ' A' ' 783' ' ' ILE . 26.5 t -56.5 -49.15 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.364 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . 0.593 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -63.52 -33.42 75.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.594 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 770' ' ' ARG . . . . . 0.476 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 21.2 mtt180 -70.73 -42.65 70.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.231 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.493 ' HD3' ' HD2' ' A' ' 756' ' ' PHE . 0.0 OUTLIER -78.53 -36.15 45.22 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.522 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 772' ' ' LEU . . . . . 0.948 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -90.87 -10.13 43.77 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp 60.67 41.29 15.34 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 774' ' ' ILE . . . . . 0.802 ' CG2' HD13 ' A' ' 749' ' ' LEU . 22.6 pt -111.75 -173.88 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.486 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.57 153.75 23.53 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.02 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -56.94 -46.42 82.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 0.0 110.797 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -63.57 -44.52 93.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.799 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.797 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.4 OUTLIER -62.06 -50.22 72.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.753 179.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -58.34 -48.54 80.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.092 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 780' ' ' ALA . . . . . 0.699 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.07 -43.43 77.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.899 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -59.12 -48.53 81.26 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.855 0.359 . . . . 0.0 110.125 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 782' ' ' MET . . . . . 0.423 ' HE2' ' HB2' ' A' ' 753' ' ' ALA . 2.7 mtp -63.7 -38.31 90.62 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 783' ' ' ILE . . . . . 0.886 HD11 HG21 ' A' ' 768' ' ' VAL . 7.8 mm -61.31 -40.53 86.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.259 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -44.19 91.21 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 743' ' ' GLY . . . -58.97 -33.65 70.91 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.92 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 786' ' ' MET . . . . . 0.658 ' SD ' HG21 ' A' ' 757' ' ' VAL . 14.0 mtm -66.46 -37.73 85.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.106 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 787' ' ' GLU . . . . . 0.462 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 2.5 mt-10 -62.46 -54.17 44.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.519 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 73.4 mtp -68.07 -38.22 82.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.473 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -70.14 -21.57 63.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.955 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 790' ' ' GLY . . . . . 0.444 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 89.79 16.85 55.78 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.85 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.677 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 44.8 t -81.93 -31.68 10.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.796 0.331 . . . . 0.0 110.887 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 792' ' ' VAL . . . . . 0.673 HG21 HH21 ' A' ' 801' ' ' ARG . 7.1 m -135.59 140.76 43.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.074 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 793' ' ' THR . . . . . 0.525 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 9.4 p -78.59 159.69 73.87 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.737 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 794' ' ' PRO . . . . . 0.525 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 19.3 Cg_endo -59.49 167.25 6.65 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.049 1.832 . . . . 0.0 111.824 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -59.5 163.57 4.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.036 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -105.56 176.55 5.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.859 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 5.4 t -57.27 -30.33 64.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.796 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -88.13 -17.63 30.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.048 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.92 36.71 3.61 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.664 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 17.1 m -127.88 129.13 46.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.906 0.384 . . . . 0.0 111.267 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 801' ' ' ARG . . . . . 0.673 HH21 HG21 ' A' ' 792' ' ' VAL . 6.7 mtp85 -83.64 170.36 14.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.287 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 802' ' ' GLU . . . . . 0.47 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 3.2 mt-10 -134.87 174.2 10.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.698 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 803' ' ' VAL . . . . . 1.026 HG22 HG12 ' A' ' 757' ' ' VAL . 20.7 t -109.74 136.25 46.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.06 0.457 . . . . 0.0 112.13 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 804' ' ' ILE . . . . . 0.494 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -109.78 -26.94 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.264 178.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 805' ' ' ALA . . . . . 0.677 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -76.32 122.59 87.04 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.041 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -50.26 163.96 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.604 2.203 . . . . 0.0 112.897 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.137 179.99 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.606 -0.198 . . . . 0.0 112.606 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . 0.773 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 4.5 m -121.55 -62.68 1.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.122 0.487 . . . . 0.0 110.392 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -145.41 -49.16 0.23 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.234 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.62 95.23 4.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.556 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . 0.522 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.9 t70 -122.48 142.31 36.96 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.373 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -38.51 -27.45 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.848 2.366 . . . . 0.0 113.513 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 749' ' ' LEU . . . . . 0.849 HD13 ' CG2' ' A' ' 774' ' ' ILE . 48.4 mt -120.01 -17.02 8.52 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 750' ' ' TYR . . . . . 0.663 ' CE2' HG21 ' A' ' 754' ' ' VAL . 65.3 t80 -55.62 -46.82 77.33 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.349 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -53.38 -35.67 60.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 752' ' ' GLU . . . . . 0.896 ' HB2' HD21 ' A' ' 772' ' ' LEU . 2.5 mt-10 -71.02 -43.7 67.38 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.161 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 753' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 757' ' ' VAL . . . -61.92 -51.7 67.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.206 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 754' ' ' VAL . . . . . 0.749 HG22 HG11 ' A' ' 791' ' ' VAL . 2.3 t -56.33 -42.25 73.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.261 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -69.16 -35.4 76.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.192 0.52 . . . . 0.0 109.909 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 756' ' ' PHE . . . . . 0.746 ' CE2' HG22 ' A' ' 768' ' ' VAL . 2.3 t80 -66.58 -45.93 77.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.922 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 757' ' ' VAL . . . . . 0.943 HG12 HG22 ' A' ' 803' ' ' VAL . 47.4 t -69.2 -44.56 80.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.926 0.393 . . . . 0.0 110.951 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 758' ' ' THR . . . . . 0.58 ' HA ' HG11 ' A' ' 803' ' ' VAL . 3.9 p -58.21 -43.73 87.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.295 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.76 -43.23 26.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.433 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 760' ' ' SER . . . . . 0.424 ' OG ' ' HD2' ' A' ' 762' ' ' ARG . 83.1 p -71.93 -19.96 61.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.039 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 63.52 50.63 2.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.599 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 762' ' ' ARG . . . . . 0.712 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.0 OUTLIER 179.81 139.61 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.49 179.399 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 763' ' ' ALA . . . . . 0.585 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -108.75 89.73 3.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.989 0.423 . . . . 0.0 111.597 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 764' ' ' SER . . . . . 0.739 ' O ' HG23 ' A' ' 768' ' ' VAL . 0.7 OUTLIER -125.54 118.44 25.75 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.705 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 765' ' ' ILE . . . . . 0.552 HG21 ' HB2' ' A' ' 780' ' ' ALA . 2.3 mp -53.16 -51.3 40.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.897 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 766' ' ' SER . . . . . 0.477 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 12.4 t -53.42 -41.84 66.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.116 0.484 . . . . 0.0 110.622 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -70.02 -42.96 72.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.536 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 768' ' ' VAL . . . . . 0.977 HG21 HD11 ' A' ' 783' ' ' ILE . 45.6 t -59.03 -47.14 90.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.268 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . 0.593 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.7 OUTLIER -65.56 -33.55 76.19 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.694 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 770' ' ' ARG . . . . . 0.468 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 0.4 OUTLIER -68.26 -42.78 79.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.093 179.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.62 -42.06 29.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.806 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 772' ' ' LEU . . . . . 0.896 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -85.02 -8.54 58.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.742 -179.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt 58.29 41.94 22.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.185 0.517 . . . . 0.0 109.75 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 774' ' ' ILE . . . . . 0.849 ' CG2' HD13 ' A' ' 749' ' ' LEU . 29.9 pt -112.01 -173.91 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.789 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -91.87 152.52 21.43 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.872 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -57.91 -46.57 84.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.886 0.374 . . . . 0.0 110.838 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -57.49 -47.51 81.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.13 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.821 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.0 OUTLIER -66.45 -50.31 63.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.909 0.385 . . . . 0.0 110.773 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 779' ' ' ALA . . . . . 0.422 ' HB2' ' CD1' ' A' ' 774' ' ' ILE . . . -54.6 -50.05 68.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.658 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 780' ' ' ALA . . . . . 0.552 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -58.85 -42.95 90.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.826 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -58.97 -48.38 81.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.108 0.48 . . . . 0.0 109.814 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 782' ' ' MET . . . . . 0.448 ' HE3' ' HB2' ' A' ' 753' ' ' ALA . 34.8 mtm -65.27 -34.88 79.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.497 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 783' ' ' ILE . . . . . 0.977 HD11 HG21 ' A' ' 768' ' ' VAL . 6.5 mm -64.21 -37.27 79.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -64.47 -39.45 93.83 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.773 ' HB1' ' O ' ' A' ' 744' ' ' SER . . . -60.68 -34.32 74.15 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.418 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 786' ' ' MET . . . . . 0.698 ' HB3' HG22 ' A' ' 792' ' ' VAL . 14.4 mtm -66.81 -39.96 87.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.992 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -59.59 -54.18 49.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.708 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 68.4 mtm -68.92 -38.29 79.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.147 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -66.54 -21.51 66.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.728 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 790' ' ' GLY . . . . . 0.617 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 91.39 14.14 57.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.903 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.749 HG11 HG22 ' A' ' 754' ' ' VAL . 24.0 t -84.27 -30.4 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.817 0.341 . . . . 0.0 110.85 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 792' ' ' VAL . . . . . 0.698 HG22 ' HB3' ' A' ' 786' ' ' MET . 17.7 m -136.83 141.1 41.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.538 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 793' ' ' THR . . . . . 0.528 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 6.2 p -82.61 160.28 61.95 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.818 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 794' ' ' PRO . . . . . 0.528 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 20.7 Cg_endo -60.05 166.64 8.51 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.137 1.891 . . . . 0.0 112.15 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 2.6 mtt -65.5 163.26 16.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.116 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -105.48 176.55 5.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 7.3 t -58.34 -34.6 70.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -82.01 -17.5 46.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.124 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 100.82 34.6 4.59 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.608 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 15.8 m -124.68 129.06 49.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.971 0.415 . . . . 0.0 111.061 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 801' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' A' ' 763' ' ' ALA . 10.4 mtt-85 -89.9 170.71 10.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.441 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 802' ' ' GLU . . . . . 0.432 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 0.1 OUTLIER -134.14 169.82 16.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.071 179.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 803' ' ' VAL . . . . . 0.943 HG22 HG12 ' A' ' 757' ' ' VAL . 21.5 t -109.94 136.19 46.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.993 0.425 . . . . 0.0 111.718 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 804' ' ' ILE . . . . . 0.617 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -104.92 -30.53 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.261 179.083 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 805' ' ' ALA . . . . . 0.678 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -75.46 127.59 85.79 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.887 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.62 163.85 25.93 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.744 2.296 . . . . 0.0 112.159 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.243 -179.836 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 743' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.45 -0.37 0 N-CA-C 112.635 -0.186 . . . . 0.0 112.635 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . 0.44 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 1.1 m -126.37 -51.11 1.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.108 0.48 . . . . 0.0 110.542 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -154.94 -51.06 0.09 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.435 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -124.9 95.39 4.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.502 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.49 142.32 37.01 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.41 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 748' ' ' PRO . . . . . 0.408 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 44.2 Cg_exo -36.01 -29.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.094 2.53 . . . . 0.0 113.692 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 749' ' ' LEU . . . . . 0.768 HD13 ' CG2' ' A' ' 774' ' ' ILE . 39.9 mt -120.09 -17.12 8.45 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 750' ' ' TYR . . . . . 0.729 ' CE2' HG21 ' A' ' 754' ' ' VAL . 69.2 t80 -54.94 -47.67 74.16 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.29 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -53.2 -36.71 61.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 752' ' ' GLU . . . . . 1.041 ' HB3' HD21 ' A' ' 772' ' ' LEU . 4.1 tp10 -70.97 -43.39 68.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.352 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -61.51 -52.39 64.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.086 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 754' ' ' VAL . . . . . 0.73 HG22 HG11 ' A' ' 791' ' ' VAL . 4.0 t -56.15 -39.93 61.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.939 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -67.93 -36.1 79.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.387 0.613 . . . . 0.0 109.545 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 756' ' ' PHE . . . . . 0.706 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.4 t80 -66.59 -46.21 76.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.076 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 757' ' ' VAL . . . . . 0.92 HG12 HG22 ' A' ' 803' ' ' VAL . 57.6 t -69.52 -44.64 79.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.866 0.365 . . . . 0.0 110.798 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 758' ' ' THR . . . . . 0.676 ' HA ' HG11 ' A' ' 803' ' ' VAL . 4.8 p -55.26 -44.18 75.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.773 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -78.78 -31.63 46.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.27 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 24.3 p -81.02 -14.69 57.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.57 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.95 16.1 8.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.633 0.254 . . . . 0.0 111.504 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 762' ' ' ARG . . . . . 0.629 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.0 OUTLIER -151.83 142.31 22.59 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.701 0.286 . . . . 0.0 110.741 179.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 763' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -109.24 89.93 3.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.852 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 764' ' ' SER . . . . . 0.775 ' O ' HG23 ' A' ' 768' ' ' VAL . 63.7 m -121.02 118.57 30.15 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 765' ' ' ILE . . . . . 0.575 HG21 ' HB2' ' A' ' 780' ' ' ALA . 14.8 mt -54.15 -48.9 65.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.622 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 766' ' ' SER . . . . . 0.433 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 23.2 t -54.85 -42.25 71.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.229 0.537 . . . . 0.0 110.368 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -69.88 -40.25 75.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.584 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 768' ' ' VAL . . . . . 0.88 HG21 HD11 ' A' ' 783' ' ' ILE . 39.0 t -61.59 -46.66 96.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.212 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . 0.591 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.15 -34.07 77.51 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.618 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 770' ' ' ARG . . . . . 0.492 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 12.6 mtt180 -71.0 -42.19 69.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.131 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.419 ' HB2' ' CE1' ' A' ' 756' ' ' PHE . 0.1 OUTLIER -78.56 -36.06 45.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.961 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 772' ' ' LEU . . . . . 1.041 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -91.23 -9.92 43.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.755 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt 59.76 41.55 18.13 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 774' ' ' ILE . . . . . 0.768 ' CG2' HD13 ' A' ' 749' ' ' LEU . 20.7 pt -111.82 -174.01 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.345 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.79 150.97 21.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.013 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -54.94 -45.87 74.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.948 0.404 . . . . 0.0 110.748 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -62.96 -45.39 92.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.764 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.767 ' HE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -62.18 -50.31 72.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.762 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.53 -50.63 71.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.395 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 780' ' ' ALA . . . . . 0.575 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -55.99 -39.3 71.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.759 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -59.0 -48.38 81.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.897 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 782' ' ' MET . . . . . 0.488 ' HE3' ' HB2' ' A' ' 749' ' ' LEU . 0.0 OUTLIER -63.45 -44.68 93.81 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 783' ' ' ILE . . . . . 0.88 HD11 HG21 ' A' ' 768' ' ' VAL . 16.9 mm -54.69 -44.59 70.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.492 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.02 -46.63 82.2 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.519 ' HB3' ' CE1' ' A' ' 750' ' ' TYR . . . -58.17 -33.54 69.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.888 178.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 786' ' ' MET . . . . . 0.578 ' HB3' HG13 ' A' ' 792' ' ' VAL . 13.2 mtm -66.11 -37.59 86.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.131 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 787' ' ' GLU . . . . . 0.463 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 2.8 mt-10 -63.32 -53.86 46.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.13 0.491 . . . . 0.0 110.526 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 63.2 mtp -67.16 -38.01 84.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.352 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -71.09 -21.51 62.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.973 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 790' ' ' GLY . . . . . 0.539 ' CA ' HD12 ' A' ' 804' ' ' ILE . . . 89.35 18.33 53.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.863 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.73 HG11 HG22 ' A' ' 754' ' ' VAL . 41.0 t -83.45 -32.05 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.797 0.332 . . . . 0.0 110.85 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 792' ' ' VAL . . . . . 0.663 HG21 HH21 ' A' ' 801' ' ' ARG . 8.4 m -135.34 142.08 40.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.1 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 793' ' ' THR . . . . . 0.49 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.2 p -80.99 160.61 65.65 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.773 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 794' ' ' PRO . . . . . 0.49 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 18.6 Cg_endo -58.26 167.38 4.75 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.04 1.826 . . . . 0.0 111.93 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 1.2 mtt -60.12 163.37 4.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.045 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 37.8 m-20 -103.83 176.5 5.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.876 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 5.4 t -57.73 -31.02 66.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -87.08 -17.5 32.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.128 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 102.86 35.98 3.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.748 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 15.3 m -127.77 129.53 47.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.947 0.403 . . . . 0.0 111.137 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 801' ' ' ARG . . . . . 0.663 HH21 HG21 ' A' ' 792' ' ' VAL . 6.7 mtp85 -82.23 170.57 15.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.181 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -132.85 178.2 7.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.637 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 803' ' ' VAL . . . . . 0.92 HG22 HG12 ' A' ' 757' ' ' VAL . 19.9 t -116.21 134.07 60.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.102 0.477 . . . . 0.0 112.218 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 804' ' ' ILE . . . . . 0.539 HD12 ' CA ' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -104.73 -29.38 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.767 178.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 805' ' ' ALA . . . . . 0.603 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -79.86 123.42 83.78 Favored Pre-proline 0 N--CA 1.451 -0.401 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.463 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.2 163.74 22.09 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.483 2.122 . . . . 0.0 112.163 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.094 -179.77 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 743' ' ' GLY . . . . . 0.673 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.442 -0.263 . . . . 0.0 112.442 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . 0.86 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 0.1 OUTLIER -118.74 -74.38 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.98 0.419 . . . . 0.0 110.636 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -134.0 -48.29 0.8 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.558 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -125.29 95.43 4.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.751 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.4 t70 -122.27 141.89 35.62 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.373 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -36.5 -29.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.125 2.55 . . . . 0.0 113.706 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 749' ' ' LEU . . . . . 0.825 HD13 ' CG2' ' A' ' 774' ' ' ILE . 53.5 mt -120.02 -17.26 8.46 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 750' ' ' TYR . . . . . 0.682 ' CE2' HG21 ' A' ' 754' ' ' VAL . 65.9 t80 -55.88 -46.95 78.18 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.678 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -53.26 -36.06 60.72 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 752' ' ' GLU . . . . . 0.89 ' HB3' HD21 ' A' ' 772' ' ' LEU . 0.0 OUTLIER -71.15 -45.41 63.6 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.138 178.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 753' ' ' ALA . . . . . 0.457 ' HB2' ' HE3' ' A' ' 782' ' ' MET . . . -59.22 -52.86 63.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.3 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 754' ' ' VAL . . . . . 0.682 HG21 ' CE2' ' A' ' 750' ' ' TYR . 2.4 t -56.17 -42.29 72.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.958 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 37.5 mtt180 -66.88 -35.41 79.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.322 0.582 . . . . 0.0 109.692 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 756' ' ' PHE . . . . . 0.754 ' CE2' HG22 ' A' ' 768' ' ' VAL . 3.4 t80 -66.66 -46.05 76.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.911 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 757' ' ' VAL . . . . . 0.882 HG12 HG22 ' A' ' 803' ' ' VAL . 40.8 t -70.28 -44.11 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.992 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 758' ' ' THR . . . . . 0.595 ' HA ' HG11 ' A' ' 803' ' ' VAL . 5.1 p -57.54 -42.82 83.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.953 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.86 -40.85 31.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.26 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 21.1 p -73.86 -18.68 60.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.246 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 63.16 28.58 15.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.183 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 762' ' ' ARG . . . . . 0.514 ' C ' HG13 ' A' ' 757' ' ' VAL . 13.0 ptt180 -157.49 131.18 7.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.901 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 763' ' ' ALA . . . . . 0.474 ' HB2' ' CG1' ' A' ' 792' ' ' VAL . . . -102.35 89.84 3.7 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.973 0.416 . . . . 0.0 111.253 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 764' ' ' SER . . . . . 0.805 ' O ' HG23 ' A' ' 768' ' ' VAL . 1.0 OUTLIER -126.08 118.64 25.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.434 179.082 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 765' ' ' ILE . . . . . 0.875 HD13 ' CB ' ' A' ' 780' ' ' ALA . 23.2 mt -53.05 -50.64 44.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.822 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 766' ' ' SER . . . . . 0.444 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 47.5 t -53.3 -43.56 67.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.207 0.527 . . . . 0.0 110.659 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.78 76.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.634 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 768' ' ' VAL . . . . . 1.002 HG21 HD11 ' A' ' 783' ' ' ILE . 40.1 t -58.67 -47.25 89.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.291 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . 0.59 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.8 OUTLIER -65.64 -33.34 75.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.679 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 770' ' ' ARG . . . . . 0.465 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 14.9 mtt180 -69.05 -42.22 76.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.109 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 7.4 tptt -78.6 -42.18 29.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.911 0.386 . . . . 0.0 111.688 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 772' ' ' LEU . . . . . 0.89 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -84.81 -9.09 58.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.854 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt 57.7 42.75 23.25 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 774' ' ' ILE . . . . . 0.825 ' CG2' HD13 ' A' ' 749' ' ' LEU . 24.7 pt -111.8 -173.92 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.73 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -91.08 151.31 21.01 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.074 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -56.53 -46.59 80.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.935 0.397 . . . . 0.0 110.778 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -59.51 -44.63 93.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.069 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.807 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -67.18 -50.34 61.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.888 0.375 . . . . 0.0 110.869 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.1 -48.59 75.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.269 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 780' ' ' ALA . . . . . 0.875 ' CB ' HD13 ' A' ' 765' ' ' ILE . . . -56.2 -45.98 79.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.901 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 -58.92 -48.5 81.24 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.059 0.457 . . . . 0.0 110.333 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 782' ' ' MET . . . . . 0.457 ' HE3' ' HB2' ' A' ' 753' ' ' ALA . 32.7 mtm -64.84 -34.96 79.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.884 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 783' ' ' ILE . . . . . 1.002 HD11 HG21 ' A' ' 768' ' ' VAL . 7.7 mm -65.38 -38.56 82.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.199 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -63.65 -38.82 92.56 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.86 ' HB1' ' O ' ' A' ' 744' ' ' SER . . . -61.75 -34.28 75.56 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.37 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 786' ' ' MET . . . . . 0.744 ' HB3' HG22 ' A' ' 792' ' ' VAL . 13.9 mtm -66.68 -39.13 88.01 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.087 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -61.18 -54.04 49.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.663 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 49.6 mtm -68.46 -37.95 80.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.158 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -67.11 -21.5 65.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.716 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 790' ' ' GLY . . . . . 0.678 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 90.93 18.29 47.88 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.835 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.657 HG11 HG22 ' A' ' 754' ' ' VAL . 21.7 t -88.57 -30.33 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.76 0.314 . . . . 0.0 111.122 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 792' ' ' VAL . . . . . 0.744 HG22 ' HB3' ' A' ' 786' ' ' MET . 19.4 m -137.38 137.69 45.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.419 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 793' ' ' THR . . . . . . . . . . . . . 1.1 p -85.07 159.98 55.92 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.845 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 794' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -52.12 172.09 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.267 1.978 . . . . 0.0 112.368 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.02 164.99 24.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.98 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -105.52 176.48 5.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.852 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 3.2 t -60.67 -34.73 74.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -79.27 -17.57 54.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 102.74 29.14 5.98 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.514 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 9.8 m -123.68 129.93 51.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 111.053 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 801' ' ' ARG . . . . . 0.492 ' NH1' HG21 ' A' ' 792' ' ' VAL . 7.1 mtt-85 -85.34 170.66 12.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.186 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -128.64 167.19 17.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.104 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 803' ' ' VAL . . . . . 0.882 HG22 HG12 ' A' ' 757' ' ' VAL . 22.0 t -110.47 135.06 50.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.921 0.391 . . . . 0.0 111.558 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 804' ' ' ILE . . . . . 0.678 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -103.58 -27.76 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.251 179.178 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 805' ' ' ALA . . . . . 0.635 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -82.85 123.54 77.89 Favored Pre-proline 0 N--CA 1.453 -0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.887 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.4 163.7 28.65 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.608 2.205 . . . . 0.0 112.167 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.162 -179.86 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 743' ' ' GLY . . . . . 0.596 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.45 -0.375 0 N-CA-C 112.587 -0.205 . . . . 0.0 112.587 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . 0.436 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 64.8 m -117.29 -46.68 2.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.153 0.501 . . . . 0.0 110.15 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -159.97 -49.48 0.05 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.132 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -126.0 95.16 4.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.386 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 13.2 t70 -122.47 143.33 39.39 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.335 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 748' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 46.8 Cg_exo -37.7 -28.04 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.044 2.496 . . . . 0.0 113.563 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 749' ' ' LEU . . . . . 0.882 HD13 ' CG2' ' A' ' 774' ' ' ILE . 28.5 mt -119.97 -17.08 8.53 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 750' ' ' TYR . . . . . 0.734 ' CE2' HG21 ' A' ' 754' ' ' VAL . 80.1 t80 -52.61 -50.17 63.62 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.503 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -53.07 -36.54 60.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 752' ' ' GLU . . . . . 0.891 ' HB2' HD21 ' A' ' 772' ' ' LEU . 40.5 mt-10 -70.95 -40.76 71.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.966 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 753' ' ' ALA . . . . . 0.519 ' HB2' ' HE1' ' A' ' 782' ' ' MET . . . -63.84 -53.38 51.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.075 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 754' ' ' VAL . . . . . 0.734 HG21 ' CE2' ' A' ' 750' ' ' TYR . 8.0 t -56.15 -39.39 58.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.301 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -70.14 -36.83 75.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.231 0.539 . . . . 0.0 109.711 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 756' ' ' PHE . . . . . 0.786 ' CE1' HG22 ' A' ' 768' ' ' VAL . 1.0 OUTLIER -66.77 -46.19 76.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.676 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 757' ' ' VAL . . . . . 0.676 HG11 ' CG1' ' A' ' 792' ' ' VAL . 61.5 t -69.29 -42.94 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 110.775 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 758' ' ' THR . . . . . 0.552 ' HA ' HG11 ' A' ' 803' ' ' VAL . 8.0 p -56.78 -44.57 81.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.85 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -78.82 -33.5 46.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.241 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 760' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' A' ' 756' ' ' PHE . 18.5 p -74.69 -16.39 60.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.244 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 64.72 15.03 9.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.436 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 762' ' ' ARG . . . . . 0.538 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.1 OUTLIER -153.71 143.01 21.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.445 179.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 763' ' ' ALA . . . . . 0.561 ' HB2' ' CG1' ' A' ' 792' ' ' VAL . . . -107.74 89.62 3.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.883 0.373 . . . . 0.0 111.941 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 764' ' ' SER . . . . . 0.733 ' O ' HG23 ' A' ' 768' ' ' VAL . 1.3 m -118.97 118.47 31.58 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 765' ' ' ILE . . . . . 0.537 HD13 ' HB2' ' A' ' 780' ' ' ALA . 14.7 mt -54.1 -48.6 65.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.506 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 766' ' ' SER . . . . . 0.474 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 16.7 p -55.08 -42.15 72.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.303 0.573 . . . . 0.0 110.538 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -70.51 -40.91 73.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.571 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 768' ' ' VAL . . . . . 0.871 HG21 HD11 ' A' ' 783' ' ' ILE . 48.2 t -59.64 -47.86 89.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . 0.584 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.21 -33.9 77.1 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.804 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 770' ' ' ARG . . . . . 0.48 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 15.9 mtt180 -69.35 -42.42 75.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.184 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.404 ' HD3' ' HE2' ' A' ' 756' ' ' PHE . 2.3 tptt -78.63 -40.03 35.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.829 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 772' ' ' LEU . . . . . 0.891 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -86.69 -9.66 55.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.847 -179.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp 60.92 40.6 15.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.019 0.438 . . . . 0.0 109.874 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 774' ' ' ILE . . . . . 0.882 ' CG2' HD13 ' A' ' 749' ' ' LEU . 21.1 pt -111.85 -173.86 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.542 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.91 150.27 20.93 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.028 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -54.72 -45.12 74.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.966 0.412 . . . . 0.0 110.722 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -63.85 -47.82 79.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.873 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.768 ' HE ' HD12 ' A' ' 749' ' ' LEU . 0.7 OUTLIER -60.06 -50.31 74.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.935 0.398 . . . . 0.0 110.716 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -55.99 -48.67 75.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.272 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 780' ' ' ALA . . . . . 0.537 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.2 -41.67 75.95 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.003 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 17.4 mtm-85 -58.87 -47.31 85.38 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 782' ' ' MET . . . . . 0.519 ' HE1' ' HB2' ' A' ' 753' ' ' ALA . 2.3 mtp -63.61 -42.91 98.18 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 783' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 768' ' ' VAL . 9.9 mm -57.5 -37.68 59.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.71 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -62.31 -45.88 91.25 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 743' ' ' GLY . . . -58.12 -33.59 69.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.805 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 786' ' ' MET . . . . . 0.745 ' HB3' HG22 ' A' ' 792' ' ' VAL . 13.2 mtm -66.49 -39.65 88.86 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.476 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.58 -49.68 74.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.12 0.486 . . . . 0.0 110.518 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 32.2 mtm -70.57 -36.92 73.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.371 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -71.25 -21.53 62.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.123 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 790' ' ' GLY . . . . . 0.75 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 92.05 19.75 38.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.693 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.766 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 63.2 t -88.94 -30.47 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 122.517 0.327 . . . . 0.0 111.092 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 792' ' ' VAL . . . . . 0.745 HG22 ' HB3' ' A' ' 786' ' ' MET . 20.4 m -139.33 142.79 32.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.53 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 793' ' ' THR . . . . . 0.552 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.2 p -85.24 164.69 40.01 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 794' ' ' PRO . . . . . 0.552 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 29.5 Cg_endo -61.94 164.65 16.05 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 121.989 1.793 . . . . 0.0 112.003 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.67 162.48 3.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.329 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -105.18 176.5 5.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.743 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 15.3 t -63.18 -32.64 74.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -80.66 -17.64 50.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.231 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 102.48 28.56 6.31 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.364 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 57.5 m -125.75 130.75 52.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.988 0.423 . . . . 0.0 110.919 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 801' ' ' ARG . . . . . 0.508 ' HB3' ' HB3' ' A' ' 763' ' ' ALA . 15.4 mtt-85 -84.25 170.7 13.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.44 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -129.68 167.73 17.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.992 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 803' ' ' VAL . . . . . 0.611 HG22 HG12 ' A' ' 757' ' ' VAL . 11.9 t -108.8 139.19 32.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.004 0.431 . . . . 0.0 112.076 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 804' ' ' ILE . . . . . 0.75 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -110.84 -27.96 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.454 178.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 805' ' ' ALA . . . . . 0.766 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -77.97 121.05 83.51 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.078 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -50.29 163.94 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.731 2.287 . . . . 0.0 112.916 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.552 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.997 179.824 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 743' ' ' GLY . . . . . 0.454 ' CA ' ' HG3' ' A' ' 782' ' ' MET . . . . . . . . 0 N--CA 1.45 -0.371 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.72 -158.92 0.65 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.579 0.228 . . . . 0.0 110.626 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -51.91 -42.97 63.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.842 0.353 . . . . 0.0 111.329 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.01 95.42 4.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.059 0.456 . . . . 0.0 110.911 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 12.1 t70 -122.61 142.52 37.68 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.647 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 748' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 43.0 Cg_exo -37.49 -28.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.034 2.49 . . . . 0.0 113.672 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 749' ' ' LEU . . . . . 0.819 HD13 ' CG2' ' A' ' 774' ' ' ILE . 40.6 mt -119.93 -17.27 8.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 750' ' ' TYR . . . . . 0.727 ' CE2' HG21 ' A' ' 754' ' ' VAL . 64.5 t80 -53.81 -47.42 70.86 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.67 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -53.34 -37.41 62.31 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 752' ' ' GLU . . . . . 1.072 ' HB3' HD21 ' A' ' 772' ' ' LEU . 0.7 OUTLIER -70.9 -39.95 72.48 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.264 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 753' ' ' ALA . . . . . 0.489 ' HB2' ' HE1' ' A' ' 782' ' ' MET . . . -63.89 -54.35 36.11 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.217 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 754' ' ' VAL . . . . . 0.764 HG22 HG11 ' A' ' 791' ' ' VAL . 4.3 t -56.19 -38.3 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.01 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 755' ' ' ARG . . . . . 0.41 ' HA ' ' HG1' ' A' ' 758' ' ' THR . 53.8 ttt85 -69.53 -36.58 76.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.646 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 756' ' ' PHE . . . . . 0.67 ' CE2' HG22 ' A' ' 768' ' ' VAL . 3.3 t80 -67.07 -46.11 75.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.189 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 757' ' ' VAL . . . . . 0.897 HG13 ' O ' ' A' ' 762' ' ' ARG . 39.0 t -70.28 -45.42 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 120.928 0.394 . . . . 0.0 110.715 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 758' ' ' THR . . . . . 0.602 ' HA ' HG11 ' A' ' 803' ' ' VAL . 17.8 p -53.78 -44.18 69.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.815 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.96 -35.55 50.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.347 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 16.7 p -78.51 -14.98 59.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.45 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 63.46 19.86 11.93 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.727 0.299 . . . . 0.0 111.348 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 762' ' ' ARG . . . . . 0.897 ' O ' HG13 ' A' ' 757' ' ' VAL . 10.3 ptt180 -152.72 143.78 23.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.569 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 763' ' ' ALA . . . . . 0.692 ' HB2' HG11 ' A' ' 757' ' ' VAL . . . -115.47 89.93 3.22 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 764' ' ' SER . . . . . 0.622 ' O ' HG23 ' A' ' 768' ' ' VAL . 7.3 m -120.96 118.31 29.53 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 765' ' ' ILE . . . . . 0.697 HD13 ' HB2' ' A' ' 780' ' ' ALA . 21.2 mt -51.12 -46.06 31.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.525 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 766' ' ' SER . . . . . 0.503 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 11.7 p -58.53 -39.19 79.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.347 0.594 . . . . 0.0 110.393 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . 0.414 ' HB1' ' HZ ' ' A' ' 756' ' ' PHE . . . -72.39 -35.94 68.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.481 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 768' ' ' VAL . . . . . 0.851 HG21 HD11 ' A' ' 783' ' ' ILE . 40.3 t -66.88 -47.28 83.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.384 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . 0.619 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.57 -33.97 77.15 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.845 0.355 . . . . 0.0 110.599 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 19.0 mtt-85 -70.62 -42.16 71.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.985 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.61 -36.95 43.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.297 -0.41 . . . . 0.0 112.095 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 772' ' ' LEU . . . . . 1.072 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -89.8 -10.65 44.69 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp 61.61 40.43 13.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.237 0.541 . . . . 0.0 109.55 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 774' ' ' ILE . . . . . 0.819 ' CG2' HD13 ' A' ' 749' ' ' LEU . 23.6 pt -111.75 -174.53 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.381 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.15 150.08 21.17 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.163 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -54.11 -45.85 71.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 110.776 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -63.03 -47.54 82.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.854 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.781 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -59.94 -49.6 77.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.755 179.821 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.02 -50.0 74.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.57 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 780' ' ' ALA . . . . . 0.697 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.02 -40.76 73.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.584 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.74 -48.02 82.64 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.994 0.426 . . . . 0.0 109.913 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 782' ' ' MET . . . . . 0.489 ' HE1' ' HB2' ' A' ' 753' ' ' ALA . 2.0 mtp -62.78 -43.72 98.07 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 783' ' ' ILE . . . . . 0.851 HD11 HG21 ' A' ' 768' ' ' VAL . 12.4 mm -57.16 -40.59 74.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.456 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.7 -45.43 92.15 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.568 ' HB3' ' CE1' ' A' ' 750' ' ' TYR . . . -59.63 -33.37 71.43 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.79 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 786' ' ' MET . . . . . 0.605 ' CE ' HD13 ' A' ' 783' ' ' ILE . 13.3 mtm -64.96 -37.63 88.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.063 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 787' ' ' GLU . . . . . 0.474 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 1.6 mt-10 -64.54 -52.88 55.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.458 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 51.5 mtm -66.5 -38.4 87.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.764 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -73.0 -21.61 60.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.067 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 790' ' ' GLY . . . . . 0.51 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 90.91 18.95 45.22 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.754 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.764 HG11 HG22 ' A' ' 754' ' ' VAL . 44.0 t -83.26 -30.05 8.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.726 0.298 . . . . 0.0 110.825 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 792' ' ' VAL . . . . . 0.689 HG21 HH21 ' A' ' 801' ' ' ARG . 5.7 m -137.15 143.66 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.901 0.381 . . . . 0.0 111.434 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 793' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.6 p -81.9 160.63 63.12 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.961 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 794' ' ' PRO . . . . . 0.499 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 22.5 Cg_endo -60.55 167.0 8.82 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.122 1.882 . . . . 0.0 111.988 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 1.5 mtt -58.31 158.83 6.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.243 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -99.55 176.51 5.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.881 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 10.0 t -58.44 -29.13 65.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.981 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -89.08 -17.53 29.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.188 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 103.9 35.16 3.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.728 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 18.0 m -127.79 129.73 47.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.779 0.323 . . . . 0.0 111.14 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 801' ' ' ARG . . . . . 0.689 HH21 HG21 ' A' ' 792' ' ' VAL . 6.8 mtp85 -81.7 170.54 15.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.015 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 802' ' ' GLU . . . . . 0.415 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 2.6 mt-10 -134.97 173.53 11.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.8 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 803' ' ' VAL . . . . . 0.879 HG22 HG12 ' A' ' 757' ' ' VAL . 31.2 t -109.94 135.89 47.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 804' ' ' ILE . . . . . 0.514 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -106.07 -27.87 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.693 178.246 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 805' ' ' ALA . . . . . 0.615 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -81.67 123.88 80.22 Favored Pre-proline 0 N--CA 1.453 -0.289 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.71 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -63.16 163.81 21.78 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.66 2.24 . . . . 0.0 112.604 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.102 -179.879 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.617 -0.193 . . . . 0.0 112.617 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . 0.775 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 0.8 OUTLIER -121.98 -60.95 1.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.056 0.455 . . . . 0.0 110.537 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -144.71 -49.75 0.26 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.331 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -124.03 95.34 4.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.585 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . 0.509 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.31 141.82 35.54 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.476 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -36.87 -29.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.172 2.581 . . . . 0.0 113.614 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 749' ' ' LEU . . . . . 0.806 HD13 ' CG2' ' A' ' 774' ' ' ILE . 42.9 mt -119.94 -16.98 8.57 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 750' ' ' TYR . . . . . 0.754 ' CE2' HG21 ' A' ' 754' ' ' VAL . 68.0 t80 -54.62 -46.75 73.91 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.123 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -53.49 -36.1 61.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 752' ' ' GLU . . . . . 0.928 ' HB2' HD21 ' A' ' 772' ' ' LEU . 1.3 mm-40 -71.04 -42.62 69.24 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.297 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -62.43 -53.77 50.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.021 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 754' ' ' VAL . . . . . 0.754 HG21 ' CE2' ' A' ' 750' ' ' TYR . 5.0 t -56.22 -42.26 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.324 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -67.26 -35.24 79.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.272 0.558 . . . . 0.0 109.622 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 756' ' ' PHE . . . . . 0.661 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.5 t80 -67.82 -46.12 72.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.141 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 757' ' ' VAL . . . . . 0.878 HG12 HG22 ' A' ' 803' ' ' VAL . 43.9 t -71.18 -42.24 75.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.796 0.331 . . . . 0.0 110.873 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 758' ' ' THR . . . . . 0.702 ' HA ' HG11 ' A' ' 803' ' ' VAL . 14.3 p -60.58 -40.3 91.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.016 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -78.03 -49.09 14.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.329 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 760' ' ' SER . . . . . 0.467 ' O ' ' HD3' ' A' ' 762' ' ' ARG . 7.8 p -69.55 -28.13 65.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.902 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 761' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 760' ' ' SER . 20.7 mmt180 73.96 32.11 1.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.55 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 762' ' ' ARG . . . . . 0.667 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.3 OUTLIER -150.14 131.18 14.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.699 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 763' ' ' ALA . . . . . 0.673 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -107.4 89.67 3.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.047 0.451 . . . . 0.0 110.638 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 764' ' ' SER . . . . . 0.711 ' O ' HG23 ' A' ' 768' ' ' VAL . 6.2 m -131.74 118.58 20.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.569 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 765' ' ' ILE . . . . . 0.888 HD13 ' HB2' ' A' ' 780' ' ' ALA . 23.3 mt -51.44 -49.79 31.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.802 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 766' ' ' SER . . . . . 0.443 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 11.7 t -54.19 -43.03 70.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.097 0.475 . . . . 0.0 110.649 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -69.82 -39.68 76.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.772 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 768' ' ' VAL . . . . . 0.899 HG21 HD11 ' A' ' 783' ' ' ILE . 45.4 t -62.54 -45.83 97.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.29 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . 0.59 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.4 OUTLIER -66.36 -33.47 75.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.542 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 770' ' ' ARG . . . . . 0.473 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 17.8 mtt180 -71.32 -42.3 68.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.084 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -37.11 42.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.954 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 772' ' ' LEU . . . . . 0.928 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -90.52 -10.29 44.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.664 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt 60.77 41.53 14.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.185 0.517 . . . . 0.0 109.688 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 774' ' ' ILE . . . . . 0.806 ' CG2' HD13 ' A' ' 749' ' ' LEU . 26.0 pt -111.9 -174.0 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.595 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.58 154.19 24.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.081 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -58.75 -46.11 88.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 0.0 110.71 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -63.53 -43.59 96.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.877 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.772 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -64.44 -50.25 68.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.716 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.0 -50.12 71.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.301 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 780' ' ' ALA . . . . . 0.888 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -55.96 -39.62 72.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.786 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.0 -48.49 81.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.977 0.418 . . . . 0.0 110.019 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 782' ' ' MET . . . . . 0.445 ' CE ' ' CB ' ' A' ' 749' ' ' LEU . 0.0 OUTLIER -63.9 -44.58 92.54 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 783' ' ' ILE . . . . . 0.899 HD11 HG21 ' A' ' 768' ' ' VAL . 7.4 mm -56.33 -41.46 71.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.708 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.96 -45.04 91.49 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.775 ' HB1' ' O ' ' A' ' 744' ' ' SER . . . -59.61 -33.57 71.66 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.519 -1.218 . . . . 0.0 109.816 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 786' ' ' MET . . . . . 0.57 ' HB3' HG22 ' A' ' 792' ' ' VAL . 13.8 mtm -65.4 -37.64 87.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.047 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 787' ' ' GLU . . . . . 0.455 ' HG3' ' CZ ' ' A' ' 801' ' ' ARG . 2.6 mt-10 -64.19 -54.04 39.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.704 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 40.0 mtp -67.28 -38.19 84.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.551 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 789' ' ' ALA . . . . . 0.469 ' HB3' HG23 ' A' ' 791' ' ' VAL . . . -70.41 -21.71 62.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.951 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 790' ' ' GLY . . . . . 0.451 ' CA ' HD12 ' A' ' 804' ' ' ILE . . . 89.54 19.79 47.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.978 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.671 HG11 HG22 ' A' ' 754' ' ' VAL . 14.1 t -83.61 -32.58 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 120.892 0.377 . . . . 0.0 110.866 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 792' ' ' VAL . . . . . 0.679 HG21 HH21 ' A' ' 801' ' ' ARG . 11.3 m -134.49 139.13 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.184 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 793' ' ' THR . . . . . 0.502 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 8.0 p -75.95 158.56 82.26 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.918 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 794' ' ' PRO . . . . . 0.502 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 19.7 Cg_endo -59.52 166.66 7.55 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.14 1.893 . . . . 0.0 112.01 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -56.98 161.02 3.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.149 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -104.73 176.55 5.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.788 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 5.2 t -54.68 -32.78 59.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.032 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -87.21 -17.64 32.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.15 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.46 37.29 3.56 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.5 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 16.2 m -127.82 129.14 46.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.003 0.43 . . . . 0.0 111.042 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 801' ' ' ARG . . . . . 0.679 HH21 HG21 ' A' ' 792' ' ' VAL . 6.8 mtp85 -83.64 170.62 14.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.327 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 802' ' ' GLU . . . . . 0.473 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 3.0 mt-10 -132.43 -170.77 2.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.606 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 803' ' ' VAL . . . . . 0.878 HG22 HG12 ' A' ' 757' ' ' VAL . 20.6 t -125.03 135.16 64.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.067 0.46 . . . . 0.0 112.018 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 804' ' ' ILE . . . . . 0.483 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -108.43 -33.66 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.352 179.241 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 805' ' ' ALA . . . . . 0.868 ' HB1' ' HD2' ' A' ' 806' ' ' PRO . . . -59.16 171.04 0.77 Allowed Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.242 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 806' ' ' PRO . . . . . 0.868 ' HD2' ' HB1' ' A' ' 805' ' ' ALA . 56.6 Cg_endo -71.2 163.62 38.53 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.771 2.314 . . . . 0.0 112.233 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.101 -179.947 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 743' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.452 -0.253 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . 0.807 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 5.9 m -116.16 -62.27 1.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.14 0.495 . . . . 0.0 110.73 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -140.01 -49.85 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.199 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -123.67 95.3 4.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.364 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . 0.552 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 14.1 t70 -122.28 142.35 36.72 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.426 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -33.82 -31.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.387 2.724 . . . . 0.0 114.016 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 749' ' ' LEU . . . . . 0.799 HD13 ' CG2' ' A' ' 774' ' ' ILE . 33.8 mt -120.06 -17.15 8.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 750' ' ' TYR . . . . . 0.65 ' CE2' HG21 ' A' ' 754' ' ' VAL . 67.9 t80 -53.26 -47.43 69.08 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.968 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -53.23 -37.18 61.81 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 752' ' ' GLU . . . . . 1.054 ' HB3' HD21 ' A' ' 772' ' ' LEU . 51.7 tt0 -71.01 -41.56 70.74 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.305 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 753' ' ' ALA . . . . . 0.497 ' HB2' ' HE2' ' A' ' 782' ' ' MET . . . -62.53 -51.52 67.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.034 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 754' ' ' VAL . . . . . 0.85 HG22 HG11 ' A' ' 791' ' ' VAL . 2.2 t -56.15 -41.2 68.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.735 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -67.91 -35.4 78.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.746 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 756' ' ' PHE . . . . . 0.744 ' CE2' HG22 ' A' ' 768' ' ' VAL . 3.5 t80 -67.01 -46.09 75.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.991 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 757' ' ' VAL . . . . . 1.055 HG12 HG22 ' A' ' 803' ' ' VAL . 43.6 t -70.16 -47.34 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 120.811 0.338 . . . . 0.0 110.794 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 758' ' ' THR . . . . . 0.796 ' HA ' HG11 ' A' ' 803' ' ' VAL . 6.6 p -54.78 -43.74 73.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.002 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -78.88 -37.95 38.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.182 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 54.6 p -75.79 -16.25 60.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.46 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 60.11 31.38 20.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.931 0.396 . . . . 0.0 110.552 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 762' ' ' ARG . . . . . 0.632 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.3 OUTLIER -160.55 137.3 8.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.338 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 763' ' ' ALA . . . . . 0.493 ' HB3' ' CB ' ' A' ' 801' ' ' ARG . . . -110.58 89.84 3.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.91 0.386 . . . . 0.0 111.409 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 764' ' ' SER . . . . . 0.758 ' O ' HG23 ' A' ' 768' ' ' VAL . 15.2 m -127.14 118.61 24.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.617 178.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 765' ' ' ILE . . . . . 0.882 HD13 ' HB2' ' A' ' 780' ' ' ALA . 25.0 mt -51.83 -50.19 33.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.755 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 766' ' ' SER . . . . . 0.433 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 22.0 t -53.45 -43.82 68.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.238 0.542 . . . . 0.0 110.537 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -69.12 -41.59 77.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.661 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 768' ' ' VAL . . . . . 0.925 HG21 HD11 ' A' ' 783' ' ' ILE . 40.9 t -59.4 -47.53 90.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.212 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . 0.578 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.7 OUTLIER -65.46 -33.39 75.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.744 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 770' ' ' ARG . . . . . 0.47 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 5.8 mtt180 -68.75 -42.49 77.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.133 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.63 -42.13 29.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.877 0.37 . . . . 0.0 111.684 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 772' ' ' LEU . . . . . 1.054 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -84.81 -8.58 58.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.791 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 22.6 mtpt 57.41 42.35 24.86 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 774' ' ' ILE . . . . . 0.799 ' CG2' HD13 ' A' ' 749' ' ' LEU . 30.1 pt -111.87 -174.14 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.626 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.25 155.45 25.19 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.238 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -59.2 -46.56 88.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.916 0.389 . . . . 0.0 110.653 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -62.22 -47.47 84.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.771 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.623 ' NE ' HD12 ' A' ' 749' ' ' LEU . 2.8 ttt180 -61.17 -50.37 73.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.775 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.41 -50.55 71.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.427 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 780' ' ' ALA . . . . . 0.882 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.03 -41.03 74.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.81 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -58.95 -48.42 81.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.978 0.418 . . . . 0.0 110.009 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 782' ' ' MET . . . . . 0.497 ' HE2' ' HB2' ' A' ' 753' ' ' ALA . 0.5 OUTLIER -63.67 -43.12 97.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.386 178.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 783' ' ' ILE . . . . . 0.925 HD11 HG21 ' A' ' 768' ' ' VAL . 7.6 mm -56.96 -41.72 77.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.318 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.21 -44.9 92.27 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.807 ' HB1' ' O ' ' A' ' 744' ' ' SER . . . -58.39 -33.63 69.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.048 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 786' ' ' MET . . . . . 0.594 ' HB3' HG22 ' A' ' 792' ' ' VAL . 16.3 mtm -66.85 -38.59 86.65 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.991 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 787' ' ' GLU . . . . . 0.444 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 2.0 mt-10 -61.55 -54.05 48.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.664 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 24.1 mtm -68.85 -38.39 79.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.418 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -68.52 -21.67 64.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.775 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 790' ' ' GLY . . . . . 0.501 ' O ' HD12 ' A' ' 804' ' ' ILE . . . 90.74 15.07 57.25 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.897 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.85 HG11 HG22 ' A' ' 754' ' ' VAL . 40.6 t -80.67 -31.91 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.924 0.392 . . . . 0.0 110.896 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 792' ' ' VAL . . . . . 0.667 HG21 HH21 ' A' ' 801' ' ' ARG . 11.2 m -136.58 135.45 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.143 0.497 . . . . 0.0 111.161 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 793' ' ' THR . . . . . 0.767 HG23 ' O ' ' A' ' 802' ' ' GLU . 10.3 p -72.92 159.81 84.42 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.686 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 794' ' ' PRO . . . . . 0.527 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 25.4 Cg_endo -60.58 165.13 11.97 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 121.996 1.797 . . . . 0.0 111.771 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -58.78 162.74 3.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.185 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -105.58 176.57 5.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.954 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 55.8 p -56.4 -31.11 63.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -86.32 -17.57 34.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.115 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 100.71 34.44 4.67 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.542 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 28.8 m -127.75 130.31 48.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 111.113 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 801' ' ' ARG . . . . . 0.667 HH21 HG21 ' A' ' 792' ' ' VAL . 4.5 mtp85 -81.57 170.13 16.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.397 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 802' ' ' GLU . . . . . 0.767 ' O ' HG23 ' A' ' 793' ' ' THR . 3.5 mt-10 -138.52 124.18 19.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.909 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 803' ' ' VAL . . . . . 1.055 HG22 HG12 ' A' ' 757' ' ' VAL . 18.8 t -64.92 134.22 29.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.96 0.409 . . . . 0.0 112.065 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 804' ' ' ILE . . . . . 0.629 HG23 HG22 ' A' ' 793' ' ' THR . 0.0 OUTLIER -103.77 -33.29 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.891 178.546 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 805' ' ' ALA . . . . . 0.559 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -74.63 126.03 89.03 Favored Pre-proline 0 N--CA 1.451 -0.4 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.836 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.07 163.81 24.46 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.71 2.273 . . . . 0.0 112.168 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.272 -179.856 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 743' ' ' GLY . . . . . 0.709 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.45 -0.424 0 N-CA-C 112.09 -0.404 . . . . 0.0 112.09 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 3.5 m -115.57 -39.3 3.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.065 0.459 . . . . 0.0 110.462 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 745' ' ' GLU . . . . . 0.429 ' O ' ' CD2' ' A' ' 750' ' ' TYR . 0.9 OUTLIER -168.57 -45.97 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.941 179.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -129.13 95.06 3.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.439 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.47 143.35 39.43 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.376 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 748' ' ' PRO . . . . . 0.423 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 28.7 Cg_exo -35.34 -30.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.258 2.639 . . . . 0.0 113.795 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 749' ' ' LEU . . . . . 0.729 HD12 ' NE ' ' A' ' 778' ' ' ARG . 21.8 mt -120.09 -17.08 8.46 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -178.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 750' ' ' TYR . . . . . 0.669 ' CE2' HG21 ' A' ' 754' ' ' VAL . 83.7 t80 -51.73 -50.65 60.14 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.837 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -53.17 -35.89 60.29 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.71 -0.396 . . . . 0.0 109.984 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 752' ' ' GLU . . . . . 0.988 ' HB3' HD21 ' A' ' 772' ' ' LEU . 6.0 tp10 -70.93 -38.5 72.9 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.803 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 753' ' ' ALA . . . . . 0.409 ' HB2' ' HE2' ' A' ' 782' ' ' MET . . . -66.28 -52.93 42.57 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.804 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 754' ' ' VAL . . . . . 0.688 HG22 HG11 ' A' ' 791' ' ' VAL . 7.0 t -56.36 -38.42 55.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.751 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -69.87 -39.16 76.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.601 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 756' ' ' PHE . . . . . 0.751 ' CE2' HG22 ' A' ' 768' ' ' VAL . 1.4 t80 -65.77 -45.09 83.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.611 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 757' ' ' VAL . . . . . 0.684 HG11 HG12 ' A' ' 792' ' ' VAL . 84.5 t -69.84 -41.33 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.781 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 758' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 754' ' ' VAL . 9.9 p -59.12 -46.08 89.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.335 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -77.97 -30.36 50.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.795 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 39.5 p -78.02 -16.0 58.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.5 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 63.39 20.09 12.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.718 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -157.61 137.58 12.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.745 0.307 . . . . 0.0 110.931 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 763' ' ' ALA . . . . . 0.528 ' HB3' ' CB ' ' A' ' 801' ' ' ARG . . . -100.7 89.87 4.04 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.949 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 764' ' ' SER . . . . . 0.764 ' O ' HG23 ' A' ' 768' ' ' VAL . 5.9 m -120.65 118.44 30.12 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 765' ' ' ILE . . . . . 0.474 HG21 ' HB2' ' A' ' 780' ' ' ALA . 10.3 mt -57.1 -51.32 70.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.368 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 766' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 11.3 t -53.93 -38.41 64.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.291 0.567 . . . . 0.0 110.103 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' A' ' 764' ' ' SER . . . -71.36 -40.22 70.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.234 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 768' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 764' ' ' SER . 45.5 t -61.43 -49.94 82.44 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.179 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . 0.608 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -63.64 -33.57 75.92 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.974 -179.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -69.45 -42.52 74.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.37 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.489 ' HD3' ' HE1' ' A' ' 756' ' ' PHE . 3.1 tptt -78.59 -38.24 40.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.766 0.317 . . . . 0.0 111.677 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 772' ' ' LEU . . . . . 0.988 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -86.87 -10.91 52.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt 61.21 39.58 15.64 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 774' ' ' ILE . . . . . 0.69 ' CG2' HD13 ' A' ' 749' ' ' LEU . 25.6 pt -111.86 -173.98 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.424 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -90.34 153.55 22.85 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.236 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -56.6 -45.79 81.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.816 0.341 . . . . 0.0 110.87 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -63.25 -47.79 80.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.82 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.729 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.5 OUTLIER -59.1 -49.98 75.8 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.641 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.23 -50.69 72.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.637 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 780' ' ' ALA . . . . . 0.474 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -55.99 -40.42 73.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.947 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -60.66 -43.77 97.23 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 782' ' ' MET . . . . . 0.448 ' HE3' ' HB2' ' A' ' 749' ' ' LEU . 0.1 OUTLIER -64.94 -43.62 92.14 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.293 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 783' ' ' ILE . . . . . 0.73 HD11 HG21 ' A' ' 768' ' ' VAL . 15.0 mm -57.62 -39.73 71.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.696 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -61.85 -46.78 87.95 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 743' ' ' GLY . . . -58.01 -33.64 69.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.808 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 786' ' ' MET . . . . . 0.646 ' HG2' HG22 ' A' ' 754' ' ' VAL . 15.4 mtm -67.79 -38.29 83.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.565 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 787' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 792' ' ' VAL . 1.6 mt-10 -62.41 -45.93 90.89 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.124 0.488 . . . . 0.0 110.072 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 37.0 mtm -73.08 -37.98 66.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.245 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -70.81 -21.53 62.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.982 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 790' ' ' GLY . . . . . 0.746 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 94.62 15.94 44.55 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.67 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.823 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 77.5 t -84.96 -34.2 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 122.637 0.375 . . . . 0.0 111.476 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 792' ' ' VAL . . . . . 0.684 HG12 HG11 ' A' ' 757' ' ' VAL . 15.4 m -136.61 148.41 27.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.887 0.375 . . . . 0.0 111.655 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 793' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 802' ' ' GLU . 10.3 p -96.75 171.8 5.73 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 794' ' ' PRO . . . . . 0.434 ' CD ' ' HB ' ' A' ' 793' ' ' THR . 31.1 Cg_exo -59.47 178.86 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 121.982 1.788 . . . . 0.0 111.812 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . 0.518 ' HA ' ' HG3' ' A' ' 801' ' ' ARG . 0.0 OUTLIER -77.04 170.12 17.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.499 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -105.61 176.59 5.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.754 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 4.6 t -60.78 -26.99 67.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.052 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -92.19 -17.62 24.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.398 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 108.73 29.84 3.97 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.649 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 18.0 m -124.42 131.13 53.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.923 0.392 . . . . 0.0 110.647 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 801' ' ' ARG . . . . . 0.528 ' CB ' ' HB3' ' A' ' 763' ' ' ALA . 8.8 mtt-85 -85.34 170.65 12.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.078 0.466 . . . . 0.0 111.524 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 802' ' ' GLU . . . . . 0.74 ' O ' HG23 ' A' ' 793' ' ' THR . 6.9 mt-10 -127.13 126.76 43.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.576 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 803' ' ' VAL . . . . . 0.57 HG22 HG12 ' A' ' 757' ' ' VAL . 19.4 t -69.25 137.94 23.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.836 0.35 . . . . 0.0 111.8 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 804' ' ' ILE . . . . . 0.746 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -108.19 -28.08 2.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.292 178.415 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 805' ' ' ALA . . . . . 0.823 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -78.24 119.56 77.81 Favored Pre-proline 0 N--CA 1.455 -0.209 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.641 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.24 163.82 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.413 2.075 . . . . 0.0 112.733 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.961 -179.99 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 743' ' ' GLY . . . . . 0.426 ' CA ' ' HG2' ' A' ' 782' ' ' MET . . . . . . . . 0 N--CA 1.452 -0.289 0 N-CA-C 112.528 -0.229 . . . . 0.0 112.528 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.0 -157.83 0.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.584 0.23 . . . . 0.0 110.43 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -51.29 -38.44 52.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.666 0.27 . . . . 0.0 111.445 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -129.06 95.51 4.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.062 0.458 . . . . 0.0 111.415 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . 0.574 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.4 t70 -122.49 141.52 35.1 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.372 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -38.32 -28.02 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.956 2.437 . . . . 0.0 113.64 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 749' ' ' LEU . . . . . 0.854 HD13 ' CG2' ' A' ' 774' ' ' ILE . 40.4 mt -119.94 -16.85 8.59 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 750' ' ' TYR . . . . . 0.691 ' CE2' ' HB3' ' A' ' 785' ' ' ALA . 62.2 t80 -55.12 -46.5 75.59 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.469 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -53.51 -36.37 61.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 752' ' ' GLU . . . . . 0.909 ' HB2' HD21 ' A' ' 772' ' ' LEU . 28.7 mt-10 -70.95 -43.09 68.85 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.217 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 753' ' ' ALA . . . . . 0.517 ' HB2' ' HE3' ' A' ' 782' ' ' MET . . . -61.93 -51.67 67.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.238 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 754' ' ' VAL . . . . . 0.747 HG22 HG11 ' A' ' 791' ' ' VAL . 2.3 t -56.21 -42.69 74.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.39 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -69.16 -38.13 78.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.294 0.569 . . . . 0.0 110.231 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 756' ' ' PHE . . . . . 0.644 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.0 t80 -65.15 -46.15 82.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.114 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 757' ' ' VAL . . . . . 0.83 HG12 HG22 ' A' ' 803' ' ' VAL . 59.7 t -69.49 -45.13 79.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.902 0.382 . . . . 0.0 110.775 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 758' ' ' THR . . . . . 0.648 ' HA ' HG11 ' A' ' 803' ' ' VAL . 6.8 p -55.22 -42.65 73.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.96 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -78.8 -35.63 43.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.414 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 6.8 p -76.84 -19.61 57.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.575 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 67.2 24.93 9.08 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.662 0.268 . . . . 0.0 111.477 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 762' ' ' ARG . . . . . 0.554 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.2 OUTLIER -159.26 132.39 7.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.883 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 763' ' ' ALA . . . . . 0.548 ' HB2' ' CG1' ' A' ' 792' ' ' VAL . . . -100.05 89.71 4.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.933 0.397 . . . . 0.0 111.281 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 764' ' ' SER . . . . . 0.726 ' O ' HG23 ' A' ' 768' ' ' VAL . 7.6 m -121.78 118.59 29.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.593 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 765' ' ' ILE . . . . . 0.811 HD13 ' HB2' ' A' ' 780' ' ' ALA . 26.3 mt -54.54 -47.34 71.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.487 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 766' ' ' SER . . . . . 0.423 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 60.5 p -57.69 -40.5 79.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.172 0.51 . . . . 0.0 110.493 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 764' ' ' SER . . . -71.58 -36.23 70.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.612 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 768' ' ' VAL . . . . . 0.866 HG21 HD11 ' A' ' 783' ' ' ILE . 58.8 t -66.4 -46.44 86.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.223 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . 0.602 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -66.05 -33.37 75.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.486 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 770' ' ' ARG . . . . . 0.461 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 20.8 mtt-85 -69.98 -42.41 73.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.087 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.442 ' HB2' ' CE1' ' A' ' 756' ' ' PHE . 1.8 tmtt? -78.62 -39.62 36.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.042 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 772' ' ' LEU . . . . . 0.909 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -88.33 -9.23 53.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.664 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt 60.03 42.31 16.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.061 0.458 . . . . 0.0 109.775 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 774' ' ' ILE . . . . . 0.854 ' CG2' HD13 ' A' ' 749' ' ' LEU . 26.8 pt -111.94 -173.94 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.609 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.42 147.18 19.36 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.027 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -54.11 -42.54 69.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.834 0.35 . . . . 0.0 110.703 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 -64.12 -47.53 79.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.923 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.811 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.2 OUTLIER -62.52 -50.3 71.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.894 0.378 . . . . 0.0 110.835 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 779' ' ' ALA . . . . . 0.413 ' HB2' ' CD1' ' A' ' 774' ' ' ILE . . . -54.48 -49.13 70.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.411 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 780' ' ' ALA . . . . . 0.811 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.07 -43.63 78.14 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.911 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -58.98 -48.41 81.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.034 0.445 . . . . 0.0 109.973 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 782' ' ' MET . . . . . 0.517 ' HE3' ' HB2' ' A' ' 753' ' ' ALA . 34.4 mtm -65.3 -34.3 78.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.711 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 783' ' ' ILE . . . . . 0.866 HD11 HG21 ' A' ' 768' ' ' VAL . 7.1 mm -65.45 -35.71 75.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.11 -44.69 94.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.691 ' HB3' ' CE2' ' A' ' 750' ' ' TYR . . . -59.12 -33.76 71.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.766 178.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 786' ' ' MET . . . . . 0.747 ' HB3' HG22 ' A' ' 792' ' ' VAL . 12.7 mtm -65.62 -39.14 91.17 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.912 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -62.43 -51.15 68.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.45 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 25.4 mtm -67.9 -38.49 83.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.574 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 789' ' ' ALA . . . . . 0.482 ' HB3' HG23 ' A' ' 791' ' ' VAL . . . -71.4 -21.62 61.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.882 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 790' ' ' GLY . . . . . 0.672 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 93.12 16.76 46.04 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.914 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.747 HG11 HG22 ' A' ' 754' ' ' VAL . 10.1 t -83.57 -33.28 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.887 0.375 . . . . 0.0 110.726 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 792' ' ' VAL . . . . . 0.747 HG22 ' HB3' ' A' ' 786' ' ' MET . 19.8 m -135.94 139.54 45.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.404 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 793' ' ' THR . . . . . 0.547 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 2.8 p -83.77 161.87 54.54 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.709 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 794' ' ' PRO . . . . . 0.547 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 18.1 Cg_endo -58.62 167.23 5.35 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.153 1.902 . . . . 0.0 112.083 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.88 160.06 15.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.201 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -104.31 176.59 5.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.803 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 39.1 p -61.76 -34.74 76.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.926 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.14 -17.61 58.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.195 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 100.58 28.38 7.11 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.515 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 58.0 m -126.64 130.39 50.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.942 0.401 . . . . 0.0 110.964 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 801' ' ' ARG . . . . . 0.503 ' NH1' HG21 ' A' ' 792' ' ' VAL . 9.4 mtt-85 -82.72 170.72 14.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.222 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 802' ' ' GLU . . . . . 0.405 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 5.8 mt-10 -130.2 166.28 20.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.814 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 803' ' ' VAL . . . . . 0.83 HG22 HG12 ' A' ' 757' ' ' VAL . 39.0 t -109.63 135.19 49.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.064 0.459 . . . . 0.0 111.597 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 804' ' ' ILE . . . . . 0.672 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -103.35 -28.56 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.266 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 805' ' ' ALA . . . . . 0.635 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -82.22 124.51 78.4 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.934 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.9 163.71 27.26 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.632 2.221 . . . . 0.0 112.082 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.241 -179.812 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 743' ' ' GLY . . . . . 0.569 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.45 -0.41 0 N-CA-C 112.455 -0.258 . . . . 0.0 112.455 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . 0.6 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 0.9 OUTLIER -117.68 -53.57 2.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.159 0.504 . . . . 0.0 110.396 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -153.13 -50.13 0.1 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.968 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -124.01 95.11 4.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.416 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.7 t70 -122.37 142.09 36.25 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.439 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -37.73 -28.35 0.1 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.989 2.459 . . . . 0.0 113.51 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 749' ' ' LEU . . . . . 0.842 HD13 ' CG2' ' A' ' 774' ' ' ILE . 31.8 mt -120.05 -16.87 8.52 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 750' ' ' TYR . . . . . 0.708 ' CE2' HG21 ' A' ' 754' ' ' VAL . 71.3 t80 -53.99 -47.76 71.1 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.376 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -53.4 -36.3 61.31 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 752' ' ' GLU . . . . . 0.937 ' HB2' HD21 ' A' ' 772' ' ' LEU . 5.5 mm-40 -71.0 -42.27 69.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.117 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 753' ' ' ALA . . . . . 0.43 ' HB2' ' CE ' ' A' ' 782' ' ' MET . . . -61.85 -53.82 50.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.068 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 754' ' ' VAL . . . . . 0.71 HG22 HG11 ' A' ' 791' ' ' VAL . 4.0 t -56.19 -42.97 74.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.407 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -66.43 -36.94 84.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.37 0.605 . . . . 0.0 109.797 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 756' ' ' PHE . . . . . 0.68 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.0 t80 -66.82 -46.18 75.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.169 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 757' ' ' VAL . . . . . 0.791 HG12 HG22 ' A' ' 803' ' ' VAL . 61.8 t -69.56 -45.41 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 120.8 0.333 . . . . 0.0 110.664 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 758' ' ' THR . . . . . 0.661 ' HA ' HG11 ' A' ' 803' ' ' VAL . 4.8 p -55.37 -43.45 75.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.783 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -78.71 -32.15 46.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.214 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 27.3 p -81.63 -14.83 56.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.531 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 61.92 18.92 10.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.614 0.245 . . . . 0.0 111.223 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 762' ' ' ARG . . . . . 0.555 ' O ' HG13 ' A' ' 757' ' ' VAL . 10.2 ptt180 -151.88 136.35 16.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.763 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 763' ' ' ALA . . . . . 0.547 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -106.06 89.88 3.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.602 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 764' ' ' SER . . . . . 0.714 ' O ' HG23 ' A' ' 768' ' ' VAL . 3.9 m -122.32 118.59 28.86 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 765' ' ' ILE . . . . . 0.698 HD13 ' HB2' ' A' ' 780' ' ' ALA . 19.5 mt -53.6 -48.28 59.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.499 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 766' ' ' SER . . . . . 0.423 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 11.4 t -55.74 -41.23 73.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.114 0.483 . . . . 0.0 110.284 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -70.58 -39.48 73.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.688 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 768' ' ' VAL . . . . . 0.84 HG21 HD11 ' A' ' 783' ' ' ILE . 41.9 t -62.94 -46.72 95.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.291 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . 0.587 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.93 -33.41 75.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.452 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 770' ' ' ARG . . . . . 0.474 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 24.8 mtt180 -71.54 -41.84 68.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.059 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.7 -37.26 42.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.967 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 772' ' ' LEU . . . . . 0.937 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -91.17 -9.64 44.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.634 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt 60.8 41.55 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.038 0.447 . . . . 0.0 109.8 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 774' ' ' ILE . . . . . 0.842 ' CG2' HD13 ' A' ' 749' ' ' LEU . 22.0 pt -111.84 -173.92 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.476 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.51 151.13 22.3 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.201 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -55.38 -46.05 76.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.965 0.412 . . . . 0.0 110.707 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -63.37 -47.79 80.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.823 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.824 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.6 OUTLIER -59.61 -50.13 75.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.845 0.355 . . . . 0.0 110.793 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.33 -49.9 74.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.271 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 780' ' ' ALA . . . . . 0.698 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.11 -40.35 73.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -60.69 -48.41 81.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.92 0.39 . . . . 0.0 109.999 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 782' ' ' MET . . . . . 0.472 ' HE3' ' HA ' ' A' ' 750' ' ' TYR . 3.1 mtp -63.79 -38.41 91.01 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 783' ' ' ILE . . . . . 0.84 HD11 HG21 ' A' ' 768' ' ' VAL . 7.3 mm -61.32 -40.85 87.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.132 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.23 -43.52 87.8 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 177.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 744' ' ' SER . . . -60.32 -33.48 72.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.526 -1.216 . . . . 0.0 109.828 178.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 786' ' ' MET . . . . . 0.571 ' HB3' HG22 ' A' ' 792' ' ' VAL . 12.9 mtm -65.67 -37.56 86.84 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.974 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 787' ' ' GLU . . . . . 0.456 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 2.4 mt-10 -63.38 -54.13 41.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.111 0.481 . . . . 0.0 110.548 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 33.5 mtm -67.85 -37.12 81.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.49 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -70.94 -21.59 62.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.985 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 790' ' ' GLY . . . . . 0.537 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 89.62 18.37 52.1 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.875 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.71 HG11 HG22 ' A' ' 754' ' ' VAL . 52.4 t -83.23 -32.72 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.854 0.359 . . . . 0.0 110.809 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 792' ' ' VAL . . . . . 0.681 HG21 HH21 ' A' ' 801' ' ' ARG . 11.4 m -135.61 140.64 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.188 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 793' ' ' THR . . . . . 0.452 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.3 p -78.34 159.06 75.81 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 794' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 18.6 Cg_endo -58.8 166.11 7.18 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.115 1.876 . . . . 0.0 111.743 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -66.08 155.38 36.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.972 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -105.43 176.56 5.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.918 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 5.5 t -55.37 -29.98 59.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.06 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -78.65 -17.52 55.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.151 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 91.9 29.62 11.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.48 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 24.6 m -127.82 130.19 48.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.905 0.383 . . . . 0.0 111.031 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 801' ' ' ARG . . . . . 0.681 HH21 HG21 ' A' ' 792' ' ' VAL . 6.8 mtp85 -81.63 170.59 15.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.307 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -129.9 -176.93 4.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.667 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 803' ' ' VAL . . . . . 0.791 HG22 HG12 ' A' ' 757' ' ' VAL . 16.9 t -119.81 134.64 62.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 804' ' ' ILE . . . . . 0.537 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -106.99 -28.09 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.961 178.56 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 805' ' ' ALA . . . . . 0.633 ' O ' HG22 ' A' ' 758' ' ' THR . . . -82.74 121.49 77.8 Favored Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.586 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.49 163.8 22.79 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.475 2.116 . . . . 0.0 112.304 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.225 -179.8 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 743' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.496 -0.241 . . . . 0.0 112.496 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . 0.458 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 1.3 m -119.3 -47.24 2.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.121 0.486 . . . . 0.0 110.396 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -159.33 -48.63 0.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.182 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -126.9 95.1 4.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.337 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . 0.517 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.6 t70 -122.51 143.09 38.85 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.425 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 748' ' ' PRO . . . . . 0.422 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 35.7 Cg_exo -35.97 -29.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.157 2.571 . . . . 0.0 113.763 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 749' ' ' LEU . . . . . 0.821 HD12 ' NE ' ' A' ' 778' ' ' ARG . 34.6 mt -120.03 -17.27 8.45 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 750' ' ' TYR . . . . . 0.739 ' CE2' HG21 ' A' ' 754' ' ' VAL . 74.5 t80 -53.3 -48.54 68.29 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.797 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.27 -36.34 61.03 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 752' ' ' GLU . . . . . 1.02 ' HB3' HD21 ' A' ' 772' ' ' LEU . 12.6 tt0 -71.0 -42.05 70.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.242 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 753' ' ' ALA . . . . . 0.404 ' HB2' ' HE2' ' A' ' 782' ' ' MET . . . -62.92 -52.5 62.8 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.182 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 754' ' ' VAL . . . . . 0.739 HG21 ' CE2' ' A' ' 750' ' ' TYR . 5.1 t -56.2 -40.32 64.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.675 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -67.01 -35.52 80.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.41 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 756' ' ' PHE . . . . . 0.835 ' CE1' HG22 ' A' ' 768' ' ' VAL . 1.4 t80 -67.65 -45.94 73.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.018 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 757' ' ' VAL . . . . . 0.851 HG12 HG22 ' A' ' 803' ' ' VAL . 47.4 t -69.64 -42.08 80.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.937 0.399 . . . . 0.0 110.837 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 758' ' ' THR . . . . . 0.456 ' HA ' HG11 ' A' ' 803' ' ' VAL . 8.2 p -58.71 -45.38 89.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.69 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -77.75 -35.26 51.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.101 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 48.7 p -76.38 -14.74 60.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.291 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 56.5 28.0 13.12 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.008 0.433 . . . . 0.0 110.577 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 762' ' ' ARG . . . . . 0.406 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.2 OUTLIER -160.87 136.0 7.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.92 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 763' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -106.32 89.6 3.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.09 0.472 . . . . 0.0 111.698 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 764' ' ' SER . . . . . 0.769 ' O ' HG23 ' A' ' 768' ' ' VAL . 68.1 m -121.24 118.64 30.11 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 765' ' ' ILE . . . . . 0.643 HD13 ' HB2' ' A' ' 780' ' ' ALA . 17.5 mt -54.06 -47.58 65.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.637 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 766' ' ' SER . . . . . 0.608 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 10.9 t -58.89 -36.73 75.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.27 0.557 . . . . 0.0 110.363 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . 0.404 ' CB ' ' HZ ' ' A' ' 756' ' ' PHE . . . -72.78 -41.34 65.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.217 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 768' ' ' VAL . . . . . 0.835 HG22 ' CE1' ' A' ' 756' ' ' PHE . 23.2 t -61.13 -49.8 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.096 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . 0.616 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -63.05 -33.85 76.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.374 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 21.2 mtt180 -70.08 -42.54 72.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.279 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.507 ' HD3' ' HD2' ' A' ' 756' ' ' PHE . 0.0 OUTLIER -78.53 -35.72 45.8 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.527 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 772' ' ' LEU . . . . . 1.02 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -90.6 -10.35 43.66 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm 60.61 40.61 16.42 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 774' ' ' ILE . . . . . 0.759 ' CG2' HD13 ' A' ' 749' ' ' LEU . 27.7 pt -111.69 -175.33 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.39 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.63 150.54 21.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.097 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -54.28 -45.97 72.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.653 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -61.91 -47.48 84.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.759 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.821 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -60.37 -50.19 74.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.687 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.22 -49.76 74.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.354 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 780' ' ' ALA . . . . . 0.643 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.2 -41.52 75.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.771 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 -59.54 -48.26 82.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.045 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 782' ' ' MET . . . . . 0.437 ' HE3' ' HB2' ' A' ' 749' ' ' LEU . 0.0 OUTLIER -61.71 -44.55 96.71 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.407 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 783' ' ' ILE . . . . . 0.805 HD11 HG21 ' A' ' 768' ' ' VAL . 12.0 mm -55.32 -37.07 42.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.786 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -64.03 -46.03 86.26 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.576 ' HB3' ' CE1' ' A' ' 750' ' ' TYR . . . -59.26 -33.56 71.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.633 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 786' ' ' MET . . . . . 0.726 ' HB3' HG22 ' A' ' 792' ' ' VAL . 13.4 mtm -65.46 -40.68 93.47 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.316 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.16 -49.14 77.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.092 0.472 . . . . 0.0 110.587 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 32.9 mtm -70.66 -36.85 73.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.385 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -71.86 -21.56 61.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.082 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 790' ' ' GLY . . . . . 0.7 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 93.72 17.23 42.33 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.718 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.757 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 60.2 t -87.72 -29.46 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 122.505 0.322 . . . . 0.0 111.27 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 792' ' ' VAL . . . . . 0.726 HG22 ' HB3' ' A' ' 786' ' ' MET . 20.5 m -139.58 141.93 33.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.869 0.366 . . . . 0.0 111.824 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 793' ' ' THR . . . . . 0.559 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.1 p -86.17 165.65 32.83 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 794' ' ' PRO . . . . . 0.559 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 32.6 Cg_endo -63.45 166.38 15.39 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 121.951 1.767 . . . . 0.0 111.815 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -69.6 158.1 35.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.373 . . . . 0.0 111.213 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 36.8 p30 -105.72 176.56 5.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.83 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 2.8 t -57.84 -31.21 66.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.999 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -74.22 -17.58 60.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.246 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 93.62 26.44 15.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.566 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 17.9 m -127.24 134.6 50.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 0.0 110.809 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 801' ' ' ARG . . . . . 0.571 ' HB3' ' HB3' ' A' ' 763' ' ' ALA . 13.5 mtt-85 -85.03 170.79 12.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.251 0.548 . . . . 0.0 111.545 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -129.1 166.5 19.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.842 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 803' ' ' VAL . . . . . 0.851 HG22 HG12 ' A' ' 757' ' ' VAL . 19.3 t -107.6 138.55 33.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.885 0.374 . . . . 0.0 111.978 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 804' ' ' ILE . . . . . 0.7 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -109.98 -25.35 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.555 179.03 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 805' ' ' ALA . . . . . 0.757 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -80.87 121.56 81.07 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.239 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -50.34 163.94 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.639 2.226 . . . . 0.0 112.885 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.558 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.053 179.934 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 743' ' ' GLY . . . . . 0.567 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.45 -0.405 0 N-CA-C 112.439 -0.264 . . . . 0.0 112.439 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . 0.464 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 50.4 m -118.97 -46.87 2.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.126 0.489 . . . . 0.0 110.487 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -159.17 -47.48 0.06 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.19 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -128.89 95.27 4.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.394 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . 0.548 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.2 t70 -122.5 143.48 39.81 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.312 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 748' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 40.0 Cg_exo -36.75 -28.77 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.081 2.521 . . . . 0.0 113.793 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 749' ' ' LEU . . . . . 0.817 HD13 ' CG2' ' A' ' 774' ' ' ILE . 28.7 mt -119.99 -17.09 8.51 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 750' ' ' TYR . . . . . 0.656 ' CE2' HG21 ' A' ' 754' ' ' VAL . 78.5 t80 -53.15 -50.91 63.58 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.935 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -53.07 -35.11 59.18 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 752' ' ' GLU . . . . . 1.022 ' HB3' HD21 ' A' ' 772' ' ' LEU . 9.1 tp10 -71.1 -42.02 69.84 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.174 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 753' ' ' ALA . . . . . 0.472 ' O ' HG23 ' A' ' 757' ' ' VAL . . . -63.58 -53.73 47.11 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.188 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 754' ' ' VAL . . . . . 0.758 HG22 HG11 ' A' ' 791' ' ' VAL . 6.2 t -56.1 -39.27 57.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.865 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -68.22 -35.47 78.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.652 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 756' ' ' PHE . . . . . 0.624 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.7 t80 -68.79 -46.33 68.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.038 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 757' ' ' VAL . . . . . 0.617 HG12 HG22 ' A' ' 803' ' ' VAL . 21.1 t -71.29 -38.88 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 120.903 0.383 . . . . 0.0 111.114 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 758' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 754' ' ' VAL . 20.6 p -63.12 -41.43 99.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.702 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -76.96 -46.63 23.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.148 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 760' ' ' SER . . . . . 0.468 ' O ' ' HD3' ' A' ' 762' ' ' ARG . 22.8 p -70.6 -33.86 71.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.975 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 761' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 760' ' ' SER . 0.0 OUTLIER 78.27 23.73 0.69 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.401 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 762' ' ' ARG . . . . . 0.468 ' HD3' ' O ' ' A' ' 760' ' ' SER . 0.5 OUTLIER -145.03 114.29 7.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.507 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 763' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' A' ' 801' ' ' ARG . . . -88.19 89.49 8.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.039 0.447 . . . . 0.0 111.442 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 764' ' ' SER . . . . . 0.719 ' O ' HG23 ' A' ' 768' ' ' VAL . 17.0 m -126.84 118.35 24.45 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 765' ' ' ILE . . . . . 0.603 HG21 ' HB2' ' A' ' 780' ' ' ALA . 11.0 mt -52.99 -45.56 52.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.491 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 766' ' ' SER . . . . . 0.5 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 6.6 t -60.57 -37.7 82.15 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.152 0.501 . . . . 0.0 110.308 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 764' ' ' SER . . . -73.64 -35.26 65.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.52 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 768' ' ' VAL . . . . . 0.799 HG21 HD11 ' A' ' 783' ' ' ILE . 40.4 t -67.71 -46.98 81.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . 0.599 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.12 -34.12 77.66 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.491 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 14.9 mtt-85 -71.32 -42.57 68.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.2 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.74 -34.92 45.41 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 772' ' ' LEU . . . . . 1.022 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -92.41 -10.41 38.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp 61.71 40.79 12.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.106 0.479 . . . . 0.0 109.721 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 774' ' ' ILE . . . . . 0.817 ' CG2' HD13 ' A' ' 749' ' ' LEU . 23.0 pt -111.74 -173.78 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.661 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.59 151.69 22.67 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.186 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -56.9 -45.78 82.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 0.0 110.729 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 -63.29 -46.56 86.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.69 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.782 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.2 OUTLIER -61.23 -50.07 74.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.776 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.41 -49.46 76.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.21 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 780' ' ' ALA . . . . . 0.603 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -55.93 -42.47 76.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.966 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -59.38 -43.37 92.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.125 0.488 . . . . 0.0 110.016 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 782' ' ' MET . . . . . 0.445 ' HE2' ' HB2' ' A' ' 753' ' ' ALA . 2.5 mtp -67.66 -42.02 82.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.592 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 783' ' ' ILE . . . . . 0.799 HD11 HG21 ' A' ' 768' ' ' VAL . 9.5 mm -58.59 -37.32 64.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.443 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -63.56 -48.27 78.15 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.6 ' HB3' ' CE1' ' A' ' 750' ' ' TYR . . . -56.16 -33.41 65.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.693 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 786' ' ' MET . . . . . 0.698 ' HG2' HG22 ' A' ' 754' ' ' VAL . 13.1 mtm -66.8 -40.77 88.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.178 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 787' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 792' ' ' VAL . 0.5 OUTLIER -59.93 -49.41 77.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.61 179.711 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 28.5 mtm -72.81 -37.79 67.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.546 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -68.16 -21.5 64.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.136 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 790' ' ' GLY . . . . . 0.763 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 94.91 16.93 39.76 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.459 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.758 HG11 HG22 ' A' ' 754' ' ' VAL . 55.1 t -86.34 -35.45 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 122.422 0.289 . . . . 0.0 111.306 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 792' ' ' VAL . . . . . 0.687 HG22 ' HB3' ' A' ' 786' ' ' MET . 22.0 m -136.4 151.44 28.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.128 0.49 . . . . 0.0 111.69 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 793' ' ' THR . . . . . 0.575 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.3 p -94.83 165.67 16.65 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.282 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 794' ' ' PRO . . . . . 0.575 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 29.6 Cg_endo -62.3 166.01 13.87 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 121.869 1.713 . . . . 0.0 111.94 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -72.07 158.5 35.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.985 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -105.51 176.51 5.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 53.1 p -57.86 -30.17 65.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.202 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -75.34 -17.6 60.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.296 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 94.15 23.23 22.94 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.576 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 58.9 m -123.26 132.54 54.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.824 0.345 . . . . 0.0 110.649 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 801' ' ' ARG . . . . . 0.569 ' HB2' ' O ' ' A' ' 763' ' ' ALA . 11.7 mtt-85 -85.14 170.79 12.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.189 0.519 . . . . 0.0 111.716 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 802' ' ' GLU . . . . . 0.425 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 3.8 mt-10 -127.54 171.05 11.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.868 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 803' ' ' VAL . . . . . 0.617 HG22 HG12 ' A' ' 757' ' ' VAL . 22.3 t -114.22 138.38 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 804' ' ' ILE . . . . . 0.763 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -106.89 -28.31 2.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.454 178.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 805' ' ' ALA . . . . . 0.725 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -82.7 121.44 77.84 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.001 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -65.48 163.73 28.71 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.541 2.161 . . . . 0.0 112.088 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.144 -179.753 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 743' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.355 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.15 -160.78 0.7 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.635 0.255 . . . . 0.0 110.611 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -51.11 -44.35 61.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.808 0.337 . . . . 0.0 111.121 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -127.39 95.56 4.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.122 0.487 . . . . 0.0 110.956 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . 0.56 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.57 143.21 39.26 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.445 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 748' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 40.5 Cg_exo -36.22 -29.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.108 2.538 . . . . 0.0 113.962 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 749' ' ' LEU . . . . . 0.84 HD13 ' CG2' ' A' ' 774' ' ' ILE . 26.3 mt -120.02 -17.15 8.48 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 750' ' ' TYR . . . . . 0.732 ' CE1' HG21 ' A' ' 754' ' ' VAL . 65.6 t80 -53.81 -47.81 70.5 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.783 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -53.23 -37.49 62.09 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 752' ' ' GLU . . . . . 1.092 ' HB3' HD21 ' A' ' 772' ' ' LEU . 11.8 tt0 -71.0 -43.38 68.1 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.083 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 753' ' ' ALA . . . . . 0.67 ' HB2' ' HE1' ' A' ' 782' ' ' MET . . . -59.74 -54.4 46.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.159 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 754' ' ' VAL . . . . . 0.774 HG22 HG11 ' A' ' 791' ' ' VAL . 4.8 t -56.19 -40.82 67.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.142 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 44.5 ttt85 -65.89 -36.02 82.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.543 178.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 756' ' ' PHE . . . . . 0.787 ' CE1' HG22 ' A' ' 768' ' ' VAL . 1.2 t80 -69.78 -44.95 69.06 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.83 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 757' ' ' VAL . . . . . 0.746 HG11 ' CG1' ' A' ' 792' ' ' VAL . 61.2 t -69.74 -39.59 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 121.002 0.43 . . . . 0.0 110.763 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 758' ' ' THR . . . . . 0.445 ' HA ' HG11 ' A' ' 803' ' ' VAL . 10.1 p -62.8 -44.81 95.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.8 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -78.58 -33.08 47.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.177 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 760' ' ' SER . . . . . 0.485 ' OG ' ' HA ' ' A' ' 757' ' ' VAL . 93.7 p -75.54 -15.68 60.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.278 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 62.84 17.34 9.85 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.426 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 -155.77 140.37 16.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.572 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 763' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 801' ' ' ARG . . . -105.57 89.62 3.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.922 0.391 . . . . 0.0 111.658 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 764' ' ' SER . . . . . 0.767 ' O ' HG23 ' A' ' 768' ' ' VAL . 1.7 m -118.96 118.67 32.12 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 765' ' ' ILE . . . . . 0.522 HG21 ' HB2' ' A' ' 780' ' ' ALA . 7.4 mt -55.69 -47.74 78.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.563 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 766' ' ' SER . . . . . 0.468 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 39.3 t -57.4 -39.09 75.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.14 0.495 . . . . 0.0 110.275 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 764' ' ' SER . . . -71.88 -39.56 69.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.448 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 768' ' ' VAL . . . . . 0.797 HG21 HD11 ' A' ' 783' ' ' ILE . 46.2 t -61.81 -48.15 89.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.996 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . 0.59 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.46 -33.33 75.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 770' ' ' ARG . . . . . 0.466 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 20.1 mtt180 -70.1 -41.85 73.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.139 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.429 ' HD3' ' HE2' ' A' ' 756' ' ' PHE . 4.5 tptt -78.49 -39.84 37.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.644 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 772' ' ' LEU . . . . . 1.092 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -87.68 -9.49 54.01 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.522 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt 60.32 41.27 16.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.025 0.44 . . . . 0.0 109.825 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 774' ' ' ILE . . . . . 0.84 ' CG2' HD13 ' A' ' 749' ' ' LEU . 20.1 pt -111.89 -173.95 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.342 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.51 150.03 20.97 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.05 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -54.24 -45.34 72.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.879 0.371 . . . . 0.0 110.751 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -64.19 -47.92 77.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.712 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.769 ' HE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -58.76 -49.97 75.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.766 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.54 -49.9 74.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.28 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 780' ' ' ALA . . . . . 0.522 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -55.94 -40.04 72.59 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.797 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -59.63 -47.04 87.14 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 782' ' ' MET . . . . . 0.67 ' HE1' ' HB2' ' A' ' 753' ' ' ALA . 1.6 mtp -63.07 -43.13 99.42 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 783' ' ' ILE . . . . . 0.797 HD11 HG21 ' A' ' 768' ' ' VAL . 12.3 mm -57.45 -38.77 64.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.682 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -62.15 -43.3 99.14 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.645 ' HB3' ' CE2' ' A' ' 750' ' ' TYR . . . -61.15 -33.41 73.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.581 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 786' ' ' MET . . . . . 0.754 ' HB3' HG22 ' A' ' 792' ' ' VAL . 13.2 mtm -65.63 -39.44 91.48 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.275 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -63.57 -45.3 91.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.19 0.519 . . . . 0.0 110.312 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 53.0 mtm -72.01 -36.86 69.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.664 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -75.53 -21.66 57.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.137 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 790' ' ' GLY . . . . . 0.808 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 94.14 18.52 36.44 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.621 -178.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.774 HG11 HG22 ' A' ' 754' ' ' VAL . 57.5 t -86.82 -30.2 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.723 0.296 . . . . 0.0 110.961 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 792' ' ' VAL . . . . . 0.754 HG22 ' HB3' ' A' ' 786' ' ' MET . 22.2 m -139.31 144.06 29.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.629 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 793' ' ' THR . . . . . 0.585 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.1 p -87.37 166.81 23.68 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 794' ' ' PRO . . . . . 0.585 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 28.5 Cg_endo -62.07 166.13 13.17 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.074 1.849 . . . . 0.0 112.262 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.31 161.92 13.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.173 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -105.31 176.34 5.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.826 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 44.8 p -61.79 -32.5 72.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.818 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -79.69 -17.55 53.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.178 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.27 25.1 8.47 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.46 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 20.8 m -122.14 129.96 52.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 110.935 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 801' ' ' ARG . . . . . 0.518 ' NH1' ' CG2' ' A' ' 783' ' ' ILE . 12.1 mtt-85 -83.82 170.67 13.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.287 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -127.81 167.75 16.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.926 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 803' ' ' VAL . . . . . 0.613 HG22 HG12 ' A' ' 757' ' ' VAL . 16.4 t -109.05 137.92 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.956 0.407 . . . . 0.0 112.017 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 804' ' ' ILE . . . . . 0.808 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -108.26 -27.36 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.267 178.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 805' ' ' ALA . . . . . 0.725 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -83.11 123.96 76.9 Favored Pre-proline 0 N--CA 1.454 -0.237 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.996 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.57 163.79 31.36 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.679 2.253 . . . . 0.0 112.252 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.216 -179.923 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 743' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.61 -0.196 . . . . 0.0 112.61 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . 0.589 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 1.4 m -123.04 -55.96 1.76 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.148 0.499 . . . . 0.0 110.282 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -151.05 -47.92 0.12 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.23 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.03 95.33 4.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.527 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.9 t70 -122.5 142.34 37.04 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.353 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -38.04 -27.82 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.921 2.414 . . . . 0.0 113.556 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 749' ' ' LEU . . . . . 0.839 HD13 ' CG2' ' A' ' 774' ' ' ILE . 43.5 mt -119.91 -17.36 8.49 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 750' ' ' TYR . . . . . 0.666 ' CE2' HG21 ' A' ' 754' ' ' VAL . 66.3 t80 -55.14 -46.94 75.69 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.816 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -53.27 -36.73 61.46 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 752' ' ' GLU . . . . . 0.879 ' HB3' HD21 ' A' ' 772' ' ' LEU . 0.6 OUTLIER -71.04 -45.04 64.58 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.018 178.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 753' ' ' ALA . . . . . 0.445 ' O ' HG23 ' A' ' 757' ' ' VAL . . . -59.35 -52.3 66.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.352 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 754' ' ' VAL . . . . . 0.735 HG22 HG11 ' A' ' 791' ' ' VAL . 2.3 t -56.12 -43.02 74.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.958 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -66.72 -35.56 80.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.353 0.597 . . . . 0.0 109.708 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 756' ' ' PHE . . . . . 0.744 ' CE2' HG22 ' A' ' 768' ' ' VAL . 3.5 t80 -66.24 -46.1 78.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.921 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 757' ' ' VAL . . . . . 0.909 HG12 HG22 ' A' ' 803' ' ' VAL . 43.7 t -69.31 -45.05 79.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.932 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 758' ' ' THR . . . . . 0.609 HG22 ' O ' ' A' ' 805' ' ' ALA . 2.0 p -56.64 -42.92 79.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.794 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -78.9 -39.82 33.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.285 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 760' ' ' SER . . . . . 0.415 ' OG ' ' HA ' ' A' ' 757' ' ' VAL . 92.4 p -74.46 -16.88 60.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.35 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 9.0 mmm-85 62.35 24.96 14.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.591 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 762' ' ' ARG . . . . . 0.425 ' C ' HG13 ' A' ' 757' ' ' VAL . 6.3 ptt180 -157.87 133.14 8.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.678 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 763' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -102.61 89.77 3.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.965 0.412 . . . . 0.0 111.564 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 764' ' ' SER . . . . . 0.716 ' O ' HG23 ' A' ' 768' ' ' VAL . 1.8 m -125.02 118.53 26.4 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 765' ' ' ILE . . . . . 0.547 HG21 ' HB2' ' A' ' 780' ' ' ALA . 2.2 mp -51.16 -51.49 22.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.952 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 766' ' ' SER . . . . . 0.472 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 14.3 t -53.32 -42.21 66.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.155 0.502 . . . . 0.0 110.629 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -70.1 -42.12 73.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.549 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 768' ' ' VAL . . . . . 0.969 HG21 HD11 ' A' ' 783' ' ' ILE . 42.5 t -59.47 -47.48 90.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.215 179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . 0.589 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.8 OUTLIER -65.49 -33.46 75.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.719 -179.729 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 770' ' ' ARG . . . . . 0.468 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 0.0 OUTLIER -68.89 -42.25 77.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.046 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -78.55 -42.16 30.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.693 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 772' ' ' LEU . . . . . 0.879 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -84.98 -8.79 58.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.889 -179.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp 58.21 41.83 22.94 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 774' ' ' ILE . . . . . 0.839 ' CG2' HD13 ' A' ' 749' ' ' LEU . 26.9 pt -111.84 -173.9 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.72 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -91.53 153.08 21.88 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.972 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 776' ' ' TYR . . . . . 0.401 ' HB2' ' NE2' ' A' ' 769' ' ' GLN . 52.7 t80 -58.5 -46.69 86.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.832 0.349 . . . . 0.0 110.73 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -57.57 -47.74 81.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.064 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.798 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.0 OUTLIER -66.0 -50.28 64.83 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.693 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -54.85 -50.09 69.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.674 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 780' ' ' ALA . . . . . 0.547 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -59.31 -42.92 92.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.76 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -58.93 -48.49 81.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.105 0.478 . . . . 0.0 109.88 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 782' ' ' MET . . . . . . . . . . . . . 33.5 mtm -65.21 -34.52 78.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.45 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 783' ' ' ILE . . . . . 0.969 HD11 HG21 ' A' ' 768' ' ' VAL . 5.9 mm -64.6 -36.2 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.094 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.99 -39.94 94.22 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.589 ' HB1' ' O ' ' A' ' 744' ' ' SER . . . -60.11 -34.6 73.72 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.42 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 786' ' ' MET . . . . . 0.741 ' HB3' HG22 ' A' ' 792' ' ' VAL . 13.9 mtm -67.07 -39.07 86.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.975 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 787' ' ' GLU . . . . . 0.416 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 0.1 OUTLIER -59.51 -54.12 50.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.726 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 20.1 mtm -70.36 -38.34 74.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.129 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -65.54 -21.59 66.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.558 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 790' ' ' GLY . . . . . 0.647 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 91.14 14.97 56.84 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.84 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.735 HG11 HG22 ' A' ' 754' ' ' VAL . 23.7 t -84.51 -30.69 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-O 120.892 0.377 . . . . 0.0 111.028 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 792' ' ' VAL . . . . . 0.741 HG22 ' HB3' ' A' ' 786' ' ' MET . 18.9 m -137.07 140.06 43.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.278 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 793' ' ' THR . . . . . 0.515 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 2.3 p -85.18 160.56 54.43 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.831 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 794' ' ' PRO . . . . . 0.515 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 17.7 Cg_endo -58.94 167.55 5.41 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.137 1.891 . . . . 0.0 111.873 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.54 157.01 38.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.202 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 35.9 p30 -105.55 176.61 5.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.826 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 7.9 t -57.31 -33.95 68.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.023 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -71.95 -17.51 62.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.14 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 92.99 27.76 13.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.474 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 3.5 m -127.72 133.95 49.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 0.0 110.898 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 801' ' ' ARG . . . . . 0.509 ' NH1' HG21 ' A' ' 792' ' ' VAL . 8.4 mtt-85 -85.6 170.66 12.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.243 0.544 . . . . 0.0 111.354 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -130.86 167.34 19.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.042 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 803' ' ' VAL . . . . . 0.909 HG22 HG12 ' A' ' 757' ' ' VAL . 21.9 t -109.5 135.87 47.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.951 0.405 . . . . 0.0 111.63 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 804' ' ' ILE . . . . . 0.647 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -104.51 -28.43 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.259 179.058 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 805' ' ' ALA . . . . . 0.645 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -81.33 124.15 80.77 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.87 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.32 163.85 25.05 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.671 2.247 . . . . 0.0 112.188 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.407 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.2 -179.799 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 743' ' ' GLY . . . . . 0.558 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.743 -0.143 . . . . 0.0 112.743 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . 0.55 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 0.7 OUTLIER -117.5 -51.69 2.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.141 0.496 . . . . 0.0 110.267 179.608 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -157.03 -49.14 0.07 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.024 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -124.93 95.07 4.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.227 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . 0.565 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 13.1 t70 -122.57 143.31 39.52 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.344 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 748' ' ' PRO . . . . . 0.405 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 45.3 Cg_exo -36.14 -29.32 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.011 2.474 . . . . 0.0 113.789 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 749' ' ' LEU . . . . . 0.837 HD13 ' CG2' ' A' ' 774' ' ' ILE . 23.8 mt -120.05 -17.24 8.44 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 750' ' ' TYR . . . . . 0.744 ' CE2' HG21 ' A' ' 754' ' ' VAL . 70.1 t80 -53.39 -48.37 68.72 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.949 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -53.24 -37.29 61.94 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 752' ' ' GLU . . . . . 1.014 ' HB3' HD21 ' A' ' 772' ' ' LEU . 0.5 OUTLIER -70.94 -42.12 70.25 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.085 178.679 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 753' ' ' ALA . . . . . 0.44 ' HB2' ' HE2' ' A' ' 782' ' ' MET . . . -60.96 -53.7 54.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.202 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 754' ' ' VAL . . . . . 0.744 HG21 ' CE2' ' A' ' 750' ' ' TYR . 8.0 t -56.27 -39.98 63.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.063 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 37.9 mtt180 -67.62 -37.37 82.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.39 0.614 . . . . 0.0 109.766 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 756' ' ' PHE . . . . . 0.678 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.6 t80 -67.68 -46.06 73.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.288 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 757' ' ' VAL . . . . . 0.93 HG12 HG22 ' A' ' 803' ' ' VAL . 54.3 t -69.46 -43.94 80.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.958 0.409 . . . . 0.0 110.61 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 758' ' ' THR . . . . . 0.715 ' HA ' HG11 ' A' ' 803' ' ' VAL . 12.5 p -56.67 -45.6 81.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.052 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -78.8 -34.39 45.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.634 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 760' ' ' SER . . . . . 0.505 ' HB2' ' NE ' ' A' ' 762' ' ' ARG . 91.7 p -75.25 -17.76 60.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.527 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 5.9 mmm-85 63.68 33.55 12.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.349 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 762' ' ' ARG . . . . . 0.53 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.0 OUTLIER -170.61 136.64 1.27 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.403 179.535 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 763' ' ' ALA . . . . . 0.455 ' HB2' HG11 ' A' ' 757' ' ' VAL . . . -104.46 89.76 3.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 0.0 111.82 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 764' ' ' SER . . . . . 0.704 ' O ' HG23 ' A' ' 768' ' ' VAL . 1.0 OUTLIER -121.36 118.52 29.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.571 178.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 765' ' ' ILE . . . . . 0.606 HG21 ' HB2' ' A' ' 780' ' ' ALA . 1.6 mt -53.33 -50.49 47.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.618 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 766' ' ' SER . . . . . 0.464 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 16.3 t -55.27 -39.04 69.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.167 0.508 . . . . 0.0 110.492 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . 0.408 ' HB1' ' HZ ' ' A' ' 756' ' ' PHE . . . -71.8 -37.54 70.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.503 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 768' ' ' VAL . . . . . 0.782 HG21 HD11 ' A' ' 783' ' ' ILE . 44.5 t -65.57 -47.85 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.241 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . 0.593 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -64.85 -33.39 75.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.478 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 770' ' ' ARG . . . . . 0.447 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 2.6 mtt180 -70.91 -42.5 69.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.117 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.426 ' HB2' ' CE1' ' A' ' 756' ' ' PHE . 0.2 OUTLIER -78.52 -36.43 44.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.086 -179.425 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 772' ' ' LEU . . . . . 1.014 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -91.59 -9.35 44.48 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt 60.76 40.94 15.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.073 0.463 . . . . 0.0 109.815 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 774' ' ' ILE . . . . . 0.837 ' CG2' HD13 ' A' ' 749' ' ' LEU . 20.5 pt -111.84 -173.92 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.292 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.91 150.96 21.87 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.12 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -55.63 -45.37 77.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.855 0.359 . . . . 0.0 110.582 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 777' ' ' ASN . . . . . 0.404 ' O ' ' HG3' ' A' ' 781' ' ' ARG . 21.5 m-80 -63.77 -47.94 78.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.771 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.754 ' HE ' HD12 ' A' ' 749' ' ' LEU . 0.2 OUTLIER -59.44 -50.12 75.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.893 0.378 . . . . 0.0 110.783 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.64 72.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.458 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 780' ' ' ALA . . . . . 0.606 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -56.27 -40.69 74.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.941 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 781' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 777' ' ' ASN . 12.5 mtt180 -58.86 -46.35 87.97 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 782' ' ' MET . . . . . 0.44 ' HE2' ' HB2' ' A' ' 753' ' ' ALA . 2.3 mtp -64.74 -42.59 95.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 783' ' ' ILE . . . . . 0.782 HD11 HG21 ' A' ' 768' ' ' VAL . 9.9 mm -57.22 -35.64 49.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.291 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.12 -45.47 88.45 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.604 ' HB3' ' CE1' ' A' ' 750' ' ' TYR . . . -58.26 -33.62 69.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.603 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 786' ' ' MET . . . . . 0.716 ' HB3' HG22 ' A' ' 792' ' ' VAL . 14.4 mtm -67.2 -38.21 84.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.083 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -62.27 -47.9 82.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.582 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 36.3 mtm -73.56 -37.53 65.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.272 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -70.46 -21.58 62.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.599 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 790' ' ' GLY . . . . . 0.616 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 92.22 15.51 53.44 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.819 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.763 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 59.7 t -83.93 -29.12 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.744 0.307 . . . . 0.0 111.101 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 792' ' ' VAL . . . . . 0.716 HG22 ' HB3' ' A' ' 786' ' ' MET . 18.8 m -139.39 135.42 40.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.953 0.406 . . . . 0.0 111.375 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 793' ' ' THR . . . . . 0.696 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 4.7 p -80.49 168.31 26.45 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.597 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 794' ' ' PRO . . . . . 0.696 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 38.7 Cg_endo -65.44 163.38 29.93 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 121.877 1.718 . . . . 0.0 111.965 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . 0.423 ' HA ' ' HG3' ' A' ' 801' ' ' ARG . 0.1 OUTLIER -60.8 162.27 6.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.453 -179.69 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -105.53 176.5 5.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.892 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 60.2 p -60.58 -30.41 69.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.022 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -83.79 -17.53 40.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.252 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.41 26.41 7.74 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.513 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 50.7 m -123.27 130.44 52.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.911 0.386 . . . . 0.0 110.825 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 801' ' ' ARG . . . . . 0.431 ' NH1' ' CG2' ' A' ' 783' ' ' ILE . 9.3 mtt-85 -83.68 170.57 14.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.213 0.53 . . . . 0.0 111.465 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 802' ' ' GLU . . . . . 0.627 ' O ' HG23 ' A' ' 793' ' ' THR . 5.0 mt-10 -132.14 134.51 45.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.934 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 803' ' ' VAL . . . . . 0.93 HG22 HG12 ' A' ' 757' ' ' VAL . 18.9 t -76.91 136.86 23.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.985 0.422 . . . . 0.0 111.904 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 804' ' ' ILE . . . . . 0.616 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -107.04 -29.78 2.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.516 178.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 805' ' ' ALA . . . . . 0.763 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -75.08 120.15 80.29 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -50.2 163.9 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.678 2.252 . . . . 0.0 112.92 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.148 179.989 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 743' ' ' GLY . . . . . 0.628 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 14.6 m -119.35 -47.5 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.134 0.492 . . . . 0.0 110.363 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -159.26 -49.67 0.06 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.223 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.38 95.21 4.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.355 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.42 142.96 38.39 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.316 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 748' ' ' PRO . . . . . 0.418 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 43.8 Cg_exo -36.69 -28.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.015 2.477 . . . . 0.0 113.774 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 749' ' ' LEU . . . . . 0.829 HD13 ' CG2' ' A' ' 774' ' ' ILE . 28.6 mt -119.99 -17.1 8.51 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 750' ' ' TYR . . . . . 0.725 ' CE2' HG21 ' A' ' 754' ' ' VAL . 82.3 t80 -52.81 -50.47 63.59 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.791 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -52.93 -35.99 59.17 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 752' ' ' GLU . . . . . 1.073 ' HB3' HD21 ' A' ' 772' ' ' LEU . 5.9 tt0 -71.05 -41.89 70.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.23 178.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 753' ' ' ALA . . . . . 0.553 ' HB2' ' HE1' ' A' ' 782' ' ' MET . . . -62.89 -53.77 48.98 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.987 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 754' ' ' VAL . . . . . 0.725 HG21 ' CE2' ' A' ' 750' ' ' TYR . 9.1 t -56.02 -41.43 68.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.738 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 755' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' A' ' 759' ' ' GLU . 1.5 ttm-85 -65.6 -35.11 79.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.281 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 756' ' ' PHE . . . . . 0.665 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.7 t80 -69.73 -46.3 66.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.367 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 757' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 762' ' ' ARG . 51.6 t -70.44 -38.37 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 120.921 0.391 . . . . 0.0 110.843 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 758' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 754' ' ' VAL . 22.4 p -65.21 -42.48 93.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.177 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 755' ' ' ARG . 1.8 tt0 -77.14 -46.48 23.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.373 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 92.5 p -74.68 -10.47 59.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.154 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.65 30.25 17.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.06 0.457 . . . . 0.0 110.607 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 762' ' ' ARG . . . . . 0.716 ' O ' HG13 ' A' ' 757' ' ' VAL . 10.6 mtm180 -145.5 138.46 26.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.543 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 763' ' ' ALA . . . . . 0.925 ' HB1' HH21 ' A' ' 801' ' ' ARG . . . -117.76 89.57 3.15 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.97 0.414 . . . . 0.0 111.025 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 764' ' ' SER . . . . . 0.63 ' O ' HG23 ' A' ' 768' ' ' VAL . 2.7 m -133.91 118.45 17.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.637 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 765' ' ' ILE . . . . . 0.731 HD13 ' HB2' ' A' ' 780' ' ' ALA . 19.1 mt -50.01 -46.65 23.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.704 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 766' ' ' SER . . . . . 0.485 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 12.1 t -58.9 -39.0 80.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.136 0.493 . . . . 0.0 110.534 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -72.93 -36.61 67.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.349 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 768' ' ' VAL . . . . . 0.679 HG21 HD11 ' A' ' 783' ' ' ILE . 40.7 t -65.22 -48.01 85.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.067 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . 0.602 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.41 -33.47 76.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.569 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 770' ' ' ARG . . . . . 0.414 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 12.1 mtt180 -71.54 -41.53 69.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.065 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.63 -36.52 43.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.829 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 772' ' ' LEU . . . . . 1.073 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -91.28 -10.03 42.93 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt 61.61 39.94 13.97 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 774' ' ' ILE . . . . . 0.829 ' CG2' HD13 ' A' ' 749' ' ' LEU . 24.1 pt -111.77 -174.49 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.481 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.69 152.98 23.57 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.228 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -57.16 -46.34 82.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.926 0.393 . . . . 0.0 110.625 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -62.87 -47.83 81.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.724 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.79 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.4 OUTLIER -60.27 -50.24 74.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.82 -179.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.84 -50.04 73.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.349 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 780' ' ' ALA . . . . . 0.731 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -55.64 -42.89 75.63 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.781 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -58.66 -43.09 89.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.097 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 782' ' ' MET . . . . . 0.553 ' HE1' ' HB2' ' A' ' 753' ' ' ALA . 2.6 mtp -68.38 -40.04 81.55 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 783' ' ' ILE . . . . . 0.93 HG23 ' NH2' ' A' ' 801' ' ' ARG . 5.3 mm -58.14 -40.08 75.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.798 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 784' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 787' ' ' GLU . 2.3 mt-10 -63.99 -46.18 85.7 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.628 ' HB2' ' O ' ' A' ' 743' ' ' GLY . . . -54.76 -33.42 61.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.508 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 786' ' ' MET . . . . . 0.743 ' HB3' HG22 ' A' ' 792' ' ' VAL . 14.9 mtm -67.7 -39.36 84.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.848 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 787' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 784' ' ' GLU . 0.4 OUTLIER -57.62 -51.5 69.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.669 179.415 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 46.9 mtm -75.46 -38.37 59.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.915 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -64.31 -21.2 66.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.921 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 790' ' ' GLY . . . . . 0.551 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 91.87 19.77 39.04 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.419 -178.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.701 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 79.2 t -89.2 -32.78 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.793 0.33 . . . . 0.0 111.059 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 792' ' ' VAL . . . . . 0.864 HG21 ' NH2' ' A' ' 801' ' ' ARG . 28.3 m -137.49 143.44 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.0 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 793' ' ' THR . . . . . 0.426 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 6.8 p -82.03 155.2 70.16 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.421 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 794' ' ' PRO . . . . . 0.426 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 19.1 Cg_endo -58.75 169.03 3.62 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.424 2.083 . . . . 0.0 112.345 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . 0.507 ' HA ' ' HG3' ' A' ' 801' ' ' ARG . 1.4 mtp -60.92 159.52 11.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.303 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -102.48 176.56 5.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.805 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 38.2 p -60.59 -28.01 68.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.07 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -90.9 -17.59 26.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.327 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 104.8 28.55 5.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.765 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 19.3 m -121.91 129.88 52.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.871 0.367 . . . . 0.0 110.929 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 801' ' ' ARG . . . . . 0.93 ' NH2' HG23 ' A' ' 783' ' ' ILE . 0.4 OUTLIER -94.46 170.49 9.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.125 0.488 . . . . 0.0 111.387 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.95 -172.42 2.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.488 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 803' ' ' VAL . . . . . 0.594 HG22 HG12 ' A' ' 757' ' ' VAL . 30.2 t -121.14 138.66 50.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.843 0.354 . . . . 0.0 111.741 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 804' ' ' ILE . . . . . 0.551 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -110.16 -27.13 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.777 179.282 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 805' ' ' ALA . . . . . 0.701 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -84.74 120.87 74.43 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.889 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.42 163.71 28.63 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.59 2.193 . . . . 0.0 112.163 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.168 -179.903 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 743' ' ' GLY . . . . . 0.595 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.45 -0.375 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 9.8 p -101.76 -158.04 0.65 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.592 0.234 . . . . 0.0 110.656 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -50.78 -45.31 59.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.722 0.296 . . . . 0.0 111.505 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -128.13 95.61 4.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.069 0.461 . . . . 0.0 111.34 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . 0.58 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 14.6 t70 -122.36 142.34 36.82 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.413 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 748' ' ' PRO . . . . . 0.402 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 41.0 Cg_exo -35.12 -30.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.311 2.674 . . . . 0.0 113.993 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 749' ' ' LEU . . . . . 0.83 HD12 ' NE ' ' A' ' 778' ' ' ARG . 44.7 mt -120.02 -16.91 8.54 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 750' ' ' TYR . . . . . 0.712 ' CE2' HG21 ' A' ' 754' ' ' VAL . 67.7 t80 -54.08 -47.81 71.31 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.483 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -53.45 -35.73 60.81 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 752' ' ' GLU . . . . . 0.97 ' HB2' HD21 ' A' ' 772' ' ' LEU . 8.4 mt-10 -70.95 -40.91 71.74 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.182 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 753' ' ' ALA . . . . . 0.473 ' HB2' ' HE1' ' A' ' 782' ' ' MET . . . -64.24 -52.35 59.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.118 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 754' ' ' VAL . . . . . 0.712 HG21 ' CE2' ' A' ' 750' ' ' TYR . 3.1 t -56.35 -40.09 64.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.005 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.59 -35.32 77.2 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 756' ' ' PHE . . . . . 0.829 ' CE1' HG22 ' A' ' 768' ' ' VAL . 1.1 t80 -67.42 -46.12 74.11 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.93 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 757' ' ' VAL . . . . . 0.78 HG13 ' O ' ' A' ' 762' ' ' ARG . 43.3 t -70.82 -41.07 77.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.86 0.362 . . . . 0.0 110.757 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 758' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 754' ' ' VAL . 20.3 p -62.18 -42.08 98.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.568 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -77.26 -47.03 21.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.882 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 6.3 p -70.98 -18.54 62.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.765 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 761' ' ' ARG . . . . . 0.404 ' N ' ' O ' ' A' ' 757' ' ' VAL . 0.0 OUTLIER 65.17 18.69 11.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.771 -179.626 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 762' ' ' ARG . . . . . 0.78 ' O ' HG13 ' A' ' 757' ' ' VAL . 1.0 OUTLIER -139.74 145.39 38.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.749 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 763' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' A' ' 801' ' ' ARG . . . -117.43 89.46 3.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.237 0.541 . . . . 0.0 110.83 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 764' ' ' SER . . . . . 0.726 ' O ' HG23 ' A' ' 768' ' ' VAL . 23.7 m -129.99 118.59 21.84 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 765' ' ' ILE . . . . . 0.525 HG21 ' HB2' ' A' ' 780' ' ' ALA . 11.2 mt -51.77 -47.17 39.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.697 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 766' ' ' SER . . . . . 0.571 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 22.2 t -59.3 -37.73 78.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.149 0.499 . . . . 0.0 110.571 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -73.1 -42.17 63.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.229 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 768' ' ' VAL . . . . . 0.871 HG21 HD11 ' A' ' 783' ' ' ILE . 30.4 t -59.76 -50.91 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.971 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . 0.641 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -63.58 -33.45 75.63 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.713 -179.649 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -67.03 -43.87 81.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.122 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.552 ' HD2' ' HD2' ' A' ' 756' ' ' PHE . 0.9 OUTLIER -78.64 -42.16 29.5 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.838 0.351 . . . . 0.0 111.794 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 772' ' ' LEU . . . . . 0.97 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -81.37 -10.57 59.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.815 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm 60.03 40.76 18.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.193 0.521 . . . . 0.0 109.701 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 774' ' ' ILE . . . . . 0.766 ' CG2' HD13 ' A' ' 749' ' ' LEU . 24.2 pt -111.82 -173.99 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.563 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.55 149.91 21.45 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.111 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -53.98 -44.72 71.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 110.662 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 777' ' ' ASN . . . . . 0.435 ' O ' ' HG3' ' A' ' 781' ' ' ARG . 79.3 m-20 -65.01 -47.89 75.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.692 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.83 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.2 OUTLIER -57.83 -50.07 74.51 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.865 0.364 . . . . 0.0 110.752 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 779' ' ' ALA . . . . . 0.4 ' HB2' ' CD1' ' A' ' 774' ' ' ILE . . . -58.14 -45.88 86.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.105 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 780' ' ' ALA . . . . . 0.525 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -56.93 -44.3 82.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.103 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 781' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 777' ' ' ASN . 7.4 mtt180 -58.76 -46.86 86.51 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 782' ' ' MET . . . . . 0.473 ' HE1' ' HB2' ' A' ' 753' ' ' ALA . 2.5 mtp -64.06 -41.81 97.22 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 783' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 768' ' ' VAL . 7.2 mm -58.73 -37.16 64.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.448 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.26 -45.2 92.61 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.637 ' HB3' ' CE1' ' A' ' 750' ' ' TYR . . . -58.99 -33.53 70.8 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.63 178.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 786' ' ' MET . . . . . 0.736 ' HB3' HG22 ' A' ' 792' ' ' VAL . 12.4 mtm -65.79 -39.79 91.3 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.118 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.32 -47.84 82.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.147 0.499 . . . . 0.0 110.492 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 25.8 mtp -70.95 -38.29 72.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.552 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -71.19 -21.64 62.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.962 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 790' ' ' GLY . . . . . 0.768 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 93.3 19.03 36.96 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.605 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.733 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 38.1 t -88.27 -30.19 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.716 0.293 . . . . 0.0 111.168 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 792' ' ' VAL . . . . . 0.736 HG22 ' HB3' ' A' ' 786' ' ' MET . 20.9 m -138.76 143.73 31.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.408 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 793' ' ' THR . . . . . 0.533 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.3 p -88.06 163.59 36.83 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 794' ' ' PRO . . . . . 0.533 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 18.6 Cg_endo -59.93 166.41 8.67 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 121.957 1.772 . . . . 0.0 112.129 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 1.5 mtt -61.12 162.03 7.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.227 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -105.55 176.54 5.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.766 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 44.1 p -61.62 -33.92 74.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.779 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -79.56 -17.57 53.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.56 28.07 6.87 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.417 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 19.2 m -124.68 130.45 52.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 110.909 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 801' ' ' ARG . . . . . 0.56 ' HB2' ' O ' ' A' ' 763' ' ' ALA . 11.3 mtt-85 -83.95 170.69 13.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.449 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -129.02 168.98 15.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.254 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 803' ' ' VAL . . . . . 0.766 HG22 HG12 ' A' ' 757' ' ' VAL . 21.4 t -110.62 137.27 43.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.011 0.434 . . . . 0.0 111.844 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 804' ' ' ILE . . . . . 0.768 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -107.5 -27.96 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.314 178.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 805' ' ' ALA . . . . . 0.733 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -79.34 122.73 84.39 Favored Pre-proline 0 N--CA 1.455 -0.207 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.742 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.38 163.66 31.38 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.513 2.142 . . . . 0.0 112.198 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.857 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 743' ' ' GLY . . . . . 0.645 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.678 -0.169 . . . . 0.0 112.678 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.43 -47.97 2.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.149 0.5 . . . . 0.0 110.252 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -159.1 -49.59 0.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.177 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -126.35 95.17 4.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.318 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . 0.55 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.6 t70 -122.49 143.2 39.1 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.535 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 748' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 37.9 Cg_exo -36.72 -28.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.069 2.513 . . . . 0.0 113.895 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 749' ' ' LEU . . . . . 0.855 HD13 ' CG2' ' A' ' 774' ' ' ILE . 28.9 mt -120.03 -17.2 8.46 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 750' ' ' TYR . . . . . 0.728 ' CE2' HG21 ' A' ' 754' ' ' VAL . 80.5 t80 -52.88 -50.34 64.04 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.948 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -53.17 -35.72 60.1 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 752' ' ' GLU . . . . . 1.036 ' HB3' HD21 ' A' ' 772' ' ' LEU . 8.0 tt0 -71.12 -41.5 70.44 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.293 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 753' ' ' ALA . . . . . 0.558 ' HB2' ' HE1' ' A' ' 782' ' ' MET . . . -64.57 -51.95 60.15 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.125 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 754' ' ' VAL . . . . . 0.728 HG21 ' CE2' ' A' ' 750' ' ' TYR . 5.0 t -56.12 -38.7 54.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.504 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -69.38 -35.16 75.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.435 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 756' ' ' PHE . . . . . 0.76 ' CE2' HG22 ' A' ' 768' ' ' VAL . 1.5 t80 -68.57 -46.2 70.05 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.329 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 757' ' ' VAL . . . . . 0.643 HG11 ' HB2' ' A' ' 763' ' ' ALA . 35.4 t -71.23 -41.38 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-O 120.991 0.424 . . . . 0.0 110.751 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 758' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 754' ' ' VAL . 30.1 p -62.72 -42.89 99.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.993 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -77.48 -46.31 22.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.275 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 760' ' ' SER . . . . . 0.513 ' O ' ' HD3' ' A' ' 762' ' ' ARG . 50.0 p -70.06 -29.17 66.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 761' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 760' ' ' SER . 0.0 OUTLIER 70.86 28.53 3.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.302 -179.248 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 762' ' ' ARG . . . . . 0.513 ' HD3' ' O ' ' A' ' 760' ' ' SER . 0.4 OUTLIER -147.8 110.55 4.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.368 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 763' ' ' ALA . . . . . 0.873 ' HB1' HH21 ' A' ' 801' ' ' ARG . . . -91.06 89.69 7.51 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.052 0.453 . . . . 0.0 111.257 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 764' ' ' SER . . . . . 0.616 ' O ' HG23 ' A' ' 768' ' ' VAL . 1.3 m -133.94 118.85 18.35 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.472 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 765' ' ' ILE . . . . . 0.557 HG21 ' HB2' ' A' ' 780' ' ' ALA . 1.5 mp -48.85 -52.7 9.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.952 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 766' ' ' SER . . . . . 0.534 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 7.9 t -53.34 -40.12 64.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.203 0.525 . . . . 0.0 110.635 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -71.64 -39.75 70.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.445 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 768' ' ' VAL . . . . . 0.76 HG22 ' CE2' ' A' ' 756' ' ' PHE . 44.4 t -61.89 -49.88 82.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.114 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . 0.596 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -63.47 -33.91 76.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.869 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 770' ' ' ARG . . . . . 0.418 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 7.2 mtt85 -68.95 -42.53 76.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.218 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.7 -39.3 36.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.701 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 772' ' ' LEU . . . . . 1.036 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -87.07 -9.78 54.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.248 -179.314 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp 60.95 39.7 16.3 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 774' ' ' ILE . . . . . 0.855 ' CG2' HD13 ' A' ' 749' ' ' LEU . 17.8 pt -111.86 -173.83 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.165 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -90.17 153.18 22.69 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.023 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -57.09 -45.57 83.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.817 0.341 . . . . 0.0 110.64 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 777' ' ' ASN . . . . . 0.442 ' O ' ' HG3' ' A' ' 781' ' ' ARG . 66.4 m-20 -63.13 -48.08 80.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.735 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.778 ' HE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -59.88 -50.17 74.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.979 0.418 . . . . 0.0 110.751 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.12 76.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.441 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 780' ' ' ALA . . . . . 0.557 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -56.97 -40.87 77.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.027 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 781' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 777' ' ' ASN . 17.3 mtt180 -58.88 -46.77 87.02 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 782' ' ' MET . . . . . 0.558 ' HE1' ' HB2' ' A' ' 753' ' ' ALA . 2.3 mtp -64.83 -42.24 95.09 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 783' ' ' ILE . . . . . 1.014 HG23 ' NH2' ' A' ' 801' ' ' ARG . 5.9 mm -55.8 -39.54 56.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.502 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.97 -46.69 86.51 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.645 ' HB2' ' O ' ' A' ' 743' ' ' GLY . . . -55.19 -33.54 63.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.827 178.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 786' ' ' MET . . . . . 0.749 ' HB3' HG22 ' A' ' 792' ' ' VAL . 14.5 mtm -67.38 -40.53 85.7 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.197 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 787' ' ' GLU . . . . . 0.484 ' HG3' ' NH1' ' A' ' 801' ' ' ARG . 4.2 mt-10 -58.61 -53.66 55.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.647 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 30.9 mtm -71.06 -38.32 72.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.429 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -65.71 -21.42 66.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.7 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 790' ' ' GLY . . . . . 0.701 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 91.15 15.18 56.4 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.608 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.723 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 86.1 t -84.02 -29.78 7.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.023 0.44 . . . . 0.0 110.672 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 792' ' ' VAL . . . . . 0.918 HG21 ' NH2' ' A' ' 801' ' ' ARG . 17.6 m -139.54 144.47 28.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.977 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 793' ' ' THR . . . . . 0.478 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 6.6 p -83.69 156.84 64.72 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.608 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 794' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 19.0 Cg_endo -58.77 169.51 3.3 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.498 2.132 . . . . 0.0 112.177 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . 0.447 ' HA ' ' HG3' ' A' ' 801' ' ' ARG . 2.1 mtt -65.13 159.82 22.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.021 0.439 . . . . 0.0 111.254 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 56.6 m-20 -102.15 176.58 5.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.841 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 9.8 t -59.63 -29.52 68.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.069 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 39.1 p30 -87.3 -17.58 32.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.378 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 102.48 31.79 5.1 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.722 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 15.9 m -125.0 129.65 50.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.347 . . . . 0.0 110.75 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 801' ' ' ARG . . . . . 1.014 ' NH2' HG23 ' A' ' 783' ' ' ILE . 0.5 OUTLIER -93.51 169.63 10.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.348 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -130.48 -170.81 2.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.713 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 803' ' ' VAL . . . . . 0.608 HG22 HG12 ' A' ' 757' ' ' VAL . 30.0 t -124.58 138.52 53.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.928 0.394 . . . . 0.0 111.887 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 804' ' ' ILE . . . . . 0.701 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -108.97 -30.22 2.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.519 179.232 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 805' ' ' ALA . . . . . 0.723 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -79.55 119.79 78.06 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.892 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.89 163.75 32.38 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.536 2.157 . . . . 0.0 112.219 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.134 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.675 -0.17 . . . . 0.0 112.675 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . 0.544 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 56.2 m -122.36 -56.89 1.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.068 0.461 . . . . 0.0 110.322 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -151.37 -48.81 0.12 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.208 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -124.86 95.27 4.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.532 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 747' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.0 t70 -122.45 142.42 37.18 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.501 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -38.73 -27.3 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.873 2.382 . . . . 0.0 113.547 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 749' ' ' LEU . . . . . 0.855 HD13 ' CG2' ' A' ' 774' ' ' ILE . 46.2 mt -119.99 -17.06 8.53 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 750' ' ' TYR . . . . . 0.714 ' CE2' HG21 ' A' ' 754' ' ' VAL . 71.1 t80 -55.62 -47.14 77.05 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.386 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -53.27 -35.72 60.36 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 752' ' ' GLU . . . . . 0.891 ' HB2' HD21 ' A' ' 772' ' ' LEU . 1.2 mm-40 -71.03 -43.58 67.6 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.255 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 753' ' ' ALA . . . . . 0.469 ' HB2' ' HE3' ' A' ' 782' ' ' MET . . . -61.87 -53.39 56.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.205 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 754' ' ' VAL . . . . . 0.714 HG21 ' CE2' ' A' ' 750' ' ' TYR . 3.2 t -56.18 -41.14 68.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.552 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -69.68 -35.43 75.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.333 0.587 . . . . 0.0 109.844 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 756' ' ' PHE . . . . . 0.679 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.0 t80 -66.95 -46.07 75.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.044 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 757' ' ' VAL . . . . . 0.801 HG12 HG22 ' A' ' 803' ' ' VAL . 59.5 t -70.47 -44.86 76.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.883 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 758' ' ' THR . . . . . 0.771 ' HA ' HG11 ' A' ' 803' ' ' VAL . 9.1 p -56.83 -44.87 82.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.277 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -78.84 -39.73 34.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.463 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 760' ' ' SER . . . . . 0.466 ' HB2' ' NE ' ' A' ' 762' ' ' ARG . 94.6 p -72.56 -25.04 61.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.254 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 67.98 42.71 1.8 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.377 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 762' ' ' ARG . . . . . 0.466 ' NE ' ' HB2' ' A' ' 760' ' ' SER . 0.0 OUTLIER -174.61 121.19 0.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.564 179.495 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 763' ' ' ALA . . . . . 0.546 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -93.87 89.77 6.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.972 0.415 . . . . 0.0 111.646 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 764' ' ' SER . . . . . 0.744 ' O ' HG23 ' A' ' 768' ' ' VAL . 9.9 m -123.54 118.55 27.61 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 765' ' ' ILE . . . . . 0.84 HD13 ' HB2' ' A' ' 780' ' ' ALA . 24.1 mt -53.51 -50.15 50.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.738 -179.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 766' ' ' SER . . . . . 0.438 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 11.4 t -53.35 -43.24 67.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.221 0.534 . . . . 0.0 110.499 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -69.75 -39.87 76.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.768 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 768' ' ' VAL . . . . . 0.91 HG21 HD11 ' A' ' 783' ' ' ILE . 47.0 t -61.85 -45.71 98.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.253 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 769' ' ' GLN . . . . . 0.583 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.8 OUTLIER -66.5 -33.48 75.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.416 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 770' ' ' ARG . . . . . 0.466 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 20.5 mtt180 -70.95 -42.06 70.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.037 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.414 ' HB2' ' CE1' ' A' ' 756' ' ' PHE . 0.7 OUTLIER -78.53 -38.27 40.94 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.007 -179.488 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 772' ' ' LEU . . . . . 0.891 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -90.35 -9.32 48.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.573 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt 60.16 42.24 15.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 774' ' ' ILE . . . . . 0.855 ' CG2' HD13 ' A' ' 749' ' ' LEU . 29.4 pt -112.0 -174.05 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.816 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -90.95 150.49 20.58 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.088 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -55.03 -46.52 75.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.902 0.382 . . . . 0.0 110.885 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -59.6 -45.91 90.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.206 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 778' ' ' ARG . . . . . 0.818 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -66.11 -50.44 64.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.833 0.349 . . . . 0.0 110.858 -179.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 779' ' ' ALA . . . . . 0.421 ' HB2' ' CD1' ' A' ' 774' ' ' ILE . . . -55.12 -50.21 69.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.202 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 780' ' ' ALA . . . . . 0.84 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.06 -46.45 78.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.985 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -58.9 -48.42 81.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.253 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 782' ' ' MET . . . . . 0.469 ' HE3' ' HB2' ' A' ' 753' ' ' ALA . 33.8 mtm -63.41 -36.36 83.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.307 0.575 . . . . 0.0 109.461 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 783' ' ' ILE . . . . . 0.91 HD11 HG21 ' A' ' 768' ' ' VAL . 7.4 mm -63.37 -40.28 88.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.18 -42.71 91.48 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 785' ' ' ALA . . . . . 0.544 ' HB1' ' O ' ' A' ' 744' ' ' SER . . . -60.02 -33.58 72.21 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.719 178.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 786' ' ' MET . . . . . 0.61 ' CE ' HD13 ' A' ' 783' ' ' ILE . 12.7 mtm -66.05 -37.62 86.29 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.062 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 787' ' ' GLU . . . . . 0.447 ' HG3' ' CZ ' ' A' ' 801' ' ' ARG . 3.3 mt-10 -63.36 -53.97 44.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.742 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 24.5 mtm -68.55 -37.64 80.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.494 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 789' ' ' ALA . . . . . 0.468 ' HB3' HG23 ' A' ' 791' ' ' VAL . . . -68.73 -21.59 64.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.796 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 790' ' ' GLY . . . . . 0.55 ' CA ' HD12 ' A' ' 804' ' ' ILE . . . 89.75 19.55 47.47 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.926 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 791' ' ' VAL . . . . . 0.689 HG11 HG22 ' A' ' 754' ' ' VAL . 11.3 t -84.45 -34.67 9.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.804 0.335 . . . . 0.0 110.756 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 792' ' ' VAL . . . . . 0.661 HG21 HH21 ' A' ' 801' ' ' ARG . 11.7 m -133.88 140.21 46.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.28 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 793' ' ' THR . . . . . 0.49 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.2 p -77.85 160.89 73.21 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 794' ' ' PRO . . . . . 0.49 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 22.7 Cg_endo -60.29 166.08 9.87 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.088 1.859 . . . . 0.0 111.967 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 2.1 mtt -56.56 158.46 4.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.196 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -101.25 176.47 5.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.921 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 9.7 t -55.63 -33.26 63.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -85.18 -17.58 36.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.121 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.6 35.96 3.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.548 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 6.0 m -127.82 130.01 47.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.956 0.408 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 801' ' ' ARG . . . . . 0.661 HH21 HG21 ' A' ' 792' ' ' VAL . 6.5 mtp85 -81.67 170.58 15.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.331 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -131.27 -170.7 2.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.659 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 803' ' ' VAL . . . . . 0.801 HG22 HG12 ' A' ' 757' ' ' VAL . 23.0 t -127.26 133.7 67.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.17 0.51 . . . . 0.0 112.098 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 804' ' ' ILE . . . . . 0.55 HD12 ' CA ' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -105.15 -28.76 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.858 178.69 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 805' ' ' ALA . . . . . 0.583 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -80.85 126.49 77.59 Favored Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.778 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.61 163.77 23.22 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.713 2.275 . . . . 0.0 112.228 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.374 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.234 -179.783 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.486 -0.245 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 2.4 p -127.29 -56.42 1.32 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.81 0.338 . . . . 0.0 110.863 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -107.02 112.2 25.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.974 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 743' ' ' GLY . . . . . 0.622 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . 102.47 57.8 0.79 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.588 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . 0.503 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 0.8 OUTLIER -116.56 -49.75 2.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.141 0.496 . . . . 0.0 110.262 179.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.69 -50.52 0.08 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.95 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -124.1 95.23 4.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.266 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . 0.537 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.3 t70 -122.44 142.46 37.25 Favored Pre-proline 0 C--N 1.327 -0.408 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.531 179.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 748' ' ' PRO . . . . . 0.408 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 45.7 Cg_exo -37.24 -28.88 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.057 2.505 . . . . 0.0 113.582 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 749' ' ' LEU . . . . . 0.802 HD13 ' CG2' ' A' ' 774' ' ' ILE . 31.6 mt -119.96 -16.87 8.58 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.56 0.578 . . . . 0.0 112.56 -179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.751 ' CE2' HG21 ' A' ' 754' ' ' VAL . 72.4 t80 -53.4 -48.54 68.6 Favored 'General case' 0 C--O 1.221 -0.414 0 C-N-CA 120.344 -0.543 . . . . 0.0 110.457 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -53.37 -36.15 61.08 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 0.948 ' HB2' HD21 ' A' ' 772' ' ' LEU . 1.8 mt-10 -70.95 -40.95 71.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.024 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 753' ' ' ALA . . . . . 0.447 ' O ' HG23 ' A' ' 757' ' ' VAL . . . -63.85 -52.93 57.84 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.043 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 754' ' ' VAL . . . . . 0.751 HG21 ' CE2' ' A' ' 750' ' ' TYR . 8.8 t -56.14 -39.99 62.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.281 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -69.65 -35.71 75.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.312 0.577 . . . . 0.0 109.461 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 756' ' ' PHE . . . . . 0.847 ' CE1' HG22 ' A' ' 768' ' ' VAL . 1.0 OUTLIER -66.58 -46.05 77.24 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.861 179.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 757' ' ' VAL . . . . . 1.026 HG12 HG22 ' A' ' 803' ' ' VAL . 45.6 t -68.6 -47.1 78.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.973 0.416 . . . . 0.0 110.452 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . 0.7 ' HA ' HG11 ' A' ' 803' ' ' VAL . 8.4 p -53.93 -43.18 69.56 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.972 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -78.88 -36.81 41.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.361 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 17.9 p -76.63 -15.07 59.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.454 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 3.8 mmt180 63.07 19.9 11.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.696 0.284 . . . . 0.0 111.415 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 762' ' ' ARG . . . . . 0.561 ' O ' HG13 ' A' ' 757' ' ' VAL . 5.4 ptt180 -154.87 140.03 17.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.844 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 763' ' ' ALA . . . . . 0.585 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -106.84 89.76 3.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.879 0.371 . . . . 0.0 111.528 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 764' ' ' SER . . . . . 0.81 ' O ' HG23 ' A' ' 768' ' ' VAL . 1.4 m -122.62 118.64 28.66 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 765' ' ' ILE . . . . . 0.699 HD13 ' HB2' ' A' ' 780' ' ' ALA . 22.6 mt -53.46 -49.71 52.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.75 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 766' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 12.9 t -53.77 -43.81 69.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.2 0.524 . . . . 0.0 110.578 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -67.86 -45.12 75.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.533 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 768' ' ' VAL . . . . . 0.886 HG21 HD11 ' A' ' 783' ' ' ILE . 26.5 t -56.5 -49.15 78.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.364 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . 0.593 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -63.52 -33.42 75.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.594 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 770' ' ' ARG . . . . . 0.476 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 21.2 mtt180 -70.73 -42.65 70.26 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.231 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.493 ' HD3' ' HD2' ' A' ' 756' ' ' PHE . 0.0 OUTLIER -78.53 -36.15 45.22 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.522 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 772' ' ' LEU . . . . . 0.948 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -90.87 -10.13 43.77 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -179.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 10.3 mtpp 60.67 41.29 15.34 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 774' ' ' ILE . . . . . 0.802 ' CG2' HD13 ' A' ' 749' ' ' LEU . 22.6 pt -111.75 -173.88 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.486 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.57 153.75 23.53 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.02 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -56.94 -46.42 82.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 0.0 110.797 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -63.57 -44.52 93.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.799 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.797 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.4 OUTLIER -62.06 -50.22 72.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.753 179.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -58.34 -48.54 80.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.092 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 780' ' ' ALA . . . . . 0.699 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.07 -43.43 77.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.899 179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -59.12 -48.53 81.26 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.855 0.359 . . . . 0.0 110.125 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 782' ' ' MET . . . . . 0.423 ' HE2' ' HB2' ' A' ' 753' ' ' ALA . 2.7 mtp -63.7 -38.31 90.62 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 783' ' ' ILE . . . . . 0.886 HD11 HG21 ' A' ' 768' ' ' VAL . 7.8 mm -61.31 -40.53 86.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.259 178.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -44.19 91.21 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 743' ' ' GLY . . . -58.97 -33.65 70.91 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 114.622 -1.172 . . . . 0.0 109.92 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 786' ' ' MET . . . . . 0.658 ' SD ' HG21 ' A' ' 757' ' ' VAL . 14.0 mtm -66.46 -37.73 85.77 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.106 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 787' ' ' GLU . . . . . 0.462 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 2.5 mt-10 -62.46 -54.17 44.03 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.519 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 73.4 mtp -68.07 -38.22 82.16 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.473 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -70.14 -21.57 63.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.955 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 790' ' ' GLY . . . . . 0.444 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 89.79 16.85 55.78 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.518 -0.849 . . . . 0.0 111.85 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.677 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 44.8 t -81.93 -31.68 10.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.796 0.331 . . . . 0.0 110.887 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 792' ' ' VAL . . . . . 0.673 HG21 HH21 ' A' ' 801' ' ' ARG . 7.1 m -135.59 140.76 43.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.074 178.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 793' ' ' THR . . . . . 0.525 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 9.4 p -78.59 159.69 73.87 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.737 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 794' ' ' PRO . . . . . 0.525 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 19.3 Cg_endo -59.49 167.25 6.65 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.049 1.832 . . . . 0.0 111.824 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -59.5 163.57 4.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.036 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -105.56 176.55 5.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.859 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 5.4 t -57.27 -30.33 64.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.796 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -88.13 -17.63 30.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.048 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.92 36.71 3.61 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.664 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 17.1 m -127.88 129.13 46.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.906 0.384 . . . . 0.0 111.267 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . 0.673 HH21 HG21 ' A' ' 792' ' ' VAL . 6.7 mtp85 -83.64 170.36 14.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.287 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 802' ' ' GLU . . . . . 0.47 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 3.2 mt-10 -134.87 174.2 10.86 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.698 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 803' ' ' VAL . . . . . 1.026 HG22 HG12 ' A' ' 757' ' ' VAL . 20.7 t -109.74 136.25 46.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.06 0.457 . . . . 0.0 112.13 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 804' ' ' ILE . . . . . 0.494 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -109.78 -26.94 3.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.264 178.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 805' ' ' ALA . . . . . 0.677 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -76.32 122.59 87.04 Favored Pre-proline 0 N--CA 1.453 -0.291 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.041 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -50.26 163.96 0.55 Allowed 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.604 2.203 . . . . 0.0 112.897 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 807' ' ' ALA . . . . . 0.54 ' HB1' ' HD2' ' A' ' 808' ' ' PRO . . . -106.87 160.71 25.35 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.137 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . 0.54 ' HD2' ' HB1' ' A' ' 807' ' ' ALA . 61.2 Cg_endo -73.06 92.75 0.81 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.551 2.168 . . . . 0.0 112.302 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 21.9 t -83.07 -37.14 13.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.118 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 4.1 mtm105 -160.75 -44.12 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.848 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.91 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.206 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 1.2 m -114.12 -49.11 2.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.803 0.335 . . . . 0.0 110.838 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.22 -167.92 2.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.896 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . -70.49 84.11 0.35 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.606 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . 0.773 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 4.5 m -121.55 -62.68 1.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.122 0.487 . . . . 0.0 110.392 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -145.41 -49.16 0.23 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.234 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -123.62 95.23 4.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.556 179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . 0.522 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.9 t70 -122.48 142.31 36.96 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.373 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -38.51 -27.45 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.848 2.366 . . . . 0.0 113.513 179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 749' ' ' LEU . . . . . 0.849 HD13 ' CG2' ' A' ' 774' ' ' ILE . 48.4 mt -120.01 -17.02 8.52 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.663 ' CE2' HG21 ' A' ' 754' ' ' VAL . 65.3 t80 -55.62 -46.82 77.33 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.349 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -53.38 -35.67 60.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 0.896 ' HB2' HD21 ' A' ' 772' ' ' LEU . 2.5 mt-10 -71.02 -43.7 67.38 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.161 178.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 753' ' ' ALA . . . . . 0.464 ' O ' HG23 ' A' ' 757' ' ' VAL . . . -61.92 -51.7 67.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.206 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 754' ' ' VAL . . . . . 0.749 HG22 HG11 ' A' ' 791' ' ' VAL . 2.3 t -56.33 -42.25 73.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.261 179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 2.8 ttt180 -69.16 -35.4 76.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.192 0.52 . . . . 0.0 109.909 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 756' ' ' PHE . . . . . 0.746 ' CE2' HG22 ' A' ' 768' ' ' VAL . 2.3 t80 -66.58 -45.93 77.63 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.922 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 757' ' ' VAL . . . . . 0.943 HG12 HG22 ' A' ' 803' ' ' VAL . 47.4 t -69.2 -44.56 80.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.926 0.393 . . . . 0.0 110.951 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . 0.58 ' HA ' HG11 ' A' ' 803' ' ' VAL . 3.9 p -58.21 -43.73 87.81 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.295 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.76 -43.23 26.05 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.433 -179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 760' ' ' SER . . . . . 0.424 ' OG ' ' HD2' ' A' ' 762' ' ' ARG . 83.1 p -71.93 -19.96 61.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.039 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 19.5 mmm180 63.52 50.63 2.76 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.599 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 762' ' ' ARG . . . . . 0.712 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.0 OUTLIER 179.81 139.61 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.49 179.399 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 763' ' ' ALA . . . . . 0.585 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -108.75 89.73 3.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.989 0.423 . . . . 0.0 111.597 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 764' ' ' SER . . . . . 0.739 ' O ' HG23 ' A' ' 768' ' ' VAL . 0.7 OUTLIER -125.54 118.44 25.75 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.705 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 765' ' ' ILE . . . . . 0.552 HG21 ' HB2' ' A' ' 780' ' ' ALA . 2.3 mp -53.16 -51.3 40.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.897 -178.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 766' ' ' SER . . . . . 0.477 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 12.4 t -53.42 -41.84 66.44 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.116 0.484 . . . . 0.0 110.622 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -70.02 -42.96 72.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.536 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 768' ' ' VAL . . . . . 0.977 HG21 HD11 ' A' ' 783' ' ' ILE . 45.6 t -59.03 -47.14 90.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.268 179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . 0.593 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.7 OUTLIER -65.56 -33.55 76.19 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.694 -179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 770' ' ' ARG . . . . . 0.468 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 0.4 OUTLIER -68.26 -42.78 79.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.093 179.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.62 -42.06 29.9 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.806 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 772' ' ' LEU . . . . . 0.896 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -85.02 -8.54 58.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.742 -179.522 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 15.2 mtpt 58.29 41.94 22.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.185 0.517 . . . . 0.0 109.75 -179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 774' ' ' ILE . . . . . 0.849 ' CG2' HD13 ' A' ' 749' ' ' LEU . 29.9 pt -112.01 -173.91 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.789 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -91.87 152.52 21.43 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.872 179.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 50.7 t80 -57.91 -46.57 84.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.886 0.374 . . . . 0.0 110.838 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 19.5 m-20 -57.49 -47.51 81.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.13 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.821 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.0 OUTLIER -66.45 -50.31 63.77 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.909 0.385 . . . . 0.0 110.773 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 779' ' ' ALA . . . . . 0.422 ' HB2' ' CD1' ' A' ' 774' ' ' ILE . . . -54.6 -50.05 68.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.658 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 780' ' ' ALA . . . . . 0.552 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -58.85 -42.95 90.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.826 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -58.97 -48.38 81.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.108 0.48 . . . . 0.0 109.814 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 782' ' ' MET . . . . . 0.448 ' HE3' ' HB2' ' A' ' 753' ' ' ALA . 34.8 mtm -65.27 -34.88 79.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.497 178.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 783' ' ' ILE . . . . . 0.977 HD11 HG21 ' A' ' 768' ' ' VAL . 6.5 mm -64.21 -37.27 79.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -64.47 -39.45 93.83 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.773 ' HB1' ' O ' ' A' ' 744' ' ' SER . . . -60.68 -34.32 74.15 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.418 178.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 786' ' ' MET . . . . . 0.698 ' HB3' HG22 ' A' ' 792' ' ' VAL . 14.4 mtm -66.81 -39.96 87.91 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.992 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -59.59 -54.18 49.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.708 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 68.4 mtm -68.92 -38.29 79.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.147 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -66.54 -21.51 66.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.728 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 790' ' ' GLY . . . . . 0.617 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 91.39 14.14 57.57 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.903 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.749 HG11 HG22 ' A' ' 754' ' ' VAL . 24.0 t -84.27 -30.4 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.817 0.341 . . . . 0.0 110.85 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 792' ' ' VAL . . . . . 0.698 HG22 ' HB3' ' A' ' 786' ' ' MET . 17.7 m -136.83 141.1 41.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.538 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 793' ' ' THR . . . . . 0.528 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 6.2 p -82.61 160.28 61.95 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.818 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 794' ' ' PRO . . . . . 0.528 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 20.7 Cg_endo -60.05 166.64 8.51 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.137 1.891 . . . . 0.0 112.15 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 2.6 mtt -65.5 163.26 16.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.116 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -105.48 176.55 5.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 7.3 t -58.34 -34.6 70.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -82.01 -17.5 46.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.124 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 100.82 34.6 4.59 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.608 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 15.8 m -124.68 129.06 49.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.971 0.415 . . . . 0.0 111.061 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' A' ' 763' ' ' ALA . 10.4 mtt-85 -89.9 170.71 10.15 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.441 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 802' ' ' GLU . . . . . 0.432 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 0.1 OUTLIER -134.14 169.82 16.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.071 179.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 803' ' ' VAL . . . . . 0.943 HG22 HG12 ' A' ' 757' ' ' VAL . 21.5 t -109.94 136.19 46.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.993 0.425 . . . . 0.0 111.718 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 804' ' ' ILE . . . . . 0.617 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -104.92 -30.53 2.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.261 179.083 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 805' ' ' ALA . . . . . 0.678 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -75.46 127.59 85.79 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.887 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.62 163.85 25.93 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.744 2.296 . . . . 0.0 112.159 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -86.14 154.77 57.74 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.243 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.95 105.82 0.2 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.642 2.228 . . . . 0.0 112.273 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 12.1 t 68.6 -67.98 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.23 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 41.5 ttp180 -143.12 -47.0 0.3 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.963 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.944 179.997 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.45 31.23 3.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.857 0.36 . . . . 0.0 110.887 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 61.08 92.44 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.876 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 743' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . 92.97 68.91 1.11 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.635 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . 0.44 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 1.1 m -126.37 -51.11 1.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.108 0.48 . . . . 0.0 110.542 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -154.94 -51.06 0.09 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.435 179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -124.9 95.39 4.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.502 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.49 142.32 37.01 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.41 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 748' ' ' PRO . . . . . 0.408 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 44.2 Cg_exo -36.01 -29.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.094 2.53 . . . . 0.0 113.692 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 749' ' ' LEU . . . . . 0.768 HD13 ' CG2' ' A' ' 774' ' ' ILE . 39.9 mt -120.09 -17.12 8.45 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.729 ' CE2' HG21 ' A' ' 754' ' ' VAL . 69.2 t80 -54.94 -47.67 74.16 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.29 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -53.2 -36.71 61.28 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 1.041 ' HB3' HD21 ' A' ' 772' ' ' LEU . 4.1 tp10 -70.97 -43.39 68.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.352 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -61.51 -52.39 64.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.086 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 754' ' ' VAL . . . . . 0.73 HG22 HG11 ' A' ' 791' ' ' VAL . 4.0 t -56.15 -39.93 61.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.939 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 3.1 ttm180 -67.93 -36.1 79.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.387 0.613 . . . . 0.0 109.545 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 756' ' ' PHE . . . . . 0.706 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.4 t80 -66.59 -46.21 76.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.076 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 757' ' ' VAL . . . . . 0.92 HG12 HG22 ' A' ' 803' ' ' VAL . 57.6 t -69.52 -44.64 79.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.866 0.365 . . . . 0.0 110.798 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . 0.676 ' HA ' HG11 ' A' ' 803' ' ' VAL . 4.8 p -55.26 -44.18 75.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.773 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -78.78 -31.63 46.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.27 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 24.3 p -81.02 -14.69 57.67 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.57 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.95 16.1 8.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.633 0.254 . . . . 0.0 111.504 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 762' ' ' ARG . . . . . 0.629 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.0 OUTLIER -151.83 142.31 22.59 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.701 0.286 . . . . 0.0 110.741 179.81 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 763' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -109.24 89.93 3.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.852 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 764' ' ' SER . . . . . 0.775 ' O ' HG23 ' A' ' 768' ' ' VAL . 63.7 m -121.02 118.57 30.15 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 178.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 765' ' ' ILE . . . . . 0.575 HG21 ' HB2' ' A' ' 780' ' ' ALA . 14.8 mt -54.15 -48.9 65.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.622 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 766' ' ' SER . . . . . 0.433 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 23.2 t -54.85 -42.25 71.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.229 0.537 . . . . 0.0 110.368 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -69.88 -40.25 75.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.584 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 768' ' ' VAL . . . . . 0.88 HG21 HD11 ' A' ' 783' ' ' ILE . 39.0 t -61.59 -46.66 96.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.212 179.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . 0.591 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.15 -34.07 77.51 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.618 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 770' ' ' ARG . . . . . 0.492 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 12.6 mtt180 -71.0 -42.19 69.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.131 179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.419 ' HB2' ' CE1' ' A' ' 756' ' ' PHE . 0.1 OUTLIER -78.56 -36.06 45.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.961 -179.338 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 772' ' ' LEU . . . . . 1.041 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -91.23 -9.92 43.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.755 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 13.4 mtpt 59.76 41.55 18.13 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 774' ' ' ILE . . . . . 0.768 ' CG2' HD13 ' A' ' 749' ' ' LEU . 20.7 pt -111.82 -174.01 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.345 -179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.79 150.97 21.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.013 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -54.94 -45.87 74.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.948 0.404 . . . . 0.0 110.748 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 -62.96 -45.39 92.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.764 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.767 ' HE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -62.18 -50.31 72.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.762 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.53 -50.63 71.27 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.395 179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 780' ' ' ALA . . . . . 0.575 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -55.99 -39.3 71.65 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.759 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 9.5 mmt85 -59.0 -48.38 81.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.897 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 782' ' ' MET . . . . . 0.488 ' HE3' ' HB2' ' A' ' 749' ' ' LEU . 0.0 OUTLIER -63.45 -44.68 93.81 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.78 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 783' ' ' ILE . . . . . 0.88 HD11 HG21 ' A' ' 768' ' ' VAL . 16.9 mm -54.69 -44.59 70.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.492 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -57.02 -46.63 82.2 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 177.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.519 ' HB3' ' CE1' ' A' ' 750' ' ' TYR . . . -58.17 -33.54 69.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.536 -1.211 . . . . 0.0 109.888 178.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 786' ' ' MET . . . . . 0.578 ' HB3' HG13 ' A' ' 792' ' ' VAL . 13.2 mtm -66.11 -37.59 86.13 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.131 179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 787' ' ' GLU . . . . . 0.463 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 2.8 mt-10 -63.32 -53.86 46.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.13 0.491 . . . . 0.0 110.526 179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 63.2 mtp -67.16 -38.01 84.73 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.352 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -71.09 -21.51 62.22 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.973 -179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 790' ' ' GLY . . . . . 0.539 ' CA ' HD12 ' A' ' 804' ' ' ILE . . . 89.35 18.33 53.12 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.863 -179.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.73 HG11 HG22 ' A' ' 754' ' ' VAL . 41.0 t -83.45 -32.05 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.797 0.332 . . . . 0.0 110.85 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 792' ' ' VAL . . . . . 0.663 HG21 HH21 ' A' ' 801' ' ' ARG . 8.4 m -135.34 142.08 40.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.1 178.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 793' ' ' THR . . . . . 0.49 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.2 p -80.99 160.61 65.65 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.773 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 794' ' ' PRO . . . . . 0.49 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 18.6 Cg_endo -58.26 167.38 4.75 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.04 1.826 . . . . 0.0 111.93 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 1.2 mtt -60.12 163.37 4.92 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.045 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 37.8 m-20 -103.83 176.5 5.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.876 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 5.4 t -57.73 -31.02 66.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.844 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -87.08 -17.5 32.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.128 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 102.86 35.98 3.58 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.748 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 15.3 m -127.77 129.53 47.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.947 0.403 . . . . 0.0 111.137 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . 0.663 HH21 HG21 ' A' ' 792' ' ' VAL . 6.7 mtp85 -82.23 170.57 15.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.181 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -132.85 178.2 7.06 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.637 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 803' ' ' VAL . . . . . 0.92 HG22 HG12 ' A' ' 757' ' ' VAL . 19.9 t -116.21 134.07 60.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.102 0.477 . . . . 0.0 112.218 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 804' ' ' ILE . . . . . 0.539 HD12 ' CA ' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -104.73 -29.38 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.767 178.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 805' ' ' ALA . . . . . 0.603 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -79.86 123.42 83.78 Favored Pre-proline 0 N--CA 1.451 -0.401 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.463 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.2 163.74 22.09 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.483 2.122 . . . . 0.0 112.163 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 807' ' ' ALA . . . . . 0.665 ' HB1' ' HD2' ' A' ' 808' ' ' PRO . . . -93.54 165.18 18.7 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.094 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . 0.665 ' HD2' ' HB1' ' A' ' 807' ' ' ALA . 72.9 Cg_endo -76.0 111.63 3.32 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.568 2.179 . . . . 0.0 112.432 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 31.2 t -86.58 -35.99 9.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.991 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.54 96.82 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.003 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.819 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 39.0 m -149.01 -69.52 0.21 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.792 0.329 . . . . 0.0 110.895 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -122.84 -78.14 0.6 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.799 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 743' ' ' GLY . . . . . 0.673 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . -73.93 85.05 0.67 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.442 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . 0.86 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 0.1 OUTLIER -118.74 -74.38 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.98 0.419 . . . . 0.0 110.636 -179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -134.0 -48.29 0.8 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.558 179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -125.29 95.43 4.47 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.751 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.4 t70 -122.27 141.89 35.62 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.373 179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -36.5 -29.27 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.125 2.55 . . . . 0.0 113.706 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 749' ' ' LEU . . . . . 0.825 HD13 ' CG2' ' A' ' 774' ' ' ILE . 53.5 mt -120.02 -17.26 8.46 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.682 ' CE2' HG21 ' A' ' 754' ' ' VAL . 65.9 t80 -55.88 -46.95 78.18 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.678 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -53.26 -36.06 60.72 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 0.89 ' HB3' HD21 ' A' ' 772' ' ' LEU . 0.0 OUTLIER -71.15 -45.41 63.6 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.138 178.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 753' ' ' ALA . . . . . 0.457 ' HB2' ' HE3' ' A' ' 782' ' ' MET . . . -59.22 -52.86 63.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.3 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 754' ' ' VAL . . . . . 0.682 HG21 ' CE2' ' A' ' 750' ' ' TYR . 2.4 t -56.17 -42.29 72.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.958 179.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 37.5 mtt180 -66.88 -35.41 79.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.322 0.582 . . . . 0.0 109.692 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 756' ' ' PHE . . . . . 0.754 ' CE2' HG22 ' A' ' 768' ' ' VAL . 3.4 t80 -66.66 -46.05 76.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.911 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 757' ' ' VAL . . . . . 0.882 HG12 HG22 ' A' ' 803' ' ' VAL . 40.8 t -70.28 -44.11 77.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.992 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . 0.595 ' HA ' HG11 ' A' ' 803' ' ' VAL . 5.1 p -57.54 -42.82 83.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.953 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.86 -40.85 31.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.26 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 21.1 p -73.86 -18.68 60.89 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.246 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 14.5 mmm180 63.16 28.58 15.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.183 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 762' ' ' ARG . . . . . 0.514 ' C ' HG13 ' A' ' 757' ' ' VAL . 13.0 ptt180 -157.49 131.18 7.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.901 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 763' ' ' ALA . . . . . 0.474 ' HB2' ' CG1' ' A' ' 792' ' ' VAL . . . -102.35 89.84 3.7 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 120.973 0.416 . . . . 0.0 111.253 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 764' ' ' SER . . . . . 0.805 ' O ' HG23 ' A' ' 768' ' ' VAL . 1.0 OUTLIER -126.08 118.64 25.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.434 179.082 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 765' ' ' ILE . . . . . 0.875 HD13 ' CB ' ' A' ' 780' ' ' ALA . 23.2 mt -53.05 -50.64 44.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.822 -179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 766' ' ' SER . . . . . 0.444 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 47.5 t -53.3 -43.56 67.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.207 0.527 . . . . 0.0 110.659 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -68.94 -42.78 76.24 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.634 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 768' ' ' VAL . . . . . 1.002 HG21 HD11 ' A' ' 783' ' ' ILE . 40.1 t -58.67 -47.25 89.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.291 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . 0.59 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.8 OUTLIER -65.64 -33.34 75.68 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.679 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 770' ' ' ARG . . . . . 0.465 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 14.9 mtt180 -69.05 -42.22 76.59 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.109 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 7.4 tptt -78.6 -42.18 29.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.911 0.386 . . . . 0.0 111.688 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 772' ' ' LEU . . . . . 0.89 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -84.81 -9.09 58.5 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.854 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt 57.7 42.75 23.25 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 774' ' ' ILE . . . . . 0.825 ' CG2' HD13 ' A' ' 749' ' ' LEU . 24.7 pt -111.8 -173.92 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.73 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -91.08 151.31 21.01 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.074 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 40.7 t80 -56.53 -46.59 80.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.935 0.397 . . . . 0.0 110.778 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 11.7 m-20 -59.51 -44.63 93.09 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.069 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.807 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -67.18 -50.34 61.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.888 0.375 . . . . 0.0 110.869 -179.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.1 -48.59 75.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.269 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 780' ' ' ALA . . . . . 0.875 ' CB ' HD13 ' A' ' 765' ' ' ILE . . . -56.2 -45.98 79.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.901 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 13.7 mtm180 -58.92 -48.5 81.24 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.059 0.457 . . . . 0.0 110.333 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 782' ' ' MET . . . . . 0.457 ' HE3' ' HB2' ' A' ' 753' ' ' ALA . 32.7 mtm -64.84 -34.96 79.62 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.884 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 783' ' ' ILE . . . . . 1.002 HD11 HG21 ' A' ' 768' ' ' VAL . 7.7 mm -65.38 -38.56 82.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.199 178.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 41.9 mm-40 -63.65 -38.82 92.56 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.86 ' HB1' ' O ' ' A' ' 744' ' ' SER . . . -61.75 -34.28 75.56 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.37 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 786' ' ' MET . . . . . 0.744 ' HB3' HG22 ' A' ' 792' ' ' VAL . 13.9 mtm -66.68 -39.13 88.01 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.087 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -61.18 -54.04 49.37 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.663 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 49.6 mtm -68.46 -37.95 80.65 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.158 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -67.11 -21.5 65.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.716 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 790' ' ' GLY . . . . . 0.678 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 90.93 18.29 47.88 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.835 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.657 HG11 HG22 ' A' ' 754' ' ' VAL . 21.7 t -88.57 -30.33 5.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.76 0.314 . . . . 0.0 111.122 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 792' ' ' VAL . . . . . 0.744 HG22 ' HB3' ' A' ' 786' ' ' MET . 19.4 m -137.38 137.69 45.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.419 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 793' ' ' THR . . . . . . . . . . . . . 1.1 p -85.07 159.98 55.92 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.845 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 794' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -52.12 172.09 0.16 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.267 1.978 . . . . 0.0 112.368 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.02 164.99 24.43 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.98 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -105.52 176.48 5.15 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.852 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 3.2 t -60.67 -34.73 74.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.882 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -79.27 -17.57 54.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 102.74 29.14 5.98 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.514 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 9.8 m -123.68 129.93 51.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 111.053 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . 0.492 ' NH1' HG21 ' A' ' 792' ' ' VAL . 7.1 mtt-85 -85.34 170.66 12.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.186 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -128.64 167.19 17.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.104 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 803' ' ' VAL . . . . . 0.882 HG22 HG12 ' A' ' 757' ' ' VAL . 22.0 t -110.47 135.06 50.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.921 0.391 . . . . 0.0 111.558 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 804' ' ' ILE . . . . . 0.678 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -103.58 -27.76 3.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.251 179.178 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 805' ' ' ALA . . . . . 0.635 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -82.85 123.54 77.89 Favored Pre-proline 0 N--CA 1.453 -0.279 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.887 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.4 163.7 28.65 Favored 'Trans proline' 0 C--N 1.343 0.244 0 C-N-CA 122.608 2.205 . . . . 0.0 112.167 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 807' ' ' ALA . . . . . 0.746 ' HB1' ' HD2' ' A' ' 808' ' ' PRO . . . -95.67 167.33 12.83 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.162 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . 0.746 ' HD2' ' HB1' ' A' ' 807' ' ' ALA . 53.8 Cg_endo -69.6 104.81 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.481 2.12 . . . . 0.0 112.279 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.33 -32.96 2.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.158 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -174.44 -40.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.925 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.961 179.939 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.38 28.46 16.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.803 0.335 . . . . 0.0 110.88 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -94.25 108.93 20.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.716 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 743' ' ' GLY . . . . . 0.596 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . 90.48 57.94 1.59 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.587 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . 0.436 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 64.8 m -117.29 -46.68 2.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.153 0.501 . . . . 0.0 110.15 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -159.97 -49.48 0.05 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.132 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -126.0 95.16 4.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.386 178.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 13.2 t70 -122.47 143.33 39.39 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.335 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 748' ' ' PRO . . . . . 0.414 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 46.8 Cg_exo -37.7 -28.04 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.044 2.496 . . . . 0.0 113.563 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 749' ' ' LEU . . . . . 0.882 HD13 ' CG2' ' A' ' 774' ' ' ILE . 28.5 mt -119.97 -17.08 8.53 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.734 ' CE2' HG21 ' A' ' 754' ' ' VAL . 80.1 t80 -52.61 -50.17 63.62 Favored 'General case' 0 C--O 1.22 -0.464 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.503 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -53.07 -36.54 60.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 0.891 ' HB2' HD21 ' A' ' 772' ' ' LEU . 40.5 mt-10 -70.95 -40.76 71.83 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.966 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 753' ' ' ALA . . . . . 0.519 ' HB2' ' HE1' ' A' ' 782' ' ' MET . . . -63.84 -53.38 51.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.075 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 754' ' ' VAL . . . . . 0.734 HG21 ' CE2' ' A' ' 750' ' ' TYR . 8.0 t -56.15 -39.39 58.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.301 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 70.2 mtt180 -70.14 -36.83 75.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.231 0.539 . . . . 0.0 109.711 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 756' ' ' PHE . . . . . 0.786 ' CE1' HG22 ' A' ' 768' ' ' VAL . 1.0 OUTLIER -66.77 -46.19 76.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.676 179.597 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 757' ' ' VAL . . . . . 0.676 HG11 ' CG1' ' A' ' 792' ' ' VAL . 61.5 t -69.29 -42.94 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 CA-C-O 120.951 0.405 . . . . 0.0 110.775 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . 0.552 ' HA ' HG11 ' A' ' 803' ' ' VAL . 8.0 p -56.78 -44.57 81.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.85 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -78.82 -33.5 46.02 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.241 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 760' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' A' ' 756' ' ' PHE . 18.5 p -74.69 -16.39 60.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.244 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 64.72 15.03 9.52 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.436 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 762' ' ' ARG . . . . . 0.538 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.1 OUTLIER -153.71 143.01 21.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.445 179.808 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 763' ' ' ALA . . . . . 0.561 ' HB2' ' CG1' ' A' ' 792' ' ' VAL . . . -107.74 89.62 3.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.883 0.373 . . . . 0.0 111.941 -179.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 764' ' ' SER . . . . . 0.733 ' O ' HG23 ' A' ' 768' ' ' VAL . 1.3 m -118.97 118.47 31.58 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 765' ' ' ILE . . . . . 0.537 HD13 ' HB2' ' A' ' 780' ' ' ALA . 14.7 mt -54.1 -48.6 65.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.506 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 766' ' ' SER . . . . . 0.474 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 16.7 p -55.08 -42.15 72.43 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.303 0.573 . . . . 0.0 110.538 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -70.51 -40.91 73.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.571 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 768' ' ' VAL . . . . . 0.871 HG21 HD11 ' A' ' 783' ' ' ILE . 48.2 t -59.64 -47.86 89.55 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . 0.584 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.21 -33.9 77.1 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.804 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 770' ' ' ARG . . . . . 0.48 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 15.9 mtt180 -69.35 -42.42 75.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.184 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.404 ' HD3' ' HE2' ' A' ' 756' ' ' PHE . 2.3 tptt -78.63 -40.03 35.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.829 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 772' ' ' LEU . . . . . 0.891 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -86.69 -9.66 55.47 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.847 -179.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 6.2 mtpp 60.92 40.6 15.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.019 0.438 . . . . 0.0 109.874 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 774' ' ' ILE . . . . . 0.882 ' CG2' HD13 ' A' ' 749' ' ' LEU . 21.1 pt -111.85 -173.86 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.542 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.91 150.27 20.93 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.028 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 23.6 t80 -54.72 -45.12 74.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.966 0.412 . . . . 0.0 110.722 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -63.85 -47.82 79.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.873 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.768 ' HE ' HD12 ' A' ' 749' ' ' LEU . 0.7 OUTLIER -60.06 -50.31 74.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.935 0.398 . . . . 0.0 110.716 179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -55.99 -48.67 75.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.272 179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 780' ' ' ALA . . . . . 0.537 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.2 -41.67 75.95 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.003 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 17.4 mtm-85 -58.87 -47.31 85.38 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 782' ' ' MET . . . . . 0.519 ' HE1' ' HB2' ' A' ' 753' ' ' ALA . 2.3 mtp -63.61 -42.91 98.18 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 783' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 768' ' ' VAL . 9.9 mm -57.5 -37.68 59.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.71 179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -62.31 -45.88 91.25 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.596 ' HB2' ' O ' ' A' ' 743' ' ' GLY . . . -58.12 -33.59 69.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.805 178.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 786' ' ' MET . . . . . 0.745 ' HB3' HG22 ' A' ' 792' ' ' VAL . 13.2 mtm -66.49 -39.65 88.86 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.476 179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.58 -49.68 74.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.12 0.486 . . . . 0.0 110.518 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 32.2 mtm -70.57 -36.92 73.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.371 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -71.25 -21.53 62.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.123 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 790' ' ' GLY . . . . . 0.75 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 92.05 19.75 38.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.693 -178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.766 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 63.2 t -88.94 -30.47 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 122.517 0.327 . . . . 0.0 111.092 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 792' ' ' VAL . . . . . 0.745 HG22 ' HB3' ' A' ' 786' ' ' MET . 20.4 m -139.33 142.79 32.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.53 179.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 793' ' ' THR . . . . . 0.552 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.2 p -85.24 164.69 40.01 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 794' ' ' PRO . . . . . 0.552 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 29.5 Cg_endo -61.94 164.65 16.05 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 121.989 1.793 . . . . 0.0 112.003 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.67 162.48 3.91 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.329 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -105.18 176.5 5.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.743 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 15.3 t -63.18 -32.64 74.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 15.2 m-20 -80.66 -17.64 50.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.231 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 102.48 28.56 6.31 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.364 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 57.5 m -125.75 130.75 52.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.988 0.423 . . . . 0.0 110.919 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . 0.508 ' HB3' ' HB3' ' A' ' 763' ' ' ALA . 15.4 mtt-85 -84.25 170.7 13.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.44 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -129.68 167.73 17.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.992 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 803' ' ' VAL . . . . . 0.611 HG22 HG12 ' A' ' 757' ' ' VAL . 11.9 t -108.8 139.19 32.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.004 0.431 . . . . 0.0 112.076 -179.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 804' ' ' ILE . . . . . 0.75 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -110.84 -27.96 2.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.454 178.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 805' ' ' ALA . . . . . 0.766 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -77.97 121.05 83.51 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.078 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -50.29 163.94 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.731 2.287 . . . . 0.0 112.916 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -104.37 143.92 27.65 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.997 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.65 107.12 2.24 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.477 2.118 . . . . 0.0 112.343 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 21.4 t -91.69 -32.68 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.135 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 2.0 ttt180 -173.68 -40.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.868 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.822 -179.952 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 48.6 p -171.42 80.29 0.07 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.838 0.351 . . . . 0.0 110.912 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -114.48 -34.38 5.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.994 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 743' ' ' GLY . . . . . 0.454 ' CA ' ' HG3' ' A' ' 782' ' ' MET . . . 74.11 44.3 29.98 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.457 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.72 -158.92 0.65 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.579 0.228 . . . . 0.0 110.626 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -51.91 -42.97 63.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.842 0.353 . . . . 0.0 111.329 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.01 95.42 4.19 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.059 0.456 . . . . 0.0 110.911 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 12.1 t70 -122.61 142.52 37.68 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.647 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 748' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 43.0 Cg_exo -37.49 -28.46 0.1 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.034 2.49 . . . . 0.0 113.672 179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 749' ' ' LEU . . . . . 0.819 HD13 ' CG2' ' A' ' 774' ' ' ILE . 40.6 mt -119.93 -17.27 8.51 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.727 ' CE2' HG21 ' A' ' 754' ' ' VAL . 64.5 t80 -53.81 -47.42 70.86 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.67 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -53.34 -37.41 62.31 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 1.072 ' HB3' HD21 ' A' ' 772' ' ' LEU . 0.7 OUTLIER -70.9 -39.95 72.48 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.264 178.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 753' ' ' ALA . . . . . 0.489 ' HB2' ' HE1' ' A' ' 782' ' ' MET . . . -63.89 -54.35 36.11 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.217 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 754' ' ' VAL . . . . . 0.764 HG22 HG11 ' A' ' 791' ' ' VAL . 4.3 t -56.19 -38.3 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.01 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 755' ' ' ARG . . . . . 0.41 ' HA ' ' HG1' ' A' ' 758' ' ' THR . 53.8 ttt85 -69.53 -36.58 76.52 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.646 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 756' ' ' PHE . . . . . 0.67 ' CE2' HG22 ' A' ' 768' ' ' VAL . 3.3 t80 -67.07 -46.11 75.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.189 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 757' ' ' VAL . . . . . 0.897 HG13 ' O ' ' A' ' 762' ' ' ARG . 39.0 t -70.28 -45.42 75.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 120.928 0.394 . . . . 0.0 110.715 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . 0.602 ' HA ' HG11 ' A' ' 803' ' ' VAL . 17.8 p -53.78 -44.18 69.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.815 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -77.96 -35.55 50.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.347 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 16.7 p -78.51 -14.98 59.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.45 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 63.46 19.86 11.93 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-O 120.727 0.299 . . . . 0.0 111.348 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 762' ' ' ARG . . . . . 0.897 ' O ' HG13 ' A' ' 757' ' ' VAL . 10.3 ptt180 -152.72 143.78 23.07 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.569 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 763' ' ' ALA . . . . . 0.692 ' HB2' HG11 ' A' ' 757' ' ' VAL . . . -115.47 89.93 3.22 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 764' ' ' SER . . . . . 0.622 ' O ' HG23 ' A' ' 768' ' ' VAL . 7.3 m -120.96 118.31 29.53 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 765' ' ' ILE . . . . . 0.697 HD13 ' HB2' ' A' ' 780' ' ' ALA . 21.2 mt -51.12 -46.06 31.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.525 -179.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 766' ' ' SER . . . . . 0.503 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 11.7 p -58.53 -39.19 79.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.347 0.594 . . . . 0.0 110.393 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . 0.414 ' HB1' ' HZ ' ' A' ' 756' ' ' PHE . . . -72.39 -35.94 68.56 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.481 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 768' ' ' VAL . . . . . 0.851 HG21 HD11 ' A' ' 783' ' ' ILE . 40.3 t -66.88 -47.28 83.05 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.384 179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . 0.619 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.57 -33.97 77.15 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 120.845 0.355 . . . . 0.0 110.599 -179.86 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 19.0 mtt-85 -70.62 -42.16 71.29 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.985 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.61 -36.95 43.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.297 -0.41 . . . . 0.0 112.095 -179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 772' ' ' LEU . . . . . 1.072 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -89.8 -10.65 44.69 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp 61.61 40.43 13.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.237 0.541 . . . . 0.0 109.55 -178.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 774' ' ' ILE . . . . . 0.819 ' CG2' HD13 ' A' ' 749' ' ' LEU . 23.6 pt -111.75 -174.53 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.381 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.15 150.08 21.17 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.163 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -54.11 -45.85 71.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.907 0.384 . . . . 0.0 110.776 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 4.2 m-80 -63.03 -47.54 82.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.854 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.781 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -59.94 -49.6 77.04 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.755 179.821 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.02 -50.0 74.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.57 179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 780' ' ' ALA . . . . . 0.697 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.02 -40.76 73.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.584 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.74 -48.02 82.64 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.994 0.426 . . . . 0.0 109.913 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 782' ' ' MET . . . . . 0.489 ' HE1' ' HB2' ' A' ' 753' ' ' ALA . 2.0 mtp -62.78 -43.72 98.07 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 178.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 783' ' ' ILE . . . . . 0.851 HD11 HG21 ' A' ' 768' ' ' VAL . 12.4 mm -57.16 -40.59 74.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.456 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.7 -45.43 92.15 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 177.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.568 ' HB3' ' CE1' ' A' ' 750' ' ' TYR . . . -59.63 -33.37 71.43 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.79 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 786' ' ' MET . . . . . 0.605 ' CE ' HD13 ' A' ' 783' ' ' ILE . 13.3 mtm -64.96 -37.63 88.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.063 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 787' ' ' GLU . . . . . 0.474 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 1.6 mt-10 -64.54 -52.88 55.41 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.458 179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 51.5 mtm -66.5 -38.4 87.16 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.764 -179.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -73.0 -21.61 60.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.067 -179.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 790' ' ' GLY . . . . . 0.51 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 90.91 18.95 45.22 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.467 -0.873 . . . . 0.0 111.754 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.764 HG11 HG22 ' A' ' 754' ' ' VAL . 44.0 t -83.26 -30.05 8.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.726 0.298 . . . . 0.0 110.825 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 792' ' ' VAL . . . . . 0.689 HG21 HH21 ' A' ' 801' ' ' ARG . 5.7 m -137.15 143.66 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.901 0.381 . . . . 0.0 111.434 178.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 793' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.6 p -81.9 160.63 63.12 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.961 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 794' ' ' PRO . . . . . 0.499 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 22.5 Cg_endo -60.55 167.0 8.82 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.122 1.882 . . . . 0.0 111.988 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 1.5 mtt -58.31 158.83 6.75 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.243 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -99.55 176.51 5.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.881 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 10.0 t -58.44 -29.13 65.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.981 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -89.08 -17.53 29.09 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.188 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 103.9 35.16 3.54 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.728 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 18.0 m -127.79 129.73 47.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.779 0.323 . . . . 0.0 111.14 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . 0.689 HH21 HG21 ' A' ' 792' ' ' VAL . 6.8 mtp85 -81.7 170.54 15.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.015 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 802' ' ' GLU . . . . . 0.415 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 2.6 mt-10 -134.97 173.53 11.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.8 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 803' ' ' VAL . . . . . 0.879 HG22 HG12 ' A' ' 757' ' ' VAL . 31.2 t -109.94 135.89 47.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -178.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 804' ' ' ILE . . . . . 0.514 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -106.07 -27.87 2.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.693 178.246 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 805' ' ' ALA . . . . . 0.615 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -81.67 123.88 80.22 Favored Pre-proline 0 N--CA 1.453 -0.289 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.71 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -63.16 163.81 21.78 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.66 2.24 . . . . 0.0 112.604 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 807' ' ' ALA . . . . . 0.571 ' HB1' ' HD2' ' A' ' 808' ' ' PRO . . . -93.98 162.92 25.4 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.102 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . 0.571 ' HD2' ' HB1' ' A' ' 807' ' ' ALA . 73.1 Cg_endo -77.54 114.36 3.69 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.668 2.245 . . . . 0.0 112.461 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 22.0 t -99.5 -32.55 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -176.14 -39.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.782 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 5.7 t70 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.865 179.957 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.468 -0.253 . . . . 0.0 112.468 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -145.22 -50.22 0.25 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.839 0.352 . . . . 0.0 110.923 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -142.36 108.58 5.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.965 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . 85.97 65.23 1.44 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.617 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . 0.775 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 0.8 OUTLIER -121.98 -60.95 1.54 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.056 0.455 . . . . 0.0 110.537 179.732 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -144.71 -49.75 0.26 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.331 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -124.03 95.34 4.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.585 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . 0.509 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.31 141.82 35.54 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.476 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_exo -36.87 -29.32 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.172 2.581 . . . . 0.0 113.614 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 749' ' ' LEU . . . . . 0.806 HD13 ' CG2' ' A' ' 774' ' ' ILE . 42.9 mt -119.94 -16.98 8.57 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.754 ' CE2' HG21 ' A' ' 754' ' ' VAL . 68.0 t80 -54.62 -46.75 73.91 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 120.388 -0.525 . . . . 0.0 110.123 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -53.49 -36.1 61.33 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 0.928 ' HB2' HD21 ' A' ' 772' ' ' LEU . 1.3 mm-40 -71.04 -42.62 69.24 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.297 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 753' ' ' ALA . . . . . . . . . . . . . . . -62.43 -53.77 50.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.021 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 754' ' ' VAL . . . . . 0.754 HG21 ' CE2' ' A' ' 750' ' ' TYR . 5.0 t -56.22 -42.26 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.324 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 60.0 ttt180 -67.26 -35.24 79.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.272 0.558 . . . . 0.0 109.622 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 756' ' ' PHE . . . . . 0.661 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.5 t80 -67.82 -46.12 72.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.141 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 757' ' ' VAL . . . . . 0.878 HG12 HG22 ' A' ' 803' ' ' VAL . 43.9 t -71.18 -42.24 75.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.796 0.331 . . . . 0.0 110.873 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . 0.702 ' HA ' HG11 ' A' ' 803' ' ' VAL . 14.3 p -60.58 -40.3 91.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.016 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -78.03 -49.09 14.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.329 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 760' ' ' SER . . . . . 0.467 ' O ' ' HD3' ' A' ' 762' ' ' ARG . 7.8 p -69.55 -28.13 65.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.902 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 761' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 760' ' ' SER . 20.7 mmt180 73.96 32.11 1.11 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.55 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 762' ' ' ARG . . . . . 0.667 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.3 OUTLIER -150.14 131.18 14.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.699 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 763' ' ' ALA . . . . . 0.673 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -107.4 89.67 3.07 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.047 0.451 . . . . 0.0 110.638 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 764' ' ' SER . . . . . 0.711 ' O ' HG23 ' A' ' 768' ' ' VAL . 6.2 m -131.74 118.58 20.15 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.569 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 765' ' ' ILE . . . . . 0.888 HD13 ' HB2' ' A' ' 780' ' ' ALA . 23.3 mt -51.44 -49.79 31.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.802 -179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 766' ' ' SER . . . . . 0.443 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 11.7 t -54.19 -43.03 70.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.097 0.475 . . . . 0.0 110.649 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -69.82 -39.68 76.35 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.772 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 768' ' ' VAL . . . . . 0.899 HG21 HD11 ' A' ' 783' ' ' ILE . 45.4 t -62.54 -45.83 97.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.29 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . 0.59 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.4 OUTLIER -66.36 -33.47 75.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.542 179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 770' ' ' ARG . . . . . 0.473 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 17.8 mtt180 -71.32 -42.3 68.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.084 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.68 -37.11 42.58 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.954 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 772' ' ' LEU . . . . . 0.928 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -90.52 -10.29 44.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.664 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt 60.77 41.53 14.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.185 0.517 . . . . 0.0 109.688 -178.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 774' ' ' ILE . . . . . 0.806 ' CG2' HD13 ' A' ' 749' ' ' LEU . 26.0 pt -111.9 -174.0 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.595 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.58 154.19 24.72 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.081 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -58.75 -46.11 88.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.89 0.376 . . . . 0.0 110.71 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -63.53 -43.59 96.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.877 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.772 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -64.44 -50.25 68.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.716 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.0 -50.12 71.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.301 179.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 780' ' ' ALA . . . . . 0.888 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -55.96 -39.62 72.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.786 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -59.0 -48.49 81.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.977 0.418 . . . . 0.0 110.019 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 782' ' ' MET . . . . . 0.445 ' CE ' ' CB ' ' A' ' 749' ' ' LEU . 0.0 OUTLIER -63.9 -44.58 92.54 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 783' ' ' ILE . . . . . 0.899 HD11 HG21 ' A' ' 768' ' ' VAL . 7.4 mm -56.33 -41.46 71.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.708 178.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -58.96 -45.04 91.49 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.775 ' HB1' ' O ' ' A' ' 744' ' ' SER . . . -59.61 -33.57 71.66 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 114.519 -1.218 . . . . 0.0 109.816 178.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 786' ' ' MET . . . . . 0.57 ' HB3' HG22 ' A' ' 792' ' ' VAL . 13.8 mtm -65.4 -37.64 87.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.047 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 787' ' ' GLU . . . . . 0.455 ' HG3' ' CZ ' ' A' ' 801' ' ' ARG . 2.6 mt-10 -64.19 -54.04 39.89 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.704 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 40.0 mtp -67.28 -38.19 84.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.551 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 789' ' ' ALA . . . . . 0.469 ' HB3' HG23 ' A' ' 791' ' ' VAL . . . -70.41 -21.71 62.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.951 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 790' ' ' GLY . . . . . 0.451 ' CA ' HD12 ' A' ' 804' ' ' ILE . . . 89.54 19.79 47.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.602 -0.808 . . . . 0.0 111.978 -179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.671 HG11 HG22 ' A' ' 754' ' ' VAL . 14.1 t -83.61 -32.58 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 120.892 0.377 . . . . 0.0 110.866 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 792' ' ' VAL . . . . . 0.679 HG21 HH21 ' A' ' 801' ' ' ARG . 11.3 m -134.49 139.13 48.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.184 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 793' ' ' THR . . . . . 0.502 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 8.0 p -75.95 158.56 82.26 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.918 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 794' ' ' PRO . . . . . 0.502 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 19.7 Cg_endo -59.52 166.66 7.55 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.14 1.893 . . . . 0.0 112.01 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -56.98 161.02 3.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.149 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -104.73 176.55 5.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.788 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 5.2 t -54.68 -32.78 59.87 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.032 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -87.21 -17.64 32.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.15 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.46 37.29 3.56 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.5 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 16.2 m -127.82 129.14 46.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.003 0.43 . . . . 0.0 111.042 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . 0.679 HH21 HG21 ' A' ' 792' ' ' VAL . 6.8 mtp85 -83.64 170.62 14.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.327 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 802' ' ' GLU . . . . . 0.473 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 3.0 mt-10 -132.43 -170.77 2.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.288 -0.869 . . . . 0.0 109.606 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 803' ' ' VAL . . . . . 0.878 HG22 HG12 ' A' ' 757' ' ' VAL . 20.6 t -125.03 135.16 64.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.067 0.46 . . . . 0.0 112.018 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 804' ' ' ILE . . . . . 0.483 HG13 ' C ' ' A' ' 791' ' ' VAL . 0.0 OUTLIER -108.43 -33.66 2.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.352 179.241 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 805' ' ' ALA . . . . . 0.868 ' HB1' ' HD2' ' A' ' 806' ' ' PRO . . . -59.16 171.04 0.77 Allowed Pre-proline 0 N--CA 1.449 -0.495 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.242 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 806' ' ' PRO . . . . . 0.868 ' HD2' ' HB1' ' A' ' 805' ' ' ALA . 56.6 Cg_endo -71.2 163.62 38.53 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.771 2.314 . . . . 0.0 112.233 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -119.53 111.66 36.18 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.101 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -53.89 117.61 4.06 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.401 2.067 . . . . 0.0 112.306 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 809' ' ' VAL . . . . . 0.552 HG12 ' H ' ' A' ' 810' ' ' ARG . 0.5 OUTLIER -124.26 175.83 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.877 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 810' ' ' ARG . . . . . 0.552 ' H ' HG12 ' A' ' 809' ' ' VAL . 63.1 mtt180 -87.02 -33.18 19.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.83 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 3.3 p30 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.153 -0.927 . . . . 0.0 110.876 -179.954 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.471 -0.251 . . . . 0.0 112.471 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 99.9 p -163.81 38.07 0.09 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.748 0.308 . . . . 0.0 110.884 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -153.01 -177.85 6.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.945 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 743' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . 122.51 76.66 0.38 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.484 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . 0.807 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 5.9 m -116.16 -62.27 1.61 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.14 0.495 . . . . 0.0 110.73 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -140.01 -49.85 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.199 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -123.67 95.3 4.53 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.364 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . 0.552 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 14.1 t70 -122.28 142.35 36.72 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.426 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -33.82 -31.83 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.387 2.724 . . . . 0.0 114.016 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 749' ' ' LEU . . . . . 0.799 HD13 ' CG2' ' A' ' 774' ' ' ILE . 33.8 mt -120.06 -17.15 8.46 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.65 ' CE2' HG21 ' A' ' 754' ' ' VAL . 67.9 t80 -53.26 -47.43 69.08 Favored 'General case' 0 C--O 1.223 -0.341 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.968 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -53.23 -37.18 61.81 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 1.054 ' HB3' HD21 ' A' ' 772' ' ' LEU . 51.7 tt0 -71.01 -41.56 70.74 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.305 178.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 753' ' ' ALA . . . . . 0.497 ' HB2' ' HE2' ' A' ' 782' ' ' MET . . . -62.53 -51.52 67.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.034 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 754' ' ' VAL . . . . . 0.85 HG22 HG11 ' A' ' 791' ' ' VAL . 2.2 t -56.15 -41.2 68.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.735 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -67.91 -35.4 78.4 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.746 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 756' ' ' PHE . . . . . 0.744 ' CE2' HG22 ' A' ' 768' ' ' VAL . 3.5 t80 -67.01 -46.09 75.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.991 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 757' ' ' VAL . . . . . 1.055 HG12 HG22 ' A' ' 803' ' ' VAL . 43.6 t -70.16 -47.34 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 120.811 0.338 . . . . 0.0 110.794 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . 0.796 ' HA ' HG11 ' A' ' 803' ' ' VAL . 6.6 p -54.78 -43.74 73.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.002 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -78.88 -37.95 38.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.182 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 54.6 p -75.79 -16.25 60.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.46 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 22.9 mmt180 60.11 31.38 20.54 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.931 0.396 . . . . 0.0 110.552 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 762' ' ' ARG . . . . . 0.632 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.3 OUTLIER -160.55 137.3 8.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.338 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 763' ' ' ALA . . . . . 0.493 ' HB3' ' CB ' ' A' ' 801' ' ' ARG . . . -110.58 89.84 3.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.91 0.386 . . . . 0.0 111.409 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 764' ' ' SER . . . . . 0.758 ' O ' HG23 ' A' ' 768' ' ' VAL . 15.2 m -127.14 118.61 24.68 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.617 178.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 765' ' ' ILE . . . . . 0.882 HD13 ' HB2' ' A' ' 780' ' ' ALA . 25.0 mt -51.83 -50.19 33.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.755 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 766' ' ' SER . . . . . 0.433 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 22.0 t -53.45 -43.82 68.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.238 0.542 . . . . 0.0 110.537 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -69.12 -41.59 77.17 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.661 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 768' ' ' VAL . . . . . 0.925 HG21 HD11 ' A' ' 783' ' ' ILE . 40.9 t -59.4 -47.53 90.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.212 179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . 0.578 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.7 OUTLIER -65.46 -33.39 75.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.744 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 770' ' ' ARG . . . . . 0.47 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 5.8 mtt180 -68.75 -42.49 77.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.133 179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.63 -42.13 29.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.877 0.37 . . . . 0.0 111.684 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 772' ' ' LEU . . . . . 1.054 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -84.81 -8.58 58.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.791 -179.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 22.6 mtpt 57.41 42.35 24.86 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 774' ' ' ILE . . . . . 0.799 ' CG2' HD13 ' A' ' 749' ' ' LEU . 30.1 pt -111.87 -174.14 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.626 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.25 155.45 25.19 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.238 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -59.2 -46.56 88.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.916 0.389 . . . . 0.0 110.653 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -62.22 -47.47 84.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.771 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.623 ' NE ' HD12 ' A' ' 749' ' ' LEU . 2.8 ttt180 -61.17 -50.37 73.41 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.775 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.41 -50.55 71.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.427 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 780' ' ' ALA . . . . . 0.882 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.03 -41.03 74.32 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.81 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -58.95 -48.42 81.59 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.978 0.418 . . . . 0.0 110.009 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 782' ' ' MET . . . . . 0.497 ' HE2' ' HB2' ' A' ' 753' ' ' ALA . 0.5 OUTLIER -63.67 -43.12 97.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.386 178.781 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 783' ' ' ILE . . . . . 0.925 HD11 HG21 ' A' ' 768' ' ' VAL . 7.6 mm -56.96 -41.72 77.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.318 178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.21 -44.9 92.27 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 177.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.807 ' HB1' ' O ' ' A' ' 744' ' ' SER . . . -58.39 -33.63 69.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.048 178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 786' ' ' MET . . . . . 0.594 ' HB3' HG22 ' A' ' 792' ' ' VAL . 16.3 mtm -66.85 -38.59 86.65 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.991 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 787' ' ' GLU . . . . . 0.444 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 2.0 mt-10 -61.55 -54.05 48.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.664 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 24.1 mtm -68.85 -38.39 79.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.418 -179.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -68.52 -21.67 64.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.775 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 790' ' ' GLY . . . . . 0.501 ' O ' HD12 ' A' ' 804' ' ' ILE . . . 90.74 15.07 57.25 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.897 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.85 HG11 HG22 ' A' ' 754' ' ' VAL . 40.6 t -80.67 -31.91 12.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.924 0.392 . . . . 0.0 110.896 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 792' ' ' VAL . . . . . 0.667 HG21 HH21 ' A' ' 801' ' ' ARG . 11.2 m -136.58 135.45 48.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.143 0.497 . . . . 0.0 111.161 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 793' ' ' THR . . . . . 0.767 HG23 ' O ' ' A' ' 802' ' ' GLU . 10.3 p -72.92 159.81 84.42 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.686 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 794' ' ' PRO . . . . . 0.527 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 25.4 Cg_endo -60.58 165.13 11.97 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 121.996 1.797 . . . . 0.0 111.771 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -58.78 162.74 3.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.185 -179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -105.58 176.57 5.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.954 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 55.8 p -56.4 -31.11 63.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -86.32 -17.57 34.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.115 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 100.71 34.44 4.67 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.542 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 28.8 m -127.75 130.31 48.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 111.113 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . 0.667 HH21 HG21 ' A' ' 792' ' ' VAL . 4.5 mtp85 -81.57 170.13 16.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.397 -179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 802' ' ' GLU . . . . . 0.767 ' O ' HG23 ' A' ' 793' ' ' THR . 3.5 mt-10 -138.52 124.18 19.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.909 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 803' ' ' VAL . . . . . 1.055 HG22 HG12 ' A' ' 757' ' ' VAL . 18.8 t -64.92 134.22 29.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.96 0.409 . . . . 0.0 112.065 -179.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 804' ' ' ILE . . . . . 0.629 HG23 HG22 ' A' ' 793' ' ' THR . 0.0 OUTLIER -103.77 -33.29 3.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.891 178.546 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 805' ' ' ALA . . . . . 0.559 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -74.63 126.03 89.03 Favored Pre-proline 0 N--CA 1.451 -0.4 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.836 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -64.07 163.81 24.46 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.71 2.273 . . . . 0.0 112.168 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 807' ' ' ALA . . . . . 0.627 ' HB1' ' HD2' ' A' ' 808' ' ' PRO . . . -101.41 163.96 16.89 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.272 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . 0.627 ' HD2' ' HB1' ' A' ' 807' ' ' ALA . 68.6 Cg_endo -74.22 106.2 2.18 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.644 2.229 . . . . 0.0 112.354 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 21.4 t -123.79 -43.13 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.153 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.23 94.84 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.927 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 12.3 t70 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.877 179.933 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.199 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 24.3 t -97.19 33.62 1.92 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 0.0 111.031 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 56.4 mt-10 -98.32 102.89 14.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.685 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 743' ' ' GLY . . . . . 0.709 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . 103.06 58.85 0.74 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.09 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 3.5 m -115.57 -39.3 3.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.065 0.459 . . . . 0.0 110.462 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 745' ' ' GLU . . . . . 0.429 ' O ' ' CD2' ' A' ' 750' ' ' TYR . 0.9 OUTLIER -168.57 -45.97 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.941 179.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -129.13 95.06 3.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.439 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.47 143.35 39.43 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.376 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 748' ' ' PRO . . . . . 0.423 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 28.7 Cg_exo -35.34 -30.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.258 2.639 . . . . 0.0 113.795 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 749' ' ' LEU . . . . . 0.729 HD12 ' NE ' ' A' ' 778' ' ' ARG . 21.8 mt -120.09 -17.08 8.46 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -178.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.669 ' CE2' HG21 ' A' ' 754' ' ' VAL . 83.7 t80 -51.73 -50.65 60.14 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.837 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -53.17 -35.89 60.29 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.71 -0.396 . . . . 0.0 109.984 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 0.988 ' HB3' HD21 ' A' ' 772' ' ' LEU . 6.0 tp10 -70.93 -38.5 72.9 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.803 178.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 753' ' ' ALA . . . . . 0.409 ' HB2' ' HE2' ' A' ' 782' ' ' MET . . . -66.28 -52.93 42.57 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.804 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 754' ' ' VAL . . . . . 0.688 HG22 HG11 ' A' ' 791' ' ' VAL . 7.0 t -56.36 -38.42 55.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.751 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 47.7 ttt180 -69.87 -39.16 76.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.601 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 756' ' ' PHE . . . . . 0.751 ' CE2' HG22 ' A' ' 768' ' ' VAL . 1.4 t80 -65.77 -45.09 83.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.611 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 757' ' ' VAL . . . . . 0.684 HG11 HG12 ' A' ' 792' ' ' VAL . 84.5 t -69.84 -41.33 79.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.781 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 754' ' ' VAL . 9.9 p -59.12 -46.08 89.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.335 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 63.9 mt-10 -77.97 -30.36 50.26 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.795 -179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 39.5 p -78.02 -16.0 58.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.5 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 63.39 20.09 12.06 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.718 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 1.2 ptt180 -157.61 137.58 12.44 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.745 0.307 . . . . 0.0 110.931 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 763' ' ' ALA . . . . . 0.528 ' HB3' ' CB ' ' A' ' 801' ' ' ARG . . . -100.7 89.87 4.04 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.949 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 764' ' ' SER . . . . . 0.764 ' O ' HG23 ' A' ' 768' ' ' VAL . 5.9 m -120.65 118.44 30.12 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 765' ' ' ILE . . . . . 0.474 HG21 ' HB2' ' A' ' 780' ' ' ALA . 10.3 mt -57.1 -51.32 70.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.368 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 766' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 11.3 t -53.93 -38.41 64.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.291 0.567 . . . . 0.0 110.103 179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . 0.52 ' HB3' ' HB2' ' A' ' 764' ' ' SER . . . -71.36 -40.22 70.77 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.234 179.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 768' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 764' ' ' SER . 45.5 t -61.43 -49.94 82.44 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.179 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . 0.608 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -63.64 -33.57 75.92 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.974 -179.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 7.9 mtp180 -69.45 -42.52 74.8 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.37 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.489 ' HD3' ' HE1' ' A' ' 756' ' ' PHE . 3.1 tptt -78.59 -38.24 40.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.766 0.317 . . . . 0.0 111.677 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 772' ' ' LEU . . . . . 0.988 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -86.87 -10.91 52.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt 61.21 39.58 15.64 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 774' ' ' ILE . . . . . 0.69 ' CG2' HD13 ' A' ' 749' ' ' LEU . 25.6 pt -111.86 -173.98 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.424 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -90.34 153.55 22.85 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.236 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -56.6 -45.79 81.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.816 0.341 . . . . 0.0 110.87 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -63.25 -47.79 80.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.82 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.729 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.5 OUTLIER -59.1 -49.98 75.8 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.641 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.23 -50.69 72.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.637 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 780' ' ' ALA . . . . . 0.474 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -55.99 -40.42 73.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.947 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -60.66 -43.77 97.23 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 782' ' ' MET . . . . . 0.448 ' HE3' ' HB2' ' A' ' 749' ' ' LEU . 0.1 OUTLIER -64.94 -43.62 92.14 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 178.293 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 783' ' ' ILE . . . . . 0.73 HD11 HG21 ' A' ' 768' ' ' VAL . 15.0 mm -57.62 -39.73 71.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.696 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -61.85 -46.78 87.95 Favored 'General case' 0 C--O 1.238 0.478 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 743' ' ' GLY . . . -58.01 -33.64 69.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 114.636 -1.166 . . . . 0.0 109.808 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 786' ' ' MET . . . . . 0.646 ' HG2' HG22 ' A' ' 754' ' ' VAL . 15.4 mtm -67.79 -38.29 83.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.565 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 787' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 792' ' ' VAL . 1.6 mt-10 -62.41 -45.93 90.89 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.124 0.488 . . . . 0.0 110.072 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 37.0 mtm -73.08 -37.98 66.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.245 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -70.81 -21.53 62.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.982 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 790' ' ' GLY . . . . . 0.746 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 94.62 15.94 44.55 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.64 -0.79 . . . . 0.0 111.67 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.823 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 77.5 t -84.96 -34.2 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 122.637 0.375 . . . . 0.0 111.476 -179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 792' ' ' VAL . . . . . 0.684 HG12 HG11 ' A' ' 757' ' ' VAL . 15.4 m -136.61 148.41 27.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.887 0.375 . . . . 0.0 111.655 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 793' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 802' ' ' GLU . 10.3 p -96.75 171.8 5.73 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 794' ' ' PRO . . . . . 0.434 ' CD ' ' HB ' ' A' ' 793' ' ' THR . 31.1 Cg_exo -59.47 178.86 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 121.982 1.788 . . . . 0.0 111.812 179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . 0.518 ' HA ' ' HG3' ' A' ' 801' ' ' ARG . 0.0 OUTLIER -77.04 170.12 17.1 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.499 -179.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -105.61 176.59 5.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.754 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 4.6 t -60.78 -26.99 67.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.052 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -92.19 -17.62 24.62 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.398 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 108.73 29.84 3.97 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.649 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 18.0 m -124.42 131.13 53.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.923 0.392 . . . . 0.0 110.647 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . 0.528 ' CB ' ' HB3' ' A' ' 763' ' ' ALA . 8.8 mtt-85 -85.34 170.65 12.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.078 0.466 . . . . 0.0 111.524 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 802' ' ' GLU . . . . . 0.74 ' O ' HG23 ' A' ' 793' ' ' THR . 6.9 mt-10 -127.13 126.76 43.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.576 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 803' ' ' VAL . . . . . 0.57 HG22 HG12 ' A' ' 757' ' ' VAL . 19.4 t -69.25 137.94 23.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.836 0.35 . . . . 0.0 111.8 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 804' ' ' ILE . . . . . 0.746 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -108.19 -28.08 2.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.292 178.415 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 805' ' ' ALA . . . . . 0.823 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -78.24 119.56 77.81 Favored Pre-proline 0 N--CA 1.455 -0.209 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.641 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -50.24 163.82 0.56 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.413 2.075 . . . . 0.0 112.733 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -109.48 137.56 20.34 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.373 -0.831 . . . . 0.0 110.961 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.82 117.65 5.12 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.558 2.172 . . . . 0.0 112.559 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 21.8 t -126.37 -38.49 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.306 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 37.0 ttt180 63.06 97.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.819 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.92 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.19 0 N-CA-C 112.469 -0.253 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 1.6 m 60.1 82.07 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.849 0.357 . . . . 0.0 110.905 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -95.57 99.39 11.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.949 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 743' ' ' GLY . . . . . 0.426 ' CA ' ' HG2' ' A' ' 782' ' ' MET . . . 116.37 46.35 0.54 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.528 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.0 -157.83 0.56 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.584 0.23 . . . . 0.0 110.43 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -51.29 -38.44 52.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.666 0.27 . . . . 0.0 111.445 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -129.06 95.51 4.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.062 0.458 . . . . 0.0 111.415 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . 0.574 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.4 t70 -122.49 141.52 35.1 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.372 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -38.32 -28.02 0.12 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.956 2.437 . . . . 0.0 113.64 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 749' ' ' LEU . . . . . 0.854 HD13 ' CG2' ' A' ' 774' ' ' ILE . 40.4 mt -119.94 -16.85 8.59 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.691 ' CE2' ' HB3' ' A' ' 785' ' ' ALA . 62.2 t80 -55.12 -46.5 75.59 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.469 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -53.51 -36.37 61.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 0.909 ' HB2' HD21 ' A' ' 772' ' ' LEU . 28.7 mt-10 -70.95 -43.09 68.85 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.217 178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 753' ' ' ALA . . . . . 0.517 ' HB2' ' HE3' ' A' ' 782' ' ' MET . . . -61.93 -51.67 67.17 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.238 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 754' ' ' VAL . . . . . 0.747 HG22 HG11 ' A' ' 791' ' ' VAL . 2.3 t -56.21 -42.69 74.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.39 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -69.16 -38.13 78.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.294 0.569 . . . . 0.0 110.231 179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 756' ' ' PHE . . . . . 0.644 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.0 t80 -65.15 -46.15 82.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.114 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 757' ' ' VAL . . . . . 0.83 HG12 HG22 ' A' ' 803' ' ' VAL . 59.7 t -69.49 -45.13 79.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.902 0.382 . . . . 0.0 110.775 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . 0.648 ' HA ' HG11 ' A' ' 803' ' ' VAL . 6.8 p -55.22 -42.65 73.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.96 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -78.8 -35.63 43.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.414 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 6.8 p -76.84 -19.61 57.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.575 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 67.2 24.93 9.08 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.662 0.268 . . . . 0.0 111.477 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 762' ' ' ARG . . . . . 0.554 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.2 OUTLIER -159.26 132.39 7.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.883 179.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 763' ' ' ALA . . . . . 0.548 ' HB2' ' CG1' ' A' ' 792' ' ' VAL . . . -100.05 89.71 4.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.933 0.397 . . . . 0.0 111.281 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 764' ' ' SER . . . . . 0.726 ' O ' HG23 ' A' ' 768' ' ' VAL . 7.6 m -121.78 118.59 29.41 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.593 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 765' ' ' ILE . . . . . 0.811 HD13 ' HB2' ' A' ' 780' ' ' ALA . 26.3 mt -54.54 -47.34 71.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.487 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 766' ' ' SER . . . . . 0.423 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 60.5 p -57.69 -40.5 79.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.172 0.51 . . . . 0.0 110.493 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . 0.421 ' HB3' ' HB2' ' A' ' 764' ' ' SER . . . -71.58 -36.23 70.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.612 179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 768' ' ' VAL . . . . . 0.866 HG21 HD11 ' A' ' 783' ' ' ILE . 58.8 t -66.4 -46.44 86.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.223 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . 0.602 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -66.05 -33.37 75.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.486 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 770' ' ' ARG . . . . . 0.461 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 20.8 mtt-85 -69.98 -42.41 73.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.087 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.442 ' HB2' ' CE1' ' A' ' 756' ' ' PHE . 1.8 tmtt? -78.62 -39.62 36.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.042 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 772' ' ' LEU . . . . . 0.909 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -88.33 -9.23 53.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.664 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt 60.03 42.31 16.05 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.061 0.458 . . . . 0.0 109.775 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 774' ' ' ILE . . . . . 0.854 ' CG2' HD13 ' A' ' 749' ' ' LEU . 26.8 pt -111.94 -173.94 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.609 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.42 147.18 19.36 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.027 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -54.11 -42.54 69.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.834 0.35 . . . . 0.0 110.703 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 54.3 m-20 -64.12 -47.53 79.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.923 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.811 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.2 OUTLIER -62.52 -50.3 71.93 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.894 0.378 . . . . 0.0 110.835 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 779' ' ' ALA . . . . . 0.413 ' HB2' ' CD1' ' A' ' 774' ' ' ILE . . . -54.48 -49.13 70.86 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.411 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 780' ' ' ALA . . . . . 0.811 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.07 -43.63 78.14 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.911 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -58.98 -48.41 81.68 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.034 0.445 . . . . 0.0 109.973 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 782' ' ' MET . . . . . 0.517 ' HE3' ' HB2' ' A' ' 753' ' ' ALA . 34.4 mtm -65.3 -34.3 78.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.711 179.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 783' ' ' ILE . . . . . 0.866 HD11 HG21 ' A' ' 768' ' ' VAL . 7.1 mm -65.45 -35.71 75.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.11 -44.69 94.96 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 177.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.691 ' HB3' ' CE2' ' A' ' 750' ' ' TYR . . . -59.12 -33.76 71.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.766 178.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 786' ' ' MET . . . . . 0.747 ' HB3' HG22 ' A' ' 792' ' ' VAL . 12.7 mtm -65.62 -39.14 91.17 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.912 179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -62.43 -51.15 68.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.45 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 25.4 mtm -67.9 -38.49 83.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.574 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 789' ' ' ALA . . . . . 0.482 ' HB3' HG23 ' A' ' 791' ' ' VAL . . . -71.4 -21.62 61.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.882 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 790' ' ' GLY . . . . . 0.672 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 93.12 16.76 46.04 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.914 -179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.747 HG11 HG22 ' A' ' 754' ' ' VAL . 10.1 t -83.57 -33.28 9.59 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.263 0 CA-C-O 120.887 0.375 . . . . 0.0 110.726 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 792' ' ' VAL . . . . . 0.747 HG22 ' HB3' ' A' ' 786' ' ' MET . 19.8 m -135.94 139.54 45.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.404 179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 793' ' ' THR . . . . . 0.547 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 2.8 p -83.77 161.87 54.54 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.709 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 794' ' ' PRO . . . . . 0.547 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 18.1 Cg_endo -58.62 167.23 5.35 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.153 1.902 . . . . 0.0 112.083 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -62.88 160.06 15.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.201 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -104.31 176.59 5.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.803 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 39.1 p -61.76 -34.74 76.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.926 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -77.14 -17.61 58.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.195 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 100.58 28.38 7.11 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.515 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 58.0 m -126.64 130.39 50.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.942 0.401 . . . . 0.0 110.964 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . 0.503 ' NH1' HG21 ' A' ' 792' ' ' VAL . 9.4 mtt-85 -82.72 170.72 14.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.222 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 802' ' ' GLU . . . . . 0.405 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 5.8 mt-10 -130.2 166.28 20.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.814 179.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 803' ' ' VAL . . . . . 0.83 HG22 HG12 ' A' ' 757' ' ' VAL . 39.0 t -109.63 135.19 49.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.064 0.459 . . . . 0.0 111.597 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 804' ' ' ILE . . . . . 0.672 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -103.35 -28.56 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.266 179.186 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 805' ' ' ALA . . . . . 0.635 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -82.22 124.51 78.4 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.934 179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.9 163.71 27.26 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.632 2.221 . . . . 0.0 112.082 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -85.83 153.86 58.02 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.241 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.11 120.9 6.22 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.649 2.233 . . . . 0.0 112.216 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 809' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 810' ' ' ARG . 0.7 OUTLIER -82.28 176.12 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.785 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 810' ' ' ARG . . . . . 0.568 ' H ' HG12 ' A' ' 809' ' ' VAL . 14.0 mtt180 -150.34 -46.05 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.936 0.398 . . . . 0.0 111.057 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.216 -0.897 . . . . 0.0 110.847 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 12.3 m -162.51 -46.97 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.742 0.306 . . . . 0.0 110.844 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -111.59 109.62 19.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.774 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 743' ' ' GLY . . . . . 0.569 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . 104.28 59.09 0.69 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.455 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . 0.6 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 0.9 OUTLIER -117.68 -53.57 2.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.159 0.504 . . . . 0.0 110.396 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -153.13 -50.13 0.1 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.426 -0.807 . . . . 0.0 109.968 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -124.01 95.11 4.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.416 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.7 t70 -122.37 142.09 36.25 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.439 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -37.73 -28.35 0.1 Allowed 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.989 2.459 . . . . 0.0 113.51 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 749' ' ' LEU . . . . . 0.842 HD13 ' CG2' ' A' ' 774' ' ' ILE . 31.8 mt -120.05 -16.87 8.52 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.708 ' CE2' HG21 ' A' ' 754' ' ' VAL . 71.3 t80 -53.99 -47.76 71.1 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 120.391 -0.523 . . . . 0.0 110.376 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -53.4 -36.3 61.31 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 0.937 ' HB2' HD21 ' A' ' 772' ' ' LEU . 5.5 mm-40 -71.0 -42.27 69.84 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.117 178.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 753' ' ' ALA . . . . . 0.43 ' HB2' ' CE ' ' A' ' 782' ' ' MET . . . -61.85 -53.82 50.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.068 179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 754' ' ' VAL . . . . . 0.71 HG22 HG11 ' A' ' 791' ' ' VAL . 4.0 t -56.19 -42.97 74.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.407 179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 40.4 ttt180 -66.43 -36.94 84.05 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.37 0.605 . . . . 0.0 109.797 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 756' ' ' PHE . . . . . 0.68 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.0 t80 -66.82 -46.18 75.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.169 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 757' ' ' VAL . . . . . 0.791 HG12 HG22 ' A' ' 803' ' ' VAL . 61.8 t -69.56 -45.41 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-O 120.8 0.333 . . . . 0.0 110.664 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . 0.661 ' HA ' HG11 ' A' ' 803' ' ' VAL . 4.8 p -55.37 -43.45 75.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.783 179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -78.71 -32.15 46.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.214 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 27.3 p -81.63 -14.83 56.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.531 -179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 61.92 18.92 10.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.614 0.245 . . . . 0.0 111.223 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 762' ' ' ARG . . . . . 0.555 ' O ' HG13 ' A' ' 757' ' ' VAL . 10.2 ptt180 -151.88 136.35 16.87 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.763 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 763' ' ' ALA . . . . . 0.547 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -106.06 89.88 3.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.602 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 764' ' ' SER . . . . . 0.714 ' O ' HG23 ' A' ' 768' ' ' VAL . 3.9 m -122.32 118.59 28.86 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 178.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 765' ' ' ILE . . . . . 0.698 HD13 ' HB2' ' A' ' 780' ' ' ALA . 19.5 mt -53.6 -48.28 59.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.499 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 766' ' ' SER . . . . . 0.423 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 11.4 t -55.74 -41.23 73.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.114 0.483 . . . . 0.0 110.284 179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -70.58 -39.48 73.86 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.688 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 768' ' ' VAL . . . . . 0.84 HG21 HD11 ' A' ' 783' ' ' ILE . 41.9 t -62.94 -46.72 95.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.291 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . 0.587 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.93 -33.41 75.76 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.452 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 770' ' ' ARG . . . . . 0.474 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 24.8 mtt180 -71.54 -41.84 68.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.059 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -78.7 -37.26 42.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.967 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 772' ' ' LEU . . . . . 0.937 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -91.17 -9.64 44.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.634 -179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 23.1 mtpt 60.8 41.55 14.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.038 0.447 . . . . 0.0 109.8 -179.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 774' ' ' ILE . . . . . 0.842 ' CG2' HD13 ' A' ' 749' ' ' LEU . 22.0 pt -111.84 -173.92 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.476 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.51 151.13 22.3 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.201 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 31.2 t80 -55.38 -46.05 76.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.965 0.412 . . . . 0.0 110.707 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -63.37 -47.79 80.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.823 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.824 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.6 OUTLIER -59.61 -50.13 75.06 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.845 0.355 . . . . 0.0 110.793 179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.33 -49.9 74.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.271 179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 780' ' ' ALA . . . . . 0.698 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.11 -40.35 73.57 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.849 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -60.69 -48.41 81.93 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.92 0.39 . . . . 0.0 109.999 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 782' ' ' MET . . . . . 0.472 ' HE3' ' HA ' ' A' ' 750' ' ' TYR . 3.1 mtp -63.79 -38.41 91.01 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 178.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 783' ' ' ILE . . . . . 0.84 HD11 HG21 ' A' ' 768' ' ' VAL . 7.3 mm -61.32 -40.85 87.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.132 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.23 -43.52 87.8 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 108.507 -0.924 . . . . 0.0 108.507 177.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 744' ' ' SER . . . -60.32 -33.48 72.45 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 114.526 -1.216 . . . . 0.0 109.828 178.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 786' ' ' MET . . . . . 0.571 ' HB3' HG22 ' A' ' 792' ' ' VAL . 12.9 mtm -65.67 -37.56 86.84 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.974 179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 787' ' ' GLU . . . . . 0.456 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 2.4 mt-10 -63.38 -54.13 41.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.111 0.481 . . . . 0.0 110.548 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 33.5 mtm -67.85 -37.12 81.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.49 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -70.94 -21.59 62.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.985 -179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 790' ' ' GLY . . . . . 0.537 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 89.62 18.37 52.1 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.875 -178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.71 HG11 HG22 ' A' ' 754' ' ' VAL . 52.4 t -83.23 -32.72 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-O 120.854 0.359 . . . . 0.0 110.809 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 792' ' ' VAL . . . . . 0.681 HG21 HH21 ' A' ' 801' ' ' ARG . 11.4 m -135.61 140.64 44.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.188 179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 793' ' ' THR . . . . . 0.452 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.3 p -78.34 159.06 75.81 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 794' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 18.6 Cg_endo -58.8 166.11 7.18 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.115 1.876 . . . . 0.0 111.743 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -66.08 155.38 36.95 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.972 -179.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 49.1 p30 -105.43 176.56 5.12 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.918 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 5.5 t -55.37 -29.98 59.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.06 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -78.65 -17.52 55.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.151 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 91.9 29.62 11.47 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.48 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 24.6 m -127.82 130.19 48.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.905 0.383 . . . . 0.0 111.031 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . 0.681 HH21 HG21 ' A' ' 792' ' ' VAL . 6.8 mtp85 -81.63 170.59 15.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.307 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -129.9 -176.93 4.08 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.667 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 803' ' ' VAL . . . . . 0.791 HG22 HG12 ' A' ' 757' ' ' VAL . 16.9 t -119.81 134.64 62.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 804' ' ' ILE . . . . . 0.537 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -106.99 -28.09 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.961 178.56 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 805' ' ' ALA . . . . . 0.633 ' O ' HG22 ' A' ' 758' ' ' THR . . . -82.74 121.49 77.8 Favored Pre-proline 0 N--CA 1.453 -0.304 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.586 179.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -63.49 163.8 22.79 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.475 2.116 . . . . 0.0 112.304 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 807' ' ' ALA . . . . . 0.806 ' HB1' ' HD2' ' A' ' 808' ' ' PRO . . . -111.2 170.87 4.82 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.225 -179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . 0.806 ' HD2' ' HB1' ' A' ' 807' ' ' ALA . 71.7 Cg_endo -77.15 119.77 5.14 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.634 2.223 . . . . 0.0 112.426 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 21.6 t -125.64 -42.77 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.182 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.93 96.29 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.853 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.891 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.156 0 N-CA-C 112.557 -0.217 . . . . 0.0 112.557 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 14.9 m 61.09 92.98 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.759 0.314 . . . . 0.0 110.906 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -149.35 100.84 3.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.836 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 743' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . 92.23 62.79 1.15 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.496 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . 0.458 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 1.3 m -119.3 -47.24 2.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.121 0.486 . . . . 0.0 110.396 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -159.33 -48.63 0.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.182 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -126.9 95.1 4.22 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.337 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . 0.517 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.6 t70 -122.51 143.09 38.85 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.425 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 748' ' ' PRO . . . . . 0.422 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 35.7 Cg_exo -35.97 -29.38 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.157 2.571 . . . . 0.0 113.763 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 749' ' ' LEU . . . . . 0.821 HD12 ' NE ' ' A' ' 778' ' ' ARG . 34.6 mt -120.03 -17.27 8.45 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.739 ' CE2' HG21 ' A' ' 754' ' ' VAL . 74.5 t80 -53.3 -48.54 68.29 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.797 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -53.27 -36.34 61.03 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 1.02 ' HB3' HD21 ' A' ' 772' ' ' LEU . 12.6 tt0 -71.0 -42.05 70.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.242 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 753' ' ' ALA . . . . . 0.404 ' HB2' ' HE2' ' A' ' 782' ' ' MET . . . -62.92 -52.5 62.8 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.182 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 754' ' ' VAL . . . . . 0.739 HG21 ' CE2' ' A' ' 750' ' ' TYR . 5.1 t -56.2 -40.32 64.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.675 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -67.01 -35.52 80.1 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.41 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 756' ' ' PHE . . . . . 0.835 ' CE1' HG22 ' A' ' 768' ' ' VAL . 1.4 t80 -67.65 -45.94 73.85 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.018 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 757' ' ' VAL . . . . . 0.851 HG12 HG22 ' A' ' 803' ' ' VAL . 47.4 t -69.64 -42.08 80.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.937 0.399 . . . . 0.0 110.837 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . 0.456 ' HA ' HG11 ' A' ' 803' ' ' VAL . 8.2 p -58.71 -45.38 89.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.69 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -77.75 -35.26 51.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.101 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 48.7 p -76.38 -14.74 60.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.291 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 56.5 28.0 13.12 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.008 0.433 . . . . 0.0 110.577 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 762' ' ' ARG . . . . . 0.406 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.2 OUTLIER -160.87 136.0 7.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.92 -179.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 763' ' ' ALA . . . . . 0.571 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -106.32 89.6 3.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.09 0.472 . . . . 0.0 111.698 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 764' ' ' SER . . . . . 0.769 ' O ' HG23 ' A' ' 768' ' ' VAL . 68.1 m -121.24 118.64 30.11 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 765' ' ' ILE . . . . . 0.643 HD13 ' HB2' ' A' ' 780' ' ' ALA . 17.5 mt -54.06 -47.58 65.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.637 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 766' ' ' SER . . . . . 0.608 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 10.9 t -58.89 -36.73 75.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.27 0.557 . . . . 0.0 110.363 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . 0.404 ' CB ' ' HZ ' ' A' ' 756' ' ' PHE . . . -72.78 -41.34 65.1 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.217 179.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 768' ' ' VAL . . . . . 0.835 HG22 ' CE1' ' A' ' 756' ' ' PHE . 23.2 t -61.13 -49.8 83.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.318 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.096 178.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . 0.616 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -63.05 -33.85 76.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.374 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 21.2 mtt180 -70.08 -42.54 72.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.279 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.507 ' HD3' ' HD2' ' A' ' 756' ' ' PHE . 0.0 OUTLIER -78.53 -35.72 45.8 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.036 0.384 . . . . 0.0 112.036 -179.527 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 772' ' ' LEU . . . . . 1.02 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -90.6 -10.35 43.66 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.732 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm 60.61 40.61 16.42 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 774' ' ' ILE . . . . . 0.759 ' CG2' HD13 ' A' ' 749' ' ' LEU . 27.7 pt -111.69 -175.33 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.39 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.63 150.54 21.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.097 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -54.28 -45.97 72.6 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.898 0.38 . . . . 0.0 110.653 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -61.91 -47.48 84.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.759 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.821 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -60.37 -50.19 74.57 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.687 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.22 -49.76 74.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.354 179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 780' ' ' ALA . . . . . 0.643 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.2 -41.52 75.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.771 179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 23.1 mtt180 -59.54 -48.26 82.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.045 179.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 782' ' ' MET . . . . . 0.437 ' HE3' ' HB2' ' A' ' 749' ' ' LEU . 0.0 OUTLIER -61.71 -44.55 96.71 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.407 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 783' ' ' ILE . . . . . 0.805 HD11 HG21 ' A' ' 768' ' ' VAL . 12.0 mm -55.32 -37.07 42.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.786 178.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -64.03 -46.03 86.26 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.576 ' HB3' ' CE1' ' A' ' 750' ' ' TYR . . . -59.26 -33.56 71.18 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.633 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 786' ' ' MET . . . . . 0.726 ' HB3' HG22 ' A' ' 792' ' ' VAL . 13.4 mtm -65.46 -40.68 93.47 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.316 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.16 -49.14 77.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.092 0.472 . . . . 0.0 110.587 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 32.9 mtm -70.66 -36.85 73.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.385 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -71.86 -21.56 61.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.082 -179.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 790' ' ' GLY . . . . . 0.7 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 93.72 17.23 42.33 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.718 -178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.757 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 60.2 t -87.72 -29.46 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 C-N-CA 122.505 0.322 . . . . 0.0 111.27 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 792' ' ' VAL . . . . . 0.726 HG22 ' HB3' ' A' ' 786' ' ' MET . 20.5 m -139.58 141.93 33.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.869 0.366 . . . . 0.0 111.824 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 793' ' ' THR . . . . . 0.559 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.1 p -86.17 165.65 32.83 Favored Pre-proline 0 C--N 1.327 -0.388 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 794' ' ' PRO . . . . . 0.559 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 32.6 Cg_endo -63.45 166.38 15.39 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 121.951 1.767 . . . . 0.0 111.815 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -69.6 158.1 35.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.884 0.373 . . . . 0.0 111.213 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 36.8 p30 -105.72 176.56 5.13 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.83 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 2.8 t -57.84 -31.21 66.44 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.999 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -74.22 -17.58 60.87 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.246 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 93.62 26.44 15.26 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.566 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 17.9 m -127.24 134.6 50.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 0.0 110.809 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . 0.571 ' HB3' ' HB3' ' A' ' 763' ' ' ALA . 13.5 mtt-85 -85.03 170.79 12.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.251 0.548 . . . . 0.0 111.545 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -129.1 166.5 19.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.842 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 803' ' ' VAL . . . . . 0.851 HG22 HG12 ' A' ' 757' ' ' VAL . 19.3 t -107.6 138.55 33.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.885 0.374 . . . . 0.0 111.978 -179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 804' ' ' ILE . . . . . 0.7 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -109.98 -25.35 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.555 179.03 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 805' ' ' ALA . . . . . 0.757 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -80.87 121.56 81.07 Favored Pre-proline 0 C--N 1.331 -0.2 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.239 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -50.34 163.94 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.639 2.226 . . . . 0.0 112.885 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -109.26 145.17 31.26 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.053 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.54 107.46 2.17 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.498 2.132 . . . . 0.0 112.243 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 22.8 t -85.3 -68.53 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.185 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 16.2 ttt-85 -92.9 -32.2 14.67 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.844 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.911 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 112.524 -0.23 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 53.4 p -164.94 31.91 0.06 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.881 0.372 . . . . 0.0 110.948 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -140.09 86.39 2.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.793 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 743' ' ' GLY . . . . . 0.567 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . 72.92 59.46 4.32 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.439 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . 0.464 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 50.4 m -118.97 -46.87 2.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.126 0.489 . . . . 0.0 110.487 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -159.17 -47.48 0.06 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.19 179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -128.89 95.27 4.04 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.394 178.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . 0.548 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.2 t70 -122.5 143.48 39.81 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.312 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 748' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 40.0 Cg_exo -36.75 -28.77 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 123.081 2.521 . . . . 0.0 113.793 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 749' ' ' LEU . . . . . 0.817 HD13 ' CG2' ' A' ' 774' ' ' ILE . 28.7 mt -119.99 -17.09 8.51 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.656 ' CE2' HG21 ' A' ' 754' ' ' VAL . 78.5 t80 -53.15 -50.91 63.58 Favored 'General case' 0 C--O 1.222 -0.347 0 C-N-CA 120.654 -0.418 . . . . 0.0 110.935 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -53.07 -35.11 59.18 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 1.022 ' HB3' HD21 ' A' ' 772' ' ' LEU . 9.1 tp10 -71.1 -42.02 69.84 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.174 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 753' ' ' ALA . . . . . 0.472 ' O ' HG23 ' A' ' 757' ' ' VAL . . . -63.58 -53.73 47.11 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.188 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 754' ' ' VAL . . . . . 0.758 HG22 HG11 ' A' ' 791' ' ' VAL . 6.2 t -56.1 -39.27 57.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.865 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -68.22 -35.47 78.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.652 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 756' ' ' PHE . . . . . 0.624 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.7 t80 -68.79 -46.33 68.97 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.038 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 757' ' ' VAL . . . . . 0.617 HG12 HG22 ' A' ' 803' ' ' VAL . 21.1 t -71.29 -38.88 71.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 120.903 0.383 . . . . 0.0 111.114 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 754' ' ' VAL . 20.6 p -63.12 -41.43 99.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.702 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -76.96 -46.63 23.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.148 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 760' ' ' SER . . . . . 0.468 ' O ' ' HD3' ' A' ' 762' ' ' ARG . 22.8 p -70.6 -33.86 71.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.975 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 761' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 760' ' ' SER . 0.0 OUTLIER 78.27 23.73 0.69 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.401 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 762' ' ' ARG . . . . . 0.468 ' HD3' ' O ' ' A' ' 760' ' ' SER . 0.5 OUTLIER -145.03 114.29 7.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.507 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 763' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' A' ' 801' ' ' ARG . . . -88.19 89.49 8.01 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.039 0.447 . . . . 0.0 111.442 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 764' ' ' SER . . . . . 0.719 ' O ' HG23 ' A' ' 768' ' ' VAL . 17.0 m -126.84 118.35 24.45 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 178.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 765' ' ' ILE . . . . . 0.603 HG21 ' HB2' ' A' ' 780' ' ' ALA . 11.0 mt -52.99 -45.56 52.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.491 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 766' ' ' SER . . . . . 0.5 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 6.6 t -60.57 -37.7 82.15 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.152 0.501 . . . . 0.0 110.308 179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . 0.432 ' HB3' ' HB2' ' A' ' 764' ' ' SER . . . -73.64 -35.26 65.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.52 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 768' ' ' VAL . . . . . 0.799 HG21 HD11 ' A' ' 783' ' ' ILE . 40.4 t -67.71 -46.98 81.57 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . 0.599 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.12 -34.12 77.66 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.491 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 14.9 mtt-85 -71.32 -42.57 68.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.2 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.74 -34.92 45.41 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 772' ' ' LEU . . . . . 1.022 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -92.41 -10.41 38.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 179.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 8.3 mtpp 61.71 40.79 12.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.106 0.479 . . . . 0.0 109.721 -178.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 774' ' ' ILE . . . . . 0.817 ' CG2' HD13 ' A' ' 749' ' ' LEU . 23.0 pt -111.74 -173.78 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.661 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.59 151.69 22.67 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.186 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 25.8 t80 -56.9 -45.78 82.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.36 . . . . 0.0 110.729 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 -63.29 -46.56 86.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.69 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.782 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.2 OUTLIER -61.23 -50.07 74.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.776 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.41 -49.46 76.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.21 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 780' ' ' ALA . . . . . 0.603 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -55.93 -42.47 76.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.966 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -59.38 -43.37 92.9 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.125 0.488 . . . . 0.0 110.016 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 782' ' ' MET . . . . . 0.445 ' HE2' ' HB2' ' A' ' 753' ' ' ALA . 2.5 mtp -67.66 -42.02 82.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.592 178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 783' ' ' ILE . . . . . 0.799 HD11 HG21 ' A' ' 768' ' ' VAL . 9.5 mm -58.59 -37.32 64.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.443 178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -63.56 -48.27 78.15 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.6 ' HB3' ' CE1' ' A' ' 750' ' ' TYR . . . -56.16 -33.41 65.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.693 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 786' ' ' MET . . . . . 0.698 ' HG2' HG22 ' A' ' 754' ' ' VAL . 13.1 mtm -66.8 -40.77 88.2 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.178 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 787' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 792' ' ' VAL . 0.5 OUTLIER -59.93 -49.41 77.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.61 179.711 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 28.5 mtm -72.81 -37.79 67.41 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.546 -179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -68.16 -21.5 64.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.958 -0.564 . . . . 0.0 112.136 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 790' ' ' GLY . . . . . 0.763 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 94.91 16.93 39.76 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.459 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.758 HG11 HG22 ' A' ' 754' ' ' VAL . 55.1 t -86.34 -35.45 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 122.422 0.289 . . . . 0.0 111.306 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 792' ' ' VAL . . . . . 0.687 HG22 ' HB3' ' A' ' 786' ' ' MET . 22.0 m -136.4 151.44 28.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.128 0.49 . . . . 0.0 111.69 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 793' ' ' THR . . . . . 0.575 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.3 p -94.83 165.67 16.65 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.282 179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 794' ' ' PRO . . . . . 0.575 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 29.6 Cg_endo -62.3 166.01 13.87 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 121.869 1.713 . . . . 0.0 111.94 179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -72.07 158.5 35.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.985 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 38.9 p30 -105.51 176.51 5.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 53.1 p -57.86 -30.17 65.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.202 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -75.34 -17.6 60.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.296 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 94.15 23.23 22.94 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.576 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 58.9 m -123.26 132.54 54.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.824 0.345 . . . . 0.0 110.649 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . 0.569 ' HB2' ' O ' ' A' ' 763' ' ' ALA . 11.7 mtt-85 -85.14 170.79 12.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.189 0.519 . . . . 0.0 111.716 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 802' ' ' GLU . . . . . 0.425 ' HB2' ' OG1' ' A' ' 793' ' ' THR . 3.8 mt-10 -127.54 171.05 11.95 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.868 178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 803' ' ' VAL . . . . . 0.617 HG22 HG12 ' A' ' 757' ' ' VAL . 22.3 t -114.22 138.38 44.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 804' ' ' ILE . . . . . 0.763 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -106.89 -28.31 2.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.454 178.811 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 805' ' ' ALA . . . . . 0.725 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -82.7 121.44 77.84 Favored Pre-proline 0 C--N 1.332 -0.156 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.001 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -65.48 163.73 28.71 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.541 2.161 . . . . 0.0 112.088 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -91.5 147.2 34.78 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.144 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -56.74 117.02 3.62 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.518 2.146 . . . . 0.0 112.265 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 809' ' ' VAL . . . . . 0.605 HG12 ' H ' ' A' ' 810' ' ' ARG . 0.9 OUTLIER -79.37 176.72 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.735 179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 810' ' ' ARG . . . . . 0.605 ' H ' HG12 ' A' ' 809' ' ' VAL . 0.0 OUTLIER -112.02 -35.43 5.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.353 . . . . 0.0 110.975 -179.844 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 2.0 p30 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.186 -0.912 . . . . 0.0 110.894 -179.868 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 78.9 p -171.78 89.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.877 0.37 . . . . 0.0 110.969 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -111.2 173.4 6.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.881 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 743' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . 75.78 36.57 42.02 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.532 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.15 -160.78 0.7 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.635 0.255 . . . . 0.0 110.611 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -51.11 -44.35 61.29 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.808 0.337 . . . . 0.0 111.121 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -127.39 95.56 4.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.122 0.487 . . . . 0.0 110.956 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . 0.56 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.57 143.21 39.26 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.445 179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 748' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 40.5 Cg_exo -36.22 -29.24 0.07 OUTLIER 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 123.108 2.538 . . . . 0.0 113.962 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 749' ' ' LEU . . . . . 0.84 HD13 ' CG2' ' A' ' 774' ' ' ILE . 26.3 mt -120.02 -17.15 8.48 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.732 ' CE1' HG21 ' A' ' 754' ' ' VAL . 65.6 t80 -53.81 -47.81 70.5 Favored 'General case' 0 C--O 1.222 -0.349 0 C-N-CA 120.451 -0.499 . . . . 0.0 110.783 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -53.23 -37.49 62.09 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 1.092 ' HB3' HD21 ' A' ' 772' ' ' LEU . 11.8 tt0 -71.0 -43.38 68.1 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.083 178.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 753' ' ' ALA . . . . . 0.67 ' HB2' ' HE1' ' A' ' 782' ' ' MET . . . -59.74 -54.4 46.71 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.159 179.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 754' ' ' VAL . . . . . 0.774 HG22 HG11 ' A' ' 791' ' ' VAL . 4.8 t -56.19 -40.82 67.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.142 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 44.5 ttt85 -65.89 -36.02 82.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.543 178.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 756' ' ' PHE . . . . . 0.787 ' CE1' HG22 ' A' ' 768' ' ' VAL . 1.2 t80 -69.78 -44.95 69.06 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.83 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 757' ' ' VAL . . . . . 0.746 HG11 ' CG1' ' A' ' 792' ' ' VAL . 61.2 t -69.74 -39.59 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-O 121.002 0.43 . . . . 0.0 110.763 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . 0.445 ' HA ' HG11 ' A' ' 803' ' ' VAL . 10.1 p -62.8 -44.81 95.18 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.8 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -78.58 -33.08 47.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.177 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 760' ' ' SER . . . . . 0.485 ' OG ' ' HA ' ' A' ' 757' ' ' VAL . 93.7 p -75.54 -15.68 60.35 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.278 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 16.5 mmt180 62.84 17.34 9.85 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.493 -0.322 . . . . 0.0 111.426 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 762' ' ' ARG . . . . . . . . . . . . . 3.1 ptt180 -155.77 140.37 16.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.572 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 763' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 801' ' ' ARG . . . -105.57 89.62 3.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.922 0.391 . . . . 0.0 111.658 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 764' ' ' SER . . . . . 0.767 ' O ' HG23 ' A' ' 768' ' ' VAL . 1.7 m -118.96 118.67 32.12 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 765' ' ' ILE . . . . . 0.522 HG21 ' HB2' ' A' ' 780' ' ' ALA . 7.4 mt -55.69 -47.74 78.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.563 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 766' ' ' SER . . . . . 0.468 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 39.3 t -57.4 -39.09 75.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.14 0.495 . . . . 0.0 110.275 179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 764' ' ' SER . . . -71.88 -39.56 69.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.448 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 768' ' ' VAL . . . . . 0.797 HG21 HD11 ' A' ' 783' ' ' ILE . 46.2 t -61.81 -48.15 89.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.297 -0.41 . . . . 0.0 109.996 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . 0.59 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.46 -33.33 75.69 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.858 -179.672 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 770' ' ' ARG . . . . . 0.466 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 20.1 mtt180 -70.1 -41.85 73.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.139 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.429 ' HD3' ' HE2' ' A' ' 756' ' ' PHE . 4.5 tptt -78.49 -39.84 37.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.644 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 772' ' ' LEU . . . . . 1.092 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -87.68 -9.49 54.01 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.522 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt 60.32 41.27 16.59 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.025 0.44 . . . . 0.0 109.825 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 774' ' ' ILE . . . . . 0.84 ' CG2' HD13 ' A' ' 749' ' ' LEU . 20.1 pt -111.89 -173.95 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.342 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -89.51 150.03 20.97 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.05 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 24.1 t80 -54.24 -45.34 72.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.879 0.371 . . . . 0.0 110.751 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -64.19 -47.92 77.94 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.712 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.769 ' HE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -58.76 -49.97 75.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.766 179.887 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.54 -49.9 74.83 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.28 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 780' ' ' ALA . . . . . 0.522 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -55.94 -40.04 72.59 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.797 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 12.0 mtm180 -59.63 -47.04 87.14 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 782' ' ' MET . . . . . 0.67 ' HE1' ' HB2' ' A' ' 753' ' ' ALA . 1.6 mtp -63.07 -43.13 99.42 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 783' ' ' ILE . . . . . 0.797 HD11 HG21 ' A' ' 768' ' ' VAL . 12.3 mm -57.45 -38.77 64.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.682 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -62.15 -43.3 99.14 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 177.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.645 ' HB3' ' CE2' ' A' ' 750' ' ' TYR . . . -61.15 -33.41 73.38 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.581 178.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 786' ' ' MET . . . . . 0.754 ' HB3' HG22 ' A' ' 792' ' ' VAL . 13.2 mtm -65.63 -39.44 91.48 Favored 'General case' 0 N--CA 1.453 -0.278 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.275 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -63.57 -45.3 91.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.19 0.519 . . . . 0.0 110.312 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 53.0 mtm -72.01 -36.86 69.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.664 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -75.53 -21.66 57.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.137 -179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 790' ' ' GLY . . . . . 0.808 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 94.14 18.52 36.44 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.621 -178.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.774 HG11 HG22 ' A' ' 754' ' ' VAL . 57.5 t -86.82 -30.2 5.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.723 0.296 . . . . 0.0 110.961 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 792' ' ' VAL . . . . . 0.754 HG22 ' HB3' ' A' ' 786' ' ' MET . 22.2 m -139.31 144.06 29.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.629 179.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 793' ' ' THR . . . . . 0.585 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.1 p -87.37 166.81 23.68 Favored Pre-proline 0 C--N 1.328 -0.346 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 794' ' ' PRO . . . . . 0.585 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 28.5 Cg_endo -62.07 166.13 13.17 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.074 1.849 . . . . 0.0 112.262 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.31 161.92 13.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.173 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -105.31 176.34 5.19 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.826 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 44.8 p -61.79 -32.5 72.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.818 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -79.69 -17.55 53.38 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.178 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.27 25.1 8.47 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.46 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 20.8 m -122.14 129.96 52.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 110.935 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . 0.518 ' NH1' ' CG2' ' A' ' 783' ' ' ILE . 12.1 mtt-85 -83.82 170.67 13.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.287 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -127.81 167.75 16.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.926 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 803' ' ' VAL . . . . . 0.613 HG22 HG12 ' A' ' 757' ' ' VAL . 16.4 t -109.05 137.92 38.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.956 0.407 . . . . 0.0 112.017 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 804' ' ' ILE . . . . . 0.808 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -108.26 -27.36 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.267 178.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 805' ' ' ALA . . . . . 0.725 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -83.11 123.96 76.9 Favored Pre-proline 0 N--CA 1.454 -0.237 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.996 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -66.57 163.79 31.36 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.679 2.253 . . . . 0.0 112.252 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 807' ' ' ALA . . . . . 0.672 ' HB1' ' HD2' ' A' ' 808' ' ' PRO . . . -104.09 165.3 13.66 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.216 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . 0.672 ' HD2' ' HB1' ' A' ' 807' ' ' ALA . 73.2 Cg_endo -75.09 112.18 3.49 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.625 2.217 . . . . 0.0 112.351 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 21.7 t -125.49 -37.24 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.375 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -172.44 -39.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.007 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.287 -0.863 . . . . 0.0 110.889 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.23 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 2.7 m -155.7 -46.0 0.08 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.827 0.346 . . . . 0.0 110.924 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -131.63 109.01 9.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.981 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 743' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . 101.91 67.02 0.78 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.61 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . 0.589 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 1.4 m -123.04 -55.96 1.76 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.148 0.499 . . . . 0.0 110.282 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -151.05 -47.92 0.12 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.23 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.03 95.33 4.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.527 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.9 t70 -122.5 142.34 37.04 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.353 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_exo -38.04 -27.82 0.1 Allowed 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.921 2.414 . . . . 0.0 113.556 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 749' ' ' LEU . . . . . 0.839 HD13 ' CG2' ' A' ' 774' ' ' ILE . 43.5 mt -119.91 -17.36 8.49 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.666 ' CE2' HG21 ' A' ' 754' ' ' VAL . 66.3 t80 -55.14 -46.94 75.69 Favored 'General case' 0 CA--C 1.514 -0.427 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.816 -179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -53.27 -36.73 61.46 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 0.879 ' HB3' HD21 ' A' ' 772' ' ' LEU . 0.6 OUTLIER -71.04 -45.04 64.58 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.018 178.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 753' ' ' ALA . . . . . 0.445 ' O ' HG23 ' A' ' 757' ' ' VAL . . . -59.35 -52.3 66.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.352 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 754' ' ' VAL . . . . . 0.735 HG22 HG11 ' A' ' 791' ' ' VAL . 2.3 t -56.12 -43.02 74.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.958 179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 28.8 ttt180 -66.72 -35.56 80.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.353 0.597 . . . . 0.0 109.708 178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 756' ' ' PHE . . . . . 0.744 ' CE2' HG22 ' A' ' 768' ' ' VAL . 3.5 t80 -66.24 -46.1 78.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.921 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 757' ' ' VAL . . . . . 0.909 HG12 HG22 ' A' ' 803' ' ' VAL . 43.7 t -69.31 -45.05 79.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.932 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . 0.609 HG22 ' O ' ' A' ' 805' ' ' ALA . 2.0 p -56.64 -42.92 79.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.794 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -78.9 -39.82 33.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.285 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 760' ' ' SER . . . . . 0.415 ' OG ' ' HA ' ' A' ' 757' ' ' VAL . 92.4 p -74.46 -16.88 60.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.35 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 9.0 mmm-85 62.35 24.96 14.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.591 179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 762' ' ' ARG . . . . . 0.425 ' C ' HG13 ' A' ' 757' ' ' VAL . 6.3 ptt180 -157.87 133.14 8.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.678 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 763' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -102.61 89.77 3.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.965 0.412 . . . . 0.0 111.564 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 764' ' ' SER . . . . . 0.716 ' O ' HG23 ' A' ' 768' ' ' VAL . 1.8 m -125.02 118.53 26.4 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 765' ' ' ILE . . . . . 0.547 HG21 ' HB2' ' A' ' 780' ' ' ALA . 2.2 mp -51.16 -51.49 22.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.952 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 766' ' ' SER . . . . . 0.472 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 14.3 t -53.32 -42.21 66.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.155 0.502 . . . . 0.0 110.629 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -70.1 -42.12 73.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.549 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 768' ' ' VAL . . . . . 0.969 HG21 HD11 ' A' ' 783' ' ' ILE . 42.5 t -59.47 -47.48 90.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.215 179.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . 0.589 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.8 OUTLIER -65.49 -33.46 75.99 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.719 -179.729 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 770' ' ' ARG . . . . . 0.468 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 0.0 OUTLIER -68.89 -42.25 77.2 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.046 179.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -78.55 -42.16 30.07 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.693 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 772' ' ' LEU . . . . . 0.879 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -84.98 -8.79 58.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.889 -179.594 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 15.9 mtpp 58.21 41.83 22.94 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 774' ' ' ILE . . . . . 0.839 ' CG2' HD13 ' A' ' 749' ' ' LEU . 26.9 pt -111.84 -173.9 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.72 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -91.53 153.08 21.88 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.972 179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 776' ' ' TYR . . . . . 0.401 ' HB2' ' NE2' ' A' ' 769' ' ' GLN . 52.7 t80 -58.5 -46.69 86.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.832 0.349 . . . . 0.0 110.73 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 47.4 m-20 -57.57 -47.74 81.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.064 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.798 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.0 OUTLIER -66.0 -50.28 64.83 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.693 -179.959 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -54.85 -50.09 69.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.674 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 780' ' ' ALA . . . . . 0.547 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -59.31 -42.92 92.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.76 179.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 4.4 mmt85 -58.93 -48.49 81.31 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.105 0.478 . . . . 0.0 109.88 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 782' ' ' MET . . . . . . . . . . . . . 33.5 mtm -65.21 -34.52 78.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.45 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 783' ' ' ILE . . . . . 0.969 HD11 HG21 ' A' ' 768' ' ' VAL . 5.9 mm -64.6 -36.2 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.094 178.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -64.99 -39.94 94.22 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.589 ' HB1' ' O ' ' A' ' 744' ' ' SER . . . -60.11 -34.6 73.72 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.42 178.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 786' ' ' MET . . . . . 0.741 ' HB3' HG22 ' A' ' 792' ' ' VAL . 13.9 mtm -67.07 -39.07 86.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.975 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 787' ' ' GLU . . . . . 0.416 ' HG3' ' NH2' ' A' ' 801' ' ' ARG . 0.1 OUTLIER -59.51 -54.12 50.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.726 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 20.1 mtm -70.36 -38.34 74.76 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.129 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -65.54 -21.59 66.62 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.558 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 790' ' ' GLY . . . . . 0.647 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 91.14 14.97 56.84 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.84 -179.09 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.735 HG11 HG22 ' A' ' 754' ' ' VAL . 23.7 t -84.51 -30.69 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-O 120.892 0.377 . . . . 0.0 111.028 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 792' ' ' VAL . . . . . 0.741 HG22 ' HB3' ' A' ' 786' ' ' MET . 18.9 m -137.07 140.06 43.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.278 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 793' ' ' THR . . . . . 0.515 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 2.3 p -85.18 160.56 54.43 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.831 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 794' ' ' PRO . . . . . 0.515 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 17.7 Cg_endo -58.94 167.55 5.41 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.137 1.891 . . . . 0.0 111.873 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.54 157.01 38.65 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.202 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 35.9 p30 -105.55 176.61 5.11 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.826 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 7.9 t -57.31 -33.95 68.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.023 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -71.95 -17.51 62.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.14 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 92.99 27.76 13.21 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.474 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 3.5 m -127.72 133.95 49.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.822 0.344 . . . . 0.0 110.898 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . 0.509 ' NH1' HG21 ' A' ' 792' ' ' VAL . 8.4 mtt-85 -85.6 170.66 12.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.243 0.544 . . . . 0.0 111.354 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -130.86 167.34 19.09 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.042 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 803' ' ' VAL . . . . . 0.909 HG22 HG12 ' A' ' 757' ' ' VAL . 21.9 t -109.5 135.87 47.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.951 0.405 . . . . 0.0 111.63 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 804' ' ' ILE . . . . . 0.647 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -104.51 -28.43 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.259 179.058 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 805' ' ' ALA . . . . . 0.645 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -81.33 124.15 80.77 Favored Pre-proline 0 N--CA 1.452 -0.348 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.87 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -64.32 163.85 25.05 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.671 2.247 . . . . 0.0 112.188 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 807' ' ' ALA . . . . . 0.51 ' HB1' ' HD2' ' A' ' 808' ' ' PRO . . . -92.22 166.78 16.45 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.2 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . 0.51 ' HD2' ' HB1' ' A' ' 807' ' ' ALA . 52.6 Cg_exo -54.99 95.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.625 2.217 . . . . 0.0 112.277 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 11.9 t 69.12 -67.31 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.184 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 17.7 ttt180 -136.87 -46.22 0.59 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.005 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 2.0 p30 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.908 179.974 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.428 -0.269 . . . . 0.0 112.428 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.6 -47.9 0.09 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.807 0.337 . . . . 0.0 110.855 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 63.1 88.57 0.1 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.086 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 743' ' ' GLY . . . . . 0.558 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . 101.79 60.11 0.77 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.743 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . 0.55 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 0.7 OUTLIER -117.5 -51.69 2.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.141 0.496 . . . . 0.0 110.267 179.608 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -157.03 -49.14 0.07 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.024 179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -124.93 95.07 4.37 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.227 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . 0.565 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 13.1 t70 -122.57 143.31 39.52 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.344 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 748' ' ' PRO . . . . . 0.405 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 45.3 Cg_exo -36.14 -29.32 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.011 2.474 . . . . 0.0 113.789 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 749' ' ' LEU . . . . . 0.837 HD13 ' CG2' ' A' ' 774' ' ' ILE . 23.8 mt -120.05 -17.24 8.44 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -179.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.744 ' CE2' HG21 ' A' ' 754' ' ' VAL . 70.1 t80 -53.39 -48.37 68.72 Favored 'General case' 0 C--O 1.223 -0.317 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.949 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -53.24 -37.29 61.94 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 1.014 ' HB3' HD21 ' A' ' 772' ' ' LEU . 0.5 OUTLIER -70.94 -42.12 70.25 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.085 178.679 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 753' ' ' ALA . . . . . 0.44 ' HB2' ' HE2' ' A' ' 782' ' ' MET . . . -60.96 -53.7 54.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.202 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 754' ' ' VAL . . . . . 0.744 HG21 ' CE2' ' A' ' 750' ' ' TYR . 8.0 t -56.27 -39.98 63.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.063 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 37.9 mtt180 -67.62 -37.37 82.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.39 0.614 . . . . 0.0 109.766 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 756' ' ' PHE . . . . . 0.678 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.6 t80 -67.68 -46.06 73.4 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.288 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 757' ' ' VAL . . . . . 0.93 HG12 HG22 ' A' ' 803' ' ' VAL . 54.3 t -69.46 -43.94 80.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.958 0.409 . . . . 0.0 110.61 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . 0.715 ' HA ' HG11 ' A' ' 803' ' ' VAL . 12.5 p -56.67 -45.6 81.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.052 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -78.8 -34.39 45.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.634 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 760' ' ' SER . . . . . 0.505 ' HB2' ' NE ' ' A' ' 762' ' ' ARG . 91.7 p -75.25 -17.76 60.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.527 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 5.9 mmm-85 63.68 33.55 12.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.349 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 762' ' ' ARG . . . . . 0.53 ' O ' HG13 ' A' ' 757' ' ' VAL . 0.0 OUTLIER -170.61 136.64 1.27 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.403 179.535 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 763' ' ' ALA . . . . . 0.455 ' HB2' HG11 ' A' ' 757' ' ' VAL . . . -104.46 89.76 3.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 0.0 111.82 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 764' ' ' SER . . . . . 0.704 ' O ' HG23 ' A' ' 768' ' ' VAL . 1.0 OUTLIER -121.36 118.52 29.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.571 178.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 765' ' ' ILE . . . . . 0.606 HG21 ' HB2' ' A' ' 780' ' ' ALA . 1.6 mt -53.33 -50.49 47.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.618 -179.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 766' ' ' SER . . . . . 0.464 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 16.3 t -55.27 -39.04 69.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.167 0.508 . . . . 0.0 110.492 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . 0.408 ' HB1' ' HZ ' ' A' ' 756' ' ' PHE . . . -71.8 -37.54 70.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.503 179.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 768' ' ' VAL . . . . . 0.782 HG21 HD11 ' A' ' 783' ' ' ILE . 44.5 t -65.57 -47.85 84.89 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.241 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . 0.593 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -64.85 -33.39 75.89 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.478 -179.854 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 770' ' ' ARG . . . . . 0.447 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 2.6 mtt180 -70.91 -42.5 69.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.117 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.426 ' HB2' ' CE1' ' A' ' 756' ' ' PHE . 0.2 OUTLIER -78.52 -36.43 44.85 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.086 -179.425 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 772' ' ' LEU . . . . . 1.014 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -91.59 -9.35 44.48 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -179.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt 60.76 40.94 15.51 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.073 0.463 . . . . 0.0 109.815 -179.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 774' ' ' ILE . . . . . 0.837 ' CG2' HD13 ' A' ' 749' ' ' LEU . 20.5 pt -111.84 -173.92 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.292 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.91 150.96 21.87 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.12 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -55.63 -45.37 77.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.855 0.359 . . . . 0.0 110.582 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 777' ' ' ASN . . . . . 0.404 ' O ' ' HG3' ' A' ' 781' ' ' ARG . 21.5 m-80 -63.77 -47.94 78.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.771 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.754 ' HE ' HD12 ' A' ' 749' ' ' LEU . 0.2 OUTLIER -59.44 -50.12 75.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.893 0.378 . . . . 0.0 110.783 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.17 -50.64 72.21 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.458 179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 780' ' ' ALA . . . . . 0.606 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -56.27 -40.69 74.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.941 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 781' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 777' ' ' ASN . 12.5 mtt180 -58.86 -46.35 87.97 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 782' ' ' MET . . . . . 0.44 ' HE2' ' HB2' ' A' ' 753' ' ' ALA . 2.3 mtp -64.74 -42.59 95.08 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 783' ' ' ILE . . . . . 0.782 HD11 HG21 ' A' ' 768' ' ' VAL . 9.9 mm -57.22 -35.64 49.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.291 178.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -64.12 -45.47 88.45 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.604 ' HB3' ' CE1' ' A' ' 750' ' ' TYR . . . -58.26 -33.62 69.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.823 -1.081 . . . . 0.0 109.603 178.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 786' ' ' MET . . . . . 0.716 ' HB3' HG22 ' A' ' 792' ' ' VAL . 14.4 mtm -67.2 -38.21 84.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.083 179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -62.27 -47.9 82.28 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.582 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 36.3 mtm -73.56 -37.53 65.51 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.272 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -70.46 -21.58 62.78 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.599 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 790' ' ' GLY . . . . . 0.616 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 92.22 15.51 53.44 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.819 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.763 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 59.7 t -83.93 -29.12 7.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.744 0.307 . . . . 0.0 111.101 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 792' ' ' VAL . . . . . 0.716 HG22 ' HB3' ' A' ' 786' ' ' MET . 18.8 m -139.39 135.42 40.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.953 0.406 . . . . 0.0 111.375 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 793' ' ' THR . . . . . 0.696 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 4.7 p -80.49 168.31 26.45 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.597 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 794' ' ' PRO . . . . . 0.696 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 38.7 Cg_endo -65.44 163.38 29.93 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 121.877 1.718 . . . . 0.0 111.965 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . 0.423 ' HA ' ' HG3' ' A' ' 801' ' ' ARG . 0.1 OUTLIER -60.8 162.27 6.98 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.453 -179.69 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -105.53 176.5 5.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.892 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 60.2 p -60.58 -30.41 69.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.022 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -83.79 -17.53 40.77 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.252 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.41 26.41 7.74 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.513 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 50.7 m -123.27 130.44 52.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.911 0.386 . . . . 0.0 110.825 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . 0.431 ' NH1' ' CG2' ' A' ' 783' ' ' ILE . 9.3 mtt-85 -83.68 170.57 14.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.213 0.53 . . . . 0.0 111.465 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 802' ' ' GLU . . . . . 0.627 ' O ' HG23 ' A' ' 793' ' ' THR . 5.0 mt-10 -132.14 134.51 45.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.934 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 803' ' ' VAL . . . . . 0.93 HG22 HG12 ' A' ' 757' ' ' VAL . 18.9 t -76.91 136.86 23.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.985 0.422 . . . . 0.0 111.904 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 804' ' ' ILE . . . . . 0.616 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -107.04 -29.78 2.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.516 178.875 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 805' ' ' ALA . . . . . 0.763 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -75.08 120.15 80.29 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.13 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -50.2 163.9 0.54 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.678 2.252 . . . . 0.0 112.92 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 807' ' ' ALA . . . . . 0.63 ' HB1' ' OXT' ' A' ' 811' ' ' ASP . . . -95.34 146.1 30.71 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.148 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.77 111.51 0.71 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.549 2.166 . . . . 0.0 112.335 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 16.7 t 67.56 -69.88 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.285 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 14.7 ttt180 -142.97 -46.3 0.31 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.927 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 811' ' ' ASP . . . . . 0.63 ' OXT' ' HB1' ' A' ' 807' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.909 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 6.0 t -157.06 -47.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.772 0.32 . . . . 0.0 110.769 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 -139.23 129.65 25.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.893 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 743' ' ' GLY . . . . . 0.628 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . 78.96 61.5 2.38 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.518 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 14.6 m -119.35 -47.5 2.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.134 0.492 . . . . 0.0 110.363 179.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -159.26 -49.67 0.06 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.223 179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -126.38 95.21 4.29 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.355 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . 0.534 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 10.7 t70 -122.42 142.96 38.39 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.316 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 748' ' ' PRO . . . . . 0.418 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 43.8 Cg_exo -36.69 -28.49 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 123.015 2.477 . . . . 0.0 113.774 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 749' ' ' LEU . . . . . 0.829 HD13 ' CG2' ' A' ' 774' ' ' ILE . 28.6 mt -119.99 -17.1 8.51 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.725 ' CE2' HG21 ' A' ' 754' ' ' VAL . 82.3 t80 -52.81 -50.47 63.59 Favored 'General case' 0 C--O 1.222 -0.377 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.791 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -52.93 -35.99 59.17 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 1.073 ' HB3' HD21 ' A' ' 772' ' ' LEU . 5.9 tt0 -71.05 -41.89 70.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.23 178.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 753' ' ' ALA . . . . . 0.553 ' HB2' ' HE1' ' A' ' 782' ' ' MET . . . -62.89 -53.77 48.98 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.987 179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 754' ' ' VAL . . . . . 0.725 HG21 ' CE2' ' A' ' 750' ' ' TYR . 9.1 t -56.02 -41.43 68.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.738 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 755' ' ' ARG . . . . . 0.412 ' O ' ' HB2' ' A' ' 759' ' ' GLU . 1.5 ttm-85 -65.6 -35.11 79.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.281 178.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 756' ' ' PHE . . . . . 0.665 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.7 t80 -69.73 -46.3 66.22 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.367 -179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 757' ' ' VAL . . . . . 0.716 HG13 ' O ' ' A' ' 762' ' ' ARG . 51.6 t -70.44 -38.37 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 120.921 0.391 . . . . 0.0 110.843 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 754' ' ' VAL . 22.4 p -65.21 -42.48 93.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.177 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 755' ' ' ARG . 1.8 tt0 -77.14 -46.48 23.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.373 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 92.5 p -74.68 -10.47 59.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.154 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 56.65 30.25 17.14 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.06 0.457 . . . . 0.0 110.607 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 762' ' ' ARG . . . . . 0.716 ' O ' HG13 ' A' ' 757' ' ' VAL . 10.6 mtm180 -145.5 138.46 26.14 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.543 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 763' ' ' ALA . . . . . 0.925 ' HB1' HH21 ' A' ' 801' ' ' ARG . . . -117.76 89.57 3.15 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 120.97 0.414 . . . . 0.0 111.025 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 764' ' ' SER . . . . . 0.63 ' O ' HG23 ' A' ' 768' ' ' VAL . 2.7 m -133.91 118.45 17.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.637 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 765' ' ' ILE . . . . . 0.731 HD13 ' HB2' ' A' ' 780' ' ' ALA . 19.1 mt -50.01 -46.65 23.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.704 -179.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 766' ' ' SER . . . . . 0.485 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 12.1 t -58.9 -39.0 80.19 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.136 0.493 . . . . 0.0 110.534 179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -72.93 -36.61 67.26 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.349 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 768' ' ' VAL . . . . . 0.679 HG21 HD11 ' A' ' 783' ' ' ILE . 40.7 t -65.22 -48.01 85.2 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.067 179.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . 0.602 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -65.41 -33.47 76.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.569 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 770' ' ' ARG . . . . . 0.414 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 12.1 mtt180 -71.54 -41.53 69.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.065 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.63 -36.52 43.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.829 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 772' ' ' LEU . . . . . 1.073 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -91.28 -10.03 42.93 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.867 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt 61.61 39.94 13.97 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 -178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 774' ' ' ILE . . . . . 0.829 ' CG2' HD13 ' A' ' 749' ' ' LEU . 24.1 pt -111.77 -174.49 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.481 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.69 152.98 23.57 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.228 -179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -57.16 -46.34 82.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.926 0.393 . . . . 0.0 110.625 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 50.0 m-80 -62.87 -47.83 81.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.724 179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.79 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.4 OUTLIER -60.27 -50.24 74.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.82 -179.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -56.84 -50.04 73.61 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.349 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 780' ' ' ALA . . . . . 0.731 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -55.64 -42.89 75.63 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.781 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -58.66 -43.09 89.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.097 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 782' ' ' MET . . . . . 0.553 ' HE1' ' HB2' ' A' ' 753' ' ' ALA . 2.6 mtp -68.38 -40.04 81.55 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 783' ' ' ILE . . . . . 0.93 HG23 ' NH2' ' A' ' 801' ' ' ARG . 5.3 mm -58.14 -40.08 75.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.798 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 784' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 787' ' ' GLU . 2.3 mt-10 -63.99 -46.18 85.7 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 177.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.628 ' HB2' ' O ' ' A' ' 743' ' ' GLY . . . -54.76 -33.42 61.26 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.508 178.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 786' ' ' MET . . . . . 0.743 ' HB3' HG22 ' A' ' 792' ' ' VAL . 14.9 mtm -67.7 -39.36 84.39 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.848 178.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 787' ' ' GLU . . . . . 0.43 ' HB2' ' O ' ' A' ' 784' ' ' GLU . 0.4 OUTLIER -57.62 -51.5 69.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.669 179.415 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 46.9 mtm -75.46 -38.37 59.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.915 -179.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -64.31 -21.2 66.53 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.921 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 790' ' ' GLY . . . . . 0.551 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 91.87 19.77 39.04 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.419 -178.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.701 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 79.2 t -89.2 -32.78 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 CA-C-O 120.793 0.33 . . . . 0.0 111.059 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 792' ' ' VAL . . . . . 0.864 HG21 ' NH2' ' A' ' 801' ' ' ARG . 28.3 m -137.49 143.44 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.0 179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 793' ' ' THR . . . . . 0.426 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 6.8 p -82.03 155.2 70.16 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.421 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 794' ' ' PRO . . . . . 0.426 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 19.1 Cg_endo -58.75 169.03 3.62 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.424 2.083 . . . . 0.0 112.345 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . 0.507 ' HA ' ' HG3' ' A' ' 801' ' ' ARG . 1.4 mtp -60.92 159.52 11.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.303 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 59.2 m-20 -102.48 176.56 5.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.805 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 38.2 p -60.59 -28.01 68.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.07 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -90.9 -17.59 26.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.327 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 104.8 28.55 5.6 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.765 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 19.3 m -121.91 129.88 52.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.871 0.367 . . . . 0.0 110.929 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . 0.93 ' NH2' HG23 ' A' ' 783' ' ' ILE . 0.4 OUTLIER -94.46 170.49 9.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.125 0.488 . . . . 0.0 111.387 -179.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.95 -172.42 2.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.488 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 803' ' ' VAL . . . . . 0.594 HG22 HG12 ' A' ' 757' ' ' VAL . 30.2 t -121.14 138.66 50.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.843 0.354 . . . . 0.0 111.741 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 804' ' ' ILE . . . . . 0.551 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -110.16 -27.13 2.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.777 179.282 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 805' ' ' ALA . . . . . 0.701 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -84.74 120.87 74.43 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.889 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.42 163.71 28.63 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.59 2.193 . . . . 0.0 112.163 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -92.28 148.23 36.16 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.168 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -55.57 110.37 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.577 2.184 . . . . 0.0 112.278 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 21.8 t -91.15 -33.38 5.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.083 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -125.33 30.6 5.77 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.881 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.914 -179.979 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 112.55 -0.22 . . . . 0.0 112.55 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 5.4 m -108.62 30.2 6.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.775 0.321 . . . . 0.0 110.892 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.21 148.93 52.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.872 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 743' ' ' GLY . . . . . 0.595 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . -69.08 67.25 0.49 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.515 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 9.8 p -101.76 -158.04 0.65 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.592 0.234 . . . . 0.0 110.656 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -50.78 -45.31 59.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.722 0.296 . . . . 0.0 111.505 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -128.13 95.61 4.23 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.069 0.461 . . . . 0.0 111.34 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . 0.58 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 14.6 t70 -122.36 142.34 36.82 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.413 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 748' ' ' PRO . . . . . 0.402 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 41.0 Cg_exo -35.12 -30.9 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.311 2.674 . . . . 0.0 113.993 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 749' ' ' LEU . . . . . 0.83 HD12 ' NE ' ' A' ' 778' ' ' ARG . 44.7 mt -120.02 -16.91 8.54 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -179.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.712 ' CE2' HG21 ' A' ' 754' ' ' VAL . 67.7 t80 -54.08 -47.81 71.31 Favored 'General case' 0 C--O 1.223 -0.313 0 C-N-CA 120.429 -0.509 . . . . 0.0 110.483 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -53.45 -35.73 60.81 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 0.97 ' HB2' HD21 ' A' ' 772' ' ' LEU . 8.4 mt-10 -70.95 -40.91 71.74 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.182 178.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 753' ' ' ALA . . . . . 0.473 ' HB2' ' HE1' ' A' ' 782' ' ' MET . . . -64.24 -52.35 59.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.118 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 754' ' ' VAL . . . . . 0.712 HG21 ' CE2' ' A' ' 750' ' ' TYR . 3.1 t -56.35 -40.09 64.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.005 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.59 -35.32 77.2 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.488 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 756' ' ' PHE . . . . . 0.829 ' CE1' HG22 ' A' ' 768' ' ' VAL . 1.1 t80 -67.42 -46.12 74.11 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.93 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 757' ' ' VAL . . . . . 0.78 HG13 ' O ' ' A' ' 762' ' ' ARG . 43.3 t -70.82 -41.07 77.32 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.86 0.362 . . . . 0.0 110.757 179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . 0.506 HG23 ' O ' ' A' ' 754' ' ' VAL . 20.3 p -62.18 -42.08 98.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.568 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -77.26 -47.03 21.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.882 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 760' ' ' SER . . . . . . . . . . . . . 6.3 p -70.98 -18.54 62.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.765 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 761' ' ' ARG . . . . . 0.404 ' N ' ' O ' ' A' ' 757' ' ' VAL . 0.0 OUTLIER 65.17 18.69 11.53 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.771 -179.626 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 762' ' ' ARG . . . . . 0.78 ' O ' HG13 ' A' ' 757' ' ' VAL . 1.0 OUTLIER -139.74 145.39 38.23 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.749 -179.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 763' ' ' ALA . . . . . 0.56 ' O ' ' HB2' ' A' ' 801' ' ' ARG . . . -117.43 89.46 3.12 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.237 0.541 . . . . 0.0 110.83 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 764' ' ' SER . . . . . 0.726 ' O ' HG23 ' A' ' 768' ' ' VAL . 23.7 m -129.99 118.59 21.84 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 765' ' ' ILE . . . . . 0.525 HG21 ' HB2' ' A' ' 780' ' ' ALA . 11.2 mt -51.77 -47.17 39.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.697 -178.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 766' ' ' SER . . . . . 0.571 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 22.2 t -59.3 -37.73 78.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.149 0.499 . . . . 0.0 110.571 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -73.1 -42.17 63.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.229 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 768' ' ' VAL . . . . . 0.871 HG21 HD11 ' A' ' 783' ' ' ILE . 30.4 t -59.76 -50.91 78.24 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.971 178.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . 0.641 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -63.58 -33.45 75.63 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.713 -179.649 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 770' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -67.03 -43.87 81.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.122 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.552 ' HD2' ' HD2' ' A' ' 756' ' ' PHE . 0.9 OUTLIER -78.64 -42.16 29.5 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.838 0.351 . . . . 0.0 111.794 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 772' ' ' LEU . . . . . 0.97 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -81.37 -10.57 59.51 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.815 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 29.4 mtmm 60.03 40.76 18.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.193 0.521 . . . . 0.0 109.701 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 774' ' ' ILE . . . . . 0.766 ' CG2' HD13 ' A' ' 749' ' ' LEU . 24.2 pt -111.82 -173.99 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.563 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -88.55 149.91 21.45 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.111 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -53.98 -44.72 71.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.835 0.35 . . . . 0.0 110.662 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 777' ' ' ASN . . . . . 0.435 ' O ' ' HG3' ' A' ' 781' ' ' ARG . 79.3 m-20 -65.01 -47.89 75.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.692 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.83 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.2 OUTLIER -57.83 -50.07 74.51 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.865 0.364 . . . . 0.0 110.752 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 779' ' ' ALA . . . . . 0.4 ' HB2' ' CD1' ' A' ' 774' ' ' ILE . . . -58.14 -45.88 86.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.105 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 780' ' ' ALA . . . . . 0.525 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -56.93 -44.3 82.35 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.103 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 781' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 777' ' ' ASN . 7.4 mtt180 -58.76 -46.86 86.51 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 782' ' ' MET . . . . . 0.473 ' HE1' ' HB2' ' A' ' 753' ' ' ALA . 2.5 mtp -64.06 -41.81 97.22 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 178.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 783' ' ' ILE . . . . . 0.871 HD11 HG21 ' A' ' 768' ' ' VAL . 7.2 mm -58.73 -37.16 64.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.448 178.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.26 -45.2 92.61 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.637 ' HB3' ' CE1' ' A' ' 750' ' ' TYR . . . -58.99 -33.53 70.8 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.7 -1.137 . . . . 0.0 109.63 178.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 786' ' ' MET . . . . . 0.736 ' HB3' HG22 ' A' ' 792' ' ' VAL . 12.4 mtm -65.79 -39.79 91.3 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.118 179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 787' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.32 -47.84 82.5 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.147 0.499 . . . . 0.0 110.492 179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 25.8 mtp -70.95 -38.29 72.84 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.552 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -71.19 -21.64 62.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.962 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 790' ' ' GLY . . . . . 0.768 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 93.3 19.03 36.96 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.605 -178.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.733 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 38.1 t -88.27 -30.19 5.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.716 0.293 . . . . 0.0 111.168 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 792' ' ' VAL . . . . . 0.736 HG22 ' HB3' ' A' ' 786' ' ' MET . 20.9 m -138.76 143.73 31.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.408 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 793' ' ' THR . . . . . 0.533 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.3 p -88.06 163.59 36.83 Favored Pre-proline 0 C--N 1.328 -0.355 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 794' ' ' PRO . . . . . 0.533 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 18.6 Cg_endo -59.93 166.41 8.67 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 121.957 1.772 . . . . 0.0 112.129 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 1.5 mtt -61.12 162.03 7.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.227 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -105.55 176.54 5.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.766 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 44.1 p -61.62 -33.92 74.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.779 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -79.56 -17.57 53.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.102 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.56 28.07 6.87 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.417 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 19.2 m -124.68 130.45 52.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.944 0.402 . . . . 0.0 110.909 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . 0.56 ' HB2' ' O ' ' A' ' 763' ' ' ALA . 11.3 mtt-85 -83.95 170.69 13.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.449 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -129.02 168.98 15.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.254 179.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 803' ' ' VAL . . . . . 0.766 HG22 HG12 ' A' ' 757' ' ' VAL . 21.4 t -110.62 137.27 43.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.011 0.434 . . . . 0.0 111.844 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 804' ' ' ILE . . . . . 0.768 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -107.5 -27.96 2.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.314 178.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 805' ' ' ALA . . . . . 0.733 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -79.34 122.73 84.39 Favored Pre-proline 0 N--CA 1.455 -0.207 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.742 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -66.38 163.66 31.38 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.513 2.142 . . . . 0.0 112.198 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -79.34 148.23 70.16 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -74.24 110.85 3.17 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.535 2.157 . . . . 0.0 112.335 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 809' ' ' VAL . . . . . . . . . . . . . 21.5 t -72.74 -32.73 41.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.086 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 810' ' ' ARG . . . . . . . . . . . . . 1.4 ttt180 -171.75 -41.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.958 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 9.0 t0 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.266 -0.873 . . . . 0.0 110.891 179.995 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.28 0 N-CA-C 112.392 -0.283 . . . . 0.0 112.392 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 2.0 m -146.1 28.46 1.12 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.804 0.335 . . . . 0.0 110.949 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -94.25 104.83 16.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.991 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 743' ' ' GLY . . . . . 0.645 ' O ' ' HB2' ' A' ' 785' ' ' ALA . . . 75.44 60.68 3.18 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.678 179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.43 -47.97 2.53 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.149 0.5 . . . . 0.0 110.252 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -159.1 -49.59 0.06 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.177 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -126.35 95.17 4.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.318 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . 0.55 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.6 t70 -122.49 143.2 39.1 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.535 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 748' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 747' ' ' ASP . 37.9 Cg_exo -36.72 -28.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.069 2.513 . . . . 0.0 113.895 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 749' ' ' LEU . . . . . 0.855 HD13 ' CG2' ' A' ' 774' ' ' ILE . 28.9 mt -120.03 -17.2 8.46 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.728 ' CE2' HG21 ' A' ' 754' ' ' VAL . 80.5 t80 -52.88 -50.34 64.04 Favored 'General case' 0 C--O 1.219 -0.502 0 C-N-CA 120.571 -0.451 . . . . 0.0 110.948 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -53.17 -35.72 60.1 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 1.036 ' HB3' HD21 ' A' ' 772' ' ' LEU . 8.0 tt0 -71.12 -41.5 70.44 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.293 178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 753' ' ' ALA . . . . . 0.558 ' HB2' ' HE1' ' A' ' 782' ' ' MET . . . -64.57 -51.95 60.15 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.125 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 754' ' ' VAL . . . . . 0.728 HG21 ' CE2' ' A' ' 750' ' ' TYR . 5.0 t -56.12 -38.7 54.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.504 178.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -69.38 -35.16 75.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.435 178.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 756' ' ' PHE . . . . . 0.76 ' CE2' HG22 ' A' ' 768' ' ' VAL . 1.5 t80 -68.57 -46.2 70.05 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.329 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 757' ' ' VAL . . . . . 0.643 HG11 ' HB2' ' A' ' 763' ' ' ALA . 35.4 t -71.23 -41.38 74.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-O 120.991 0.424 . . . . 0.0 110.751 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 754' ' ' VAL . 30.1 p -62.72 -42.89 99.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.993 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -77.48 -46.31 22.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.275 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 760' ' ' SER . . . . . 0.513 ' O ' ' HD3' ' A' ' 762' ' ' ARG . 50.0 p -70.06 -29.17 66.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.905 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 761' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 760' ' ' SER . 0.0 OUTLIER 70.86 28.53 3.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.302 -179.248 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 762' ' ' ARG . . . . . 0.513 ' HD3' ' O ' ' A' ' 760' ' ' SER . 0.4 OUTLIER -147.8 110.55 4.74 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.368 -179.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 763' ' ' ALA . . . . . 0.873 ' HB1' HH21 ' A' ' 801' ' ' ARG . . . -91.06 89.69 7.51 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.052 0.453 . . . . 0.0 111.257 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 764' ' ' SER . . . . . 0.616 ' O ' HG23 ' A' ' 768' ' ' VAL . 1.3 m -133.94 118.85 18.35 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.472 179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 765' ' ' ILE . . . . . 0.557 HG21 ' HB2' ' A' ' 780' ' ' ALA . 1.5 mp -48.85 -52.7 9.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.952 -178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 766' ' ' SER . . . . . 0.534 ' O ' ' HG3' ' A' ' 769' ' ' GLN . 7.9 t -53.34 -40.12 64.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.203 0.525 . . . . 0.0 110.635 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -71.64 -39.75 70.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.445 179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 768' ' ' VAL . . . . . 0.76 HG22 ' CE2' ' A' ' 756' ' ' PHE . 44.4 t -61.89 -49.88 82.43 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.292 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.114 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . 0.596 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.0 OUTLIER -63.47 -33.91 76.61 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.869 -179.614 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 770' ' ' ARG . . . . . 0.418 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 7.2 mtt85 -68.95 -42.53 76.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.218 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.7 -39.3 36.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.701 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 772' ' ' LEU . . . . . 1.036 HD21 ' HB3' ' A' ' 752' ' ' GLU . 0.1 OUTLIER -87.07 -9.78 54.58 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.248 -179.314 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp 60.95 39.7 16.3 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 774' ' ' ILE . . . . . 0.855 ' CG2' HD13 ' A' ' 749' ' ' LEU . 17.8 pt -111.86 -173.83 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.165 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -90.17 153.18 22.69 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.023 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -57.09 -45.57 83.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.817 0.341 . . . . 0.0 110.64 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 777' ' ' ASN . . . . . 0.442 ' O ' ' HG3' ' A' ' 781' ' ' ARG . 66.4 m-20 -63.13 -48.08 80.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.735 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.778 ' HE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -59.88 -50.17 74.83 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.979 0.418 . . . . 0.0 110.751 179.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 779' ' ' ALA . . . . . . . . . . . . . . . -57.18 -49.12 76.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.441 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 780' ' ' ALA . . . . . 0.557 ' HB2' HG21 ' A' ' 765' ' ' ILE . . . -56.97 -40.87 77.33 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.027 179.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 781' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 777' ' ' ASN . 17.3 mtt180 -58.88 -46.77 87.02 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 782' ' ' MET . . . . . 0.558 ' HE1' ' HB2' ' A' ' 753' ' ' ALA . 2.3 mtp -64.83 -42.24 95.09 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 178.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 783' ' ' ILE . . . . . 1.014 HG23 ' NH2' ' A' ' 801' ' ' ARG . 5.9 mm -55.8 -39.54 56.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.502 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.97 -46.69 86.51 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.645 ' HB2' ' O ' ' A' ' 743' ' ' GLY . . . -55.19 -33.54 63.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.827 178.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 786' ' ' MET . . . . . 0.749 ' HB3' HG22 ' A' ' 792' ' ' VAL . 14.5 mtm -67.38 -40.53 85.7 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.197 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 787' ' ' GLU . . . . . 0.484 ' HG3' ' NH1' ' A' ' 801' ' ' ARG . 4.2 mt-10 -58.61 -53.66 55.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.647 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 30.9 mtm -71.06 -38.32 72.5 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.429 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 789' ' ' ALA . . . . . . . . . . . . . . . -65.71 -21.42 66.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.7 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 790' ' ' GLY . . . . . 0.701 ' HA2' HD12 ' A' ' 804' ' ' ILE . . . 91.15 15.18 56.4 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.633 -0.794 . . . . 0.0 111.608 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.723 ' HA ' ' HB2' ' A' ' 805' ' ' ALA . 86.1 t -84.02 -29.78 7.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.023 0.44 . . . . 0.0 110.672 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 792' ' ' VAL . . . . . 0.918 HG21 ' NH2' ' A' ' 801' ' ' ARG . 17.6 m -139.54 144.47 28.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.977 179.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 793' ' ' THR . . . . . 0.478 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 6.6 p -83.69 156.84 64.72 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.608 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 794' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 19.0 Cg_endo -58.77 169.51 3.3 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.498 2.132 . . . . 0.0 112.177 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . 0.447 ' HA ' ' HG3' ' A' ' 801' ' ' ARG . 2.1 mtt -65.13 159.82 22.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.021 0.439 . . . . 0.0 111.254 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 56.6 m-20 -102.15 176.58 5.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.841 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 9.8 t -59.63 -29.52 68.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.069 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 39.1 p30 -87.3 -17.58 32.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.378 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 102.48 31.79 5.1 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.722 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 15.9 m -125.0 129.65 50.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.828 0.347 . . . . 0.0 110.75 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . 1.014 ' NH2' HG23 ' A' ' 783' ' ' ILE . 0.5 OUTLIER -93.51 169.63 10.21 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.348 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -130.48 -170.81 2.41 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.713 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 803' ' ' VAL . . . . . 0.608 HG22 HG12 ' A' ' 757' ' ' VAL . 30.0 t -124.58 138.52 53.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.928 0.394 . . . . 0.0 111.887 -179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 804' ' ' ILE . . . . . 0.701 HD12 ' HA2' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -108.97 -30.22 2.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.519 179.232 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 805' ' ' ALA . . . . . 0.723 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -79.55 119.79 78.06 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.892 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -66.89 163.75 32.38 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.536 2.157 . . . . 0.0 112.219 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 807' ' ' ALA . . . . . . . . . . . . . . . -79.25 145.55 64.78 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.134 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.66 115.83 4.15 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.592 2.194 . . . . 0.0 112.435 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 809' ' ' VAL . . . . . 0.582 HG12 ' H ' ' A' ' 810' ' ' ARG . 0.8 OUTLIER -98.75 176.41 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.633 179.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 810' ' ' ARG . . . . . 0.582 ' H ' HG12 ' A' ' 809' ' ' VAL . 0.0 OUTLIER -109.91 -35.6 6.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.019 -179.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.962 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 740' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.114 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 741' ' ' SER . . . . . . . . . . . . . 4.7 m -147.05 -54.28 0.23 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.871 0.367 . . . . 0.0 110.914 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 742' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 59.68 27.67 16.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.99 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 743' ' ' GLY . . . . . . . . . . . . . . . 114.36 68.93 0.48 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.675 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . 0.544 ' O ' ' HB1' ' A' ' 785' ' ' ALA . 56.2 m -122.36 -56.89 1.79 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.068 0.461 . . . . 0.0 110.322 179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 745' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -151.37 -48.81 0.12 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.208 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -124.86 95.27 4.45 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.532 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 747' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' A' ' 750' ' ' TYR . 11.0 t70 -122.45 142.42 37.18 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.501 179.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 748' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -38.73 -27.3 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.873 2.382 . . . . 0.0 113.547 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 749' ' ' LEU . . . . . 0.855 HD13 ' CG2' ' A' ' 774' ' ' ILE . 46.2 mt -119.99 -17.06 8.53 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 750' ' ' TYR . . . . . 0.714 ' CE2' HG21 ' A' ' 754' ' ' VAL . 71.1 t80 -55.62 -47.14 77.05 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.386 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 751' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -53.27 -35.72 60.36 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 752' ' ' GLU . . . . . 0.891 ' HB2' HD21 ' A' ' 772' ' ' LEU . 1.2 mm-40 -71.03 -43.58 67.6 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.255 178.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 753' ' ' ALA . . . . . 0.469 ' HB2' ' HE3' ' A' ' 782' ' ' MET . . . -61.87 -53.39 56.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.205 179.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 754' ' ' VAL . . . . . 0.714 HG21 ' CE2' ' A' ' 750' ' ' TYR . 3.2 t -56.18 -41.14 68.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.552 179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 755' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -69.68 -35.43 75.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.333 0.587 . . . . 0.0 109.844 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 756' ' ' PHE . . . . . 0.679 ' CE2' HG22 ' A' ' 768' ' ' VAL . 4.0 t80 -66.95 -46.07 75.84 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.204 -0.907 . . . . 0.0 111.044 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 757' ' ' VAL . . . . . 0.801 HG12 HG22 ' A' ' 803' ' ' VAL . 59.5 t -70.47 -44.86 76.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.883 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 758' ' ' THR . . . . . 0.771 ' HA ' HG11 ' A' ' 803' ' ' VAL . 9.1 p -56.83 -44.87 82.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.277 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -78.84 -39.73 34.67 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.463 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 760' ' ' SER . . . . . 0.466 ' HB2' ' NE ' ' A' ' 762' ' ' ARG . 94.6 p -72.56 -25.04 61.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.254 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 761' ' ' ARG . . . . . . . . . . . . . 10.8 mmt180 67.98 42.71 1.8 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.377 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 762' ' ' ARG . . . . . 0.466 ' NE ' ' HB2' ' A' ' 760' ' ' SER . 0.0 OUTLIER -174.61 121.19 0.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.564 179.495 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 763' ' ' ALA . . . . . 0.546 ' HB3' ' HB3' ' A' ' 801' ' ' ARG . . . -93.87 89.77 6.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.972 0.415 . . . . 0.0 111.646 -179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 764' ' ' SER . . . . . 0.744 ' O ' HG23 ' A' ' 768' ' ' VAL . 9.9 m -123.54 118.55 27.61 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 765' ' ' ILE . . . . . 0.84 HD13 ' HB2' ' A' ' 780' ' ' ALA . 24.1 mt -53.51 -50.15 50.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.738 -179.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 766' ' ' SER . . . . . 0.438 ' HA ' ' HG2' ' A' ' 769' ' ' GLN . 11.4 t -53.35 -43.24 67.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.221 0.534 . . . . 0.0 110.499 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 767' ' ' ALA . . . . . . . . . . . . . . . -69.75 -39.87 76.46 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.768 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 768' ' ' VAL . . . . . 0.91 HG21 HD11 ' A' ' 783' ' ' ILE . 47.0 t -61.85 -45.71 98.09 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.253 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 769' ' ' GLN . . . . . 0.583 ' HA ' ' CG1' ' A' ' 774' ' ' ILE . 0.8 OUTLIER -66.5 -33.48 75.79 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.416 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 770' ' ' ARG . . . . . 0.466 ' N ' ' HG3' ' A' ' 769' ' ' GLN . 20.5 mtt180 -70.95 -42.06 70.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.037 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.414 ' HB2' ' CE1' ' A' ' 756' ' ' PHE . 0.7 OUTLIER -78.53 -38.27 40.94 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.007 -179.488 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 772' ' ' LEU . . . . . 0.891 HD21 ' HB2' ' A' ' 752' ' ' GLU . 0.2 OUTLIER -90.35 -9.32 48.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.625 -0.261 . . . . 0.0 111.573 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 773' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt 60.16 42.24 15.74 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 774' ' ' ILE . . . . . 0.855 ' CG2' HD13 ' A' ' 749' ' ' LEU . 29.4 pt -112.0 -174.05 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.816 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 775' ' ' GLY . . . . . . . . . . . . . . . -90.95 150.49 20.58 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.088 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 776' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -55.03 -46.52 75.29 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.902 0.382 . . . . 0.0 110.885 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 777' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -59.6 -45.91 90.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.206 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 778' ' ' ARG . . . . . 0.818 ' NE ' HD12 ' A' ' 749' ' ' LEU . 0.1 OUTLIER -66.11 -50.44 64.04 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.833 0.349 . . . . 0.0 110.858 -179.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 779' ' ' ALA . . . . . 0.421 ' HB2' ' CD1' ' A' ' 774' ' ' ILE . . . -55.12 -50.21 69.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.202 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 780' ' ' ALA . . . . . 0.84 ' HB2' HD13 ' A' ' 765' ' ' ILE . . . -56.06 -46.45 78.94 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.985 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 781' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -58.9 -48.42 81.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.253 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 782' ' ' MET . . . . . 0.469 ' HE3' ' HB2' ' A' ' 753' ' ' ALA . 33.8 mtm -63.41 -36.36 83.46 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.307 0.575 . . . . 0.0 109.461 178.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 783' ' ' ILE . . . . . 0.91 HD11 HG21 ' A' ' 768' ' ' VAL . 7.4 mm -63.37 -40.28 88.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 784' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.18 -42.71 91.48 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 177.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 785' ' ' ALA . . . . . 0.544 ' HB1' ' O ' ' A' ' 744' ' ' SER . . . -60.02 -33.58 72.21 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 114.574 -1.194 . . . . 0.0 109.719 178.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 786' ' ' MET . . . . . 0.61 ' CE ' HD13 ' A' ' 783' ' ' ILE . 12.7 mtm -66.05 -37.62 86.29 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.062 179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 787' ' ' GLU . . . . . 0.447 ' HG3' ' CZ ' ' A' ' 801' ' ' ARG . 3.3 mt-10 -63.36 -53.97 44.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.742 179.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 788' ' ' MET . . . . . . . . . . . . . 24.5 mtm -68.55 -37.64 80.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.494 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 789' ' ' ALA . . . . . 0.468 ' HB3' HG23 ' A' ' 791' ' ' VAL . . . -68.73 -21.59 64.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.796 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 790' ' ' GLY . . . . . 0.55 ' CA ' HD12 ' A' ' 804' ' ' ILE . . . 89.75 19.55 47.47 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.61 -0.805 . . . . 0.0 111.926 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 791' ' ' VAL . . . . . 0.689 HG11 HG22 ' A' ' 754' ' ' VAL . 11.3 t -84.45 -34.67 9.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.804 0.335 . . . . 0.0 110.756 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 792' ' ' VAL . . . . . 0.661 HG21 HH21 ' A' ' 801' ' ' ARG . 11.7 m -133.88 140.21 46.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.28 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 793' ' ' THR . . . . . 0.49 ' HB ' ' HD2' ' A' ' 794' ' ' PRO . 1.2 p -77.85 160.89 73.21 Favored Pre-proline 0 C--N 1.328 -0.367 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 794' ' ' PRO . . . . . 0.49 ' HD2' ' HB ' ' A' ' 793' ' ' THR . 22.7 Cg_endo -60.29 166.08 9.87 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.088 1.859 . . . . 0.0 111.967 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 795' ' ' MET . . . . . . . . . . . . . 2.1 mtt -56.56 158.46 4.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.196 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 796' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -101.25 176.47 5.24 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.921 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 797' ' ' THR . . . . . . . . . . . . . 9.7 t -55.63 -33.26 63.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.954 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 798' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -85.18 -17.58 36.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.121 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 799' ' ' GLY . . . . . . . . . . . . . . . 101.6 35.96 3.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.548 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 800' ' ' SER . . . . . . . . . . . . . 6.0 m -127.82 130.01 47.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.956 0.408 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 801' ' ' ARG . . . . . 0.661 HH21 HG21 ' A' ' 792' ' ' VAL . 6.5 mtp85 -81.67 170.58 15.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.331 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 802' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -131.27 -170.7 2.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.659 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 803' ' ' VAL . . . . . 0.801 HG22 HG12 ' A' ' 757' ' ' VAL . 23.0 t -127.26 133.7 67.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.17 0.51 . . . . 0.0 112.098 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 804' ' ' ILE . . . . . 0.55 HD12 ' CA ' ' A' ' 790' ' ' GLY . 0.0 OUTLIER -105.15 -28.76 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.858 178.69 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 805' ' ' ALA . . . . . 0.583 ' HB2' ' HA ' ' A' ' 791' ' ' VAL . . . -80.85 126.49 77.59 Favored Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.778 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 806' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -63.61 163.77 23.22 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.713 2.275 . . . . 0.0 112.228 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 807' ' ' ALA . . . . . 0.471 ' HB1' ' HD2' ' A' ' 808' ' ' PRO . . . -106.95 159.64 29.2 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.234 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 808' ' ' PRO . . . . . 0.471 ' HD2' ' HB1' ' A' ' 807' ' ' ALA . 71.6 Cg_endo -77.13 115.19 3.93 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.621 2.214 . . . . 0.0 112.481 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 809' ' ' VAL . . . . . 0.555 HG12 ' H ' ' A' ' 810' ' ' ARG . 0.5 OUTLIER 58.44 175.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.966 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 810' ' ' ARG . . . . . 0.555 ' H ' HG12 ' A' ' 809' ' ' VAL . 3.9 mtt180 -95.24 -33.33 12.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 811' ' ' ASP . . . . . . . . . . . . . 3.9 p30 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.906 179.973 . . . . . . . . 0 0 . 1 stop_ save_